Structure Search

List Search MOL Search Structure Search

 EN

English - EN Chinese - ZH

 Cart 0
Chemistry
Life Science
Catalysts Ligands
Materials Science
Catalysts Ligands
Achiral Nitrogen Ligands
Pyridine and Phenanthroline Ligands (162)
Other Achiral Nitrogen Ligands (53)
Achiral Oxygen Ligands
Achiral Oxygen Ligand (54)
Achiral Phosphine Ligands
Alkyl-phosphine Ligands (17)
Aryl-phosphine Ligands (86)
2-(Diphenylphosphaneyl)Benzaldehyde (5)[1,1'-Biphenyl]-2-Yldi-Tert-Butylphosphane (4)Triphenylphosphine Oxide (7)
Bis-phosphine Ligands (90)
Mono-phosphine Ligands (256)
Multi-phosphine Ligands (5)
Chiral Nitrogen Ligands
Chiral Bis-nitrogen Ligands (133)
Salen Ligands (7)
Other Chiral Nitrogen Ligands (69)
Chiral Oxazoline Ligands
BOX Ligands (510)
Chiral Mono Oxazoline Ligands (363)
Ferrocenyl-oxazoline Ligands (10)
PHOX Ligands (218)
SOX Ligands (34)
TOX Ligands (6)
Other Oxazoline Ligands (14)
Chiral Oxygen Ligands
BINOLs (46)
BIPHENs (2)
Chiral Diphenols (112)
Other Chiral Oxygen Ligands (24)
Chiral Phosphine Ligands
Atropisomeric Bisphosphine Ligands (137)
BIDIME and BIBOP Ligands (78)
BIDIME-BIBOP (7)
2,2',3,3'-Tetrahydro-4,4'-Bibenzo[D][1,3]Oxaphosphole (7)
Chiral Aminophosphine Ligands (50)
Chiral Ferrocenyl Phosphine Ligands (96)
Chiral Phosphoramidite Ligands (98)
Duphos and BPE Ligands (28)
PHOX Ligands (218)
Sadphos Ligands (110)
Other C-Chiral Ligands (76)
Other P-Chiral Ligands (10)
Main-Group Metals
Aluminum (11)
Tin (3)
Metalloids
Metalloid (5)
Organocatalysts
Chiral Hydrogen-Bonding Organocatalysts (79)
Chiral Phosphoric Acids (161)
4-Hydroxy-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepine 4-Oxide (20)
Cinchona Alkaloids (32)
MacMillan Imidazolidinone Organocatalysts (15)
NHTf (59)
Proline-Based Organocatalysts (51)
Other Organocatalysts (45)
Phase-Transfer Catalysts
Achiral Phase-Transfer Catalysts (61)
Chiral Phase-Transfer Catalysts (25)
Photoredox Catalysts
Organic-dye Photoredox Catalysts (86)
Photoredox Acridinium Catalysts (22)
Photoredox Carbazole Catalysts (10)
Photoredox Iridiums Catalysts (104)
Photoredox Rutheniums Catalysts (37)
Other Photoredox Catalysts (13)
Transition Metals
Cadmium (1)
Cobalt (92)
Copper (108)
Gold (70)
Iridium (60)
Iron (101)
Manganese (45)
Molybdenum (11)
Nickel (95)
Osmium (2)
Palladium (240)
Platinum (75)
Rhenium (6)
Rhodium (166)
Ruthenium (199)
Silver (33)
Tantalum (1)
Titanium (10)
Tungsten (6)
Vanadium (6)
Zinc (48)
Other Cheap Metals (6)
Chemistry
Asymmetric Synthesis
Chiral Building Blocks (18939)
Boronic Acids/Esters
1,3,2-Dioxaborinane (394)
Bcat (11)
Boronic Acids (13202)
MIDA Boronates (363)
Pinacol Boronates (16140)
Pinane Boronates (96)
Potassium Organotrifluoroborate Salts (1076)
Other Boronates (132)
Heterocyclic Building Blocks
Acridines (640)
1,2,3,4-Tetrahydroacridine (9)9,10-Diphenylacridin-10-Ium (6)Acridine (18)
Aliphatic Heterocycles (103)
(1R,5S)-3-Azabicyclo[3.1.0]Hexane (11)1,2-Dithiolane (6)1,4-Diazepan-2-One (5)1,4-Diazepan-5-One (9)1,4-Dioxane (17)1,4-Oxazepane (8)10,11-Dihydro-5H-Dibenzo[B,F]Azepine (9)11,12-Didehydro-5,6-Dihydrodibenz[B,F]Azocine (14)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Glycyl)-2,2-Dimethyloxazolidine-4-Carboxylic Acid (8)3H-Diazirine (11)4-Benzyl-1,4-Oxazepane (5)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)
Aromatic Heterocycles (30)
1,2,4,5-Tetrazine (7)3,4-Dihydronaphthalen-2(1H)-One (23)
Azetidines (2997)
1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Phenylsulfonyl)Azetidine (7)1-Benzhydrylazetidine (13)1-Benzylazetidine (6)1-Methylazetidine (6)1-Phenylazetidine (8)2,7-Diazaspiro[3.5]Nonane (7)2-Azaspiro[3.3]Heptane (11)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)3-Bromoazetidine (3)3-Methylazetidin-3-Ol (3)3-Methyleneazetidine (8)3-Phenylazetidine (5)4-(Azetidin-1-Yl)Piperidine (6)Azetidin-2-One (11)Azetidin-2-Ylmethanol (7)Azetidin-3-Amine (4)Azetidin-3-Ol (11)Azetidin-3-Yl Acetate (3)Azetidin-3-Ylmethanamine (3)Azetidine-2-Carboxylic Acid (6)Azetidine-3-Carboxylic Acid (5)Benzyl Azetidine-1-Carboxylate (9)Methyl Azetidine-2-Carboxylate (3)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)Tert-Butyl Azetidine-1-Carboxylate (64)
Benzimidazoles (4428)
Benzimidazole-Carboxylic Acid (43)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)1,2-Diphenyl-1H-Benzo[D]Imidazole (7)1-Benzyl-1H-Benzo[D]Imidazole (6)1-Ethyl-1H-Benzo[D]Imidazole (4)1-Methyl-1H-Benzo[D]Imidazole (47)1-Phenyl-1H-Benzo[D]Imidazole (4)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-2-Thiol (10)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-Benzyl-1H-Benzo[D]Imidazole (7)2-Bromo-1H-Benzo[D]Imidazole (4)2-Chloro-1H-Benzo[D]Imidazole (17)2-Methyl-1H-Benzo[D]Imidazole (20)4-Bromo-1H-Benzo[D]Imidazole (14)4-Methyl-1H-Benzo[D]Imidazole (7)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5-Bromo-1H-Benzo[D]Imidazole (13)5-Chloro-1H-Benzo[D]Imidazole (14)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methyl-1H-Benzo[D]Imidazole (10)6-Chloro-1H-Benzo[D]Imidazole (25)Methyl (1H-Benzo[D]Imidazol-2-Yl)Carbamate (5)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)
Benzisoxazoles (508)
3-Chlorobenzo[D]Isoxazole (7)3-Methylbenzo[D]Isoxazole (8)6-Bromobenzo[D]Isoxazole (5)Benzo[C]Isoxazole (5)Benzo[D]Isoxazol-3-Amine (8)
Benzodioxans (697)
(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)6-Bromo-2,3-Dihydrobenzo[B][1,4]Dioxine (6)
Benzofurans (3713)
Benzofuran-Carboxylic Acid (67)Dimethoxyisobenzofuran (4)Epoxyisobenzofuran (1)Fluorobenzofuran (19)Fluoroisobenzofuran (5)Methoxyisobenzofuran (4)Methylbenzofuran (25)1-(Benzofuran-2-Yl)Ethan-1-One (3)2,2-Dimethyl-2,3-Dihydrobenzofuran (7)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,3-Dihydrobenzofuran-7-Amine (5)2-(Benzofuran-3-Yl)Acetic Acid (3)2-Bromodibenzo[B,D]Furan (6)2-Ethylbenzofuran (3)2-Methylbenzofuran (5)3-Methylbenzofuran (4)4-Bromobenzofuran (3)4-Phenyldibenzo[B,D]Furan (8)5,7,8-Trimethylchromane (3)5-Bromo-2,3-Dihydrobenzofuran (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Methoxyisobenzofuran-1(3H)-One (5)6-Bromo-2,3-Dihydrobenzofuran (6)6-Fluoro-2,3-Dihydrobenzofuran (6)6-Methoxybenzofuran (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromobenzofuran (6)7-Fluoro-2,3-Dihydrobenzofuran (6)Benzofuran-2(3H)-One (7)Benzofuran-2-Carbaldehyde (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-2-Ylboronic Acid (8)Benzofuran-3(2H)-One (15)Benzofuran-3-Carboxylic Acid (6)Benzofuran-3-Yl(Phenyl)Methanone (11)Methyl Benzofuran-2-Carboxylate (6)
Benzothiazoles (2422)
Benzothiazole-Carboxylic Acid (27)Bromobenzothiazole (7)Dichlorobenzothiazole (10)Methoxybenzothiazole (4)Methylbenzothiazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-Bromobenzo[D]Thiazole (28)2-Chlorobenzo[D]Thiazole (21)2-Methylbenzo[D]Thiazole (26)4-Bromobenzo[D]Thiazole (9)4-Chlorobenzo[D]Thiazole (7)4-Fluorobenzo[D]Thiazole (6)4-Methylbenzo[D]Thiazole (10)5-Chlorobenzo[D]Thiazole (5)5-Nitrobenzo[D]Thiazole (3)6-Bromobenzo[D]Thiazole (7)6-Chlorobenzo[D]Thiazole (6)6-Fluorobenzo[D]Thiazole (5)6-Methoxybenzo[D]Thiazole (6)6-Methylbenzo[D]Thiazole (6)6-Nitrobenzo[D]Thiazole (3)7-Bromobenzo[D]Thiazole (8)7-Chlorobenzo[D]Thiazole (6)7-Fluorobenzo[D]Thiazole (9)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzo[D]Thiazol-6-Ol (2)Benzo[D]Thiazole-2-Carbonitrile (11)Benzo[D]Thiazole-2-Thiol (11)Benzo[D]Thiazole-6-Carboxylic Acid (5)Methyl Benzo[D]Thiazole-6-Carboxylate (5)
Benzothiophenes (1116)
Benzothiophene-Carboxylic Acid (58)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-Methylbenzo[B]Thiophene (4)3-Bromobenzo[B]Thiophene (5)3-Chlorobenzo[B]Thiophene (6)3-Methylbenzo[B]Thiophene (4)4,5,6,7-Tetrahydrobenzo[B]Thiophene (21)5-Bromobenzo[B]Thiophene (3)5-Chlorobenzo[B]Thiophene (4)6-Bromobenzo[B]Thiophene (4)7-Bromobenzo[B]Thiophene (5)Benzo[B]Thiophen-2-Amine (5)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[B]Thiophene-3-Carbaldehyde (6)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Methyl Benzo[B]Thiophene-2-Carboxylate (27)
Benzoxazoles (2804)
Benzoxazole-Carboxylic Acid (25)2-Chlorobenzo[D]Oxazole (11)2-Methylbenzo[D]Oxazole (26)2-Phenylbenzo[D]Oxazole (22)3-Phenylbenzo[D]Oxazol-3-Ium (8)5-Bromobenzo[D]Oxazole (3)5-Chlorobenzo[D]Oxazole (5)5-Methylbenzo[D]Oxazole (3)6-Chlorobenzo[D]Oxazole (4)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Oxazole-2-Thiol (6)Methyl Benzo[D]Oxazole-2-Carboxylate (3)
Carbazole Series (482)
Carbazolyl-Phenyl-Boronic Acid/Ester (14)1-Methyl-9H-Carbazole (7)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2-Bromo-9H-Carbazole (4)3,9-Diphenyl-9H-Carbazole (7)3-(Tert-Butyl)-9H-Carbazole (3)3-Bromo-9-Phenyl-9H-Carbazole (16)3-Bromo-9H-Carbazole (4)3-Chloro-9H-Carbazole (3)3-Methyl-9H-Carbazole (3)7H-Benzo[C]Carbazole (5)9-([1,1'-Biphenyl]-4-Yl)-9H-Carbazole (9)9-(P-Tolyl)-9H-Carbazole (5)9-Benzyl-9H-Carbazole (7)9-Ethyl-9H-Carbazole (10)
Cinnolines (355)
Cinnoline (11)
Dioxolanes (1580)
(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)1,3-Dioxolan-2-One (11)2,2-Difluorobenzo[D][1,3]Dioxole (24)2,2-Dimethyl-1,3-Dioxolane (29)2,2-Dimethylbenzo[D][1,3]Dioxole (7)2-Phenyl-1,3-Dioxolane (18)4-Bromobenzo[D][1,3]Dioxole (6)4-Methyl-1,3-Dioxolane (5)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromobenzo[D][1,3]Dioxole (12)5-Chlorobenzo[D][1,3]Dioxole (5)5-Nitrobenzo[D][1,3]Dioxole (4)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)Benzo[D][1,3]Dioxol-5-Amine (3)
Dioxoles (13)
Epoxides (407)
Epoxy (7)Oxirane (64)7-Oxabicyclo[4.1.0]Heptane (7)Ethyl Oxirane-2-Carboxylate (4)Oxiran-2-Ylmethanol (3)
Furans (7000)
Aminodihydrofuran (7)Bromofuran (32)Chlorofuran (2)Chlorofuro (11)Cyanofuran (53)Dibromofuran (5)Dihydrofuran (31)Dihydrofuro (15)Dihydroxydihydrofuran (8)Dimethylfuran (10)Formylfuran (10)Hexahydrofuro (6)Hydroxydihydrofuran (31)Methyldihydrofuran (11)Methylfuran (58)Nitrofuran (10)2,3-Dihydrofuran-3-One (9)2-(Bromomethyl)Furan (3)2-(Chloromethyl)Furan (3)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-Bromofuran (21)2-Chlorofuran (3)2-Methylfuran (37)2-Nitrofuran (9)3-Bromofuran (13)4-Methylisobenzofuran-1(3H)-One (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Phenylfuran-2-Carbaldehyde (9)5-Phenylfuran-2-Carboxylic Acid (6)6-Chloro-2,3-Dihydrobenzofuran (3)6-Fluoroisobenzofuran-1(3H)-One (3)7-Chloro-2,3-Dihydrobenzofuran (3)Ethyl Furan-2-Carboxylate (6)Furan-2,5-Dione (8)Furan-2-Carbaldehyde (22)Furan-2-Carbonitrile (8)Furan-2-Carboxylic Acid (31)Furan-2-Ylmethanol (5)Furan-3-Carboxylic Acid (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Methyl Furan-2-Carboxylate (20)N-(Furan-2-Ylmethyl)Aniline (5)
Imidazoles (833)
Biimidazole (5)Bromoimidazo (102)Dibromoimidazo (8)Dichloroimidazo (9)Dihydroimidazo (25)Imidazol-Amine (1)Methoxyimidazo (13)Methylimidazo (121)Tetrahydroimidazo (40)1,1'-Diphenyl-4,4',5,5'-Tetrahydro-1H,1'H-2,2'-Biimidazole (11)1,2-Dimethyl-1H-Imidazole (6)1,3-Diphenyl-1H-Imidazol-3-Ium (14)1,3-Diphenyl-4,5-Dihydro-1H-Imidazol-3-Ium (5)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(Phenylsulfonyl)-1H-Imidazole (5)1-Benzyl-1H-Imidazole (19)1-Decyl-3-Methyl-1H-Imidazol-3-Ium (14)1-Ethyl-1H-Imidazole (3)1-Isopropyl-1H-Imidazole (5)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Trityl-1H-Imidazole (15)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Imidazol-2-Amine (6)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carbonitrile (2)1H-Imidazole-4-Carboxylic Acid (4)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-Bromo-1H-Imidazole (13)2-Bromoimidazo[1,2-A]Pyridine (5)2-Ethyl-1H-Imidazole (3)2-Methyl-1-Phenyl-1H-Imidazole (11)2-Methylimidazo[1,2-A]Pyridine (8)2-Phenyl-1H-Benzo[D]Imidazole (26)2-Phenyl-1H-Imidazole (26)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propyl-1H-Imidazole (5)3-Bromoimidazo[1,2-A]Pyrazine (6)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Iodoimidazo[1,2-A]Pyridine (10)3-Methylimidazo[1,2-A]Pyridine (3)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Methyl-1-Phenyl-1H-Imidazole (7)4-Methyl-1H-Imidazole (6)4-Phenyl-1H-Imidazole (8)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Benzyl-1H-Imidazole (1)5-Bromoimidazo[1,2-A]Pyridine (6)5-Chloro-1H-Imidazole (2)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Iodo-1H-Imidazole (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Phenyl-1H-Imidazole (6)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6-Bromoimidazo[1,2-A]Pyrazine (11)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloroimidazo[1,2-B]Pyridazine (30)7-Methylimidazo[1,2-A]Pyridine (3)8-Bromoimidazo[1,2-A]Pyrazine (7)8-Bromoimidazo[1,2-A]Pyridine (15)8-Chloroimidazo[1,2-A]Pyrazine (8)8-Chloroimidazo[1,2-A]Pyridine (7)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Methylimidazo[1,2-A]Pyridine (9)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Imidazo[1,2-A]Pyridin-8-Ol (3)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Imidazo[1,2-C]Pyrimidine (6)Imidazo[1,5-A]Pyrazine (9)Imidazo[2,1-B]Thiazole (14)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)
Imidazolidines (1145)
Methylimidazolidine (3)Oxoimidazolidine (8)Thioxoimidazolidin (9)(3Ar,6As)-Tetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One (18)1-Phenylimidazolidin-2-One (8)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylimidazolidine-2,4-Dione (4)Imidazolidin-2-One (16)Imidazolidine-2,4-Dione (17)
Imidazolines (695)
Indazoles (3081)
Indazol-Amide (3)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)1-Benzyl-1H-Indazole (7)1-Ethyl-1H-Indazole (7)1H-Indazol-3-Amine (23)1H-Indazol-3-Ol (10)1H-Indazol-4-Amine (12)1H-Indazol-4-Ol (4)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-6-Ol (6)1H-Indazol-7-Amine (6)1H-Indazole-3-Carbaldehyde (19)1H-Indazole-3-Carbonitrile (9)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)2,3-Dimethyl-2H-Indazole (4)2-Methyl-2H-Indazole (34)3-(Piperidin-4-Yl)-1H-Indazole (5)3-Chloro-1H-Indazole (13)4,5,6,7-Tetrahydro-1H-Indazole (12)4-Chloro-1H-Indazole (18)4-Fluoro-1H-Indazole (22)4-Methoxy-1H-Indazole (7)4-Methyl-1H-Indazole (12)4-Nitro-1H-Indazole (10)5-Bromo-1H-Indazole (14)5-Chloro-1H-Indazole (9)5-Methoxy-1H-Indazole (5)5-Nitro-1H-Indazole (5)6-(Trifluoromethyl)-1H-Indazole (6)6-Bromo-1H-Indazole (23)6-Chloro-1H-Indazole (14)6-Fluoro-1H-Indazole (15)6-Methoxy-1H-Indazole (14)6-Methyl-1H-Indazole (9)6-Nitro-1H-Indazole (9)7-Bromo-1H-Indazole (18)7-Chloro-1H-Indazole (7)7-Fluoro-1H-Indazole (12)7-Methoxy-1H-Indazole (5)7-Nitro-1H-Indazole (11)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Tert-Butyl 1H-Indazole-1-Carboxylate (29)
Indoles (7683)
Azaindole (44)Benzyloxyindole (1)Biindolinylidene (1)Bromo-Indole-Carboxylic Acid (28)Cyanoindole (5)Dihydroindolo (14)Fluoroindole (5)Formylindole (44)Hydroxyindole (7)Hydroxyisoindoline (2)Indolecarboxylic (2)Isoindole (26)Methoxyindole (9)Nitroindole (6)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1H-Indol-2-Yl)Boronic Acid (3)(1H-Indol-2-Yl)Methanol (8)(3As,7As)-Octahydro-1H-Indole (5)(9H-Fluoren-9-Yl)Methyl (2-(1H-Indol-3-Yl)Ethyl)Carbamate (12)1,2,3,4-Tetrahydrocyclopenta[B]Indole (5)1,2-Dimethyl-1H-Indole (4)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(Phenylsulfonyl)-1H-Indole (26)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)1-Benzyl-1H-Indole (10)1-Ethyl-1H-Indole (7)1-Methyl-1H-Indole (85)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Methyl-1H-Pyrrolo[2,3-B]Pyridine (14)1-Phenyl-1H-Indole (5)1H-Indol-3-Ol (5)1H-Indol-3-Yl Acetate (4)1H-Indol-4-Amine (10)1H-Indol-4-Ol (7)1H-Indol-5-Ol (4)1H-Indol-6-Amine (21)1H-Indol-6-Ol (6)1H-Indol-7-Amine (10)1H-Indole-2-Carbaldehyde (20)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carbonitrile (5)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carbonitrile (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carbonitrile (6)1H-Indole-7-Carboxylic Acid (7)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3-Dimethyl-1H-Indole (9)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(4-Fluorophenyl)-1H-Indole (4)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Methyl-1H-Pyrrolo[2,3-B]Pyridine (12)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(Piperidin-4-Yl)-1H-Indole (8)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Methyl-1H-Indole (41)3H-Indole (8)4-Bromo-1H-Indole (25)4-Chloro-1H-Indole (21)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoroindoline-2,3-Dione (3)4-Methoxy-1H-Indole (11)4-Methyl-1H-Indole (23)4-Nitro-1H-Indole (6)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(Benzyloxy)-1H-Indole (8)5-Bromo-1-Methyl-1H-Indole (4)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoroindolin-2-One (4)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methyl-1H-Indole (33)5-Nitro-1H-Indole (6)6-(Trifluoromethyl)-1H-Indole (5)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Fluoro-1H-Indole (17)6-Methoxy-1H-Indole (12)6-Methyl-1H-Indole (29)6-Methyl-1H-Pyrrolo[2,3-B]Pyridine (8)6-Nitro-1H-Indole (8)7-Bromo-1H-Indole (28)7-Bromoindoline-2,3-Dione (3)7-Chloro-1H-Indole (29)7-Fluoro-1H-Indole (24)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)7-Methoxy-1H-Indole (8)7-Methyl-1H-Indole (34)7-Nitro-1H-Indole (11)9H-Pyrido[3,4-B]Indole (5)Benzo[Cd]Indol-2(1H)-One (5)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 2-(1H-Indol-3-Yl)Acetate (3)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Tryptophan (21)
Indolines (4489)
Aminoindoline (10)Bromoindoline (17)Bromoisoindolin (5)Bromoisoindoline (6)Chloroindolin (4)Chloroisoindoline (3)Dibromoindoline (12)Dichloroindoline (16)Difluoroindoline (1)Dimethylindoline (21)Dioxoindoline (8)Dioxoisoindolin (72)Fluoroindolin (9)Fluoroindoline (9)Fluoroisoindoline (10)Hydroxyindolin (5)Indoline-Carboxylate (1)Isoindoline (20)Methoxyindoline (12)Methoxyisoindoline (9)Methylindoline (46)Methylisoindoline (18)Nitroindolin (6)Nitroindoline (11)Nitroisoindoline (8)Oxoindoline (32)Oxoisoindoline (16)Spiro-Indoline-Piperidine (34)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1-(Indolin-1-Yl)Ethan-1-One (9)1-Benzylindoline-2,3-Dione (5)1-Methylindolin-2-One (14)1-Methylindoline (3)1-Methylindoline-2,3-Dione (8)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-Methylindoline (7)2-Methylisoindolin-1-One (7)3,3-Dimethylindolin-2-One (5)3,3-Dimethylindoline (7)4-Bromoindoline (4)4-Chloroindoline-2,3-Dione (6)4-Methylindoline (3)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-Bromoindolin-2-One (5)5-Bromoindoline (8)5-Bromoisoindoline-1,3-Dione (3)5-Chloroindolin-2-One (3)5-Fluoroindoline (3)5-Methoxyindoline (4)5-Methylindolin-2-One (3)5-Methylindoline (3)6-Bromoindolin-2-One (8)6-Bromoindoline-2,3-Dione (4)6-Chloroindolin-2-One (5)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Fluoroindolin-2-One (5)6-Fluoroindoline-2,3-Dione (3)7-Bromoindoline (3)7-Fluoroindolin-2-One (3)7-Fluoroindoline-2,3-Dione (6)7-Methylindoline-2,3-Dione (7)Indoline-2-Carboxylic Acid (3)Methyl Indoline-6-Carboxylate (3)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Tert-Butyl Indoline-1-Carboxylate (24)
Isoquinolines (2729)
Bromoisoquinoline (69)Chloroisoquinoline (101)Dibromoisoquinoline (9)Dichloroisoquinoline (14)Dihydroisoquinoline (107)Fluoroisoquinoline (78)Methoxyisoquinoline (59)Methylisoquinoline (59)Nitroisoquinoline (23)1,3-Dichloroisoquinoline (14)1-Bromoisoquinoline (20)1-Chloroisoquinoline (20)1-Methylisoquinoline (9)1H-Benzo[De]Isoquinoline-1,3(2H)-Dione (14)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)3-Bromoisoquinoline (10)3-Chloroisoquinoline (20)3-Methylisoquinoline (8)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Chloroisoquinoline (11)4-Fluoroisoquinoline (6)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromoisoquinoline (17)5-Chloroisoquinoline (6)5-Methoxyisoquinoline (6)5-Nitroisoquinoline (7)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromoisoquinoline (9)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromoisoquinoline (6)7-Chloroisoquinoline (6)7-Fluoroisoquinoline (3)7-Methoxyisoquinoline (5)8-Bromoisoquinoline (17)8-Chloroisoquinoline (7)8-Fluoroisoquinolin-1(2H)-One (3)8-Fluoroisoquinoline (10)8-Methoxyisoquinoline (7)Isoquinolin-1-Amine (18)Isoquinolin-1-Ol (9)Isoquinolin-3-Amine (13)Isoquinolin-3-Ol (6)Isoquinolin-4-Amine (16)Isoquinolin-4-Ol (9)Isoquinolin-4-Ylboronic Acid (3)Isoquinolin-5-Amine (9)Isoquinolin-5-Ol (7)Isoquinolin-8-Amine (6)Isoquinoline-1-Carbonitrile (7)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-5-Sulfonyl Chloride (3)Isoquinoline-6-Carboxylic Acid (3)Methyl Isoquinoline-3-Carboxylate (3)Methyl Isoquinoline-4-Carboxylate (6)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)
Isothiazoles (343)
Methylisothiazole (5)Benzo[D]Isothiazol-3(2H)-One 1,1-Dioxide (10)Benzo[D]Isothiazole (12)Isothiazole (24)
Isoxazoles (3403)
Aminoisoxazole (7)Bromoisoxazole (5)Dihydroisoxazol (2)Dimethylisoxazole (17)Phenylisoxazole (28)(3-Phenylisoxazol-5-Yl)Methanol (7)3-Bromoisoxazole (7)3-Methyl-5-Phenylisoxazole (6)3-Methylisoxazole (30)3-Phenylisoxazol-5-Amine (8)5-(Thiophen-2-Yl)Isoxazole (5)5-Cyclopropylisoxazole (5)5-Methyl-3-Phenylisoxazole (4)5-Methylisoxazole (16)5-Phenylisoxazole-3-Carboxylic Acid (15)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Isoxazol-3-Amine (7)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Amine (15)Isoxazol-5-Ylmethanol (5)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl 5-Phenylisoxazole-3-Carboxylate (6)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)
Morpholines (4988)
Benzylmorpholine (25)Cyanomorpholine (6)Dimorpholine (3)Ethylmorpholine (9)Isopropylmorpholine (9)Methylmorpholine (68)Morpholinobenzaldehyde (11)Morpholinobenzo (13)Morpholinobenzoic (8)Morpholinoethanone (5)Morpholinoethoxy (1)Morpholinoethyl (5)Morpholinomethyl (16)Morpholinophenyl (14)Morpholinopropoxy (6)Morpholinopyrimidin (6)Morpholinosulfonyl (7)Oxomorpholine (6)(R)-3-Phenylmorpholine (7)(S)-3-Phenylmorpholine (10)2,2-Dimethylmorpholine (5)2,6-Dimethylmorpholine (5)2-(Methoxymethyl)Morpholine (4)2-(Morpholin-2-Yl)Acetic Acid (5)2-Ethylmorpholine (3)2-Isopropylmorpholine (4)2-Methylmorpholine (7)2-Phenylmorpholine (8)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-(Methoxymethyl)Morpholine (4)3-Ethylmorpholine (4)3-Isopropylmorpholine (5)3-Methylmorpholine (13)3-Phenylmorpholine (8)4-(2-Fluorophenyl)Morpholine (8)4-(3-Phenoxypropyl)Morpholine (7)4-(O-Tolyl)Morpholine (6)4-(Pyrazin-2-Yl)Morpholine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-Benzylmorpholin-3-One (6)4-Morpholinoaniline (4)4-Morpholinobenzaldehyde (8)4-Morpholinobenzoic Acid (5)4-Phenylmorpholin-3-One (6)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)Benzyl Morpholine-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Morpholin-2-Ylmethanamine (8)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Morpholine-2-Carbonitrile (4)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Morpholino(Phenyl)Methanone (11)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl Morpholine-4-Carboxylate (23)
Naphthyridines (939)
1,5-Naphthyridine-3-Carboxylic Acid (6)1,6-Naphthyridine (22)1,7-Naphthyridine (23)2,7-Naphthyridine (5)3-Bromo-1,5-Naphthyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Chloro-1,5-Naphthyridine (6)5,6,7,8-Tetrahydro-1,6-Naphthyridine (22)5,6,7,8-Tetrahydro-1,7-Naphthyridine (6)
Oxadiazoles (3559)
1,2,4-Oxadiazole (19)1,2,5-Oxadiazole (12)1,3,4-Oxadiazole (25)2,5-Diphenyl-1,3,4-Oxadiazole (6)2-Phenyl-1,3,4-Oxadiazole (26)3-Phenyl-1,2,4-Oxadiazole (23)Benzo[C][1,2,5]Oxadiazole (17)
Oxazines (235)
2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromo-2H-Benzo[B][1,4]Oxazin-3(4H)-One (7)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-2H-Benzo[B][1,4]Oxazin-3(4H)-One (8)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)
Oxazoles (2026)
Bioxazole (12)2-Bromooxazole (7)2-Chlorooxazole (7)2-Methyloxazole (19)2-Phenyloxazole (16)3,4-Diphenylisoxazole (8)4,5-Diphenyloxazole (7)4-(Oxazol-5-Yl)Aniline (3)4-Methyloxazole (9)5-(4-Nitrophenyl)Oxazole (3)5-Methyloxazole (5)6-Bromobenzo[D]Oxazole (3)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Methyl Oxazole-4-Carboxylate (9)Oxazol-2-Amine (8)Oxazole-4-Carboxylic Acid (4)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)
Oxazolidines (1298)
Dimethyloxazolidin (6)Dioxooxazolidin (2)Oxazolidinone (5)Phenyloxazolidin (9)Propionyloxazolidin (5)(R)-4-Benzyloxazolidin-2-One (5)(S)-4-Benzyloxazolidin-2-One (11)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-Phenyloxazolidin-2-One (4)4-Isopropyloxazolidine (6)Oxazolidine (21)Oxazolidine-2,5-Dione (9)
Oxazolines (1577)
(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,3-Bis(4,5-Dihydrooxazol-2-Yl)Benzene (8)2,2'-(1,3-Diphenylpropane-2,2-Diyl)Bis(4,5-Dihydrooxazole) (5)2,2'-(2-Phenylethane-1,1-Diyl)Bis(4,5-Dihydrooxazole) (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Phenyl-4,5-Dihydrooxazole (18)4,4',5,5'-Tetrahydro-2,2'-Bioxazole (10)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)Bis((3Ar,8As)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis((3As,8Ar)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis(4,5-Dihydrooxazol-2-Yl)Methane (22)
Oxetanes (772)
Methyloxetane (11)
Phthalazines (423)
Dihydrophthalazine (15)Phthalazine (16)
Piperazines (7427)
Isobutylpiperazine (6)Propylpiperazine (10)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(R)-2-Benzylpiperazine (5)1,4-Diphenylpiperazine (7)1-(2-Chlorophenyl)Piperazine (4)1-(2-Fluorophenyl)Piperazine (8)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-(Methylsulfonyl)Piperazine (5)1-(Phenylsulfonyl)Piperazine (17)1-(Piperidin-4-Yl)Piperazine (6)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-Benzhydryl-4-Benzylpiperazine (1)1-Benzhydrylpiperazine (9)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1-Benzyl-4-Methylpiperazine (10)1-Ethyl-4-Phenylpiperazine (4)1-Ethylpiperazine (5)1-Isopropylpiperazine (4)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methyl-4-Phenylpiperazine (22)1-Methylpiperazin-2-One (6)1-Methylpiperazine (21)10-(3-(Piperazin-1-Yl)Propyl)-10H-Phenothiazine (2)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperazin-1-Yl)Pyrazine (9)2-(Piperazin-1-Yl)Pyrimidine (11)2-Phenylpiperazine (17)3-(Piperazin-1-Yl)Aniline (3)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Piperazin-1-Yl)Pyridazine (7)3-Methylpiperazin-2-One (7)4-(Piperazin-1-Yl)Benzaldehyde (5)4-(Piperazin-1-Yl)Pyrimidine (13)Benzyl 2-Methylpiperazine-1-Carboxylate (7)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl 3-Methylpiperazine-1-Carboxylate (5)Phenyl(Piperazin-1-Yl)Methanone (20)Piperazine-2,5-Dione (9)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl 4-Benzylpiperazine-1-Carboxylate (13)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl Piperazine-1-Carboxylate (30)
Piperidines (21889)
Bipiperidine (12)Chloropiperidine (6)Dimethylpiperidine (46)Ethynylpiperidine (5)Fluoropiperidine (33)Formylpiperidine (9)Isopropylpiperidine (11)Piperidine-Carboxylate (3)Piperidineacetic (5)Piperidinecarboxylic (6)Piperidinyl-Phenyl-Boronic Acid/Ester (32)Propylpiperidine (8)(9H-Fluoren-9-Yl)Methyl Piperidine-1-Carboxylate (16)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(R)-2-Phenylpiperidine (10)(R)-3-Aminopiperidin-2-One (3)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)(S)-2-Phenylpiperidine (11)(S)-N-Phenylpiperidine-2-Carboxamide (1)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4'-Bipiperidine (8)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)Piperidine (23)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Piperidin-4-Yl)Piperazine (6)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-3-One (5)1-Benzylpiperidin-4-Amine (8)1-Benzylpiperidin-4-One (8)1-Isopropylpiperidine (5)1-Methyl-4-Phenylpiperidine (4)1-Methylpiperidin-2-One (3)1-Oxa-8-Azaspiro[4.5]Decane (5)1-Phenylpiperidin-2-One (8)2,2-Dimethylpiperidin-4-One (6)2,2-Dimethylpiperidine (21)2,7-Diazaspiro[3.5]Nonane (7)2,8-Diazaspiro[4.5]Decan-3-One (6)2,8-Diazaspiro[4.5]Decane (5)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-(Piperidin-4-Yl)Pyridine (5)2-Methylpiperidin-4-One (6)2-Methylpiperidine (14)2-Phenylpiperidine (14)3,3-Difluoropiperidin-4-One (3)3,3-Difluoropiperidine (29)3,3-Dimethylpiperidin-4-One (3)3,3-Dimethylpiperidine (5)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)-1H-Indazole (5)3-(Piperidin-4-Yl)-1H-Indole (8)3-(Piperidin-4-Yl)Pyridine (5)3-Fluoropiperidin-4-One (3)3-Fluoropiperidine (26)3-Methoxypiperidine (7)3-Methylpiperidin-4-One (3)3-Methylpiperidine (10)3-Phenylpiperidine (6)4,4-Difluoropiperidine (5)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-(Azetidin-1-Yl)Piperidine (6)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Benzylpiperidine (18)4-Hydrazineylpiperidine (5)4-Hydroxypiperidin-2-One (3)4-Methyl-1-Phenylpiperidine (6)4-Methylenepiperidine (14)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenylpiperidin-4-Ol (10)5-Hydroxypiperidin-2-One (3)6-Azaspiro[2.5]Octane (10)6-Oxopiperidine-2-Carboxylic Acid (3)7-Azaspiro[3.5]Nonane (7)Azepane (25)Benzyl 3-Hydroxypiperidine-1-Carboxylate (7)Benzyl 4-Oxopiperidine-1-Carboxylate (12)Benzyl Piperidin-4-Ylcarbamate (7)Benzyl Piperidine-1-Carboxylate (50)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Ethyl Piperidine-1-Carboxylate (5)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)N-Benzylpiperidin-4-Amine (3)N-Methylpiperidin-3-Amine (5)N-Phenylpiperidine-2-Carboxamide (2)Phenyl(Piperidin-1-Yl)Methanone (21)Phenyl(Piperidin-4-Yl)Methanone (21)Piperidin-2-Ylmethanamine (6)Piperidin-2-Ylmethanol (11)Piperidin-3-Amine (17)Piperidin-3-Ol (27)Piperidin-3-One (13)Piperidin-3-Ylmethanamine (5)Piperidin-3-Ylmethanol (15)Piperidin-4-Amine (14)Piperidin-4-Ol (44)Piperidin-4-Ylmethanamine (7)Piperidin-4-Ylmethanol (11)Piperidine-2,4-Dione (5)Piperidine-2,6-Dione (13)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxamide (5)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Quinuclidine (5)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Spiro[Indoline-3,4'-Piperidine] (5)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl (Piperidin-3-Ylmethyl)Carbamate (5)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Piperidin-3-Ylcarbamate (9)
Purines (2020)
(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Chloro-7H-Purine (3)2-Chloro-9H-Purine (5)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)9H-Purin-6-Amine (3)
Pyrans (1095)
Chromene-Carboxylic Acid (1)Thioglucopyranoside (4)(S)-2-Phenylchroman-4-One (17)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)2,2-Dimethylchromane (5)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2H-Chromene (16)3,4-Dihydro-2H-Pyran (11)3,6-Dihydro-2H-Pyran (8)3-Acetyl-2H-Chromen-2-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-Hydroxy-2H-Chromen-2-One (10)4-Methyl-2H-Chromen-2-One (27)5-Fluorochroman-4-One (3)5-Fluorochromane (6)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)6-Bromochroman-4-One (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Fluorochroman-4-One (5)6-Fluorochromane (6)6-Methoxychromane (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromochroman-4-One (4)7-Bromochromane (7)7-Chlorochromane (5)7-Fluorochroman-4-One (5)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxychroman-4-One (3)8-Bromochroman-4-One (4)8-Bromochromane (6)8-Chlorochromane (5)8-Fluorochromane (5)8-Methylchroman-4-One (4)8-Methylchromane (10)Chroman-2-One (5)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Chroman-4-Ol (4)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Isochromane (11)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Tetrahydro-2H-Pyran-2-One (15)Tetrahydro-2H-Thiopyran (10)Tetrahydro-4H-Pyran-4-One (12)Thiochroman-4-One (10)
Pyrazines (3359)
Dibromopyrazine (7)Dichloropyrazine (21)Dihydropyrazine (6)Dimethylpyrazine (30)Ethoxypyrazine (5)Ethylpyrazine (7)Fluoropyrazine (6)Hydroxypyrazine (4)Iodopyrazine (17)Methoxypyrazine (36)Phenylpyrazin (5)Pyrazino (5)Pyrazino-Nitrile (50)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1-(Pyrazin-2-Yl)Ethan-1-One (5)1H-Pyrazolo[3,4-B]Pyrazine (5)2,3-Diphenylpyrazine (5)2,5-Dibromopyrazine (4)2,5-Dichloropyrazine (4)2,6-Dibromopyrazine (9)2,6-Dichloropyrazine (14)2-(Piperazin-1-Yl)Pyrazine (9)2-(Trifluoromethyl)Pyrazine (6)2-Bromo-3-Methoxypyrazine (5)2-Bromo-3-Methylpyrazine (5)2-Bromo-5-Chloropyrazine (6)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Methylpyrazine (5)2-Bromopyrazine (15)2-Chloro-3-Methylpyrazine (7)2-Chloro-6-Methylpyrazine (12)2-Chloropyrazine (24)2-Ethoxypyrazine (3)2-Ethylpyrazine (9)2-Fluoropyrazine (7)2-Iodopyrazine (25)2-Methoxypyrazine (45)2-Methylpyrazine (16)2-Phenylpyrazine (12)3-Chloropyrazin-2-Amine (6)3-Chloropyrazine-2-Carbonitrile (6)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4-(Pyrazin-2-Yl)Morpholine (5)5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine (11)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Bromopyrazin-2-Amine (13)5-Bromopyrazin-2-Ol (5)5-Chloropyrazin-2-Amine (9)5H-Pyrrolo[2,3-B]Pyrazine (14)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[4,3-A]Pyrazine (11)Ethyl Pyrazine-2-Carboxylate (10)Imidazo[1,5-A]Pyrazine (9)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl Pyrazine-2-Carboxylate (19)Pyrazin-2-Amine (22)Pyrazin-2-Ol (7)Pyrazin-2-Ylmethanamine (12)Pyrazine-2-Carbaldehyde (17)Pyrazine-2-Carbohydrazide (3)Pyrazine-2-Carbonitrile (15)Pyrazine-2-Carboxamide (10)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrazine (5)Pyrido[2,3-B]Pyrazine (12)Pyrido[3,4-B]Pyrazine (11)Tert-Butyl Pyrazin-2-Ylcarbamate (8)
Pyrazoles (16157)
Bipyrazole (5)Chloropyrazolo (33)Dichloropyrazolo (11)Dihydropyrazolo (28)Dimethylpyrazolo (6)Ethylpyrazole (7)Fluoropyrazolo (9)Hydroxypyrazolo (10)Methoxypyrazolo (16)Methyl-Pyrazole-Carboxylic Acid (147)Methyl-Pyrazolone (87)Methylpyrazolo (32)Pyrazolopyridine-Carboxylic Acid (48)Tetrahydropyrazolo (23)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)1,3-Dimethyl-1H-Pyrazole (28)1,3-Diphenyl-1H-Pyrazole (6)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1,5-Diphenyl-1H-Pyrazole (13)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Pyrazole (9)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Cyclopentyl-1H-Pyrazole (5)1-Cyclopropyl-1H-Pyrazole (9)1-Methyl-1H-Pyrazol-3-Amine (14)1-Methyl-3-Phenyl-1H-Pyrazole (21)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)1-Methyl-5-Phenyl-1H-Pyrazole (7)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)1-Trityl-1H-Pyrazole (5)1H-Pyrazol-4-Amine (6)1H-Pyrazol-4-Ol (3)1H-Pyrazol-5-Amine (19)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-4-Sulfonyl Chloride (8)1H-Pyrazole-5-Carboxamide (3)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrazolo[3,4-B]Pyrazine (5)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,4-Dihydro-3H-Pyrazol-3-One (10)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-Phenyl-2,4-Dihydro-3H-Pyrazol-3-One (23)3-(Tert-Butyl)-1-Phenyl-1H-Pyrazole (4)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Cyclopropyl-1H-Pyrazole (5)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Methyl-1-Phenyl-1H-Pyrazole (23)3-Phenyl-1H-Pyrazol-5-Amine (11)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyridine (6)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Iodo-1H-Pyrazole (9)4-Methyl-1-Phenyl-1H-Pyrazole (6)4-Methyl-1H-Pyrazole (11)4-Nitro-1H-Pyrazole (8)4-Phenyl-1H-Pyrazole (18)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)5-(Difluoromethyl)-1H-Pyrazole (6)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Cyclopropyl-1H-Pyrazole (6)5-Iodo-1H-Pyrazole (4)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine (13)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)7-Chloropyrazolo[1,5-A]Pyrimidine (8)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)Pyrazolo[1,5-A]Pyrazine (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)
Pyridazines (2753)
Aminopyridazine (12)Dihydropyridazine (26)Dimethylpyridazine (9)Hexahydropyridazines (10)Pyridazinecarboxylic (1)2-Methylpyridazin-3(2H)-One (7)3,6-Dichloropyridazine (20)3-(Piperazin-1-Yl)Pyridazine (7)3-(Trifluoromethyl)Pyridazine (3)3-Bromopyridazine (25)3-Chloro-4-Methylpyridazine (7)3-Chloropyridazine (44)3-Iodopyridazine (5)3-Methoxypyridazine (17)3-Methylpyridazine (6)3-Phenylpyridazine (8)4-Aminopyridazin-3(2H)-One (4)4-Bromopyridazin-3(2H)-One (3)4-Bromopyridazine (5)4-Chloropyridazin-3(2H)-One (4)4-Chloropyridazine (16)4-Methoxypyridazine (8)4-Methylpyridazine (3)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridazin-3-Amine (5)[1,2,4]Triazolo[4,3-B]Pyridazine (10)Ethyl Pyridazine-3-Carboxylate (6)Methyl Pyridazine-3-Carboxylate (7)Pyridazin-3-Amine (18)Pyridazin-3-Ol (3)Pyridazin-4-Amine (10)Pyridazine-3-Carboxylic Acid (7)
Pyridines (70617)
Acetylpyridin (5)Aminopicolinate (8)Benzyloxypyridine (36)Bipyridine (202)Bromopicolinate (19)Bromopicolinic (4)Bromopicolinic Acid (5)Bromopicolinonitrile (6)Bromopyrido (13)Butylpyridine (5)Chloroisonicotinic Acid (5)Chloronicotinaldehyde (23)Chloronicotinamide (11)Chloronicotinate (45)Chloronicotinic (41)Cyanopicolinate (7)Cyanopicolinic (6)Cyanopyridine (34)Cyclopropoxypyridine (6)Cyclopropylpyridine (30)Dibromopicolinate (4)Dibromopicolinic Acid (3)Dibromopyridine (36)Dichloropicolinate (9)Dichloropicolinonitrile (4)Dichloropyridine (120)Difluoropicolinic Acid (3)Difluoropyridine (58)Dihydropyrido (27)Diiodopyridine (13)Dimethoxypicolinic Acid (5)Dimethoxypyridine (33)Dimethylpyridine (143)Diphenylpyridine (6)Dipyridine (28)Ethoxypicolinic Acid (3)Ethoxypyridine (35)Ethylpyridine (36)Ethynylpicolinate (3)Fluoro-Pyridine--Boronate (79)Fluoropicolinaldehyde (8)Fluoropicolinamide (8)Fluoropicolinate (22)Fluoropyridine (288)Fluoropyrido (3)Formylpyridine (23)Hexahydropyrido (7)Hydrazinylpyridine (22)Hydroxymethylpyridine (26)Hydroxypicolinate (13)Hydroxypicolinic (9)Hydroxypicolinonitrile (7)Iodopicolinate (5)Iodopicolinic Acid (4)Iodopyridine (167)Isopropoxypyridine (20)Isopropylpyridine (32)Methoxyisonicotinaldehyde (10)Methoxynicotinaldehyde (18)Methoxypicolinaldehyde (13)Methoxypicolinamide (13)Methoxypicolinate (21)Methoxypicolinic (18)Methoxypicolinic Acid (16)Methoxypicolinimidamide (5)Methoxypicolinonitrile (13)Methoxypyridine (342)Methylisonicotinamide (8)Methylnicotinaldehyde (30)Methylnicotinamide (13)Methylpicolinaldehyde (16)Methylpicolinamide (15)Methylpicolinate (27)Methylpicolinic (23)Methylpicolinonitrile (28)Methylpyrido (13)Nitropyridine (393)Oxopyridin (2)Phenoxypyridin (1)Picolinate (42)Pyridinecarbonitrile (50)Pyridyl-Benzene-Boronic Acid/Ester (16)Pyridyl-Phenyl-Boronate (2)Pyridylmethyl (6)Terpyridine (32)Tetrachloropyridine (5)Tetrafluoropyridine (21)Tetrahydropyridine (49)Tetrahydropyrido (32)Tribromopyridine (9)Trichloropyridine (17)Trifluoropyridine (8)Trimethylpyridine (5)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3-Bromopyridin-2-Yl)Methanol (7)(3-Chloropyridin-2-Yl)Methanamine (6)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanol (10)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(5-Chloropyridin-2-Yl)Methanamine (5)(6-Methylpyridin-2-Yl)Methanamine (6)(6-Methylpyridin-2-Yl)Methanol (5)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,1'-Diphenyl-[4,4'-Bipyridine]-1,1'-Diium (7)1,10-Phenanthrolin-4-Ol (3)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1,2,3,6-Tetrahydropyridine (22)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4-Di(Pyridin-4-Yl)Benzene (5)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-(Pyridin-4-Yl)Ethan-1-One (14)1-Benzyl-1,2,3,6-Tetrahydropyridine (9)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methylpyridin-1-Ium Iodide (5)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,2':6',2''-Terpyridine (15)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2,3'-Bipyridine (11)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dibromopyridine (21)2,3-Dichloropyridine (38)2,3-Difluoropyridine (13)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2,3-Dihydro-[1,4]Dioxino[2,3-B]Pyridine (5)2,3-Dihydropyridin-2-One (5)2,3-Dimethoxypyridine (7)2,3-Dimethylpyridine (8)2,4,6-Trichloropyridine (5)2,4,6-Triphenylpyridine (7)2,4-Dibromopyridine (5)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloropyridine (50)2,4-Dimethylpyridine (5)2,5-Dibromopyridine (26)2,5-Dichloropyridine (32)2,5-Difluoropyridine (8)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Iodopyridine (4)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloronicotinonitrile (8)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2,6-Difluoropyridine (29)2,6-Dimethoxypyridine (11)2,6-Dimethylpyridin-4-Ol (4)2,6-Dimethylpyridine (26)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(2-Chlorophenyl)Pyridine (3)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-Fluorophenyl)Pyridine (11)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzyloxy)Pyridine (18)2-(Bromomethyl)Pyridine (27)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Difluoromethyl)Pyridine (21)2-(Methylsulfonyl)Pyridine (11)2-(Methylthio)Pyridine (5)2-(P-Tolyl)Pyridine (6)2-(Phenoxymethyl)Pyridine (5)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-4-Yl)Pyridine (5)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)Pyridine (6)2-Aminonicotinonitrile (6)2-Benzylpyridine (12)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Iodopyridine (6)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitropyridine (5)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Methylpyridine (6)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodopyridine (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Phenylpyridine (4)2-Bromonicotinic Acid (5)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Fluoropyridine (20)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Iodopyridine (19)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methylpyridine (31)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Iodopyridine (18)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodopyridine (9)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylpyridine (49)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Ethoxypyridine (20)2-Ethylpyridine (9)2-Ethynylpyridine (31)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Fluoro-3-Iodopyridine (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methoxypyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoropyridine (15)2-Hydrazineylpyridine (32)2-Iodo-6-Methylpyridine (5)2-Iodopyridine (27)2-Isopropoxypyridine (16)2-Isopropylpyridine (14)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Methoxy-5-Methylpyridine (5)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Methylpyridine (14)2-Methoxyisonicotinic Acid (13)2-Methoxypyridin-3-Amine (6)2-Methoxypyridine (436)2-Methyl-1,10-Phenanthroline (3)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-Nitropyridine (9)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)2-Methylimidazo[1,2-A]Pyridine (8)2-Methylpyridin-3-Ol (8)2-Methylpyridin-4-Amine (7)2-Methylpyridine 1-Oxide (9)2-Nitropyridine (40)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propoxypyridine (9)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,3'-Bipyridine (7)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)3,5-Dibromopyridine (12)3,5-Dichloropyridine (16)3,5-Difluoropyridine (12)3,5-Dimethoxypyridine (4)3,5-Dimethylpyridine (8)3,5-Diphenylpyridine (5)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-(Benzyloxy)Pyridine (19)3-(Bromomethyl)Pyridine (18)3-(Chloromethyl)Pyridine (22)3-(Cyclopropylmethyl)Pyridine (6)3-(Difluoromethyl)Pyridine (5)3-(Methylsulfonyl)Pyridine (5)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)Pyridine (5)3-(Pyrrolidin-2-Yl)Pyridine (6)3-(Tert-Butyl)Pyridine (5)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Methylpyridine (13)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylpyridine (4)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Cyclopropylpyridine (28)3-Ethoxypyridine (12)3-Ethylpyridine (11)3-Ethynylpyridine (22)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-2-Methylpyridine (15)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Fluoropicolinic Acid (6)3-Fluoropicolinonitrile (5)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Hydrazineylpyridine (8)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Methoxypyridin-2-Amine (5)3-Methoxypyridine (52)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Methyl-2-Phenylpyridine (3)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)3-Methyl-5-Nitropyridine (4)3-Methylimidazo[1,2-A]Pyridine (3)3-Methylpicolinic Acid (13)3-Methylpyridin-2-Amine (7)3-Methylpyridine (50)3-Methylpyridine 1-Oxide (7)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Phenoxypyridine (12)4'-Phenyl-2,2':6',2''-Terpyridine (13)4,4'-Bipyridine (10)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,7-Diphenyl-1,10-Phenanthroline (4)4-(2,4-Diphenyl-1H-Imidazol-5-Yl)Pyridine (5)4-(Benzyloxy)Pyridine (8)4-(Bromomethyl)Pyridine (8)4-(Pyridin-2-Yl)Morpholine (21)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-(Tert-Butyl)Pyridine (5)4-(Trifluoromethyl)Nicotinic Acid (3)4-(Trifluoromethyl)Pyridine (14)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-Methylpyridine (5)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Bromopyridine (31)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-3-Methylpyridine (7)4-Chloronicotinic Acid (4)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Cyclopropylpyridine (7)4-Ethoxypyridine (7)4-Ethynylpyridine (10)4-Iodopyridine (17)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Methoxypyridine (136)4-Methyl-2,2'-Bipyridine (8)4-Methyl-2-Phenylpyridine (3)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)4-Methyl-3-Nitropyridine (8)4-Methylnicotinic Acid (5)4-Methylpyridine (24)4-Nitropyridine (11)4-Phenoxypyridine (7)4-Phenyl-1,2,3,6-Tetrahydropyridine (7)4-Phenyl-1,4-Dihydropyridine (10)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5,6-Dichloropyridin-2-Amine (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Iodopyridine (5)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Fluoro-2-Methoxypyridine (15)5-Fluoro-2-Methylpyridine (8)5-Fluoropicolinonitrile (5)5-Fluoropyridin-2-Amine (15)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5-Methoxypyridin-3-Amine (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)5-Phenylpicolinic Acid (4)6,7-Dihydro-5H-Cyclopenta[B]Pyridine (18)6,7-Dihydro-5H-Cyclopenta[C]Pyridine (7)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chloro-5-Iodopyridin-2-Amine (3)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxynicotinaldehyde (4)6-Methoxypicolinic Acid (9)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylnicotinic Acid (6)6-Methylnicotinonitrile (7)6-Methylpicolinic Acid (12)6-Methylpicolinonitrile (10)6-Methylpyridin-2-Amine (46)6-Methylpyridin-2-Ol (23)6-Methylpyridin-3-Amine (5)6-Methylpyridin-3-Ol (7)6-Phenoxypyridin-3-Amine (5)6-Phenylnicotinic Acid (8)6-Phenylpicolinic Acid (3)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methylimidazo[1,2-A]Pyridine (3)9H-Pyrido[3,4-B]Indole (5)Bis(Pyridin-2-Ylmethyl)Amine (6)Dimethyl Pyridine-2,6-Dicarboxylate (7)Dimethyl(Pyridin-2-Yl)Phosphine Oxide (8)Dimethyl(Pyridin-3-Yl)Phosphine Oxide (7)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Methylnicotinate (6)Ethyl 4,6-Dichloronicotinate (4)Ethyl 6-Chloropicolinate (7)Ethyl Isonicotinate (12)Ethyl Nicotinate (25)Ethyl Picolinate (41)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Imidazo[1,2-A]Pyridin-2-Ylmethanol (4)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinaldehyde (68)Isonicotinamide (12)Isonicotinic Acid (23)Isonicotinohydrazide (6)Isonicotinonitrile (16)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Bromopicolinate (9)Methyl 3-Chloropicolinate (9)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)Methyl 5-Hydroxypicolinate (5)Methyl 6-Bromonicotinate (6)Methyl 6-Chloropicolinate (11)Methyl 6-Fluoronicotinate (4)Methyl 6-Methoxynicotinate (4)Methyl Isonicotinate (16)Methyl Nicotinate (52)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N-(Pyridin-2-Yl)Benzamide (9)N-Benzylpyridin-2-Amine (9)N-Methylpicolinamide (10)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpicolinamide (8)N-Phenylpyridin-2-Amine (9)Nicotinaldehyde (153)Nicotinamide (64)Nicotinic Acid (53)Nicotinonitrile (82)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)Phenyl(Pyridin-2-Yl)Methanone (10)Phenyl(Pyridin-3-Yl)Methanone (9)Picolinaldehyde (98)Picolinamide (26)Picolinic Acid (22)Picolinimidamide (11)Picolinohydrazide (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyridin-2-Amine (29)Pyridin-2-Ol (170)Pyridin-2-Ylboronic Acid (9)Pyridin-2-Ylmethanamine (38)Pyridin-2-Ylmethanol (65)Pyridin-3-Amine (21)Pyridin-3-Ol (13)Pyridin-3-Ylboronic Acid (49)Pyridin-3-Ylmethanamine (29)Pyridin-3-Ylmethanol (39)Pyridin-4-Amine (22)Pyridin-4-Ol (16)Pyridin-4-Ylboronic Acid (21)Pyridin-4-Ylmethanamine (12)Pyridin-4-Ylmethanol (16)Pyridine 1-Oxide (33)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyridine-2,6-Dicarboxylic Acid (9)Pyridine-2,6-Diol (6)Pyridine-2-Sulfonamide (6)Pyridine-2-Sulfonyl Chloride (9)Pyridine-2-Thiol (8)Pyridine-3-Sulfonic Acid (6)Pyridine-3-Sulfonyl Chloride (25)Pyrido[2,3-B]Pyrazine (12)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-B]Pyrazine (11)Pyrido[3,4-D]Pyrimidine (10)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl Pyridin-2-Ylcarbamate (37)Tert-Butyl Pyridin-3-Ylcarbamate (16)Tert-Butyl Pyridin-4-Ylcarbamate (6)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[3,2-B]Pyridine (18)Thieno[3,2-C]Pyridine (13)
Pyrimidines (14557)
Bipyrimidine (4)Dibromopyrimidine (15)Methoxypyrimidine (107)Pyrimidinone (3)Tetraoxatetradecan (10)Trichloropyrimidine (11)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)1,4,5,6-Tetrahydropyrimidine (4)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyrimidine (14)2,4,6-Triphenylpyrimidine (9)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichloropyrimidin-5-Amine (6)2,4-Dimethoxypyrimidine (13)2,4-Dimethylpyrimidine (7)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(Chloromethyl)Pyrimidine (5)2-(Methylsulfonyl)Pyrimidine (25)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Piperazin-1-Yl)Pyrimidine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Propylthio)Pyrimidine (5)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Trifluoromethyl)Pyrimidine (27)2-Aminopyrimidin-4(3H)-One (11)2-Bromopyrimidine (22)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloropyrimidin-4-Amine (22)2-Cyclopropylpyrimidine (10)2-Ethoxypyrimidine (7)2-Ethylpyrimidine (6)2-Fluoropyrimidine (9)2-Hydrazineylpyrimidine (6)2-Iodopyrimidine (8)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methylpyrimidin-4-Amine (22)2-Methylpyrimidin-4-Ol (11)2-Phenoxypyrimidine (8)2-Phenylpyrimidin-5-Amine (5)3-Methylpyrimidin-4(3H)-One (6)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyrimidin-2-Amine (9)4,6-Dichloropyrimidine (14)4,6-Diphenylpyrimidine (7)4-(Dimethoxymethyl)Pyrimidine (5)4-(Piperazin-1-Yl)Pyrimidine (13)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-(Pyrimidin-4-Yl)Morpholine (13)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Bromopyrimidine (24)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Chloro-5-Iodopyrimidine (6)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-6-Methoxypyrimidine (5)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Chloropyrimidine-5-Carbonitrile (6)4-Ethoxypyrimidine (6)4-Fluoropyrimidine (8)4-Iodopyrimidine (9)4-Methoxy-2-Methylpyrimidine (8)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Methyl-2-(Methylthio)Pyrimidine (7)4-Methylpyrimidin-2-Amine (9)4-Methylpyrimidine (22)4-Phenoxypyrimidine (5)4-Phenylpyrimidin-2-Amine (15)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(Benzyloxy)Pyrimidine (5)5-Benzylpyrimidine (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Bromo-2-(Methylthio)Pyrimidine (6)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Methylpyrimidine (5)5-Bromo-4-Chloropyrimidine (4)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine (8)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Ethylpyrimidine (5)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine (11)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyrimidine (5)5-Methylpyrimidine (3)5-Phenylpyrimidine (16)5H-Pyrrolo[3,2-D]Pyrimidine (16)6,7-Dihydro-5H-Cyclopenta[D]Pyrimidine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)6-Chloropyrimidin-4-Amine (8)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)[1,2,4]Triazolo[1,5-A]Pyrimidine (14)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Imidazo[1,2-C]Pyrimidine (6)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)N,N-Dimethylpyrimidin-2-Amine (10)N-(9-((2R,5S)-5-((Trityloxy)Methyl)Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)N-Benzyl-9H-Purin-6-Amine (6)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-D]Pyrimidine (10)Pyrimidin-2-Ol (21)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-2-Ylmethanol (5)Pyrimidin-4-Amine (29)Pyrimidin-4-Ol (25)Pyrimidin-5-Amine (6)Pyrimidin-5-Ol (5)Pyrimidin-5-Ylboronic Acid (9)Pyrimidine-2,4-Diamine (14)Pyrimidine-2-Carbonitrile (14)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-2-Thiol (6)Pyrimidine-4,6(1H,5H)-Dione (3)Pyrimidine-4-Carbonitrile (9)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carbaldehyde (38)Pyrimidine-5-Carbonitrile (6)Pyrimidine-5-Carboxylic Acid (7)Tetrahydropyrimidin-2(1H)-One (6)Thiazolo[5,4-D]Pyrimidine (5)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-D]Pyrimidine (24)
Pyrroles (4953)
Bromopyrrolo (8)Chloropyrrolo (10)Dihydropyrrolo (15)Octahydropyrrolo (6)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(Phenylsulfonyl)-1H-Pyrrole (24)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-Benzylpyrrolidin-2-One (18)1-Methyl-1H-Pyrrole (43)1H-Pyrrol-1-Amine (7)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrole-3-Carbonitrile (9)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2-Bromo-1H-Pyrrole (11)2-Methyl-1H-Pyrrole (49)2-Nitro-1H-Pyrrole (5)2-Phenyl-1H-Pyrrole (24)3,6-Di(Thiophen-2-Yl)-2,5-Dihydropyrrolo[3,4-C]Pyrrole-1,4-Dione (17)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Phenyl-1H-Pyrrole (5)3-Phenylpyrrolidine (26)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4H-Thieno[3,2-B]Pyrrole (6)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5H-Pyrrolo[2,3-B]Pyrazine (14)5H-Pyrrolo[3,2-D]Pyrimidine (16)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Pyrrolo[2,1-F][1,2,4]Triazine (14)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)
Pyrrolidines (14879)
Acetylpyrrolidine (9)Benzylpyrrolidine (33)Bipyrrolidine (9)Bromopyrrolidine (7)Carbamoylpyrrolidine (5)Difluoropyrrolidine (16)Dimethylpyrrolidine (31)Dioxopyrrolidin (131)Ethylpyrrolidine (9)Fluoropyrrolidine (26)Formylpyrrolidine (10)Mercaptopyrrolidine (4)Methoxypyrrolidine (19)Methylenepyrrolidine (2)Methylpyrrolidine (129)Phenoxypyrrolidine (3)Pyrrolidine-Benzene-Boronic Acid/Ester (20)(3Ar,6As)-Octahydrocyclopenta[C]Pyrrole (5)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylpyrrolidine (8)(S)-3-Phenylpyrrolidine (14)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)(S)-N-(4-(Thiazol-5-Yl)Benzyl)Pyrrolidine-2-Carboxamide (7)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Phenylsulfonyl)Pyrrolidine (15)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzylpyrrolidin-2-One (18)1-Benzylpyrrolidine (26)1-Methylpyrrolidin-2-One (13)1-Phenylpyrrolidin-2-One (18)2,2-Dimethylpyrrolidine (4)2,5-Dioxopyrrolidin-1-Yl ((Benzyloxy)Carbonyl)Glycinate (8)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2,8-Diazaspiro[4.5]Decan-3-One (6)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(2-Chlorophenyl)Pyrrolidine (17)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Pyrrolidine (5)2-(Methoxymethyl)Pyrrolidine (6)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-1-Yl)Pyridine (11)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Azabicyclo[2.2.1]Heptane (6)2-Methyl-1-Phenyl-1H-Pyrrole (8)2-Methylpyrrolidine (21)3,3-Difluoropyrrolidine (29)3-(Pyrrolidin-2-Yl)Pyridine (6)3-Aminopyrrolidin-2-One (5)3-Bromopyrrolidine (6)3-Hydroxypyrrolidin-2-One (4)3-Phenoxypyrrolidine (5)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenylpyrrolidine (26)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Hydroxypyrrolidin-2-One (7)4-Phenylpyrrolidin-2-One (7)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Azaspiro[2.4]Heptane (13)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Azaspiro[3.4]Octane (4)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Hydroxypyrrolidine-1-Carboxylate (5)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Hexahydro-1H-Pyrrolizine (12)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl Prolinate (43)Methyl Pyrrolidine-3-Carboxylate (9)N,N-Dimethylpyrrolidin-3-Amine (7)N-Methylpyrrolidin-3-Amine (6)Octahydrocyclopenta[C]Pyrrole (6)Phenyl(Pyrrolidin-1-Yl)Methanone (12)Proline (13)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ol (59)Pyrrolidin-3-Ylmethanamine (6)Pyrrolidin-3-Ylmethanol (13)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-2-Carboxamide (12)Pyrrolidine-3-Carbonitrile (6)Pyrrolidine-3-Carboxylic Acid (14)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Hydroxypyrrolidine-1-Carboxylate (20)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl Pyrrolidin-3-Ylcarbamate (12)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Pyrrolines (1763)
1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1-Phenyl-1H-Pyrrole-2,5-Dione (12)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,5-Dihydro-1H-Pyrrol-2-One (5)2,5-Dihydro-1H-Pyrrole (13)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)3,4-Dihydro-2H-Pyrrole (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)
Quinazolines (3143)
Dichloroquinazoline (14)Iodoquinazoline (10)Methylquinazoline (46)Nitroquinazoline (20)Trichloroquinazoline (5)2,4-Dichloroquinazoline (19)2-(Trifluoromethyl)Quinazoline (4)2-Bromoquinazoline (4)2-Chloroquinazolin-4(3H)-One (4)2-Cyclopropylquinazoline (5)2-Mercaptoquinazolin-4(3H)-One (3)2-Methylquinazoline (20)4-Chloroquinazoline (39)4-Methylquinazoline (4)5,6,7,8-Tetrahydroquinazoline (8)5-Chloroquinazoline (4)6-Bromoquinazoline (7)7-Bromoquinazolin-4(3H)-One (4)7-Fluoroquinazolin-4(3H)-One (4)7-Methoxy-N-Phenylquinazolin-4-Amine (12)8-Bromoquinazoline (8)8-Chloroquinazoline (5)8-Fluoroquinazoline (4)8-Methoxyquinazoline (3)8-Methylquinazoline (3)Ethyl Quinazoline-2-Carboxylate (4)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)Quinazolin-2-Amine (13)Quinazolin-2-Ol (7)Quinazolin-4-Amine (8)Quinazolin-4-Ol (10)
Quinolines (11910)
Iodoquinoline (32)1,2-Dihydroquinoline (5)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)2,2'-Biquinoline (3)2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinoline (7)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Hydroxyquinolin-4(1H)-One (3)2-Phenylquinoline (18)3,4-Dihydroisoquinoline (11)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Phenoxyquinoline (5)4-Phenylquinoline (9)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)7,8-Dihydroquinolin-5(6H)-One (5)7-(Benzyloxy)Quinoline (6)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)N-Phenylquinolin-4-Amine (11)
Quinoxalines (1411)
Dichloroquinoxaline (8)Dihydroquinoxalin (7)1,2,3,4-Tetrahydroquinoxaline (6)2-Chloroquinoxaline (39)2-Methylquinoxaline (5)2-Phenylquinoxaline (5)3,4-Dihydroquinoxalin-2(1H)-One (7)5-Bromoquinoxaline (6)6-Bromoquinoxaline (9)6-Chloroquinoxaline (3)6-Methoxyquinoxaline (6)Quinoxalin-2-Amine (3)Quinoxalin-2-Ol (4)
Quinuclidines (202)
Spiroes (4763)
Aminospiro (4)Azaspiro (246)Bromospiro (11)Diazaspiro (182)Dihydrospiro (18)Dioxaspiro (39)Fluorospiro (4)Oxospiro (22)Triazaspiro (13)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4-Dioxaspiro[4.5]Decane (17)2,8-Diazaspiro[4.5]Decane (5)2-Oxa-8-Azaspiro[4.5]Decane (5)3-Phenyloxetane (11)6-Azaspiro[3.4]Octane (4)7-Azaspiro[3.5]Nonane (7)9,9'-Spirobi[Fluorene] (19)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidine] (5)
Tetrahydrofurans (2265)
Hydroxytetrahydrofuran (16)Iodotetrahydrofuran (3)Methoxytetrahydrofuran (11)Oxotetrahydrofuran (26)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(3Ar,6Ar)-Hexahydrofuro[3,2-B]Furan (5)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-2-Yl)Methanol (6)(Tetrahydrofuran-3-Yl)Methanamine (3)1,3-Dihydrobenzo[C][1,2]Oxaborole (20)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1-Oxa-8-Azaspiro[4.5]Decane (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Oxa-8-Azaspiro[4.5]Decane (5)2-Oxabicyclo[2.1.1]Hexane (6)3-Aminodihydrofuran-2(3H)-One (4)3-Iodotetrahydrofuran (3)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Hydroxydihydrofuran-2(3H)-One (14)5-(Hydroxymethyl)Dihydrofuran-2(3H)-One (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)Dihydrofuran-3(2H)-One (7)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Amine (6)Tetrahydrofuran-3-Carboxylic Acid (4)Tetrahydrofuran-3-Ol (7)
Tetrahydroisoquinolines (1291)
Tetrahydroisoquinoline-Carboxylic Acid (48)(9H-Fluoren-9-Yl)Methyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (7)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,4-Dihydroisoquinolin-3(2H)-One (5)1-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)2-Methyl-1,2,3,4-Tetrahydroisoquinoline (13)4,4-Dimethyl-1,2,3,4-Tetrahydroisoquinoline (3)5,6,7,8-Tetrahydroisoquinoline (5)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)Isoquinoline-1,3(2H,4H)-Dione (7)
Tetrahydropyrans (3359)
Chroman-Amine (1)Difluorochroman (16)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)4-Phenoxytetrahydro-2H-Pyran (5)9-Bromoanthracene (5)
Tetrahydroquinolines (1464)
Tetrahydroquinoline-Carboxylic Acid (18)1-Ethyl-1,2,3,4-Tetrahydroquinoline (6)1-Methyl-1,2,3,4-Tetrahydroquinoline (6)2,3-Dihydroquinolin-4(1H)-One (19)2-Methyl-1,2,3,4-Tetrahydroquinoline (3)4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline (3)4-Methyl-1,2,3,4-Tetrahydroquinoline (2)5,6,7,8-Tetrahydroquinoline (17)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)Tert-Butyl 3,4-Dihydroquinoline-1(2H)-Carboxylate (11)
Tetrazoles (82)
1-Phenyl-1H-Tetrazole (6)5-Phenyl-1H-Tetrazole (23)5-Phenyl-2H-Tetrazole (9)
Thiadiazoles (2122)
1,2,3-Thiadiazole (8)1,2,4-Thiadiazole (15)1,2,5-Thiadiazole (6)1,3,4-Thiadiazol-2-Amine (9)2-Bromo-1,3,4-Thiadiazole (11)2-Methyl-1,3,4-Thiadiazole (12)2-Phenyl-1,3,4-Thiadiazole (19)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-Bromobenzo[C][1,2,5]Thiadiazole (14)Benzo[D][1,2,3]Thiadiazole (7)
Thiazines (62)
Thiazoles (6687)
Acetylthiazole (7)Bromothiazolo (9)Chlorothiazole (32)Chlorothiazolo (18)Cyanothiazole (7)Cyclopropylthiazole (11)Dibromothiazole (7)Dichlorothiazole (8)Dihydrothiazole (16)Dihydrothiazolo (14)Dimethylthiazole (22)Ethylthiazole (8)Formylthiazole (7)Methylthiazole (109)Nitrothiazol (8)Tetrahydrothiazolo (8)1-(Thiazol-2-Yl)Ethan-1-One (9)2,4-Dibromothiazole (5)2,4-Dichlorothiazole (4)2,4-Dimethylthiazole (7)2,5-Dibromothiazole (5)2,5-Dimethylthiazole (4)2-(Chloromethyl)Thiazole (5)2-(Methylthio)Thiazole (5)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethyl)Thiazole (11)2-Bromo-4-Methylthiazole (7)2-Bromo-5-Methylthiazole (7)2-Chloro-4-Methylthiazole (5)2-Chloro-5-Methylthiazole (5)2-Chlorothiazole (32)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)2-Isopropylthiazole (11)2-Methyl-4-Phenylthiazole (6)2-Phenoxythiazole (5)2-Phenylbenzo[D]Thiazole (16)2-Phenylthiazole-4-Carbaldehyde (9)4,5,6,7-Tetrahydrobenzo[D]Thiazole (14)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5-Dihydrothiazole (8)4-(4-Fluorophenyl)Thiazole (9)4-(Trifluoromethyl)Thiazole (7)4-Bromothiazole (10)4-Cyclopropylthiazole (6)4-Methyl-2-Phenylthiazole (6)4-Methylthiazol-2-Amine (7)4-Methylthiazole (5)4-Phenylthiazol-2-Amine (37)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)5-Bromothiazol-2-Amine (6)5-Bromothiazole (8)5-Methyl-4-Phenylthiazole (5)5-Methylthiazol-2-Amine (6)5-Phenylthiazole (20)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Phenylthiazole-4-Carboxylate (12)Ethyl 2-Phenylthiazole-5-Carboxylate (9)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)N-(Thiazol-2-Yl)Acetamide (9)N-(Thiazol-2-Yl)Benzamide (9)N-Phenylthiazol-2-Amine (9)Tert-Butyl Thiazol-2-Ylcarbamate (22)Thiazol-2-Ylmethanamine (5)Thiazol-2-Ylmethanol (9)Thiazol-5-Amine (6)Thiazole-2-Carbaldehyde (9)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carbaldehyde (19)Thiazole-5-Carbonitrile (7)Thiazole-5-Carboxylic Acid (10)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thiazolo[5,4-D]Pyrimidine (5)
Thiazolidines (1260)
Thioxothiazolidin (23)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)1,2,3-Oxathiazolidine 2,2-Dioxide (14)2-Thioxothiazolidin-4-One (6)Thiazolidine (16)
Thiomorpholines (454)
Thiomorpholine (10)Thiomorpholine 1,1-Dioxide (6)
Thiophenes (960)
Acetylthiophene (5)Aminothiophene (23)Bromothieno (29)Chlorothieno (41)Chlorothiophene (61)Cyanothiophene (5)Dibromothieno (5)Dibromothiophene (17)Dichlorothieno (10)Dichlorothiophene (13)Dihydrothieno (24)Dihydrothiophene (1)Dihydroxythiophene (7)Dimethylthieno (10)Dimethylthiophene (21)Dithiophene (40)Fluorothiophene (18)Formylthiophene (16)Hydroxythiophene (7)Iodothieno (6)Iodothiophene (13)Methylthieno (27)Nitrothiophene (27)Terthiophene (10)Tetrahydrothieno (17)Thiophenecarboxaldehyde (10)Thiphen-Amine-Hydrochloride (58)Trithiophene (5)(9H-Fluoren-9-Yl)Methyl (2-(Thiophen-2-Yl)Ethyl)Carbamate (5)1-(Thiophen-2-Yl)Ethan-1-One (17)2,2'-Bithiophene (25)2,2':5',2''-Terthiophene (9)2,3-Dihydrothieno[3,4-B][1,4]Dioxine (9)2,5-Dibromothiophene (18)2,5-Diphenylthiophene (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethyl)Thiophene (11)2-Chlorothiophene (20)2-Ethynylthiophene (8)2-Iodothiophene (14)2-Methoxythiophene (7)2-Nitrothiophene (20)3-Bromothiophene (6)3-Chlorothiophene (17)3-Fluorothiophene (6)3-Methoxythiophene (9)3-Methylthiophene (14)3-Nitrothiophene (6)3-Phenylthiophene (13)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,7-Di(Thiophen-2-Yl)Benzo[C][1,2,5]Thiadiazole (9)4,8-Di(Thiophen-2-Yl)Benzo[1,2-B:4,5-B']Dithiophene (8)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-Cyclopenta[2,1-B:3,4-B']Dithiophene (9)4H-Thieno[3,2-B]Pyrrole (6)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5,6-Dihydro-4H-Cyclopenta[B]Thiophene (7)5-(Thiophen-2-Yl)Isoxazole (5)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Phenylthiophen-2-Amine (5)Benzo[1,2-B:4,5-B']Dithiophene (7)Dibenzo[B,D]Thiophene (22)Dihydrothiophen-3(2H)-One (4)Dithieno[3,2-B:2',3'-D]Thiophene (5)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Methyl Thiophene-3-Carboxylate (34)N,N-Diphenyl-4-(Thiophen-2-Yl)Aniline (5)Phenyl(Thiophen-2-Yl)Methanone (6)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-B]Pyridine (18)Thieno[3,2-B]Thiophene (19)Thieno[3,2-C]Pyridine (13)Thieno[3,2-D]Pyrimidine (24)Thieno[3,4-B]Thiophene (5)Thiophen-2-Ylboronic Acid (20)Thiophen-2-Ylmethanol (11)Thiophen-3-Amine (18)Thiophen-3-Ol (6)Thiophene-2-Carbaldehyde (43)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbaldehyde (17)Thiophene-3-Carbonitrile (13)Thiophene-3-Carboxamide (5)Thiophene-3-Carboxylic Acid (8)
Triazines (1387)
1,2,4-Triazine (9)1,3,5-Triazin-2-Amine (3)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4,6-Triphenyl-1,3,5-Triazine (24)2,4-Diphenyl-1,3,5-Triazine (6)2-Chloro-1,3,5-Triazine (10)2-Methoxy-1,3,5-Triazine (10)2-Phenyl-1,3,5-Triazine (6)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)Pyrrolo[2,1-F][1,2,4]Triazine (14)
Triazoles (7749)
(5As,10Br)-2-Phenyl-2,5A,6,10B-Tetrahydro-4H-Indeno[2,1-B][1,2,4]Triazolo[4,3-D][1,4]Oxazin-11-Ium (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-Benzyl-1H-1,2,3-Triazole (8)1-Benzyl-1H-1,2,4-Triazole (6)1-Methyl-1H-1,2,3-Triazole (9)1-Methyl-1H-1,2,4-Triazole (17)1-Methyl-1H-Benzo[D][1,2,3]Triazole (10)1-Phenethyl-1H-1,2,4-Triazole (6)1-Phenyl-1H-1,2,3-Triazole (7)1-Phenyl-1H-1,2,4-Triazole (20)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenyl-2H-Benzo[D][1,2,3]Triazole (8)2H-1,2,3-Triazole (7)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-Phenyl-4H-1,2,4-Triazole (6)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-1,2,4-Triazole (13)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)
Other Aliphatic Heterocycles (6209)
1,3-Dioxane (20)1,4-Diazepane (12)3-Azabicyclo[3.1.0]Hexane (14)
Other Aromatic Heterocycles (37751)
Indolizine (15)Phenazine (8)
NHCs
Achiral NHCs Catalysts (35)
Achiral NHCs Ligands (110)
Chiral NHCs Catalysts (138)
Chiral NHCs Ligands (84)
Organic Building Blocks
Acyl Chlorides (3025)
2-Chlorobenzoyl Chloride (13)2-Phenoxyacetyl Chloride (3)2-Phenylacetyl Chloride (9)
Alcohols (45771)
Amino-Propanol (6)Cyclopropylethanol (6)Diethanol (23)Diethanol (23)Dihydroxybenzylidene (4)Dihydroxynaphthalene (7)Dihydroxypropanoate (7)Dihydroxyterephthalic Acid (3)Hydroxyacetamide (1)Hydroxyacetimidamide (3)Hydroxyadamantan (4)Hydroxyadamantan (4)Hydroxyazetidine (7)Hydroxybenzyl (18)Hydroxybenzylidene (5)Hydroxybicyclo (7)Hydroxybutan (4)Hydroxybutan (4)Hydroxybutanoate (36)Hydroxybutanoic (33)Hydroxycarbamimidoyl (2)Hydroxycinnamic Acid (2)Hydroxycyclobutyl (3)Hydroxycyclohexyl (7)Hydroxycyclopentyl (1)Hydroxydiphenylmethyl (2)Hydroxyethoxy (22)Hydroxyethoxy (22)Hydroxyhexanoate (8)Hydroxyhexanoic (6)Hydroxyimino (11)Hydroxyisonicotinaldehyde (7)Hydroxyisonicotinate (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic Acid (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Hydroxynaphthalene (29)Hydroxynicotinaldehyde (7)Hydroxynicotinate (13)Hydroxynicotinonitrile (6)Hydroxyoctadec (1)Hydroxyoctadec (1)Hydroxyoctadecanoic (7)Hydroxypentanoate (6)Hydroxypropanoic (35)Pentahydroxyhexanal (9)Phenyl-Methanol (3)Propanediol (9)Propanediol (9)Tetrahydroxy (25)Tetrahydroxy (25)Tetrahydroxyhexanal (9)Tetrahydroxypentanal (5)Trihydroxy (246)Trihydroxy (246)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenylcyclopropyl)Methanol (3)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)(1H-Indol-2-Yl)Methanol (8)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromophenyl)Methanol (39)(2-Chlorophenyl)Methanol (39)(2-Fluorophenyl)Methanol (60)(2-Iodophenyl)Methanol (12)(2-Nitrophenyl)Methanol (29)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Methanol (21)(3-Chlorophenyl)Methanol (38)(3-Fluorophenyl)Methanol (58)(3-Iodophenyl)Methanol (13)(3-Methylpyridin-2-Yl)Methanol (10)(3-Nitrophenyl)Methanol (31)(3-Phenoxyphenyl)Methanol (3)(3-Phenylisoxazol-5-Yl)Methanol (7)(4-Fluorophenyl)Methanol (29)(4-Nitrophenyl)Methanol (17)(6-Methylpyridin-2-Yl)Methanol (5)(Tetrahydrofuran-2-Yl)Methanol (6)1,2-Diphenylethan-1-Ol (8)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenylethan-1-Ol (102)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Amino-2-Phenylethan-1-Ol (196)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxyethyl Benzoate (3)2-Phenoxyethan-1-Ol (14)2-Phenylethan-1-Ol (77)2-Phenylpropan-2-Ol (21)3-Phenylpropan-1-Ol (24)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Phenylpiperidin-4-Ol (10)Azetidin-2-Ylmethanol (7)Azetidin-3-Ol (11)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Cyclobutanol (46)Cyclobutylmethanol (15)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanol (51)Diphenylmethanol (20)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Ylmethanol (5)M-Tolylmethanol (34)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Naphthalen-1-Ylmethanol (8)O-Tolylmethanol (35)Oxiran-2-Ylmethanol (3)Piperidin-2-Ylmethanol (11)Piperidin-3-Ol (27)Piperidin-3-Ylmethanol (15)Piperidin-4-Ylmethanol (11)Pyridin-2-Ylmethanol (65)Pyridin-3-Ylmethanol (39)Pyridin-4-Ylmethanol (16)Pyrimidin-2-Ylmethanol (5)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ylmethanol (13)Quinazolin-2-Ol (7)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Thiazol-2-Ylmethanol (9)Thiophen-2-Ylmethanol (11)Triphenylmethanol (13)
Aldehydes (18914)
Aminonicotinaldehyde (5)Aminonicotinaldehyde (5)Carboxyaldehyde (1094)Dicarbaldehyde (37)Dicarbaldehyde (37)Formylisonicotinate (7)Tetracarbaldehyde (8)Tetracarbaldehyde (8)Tricarbaldehyde (10)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Naphthaldehyde (23)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Indazole-3-Carbaldehyde (19)1H-Indole-2-Carbaldehyde (20)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3-Dichlorobenzaldehyde (7)2,3-Difluorobenzaldehyde (18)2,4-Dichlorobenzaldehyde (8)2,4-Difluorobenzaldehyde (19)2,6-Dibromobenzaldehyde (4)2,6-Difluorobenzaldehyde (25)2-(Benzyloxy)Benzaldehyde (13)2-(Phenylethynyl)Benzaldehyde (9)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethyl)Benzaldehyde (27)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-6-Fluorobenzaldehyde (15)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-4-Fluorobenzaldehyde (10)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluorobenzaldehyde (175)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodobenzaldehyde (17)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Naphthaldehyde (12)2-Nitrobenzaldehyde (53)2-Oxo-2-Phenylacetaldehyde (12)2-Phenylacetaldehyde (20)3-(Benzyloxy)Benzaldehyde (13)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethyl)Benzaldehyde (31)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Methoxybenzaldehyde (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-4-Methoxybenzaldehyde (7)3-Chlorobenzaldehyde (106)3-Fluorobenzaldehyde (137)3-Iodobenzaldehyde (28)3-Methoxy-2-Nitrobenzaldehyde (3)3-Nitrobenzaldehyde (49)3-Phenoxybenzaldehyde (7)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-(Benzyloxy)Benzaldehyde (23)4-(Piperazin-1-Yl)Benzaldehyde (5)4-Fluorobenzaldehyde (78)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Morpholinobenzaldehyde (8)4-Nitrobenzaldehyde (18)4-Phenoxybenzaldehyde (12)5-Phenylfuran-2-Carbaldehyde (9)6-Methoxynicotinaldehyde (4)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-4-Carbaldehyde (31)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-3-Carbaldehyde (6)Benzo[D][1,3]Dioxole-5-Carbaldehyde (6)Benzofuran-2-Carbaldehyde (5)Furan-2-Carbaldehyde (22)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Isonicotinaldehyde (68)Methyl 3-Formylbenzoate (23)Nicotinaldehyde (153)Picolinaldehyde (98)Pyrazine-2-Carbaldehyde (17)Pyrimidine-5-Carbaldehyde (38)Thiazole-2-Carbaldehyde (9)Thiazole-5-Carbaldehyde (19)Thiophene-2-Carbaldehyde (43)Thiophene-3-Carbaldehyde (17)
Aliphatic Chain Hydrocarbons (12579)
Acetylthio (7)Acetylthio (7)Azanonadecan (7)Azanylylidene (1)Azapentadecan (10)Azapentadecan (10)Azatridecan (4)Butyloctyl (4)Butyloctyl (4)Carbonylbis (2)Carbonylbis (2)Diazirine (13)Diazirine (13)Didodecyl (7)Didodecyl (7)Diethyl (73)Diethyl (73)Dihydroxypropan (6)Diisobutyl (2)Diisopropyl (27)Diisopropyl (27)Dimethoxy (306)Dimethyladamantane (14)Dimethyladamantane (14)Dimethylalkanes (7)Dinonyl (1)Dinonyl (1)Dioctyl (1)Dioxide (451)Dioxide (451)Ethoxy (711)Ethoxyethoxy (5)Ethoxyethoxy (5)Ethoxyethyl (16)Ethoxyethyl (16)Ethoxymethyl (11)Ethoxymethylene (1)Ethoxymethylene (1)Isopropylidenebis (2)Isopropylsulfonyl (10)Isopropylsulfonyl (10)Methoxybut (2)Methoxybut (2)Methoxyethoxy (67)Methoxyethoxy (67)Methoxyethyl (69)Methoxyisonicotinic (11)Methoxyisonicotinic (11)Methoxymethoxy (23)Methoxymethoxy (23)Methoxymethyl (117)Methoxynicotinic (26)Methoxynicotinic (26)Methoxynicotinic Acid (20)Methoxypropan (24)Methoxypropan (24)Methoxypropoxy (8)Methoxypropoxy (8)Methoxypropyl (10)Methoxytetrahydro (14)Methoxytetrahydro (14)Methyladamantan (4)Methylisonicotinic (13)Oxoethoxy (1)Oxopropane (10)Oxopropyl (32)Oxopropyl (32)Pentyloxy (7)Tetramethoxy (6)Trimethoxy (15)Trimethoxy (15)Yldisulfanyl (7)
Aliphatic Cyclic Hydrocarbons (11046)
Aminobicyclo (24)Aminocyclobutanol (5)Aminocyclobutyl (5)Aminocyclohexane (55)Aminocyclohexanol (21)Aminocyclopentanol (17)Aminocyclopentyl (6)Aminocyclopropyl (4)Azabicyclo (292)Azabicyclo (292)Azatricyclo (5)Azatricyclo (5)Azetidine (185)Azetidine (185)Benzylazetidin (9)Bicyclo (61)Bicyclohexyl (6)Bromobicyclo (9)Butylcyclohexyl (9)Butylsulfonyl (6)Chlorocyclopropyl (2)Cyanoazetidine (5)Cyanocyclopropyl (4)Cyclobutanecarbonitrile (2)Cyclobutylacetic (4)Cyclobutylmethyl (4)Cyclobutylmethyl (4)Cyclodextrin (1)Cyclodextrin (1)Cyclohexa (176)Cyclohexa (176)Cyclohexane (127)Cyclohexane (127)Cyclohexanecarboxylic (19)Cyclohexanediamine (8)Cyclohexanone (92)Cyclohexylacetic (2)Cyclohexylamino (9)Cyclohexylbutanoic (4)Cyclohexylcarbamoyl (5)Cyclohexylethanamine (12)Cyclohexylmethoxy (4)Cyclohexylmethoxy (4)Cyclohexylmethyl (7)Cyclohexylmethyl (7)Cyclohexyloxy (10)Cyclohexylpropan (94)Cyclohexylpropanoic (9)Cyclopentadienyl (2)Cyclopentane (169)Cyclopentane (169)Cyclopentanecarboxylic (7)Cyclopentyl (56)Cyclopentyl (56)Cyclopentylacetic (3)Cyclopentylamino (1)Cyclopentylmethyl (4)Cyclopentyloxy (16)Cyclopentyloxy (16)Cyclopentylpropanoic (1)Cyclopropanamine (32)Cyclopropanamine (32)Cyclopropanecarbonitrile (14)Cyclopropanecarbonyl (6)Cyclopropanecarbonyl (6)Cyclopropanecarboxamide (14)Cyclopropanol (4)Cyclopropoxyphenyl (7)Cyclopropyl (355)Cyclopropyl (355)Cyclopropylacetate (6)Cyclopropylacetic (3)Cyclopropylamino (24)Cyclopropylcarbamoyl (5)Cyclopropylethan (5)Cyclopropylethan (5)Cyclopropylethynyl (1)Cyclopropylmethoxy (32)Cyclopropylmethoxy (32)Cyclopropylmethyl (22)Cyclopropylmethyl (22)Cyclopropylpropanoic (5)Cyclopropylsulfonyl (6)Cyclopropylsulfonyl (6)Diazabicyclo (77)Diazabicyclo (77)Dicyclohexyl (6)Dicyclohexyl (6)Dicyclohexylphosphino (18)Dicyclohexylphosphino (18)Difluorocyclobutyl (6)Difluorocyclohexyl (7)Dihydroinden (8)Dihydroindeno (5)Dihydroindeno (5)Dihydropteridin (6)Dimethylbicyclo (5)Dimethylbicyclo (5)Dimethylcyclohex (5)Dimethylcyclohexane (16)Dimethylcyclohexanone (7)Dioxathiolane (1)Dioxathiolane (1)Dioxol (175)Dithiolan (1)Dithiolan (1)Ethylcyclohexyl (4)Ethylcyclohexyl (4)Ethylsulfonyl (42)Fluoroazetidine (1)Fluorobicyclo (4)Hexahydrocyclohepta (6)Hexahydrocyclohepta (6)Hexahydrocyclopenta (4)Hydroxycyclobutanecarboxylic (4)Hydroxycyclohexanecarboxylic (6)Methanesulfonyl (314)Methanesulfonyl (314)Methoxycyclohexanamine (6)Methylazetidine (30)Methylbicyclo (6)Methylbicyclo (6)Methylcyclobutanamine (5)Methylcyclobutanecarboxylic (5)Methylcyclohexanamine (12)Methylcyclohexane (8)Methylcyclohexane (8)Methylcyclohexanecarboxylic (5)Methylcyclohexanecarboxylic Acid (4)Methylcyclohexanol (21)Methylcyclohexanone (5)Methylcyclohexyl (33)Methylcyclopentane (2)Methylcyclopropanamine (4)Methylcyclopropanamine (4)Methylcyclopropane (16)Methylsulfinyl (24)Methylsulfonimidoyl (6)Methylsulfonimidoyl (6)Methylsulphonyl (10)Octahydrocyclopenta (14)Oxabicyclo (40)Oxabicyclo (40)Oxazepane (13)Oxetanes (228)Oxoazetidine (8)Oxoazetidine (8)Oxobicyclo (11)Oxobicyclo (11)Oxocyclobutyl (2)Oxocyclohex (3)Oxocyclohexane (4)Oxocyclohexane (4)Oxocyclohexanecarboxylic (6)Oxocyclohexyl (3)Oxocyclohexyl (3)Oxocyclopentane (2)Oxocyclopentyl (5)Pentamethylcyclopentadienyl (11)Pentylcyclohexyl (10)Pentylcyclohexyl (10)Phenylcyclopropanamine (8)Propylcyclohexyl (15)Propylcyclohexyl (15)Tetraazacyclododecane (13)Tetraazacyclododecane (13)Tetraazacyclotetradecane (7)Tetraazacyclotetradecane (7)Tetramethylcyclohexane (4)Tetraoxatridecan (3)Tetraoxatridecan (3)Thiazepine (2)Tricyclohexylphosphine (9)Trimethylbicyclo (21)Trimethylcyclohex (20)Trimethylcyclohexane (1)Trimethylcyclohexane (1)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1-Phenylcyclopropyl)Methanol (3)(3Ar,E)-4-((Z)-2-(2-Methylenecyclohexylidene)Ethylidene)Octahydro-1H-Indene (7)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Pentylcyclohexyl)Benzene (5)(4-Propylcyclohexyl)Benzene (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Cyclopropylmethoxy)Benzene (18)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,1-Difluorocyclopentane (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-3-Cyclopropylbenzene (6)1-Chloro-2-Cyclopropylbenzene (7)1-Cyclohexyl-2-Fluorobenzene (4)1-Cyclopropyl-3-Methylbenzene (3)1-Methylcyclohex-1-Ene (26)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropan-1-Amine (26)1-Phenylcyclopropane-1-Carbonitrile (19)1-Phenylcyclopropane-1-Carboxylic Acid (23)2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-2-Phenylacetic Acid (5)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Cyclohexylacetic Acid (14)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Cyclopropylpyrimidine (10)2-Iodo-9H-Fluorene (8)2-Methylcyclohexan-1-One (3)2-Phenylcyclopropan-1-Amine (19)3,3-Dimethylcyclohexan-1-One (4)3-Cyclopropylpyridine (28)3-Methylcyclohexan-1-One (9)4-Cyclohexylbenzoic Acid (6)4-Cyclohexylbenzonitrile (10)4-Cyclohexylphenol (7)5-Azaspiro[2.4]Heptane (13)6-Azaspiro[2.5]Octane (10)9,9-Dimethyl-9H-Fluorene (16)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Bicyclo[2.2.1]Hept-2-Ene (18)Bicyclo[2.2.1]Heptane (15)Bromocyclohexane (7)Cyclobutanamine (90)Cyclobutanecarboxylic Acid (23)Cyclobutanol (46)Cyclobutylmethanol (15)Cycloheptane (12)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanamine (59)Cyclohexanecarboxylic Acid (83)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanamine (5)Cyclopentanecarboxylic Acid (26)Cyclopentanol (51)Cyclopropoxybenzene (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Isopropylcyclohexane (19)Methoxycyclohexane (7)Methyl 1-Phenylcyclopropane-1-Carboxylate (10)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)N-Methylcyclohexanamine (7)Naphthalene-1,4-Dione (23)Spiro[3.3]Heptane (11)Tert-Butyl (1-Phenylcyclopropyl)Carbamate (6)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclobutylcarbamate (17)Tert-Butyl Cyclohexylcarbamate (9)Tert-Butyl Cyclopentylcarbamate (28)
Alkenyls (16078)
Acrylaldehyde (11)Acryloyl (9)Acryloyl (9)Annulene (2)Cyclohexene (88)Cyclooctene (9)Cyclopentene (3)Diacrylamide (6)Diallyl (5)Diazene (21)Divinyl (1)Divinyl (1)Enamide (6)Enamide (6)Enecarbaldehyde (2)Enoyl (9)Methacrylamide (3)Methacrylamide (3)Methoxycinnamaldehyde (3)Nitroethylene (37)Tetrahydrocyclopenta (19)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Nitrovinyl)Benzene (28)(Allyloxy)Benzene (19)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1,2-Diphenylethene (5)1,3,3-Trimethylcyclohex-1-Ene (12)1-Bromo-4-Styrylbenzene (5)1-Methylcyclohex-1-Ene (26)2-Benzalacetophenone (36)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methyleneazetidine (8)3-Phenylacrylaldehyde (29)3-Styrylphenol (11)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Prop-1-En-2-Yl)Cyclohex-1-Ene (5)5H-Dibenzo[B,F]Azepine (4)Allyl Benzoate (5)Cyclohex-1-En-1-Yl Trifluoromethanesulfonate (3)Cyclohex-1-En-1-Ylboronic Acid (4)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohexa-1,3-Diene (5)Cyclopent-2-En-1-Amine (4)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Methyl Cinnamate (36)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methylenecyclobutane (8)Methylenecyclohexane (8)N-Phenylacrylamide (7)Styrene (81)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Vinylcyclopropane (8)
Alkyls (195)
Isopropyl-Phenyl-Boronic Acid/Ester (26)Methylpentan (11)
Alkynyls (2698)
(Bromoethynyl)Benzene (5)(Prop-2-Yn-1-Yloxy)Benzene (13)1,3,5-Tris(Phenylethynyl)Benzene (6)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-Ethynyl-2-Fluorobenzene (10)1-Methyl-4-(Phenylethynyl)Benzene (7)2-(Phenylethynyl)Benzaldehyde (9)2-Ethynylpyridine (31)2-Ethynylthiophene (8)3-Ethynylpyridine (22)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-(Phenylethynyl)Phenol (7)4-Ethynylpyridine (10)9,10-Bis(Phenylethynyl)Anthracene (5)Ethynylbenzene (145)Trimethyl(Phenylethynyl)Silane (23)
Amides (90371)
Acetamide (651)Acetamide (651)Acetamido (156)Carboxamide (929)Carboxamide (929)Diacetamide (3)Dicarboxamide (19)Diethylacetamide (4)Diethylacetamide (4)Dimethylacetamide (9)Dimethylnicotinamide (7)Dimethylnicotinamide (7)Formamidophenylboronic Acid/Ester (11)Isobutyramide (7)Oxobutanamide (10)Oxobutanamide (10)Pentanamide (18)Pentanamide (18)Propanamide (2)Propanamido (5)Propanamido (5)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)(S)-N-Phenylpiperidine-2-Carboxamide (1)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-Methylindoline-2,3-Dione (8)1-Phenylurea (11)1H-Pyrazole-5-Carboxamide (3)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Trifluoromethyl)Benzamide (6)2-Amino-3-Phenylpropanamide (8)2-Amino-N-Phenylbenzamide (21)2-Aminobenzamide (30)2-Bromo-N-Phenylacetamide (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylbenzamide (4)2-Chlorobenzamide (16)2-Fluoro-N-Methylbenzamide (12)2-Fluorobenzamide (32)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Iodobenzamide (4)2-Methoxybenzamide (9)3-Benzamidopropanoic Acid (3)3-Bromo-4-Fluorobenzamide (3)3-Fluorobenzamide (26)3-Nitrobenzamide (17)3-Oxo-N-Phenylbutanamide (10)4-Amino-N-Phenylbenzamide (7)4-Benzamidobenzoic Acid (3)4-Fluorobenzamide (19)4-Oxo-4-(Phenylamino)Butanoic Acid (7)Benzoylglycine (15)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Phenylcarbamate (15)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Isonicotinamide (12)N,N-Diethylbenzamide (17)N,N-Dimethylbenzamide (34)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)N-(2-Chlorophenyl)Acetamide (16)N-(2-Iodophenyl)Acetamide (8)N-(2-Nitrophenyl)Acetamide (11)N-(3-Fluorophenyl)Acetamide (14)N-(4-Aminophenyl)Benzamide (2)N-(4-Chlorophenyl)Acetamide (9)N-(4-Chlorophenyl)Benzamide (6)N-(4-Fluorophenyl)Benzamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-(O-Tolyl)Benzamide (9)N-(P-Tolyl)Benzamide (6)N-(Thiazol-2-Yl)Acetamide (9)N-Isopropylbenzamide (16)N-Methoxy-N-Methylbenzamide (24)N-Methylbenzamide (58)N-Methylpicolinamide (10)N-Phenylacrylamide (7)N-Phenylpivalamide (11)Nicotinamide (64)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Picolinamide (26)Piperidine-3-Carboxamide (5)Pyrazine-2-Carboxamide (10)Pyrrolidine-2-Carboxamide (12)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Thiophene-3-Carboxamide (5)
Amidines (1564)
Carbamimidoyl (16)Benzimidamide (50)N'-Hydroxybenzimidamide (13)Picolinimidamide (11)
Amines (139951)
Amino-Carboxylate (2)Amino-Propanol (6)Aminoacetamido (4)Aminoacetyl (2)Aminoadamantan (5)Aminoadamantan (5)Aminoazepane (10)Aminobutane (23)Aminobutane (23)Aminobutyl (15)Aminobutyl (15)Aminoethoxy (18)Aminoethoxy (18)Aminoethyl (157)Aminoethyl (157)Aminohexan (6)Aminohexyl (3)Aminohexyl (3)Aminoisonicotinic Acid (12)Aminomethyl (403)Aminomethyl (403)Aminooxy (6)Aminopentyl (10)Aminopentyl (10)Aminopropanamido (1)Aminopropane (20)Aminopropane (20)Aminopropoxy (2)Aminopropoxy (2)Aminotetrahydro (12)Aminotetrahydro (12)Benzylazetidine (4)Bromobenzylamine (6)Bromobenzylcarbamate (28)Butoxycarbonylamino (8)Butylcarbamoyl (5)Carbamothioyl (2)Carbamoyl (114)Chlorobenzylamine (4)Chroman-Amine (1)Diamino (90)Diamino (90)Diaminopteridin (3)Diaminopteridin (3)Dibutylamino (6)Dibutylamino (6)Dichlorobenzylamine (5)Diethylamino (91)Diethylamino (91)Diisopropylamino (1)Dimethyl-Ethylamine (2)Dimethylamino (490)Dimethylamino (490)Dimethylcarbamoyl (14)Dimethylmethanamine (16)Dipropylamino (1)Dipropylamino (1)Ethylamino (37)Ethylamino (37)Fluindamine (32)Hydroxyamino (3)Hydroxyamino (3)Imidazol-Amine (1)Methoxyethanamine (1)Methoxyethanamine (1)Methoxyimino (2)Methylamino (241)Methylamino (241)Methylcarbamoyl (19)Methylcarbamoyl (19)Propanediamine (6)Propylamino (5)Propylamino (5)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)Silanamine (3)Triamine (25)Triamine (25)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)Methanamine (12)(2-Chlorophenyl)Methanamine (28)(2-Fluorophenyl)Methanamine (49)(3-Chlorophenyl)Methanamine (19)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Fluorophenyl)Methanamine (27)(6-Methylpyridin-2-Yl)Methanamine (6)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-3-Yl)Methanamine (3)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2-Diphenylethan-1-Amine (15)1,3,4-Thiadiazol-2-Amine (9)1,3,5-Triazin-2-Amine (3)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-Aminoanthracene-9,10-Dione (8)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-4-Amine (8)1-Methyl-1H-Pyrazol-3-Amine (14)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclopropan-1-Amine (26)1-Phenylethan-1-Amine (436)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Imidazol-2-Amine (6)1H-Indazol-3-Amine (23)1H-Indazol-4-Amine (12)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-7-Amine (6)1H-Indol-4-Amine (10)1H-Indol-6-Amine (21)1H-Indol-7-Amine (10)1H-Pyrazol-4-Amine (6)1H-Pyrazol-5-Amine (19)1H-Pyrrol-1-Amine (7)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,3-Dichloroaniline (18)2,3-Difluoroaniline (34)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,4-Dibromoaniline (18)2,4-Dichloropyrimidin-5-Amine (6)2,4-Difluoroaniline (44)2,5-Difluoroaniline (34)2,6-Dibromoaniline (17)2,6-Dichloroaniline (27)2,6-Difluoroaniline (23)2,6-Diiodoaniline (8)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(Diethylamino)Ethyl Benzoate (3)2-(Methylsulfonyl)Aniline (3)2-(Phenylamino)Benzoic Acid (11)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethyl)Aniline (58)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-Phenylethan-1-Ol (196)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-Chlorophenol (4)2-Amino-3-Fluorobenzoic Acid (11)2-Amino-6-Bromophenol (3)2-Amino-6-Chlorobenzoic Acid (5)2-Amino-6-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Aminobenzamide (30)2-Aminobenzenesulfonic Acid (9)2-Aminophenol (107)2-Aminopyrimidin-4(3H)-One (11)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Methylaniline (6)2-Bromo-4-Methylaniline (14)2-Bromo-6-Methylaniline (11)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Chloro-3-Methylaniline (4)2-Chloro-4-Methylaniline (7)2-Chloro-6-Methylaniline (11)2-Chloro-N-Methylaniline (4)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,4-Diamine (6)2-Chloropyrimidin-4-Amine (22)2-Fluoro-6-Iodoaniline (7)2-Fluoro-N-Phenylaniline (4)2-Fluoroaniline (262)2-Iodo-4-Methylaniline (5)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Methoxypyridin-3-Amine (6)2-Methyl-6-Nitroaniline (10)2-Methyl-N-Phenylaniline (6)2-Methylpyridin-4-Amine (7)2-Methylpyrimidin-4-Amine (22)2-Nitro-N-Phenylaniline (3)2-Phenoxyaniline (4)2-Phenylcyclopropan-1-Amine (19)2-Phenylpyrimidin-5-Amine (5)3,4-Dibromoaniline (4)3,4-Dichloroaniline (21)3,4-Difluoroaniline (44)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(Benzyloxy)Aniline (12)3-(Methylsulfonyl)Aniline (7)3-(Piperazin-1-Yl)Aniline (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethyl)Aniline (102)3-Aminobenzenesulfonic Acid (6)3-Aminodihydrofuran-2(3H)-One (4)3-Bromo-2-Fluoroaniline (15)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methylaniline (14)3-Bromoaniline (187)3-Bromobenzene-1,2-Diamine (11)3-Chloro-2-Iodoaniline (3)3-Chloro-2-Methylaniline (11)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Iodoaniline (3)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methylaniline (12)3-Chlorobenzene-1,2-Diamine (6)3-Chloropyrazin-2-Amine (6)3-Fluoro-2-Methylaniline (9)3-Fluoroaniline (289)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Methoxypyridin-2-Amine (5)3-Methyl-N-Phenylaniline (4)3-Methylpyridin-2-Amine (7)3-Nitroaniline (98)3-Phenoxyaniline (2)3-Phenyl-1H-Pyrazol-5-Amine (11)3-Phenylisoxazol-5-Amine (8)4,6-Dichloropyrimidin-2-Amine (9)4-(Benzyloxy)Aniline (8)4-(Oxazol-5-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Trifluoromethoxy)Aniline (26)4-Amino-2-Chlorobenzonitrile (8)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorobenzoic Acid (6)4-Amino-3-Chlorophenol (5)4-Amino-N-Phenylbenzenesulfonamide (3)4-Aminopyridazin-3(2H)-One (4)4-Benzylaniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Iodoaniline (3)4-Chloro-3-Methylaniline (11)4-Chloro-N-Phenylaniline (6)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Fluoro-N-Phenylaniline (4)4-Fluoroaniline (225)4-Iodo-N,N-Diphenylaniline (3)4-Methoxy-N-Phenylaniline (5)4-Methyl-3-Nitroaniline (8)4-Methylpyrimidin-2-Amine (9)4-Methylthiazol-2-Amine (7)4-Morpholinoaniline (4)4-Nitroaniline (65)4-Phenoxyaniline (6)4-Phenylpyrimidin-2-Amine (15)4-Phenylthiazol-2-Amine (37)5-Bromopyrazin-2-Amine (13)5-Bromothiazol-2-Amine (6)5-Chloropyrazin-2-Amine (9)5-Methoxypyridin-3-Amine (4)5-Methyl-2-Nitroaniline (6)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Methylthiazol-2-Amine (6)5-Phenylthiophen-2-Amine (5)5H-Dibenzo[B,F]Azepine (4)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)6-Chloropyridazin-3-Amine (5)6-Chloropyrimidin-4-Amine (8)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylpyridin-2-Amine (46)6-Methylpyridin-3-Amine (5)6-Phenoxypyridin-3-Amine (5)7-Methoxy-N-Phenylquinazolin-4-Amine (12)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)9H-Purin-6-Amine (3)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-3-Amine (11)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Azetidin-3-Amine (4)Azetidin-3-Ylmethanamine (3)Aziridine (9)Benzo[B]Thiophen-2-Amine (5)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Bis(Pyridin-2-Ylmethyl)Amine (6)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Cyclobutanamine (90)Cyclohexanamine (59)Cyclopent-2-En-1-Amine (4)Cyclopentanamine (5)Cyclopropyl(Phenyl)Methanamine (22)Diphenylmethanamine (26)Ethyl 2-Aminobenzoate (23)Ethyl 3-Aminobenzoate (19)Ethyl 4-Aminobenzoate (23)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Isoquinolin-1-Amine (18)Isoquinolin-3-Amine (13)Isoquinolin-4-Amine (16)Isoquinolin-5-Amine (9)Isoquinolin-8-Amine (6)Isoxazol-5-Amine (15)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 4-Aminobenzoate (71)Methyl L-Phenylalaninate (20)Morpholin-2-Ylmethanamine (8)N,N-Diethylaniline (17)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N,N-Dimethylaniline (117)N,N-Dimethylnaphthalen-1-Amine (4)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N,N-Dimethylpyrimidin-2-Amine (10)N,N-Dimethylpyrrolidin-3-Amine (7)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-(4-Aminophenyl)Benzamide (2)N-(Furan-2-Ylmethyl)Aniline (5)N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine (3)N-Benzyl-1-Phenylethan-1-Amine (7)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylpiperidin-4-Amine (3)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-1,2-Diphenylethan-1-Amine (7)N-Methyl-1-Phenylmethanamine (65)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)N-Methylaniline (140)N-Methylcyclohexanamine (7)N-Methylpiperidin-3-Amine (5)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Methylpyrrolidin-3-Amine (6)N-Phenyl-3-(Trifluoromethyl)Aniline (3)N-Phenyl-4-(Trifluoromethyl)Aniline (3)N-Phenylnaphthalen-1-Amine (5)N-Phenylpyridin-2-Amine (9)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N1,N1-Diphenylbenzene-1,4-Diamine (2)N1-Phenylbenzene-1,4-Diamine (3)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Naphthalen-2-Amine (12)O-Benzylhydroxylamine (16)Oxazol-2-Amine (8)Phenylmethanamine (315)Piperidin-2-Ylmethanamine (6)Piperidin-3-Amine (17)Piperidin-3-Ylmethanamine (5)Piperidin-4-Amine (14)Piperidin-4-Ylmethanamine (7)Pyrazin-2-Amine (22)Pyrazin-2-Ylmethanamine (12)Pyridazin-3-Amine (18)Pyridazin-4-Amine (10)Pyridin-2-Amine (29)Pyridin-2-Ylmethanamine (38)Pyridin-3-Amine (21)Pyridin-3-Ylmethanamine (29)Pyridin-4-Amine (22)Pyridin-4-Ylmethanamine (12)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-4-Amine (29)Pyrimidin-5-Amine (6)Pyrimidine-2,4-Diamine (14)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-3-Ylmethanamine (6)Quinazolin-2-Amine (13)Quinazolin-4-Amine (8)Quinoxalin-2-Amine (3)Tetrahydrofuran-3-Amine (6)Thiazol-2-Ylmethanamine (5)Thiazol-5-Amine (6)Thiophen-3-Amine (18)Tri([1,1'-Biphenyl]-4-Yl)Amine (9)
Anhydrides (659)
Dianhydride (3)1H,3H-Benzo[De]Isochromene-1,3-Dione (8)Furan-2,5-Dione (8)
Aryls (187653)
Acetylbenzonitrile (3)Aminobenzyl (7)Benzylamine (21)Benzylamino (47)Benzylhydroxylamine (25)Benzylidene (16)Benzylidene (16)Benzyloxy (1061)Benzylthio (16)Benzylthio (16)Cyanobenzyl (12)Dibenzyl (15)Dibenzylamino (7)Dichlorobenzylidene (8)Difluorobenzyl (17)Dimethoxybenzyl (20)Dimethoxybenzyl (20)Dimethylbenzonitrile (25)Dimethylbenzyl (6)Dimethylbenzyl (6)Dimethylbenzylamine (6)Ethoxybenzyl (8)Ethoxybenzyl (8)Fluorobenzyl (132)Fluorobenzylidene (2)Formylbenzonitrile (35)Iodobenzyl (9)Isopropylbenzonitrile (4)Methoxybenzyl (176)Methoxybenzylamine (7)Methoxybenzylidene (6)Methylbenzonitrile (104)Methylbenzyl (73)Methylbenzyl (73)Methylbenzylamine (8)Methylbenzylidene (1)Methylbenzylidene (1)Nitrobenzyl (33)Nitrobenzylidene (2)Phenoxybenzonitrile (5)Trifluorobenzyl (2)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(8S,9S,14R)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[A]Phenanthren-3-One (1)(9H-Fluoren-9-Yl)Methyl (2-(Tritylthio)Ethyl)Carbamate (10)(9H-Fluoren-9-Yl)Methyl Cyclohexylcarbamate (8)(Benzylsulfonyl)Benzene (11)(Cyclopentyloxy)Benzene (12)1,1-Dimethylcyclopropane (5)1,3,4,5-Tetrahydro-2H-Benzo[B]Azepin-2-One (15)1,3-Diphenylurea (24)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-Benzyl-4-Chlorobenzene (6)1-Benzyl-4-Fluorobenzene (2)1-Bromonaphthalene (4)1-Chloronaphthalene (24)1-Fluoronaphthalene (23)1-Methoxynaphthalene (17)1-Methyl-4-(Phenylethynyl)Benzene (7)1-Methylnaphthalene (10)1-Naphthaldehyde (23)1-Naphthoic Acid (23)1-Nitronaphthalene (3)10H-Phenothiazine (20)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,5-Diphenylthiophene (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-Benzylaniline (5)2-Bromo-1,1'-Biphenyl (12)2-Bromonaphthalene (4)2-Chloro-1,1'-Biphenyl (8)2-Chloronaphthalene (6)2-Ethoxynaphthalene (4)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Iodonaphthalene (5)2-Methoxy-1,1'-Biphenyl (7)2-Methoxynaphthalene (22)2-Methoxytetrahydro-2H-Pyran (9)2-Methyl-1,1'-Biphenyl (26)2-Methylnaphthalene (13)2-Naphthaldehyde (12)2-Naphthoic Acid (14)2-Naphthonitrile (15)2-Nitronaphthalene (4)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)2-Phenylnaphthalene (12)3,3'-Diphenyl-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (13)3,3-Diphenyl-3H-Benzo[C][1,2]Oxathiole 1,1-Dioxide (19)3-Bromo-1,1'-Biphenyl (12)3-Chloro-1,1'-Biphenyl (12)3-Fluoro-1,1'-Biphenyl (16)3-Methyl-1,1'-Biphenyl (10)3-Methyl-1,1':4',1''-Terphenyl (3)3-Phenethylphenol (5)3-Phenyl-1,2,4,5-Tetrazine (9)3-Styrylphenol (11)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Phenylsulfonyl)Morpholine (14)4-(Tert-Butyl)-1,1'-Biphenyl (5)4-Cyclohexylphenol (7)4-Iodo-1,1'-Biphenyl (9)4-Methoxy-1,1'-Biphenyl (4)9H-Xanthene (7)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-2-Ol (16)[1,1'-Biphenyl]-3-Amine (11)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-3-Carboxylic Acid (39)[1,1'-Biphenyl]-3-Ol (9)[1,1'-Biphenyl]-4-Carbaldehyde (31)[1,1'-Biphenyl]-4-Carbonitrile (27)[1,1'-Biphenyl]-4-Ol (28)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzyltriphenylphosphonium (14)Cyclopentylbenzene (28)Cyclopropanecarboxylic Acid (11)Cyclopropyl(Phenyl)Methanamine (22)Cyclopropyl(Phenyl)Methanone (13)Diphenyl Phosphonate (11)Diphenylphosphane (25)Diphenylphosphine Oxide (27)Ethane-1,1-Diyldibenzene (3)Ethene-1,1,2-Triyltribenzene (13)Ethyl Cyclopropanecarboxylate (8)Methyl 1-Naphthoate (7)Methyl 2-Naphthoate (11)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Cyclopropanecarboxylate (8)N,1-Diphenylmethanimine (15)N,N-Dimethylnaphthalen-1-Amine (4)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-2-Phenylacetamide (5)N-Benzylbenzamide (21)N-Benzylbenzenesulfonamide (17)N-Cyclopropylbenzamide (14)N-Cyclopropylbenzenesulfonamide (10)N-Phenethylbenzamide (9)N-Phenyl-2-Naphthamide (11)Naphthalen-1-Ol (28)Naphthalen-1-Ylboronic Acid (4)Naphthalen-1-Ylmethanol (8)Naphthalen-2-Amine (12)Naphthalen-2-Ol (25)Naphthalen-2-Ylboronic Acid (8)Naphthalene-1,4-Diol (3)Naphthalene-2-Sulfonic Acid (4)Propane-2,2-Diyldibenzene (17)Tert-Butyl Cyclopropylcarbamate (7)Tetrahydro-2H-Pyran-2-Ol (12)Tetrahydro-2H-Pyran-2-Yl Acetate (12)Tetraphenylmethane (16)Triphenylene (12)Vinylcyclopropane (8)
Azides (42)
Azoes (112)
(E)-1-(Naphthalen-1-Yl)-2-Phenyldiazene (7)1,2-Diphenyldiazene (7)3-(Phenyldiazenyl)Benzoic Acid (7)
Benzene Compounds (19035)
Acetamidophenoxy (1)Acetamidophenyl (5)Acetylbenzoate (7)Acetylphenyl (13)Acetylphenyl (13)Acetylphenylboronic (3)Aminobenzoyl (4)Aminobiphenyl (4)Aminonaphthalene (14)Aminophenoxy (19)Aminophenyl (239)Anisole (4)Anthracenes (142)Benzaldehyde (1601)Benzamidophenyl (1)Benzenedimethanol (4)Benzenethiol (8)Benzhydrylazetidine (10)Benzhydrylazetidine (10)Benzhydryloxy (4)Benzhydryloxy (4)Benziodoxol (2)Benzodioxole (5)Benzoquinone (6)Benzoquinone (6)Benzoylbenzoate (4)Benzoylphenyl (4)Binaphthalene (123)Binaphthalene (123)Biphenyl (1393)Boronophenyl (1)Boronophenyl (1)Bromobenzo (104)Bromobenzoyl (6)Bromodibenzo (9)Bromophenoxy (34)Bromophenyl (989)Butoxyphenyl (8)Butylaniline (7)Butylbenzene (16)Butyldiphenylsilyl (7)Butylphenol (20)Butylphenyl (32)Butylphenyl (32)Carbamoylphenoxy (12)Carbamoylphenyl (8)Carboxyphenyl (17)Carboxyphenyl (17)Chlorobenzenesulfonyl (23)Chlorobenzoyl (9)Chlorodibenzo (18)Chloronaphthalene (36)Chlorophenethyl (7)Chlorophenoxy (44)Chlorophenylacetate (4)Chlorophenylacetate Acid (9)Chlorophenylboronic (5)Cyclopropylaniline (6)Cyclopropylbenzoate (5)Cyclopropylnaphthalen (10)Cyclopropylnaphthalen (10)Cyclopropylphenyl (12)Cyclopropylphenyl (12)Diaminobenzene (7)Dibenzaldehyde (19)Dibenzene (7)Dibenzimidamide (5)Dibenzo (108)Dibenzo (108)Dibenzoate (9)Dibenzonitrile (11)Dibromobenzene (45)Dibromobenzo (14)Dibromodibenzo (8)Dibromonaphthalene (15)Dibromophenanthrene (3)Dibromophenoxy (2)Dibromophenylboronic (3)Dichlorobenzene (38)Dichlorobenzoyl (4)Dichlorophenoxy (16)Dichlorophenyl (345)Dichlorophenylboronic (5)Didehydrodibenz (2)Didehydrodibenz (2)Diethoxyphenyl (10)Diethylaniline (6)Diethylbenzamide (7)Diethylbenzene (6)Diethylbenzene (6)Difluorobenzene (57)Difluorobenzo (12)Difluorobenzoyl (9)Difluorophenoxy (9)Difluorophenyl (403)Difluorophenylboronic (11)Dihydroanthracene (1)Dihydroanthracene (1)Dihydrobenzo (189)Dihydrobenzo (189)Dihydrodibenzo (7)Dihydronaphthalene (104)Dihydronaphthalene (104)Diiodobenzene (12)Diisopropylaniline (5)Diisopropylbenzamide (8)Diisopropylphenyl (40)Diisopropylphenyl (40)Dimesityl (12)Dimesityl (12)Dimethoxyacetophenone (5)Dimethoxyaniline (20)Dimethoxybenzaldehyde (40)Dimethoxybenzamide (6)Dimethoxybenzene (47)Dimethoxybenzo (4)Dimethoxybenzo (4)Dimethoxybenzoate (20)Dimethoxybenzohydrazide (3)Dimethoxybenzonitrile (11)Dimethoxybenzoyl (4)Dimethoxybiphenyl (3)Dimethoxybiphenyl (3)Dimethoxynaphthalene (10)Dimethoxynaphthalene (10)Dimethoxyphenol (22)Dimethoxyphenyl (257)Dimethoxyphenylboronic (17)Dimethoxyphenylboronic (17)Dimethoxystyryl (4)Dimethylaminophenyl (4)Dimethylanthracene (4)Dimethylbenzaldehyde (27)Dimethylbenzamide (37)Dimethylbenzene (334)Dimethylbenzene (334)Dimethylbenzenesulfonamide (16)Dimethylbenzo (21)Dimethylbenzo (21)Dimethylbenzoate (27)Dimethylbenzoyl (3)Dimethylbenzoyl (3)Dimethylnaphthalene (6)Dimethylphenol (36)Dimethylphenoxy (13)Dimethylphenoxy (13)Dimethylphenylboronic (6)Dimethylphenylboronic (6)Dimethylphenylhydrazine (3)Dimethylphenylisothiocyanate (4)Dinaphtho (5)Dinitrobenzene (20)Diphenol (32)Diphenylamino (27)Diphenylaniline (9)Diphenylethane (19)Diphenylethanone (5)Diphenylethene (6)Diphenylethyl (7)Diphenylethyl (7)Diphenylmethyl (8)Diphenylmethyl (8)Diphenylmethylene (6)Diphenylphosphine (204)Diphenylphosphine (204)Diphenylpropane (22)Diphenylsilane (2)Diphenylurea (4)Diphenylurea (4)Ethoxyaniline (10)Ethoxybenzaldehyde (9)Ethoxybenzoate (12)Ethoxybenzonitrile (6)Ethoxyphenoxy (7)Ethoxyphenoxy (7)Ethoxyphenyl (46)Ethoxyphenyl (46)Ethoxyphenylboronic (7)Ethylaniline (8)Ethylaniline (8)Ethylbenzenesulfonamide (338)Ethylbenzo (7)Ethylbenzo (7)Ethylbenzoate (9)Ethylphenol (12)Ethylphenyl (39)Ethylphenyl (39)Ethynylaniline (7)Ethynylbenzaldehyde (17)Ethynylphenyl (35)Fluorobenzeneboronic (24)Fluoronaphthalene (34)Fluorophenoxy (46)Formylbenzoate (39)Formylphenoxy (4)Formylphenoxy (4)Formylphenyl (43)Formylphenyl (43)Formylphenylboronic (9)Formylphenylboronic (9)Hexahydrobenzo (3)Hexahydrobenzo (3)Hexylphenyl (3)Hexylphenyl (3)Homophenylalanine (18)Hydroxybenzenesulfonate (5)Hydroxybenzimidamide (11)Hydroxyisophthalaldehyde (6)Hydroxyphenethyl (2)Hydroxyphenethyl (2)Hydroxyphenyl (461)Hydroxyphenyl (461)Iodobenzo (15)Iodobenzoic (54)Iodobenzoyl (7)Iodobiphenyl (24)Iododibenzo (7)Iodonaphthalene (9)Iodophenoxy (6)Isobutoxyphenyl (15)Isobutoxyphenyl (15)Isobutylbenzene (5)Isobutylbenzene (5)Isobutylphenyl (9)Isophthalate (8)Isophthalonitrile (4)Isopropoxyaniline (10)Isopropoxyaniline (10)Isopropoxybenzaldehyde (7)Isopropoxybenzoate (7)Isopropoxyphenyl (41)Isopropoxyphenyl (41)Isopropylaniline (18)Isopropylbenzaldehyde (6)Isopropylbenzamide (9)Isopropylbenzenesulfonamide (19)Isopropylbenzoate (8)Isopropylphenyl (58)Mercaptobenzo (21)Methanobenzo (15)Methanobenzo (15)Methoxyacetophenone (12)Methoxyaniline (74)Methoxybenzaldehyde (104)Methoxybenzene (1749)Methoxybenzene (1749)Methoxybenzenesulfonamide (6)Methoxybenzenesulfonic (3)Methoxybenzenesulfonyl (13)Methoxybenzenesulfonyl (13)Methoxybenzimidamide (5)Methoxybenzo (52)Methoxybenzo (52)Methoxybenzoate (116)Methoxybenzonitrile (67)Methoxybenzoyl (12)Methoxybenzoyl (12)Methoxycarbonylphenylboronic (5)Methoxynaphthalene (56)Methoxynaphthalene (56)Methoxyphenethyl (1)Methoxyphenethyl (1)Methoxyphenol (72)Methoxyphenoxy (41)Methoxyphenoxy (41)Methoxyphenylacetate (4)Methoxyphenylboronic (24)Methoxyphenylboronic (24)Methoxyphenylhydrazine (4)Methoxystyryl (13)Methylacetophenone (6)Methylaniline (183)Methylanisole (3)Methylanthracene (5)Methylbenzaldehyde (101)Methylbenzamide (90)Methylbenzamido (3)Methylbenzenesulfinamide (4)Methylbenzenesulfonamide (81)Methylbenzenesulfonic (9)Methylbenzenesulfonyl (4)Methylbenzenesulfonyl (4)Methylbenzimidamide (6)Methylbenzoate (193)Methylbenzohydrazide (7)Methylbenzothioamide (6)Methylbenzothioamide (6)Methylbenzotrifluoride (5)Methylbenzoyl (24)Methylbenzoyl (24)Methylnaphthalene (34)Methylnaphthalene (34)Methylphenol (107)Methylphenoxy (18)Methylphenoxy (18)Methylphenyl (529)Methylphenylacetonitrile (45)Methylphenylboronic (24)Methylphenylhydrazine (10)Methylpropiophenone (5)Methylpropiophenone (5)Naphthaldehyde (28)Naphthalene (465)Naphthalene (465)Naphthaleneboronic (15)Naphthalenesulfonic (7)Naphthamide (15)Naphthonitrile (18)Nitrobenzenesulfonyl (8)Nitrobenzo (54)Nitrobenzoyl (13)Nitronaphthalene (24)Nitrophenoxy (43)Nitrophenyl (727)Nitrophenylboronic (14)Nitrotoluene (27)Octylbenzene (11)Octylbenzene (11)Paracyclophane (2)Paracyclophane (2)Pentafluorobenzene (13)Pentylbenzene (5)Pentylbenzene (5)Pentylbenzoate (2)Pentylphenol (4)Pentylphenyl (5)Pentylphenyl (5)Perfluorophenoxy (5)Perfluorophenyl (31)Phenoxyacetate (5)Phenoxyaniline (8)Phenoxybenzaldehyde (5)Phenoxybenzoate (5)Phenoxyethyl (6)Phenoxyethyl (6)Phenoxymethyl (7)Phenoxymethyl (7)Phenoxyphenyl (61)Phenoxyphenyl (61)Phenoxypropan (4)Phenylacetamide (34)Phenylacetonitrile (8)Phenylacetyl (2)Phenylacetyl (2)Phenylacrylamide (3)Phenylalaninol (4)Phenylamino (31)Phenylaniline (19)Phenylanthracene (16)Phenylbenzamide (23)Phenylbenzenesulfonamide (3)Phenylbutanoate (12)Phenylbutoxy (2)Phenylbutoxy (2)Phenylcarbamoyl (4)Phenylcyclohexanone (6)Phenylcyclopropanecarboxylic (6)Phenylcyclopropyl (7)Phenylcyclopropyl (7)Phenyldiazenyl (4)Phenylene (169)Phenylene (169)Phenylenediamine (13)Phenylenedimethanamine (5)Phenylethanamine (12)Phenylethane (14)Phenylethane (14)Phenylethanol (10)Phenylethanone (20)Phenylethoxy (2)Phenylethyl (70)Phenylethyl (70)Phenylethylisocyanate (2)Phenylhex (3)Phenylimino (1)Phenylisocyanate (9)Phenylisoserine (4)Phenylmethanesulfonyl (2)Phenylmethanesulfonyl (2)Phenylmethanone (2)Phenylmethoxy (4)Phenylmethoxy (4)Phenylmethyl (8)Phenylmethyl (8)Phenylnaphthalene (6)Phenylpentan (11)Phenylpentan (11)Phenylpropanamide (15)Phenylpropyl (20)Phenylpyrazolo (8)Phenylsulfinyl (3)Phenylsulfinyl (3)Phenylsulfonyl (88)Phenylsulfonyl (88)Phenylthio (24)Phenylthio (24)Phenylthiophene (23)Phenylthiophene (23)Phenylthiourea (6)Phenylurea (3)Phenylurea (3)Phenylvinyl (9)Phthalate (23)Phthalimide (12)Phthalonitrile (9)Propoxybenzaldehyde (4)Propoxyphenyl (29)Propoxyphenyl (29)Propoxyphenylboronic (79)Propylphenyl (26)Propylphenyl (26)Pyrenes (52)Quaternaphthalene (6)Quaterphenyl (15)Quaterphenyl (15)Styryl (12)Sulfamoylphenyl (3)Sulfophenyl (4)Sulfophenyl (4)Terephthalaldehyde (11)Terephthalate (13)Terphenyl (239)Terphenyl (239)Tetraaniline (6)Tetrabenzaldehyde (7)Tetrafluorobenzene (17)Tetrahydrobenzo (70)Tetrahydrobenzo (70)Tetrahydronaphthalene (149)Tetrahydronaphthalene (149)Tetralone (12)Tetramethylbenzene (9)Tetramethylbenzene (9)Tetramethylbiphenyl (57)Tetramethylbiphenyl (57)Tetraphenyl (11)Tetraphenyl (11)Toluenesulfonyl (68)Tolyl (418)Tolyl (418)Tolylamino (3)Tolylazanediyl (4)Tolylazanediyl (4)Tolylethynyl (3)Tolyloxy (19)Tolyloxy (19)Tolylphosphine (8)Tolylphosphine (8)Tolylthio (3)Tolylthio (3)Trianiline (7)Tribenzaldehyde (5)Tribromobenzene (7)Trichlorobenzene (20)Trichlorophenoxy (3)Trichlorophenylboronic (6)Triethylbenzene (5)Trifluorophenyl (56)Trifluorophenylboronic (154)Triiodobenzene (5)Triisopropylbenzene (9)Triisopropylphenyl (6)Triisopropylphenyl (6)Trimethoxybenzene (43)Trimethoxystyryl (5)Trimethylaniline (18)Trimethylbenzene (28)Trimethylphenol (6)Trimethylphenyl (20)Trimethylphenyl (20)Trimethylpropiophenone (4)Triphenylphosphoranylidene (9)Triphenylphosphoranylidene (9)Triphenylvinyl (11)Trityl (19)Trityl (19)Tritylamino (2)Trityloxy (2)Tritylthio (3)Tritylthio (3)(((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid (3)(10Ar)-1,2,3,4,4A,9,10,10A-Octahydrophenanthrene (3)(1E,1'E)-N,N'-(Ethane-1,2-Diyl)Bis(1-Phenylmethanimine) (5)(1R,4R)-4-Phenyl-1,1'-Bi(Cyclohexane) (24)(9H-Fluoren-9-Yl)Methyl Benzylcarbamate (22)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(Cyclopentylmethyl)Benzene (5)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylmorpholine (7)(R)-4-Benzyloxazolidin-2-One (5)(R)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)(S)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)1,1':2',1''-Terphenyl (4)1,1':3',1''-Terphenyl (28)1,1':4',1'':4'',1'''-Quaterphenyl (7)1,1,2,2-Tetra([1,1'-Biphenyl]-4-Yl)Ethene (10)1,1-Dimethyl-1,2,3,4-Tetrahydronaphthalene (10)1,2,3,4-Tetrahydronaphthalen-1-Amine (36)1,2,3,4-Tetrahydronaphthalen-1-Ol (5)1,2,3,4-Tetrahydronaphthalene-1-Carboxylic Acid (3)1,2,3,5,6,7-Hexahydro-S-Indacene (23)1,2,4-Trimethylbenzene (41)1,2-Dihydroacenaphthylene (6)1,2-Dinitrobenzene (6)1,3,5-Tris(Phenylethynyl)Benzene (6)1,3,6,8-Tetraphenylpyrene (10)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dihydro-2H-Inden-2-One (6)1,3-Diphenoxypropane (6)1,3-Diphenyl-1H-Pyrazole (6)1,3-Diphenylpropane (7)1,3-Diphenylpropane-1,3-Dione (4)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-Benzylazetidine (6)1-Bromopyrene (4)1-Cyclohexyl-4-(Phenylethynyl)Benzene (10)1-Cyclopropylnaphthalene (6)1-Phenyl-1H-Tetrazole (6)1-Phenylnaphthalene (12)1-Trityl-1H-Pyrazole (5)1H-Indene (19)1H-Indene-1,3(2H)-Dione (5)2,2 ', 3,3' - Tetrahydro-1,1 '- Spiro [Indene] (5)2,3,4,5-Tetrahydro-1H-Benzo[C]Azepine (7)2,3-Dihydro-1H-Inden-1-Amine (52)2,3-Dihydro-1H-Inden-1-Ol (13)2,3-Dihydro-1H-Inden-4-Amine (6)2,3-Dihydro-1H-Inden-4-Ol (6)2,3-Dihydro-1H-Indene-1-Carboxylic Acid (5)2,3-Dihydro-1H-Indene-4-Carbonitrile (4)2,4-Diphenyl-1,3,5-Triazine (6)2,5-Diphenyl-1,3,4-Oxadiazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(2-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (24)2-(2-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (21)2-(2-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (29)2-(3-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (14)2-(3-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (19)2-(3-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (30)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (17)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (20)2-(4-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (15)2-(4-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Methyl-2,3-Dihydro-1H-Inden-1-One (9)2-Phenyl-1,3,5-Triazine (6)2-Phenyl-1,3-Dioxane (7)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenylisoindoline-1,3-Dione (7)2H-Benzo[B][1,4]Thiazin-3(4H)-One (6)3,3-Dimethyl-2,3-Dihydro-1H-Inden-1-One (5)3,4-Dihydro-2H-Benzo[B][1,4]Dioxepine (7)3,5,6,7-Tetrahydro-S-Indacen-1(2H)-One (5)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Chlorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-(Trifluoromethyl)Phenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Fluorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Methoxyphenyl)Propanoic Acid (4)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(O-Tolyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(P-Tolyl)Propanoic Acid (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (19)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoic Acid (12)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (13)3-Methyl-2,3-Dihydro-1H-Inden-1-One (4)3-Phenyl-1H-Pyrrole (5)3-Phenylazetidine (5)3-Phenyloxazolidin-2-One (4)3-Phenylpiperidine (6)4',5'-Diphenyl-1,1':2',1''-Terphenyl (7)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane (24)4,4,5,5-Tetramethyl-2-(M-Tolyl)-1,3,2-Dioxaborolane (21)4,4,5,5-Tetramethyl-2-(O-Tolyl)-1,3,2-Dioxaborolane (24)4,5-Diphenyloxazole (7)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-Bromo-2,3-Dihydro-1H-Inden-1-One (5)4-Bromo-2,3-Dihydro-1H-Indene (10)4-Chloro-2,3-Dihydro-1H-Inden-1-One (8)4-Chloro-2,3-Dihydro-1H-Indene (5)4-Cyclohexyl-1,1'-Biphenyl (18)4-Fluoro-2,3-Dihydro-1H-Inden-1-One (6)4-Fluoro-2,3-Dihydro-1H-Indene (14)4-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)4-Methyl-2,3-Dihydro-1H-Inden-1-One (8)4-Methyl-2,3-Dihydro-1H-Indene (3)4-Phenyl-1,1'-Bi(Cyclohexane) (8)4-Phenyl-4H-1,2,4-Triazole (6)5''-([1,1'-Biphenyl]-4-Yl)-1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl (5)5',5''-Diphenyl-1,1':3',1'':3'',1'''-Quaterphenyl (8)5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (6)5,6,7,8-Tetrahydronaphthalen-2-Ol (5)5-Bromo-1,2,3,4-Tetrahydronaphthalene (6)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Methoxy-1,2,3,4-Tetrahydronaphthalene (3)5-Methoxy-2,3-Dihydro-1H-Indene (2)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Phenyl-1H-Imidazole (6)5-Phenylcyclohexane-1,3-Dione (6)6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-5-One (6)6-Bromo-1,2,3,4-Tetrahydronaphthalene (9)6-Bromo-2,3-Dihydro-1H-Inden-1-One (8)6-Bromo-3,4-Dihydronaphthalen-1(2H)-One (3)6-Chloro-1,2,3,4-Tetrahydronaphthalene (3)6-Chloro-2,3-Dihydro-1H-Inden-1-One (5)6-Fluoro-1,2,3,4-Tetrahydronaphthalene (6)6-Fluoro-2,3-Dihydro-1H-Inden-1-One (4)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methyl-1,2,3,4-Tetrahydronaphthalene (5)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)6-Methyl-3,4-Dihydronaphthalen-1(2H)-One (2)7-Bromo-2,3-Dihydro-1H-Inden-1-One (13)7-Chloro-2,3-Dihydro-1H-Inden-1-One (9)7-Fluoro-2,3-Dihydro-1H-Inden-1-One (8)7-Hydroxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methyl-2,3-Dihydro-1H-Inden-1-One (7)9,10-Bis(Phenylethynyl)Anthracene (5)9,10-Diphenylanthracene (16)9-Methylanthracene (4)9-Phenylxanthylium (7)9H-Fluoren-9-One (17)[1,1'-Binaphthalen]-2-Amine (3)[1,1':4',1''-Terphenyl]-4,4''-Dicarbaldehyde (9)Benzenesulfinic Acid (6)Benzil (17)Benzo-18-Crown-6 (7)Benzo[Lmn][3,8]Phenanthroline-1,3,6,8(2H,7H)-Tetraone (10)Benzyl ((Benzyloxy)Carbonyl)Glycinate (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Phenylpropanoate (8)Benzyl Piperidin-4-Ylcarbamate (7)Bicyclo[4.2.0]Octa-1,3,5-Triene (13)Cumene (181)Dibenzyl Phosphonate (6)Diphenylmethanimine (9)Ethane-1,1,2-Triyltribenzene (5)Ethylbenzene (198)Mesitylene (71)Methyl 2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (14)Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (11)N,2-Diphenylacetamide (7)N,N,N-Trimethyl-1-Phenylmethanaminium (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylcyclopropanamine (6)N-Phenylcinnamamide (16)N1,N1,N4,N4-Tetraphenylbenzene-1,4-Diamine (6)N4,N4,N4',N4'-Tetraphenyl-[1,1'-Biphenyl]-4,4'-Diamine (7)Phenanthrene (23)Phenanthrene-9,10-Dione (8)Phenethyldiphenylphosphane (6)Phenothiazin-5-Ium (6)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl 4-Cyclohexylbenzoate (8)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butylbenzene (251)Triphenyl Phosphate (6)
Benzyl Bromides (1065)
1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Bromomethyl)-3-Methoxybenzene (19)1-Bromo-2-(Bromomethyl)Benzene (34)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-(Bromomethyl)Benzonitrile (15)Methyl 2-(Bromomethyl)Benzoate (33)
Benzyl Chlorides (646)
Dichlorobenzyl (39)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)
Bromides (52859)
Bromoacetyl (14)Bromoaniline (2)Bromoanthracene (5)Bromoanthracene (5)Bromobenzaldehyde (15)Bromobenzamide (7)Bromobenzimidamide (6)Bromobenzyl (36)Bromobut (2)Bromobut (2)Bromobutoxy (4)Bromobutoxy (4)Bromobutyl (6)Bromobutyl (6)Bromochroman (26)Bromochroman (26)Bromocyclopropanecarboxylate (1)Bromoethoxy (22)Bromoethoxy (22)Bromoethyl (86)Bromoethyl (86)Bromoethynyl (6)Bromohexyl (11)Bromohexyl (11)Bromomethyl (760)Bromonicotinaldehyde (5)Bromonicotinamide (5)Bromooctyl (3)Bromopentyl (8)Bromopentyl (8)Bromopropane (10)Bromopropane (10)Bromopropoxy (6)Bromopropoxy (6)Bromopropyl (25)Bromopropyl (25)Bromothiochroman (4)Bromothiochroman (4)Bromovinyl (2)Dibromo (698)Dibromo (698)Dibromoanthracene (3)Dibromoanthracene (3)Dibromobenzaldehyde (8)Dibromobenzonitrile (8)Dibromomethyl (6)Dibromomethyl (6)Dibromopropoxy (1)Dibromopropoxy (1)Tetrabromo (10)Tetrabromo (10)Tribromo (9)Tribromo (9)(1-Bromoethyl)Benzene (11)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromoethyl)Benzene (33)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Bromophenyl)Boronic Acid (39)(2-Bromophenyl)Hydrazine (8)(2-Bromophenyl)Methanamine (12)(2-Bromophenyl)Methanol (39)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Bromopropyl)Benzene (10)(3-Bromopyridin-2-Yl)Methanol (7)(4-Bromophenyl)(Phenyl)Methanone (9)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(Bromoethynyl)Benzene (5)(Dibromomethyl)Benzene (6)1,2,3-Tribromobenzene (5)1,2,4-Tribromobenzene (13)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-3-Methylbenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dibromobenzene (64)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2,4-Dimethylbenzene (3)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dibromo-2-Iodobenzene (4)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dibromo-2-Methylbenzene (14)1,3-Dibromo-2-Nitrobenzene (4)1,4-Dibromo-2-Iodobenzene (3)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Bromophenyl)Ethan-1-One (27)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-4-Bromobenzene (8)1-(Bromomethyl)-2-Iodobenzene (9)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-2-Methylbenzene (14)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Bromomethyl)-3-Methylbenzene (11)1-Benzyl-3-Bromobenzene (7)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2,3-Dimethylbenzene (23)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-(Bromomethyl)Benzene (34)1-Bromo-2-(Difluoromethyl)Benzene (5)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-2-(Tert-Butyl)Benzene (7)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Ethylbenzene (13)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-2-Iodobenzene (65)1-Bromo-2-Isopropylbenzene (10)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-3-Cyclopropylbenzene (6)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-3-Iodobenzene (70)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Bromo-4-Iodobenzene (67)1-Bromo-4-Phenoxybenzene (8)1-Bromo-4-Styrylbenzene (5)1-Bromobicyclo[1.1.1]Pentane (3)1-Bromoisoquinoline (20)1-Bromonaphthalene (4)2,3-Dibromopyridine (21)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dibromoaniline (18)2,4-Dibromophenol (16)2,4-Dibromopyridine (5)2,4-Dibromothiazole (5)2,5-Dibromopyrazine (4)2,5-Dibromopyridine (26)2,5-Dibromothiazole (5)2,5-Dibromothiophene (18)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromoaniline (17)2,6-Dibromobenzaldehyde (4)2,6-Dibromobenzonitrile (4)2,6-Dibromophenol (21)2,6-Dibromopyrazine (9)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Bromophenyl)Acetonitrile (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(Bromomethyl)Furan (3)2-(Bromomethyl)Pyridine (27)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Bromophenol (3)2-Amino-6-Bromophenol (3)2-Bromo-1,1'-Biphenyl (12)2-Bromo-1,3,4-Thiadiazole (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3,4-Trimethylbenzene (4)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,3-Dimethylbenzene (35)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1,4-Dimethylbenzene (22)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-1H-Benzo[D]Imidazole (4)2-Bromo-1H-Imidazole (13)2-Bromo-1H-Pyrrole (11)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylaniline (6)2-Bromo-3-Methylphenol (4)2-Bromo-3-Methylpyrazine (5)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-3-Nitropyridine (5)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-4-Methylaniline (14)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-4-Methylpyridine (6)2-Bromo-4-Methylthiazole (7)2-Bromo-4-Nitroaniline (12)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyrazine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Methylthiazole (7)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorobenzaldehyde (15)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Fluorobenzonitrile (7)2-Bromo-6-Fluorophenol (9)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylaniline (11)2-Bromo-6-Methylbenzoic Acid (5)2-Bromo-6-Methylphenol (7)2-Bromo-6-Methylpyrazine (5)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Bromo-6-Phenylpyridine (4)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Bromo-N-Phenylacetamide (5)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Bromobenzenesulfonyl Chloride (8)2-Bromobenzo[D]Thiazole (28)2-Bromodibenzo[B,D]Furan (6)2-Bromofuran (21)2-Bromoimidazo[1,2-A]Pyridine (5)2-Bromonaphthalene (4)2-Bromonicotinic Acid (5)2-Bromooxazole (7)2-Bromopyrazine (15)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Bromopyrimidine (22)2-Bromoquinazoline (4)3,4-Dibromoaniline (4)3,4-Dibromophenol (3)3,5-Dibromopyridine (12)3-(Bromomethyl)Pyridine (18)3-Bromo-1,1'-Biphenyl (12)3-Bromo-1,5-Naphthyridine (8)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoroaniline (15)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Fluorophenol (5)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Fluorobenzamide (3)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Fluorophenol (11)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methoxybenzaldehyde (9)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylaniline (14)3-Bromo-4-Methylbenzoic Acid (9)3-Bromo-4-Methylpyridine (13)3-Bromo-5'-Phenyl-1,1':3',1''-Terphenyl (4)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromoaniline (187)3-Bromoazetidine (3)3-Bromobenzene-1,2-Diamine (11)3-Bromobenzene-1,2-Diol (8)3-Bromobenzo[B]Thiophene (5)3-Bromobenzoic Acid (159)3-Bromobenzonitrile (110)3-Bromofuran (13)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Bromoisoquinoline (10)3-Bromoisoxazole (7)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Bromopyridazine (25)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Bromopyrrolidine (6)3-Bromothiophene (6)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Bromomethyl)Pyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Benzo[D]Imidazole (14)4-Bromo-1H-Indole (25)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Iodoaniline (8)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-(Trifluoromethyl)Aniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Methylpyridine (5)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Bromobenzo[C][1,2,5]Thiadiazole (14)4-Bromobenzo[D][1,3]Dioxole (6)4-Bromobenzo[D]Thiazole (9)4-Bromobenzofuran (3)4-Bromoindoline (4)4-Bromoisoindolin-1-One (3)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Bromopyridazine (5)4-Bromopyridine (31)4-Bromopyrimidine (24)4-Bromothiazole (10)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Bromo-1-Methyl-1H-Indole (4)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Bromo-1H-Benzo[D]Imidazole (13)5-Bromo-1H-Indazole (14)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Bromo-2,3-Dihydrobenzofuran (6)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Methylpyrimidine (5)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromobenzo[B]Thiophene (3)5-Bromobenzo[D][1,3]Dioxole (12)5-Bromobenzo[D]Oxazole (3)5-Bromoimidazo[1,2-A]Pyridine (6)5-Bromoindoline (8)5-Bromoisoindolin-1-One (8)5-Bromoisoquinoline (17)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyrazin-2-Ol (5)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Bromoquinoxaline (6)5-Bromothiazole (8)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indazole (23)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)6-Bromobenzo[B]Thiophene (4)6-Bromobenzo[D]Oxazole (3)6-Bromobenzo[D]Thiazole (7)6-Bromochroman-4-One (6)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Bromoindoline-2,3-Dione (4)6-Bromoisoindolin-1-One (4)6-Bromoisoquinoline (9)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Bromoquinazoline (7)6-Bromoquinoxaline (9)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Bromo-1H-Indazole (18)7-Bromo-1H-Indole (28)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromobenzo[B]Thiophene (5)7-Bromobenzo[D]Thiazole (8)7-Bromobenzofuran (6)7-Bromochromane (7)7-Bromoindoline (3)7-Bromoisoquinoline (6)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)8-Bromochromane (6)8-Bromoimidazo[1,2-A]Pyridine (15)8-Bromoisoquinoline (17)8-Bromoquinazoline (8)9-Bromoanthracene (5)Bromocyclohexane (7)Ethyl 2-Bromo-2-Phenylacetate (6)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopicolinate (9)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 6-Bromonicotinate (6)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)
Carbamates (7957)
Carboxylic Acid Salts (668)
Carboxylic Acids (58191)
Aceticacid (1249)Acetylbenzoic Acid (3)Acrylic (95)Aminobenzoic (7)Aminobutanoic (8)Aminoheptanoic (6)Aminohexanoic (10)Aminonicotinic Acid (4)Aminopentanoic (8)Aminophenylacetic Acid (22)Aminopropanoic (11)Aminoundecanoic Acid (4)Benzenedicarboxylic (6)Benzenedicarboxylic Acid (6)Benzylpropanoic Acid (75)Benzylsuccinic Acid (6)Boronobenzoic (4)Bromobutanoic (5)Bromododecanoate (3)Bromoisonicotinic Acid (4)Bromonicotinic (8)Bromonicotinic Acid (9)Bromophenylacetic Acid (15)Bromovalerate (4)Butanoic (124)Chlorobenzoic (35)Chloromandelic Acid (3)Chromene-Carboxylic Acid (1)Cyanonicotinic (5)Cyanonicotinic Acid (3)Diacetic (19)Diacetic (19)Diaminobenzoic (7)Diaminobutanoic (5)Diaminohexanoic (4)Dibenzoic (40)Dibromobenzoic (10)Dibromobenzoic Acid (10)Dibromonicotinic Acid (7)Dicarboxylic (183)Dicarboxylic (183)Dichlorobenzoic (21)Dichlorobenzoic Acid (22)Dichloroisonicotinic (6)Dichloroisonicotinic Acid (6)Dichlorophenylacetic Acid (4)Dienoate (14)Dienoic (10)Difluorobenzoic (54)Difluorobutanoic (3)Difluoroisonicotinic Acid (7)Difluorophenylacetic (7)Difluorophenylacetic Acid (7)Diiodobenzoic (5)Diisophthalic (17)Diisophthalic Acid (9)Diisopropylbenzoic Acid (4)Dimethoxybenzoic (33)Dimethoxyphenylacetic Acid (3)Dimethylbenzoic (32)Dimethylbutanoic (13)Dimethylbutanoic (13)Dimethylpropanoic (5)Diphenylpropanoic (8)Diyldimethanol (17)Enedioic (8)Enoic (127)Ethoxybenzoic (9)Ethylbenzoic (11)Ethylbenzoic Acid (12)Ethynylbenzoic (6)Ethynylbenzoic Acid (5)Fluoroisophthalic Acid (4)Fluorophenylacetic (10)Fluorophenylacetic Acid (11)Fluorophthalic (5)Fluorophthalic Acid (3)Fluoropicolinic (12)Formylbenzoic (22)Formylbenzoic Acid (19)Guanidinopentanoic (8)Heptanoic (6)Heptanoic (6)Hexacarboxylic Acid (5)Hexanoic (25)Hexanoic (25)Hydrazinylbenzoic (6)Hydrazinylbenzoic Acid (5)Hydroxynicotinic (15)Indolecarboxylic (2)Isophthalic (29)Isophthalic Acid (15)Isopropoxybenzoic (8)Isopropoxybenzoic Acid (7)Isopropylbenzoic (13)Isopropylnicotinic Acid (4)Malonate (39)Mercaptobenzoic (6)Mercaptobenzoic Acid (4)Mercaptopropanoic (11)Methoxybenzoic (142)Methoxybutanoic (4)Methoxybutanoic (4)Methoxyisophthalic Acid (5)Methoxyphenylacetic (10)Methoxyphenylacetic Acid (11)Methoxypropanoic (7)Methoxypropanoic (7)Methylbenzoic (175)Methylbutanoic (32)Methylbutanoic (32)Methylcinnamic Acid (9)Methylhexanoic (8)Methylhexanoic (8)Methylisophthalic Acid (17)Methylnicotinic (46)Methyloctanoic (6)Methylpentanoic (108)Methylpentanoic (108)Methylpropanoic (57)Naphthoic (64)Nitrobenzoic (161)Nitroisonicotinic Acid (5)Nitroisophthalic Acid (3)Nitronicotinic (10)Nitropicolinic (11)Octanoic (6)Octanoic (6)Oxoacetic (22)Oxobutanoic (57)Oxobutanoic (57)Oxodecanoic (5)Oxodecanoic (5)Oxododecanoic (9)Oxododecanoic (9)Oxoheptanoic (5)Oxoheptanoic (5)Oxoheptanoic Acid (4)Oxohexadecanoic (13)Oxohexadecanoic (13)Oxohexanoic (10)Oxohexanoic (10)Oxooctadecanoic (7)Oxooctadecanoic (7)Oxopentanoic (37)Oxopentanoic (37)Oxopropanoic (8)Pentanedioic (18)Pentanedioic (18)Pentanoic (27)Phenoxybenzoic (5)Phenylacetic (35)Phenylbutanoic (47)Phenylpentanoic (11)Phenylpropanoic (45)Propanoic (1167)Propenoic (6)Pyridazinecarboxylic (1)Succinic (13)Sulfamoylbenzoic (15)Sulfobenzoic (5)Terephthalic (7)Tetraacetic (5)Tetrabenzoic (13)Tetrabenzoic Acid (14)Tetracarboxylic (13)Tribenzoic (15)Tribenzoic Acid (14)Tricarboxylic (18)Trichlorobenzoic (5)Trichlorobenzoic Acid (4)Trifluorobenzoic (12)Trifluorobenzoic Acid (11)Trifluorobutanoic (3)Trifluoromethylbenzoic (5)Trifluoromethylbenzoic Acid (4)Trifluoropentanoic (4)Trifluorophenylacetic Acid (16)Trifluoropropanoic (4)Triiodobenzoic (4)Trimethylbenzoic Acid (4)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,5-Naphthyridine-3-Carboxylic Acid (6)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Naphthoic Acid (23)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropane-1-Carboxylic Acid (23)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carboxylic Acid (4)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carboxylic Acid (7)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,3-Difluorobenzoic Acid (35)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)2,4-Difluorobenzoic Acid (29)2,5-Dichlorobenzoic Acid (13)2,5-Difluorobenzoic Acid (32)2,6-Dichlorobenzoic Acid (13)2,6-Difluorobenzoic Acid (33)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(2-Methoxyphenyl)Acetic Acid (16)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-Chlorophenoxy)Acetic Acid (3)2-(4-Fluorophenyl)Acetic Acid (30)2-(4-Methoxyphenyl)Acetic Acid (19)2-(4-Nitrophenyl)Acetic Acid (9)2-(Benzofuran-3-Yl)Acetic Acid (3)2-(M-Tolyl)Acetic Acid (16)2-(Morpholin-2-Yl)Acetic Acid (5)2-(O-Tolyl)Acetic Acid (17)2-(P-Tolyl)Acetic Acid (9)2-(Phenylamino)Benzoic Acid (11)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethyl)Benzoic Acid (33)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-6-Chlorobenzoic Acid (5)2-Benzoylbenzoic Acid (10)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Methylbenzoic Acid (5)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-6-Fluorobenzoic Acid (8)2-Chlorobenzoic Acid (130)2-Cyclohexylacetic Acid (14)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluorobenzoic Acid (220)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Iodobenzoic Acid (47)2-Methoxyisonicotinic Acid (13)2-Methyl-2-Phenylpropanoic Acid (20)2-Methyl-3-Nitrobenzoic Acid (7)2-Naphthoic Acid (14)2-Nitrobenzoic Acid (65)2-Oxo-2-Phenylacetic Acid (17)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2-Phenoxypropanoic Acid (13)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-(3-Chlorophenyl)Propanoic Acid (11)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Benzoic Acid (5)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Methylsulfonyl)Benzoic Acid (6)3-(Phenyldiazenyl)Benzoic Acid (7)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethyl)Benzoic Acid (52)3-Benzamidopropanoic Acid (3)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylbenzoic Acid (9)3-Bromobenzoic Acid (159)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Methoxybenzoic Acid (5)3-Chlorobenzoic Acid (144)3-Fluoro-4-Methoxybenzoic Acid (6)3-Fluorobenzoic Acid (206)3-Fluoropicolinic Acid (6)3-Iodobenzoic Acid (55)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methylpicolinic Acid (13)3-Nitrobenzoic Acid (109)3-Phenoxybenzoic Acid (6)3-Phenoxypropanoic Acid (14)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(Benzyloxy)Benzoic Acid (5)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Trifluoromethyl)Nicotinic Acid (3)4-Amino-3-Chlorobenzoic Acid (6)4-Benzamidobenzoic Acid (3)4-Cyclohexylbenzoic Acid (6)4-Fluoro-3-Iodobenzoic Acid (5)4-Fluorobenzoic Acid (114)4-Methylnicotinic Acid (5)4-Morpholinobenzoic Acid (5)4-Nitrobenzoic Acid (35)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Oxo-4-(Phenylamino)Butanoic Acid (7)4-Oxo-4-Phenylbutanoic Acid (16)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenoxybenzoic Acid (4)4-Phenylbutanoic Acid (19)5'-(4-Carboxyphenyl)-[1,1':3',1''-Terphenyl]-4,4''-Dicarboxylic Acid (7)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)5-Phenylfuran-2-Carboxylic Acid (6)5-Phenylisoxazole-3-Carboxylic Acid (15)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)6-Methoxypicolinic Acid (9)6-Methylnicotinic Acid (6)6-Methylpicolinic Acid (12)6-Oxopiperidine-2-Carboxylic Acid (3)6-Phenylpicolinic Acid (3)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-3-Carboxylic Acid (39)Azetidine-2-Carboxylic Acid (6)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[D]Thiazole-6-Carboxylic Acid (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-3-Carboxylic Acid (6)Benzoic Acid (3519)Benzoylglycine (15)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Cyclobutanecarboxylic Acid (23)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanecarboxylic Acid (83)Cyclopentanecarboxylic Acid (26)Cyclopropanecarboxylic Acid (11)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Furan-2-Carboxylic Acid (31)Furan-3-Carboxylic Acid (11)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Indoline-2-Carboxylic Acid (3)Isonicotinic Acid (23)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-6-Carboxylic Acid (3)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl Benzofuran-2-Carboxylate (6)Methyl Isoquinoline-3-Carboxylate (3)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Nicotinic Acid (53)Oxazole-4-Carboxylic Acid (4)Picolinic Acid (22)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Proline (13)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Pyridazine-3-Carboxylic Acid (7)Pyridine-2,6-Dicarboxylic Acid (9)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carboxylic Acid (7)Pyrrolidine-3-Carboxylic Acid (14)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Carboxylic Acid (4)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carboxylic Acid (10)Thiophene-3-Carboxylic Acid (8)Tryptophan (21)
Chlorides (77875)
Chloroacetamide (17)Chloroacetyl (12)Chloroaniline (18)Chlorobenzaldehyde (18)Chlorobenzamide (12)Chlorobutyl (6)Chlorobutyl (6)Chlorocarbonyl (7)Chloroethoxy (10)Chloroethoxy (10)Chloroethyl (89)Chloromethyl (479)Chloropicolinaldehyde (8)Chloropicolinamide (5)Chloropropane (18)Chloropropane (18)Chloropropoxy (2)Chloropropoxy (2)Chloropropyl (23)Dichloride (28)Dichloroaniline (9)Dichloroanthracene (3)Dichlorobenzaldehyde (13)Dichlorobenzamide (8)Dichloroisonicotinaldehyde (4)Dichloromethyl (3)Dichloromethyl (3)Dichloronicotinaldehyde (6)Dichloronicotinic (6)Dichloronicotinic (6)Dichloronicotinic Acid (5)Dichloropalladium (4)Dichloropalladium (4)Tetrachloro (2)Tetrachloro (2)Trichloro (36)Trichloro (36)Trichloroacetimidate (5)Trichloroaniline (6)Trichlorobenzaldehyde (4)Trichloromethyl (11)Trichloromethyl (11)(2,3-Dichlorophenyl)Boronic Acid (11)(2,6-Dichlorophenyl)Boronic Acid (6)(2-Chloroethoxy)Benzene (5)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Chlorophenyl)Hydrazine (16)(2-Chlorophenyl)Methanamine (28)(2-Chlorophenyl)Methanol (39)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3,4-Dichlorophenyl)Boronic Acid (10)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Chlorophenyl)Boronic Acid (121)(3-Chlorophenyl)Hydrazine (12)(3-Chlorophenyl)Methanamine (19)(3-Chlorophenyl)Methanol (38)(3-Chloropyridin-2-Yl)Methanamine (6)(4-Chlorophenyl)(Phenyl)Methanone (10)(5-Chloropyridin-2-Yl)Methanamine (5)(Chloromethanetriyl)Tribenzene (7)(Chloromethylene)Dibenzene (5)1,2,3,4-Tetrachlorobenzene (8)1,2,4-Trichlorobenzene (26)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-3-Methylbenzene (8)1,2-Dichloro-4-Fluorobenzene (15)1,2-Dichloro-4-Methoxybenzene (11)1,2-Dichloro-4-Nitrobenzene (16)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dichloro-2-Fluorobenzene (23)1,3-Dichloro-2-Iodobenzene (5)1,3-Dichloro-2-Methoxybenzene (9)1,3-Dichloro-2-Nitrobenzene (5)1,3-Dichloroisoquinoline (14)1,4-Dichloro-2-Fluorobenzene (11)1,4-Dichloro-2-Methoxybenzene (8)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Chlorophenyl)Piperazine (4)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Chloromethyl)-2-Methylbenzene (7)1-Benzyl-2-Chlorobenzene (9)1-Benzyl-3-Chlorobenzene (3)1-Benzyl-4-Chlorobenzene (6)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-(Chloromethyl)Benzene (12)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-2-Cyclopropylbenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Iodobenzene (65)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3,5-Dimethylbenzene (8)1-Chloro-3-(Chloromethyl)Benzene (7)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Nitrobenzene (161)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Chloro-4-Iodobenzene (49)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Chloroanthracene-9,10-Dione (6)1-Chloroisoquinoline (20)1-Chloronaphthalene (24)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dichloroaniline (18)2,3-Dichlorobenzaldehyde (7)2,3-Dichlorophenol (9)2,3-Dichloropyridine (38)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyridine (5)2,4,6-Trichloropyrimidine (14)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dichloro-1-Fluorobenzene (27)2,4-Dichloro-1-Methoxybenzene (18)2,4-Dichloro-1-Nitrobenzene (19)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichlorobenzaldehyde (8)2,4-Dichlorobenzonitrile (4)2,4-Dichloropyridine (50)2,4-Dichloroquinazoline (19)2,4-Dichlorothiazole (4)2,5-Dichlorophenol (7)2,5-Dichloropyrazine (4)2,5-Dichloropyridine (32)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloroaniline (27)2,6-Dichlorobenzoic Acid (13)2,6-Dichlorobenzonitrile (8)2,6-Dichloronicotinonitrile (8)2,6-Dichlorophenol (16)2,6-Dichloropyrazine (14)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(2-Chlorophenyl)Pyridine (3)2-(2-Chlorophenyl)Pyrrolidine (17)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Chlorophenyl)Acetonitrile (16)2-(4-Chlorophenoxy)Acetic Acid (3)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Furan (3)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Chloromethyl)Pyrimidine (5)2-(Chloromethyl)Thiazole (5)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Chloro-1,1'-Biphenyl (8)2-Chloro-1,3,5-Triazine (10)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-1-Phenylethan-1-One (20)2-Chloro-1H-Benzo[D]Imidazole (17)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylaniline (4)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-3-Methylpyrazine (7)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Methylaniline (7)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-4-Methylpyridine (31)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Methylthiazole (5)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Methoxyaniline (8)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Methylthiazole (5)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorophenol (5)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodophenol (3)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylaniline (11)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylphenol (5)2-Chloro-6-Methylpyrazine (12)2-Chloro-6-Methylpyridine (49)2-Chloro-6-Nitroaniline (11)2-Chloro-7H-Purine (3)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloro-9H-Purine (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzamide (16)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,3-Diol (4)2-Chlorobenzene-1,4-Diamine (6)2-Chlorobenzenesulfonyl Chloride (24)2-Chlorobenzenethiol (7)2-Chlorobenzo[D]Oxazole (11)2-Chlorobenzo[D]Thiazole (21)2-Chlorobenzoic Acid (130)2-Chlorobenzonitrile (99)2-Chlorobenzoyl Chloride (13)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chlorofuran (3)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronaphthalene (6)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chlorooxazole (7)2-Chlorophenol (163)2-Chloropyrazine (24)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Chloroquinoxaline (39)2-Chlorothiazole (32)2-Chlorothiophene (20)3,4-Dichloroaniline (21)3,5-Dichloropyridine (16)3,6-Dichloropyridazine (20)3-(3-Chlorophenyl)Propanoic Acid (11)3-(Chloromethyl)Pyridine (22)3-Chloro-1,1'-Biphenyl (12)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Chloro-1-Phenylpropan-1-One (10)3-Chloro-1H-Indazole (13)3-Chloro-2-Fluoroaniline (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Fluorobenzonitrile (7)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylaniline (11)3-Chloro-2-Methylpyridine (4)3-Chloro-2-Nitroaniline (5)3-Chloro-4-(Trifluoromethyl)Aniline (5)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chloro-4-Methylaniline (12)3-Chloro-4-Methylpyridazine (7)3-Chloro-4-Nitroaniline (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloro-9H-Carbazole (3)3-Chlorobenzaldehyde (106)3-Chlorobenzene-1,2-Diamine (6)3-Chlorobenzene-1,2-Diol (6)3-Chlorobenzenesulfonyl Chloride (21)3-Chlorobenzo[B]Thiophene (6)3-Chlorobenzoic Acid (144)3-Chlorobenzonitrile (100)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloroisoquinoline (20)3-Chlorophenol (112)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridazine (44)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Chlorothiophene (17)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,6-Dichloropyrimidine (14)4-Chloro-1,5-Naphthyridine (6)4-Chloro-1-Phenylbutan-1-One (8)4-Chloro-1H-Indazole (18)4-Chloro-1H-Indole (21)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Methylaniline (11)4-Chloro-3-Methylpyridine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-N-Phenylaniline (6)4-Chlorobenzene-1,3-Diol (6)4-Chlorobenzenesulfonic Acid (4)4-Chlorobenzenesulfonyl Chloride (12)4-Chlorobenzo[D]Thiazole (7)4-Chloroindoline-2,3-Dione (6)4-Chloroisoquinoline (11)4-Chloronicotinic Acid (4)4-Chloropyridazine (16)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Chloroquinazoline (39)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5,6-Dichloropyridin-2-Amine (4)5-Bromo-4-Chloropyrimidine (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Chloro-1H-Imidazole (2)5-Chloro-1H-Indazole (9)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chlorobenzo[B]Thiophene (4)5-Chlorobenzo[D]Oxazole (5)5-Chlorobenzo[D]Thiazole (5)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloroindolin-2-One (3)5-Chloroisoquinoline (6)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Chloropyrimidine (8)5-Chloroquinazoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Chloro-1H-Benzo[D]Imidazole (25)6-Chloro-1H-Indazole (14)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-2,3-Dihydrobenzofuran (3)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chlorobenzo[D]Oxazole (4)6-Chlorobenzo[D]Thiazole (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Chloroquinoxaline (3)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Chloro-1H-Indazole (7)7-Chloro-1H-Indole (29)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Chloro-2,3-Dihydrobenzofuran (3)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Chlorobenzo[D]Thiazole (6)7-Chlorochromane (5)7-Chloroisoquinoline (6)7-Chloropyrazolo[1,5-A]Pyrimidine (8)8-Chlorochromane (5)8-Chloroimidazo[1,2-A]Pyridine (7)8-Chloroisoquinoline (7)8-Chloroquinazoline (5)Ethyl 4,6-Dichloronicotinate (4)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloropicolinate (7)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 2,6-Dichlorobenzoate (7)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Chlorobenzoate (88)Methyl 3-Chloropicolinate (9)Methyl 6-Chloropicolinate (11)N-(2-Chlorophenyl)Acetamide (16)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)N-(4-Chlorophenyl)Acetamide (9)Phenyl Carbonochloridate (5)Pyridine-2-Sulfonyl Chloride (9)Pyridine-3-Sulfonyl Chloride (25)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)
Diazoes (3)
Difluoromethyls (32566)
(Difluoromethyl)Benzene (63)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-(Difluoromethyl)-2-Fluorobenzene (13)1-Bromo-2-(Difluoromethyl)Benzene (5)2-(Difluoromethoxy)Phenol (5)2-(Difluoromethyl)Pyridine (21)3-(Difluoromethyl)Pyridine (5)4-(Difluoromethoxy)Aniline (6)5-(Difluoromethyl)-1H-Pyrazole (6)
Esters (51168)
Acetoxymethyl (85)Acetoxyphenyl (1)Acetyloxy (53)Acrylate (118)Acryloyloxy (3)Adipate (17)Adipate (17)Amino-Carboxylate (2)Aminobenzoate (18)Aminobenzylcarbamate (8)Aminobutanoate (14)Aminocyclobutanecarboxylic Acid (4)Aminocyclohexanecarboxylic (16)Aminocyclohexanecarboxylic Acid (10)Aminocyclopentanecarboxylic (13)Aminoheptanoate (9)Aminohexanoate (6)Aminoisonicotinate (4)Aminoisophthalate (5)Aminonicotinate (7)Aminopentanedioate (15)Aminopentanoate (7)Aminopropanoate (16)Benzoyloxy (14)Benzylcarbamate (8)Bromobenzoate (26)Bromobutanoate (9)Bromocyclopropanecarboxylate (1)Bromodecanoate (20)Bromoisonicotinate (8)Bromoisophthalate (3)Bromonicotinate (13)Bromopropanoate (9)Bromoundecanoate (3)Butoxycarbonyl (1675)Butoxycarbonyl (1675)Carbamate (1539)Chlorobenzoate (49)Chloroformate (4)Chloropicolinate (30)Chloropropanoate (5)Cyanoacrylate (6)Decanedioate (9)Decanedioate (9)Decanoate (7)Decanoate (7)Diacetate (56)Diacetoxy (1)Diacrylate (15)Diaminobenzoate (7)Dibromobenzoate (4)Dicarbamate (14)Dichlorobenzoate (24)Dichloroisonicotinate (9)Dimethacrylate (1)Dimethylbutanoate (14)Dimethylcarbamate (3)Dimethylnicotinate (10)Dimethylnicotinate (10)Dipropanoate (6)Dipropanoate (6)Diyldicarbamate (5)Dodecanoate (11)Enecarboxylate (9)Enoate (116)Ethoxycarbonyl (70)Ethylbutanoate (6)Ethynylbenzoate (7)Ethynylbenzylcarbamate (3)Glutarate (3)Glutarate (3)Hexanoate (14)Hexanoate (14)Indoline-Carboxylate (1)Iodoacrylate (6)Iodobutanoate (4)Iodopropanoate (1)Isobutyrate (18)Isobutyrate (18)Methacrylate (87)Methacryloyloxy (7)Methoxycarbonyl (169)Methoxycarbonyl (169)Methoxyisonicotinate (11)Methoxyisonicotinate (11)Methoxynicotinate (24)Methoxynicotinate (24)Methoxypropanoate (5)Methoxypropanoate (5)Methylacrylate (13)Methylbutanoate (38)Methylmalonate (6)Methylnicotinate (57)Methylpentanoate (17)Methylpropanoate (47)Nitropicolinate (13)Nonanedioate (4)Nonanedioate (4)Oxoacetate (21)Oxoacetate (21)Oxobutanoate (56)Oxobutanoate (56)Oxoheptanoate (8)Oxoheptanoate (8)Oxohexanoate (14)Oxohexanoate (14)Oxopentanoate (31)Oxopropanoate (39)Oxopropanoate (39)Pentanoate (13)Pentanoate (13)Phenylacrylate (5)Phenylpropanoate (42)Propanoate (296)Propylpentanoate (5)Propylpentanoate (5)Succinate (23)Succinate (23)Sulfamoylbenzoate (6)Tetraacetate (7)Tetraacetate (7)Tetradecanoate (10)Tetradecanoate (10)Thiophenecarboxylate (2)Tosylcarbamate (4)Tosyloxy (12)Triacetate (12)Triacetate (12)Vinylbenzoate (3)Vinylcyclopropanecarboxylic Acid (3)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1H-Indol-3-Yl Acetate (4)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Diethylamino)Ethyl Benzoate (3)2-Ethylhexyl Benzoate (13)2-Hydroxyethyl Benzoate (3)2-Phenoxyacetyl Chloride (3)4-Cyanophenyl Benzoate (11)Allyl Benzoate (5)Azetidin-3-Yl Acetate (3)Benzoic Anhydride (6)Benzyl Acetate (11)Benzyl Benzoate (12)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Morpholine-4-Carboxylate (5)Benzyl Phenylcarbamate (15)Benzyl Piperidine-1-Carboxylate (50)Butyl Benzoate (10)Dimethyl Isophthalate (32)Dimethyl Phthalate (14)Dimethyl Pyridine-2,6-Dicarboxylate (7)Ethane-1,2-Diyl Dibenzoate (11)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Aminobenzoate (23)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Bromo-2-Phenylacetate (6)Ethyl 2-Fluorobenzoate (37)Ethyl 2-Hydroxybenzoate (18)Ethyl 2-Iodobenzoate (4)Ethyl 2-Methylbenzoate (26)Ethyl 2-Methylnicotinate (6)Ethyl 2-Nitrobenzoate (9)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Ethyl 2-Phenoxyacetate (10)Ethyl 2-Phenylacetate (60)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Ethyl 3-Aminobenzoate (19)Ethyl 3-Fluorobenzoate (34)Ethyl 3-Hydroxybenzoate (12)Ethyl 3-Iodobenzoate (11)Ethyl 3-Nitrobenzoate (22)Ethyl 3-Oxo-3-Phenylpropanoate (41)Ethyl 3-Phenylpropanoate (17)Ethyl 4-Aminobenzoate (23)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Ethyl Cinnamate (26)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Ethyl Cyclopropanecarboxylate (8)Ethyl Furan-2-Carboxylate (6)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Ethyl Isonicotinate (12)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Ethyl Nicotinate (25)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Ethyl Oxirane-2-Carboxylate (4)Ethyl Picolinate (41)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Ethyl Pyrazine-2-Carboxylate (10)Ethyl Pyridazine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Ethyl Quinazoline-2-Carboxylate (4)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Hexyl Benzoate (5)Isobutyl Benzoate (10)Isopropyl Benzoate (10)Methyl 1-Naphthoate (7)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Methyl 2,6-Dichlorobenzoate (7)Methyl 2,6-Difluorobenzoate (17)Methyl 2-(1H-Indol-3-Yl)Acetate (3)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-(Bromomethyl)Benzoate (33)Methyl 2-(Chlorosulfonyl)Benzoate (7)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Cyanobenzoate (22)Methyl 2-Fluorobenzoate (132)Methyl 2-Hydroxybenzoate (74)Methyl 2-Iodobenzoate (28)Methyl 2-Methoxybenzoate (70)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Methyl 2-Methylbenzoate (101)Methyl 2-Naphthoate (11)Methyl 2-Nitrobenzoate (54)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 2-Phenylacetate (114)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-(Trifluoromethyl)Benzoate (22)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 3-Chlorobenzoate (88)Methyl 3-Cyanobenzoate (29)Methyl 3-Fluorobenzoate (136)Methyl 3-Formylbenzoate (23)Methyl 3-Hydroxybenzoate (58)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 3-Methoxybenzoate (70)Methyl 3-Methylbenzoate (75)Methyl 3-Nitrobenzoate (109)Methyl 3-Oxo-3-Phenylpropanoate (16)Methyl 3-Phenylpropanoate (28)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 4-Amino-3-Iodobenzoate (7)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Aminobenzoate (71)Methyl 4-Fluorobenzoate (75)Methyl 4-Nitrobenzoate (29)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl 4-Phenoxybenzoate (3)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 5-Hydroxypicolinate (5)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl 5-Phenylisoxazole-3-Carboxylate (6)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl 6-Methoxynicotinate (4)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Azetidine-2-Carboxylate (3)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cinnamate (36)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)Methyl Cyclopropanecarboxylate (8)Methyl Furan-2-Carboxylate (20)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Methyl Indoline-6-Carboxylate (3)Methyl Isonicotinate (16)Methyl Isoquinoline-4-Carboxylate (6)Methyl L-Phenylalaninate (20)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Methyl Nicotinate (52)Methyl Oxazole-4-Carboxylate (9)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)Methyl Prolinate (43)Methyl Pyrazine-2-Carboxylate (19)Methyl Pyridazine-3-Carboxylate (7)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)Methyl Pyrrolidine-3-Carboxylate (9)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)Methyl Thiophene-3-Carboxylate (34)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Propyl Benzoate (11)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Azetidine-1-Carboxylate (64)Tert-Butyl Benzoate (66)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclopentylcarbamate (28)Tert-Butyl Isoindoline-2-Carboxylate (13)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl Morpholine-4-Carboxylate (23)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl Piperazine-1-Carboxylate (30)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Ethers (82526)
Butoxy-Phenyl-Boronic Acid/Ester (76)Diethoxy (14)Diethoxy (14)Diethoxyethyl (9)Diethoxyethyl (9)Diethoxymethyl (8)Diethoxymethyl (8)Dimethoxyethyl (8)Dimethoxypropane (11)Dimethoxypropane (11)Dioxane (153)Dioxepine (7)Dioxepine (7)Disulfide (38)Methoxyphenylboronic-Acid (32)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Benzyloxy)Phenyl)Boronic Acid (23)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloroethoxy)Benzene (5)(2-Methoxyethoxy)Benzene (32)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Phenoxyphenyl)Methanol (3)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-Methoxyphenyl)(Phenyl)Methanone (7)(9H-Fluoren-9-Yl)Methyl (2-(Benzyloxy)Ethyl)Carbamate (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Allyloxy)Benzene (19)(Ethoxymethyl)Benzene (7)(Hexyloxy)Benzene (7)(Methoxymethyl)Benzene (30)(Prop-2-Yn-1-Yloxy)Benzene (13)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)1,2-Bis(Benzyloxy)Benzene (11)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-4-Methoxybenzene (11)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-4-Methoxybenzene (19)1,2-Dimethoxybenzene (223)1,2-Diphenoxyethane (11)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dichloro-2-Methoxybenzene (9)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Dimethoxybenzene (235)1,3-Diphenoxybenzene (8)1,4-Dichloro-2-Methoxybenzene (8)1,4-Dimethoxybenzene (66)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-2-Methoxybenzene (19)1-(Benzyloxy)-2-Methylbenzene (12)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Benzyloxy)-3-Methylbenzene (8)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Benzyloxy)-4-Bromobenzene (8)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-3-Methoxybenzene (19)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-Benzyl-4-Methoxybenzene (8)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-Phenoxybenzene (8)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Phenoxybenzene (8)1-Iodo-2-Methoxybenzene (50)1-Iodo-3-Methoxybenzene (48)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-(Phenoxymethyl)Benzene (3)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methoxy-4-Nitrobenzene (90)1-Methoxynaphthalene (17)1-Methyl-3-Phenoxybenzene (9)1-Nitro-2-Phenoxybenzene (4)1-Nitro-4-Phenoxybenzene (5)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)2,3,5,6,8,9,11,12-Octahydrobenzo[B][1,4,7,10,13]Pentaoxacyclopentadecine (8)2,3-Dimethoxypyridine (7)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dichloro-1-Methoxybenzene (18)2,4-Difluoro-1-Methoxybenzene (25)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethoxypyrimidine (13)2,6-Dimethoxypyridine (11)2-(2-Methoxyphenyl)Acetic Acid (16)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(4-Methoxyphenyl)Acetic Acid (19)2-(Benzyloxy)Benzaldehyde (13)2-(Benzyloxy)Naphthalene (5)2-(Benzyloxy)Phenol (5)2-(Methoxymethyl)Morpholine (4)2-(Methoxymethyl)Pyrrolidine (6)2-(Phenoxymethyl)Oxirane (13)2-(Phenoxymethyl)Pyridine (5)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-3-Methoxypyrazine (5)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-5-Methoxyaniline (8)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Ethoxynaphthalene (4)2-Ethoxypyridine (20)2-Ethoxypyrimidine (7)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-6-Methoxypyridine (6)2-Isopropoxypyridine (16)2-Methoxy-1,1'-Biphenyl (7)2-Methoxy-1,3,5-Triazine (10)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-Methylpyridine (5)2-Methoxy-6-Methylpyridine (14)2-Methoxy-6-Nitrophenol (5)2-Methoxybenzamide (9)2-Methoxybenzenesulfonyl Chloride (15)2-Methoxynaphthalene (22)2-Methoxyphenol (197)2-Methoxypyrazine (45)2-Methoxypyridine (436)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methoxythiophene (7)2-Methyl-N-Phenylaniline (6)2-Phenoxyacetonitrile (11)2-Phenoxyaniline (4)2-Phenoxybenzonitrile (5)2-Phenoxyethan-1-Ol (14)2-Phenoxypropanoic Acid (13)2-Phenoxypyrimidine (8)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxythiazole (5)2-Propoxypyridine (9)3,5-Dimethoxypyridine (4)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Aniline (12)3-(Benzyloxy)Benzaldehyde (13)3-(Benzyloxy)Benzoic Acid (5)3-(Benzyloxy)Phenol (5)3-(Methoxymethyl)Morpholine (4)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methoxybenzaldehyde (7)3-Chloro-4-Methoxybenzoic Acid (5)3-Ethoxypyridine (12)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-4-Methoxybenzoic Acid (6)3-Methoxypiperidine (7)3-Methoxypyridazine (17)3-Methoxypyridine (52)3-Methoxythiophene (9)3-Phenoxyaniline (2)3-Phenoxybenzaldehyde (7)3-Phenoxybenzoic Acid (6)3-Phenoxybenzonitrile (5)3-Phenoxypropanoic Acid (14)3-Phenoxypyrrolidine (5)4-(3-Phenoxypropyl)Morpholine (7)4-(Benzyloxy)Aniline (8)4-(Benzyloxy)Benzaldehyde (23)4-(Benzyloxy)Benzoic Acid (5)4-(Benzyloxy)Phenol (2)4-(Difluoromethoxy)Aniline (6)4-(Dimethoxymethyl)Pyrimidine (5)4-(Phenylethynyl)Phenol (7)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-6-Methoxypyrimidine (5)4-Ethoxypyridine (7)4-Ethoxypyrimidine (6)4-Methoxy-1,1'-Biphenyl (4)4-Methoxy-1H-Indazole (7)4-Methoxy-1H-Indole (11)4-Methoxy-2-Methylpyrimidine (8)4-Methoxy-N-Phenylaniline (5)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methoxypyridazine (8)4-Methoxypyridine (136)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Phenoxyaniline (6)4-Phenoxybenzaldehyde (12)4-Phenoxybenzoic Acid (4)4-Phenoxypyridine (7)4-Phenoxypyrimidine (5)4-Phenoxyquinoline (5)4-Phenoxytetrahydro-2H-Pyran (5)5-(Benzyloxy)Pyrimidine (5)5-Fluoro-2-Methoxypyridine (15)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methoxy-1H-Indazole (5)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methoxy-2-Nitroaniline (7)5-Methoxyindoline (4)5-Methoxyisobenzofuran-1(3H)-One (5)5-Methoxyisoquinoline (6)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1H-Indazole (14)6-Methoxy-1H-Indole (12)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)6-Methoxybenzo[D]Thiazole (6)6-Methoxybenzofuran (4)6-Methoxychromane (5)6-Methoxyisoindolin-1-One (3)6-Methoxyquinoxaline (6)7-(Benzyloxy)Quinoline (6)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Methoxy-1H-Indazole (5)7-Methoxy-1H-Indole (8)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)7-Methoxyisoquinoline (5)8-Methoxyisoquinoline (7)8-Methoxyquinazoline (3)Butoxybenzene (51)Ethoxybenzene (285)Ethyl 2-Phenoxyacetate (10)Isobutoxybenzene (22)Isopropoxybenzene (85)Methoxycyclohexane (7)Methyl 2-Methoxybenzoate (70)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-Methoxybenzoate (70)Methyl 4-Phenoxybenzoate (3)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(4-Phenoxyphenyl)Acetamide (4)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)Phenethoxybenzene (23)Propoxybenzene (63)Tert-Butoxybenzene (19)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)
Fluorinated Building Blocks (99063)
Dichlorofluorobenzene (23)Difluoro (901)Difluoroaniline (37)Difluorobenzaldehyde (33)Difluorobenzamide (6)Difluorobenzenesulfonamide (5)Difluorobenzoate (59)Difluoroethyl (27)Difluoroethyl (27)Difluoromethoxy (200)Difluoromethoxy (200)Difluoropropan (7)Difluoropropan (7)Fluindamine (32)Fluoroacetanilide (5)Fluoroacetophenone (8)Fluoroaniline (65)Fluoroanisole (9)Fluorobenzaldehyde (69)Fluorobenzamide (28)Fluorobenzenesulfonamide (7)Fluorobenzenethiol (6)Fluorobenzylamine (10)Fluorobromobenzene (3)Fluorocinnamic (10)Fluorocinnamic (10)Fluorocinnamic Acid (9)Fluorocyclopropanecarboxylic (9)Fluoroethoxy (4)Fluoroethyl (8)Fluoroethyl (8)Fluoroindan (3)Fluoroindan (3)Fluoroisonicotinaldehyde (7)Fluoroisonicotinate (8)Fluoroisonicotinic (13)Fluoroisonicotinic Acid (13)Fluoromethyl (15)Fluoromethyl (15)Fluoronicotinaldehyde (20)Fluoronicotinamide (3)Fluoronicotinic (19)Fluoronicotinic (19)Fluoronicotinic Acid (14)Fluorophenylisocyanate (3)Fluoropropan (15)Fluoropropan (15)Fluorostyryl (7)Fluorosulfonyl (12)Fluorosulfonyl (12)Hexafluoro (9)Hexafluoro (9)Hexafluoropropan (4)Hexafluoropropan (4)Nonafluoro (2)Nonafluoro (2)Octafluoro (2)Octafluoro (2)Pentafluoro (4)Pentafluorobenzoate (4)Tetrafluoro (12)Tetrafluoro (12)Tetrafluoroaniline (7)Tetrafluoroethoxy (3)Tetrafluoroethoxy (3)Trifluoro (271)Trifluoro (271)Trifluoroacetamide (8)Trifluoroacetyl (13)Trifluoroaniline (11)Trifluorobenzaldehyde (9)Trifluorobenzoate (14)Trifluorobut (36)Trifluorobut (36)Trifluoroethan (2)Trifluoroethan (2)Trifluoroethanamine (23)Trifluoroethanol (6)Trifluoroethoxy (60)Trifluoroethoxy (60)Trifluoroethyl (63)Trifluoromethanesulfonamide (4)Trifluoromethanesulfonyl (22)Trifluoromethoxy (480)Trifluoromethoxy (480)Trifluoromethylthio (5)Trifluoromethylthio (5)Trifluoropropane (36)Trifluoropropanoate (5)Trifluoropropyl (9)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Difluorophenyl)Boronic Acid (28)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Fluorophenyl)Boronic Acid (229)(2-Fluorophenyl)Hydrazine (22)(2-Fluorophenyl)Methanamine (49)(2-Fluorophenyl)Methanol (60)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Fluorophenyl)Boronic Acid (169)(3-Fluorophenyl)Methanol (58)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Fluorophenyl)Boronic Acid (93)(4-Fluorophenyl)Methanamine (27)(4-Fluorophenyl)Methanol (29)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,2,3,4,5-Pentafluorobenzene (51)1,2,3,4-Tetrafluorobenzene (73)1,2,3-Trifluorobenzene (156)1,2,4-Trifluorobenzene (210)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-4-Fluorobenzene (15)1,2-Difluoro-3-Iodobenzene (13)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-3-Methylbenzene (23)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Methoxybenzene (19)1,2-Difluoro-4-Nitrobenzene (43)1,2-Difluorobenzene (658)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dichloro-2-Fluorobenzene (23)1,3-Difluoro-2-Iodobenzene (12)1,3-Difluoro-2-Methylbenzene (18)1,3-Difluoro-2-Nitrobenzene (16)1,4-Dichloro-2-Fluorobenzene (11)1,4-Difluoro-2-Iodobenzene (8)1,4-Difluoro-2-Nitrobenzene (28)1,4-Difluorobenzene (361)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Fluorophenyl)Piperazine (8)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-Fluorophenyl)Ethan-1-One (63)1-(4-Fluorophenyl)Ethan-1-One (36)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)1-Benzyl-4-Fluorobenzene (2)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Cyclohexyl-2-Fluorobenzene (4)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethynyl-2-Fluorobenzene (10)1-Fluoro-2,3-Dimethylbenzene (8)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Methylbenzene (255)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3,5-Dimethylbenzene (12)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Methylbenzene (255)1-Fluoro-3-Nitrobenzene (216)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-Iodobenzene (65)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Methylbenzene (140)1-Fluoro-4-Phenoxybenzene (8)1-Fluorobicyclo[1.1.1]Pentane (4)1-Fluoronaphthalene (23)2'-Fluoro-1,1':4',1''-Terphenyl (6)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,3-Difluoroaniline (34)2,3-Difluorobenzaldehyde (18)2,3-Difluorobenzoic Acid (35)2,3-Difluorobenzonitrile (29)2,3-Difluorophenol (36)2,3-Difluoropyridine (13)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dichloro-1-Fluorobenzene (27)2,4-Difluoro-1-Iodobenzene (14)2,4-Difluoro-1-Methoxybenzene (25)2,4-Difluoro-1-Nitrobenzene (46)2,4-Difluoroaniline (44)2,4-Difluorobenzaldehyde (19)2,4-Difluorobenzoic Acid (29)2,4-Difluorobenzonitrile (21)2,4-Difluorophenol (21)2,5-Difluoroaniline (34)2,5-Difluorobenzoic Acid (32)2,5-Difluoropyridine (8)2,6-Difluoroaniline (23)2,6-Difluorobenzaldehyde (25)2,6-Difluorobenzoic Acid (33)2,6-Difluorobenzonitrile (28)2,6-Difluorophenol (24)2,6-Difluoropyridine (29)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Fluorophenyl)Acetonitrile (30)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Fluorophenyl)Pyrrolidine (5)2-(4-Fluorophenyl)-1H-Indole (4)2-(4-Fluorophenyl)Acetic Acid (30)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Fluorobenzoic Acid (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorophenol (9)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-3-Fluoropyridine (20)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluorobenzaldehyde (10)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-4-Fluorophenol (9)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorobenzoic Acid (8)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-6-Fluorophenol (5)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1,3-Dimethylbenzene (14)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoro-N-Methylbenzamide (12)2-Fluoro-N-Phenylaniline (4)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluoroaniline (262)2-Fluorobenzaldehyde (175)2-Fluorobenzamide (32)2-Fluorobenzenesulfonamide (12)2-Fluorobenzenesulfonyl Chloride (31)2-Fluorobenzoic Acid (220)2-Fluoropyridine (15)2-Fluoropyrimidine (9)3,3-Difluoropiperidine (29)3,3-Difluoropyrrolidine (29)3,4-Difluoroaniline (44)3,4-Difluorophenol (19)3,5-Difluoropyridine (12)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-Chloro-2-Fluoroaniline (9)3-Fluoro-1,1'-Biphenyl (16)3-Fluoro-2-Iodoaniline (8)3-Fluoro-2-Methylaniline (9)3-Fluoro-2-Methylpyridine (15)3-Fluoro-4-Nitroaniline (7)3-Fluoroaniline (289)3-Fluorobenzaldehyde (137)3-Fluorobenzamide (26)3-Fluorobenzenesulfonyl Chloride (22)3-Fluorobenzoic Acid (206)3-Fluorophenol (180)3-Fluoropiperidine (26)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Fluorothiophene (6)4,4-Difluoropiperidine (5)4-(2-Fluorophenyl)Morpholine (8)4-(4-Fluorophenyl)Thiazole (9)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-1H-Indazole (22)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-2-Nitroaniline (14)4-Fluoroaniline (225)4-Fluorobenzaldehyde (78)4-Fluorobenzamide (19)4-Fluorobenzenesulfonyl Chloride (26)4-Fluorobenzo[D]Thiazole (6)4-Fluorobenzoic Acid (114)4-Fluorobenzonitrile (89)4-Fluoroisoquinoline (6)4-Fluorophenol (111)4-Fluoropyrimidine (8)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Fluoro-2-Methylpyridine (8)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochromane (6)5-Fluoroindoline (3)5-Fluoroisoindolin-1-One (3)5-Fluoropyridin-2-Amine (15)5-Fluoropyrimidine (11)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1H-Indazole (15)6-Fluoro-1H-Indole (17)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluorobenzo[D]Thiazole (5)6-Fluorochromane (6)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1H-Indazole (12)7-Fluoro-1H-Indole (24)7-Fluorobenzo[D]Thiazole (9)7-Fluoroindoline-2,3-Dione (6)7-Fluoroisoquinoline (3)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluorochromane (5)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Fluoroisoquinoline (10)8-Fluoroquinazoline (4)Benzenesulfonyl Fluoride (51)Ethyl 2-Fluorobenzoate (37)Ethyl 3-Fluorobenzoate (34)Fluorobenzene (9967)Methyl 2,6-Difluorobenzoate (17)Methyl 2-Fluorobenzoate (132)Methyl 3-Fluorobenzoate (136)Methyl 4-Fluorobenzoate (75)Methyl 6-Fluoronicotinate (4)N-(3-Fluorophenyl)Acetamide (14)N-(4-Fluorophenyl)Benzamide (3)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl Trifluoromethanesulfonate (27)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Trifluoro(Phenyl)Borate (80)
Guanidines (776)
Biguanide (2)Biguanide (2)
Hydrazides (3103)
Acetohydrazide (17)Acetohydrazide (17)Chlorobenzhydrazide (3)Dihydrazide (5)Dihydrazide (5)Fluorobenzohydrazide (6)Pyrazine-2-Carbohydrazide (3)
Hydrazines (6277)
Dichlorophenylhydrazine (3)Hydrazinecarbothioamide (2)Hydrazinecarboxamide (1)Hydrazinylbenzoate (6)(2-Bromophenyl)Hydrazine (8)(2-Chlorophenyl)Hydrazine (16)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)Hydrazine (22)(3-Chlorophenyl)Hydrazine (12)2-Hydrazineylpyridine (32)2-Hydrazineylpyrimidine (6)3-Hydrazineylpyridine (8)4-Hydrazineylpiperidine (5)Isonicotinohydrazide (6)Phenylhydrazine (153)Picolinohydrazide (5)
Hydrazones (2042)
1-Benzylidene-2-Phenylhydrazine (4)
Hydroxylamines (623)
N-Hydroxybenzamide (8)
Iodides (14083)
Diiodo (19)Diiodobenzoate (5)Iodoaniline (60)Iodoanisole (5)Iodobenzaldehyde (38)Iodobenzamide (6)Iodobutane (1)Iodobutane (1)Iodoethoxy (6)Iodoethoxy (6)Iodoethyl (5)Iodoethyl (5)Iodomethyl (26)Iodomethyl (26)Iodonicotinaldehyde (6)Iodonicotinic (14)Iodonicotinic (14)Iodopropyl (4)Iodopropyl (4)(2-Iodophenyl)(Phenyl)Methanone (4)(2-Iodophenyl)Methanol (12)(3-Iodophenyl)Boronic Acid (5)(3-Iodophenyl)Methanol (13)1,2-Benziodoxol-3-(1H)-One (6)1,2-Difluoro-3-Iodobenzene (13)1,2-Diiodobenzene (10)1,3-Dibromo-2-Iodobenzene (4)1,3-Dichloro-2-Iodobenzene (5)1,3-Difluoro-2-Iodobenzene (12)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Diiodobenzene (59)1,4-Dibromo-2-Iodobenzene (3)1,4-Difluoro-2-Iodobenzene (8)1-(2-Iodophenyl)Ethan-1-One (4)1-(3-Iodophenyl)Ethan-1-One (7)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Iodobenzene (9)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Bromo-2-Iodobenzene (65)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Iodobenzene (70)1-Bromo-4-Iodobenzene (67)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Iodobenzene (65)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-4-Iodobenzene (49)1-Ethyl-2-Iodobenzene (6)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-4-Iodobenzene (65)1-Iodo-2,3-Dimethylbenzene (8)1-Iodo-2,4-Dimethylbenzene (9)1-Iodo-2-(Trifluoromethoxy)Benzene (6)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-2-Isopropylbenzene (4)1-Iodo-2-Methoxybenzene (50)1-Iodo-2-Methylbenzene (91)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-(Trifluoromethoxy)Benzene (6)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Iodo-3-Methoxybenzene (48)1-Iodo-3-Methylbenzene (60)1-Iodo-3-Nitrobenzene (45)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)2,4-Difluoro-1-Iodobenzene (14)2,6-Dichloro-4-Iodopyridine (4)2,6-Diiodoaniline (8)2,6-Diiodophenol (16)2-Bromo-3-Iodopyridine (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Iodopyridine (5)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-4-Iodopyridine (19)2-Chloro-5-Iodopyridine (18)2-Chloro-6-Iodophenol (3)2-Chloro-6-Iodopyridine (9)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Iodopyridine (8)2-Fluoro-6-Iodoaniline (7)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodo-1,3-Dimethylbenzene (15)2-Iodo-1,4-Dimethylbenzene (5)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-4-Methylaniline (5)2-Iodo-6-Methylpyridine (5)2-Iodo-6-Nitroaniline (3)2-Iodo-9H-Fluorene (8)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Iodobenzaldehyde (17)2-Iodobenzamide (4)2-Iodobenzene-1,3-Diol (3)2-Iodobenzoic Acid (47)2-Iodobenzonitrile (26)2-Iodonaphthalene (5)2-Iodophenol (63)2-Iodopyrazine (25)2-Iodopyridine (27)2-Iodopyrimidine (8)2-Iodothiophene (14)3-Chloro-2-Iodoaniline (3)3-Chloro-4-Iodoaniline (3)3-Fluoro-2-Iodoaniline (8)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Iodobenzaldehyde (28)3-Iodobenzoic Acid (55)3-Iodobenzonitrile (27)3-Iodoimidazo[1,2-A]Pyridine (10)3-Iodophenol (21)3-Iodopyridazine (5)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Iodotetrahydrofuran (3)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Iodoaniline (8)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Iodoaniline (3)4-Chloro-5-Iodopyrimidine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-3-Iodobenzoic Acid (5)4-Iodo-1,1'-Biphenyl (9)4-Iodo-1H-Pyrazole (9)4-Iodo-N,N-Diphenylaniline (3)4-Iodopyridine (17)4-Iodopyrimidine (9)5-Bromo-2-Iodopyridine (5)5-Iodo-1H-Imidazole (4)5-Iodo-1H-Pyrazole (4)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Iodopyrimidine (5)6-Chloro-5-Iodopyridin-2-Amine (3)Ethyl 2-Iodobenzoate (4)Ethyl 3-Iodobenzoate (11)Methyl 2-Iodobenzoate (28)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 4-Amino-3-Iodobenzoate (7)N-(2-Iodophenyl)Acetamide (8)Phenyl(O-Tolyl)Iodonium (14)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)
Isocyanates and Isothiocyanates (237)
Isocyanate (4)Isocyanate (4)(Isothiocyanatomethyl)Benzene (6)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)Isocyanatobenzene (47)Isothiocyanatobenzene (39)
Isocyanides (69)
Isocyanato (7)Isocyanide (1)Isothiocyanato (5)Isothiocyanato (5)
Ketones (40074)
Acetylacetonate (26)Bromoethanone (4)Butanedione (6)Butanedione (6)Butanone (10)Butanone (10)Carbonyl-Phenyl-Boronic Acid/Ester (184)Chloroethanone (2)Dicarbonyl (2)Dicarbonyl (2)Dichloroacetophenone (5)Dienone (2)Diethanone (5)Diethanone (5)Dione (1793)Dioxobutanoate (2)Enone (21)Ethanone (1026)Heptanedionato (7)Heptanedionato (7)Hydroxyethanone (3)Methyl-Pyrazolone (87)Oxoacetaldehyde (4)Oxoazepane (3)Oxoazepane (3)Oxochroman (5)Oxotetrahydro (11)Pyrimidinone (3)Tetraone (48)Tetraone (48)Trifluoroacetophenone (9)Trifluoroethanone (15)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Hydroxyphenyl)(Phenyl)Methanone (24)(2-Iodophenyl)(Phenyl)Methanone (4)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)(Phenyl)Methanone (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Bromophenyl)(Phenyl)Methanone (9)(4-Chlorophenyl)(Phenyl)Methanone (10)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Hydroxyphenyl)(Phenyl)Methanone (3)(4-Methoxyphenyl)(Phenyl)Methanone (7)(4-Nitrophenyl)(Phenyl)Methanone (3)(R)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-8-One (8)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1,3-Diphenylpropan-1-One (9)1,4-Diazepan-5-One (9)1,4-Dihydroisoquinolin-3(2H)-One (5)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-One (27)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(2-Iodophenyl)Ethan-1-One (4)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Fluorophenyl)Ethan-1-One (63)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-(3-Iodophenyl)Ethan-1-One (7)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Fluorophenyl)Ethan-1-One (36)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Benzofuran-2-Yl)Ethan-1-One (3)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(M-Tolyl)Ethan-1-One (37)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-(O-Tolyl)Ethan-1-One (26)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Pyrazin-2-Yl)Ethan-1-One (5)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-4-Yl)Ethan-1-One (14)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-(Thiazol-2-Yl)Ethan-1-One (9)1-(Thiophen-2-Yl)Ethan-1-One (17)1-Aminoanthracene-9,10-Dione (8)1-Benzylindoline-2,3-Dione (5)1-Benzylpiperidin-3-One (5)1-Chloroanthracene-9,10-Dione (6)1-Hydroxyanthracene-9,10-Dione (11)1-Methylpiperazin-2-One (6)1-Methylpyrrolidin-2-One (13)1-Phenylbutan-1-One (13)1-Phenylpentan-1-One (12)1-Phenylpiperidin-2-One (8)1-Phenylpropan-2-One (36)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2,2-Dimethyl-1-Phenylpropan-1-One (8)2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2,3-Dihydrofuran-3-One (9)2,3-Dihydropyridin-2-One (5)2,5-Dichlorobenzoic Acid (13)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Benzalacetophenone (36)2-Benzoylbenzoic Acid (10)2-Chloro-1-Phenylethan-1-One (20)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chloroquinazolin-4(3H)-One (4)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Hydroxyquinolin-4(1H)-One (3)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methyl-1-Phenylpropan-1-One (20)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)2-Methylcyclohexan-1-One (3)2-Methylisoindolin-1-One (7)2-Methylisoindoline-1,3-Dione (5)2-Methylpyridazin-3(2H)-One (7)2-Oxo-2-Phenylacetaldehyde (12)2-Oxo-2-Phenylacetic Acid (17)3,3-Difluoropiperidin-4-One (3)3,3-Dimethylcyclohexan-1-One (4)3,3-Dimethylpiperidin-4-One (3)3,4-Dihydroquinoxalin-2(1H)-One (7)3-Acetyl-2H-Chromen-2-One (3)3-Aminopyrrolidin-2-One (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)3-Chloro-1-Phenylpropan-1-One (10)3-Fluoropiperidin-4-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)3-Hydroxypyrrolidin-2-One (4)3-Methylcyclohexan-1-One (9)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methylpiperazin-2-One (7)3-Methylpyrimidin-4(3H)-One (6)3-Oxo-3-Phenylpropanenitrile (21)3-Oxo-N-Phenylbutanamide (10)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylacrylaldehyde (29)3-Phenylimidazolidine-2,4-Dione (4)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-Benzylmorpholin-3-One (6)4-Bromoisoindolin-1-One (3)4-Bromopyridazin-3(2H)-One (3)4-Chloro-1-Phenylbutan-1-One (8)4-Chloropyridazin-3(2H)-One (4)4-Fluoroindoline-2,3-Dione (3)4-Hydroxy-2H-Chromen-2-One (10)4-Hydroxydihydrofuran-2(3H)-One (14)4-Hydroxypiperidin-2-One (3)4-Hydroxypyrrolidin-2-One (7)4-Methyl-2H-Chromen-2-One (27)4-Methylisobenzofuran-1(3H)-One (3)4-Oxo-4-Phenylbutanoic Acid (16)4-Phenylbutan-2-One (14)4-Phenylcyclohexan-1-One (11)4-Phenylmorpholin-3-One (6)4-Phenylpyrrolidin-2-One (7)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Bromoisoindolin-1-One (8)5-Bromoisoindoline-1,3-Dione (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloroisoindoline-1,3-Dione (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochroman-4-One (3)5-Fluoroindolin-2-One (4)5-Fluoroisoindolin-1-One (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Hydroxypiperidin-2-One (3)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Methylindolin-2-One (3)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Bromoisoindolin-1-One (4)6-Fluorochroman-4-One (5)6-Fluoroindoline-2,3-Dione (3)6-Fluoroisobenzofuran-1(3H)-One (3)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methoxyisoindolin-1-One (3)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)7,8-Dihydroquinolin-5(6H)-One (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromochroman-4-One (4)7-Bromoindoline-2,3-Dione (3)7-Bromoquinazolin-4(3H)-One (4)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Fluorochroman-4-One (5)7-Fluoroindolin-2-One (3)7-Fluoroquinazolin-4(3H)-One (4)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methoxychroman-4-One (3)7-Methylindoline-2,3-Dione (7)8-Bromochroman-4-One (4)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluoroisoquinolin-1(2H)-One (3)8-Methylchroman-4-One (4)Acetophenone (1120)Azepan-2-One (18)Benzo[Cd]Indol-2(1H)-One (5)Benzofuran-2(3H)-One (7)Chroman-2-One (5)Cyclobutanone (24)Cyclohex-2-En-1-One (27)Cyclohexane-1,3-Dione (12)Cyclopent-2-En-1-One (21)Cyclopentane-1,3-Dione (6)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Dihydrofuran-2,5-Dione (12)Dihydrofuran-3(2H)-One (7)Dihydrothiophen-3(2H)-One (4)Ethene-1,1-Diyldibenzene (10)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 3-Oxo-3-Phenylpropanoate (41)Furan-2(5H)-One (26)Isoquinolin-1-Ol (9)Methyl 3-Oxo-3-Phenylpropanoate (16)Morpholin-3-One (11)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(M-Tolyl)Methanone (3)Phenyl(P-Tolyl)Methanone (4)Phenyl(Pyridin-3-Yl)Methanone (9)Phenyl(Thiophen-2-Yl)Methanone (6)Piperidine-2,4-Dione (5)Propiophenone (59)Pyrimidine-4,6(1H,5H)-Dione (3)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tetrahydropyrimidin-2(1H)-One (6)
Mercaptos (11)
Mercaptopropanoate (10)
Nitrates and Nitrites (1)
Nitriles (28529)
Acetonitrile (255)Acrylonitrile (8)Aminobutanenitrile (5)Aminocyclohexanecarbonitrile (6)Bromobenzonitrile (15)Bromonicotinonitrile (9)Bromophenylacetonitrile (2)Butanenitrile (2)Butanenitrile (2)Chlorobenzonitrile (27)Chloroisonicotinonitrile (4)Chloronicotinonitrile (40)Cyanide (434)Cyanide (434)Cyanoacetamide (4)Cyanoacetate (14)Cyanobenzaldehyde (4)Cyanobenzoate (27)Cyanobenzoic (20)Cyanoethyl (15)Cyanoethyl (15)Cyanoisonicotinate (4)Cyanomethyl (42)Cyanomethyl (42)Cyanonicotinate (8)Cyanophenoxy (8)Cyanophenyl (64)Cyanophenylboronic (5)Cyanopropan (4)Cyanopropan (4)Diacetonitrile (1)Diaminobenzonitrile (8)Dibromoisonicotinonitrile (3)Dicarbonitrile (45)Dicarbonitrile (45)Dichlorobenzonitrile (12)Dichloroisonicotinonitrile (4)Difluorobenzonitrile (41)Fluorobenzonitrile (85)Fluoroisonicotinonitrile (5)Fluoronicotinonitrile (14)Fluorophenylacetonitrile (8)Fluoropicolinonitrile (13)Formylnicotinonitrile (5)Formylnicotinonitrile (5)Hydrazinylbenzonitrile (6)Iodobenzonitrile (44)Iodonicotinonitrile (8)Malononitrile (43)Malononitrile (43)Methoxyisonicotinonitrile (7)Methoxyisonicotinonitrile (7)Methoxynicotinonitrile (18)Methoxynicotinonitrile (18)Methylnicotinonitrile (57)Methylnicotinonitrile (57)Methylpropanenitrile (9)Methylpropanenitrile (9)Nitropicolinonitrile (10)Oxopropanenitrile (8)Phenylacrylonitrile (21)Propanenitrile (41)Propanenitrile (41)Pyrazino-Nitrile (50)Tetrafluorobenzonitrile (5)Thiocyanatoaniline (3)Tricarbonitrile (5)Tricarbonitrile (5)Trifluorobenzonitrile (7)Trifluoromethylbenzonitrile (5)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclopropane-1-Carbonitrile (19)1H-Imidazole-4-Carbonitrile (2)1H-Indazole-3-Carbonitrile (9)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-5-Carbonitrile (5)1H-Indole-6-Carbonitrile (4)1H-Indole-7-Carbonitrile (6)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-3-Carbonitrile (9)2,3-Difluorobenzonitrile (29)2,4-Dichlorobenzonitrile (4)2,4-Difluorobenzonitrile (21)2,6-Dibromobenzonitrile (4)2,6-Dichlorobenzonitrile (8)2,6-Difluorobenzonitrile (28)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(2-Bromophenyl)Acetonitrile (10)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Fluorophenyl)Acetonitrile (30)2-(3-Chlorophenyl)Acetonitrile (16)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(Bromomethyl)Benzonitrile (15)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethyl)Benzonitrile (35)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorobenzonitrile (3)2-Aminonicotinonitrile (6)2-Bromo-6-Fluorobenzonitrile (7)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-N-Methylaniline (4)2-Chlorobenzonitrile (99)2-Hydroxybenzonitrile (45)2-Iodobenzonitrile (26)2-Naphthonitrile (15)2-Nitrobenzonitrile (37)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Phenoxyacetonitrile (11)2-Phenoxybenzonitrile (5)2-Phenylacetonitrile (172)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethyl)Benzonitrile (47)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromobenzonitrile (110)3-Chloro-2-Fluorobenzonitrile (7)3-Chlorobenzonitrile (100)3-Chloropyrazine-2-Carbonitrile (6)3-Fluoropicolinonitrile (5)3-Hydroxybenzonitrile (40)3-Iodobenzonitrile (27)3-Nitrobenzonitrile (59)3-Oxo-3-Phenylpropanenitrile (21)3-Phenoxybenzonitrile (5)4-Amino-2-Chlorobenzonitrile (8)4-Chloropyrimidine-5-Carbonitrile (6)4-Cyanophenyl Benzoate (11)4-Cyclohexylbenzonitrile (10)4-Fluorobenzonitrile (89)4-Nitrobenzonitrile (25)5-Fluoropicolinonitrile (5)6-Methylnicotinonitrile (7)6-Methylpicolinonitrile (10)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-4-Carbonitrile (27)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[D]Thiazole-2-Carbonitrile (11)Benzonitrile (1312)Furan-2-Carbonitrile (8)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinonitrile (16)Isoquinoline-1-Carbonitrile (7)Methyl 2-Cyanobenzoate (22)Methyl 3-Cyanobenzoate (29)Morpholine-2-Carbonitrile (4)Nicotinonitrile (82)Pyrazine-2-Carbonitrile (15)Pyrimidine-2-Carbonitrile (14)Pyrimidine-4-Carbonitrile (9)Pyrimidine-5-Carbonitrile (6)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-3-Carbonitrile (6)Thiazole-5-Carbonitrile (7)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbonitrile (13)
Nitroes (23714)
Difluoronitrobenzene (9)Dinitro (7)Dinitroaniline (5)Nitroacetophenone (7)Nitroaniline (211)Nitrobenzaldehyde (100)Nitrobenzamide (35)Nitrobenzenesulfonamide (26)Nitrobenzonitrile (106)Nitrobenzotrifluoride (16)Nitroisophthalate (4)(2-Nitrophenyl)Boronic Acid (13)(2-Nitrophenyl)Methanol (29)(2-Nitrovinyl)Benzene (28)(3-Nitrophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)Boronic Acid (32)(3-Nitrophenyl)Methanol (31)(4-Nitrophenyl)(Phenyl)Methanone (3)(4-Nitrophenyl)Methanol (17)1,2-Dichloro-4-Nitrobenzene (16)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Nitrobenzene (43)1,2-Dimethyl-3-Nitrobenzene (6)1,2-Dinitrobenzene (6)1,3-Dibromo-2-Nitrobenzene (4)1,3-Dichloro-2-Nitrobenzene (5)1,3-Difluoro-2-Nitrobenzene (16)1,3-Dimethyl-2-Nitrobenzene (9)1,3-Dinitrobenzene (31)1,4-Difluoro-2-Nitrobenzene (28)1,4-Dimethyl-2-Nitrobenzene (10)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Tert-Butyl)-2-Nitrobenzene (4)1-(Tert-Butyl)-3-Nitrobenzene (7)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Nitrobenzene (161)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-3-Nitrobenzene (216)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-Nitrobenzene (45)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-Nitrobenzene (90)1-Methyl-2-Nitrobenzene (176)1-Methyl-3-Nitrobenzene (147)1-Methyl-4-Nitrobenzene (82)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-2-Phenoxybenzene (4)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Nitro-4-Phenoxybenzene (5)1-Nitronaphthalene (3)2,4-Dichloro-1-Nitrobenzene (19)2,4-Difluoro-1-Nitrobenzene (46)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethyl-1-Nitrobenzene (15)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(4-Nitrophenyl)Acetic Acid (9)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Nitroaniline (12)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Nitrophenol (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-6-Nitroaniline (11)2-Chloro-6-Nitrophenol (7)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-6-Nitroaniline (3)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Nitrophenol (5)2-Methyl-3-Nitrobenzoic Acid (7)2-Methyl-3-Nitropyridine (9)2-Methyl-6-Nitroaniline (10)2-Nitro-1H-Pyrrole (5)2-Nitro-N-Phenylaniline (3)2-Nitrobenzaldehyde (53)2-Nitrobenzoic Acid (65)2-Nitrobenzonitrile (37)2-Nitrofuran (9)2-Nitronaphthalene (4)2-Nitropyridine (40)2-Nitrothiophene (20)3-Chloro-2-Nitroaniline (5)3-Chloro-4-Nitroaniline (5)3-Fluoro-4-Nitroaniline (7)3-Methoxy-2-Nitrobenzaldehyde (3)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methyl-5-Nitropyridine (4)3-Nitroaniline (98)3-Nitrobenzaldehyde (49)3-Nitrobenzamide (17)3-Nitrobenzene-1,2-Diol (6)3-Nitrobenzenesulfonamide (8)3-Nitrobenzoic Acid (109)3-Nitrobenzonitrile (59)3-Nitrophenol (72)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Nitrothiophene (6)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-2-Nitroaniline (14)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Methyl-3-Nitroaniline (8)4-Methyl-3-Nitropyridine (8)4-Nitro-1H-Indazole (10)4-Nitro-1H-Indole (6)4-Nitro-1H-Pyrazole (8)4-Nitroaniline (65)4-Nitrobenzaldehyde (18)4-Nitrobenzene-1,3-Diol (5)4-Nitrobenzoic Acid (35)4-Nitrobenzonitrile (25)4-Nitrophenol (67)4-Nitropyridine (11)5-(4-Nitrophenyl)Oxazole (3)5-Methoxy-2-Nitroaniline (7)5-Methyl-2-Nitroaniline (6)5-Nitro-1H-Indazole (5)5-Nitro-1H-Indole (6)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Nitrobenzo[D][1,3]Dioxole (4)5-Nitrobenzo[D]Thiazole (3)5-Nitroisoquinoline (7)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1H-Indazole (9)6-Nitro-1H-Indole (8)6-Nitrobenzo[D]Thiazole (3)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Nitro-1H-Indazole (11)7-Nitro-1H-Indole (11)Ethyl 2-Nitrobenzoate (9)Ethyl 3-Nitrobenzoate (22)Ethyl Cinnamate (26)Methyl 2-Nitrobenzoate (54)Methyl 3-Nitrobenzoate (109)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Nitrobenzoate (29)N-(2-Nitrophenyl)Acetamide (11)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)Nitrobenzene (2309)
Oximes (561)
Phenols (1786)
Aminophenol (9)Bromophenol (13)Chlorophenol (28)Dibromophenol (9)Dichlorophenol (17)Difluorophenol (36)Dihydroxybenzaldehyde (16)Dihydroxybenzamide (6)Dihydroxybenzoate (15)Dihydroxybenzoic (17)Dihydroxybenzonitrile (6)Dihydroxyphenyl (98)Dihydroxystyryl (4)Diiodophenol (7)Fluorophenol (73)Hydroxyacetophenone (16)Hydroxybenzaldehyde (88)Hydroxybenzamide (24)Hydroxybenzenesulfonic (4)Hydroxybenzenesulfonic Acid (3)Hydroxybenzoate (113)Hydroxybenzohydrazide (4)Hydroxybenzoic (89)Hydroxybenzonitrile (60)Hydroxybenzoyl (1)Hydroxyphenoxy (7)Hydroxyphenylacetic (7)Hydroxyphenylacetic Acid (7)Hydroxyphenylboronic (8)Hydroxypropiophenone (3)Iodophenol (41)Nitrophenol (134)Tetrafluorophenol (9)Trifluorophenol (5)Trihydroxybenzaldehyde (5)Trihydroxybenzoate (12)Trihydroxybenzoic (5)Trihydroxybenzoic Acid (4)Trihydroxyphenyl (10)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-Hydroxyanthracene-9,10-Dione (11)2,3-Dichlorophenol (9)2,3-Difluorophenol (36)2,4-Dibromophenol (16)2,4-Difluorophenol (21)2,5-Dichlorophenol (7)2,6-Dibromophenol (21)2,6-Dichlorophenol (16)2,6-Difluorophenol (24)2,6-Diiodophenol (16)2,6-Dimethylphenol (19)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(Benzyloxy)Phenol (5)2-(Difluoromethoxy)Phenol (5)2-(Tert-Butyl)Phenol (56)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethyl)Phenol (23)2-Amino-3-Bromophenol (3)2-Amino-3-Chlorophenol (4)2-Aminophenol (107)2-Benzylphenol (8)2-Bromo-3-Methylphenol (4)2-Bromo-6-Methylphenol (7)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Chloro-4-Fluorophenol (9)2-Chloro-4-Nitrophenol (5)2-Chloro-6-Methylphenol (5)2-Chloro-6-Nitrophenol (7)2-Chlorobenzene-1,3-Diol (4)2-Chlorophenol (163)2-Ethylphenol (10)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Hydroxybenzonitrile (45)2-Iodobenzene-1,3-Diol (3)2-Iodophenol (63)2-Isopropylphenol (28)2-Methoxyphenol (197)3,4-Dibromophenol (3)3,4-Difluorophenol (19)3-(Benzyloxy)Phenol (5)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)Phenol (43)3-Bromo-2-Fluorophenol (5)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluorophenol (11)3-Bromobenzene-1,2-Diol (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chlorobenzene-1,2-Diol (6)3-Chlorophenol (112)3-Fluorophenol (180)3-Hydroxybenzonitrile (40)3-Iodophenol (21)3-Nitrobenzene-1,2-Diol (6)3-Nitrophenol (72)4-(Benzyloxy)Phenol (2)4-(Trifluoromethyl)Phenol (18)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorophenol (5)4-Benzylphenol (14)4-Chlorobenzene-1,3-Diol (6)4-Fluorophenol (111)4-Hydroxybenzenesulfonic Acid (5)4-Nitrobenzene-1,3-Diol (5)4-Nitrophenol (67)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)Ethyl 2-Hydroxybenzoate (18)Ethyl 3-Hydroxybenzoate (12)M-Cresol (147)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-Hydroxybenzoate (74)Methyl 3-Hydroxybenzoate (58)O-Cresol (164)P-Cresol (71)Pyrocatechol (131)Resorcinol (146)
Phosphoruses (827)
Diethoxyphosphoryl (5)Diisopropylphosphoramidite (4)Dimethoxyphosphoryl (4)Dimethoxyphosphoryl (4)Dimethylphosphine (28)Dioxaphosphepine (146)Diphosphonic (9)Phosphorothioate (1)1,1,1-Trifluoro-N-(4-Oxido-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin-4-Yl)Methanesulfonamide (16)Diethyl Benzylphosphonate (17)Dimethyl(Phenyl)Phosphine Oxide (20)Ethyltriphenylphosphonium (2)Methyltriphenylphosphonium (3)Phenyl Phosphate (3)Phenylphosphonic Acid (6)
Polycyclic Aromatic Hydrocarbons (6)
Protective Groups (23)
Saturated Aliphatic Fused Rings (2)
(8Ar,12Br,14Br)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Icosahydropicene (2)
Silicon Compounds (450)
Butyldimethylsilyl (94)Butyldimethylsilyl (94)Butyldimethylsilyloxy (8)Dimethylsilane (16)Dimethylsilane (16)Dimethylsilyl (4)Tetramethyldisiloxane (3)Tetramethyldisiloxane (3)Triethoxysilyl (13)Triethoxysilyl (13)Triisopropylsilyl (22)Triisopropylsilyl (22)Trimethoxysilane (19)Trimethoxysilane (19)Trimethylsilane (155)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)Tert-Butyldimethyl(Phenoxy)Silane (17)Tetraphenylsilane (7)Trimethoxy(Phenyl)Silane (6)Trimethyl(Phenyl)Silane (22)Trimethyl(Phenylethynyl)Silane (23)
Sulfamides (10218)
Dimethylsulfamoyl (5)Dimethylsulfamoyl (5)Methanesulfonamide (54)Methanesulfonamide (54)Methylmethanesulfonamide (3)Methylmethanesulfonamide (3)Methylsulfonamido (4)Methylsulfonamido (4)Sulfinamide (55)Sulfinamide (55)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluorobenzenesulfonamide (12)2-Methylbenzenesulfonamide (8)3-Nitrobenzenesulfonamide (8)4-Amino-N-Phenylbenzenesulfonamide (3)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Chloro-N-Phenylbenzenesulfonamide (4)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methyl-N-Phenylbenzenesulfonamide (13)N,N-Diethylbenzenesulfonamide (8)N,N-Dimethylbenzenesulfonamide (23)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(O-Tolyl)Benzenesulfonamide (4)N-(Tert-Butyl)Benzenesulfonamide (14)N-Ethylbenzenesulfonamide (8)N-Isopropylbenzenesulfonamide (8)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylbenzenesulfonamide (15)N-Phenylbenzenesulfonamide (81)N-Phenylmethanesulfonamide (37)Phenylmethanesulfonamide (13)Pyridine-2-Sulfonamide (6)
Sulfides (10123)
Methylthio (432)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)1,2-Diphenyldisulfane (19)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-(Methylthio)Pyridine (5)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Methylthio)Thiazole (5)2-(Propylthio)Pyrimidine (5)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Methyl-2-(Methylthio)Pyrimidine (7)5-Bromo-2-(Methylthio)Pyrimidine (6)Benzyl(Phenyl)Sulfane (5)Ethyl(Phenyl)Sulfane (8)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl(Trifluoromethyl)Sulfane (23)
Sulfonates (1160)
4-Methylbenzenesulfonate (9)
Sulfones (3927)
(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(Ethylsulfonyl)Benzene (8)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Methylsulfonyl)Piperazine (5)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-(Phenylsulfonyl)-1H-Imidazole (5)1-(Phenylsulfonyl)Azetidine (7)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Methyl-3-(Methylsulfonyl)Benzene (5)2-(Methylsulfonyl)Aniline (3)2-(Methylsulfonyl)Pyridine (11)2-(Methylsulfonyl)Pyrimidine (25)3-(Methylsulfonyl)Aniline (7)3-(Methylsulfonyl)Benzoic Acid (6)3-(Methylsulfonyl)Pyridine (5)Benzenesulfonyl Fluoride (51)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)Tetrahydrothiophene 1,1-Dioxide (13)
Sulfonic Acids (1261)
Aminobenzenesulfonic (4)Bromobenzenesulfonic Acid (4)Disulfonic (9)Disulfonic (9)Ethanesulfonic (3)Methanesulfonic (2)Methanesulfonic (2)Methylbenzenesulfonate (144)Propanesulfonic Acid (2)Trifluoromethanesulfonic (4)2-Aminobenzenesulfonic Acid (9)2-Methylbenzenesulfonic Acid (8)3-Aminobenzenesulfonic Acid (6)4-Chlorobenzenesulfonic Acid (4)4-Hydroxybenzenesulfonic Acid (5)Naphthalene-2-Sulfonic Acid (4)Pyridine-3-Sulfonic Acid (6)
Sulfonyl Chlorides (4029)
Fluorobenzenesulfonyl (12)1H-Pyrazole-4-Sulfonyl Chloride (8)2-Bromobenzenesulfonyl Chloride (8)2-Chlorobenzenesulfonyl Chloride (24)2-Fluorobenzenesulfonyl Chloride (31)2-Methoxybenzenesulfonyl Chloride (15)2-Methylbenzenesulfonyl Chloride (22)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-Chlorobenzenesulfonyl Chloride (21)3-Fluorobenzenesulfonyl Chloride (22)4-Chlorobenzenesulfonyl Chloride (12)4-Fluorobenzenesulfonyl Chloride (26)Isoquinoline-5-Sulfonyl Chloride (3)Methyl 2-(Chlorosulfonyl)Benzoate (7)Phenylmethanesulfonyl Chloride (20)
Sulfonyl Hydrazides (25)
Benzenesulfonohydrazide (12)
Sulfoxides (333)
(Methylsulfinyl)Benzene (7)
Thioesters (625)
Thiols (468)
Dithiole (9)Dithiole (9)Ethanethioate (9)Ethanethioate (9)Methanethiol (6)1H-Benzo[D]Imidazole-2-Thiol (10)2-Chlorobenzenethiol (7)2-Mercaptoquinazolin-4(3H)-One (3)Benzo[D]Oxazole-2-Thiol (6)Benzo[D]Thiazole-2-Thiol (11)Phenylmethanethiol (16)Pyridine-2-Thiol (8)Pyrimidine-2-Thiol (6)
Thiophenols (3045)
Thioureas (1128)
Carbamimidothioate (4)1,3-Diphenylthiourea (8)1-Phenylthiourea (33)
Trifluoromethyls (28951)
Trifluoromethyl-Picolinamide (7)Trifluoromethylaniline (3)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-(Trifluoromethyl)Phenyl)Methanol (21)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(Perfluoropropane-2,2-Diyl)Dibenzene (7)(Trifluoromethyl)Benzene (1336)1,3-Bis(Trifluoromethyl)Benzene (70)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-(Trifluoromethyl)Benzene (126)1-Fluoro-3-(Trifluoromethyl)Benzene (98)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-(Trifluoromethyl)Benzene (53)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methyl-2-(Trifluoromethoxy)Benzene (5)1-Methyl-2-(Trifluoromethyl)Benzene (43)1-Methyl-3-(Trifluoromethyl)Benzene (22)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-(Trifluoromethyl)Aniline (58)2-(Trifluoromethyl)Benzaldehyde (27)2-(Trifluoromethyl)Benzamide (6)2-(Trifluoromethyl)Benzoic Acid (33)2-(Trifluoromethyl)Benzonitrile (35)2-(Trifluoromethyl)Phenol (23)2-(Trifluoromethyl)Pyrazine (6)2-(Trifluoromethyl)Pyridine (6)2-(Trifluoromethyl)Pyrimidine (27)2-(Trifluoromethyl)Quinazoline (4)2-(Trifluoromethyl)Thiazole (11)2-(Trifluoromethyl)Thiophene (11)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Aniline (102)3-(Trifluoromethyl)Benzaldehyde (31)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-(Trifluoromethyl)Benzoic Acid (52)3-(Trifluoromethyl)Benzonitrile (47)3-(Trifluoromethyl)Phenol (43)3-(Trifluoromethyl)Pyridazine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Chloro-4-(Trifluoromethyl)Aniline (5)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4-(Trifluoromethoxy)Aniline (26)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-(Trifluoromethyl)Phenol (18)4-(Trifluoromethyl)Pyridine (14)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-(Trifluoromethyl)Thiazole (7)4-Bromo-3-(Trifluoromethyl)Aniline (7)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)6-(Trifluoromethyl)-1H-Indazole (6)6-(Trifluoromethyl)-1H-Indole (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 3-(Trifluoromethyl)Benzoate (22)N-Phenyl-4-(Trifluoromethyl)Aniline (3)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(Trifluoromethyl)Sulfane (23)
Ureas (1841)
Other Function Groups (5)
Organometallic Reagents
Organoborons (34729)
Fluorene-Phenyl-Boronic Acid/Ester (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Methoxyphenylboronic-Acid (32)Phenyl-Naphthalene-Boronic Acid/Ester (9)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)(1H-Indol-2-Yl)Boronic Acid (3)(2,3-Dichlorophenyl)Boronic Acid (11)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Dichlorophenyl)Boronic Acid (6)(2,6-Difluorophenyl)Boronic Acid (28)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-Bromophenyl)Boronic Acid (39)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(2-Fluorophenyl)Boronic Acid (229)(2-Nitrophenyl)Boronic Acid (13)(3,4-Dichlorophenyl)Boronic Acid (10)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)Boronic Acid (121)(3-Fluorophenyl)Boronic Acid (169)(3-Iodophenyl)Boronic Acid (5)(3-Nitrophenyl)Boronic Acid (32)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Fluorophenyl)Boronic Acid (93)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(E)-4,4,5,5-Tetramethyl-2-Styryl-1,3,2-Dioxaborolane (16)1,3,2-Dioxaborinane (6)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Cyclopropylphenyl)-1,3,2-Dioxaborolane (5)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(4-Cyclopropylphenyl)-1,3,2-Dioxaborolane (8)2-(4-Fluorophenyl)-1,3,2-Dioxaborinane (5)2-([1,1'-Biphenyl]-4-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Cyclohex-1-En-1-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-(M-Tolyl)-1,3,2-Dioxaborinane (4)2-Benzyl-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (12)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(Naphthalen-1-Yl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(Naphthalen-2-Yl)-1,3,2-Dioxaborolane (12)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzofuran-2-Ylboronic Acid (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Cyclohex-1-En-1-Ylboronic Acid (4)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Isoquinolin-4-Ylboronic Acid (3)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)Naphthalen-1-Ylboronic Acid (4)Naphthalen-2-Ylboronic Acid (8)Phenylboronic Acid (1286)Pyridin-2-Ylboronic Acid (9)Pyridin-3-Ylboronic Acid (49)Pyridin-4-Ylboronic Acid (21)Pyrimidin-5-Ylboronic Acid (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetraphenylborate (8)Thiophen-2-Ylboronic Acid (20)
Organosilicons (73)
Organotins (5)
Other Organometallic Reagents (1)
Specialty Synthesis
Ionic Liquids (738)
Synthetic Reagents
C-C Bond Formation (62)
Condensation Agents (74)
Fluorination Reagents (20)
Halogenation Reagents (20)
Inorganic Salts (25506)
Phase Transfer Catalysts (29)
Other Synthetic Reagents (106)
Materials Science
Electronic Materials
Contact Printing & Self-Assembly Materials (77)
Liquid Crystal (LC) Materials (413)
Molecular Conductors (80)
Organic Field-Effect Transistors (OFETs) (86)
Organic Light-Emitting Diode (OLED) Materials (22)
4-(Diphenylamino)Benzaldehyde (8)4-Bromo-N,N-Bis(4-Methoxyphenyl)Aniline (3)4-Methoxy-N,N-Diphenylaniline (5)4-Methyl-N,N-Diphenylaniline (6)
Photoresist Materials (249)
Silane Coupling Agents (176)
Energy and Battery Materials
Battery Additives (75)
Battery Electrolytes Materials (16)
Battery Solvent Materials (24)
Electrode Active Materials (4)
Ionic Liquids (738)
Organic Redox Flow Battery Materials (26)
Solution & Vapor Deposition Precursors (31)
Material Building Blocks
Alkyl Chain Building Blocks (93)
Ligands for Functional Metal Complexes (198)
Liquid Crystal (LC) Building Blocks (558)
Phthalocyanine Building Blocks (71)
Small Molecule Semiconductor Building Blocks (1878)
Organic Frameworks and Supramolecular Materials
Covalent Organic Framework (COF) Linkers (1087)
Metal Organic Framework (MOF) Linkers (1693)
Metal Organic Frameworks (MOFs) (85)
Organic Framework Building Blocks (218)
Supramolecular Host Materials  (185)
Polymer Additives
Antioxidants (81)
Crosslinking Agents (75)
Flame Retardants (35)
Light Stabilizers (67)
Plasticizers (84)
Polymerization Catalysts (156)
Polymerization Initiators (141)
Polymerization Reagents (170)
Surfactants (340)
Other Additives (34)
Polymer Reagents
Dendrimer Materials (59)
Ion Exchange Resins (7)
Monomers (3050)
Photopolymer Monomers (180)
Polybenzoxazole and Polyimide Raw Materials (240)
Polymer Semiconductor Monomers (269)
Polymers (375)
Quantum Dots and Micro/Nano Materials
Nanocarbon Materials (45)
Quantum Dots (QD) Capping Agents (178)
Quantum Dots (QD) Synthetic Reagents (13)
Solar Cells and Photonic Materials
Donor Intermediates & Acceptor Intermediates (1029)
Dye-Sensitized Solar Cell (DSSC) Materials (130)
Dyes and Pigments (392)
Organic Non-Linear Optical (NLO) Materials (39)
Organic Phto-Voltaics (OPV) Materials (185)
Perovskite Solar Cell (PSC) Materials (278)
Visible Light Photoredox Catalysts (29)
Other Functional Materials
Aggregation-Induced Emission Materials (169)
Inorganic Compounds and Ceramic Materials (33)
Magnetic Materials (50)
Life Science
Inhibitors/Agonists
ADC (371)
ADC Linker (371)
Angiogenesis (1714)
ALK (86)Bcr-Abl (105)BTK (149)EGFR (403)FAK (56)FGFR (136)FLT3 (134)HER2 (31)HIF (112)JAK (245)PDGFR (127)Src (110)Syk (40)VDA (1)VEGFR (271)
Anti-Infection (4763)
3CLpro (41)Antibacterial (2101)Antifungal (525)Antiparasitic (648)Antiprotozoal (2)Antiviral (48)Arenavirus (5)BVDV (3)CMV (30)Dengue Virus (36)EBV (14)Enterovirus (33)FCoV (3)Filovirus (14)Flavivirus (64)GraR (1)HBV (151)HCV (222)HHV (1)HIV (447)HIV Integrase (39)HIV Protease (68)HPV (10)HRV (3)HSV (75)Influenza Virus (251)LpxC (2)M2 proton channel (2)MERS-CoV (1)Neuraminidase (4)NNRTI (12)NRTI (22)Orthopoxvirus (28)Penicillin-Binding Protein (7)PLP (13)Prion (1)Protein Synthesis (4)Reverse Transcriptase (99)RSV (43)SAMHD1 (1)SARS-CoV (298)SQLE (5)TMV (12)Viral MTase (3)Virus Protease (62)VSV (1)β-lactamase (51)
Antibody-Drug Conjugate/ADC Related (647)
ADC Linker (371)ADC Toxins (123)Payload-Linker Conjugate (165)
Apoptosis (2443)
Apoptosis (2143)Apoptosis Inducer (1407)Bcl-2 (195)Bcl-6 (6)BRK (3)c-Myc (47)c-RET (64)C/EBP (2)Caspase (170)DAPK (12)Ferroptosis (109)FKBP (15)GDNF Receptor (1)IAP (48)IDO (70)MDM2 (143)MRCK (2)Necroptosis (33)p32 (1)p53 (41)PERK (35)PKD (10)Pyroptosis (13)RIP Kinase (84)Survivin (12)Thymidylate Synthase (24)TNF (22)TNF Receptor (117)TNF-alpha (30)
Autophagy (745)
ATG4B (4)ATTECs (3)AUTACs (7)Autophagy (730)Beclin1 (1)FKBP (15)LC3 (1)LRRK2 (32)Lysosome (1)mitoNEET (1)Mitophagy (3)PPT (1)SPHK (27)TFEB (1)ULK (17)
Cell Cycle (4595)
Antifolate (31)APC (6)Aurora Kinase (87)BUB (3)Casein Kinase (101)CDK (475)Chk (46)CRISPR/Cas9 (7)CRM1 (17)DHFR (55)DNA polymerase θ (2)DNA/RNA Synthesis (620)DOCK (3)DYRK (60)E2F (2)eIF (43)Endonuclease (3)FOXM1 (3)G-quadruplex (6)Haspin Kinase (8)HDAC (336)HGF (1)HSF (4)HSP (161)IRE1 (27)Kinesin (35)Lats kinase (1)LIMK (17)Mad2 (1)Microtubule/Tubulin (305)MKLP (1)Mps1 (21)MTH2 (1)Nucleoside Antimetabolite/Analog (1441)p21 (1)PAK (30)PDI (1)PKMYT1 (2)PLK (50)PPAR (193)PTEN (5)RAD51 (18)Rho (14)RNA polymerase 2 (1)RNA polymerase 1 (2)ROCK (90)Separase (1)Sirtuin (129)SRPK (51)STK33 (2)TACC (3)Telomerase (21)TOPK (1)Topoisomerase (271)Wee1 (16)YB-1 (5)
Cytoskeleton (728)
Actin (1)Arp2/3 Complex (6)CYTH (1)Cytoplasmic dynein (1)Dynamin (14)FAK (56)Filamin-A (1)Gap Junction (11)Integrin (134)Kinesin (35)MARK (1)Microtubule/Tubulin (305)MLCK (5)Mps1 (21)Myosin (25)PAK (30)ROCK (90)Spastin (1)
DNA Damage (3023)
ADAR (1)AP endonuclease (1)ATAD5 (1)ATM/ATR (67)Aurora Kinase (87)Casein Kinase (101)ClpP (5)CRISPR/Cas9 (7)DNA Alkylator/Crosslinker (75)DNA-PK (39)DNA/RNA Synthesis (620)HDR (1)HSP (161)MRE11 (1)MTH1 (8)Nucleoside Antimetabolite/Analog (1441)OGG (3)p97 (15)PARP (175)RAD51 (18)RAD52 (3)Telomerase (21)Topoisomerase (271)WRN (5)YB-1 (5)
Endocrinology/Hormones (826)
5 Alpha Reductase (2)ACE (76)Adrenergic Receptor (184)Androgen Receptor (96)Aromatase (8)ERR (218)GHSR (21)Glucocorticoid Receptor (44)GNRH Receptor (19)Mineralocorticoid Receptor (12)Opioid Receptor (54)Progesterone Receptor (9)PTHR (1)Renin (18)Sepiapterin reductase (2)SSTR (28)Taste receptor (3)Thyroid Hormone Receptor (7)TPO (4)TRHR (1)TSH Receptor (17)TTR (7)
Endoplasmic Reticulum Stress (567)
Antioxidant (33)IRE1 (27)JNK (79)PDI (1)PERK (35)ROS (398)
Epigenetics (2366)
AMPK (105)Aurora Kinase (87)DNA Methyltransferase (43)Epigenetic Reader Domain (396)FTO (15)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)JAK (245)MBD-containing protein (1)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)SF3B1 (3)Sirtuin (129)TET (8)
Ferroptosis Signaling Pathway (78)
ABC Transporter (2)ACC (22)GPx (25)SCD (18)SLC (6)VDAC (6)
GPCR/G Protein (3483)
5-HT Receptor (402)Adenosine Receptor (169)Adenylyl Cyclase (1)Adiponectin Receptor (2)Adrenergic Receptor (184)Amylin receptor (1)Angiotensin Receptor (72)Apelin Receptor (22)Bombesin Receptor (7)Bradykinin Receptor (17)cAMP (34)Cannabinoid Receptor (65)CaSR (23)CCR (89)CGRP Receptor (14)Chemerin Receptor (2)Cholecystokinin Receptor (32)CRF Receptor (19)CXCR (112)Dopamine Receptor (170)Endothelin Receptor (47)Epac (9)G protein (2)GHSR (21)GLP Receptor (25)Glucagon Receptor (50)GNRH Receptor (19)GPCR (203)GPCR19 (2)GPR109A (1)GPR119 (2)GPR139 (3)GPR24 (1)GPR35 (1)GPR40 (7)GPR52 (4)GPR6 (3)GPR68 (2)GPR84 (1)GPR88 (10)Guanylate Cyclase (31)HCAR (2)Histamine Receptor (239)ICMT (61)Kisspeptin Receptor (2)LHCGR (39)LPA Receptor (11)LPL Receptor (118)Melanocortin Receptor (31)mGluR (226)Motilin Receptor (1)MRGPR (13)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NMUR (2)NPFF receptor (3)Opioid Receptor (54)OXTR (10)P2Y Receptor (77)PACAP Receptor (3)PAFR (38)PAR (55)Prostaglandin Receptor (217)Ras (275)RGS (6)RXFP Receptor (14)Sigma Receptor (53)SOS (7)SRPK (51)SSTR (28)SUCNR1 (4)TAAR (8)TSH Receptor (17)Urotensin Receptor (7)Vasopressin Receptor (23)β-arrestin (17)
Hedgehog (Hh) (832)
BMI-1 (3)c-Myc (47)Casein Kinase (101)CDK (475)Cytoplasmic dynein (1)Gli (6)GSK-3 (126)PKA (59)Smo (36)ULK (17)
Hippo (80)
Lats kinase (1)MAP4K (47)MST (2)TEAD (10)YAP (28)
Immunology/Inflammation (2700)
AIM2 (5)AP-1 (14)Arginase (15)Calcineurin (8)CCR (89)CD19 (1)CD20 (2)CD22 (2)CD28 (2)CD28-B7 (1)CD3 (3)CD38 (10)CD47 (6)CD6 (1)CD73 (26)CD80 (1)cGAS (8)Complement System (45)COX (344)CRTH2 (9)CTLA-4 (2)CXCR (112)CYPA (1)FAP (17)FKBP (15)FLAP (17)FPR (17)Galectin (3)Glucocorticoid Receptor (44)Glycoprotein VI (3)GM-CSF (2)Histamine Receptor (239)HMGB (1)IFNAR (24)IL (172)IL Receptor (9)Immunology & Inflammation Related (75)IRAK (71)IRF3 (1)LAG-3 (1)LanC-like protein (1)Legumain (1)LTA4H (3)LTR (71)MALT1 (24)MIF (18)MyD88 (6)NADPH Oxidase (32)NFAT (11)NLR (73)NO Synthesis (6)NOS (186)NOT (1)Nrf2 (99)PD-1/PD-L1 (80)PG Synthase (30)PSMA (13)Pyroptosis (13)ROS (398)Ros1 (18)S100A9 (1)Scavenger receptor (1)SIK (15)SOD (4)SPHK (27)STING (98)TENT (1)Thrombopoietin Receptor (11)Tim3 (4)TLR (163)TSPO (2)VISTA (1)XBP1 (1)
JAK-STAT-Signaling (837)
EGFR (403)JAK (245)Pim (58)STAT (160)
MAPK/ERK Pathway (712)
AP-1 (14)ERK (166)HPK1 (2)JNK (79)KLF (5)MAP3K (24)MAP3K12 (1)MAP4K (47)MAP4K4 (5)MAP4K6 (1)MEK (99)MK2 (11)MLK (14)MNK (11)p38 MAPK (163)Raf (106)RSK (33)TAOK (1)
Membrane Transporter/Ion Channel (1711)
ABC Transporter (2)AKK1 (3)ANT (1)AQP (5)AQP3 (1)ARF (2)ATP synthase (19)ATPase (41)BCRP (23)Calcium Channel (269)CFTR (61)Chloride Channel (30)CRAC Channel (14)CRM1 (17)EAAT (3)Efflux pump (1)ENT (2)Ferroportin (2)GABA Receptor (188)GLUT (32)Glutamate transporter (21)Glycine transporter (23)HCN Channel (2)IBAT (10)ITPKA (2)MAT (24)MCT (17)Na+/Ca2+ Exchanger (15)Na+/K+ ATPase (16)Na/HCO3 cotransporter (1)NKCC (1)Oct (11)OCTN (1)Organic Anion Transporter (1)P-gp (53)P2X Receptor (79)Piezo (4)Potassium Channel (287)Proton Pump (54)SEO1 (1)SGLT (44)SLC (6)Sodium Channel (195)SV2 (2)TRP Channel (182)URAT1 (18)Urea Transporter (2)VDAC (6)VRAC (1)
Metabolic Enzyme (3492)
15-PGDH (2)2OG Oxygenase (1)3-PGDH (2)3MST (1)6PGD (2)ACAT (38)ACC (22)ACMSD (2)Aconitate hydratase (1)ACS (3)Adenosine Deaminase (12)Adenosylhomocysteinase (8)ADP-ribosyltransferase (1)AhR (49)AKR (15)ALDH (30)Aldose Reductase (54)Aminopeptidase (28)Antifolate (31)AO (1)ApoE (1)Arginase (15)Asparagine synthetase (1)ATF/CREB proteins (2)ATP Citrate Lyase (6)ATP synthase (19)BDK (1)Beta-glucuronidase (3)Carbonic Anhydrase (121)Carboxylesterase (23)Carboxypeptidase (7)Cardiolipin Peroxidase (1)Cathepsin (98)Ceramidase (4)CETP (15)Cholesterol Transporter (1)CPA (5)CPSI (2)Creatine kinase (1)Cryptochrome (5)CSE (2)CYP51 (1)D-amino acid oxidase (3)D6D (1)DAPA synthase (1)Decarboxylase (8)Dehydrogenase (156)DGAT (62)DGK (20)Dopamine β-hydroxylase (8)E-NTPDase (1)Elastase (32)Enolase (7)Enteropeptidase (5)ERAP (3)FABP (8)Factor Xa (45)Farnesyl Transferase (4)FAS (35)FBPase (4)Ferroptosis (109)FOXO (3)FPR (17)FTO (15)Fumarate hydratase (2)FVII (2)FXR (71)G0/G1 switch protein 2 (2)Galactosidases (5)GCN (1)GCS (3)GGTase (6)Glucokinase (26)Glucosidase (131)GLUT (32)Glutaminase C (2)Glutathione Reductase (1)Glyoxalase (14)GOAT (1)GPx (25)GSNOR (3)GST (16)Hexokinase (8)HMGCR (45)HPSE (2)Hydrolase (12)Hydroxylase (24)IDH (37)IDO (70)Ketohexokinase (5)LDL (11)LDLR (1)Lipase (93)Lipoxygenase (109)LOX (4)LRH-1 (4)LXR (27)MAGL (2)MASTL (1)MDH (3)MetAP (10)MGAT (7)Mineralocorticoid Receptor (12)Mitochondrial Electron Transport Chain (3)Mitochondrial Metabolism (98)MPC (3)NAMPT (33)Neprilysin (20)NNMT (8)NPP (2)NPR (15)NQO (2)OGT (2)OPA1 (1)P448 (1)P450 (261)PAI-1 (25)PARG (12)PDE (366)PDHK (12)PEPCK (2)PGAM1 (1)PGC-1α (4)PHGDH (5)Phospholipase (108)Phosphorylase (10)PI5P4K (11)PKM1 (2)PKM2 (6)Procollagen C Proteinase (1)Proprotein convertases (5)Pyruvate Kinase (28)QR (2)RAR/RXR (86)RBP (3)REV-ERB (4)ROR (67)SCD (18)sEH (33)SGK (15)SHMT (7)Sialyltransferase (1)Sphingosine acyltransferase (2)SQOR (2)Srx (1)Steroid Sulfatase (8)TDO (3)TGH (1)Thioredoxin (12)Thrombin (43)Thymidylate Synthase (24)Transferase (80)Transketolase (7)TrxR (11)Trypanothione reductase (1)UGT (3)VD/VDR (47)Xanthine Oxidase (49)αKGD (2)
Neuronal Signaling (3852)
5-HT Receptor (402)AAK1 (17)AChE (43)AChR (348)Adenosine Kinase (5)Adrenergic Receptor (184)AMPAR (54)Amylin receptor (1)Amyloid-β (172)Calcium Channel (269)CaMK (54)Cannabinoid Receptor (65)CGRP Receptor (14)Cholecystokinin Receptor (32)Cholinesterase (235)CHT (1)COMT (16)DAT (21)Dopamine Receptor (170)Endorphin (1)Enkephalinase (3)FAAH (45)GABA Receptor (188)Glucosylceramide Synthase (13)GluR (208)GPR119 (2)GPR139 (3)GPR24 (1)Histamine Receptor (239)Huntingtin (3)Imidazoline Receptor (14)Kainate receptor (5)MAO (195)Melanocortin Receptor (31)mGluR (226)MT Receptor (12)NET (3)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NGF (3)NK Receptor (57)NMDA (1)NMDAR (50)Notch (26)Nurr1 (7)OLIG2 (1)Opioid Receptor (54)OX Receptor (50)P2X Receptor (79)Proprotein convertases (5)QC (3)RAGE (3)REST (1)Ryanodine Receptor-1 (1)S100β (1)Secretase (112)SERT (27)Sigma Receptor (53)SMS (4)SSRIs (5)Substance P (2)TAAR (8)Tau Protein (28)TLX (1)Trk Receptor (80)TRP Channel (182)TTR (7)α-synuclein (1)
NF-κB Signaling Pathway (540)
IKK (74)MALT1 (24)NF-κB (419)Nrf2 (99)Pirin (3)RANKL (1)RANKL/RANK (3)RIP Kinase (84)TAK1 (3)
Notch Signaling Pathway (763)
ERK (166)Gli (6)MRCK (2)Notch (26)p53 (41)ROCK (90)TGF-beta/Smad (381)β-catenin (71)
PI3K/AKT/mTOR (1044)
Akt (207)AMPK (105)ATM/ATR (67)DNA-PK (39)FOXO (3)GSK-3 (126)MELK (9)mTOR (187)PDK (22)PDK-1 (3)PI3K (340)PI4K (28)PIKfyve (9)PIN1 (10)PTEN (5)RSK (33)
PPAR Signaling Pathway (2131)
ACS (3)Akt (207)AMPK (105)AQP (5)Bcl-6 (6)FABP (8)FATP (3)IL (172)LXR (27)MMP (179)NF-κB (419)NLR (73)OxPhos (4)PDK-1 (3)PEPCK (2)PPAR (193)RAR/RXR (86)RGS (6)ROS (398)SCD (18)SGK (15)Sirtuin (129)STAT (160)TNF-alpha (30)
Protease (697)
ADAMTS (5)Aspartic Protease (2)Cysteine Protease (24)Dipeptidase 1 (2)DP-IV (2)DPP1 (2)DPP2 (2)DPP4 (72)Glutaminase (25)MMP (179)NEP (4)PE (2)Proteasome (122)Ser/Thr Protease (164)SPP (1)Tyrosinase (100)
Protein Tyrosine Kinase/RTK (2741)
Ack1 (5)ALK (86)Bcr-Abl (105)BMX Kinase (3)BRK (3)BTK (149)c-FMS (60)c-Kit (87)c-Met/HGFR (131)c-RET (64)DDR1/DDR2 Receptor (22)DYRK (60)EGFR (403)Ephrin Receptor (16)ErbB (6)FAK (56)FGF (2)FGFR (136)FLT3 (134)GAK (624)HER2 (31)IGF-1R (28)Insulin Receptor (26)ITK (18)JAK (245)MRCK (2)PDGFR (127)PTK (7)Pyk2 (4)Ros1 (18)SHP2 (48)Src (110)Syk (40)TAM Receptor (50)Tie-2 (16)Trk Receptor (80)VEGFR (271)
Pyroptosis (993)
Caspase (170)Cathepsin (98)IL (172)MyD88 (6)NF-κB (419)TLR (163)
Stem Cells (1527)
BMI-1 (3)Casein Kinase (101)CREB (5)ERK (166)Frizzled (2)Gli (6)GSK-3 (126)Hedgehog (32)JAK (245)LIN28 (4)MST (2)Notch (26)Notum (2)PKA (59)PORCN (10)ROCK (90)sFRP-1 (1)Smo (36)SOD1 (2)STAT (160)TGF-beta/Smad (381)Wnt (104)YAP (28)β-catenin (71)
TGF-beta/Smad (458)
Bcr-Abl (105)PKC (157)ROCK (90)TGF-beta/Smad (381)
Toll-Like Receptor (TLR) (549)
CREB (5)IKK (74)IRAK (71)IRF3 (1)JNK (79)MyD88 (6)p38 MAPK (163)TAK1 (3)TLR (163)
Ubiquitin (370)
DUB (83)E1/E2/E3 Enzyme (142)FBXO (2)NAE (8)p97 (15)Proteasome (122)SUMO (4)
Vitamin D Related/Nuclear Receptor (587)
Androgen Receptor (96)Glucocorticoid Receptor (44)LXR (27)Mineralocorticoid Receptor (12)PPAR (193)Progesterone Receptor (9)RAR/RXR (86)REV-ERB (4)ROR (67)Thyroid Hormone Receptor (7)VD/VDR (47)
Wnt Signaling Pathway (2371)
AP-1 (14)APC (6)ATF/CREB proteins (2)c-Myc (47)Calcineurin (8)CaMK (54)Casein Kinase (101)CDK (475)CREB (5)Frizzled (2)GSK-3 (126)JNK (79)MMP (179)NF-κB (419)NFAT (11)p300/CBP/PROTAC (2)PDE (366)Phospholipase (108)PKC (157)PKG (10)Rho (14)ROCK (90)ROR (67)Wnt (104)β-catenin (71)
Other Inhibitors/Agonists (3218)
20-HETE (2)AIMP2-DX2 (2)Amino Acids and Amino Acid Derivatives (126)Aminoacyl-tRNA Synthetase (18)Anesthetic (3)Anti-inflammation (30)Anti-Thyroid Agent (1)Anti-tumor (7)Anti-ulcer (1)Antioxidant (33)Antispasmodic Agent (3)ASGPR (11)Bcat (11)c-RET (64)Cancer Stem Cells (2)CAR (5)Cardiac transcription factor (2)CBFβ-SMMHC (1)CD20 (2)CD52 (1)CD73 (26)CerK (1)Chelating Agent (15)Choleretic (1)Choline Kinase (3)CNT (1)CRTH2 (9)CSE (2)DCLK (1)DcpS (1)Decarboxylase (8)Dehydrogenase (156)Diabetes (2)Diuretic (1)Drug Metabolite (286)DUE-B (1)E2F (2)ECE (2)Endogenous Metabolite (1247)ERO1 (2)FAP (17)FATP (3)Fer/FerT (1)FPP synthase (1)Fucosyltransferase (4)Fungicide (60)G protein (2)Galectin (3)Galectin-3 (12)GBF1 (1)GCase (4)Glucocorticoid Receptor (44)GRK (21)Herbicide (17)HIPK2 (3)Histidine kinase (1)HNF4α (1)HPPD (3)HRGP (1)Hydroxylase (24)IgE (2)IMP1 (1)Importin β (1)Insecticide (27)ITPKA (2)LAT1 (3)LDL (11)Lipase (93)Lipocalin-2 (1)LYTACs (8)MALAT1 (1)MITF (1)MLKL (4)Molecular Glues (41)MPO (5)MTTP (8)Muscle Relaxant (1)MYOF (1)NAADP (1)Neuroprotection/neurogenic Agent (4)NMD (1)NT (2)Nur77 (8)O-GlcNAcase (9)O-glycosylation (1)OSBP (1)OSBPL (1)OSC (2)Osteoclasts/Bone/Osteogenesis (15)OxPhos (4)PAM complex (1)PANK (2)PAX2 (1)PBR (4)PCA1 (1)PCSK9 (7)PDX1 (1)PEPT (1)PFKFB3 (7)Phosphatase (248)Phosphorylase (10)Photosensitizer (6)PIN1 (10)PKG (10)Platelet (5)PME-1 (2)PMO/MNA (4)PNP (1)PREP (20)Protein Synthesis (4)PXR (3)Quorum Sensing (57)RasGAP (2)Rev-ErbA (3)RUNX (7)SAP (1)SMARC (6)SQS (4)SREBP (5)SRPK (51)Sweetener (3)Tgase (2)Thioredoxin (12)TIR1 (1)TNIK (8)TNK (4)TNNI3K (1)UGT1A1 (1)Urease (5)vanin (4)VDA (1)Vitamin (61)VPS (3)XOR (1)α-amylase (15)Others (2611)
Inhibitory Monoclonal Antibody
Human Inhibitory Monoclonal Antibody (62)
Amyloid-β/monoclonal antibody (2)CA Ⅸ/monoclonal antibody (1)CCR/monoclonal antibody (1)CD19/monoclonal antibody (1)CD20/monoclonal antibody (2)CD22/monoclonal antibody (1)CD25/monoclonal antibody (1)CD3/monoclonal antibody (1)CD38/monoclonal antibody (1)CD4/monoclonal antibody (1)CD40/monoclonal antibody (1)CD47/monoclonal antibody (1)CD52/monoclonal antibody (1)CD6/monoclonal antibody (1)CD62p/monoclonal antibody (1)CD73/monoclonal antibody (1)CGRP Receptor/monoclonal antibody (2)Complement System/monoclonal antibody (1)CTLA-4/monoclonal antibody (1)EGFR/monoclonal antibody (2)HER2/monoclonal antibody (2)IFNAR/monoclonal antibody (1)IgE/monoclonal antibody (2)IGF-1R/monoclonal antibody (1)IL-13/monoclonal antibody (1)IL-17a/monoclonal antibody (1)IL-1β/monoclonal antibody (1)IL-23/monoclonal antibody (2)IL-4Ra/monoclonal antibody (1)IL-5/monoclonal antibody (1)IL-5Rα/monoclonal antibody (1)IL-6/monoclonal antibody (3)Integrin/monoclonal antibody (1)KIR/monoclonal antibody (1)LAG-3/monoclonal antibody (1)PCSK9/monoclonal antibody (2)PD-1/PD-L1/monoclonal antibody (4)RANKL /monoclonal antibody (1)Sclerostin/monoclonal antibody (1)SLAMF7/monoclonal antibody (1)TIGIT/monoclonal antibody (1)Tim3/monoclonal antibody (1)TNF Receptor/monoclonal antibody (3)TNF-alpha/monoclonal antibody (2)TROP2/monoclonal antibody (1)VEGFR/monoclonal antibody (1)
Animal Modeling Reagents
Circulatory System Disease Models (11)
Cardiomyopathy Model (1)Heart Disease Correlation Model (2)Heart Failure Model (1)Hyperlipidemia Model (1)Hypertension Model (3)Thrombolysis Model (2)Vascular Inflammation Model (1)
Digestive System Disease Models (17)
Gallstone Model (1)Gastrointestinal Disease Model (8)Liver Disease Model (5)Pancreatic Disease Model (3)
Endocrine System Disease Models (12)
Aging Model (1)Diabetes Model (4)Hyperuricemia Model (8)
Immune and Inflammatory Disease Models (29)
Arthritis Model (1)Cystitis Model (1)Dermatitis Model (1)Ear Edema Model (1)Encephalomyelitis Model (2)Foot Edema Model (2)Gastrointestinal Inflammation and Ulcer Model (8)Gouty Arthritis Model (1)Liver Inflammation Model (2)Myocarditis Model (2)Nephritis Model (1)Pancreatitis Model (5)Psoriasis Model (3)Systemic Lupus Erythematosus Model (2)
Nervous System Disease Models (10)
Alzheimers Disease Model (3)Epilepsy Model (3)Neuropathic Pain Model (1)Parkinsons Disease Model (3)Schizophrenia Model (1)
Otorhinolaryngological Disease Models (4)
Cataract Model (1)Gingival Hyperplasia Model (2)Optic Neuropathy Model (1)Other Otorhinolaryngological Disease Model (1)
Skin Disease Models (1)
Atopic Dermatitis Model (1)
Tumor Models (9)
Breast Tumor Model (2)Colon Tumor Model (1)Esophageal Tumor Model (1)Kidney Tumor Model (1)Liver Tumor Model (1)Lung Tumor Model (2)Skin Tumor Model (2)Uterine Fibroid Model (1)
Urinary System Disease Models (19)
Aging Model (1)Chronic Kidney Disease Model (2)Diabetes Model (4)Hyperuricemia Model (8)Kidney Stone Model (1)Nephrotoxicity Model (1)Renal Injury Model (5)Other Urinary System Disease Model (3)
Antibiotic and Antivirus
Function (133)
Anti-bacterial Antibiotic (2)Anti-fungal Antibiotic (7)Antivirus (62)Cell Culture Antibiotic (2)Insect Repellent (42)Plant Tissue Culture Antibiotic (2)Preservative and Disinfectant (20)
Structure (8762)
Amino Acid Derivative (3)Aminoglycoside (9)Ansamycin (2)Cephalosporin (7)Chloramphenicol (1)Imidazole (6042)Macrolide (8)Nucleoside (5)Penicillin (3)Pyridine / Pyrimidine (6)Quinolone (19)Sulfonamide (17)Tetracycline (6)β-Lactam (4)Other Antibiotics (35)Others (2611)
Biochemical Reagents
Amino Acids (799)
Amino Acid Amide (17)Biologically Modified Amino Acid (29)C-protective Amino Acid (194)N-protective Amino Acid (438)Non-protein Amino Acid (115)Protein Amino Acid (55)Side Chain Protected Amino Acid (25)
Biological Buffers (2643)
Good's Buffer (19)Other Buffers (13)Others (2611)
Cross-Linking Agents (33)
Amino-amino Crosslinker (7)Amino-sulfhydryl Crosslinker (15)Photoreactive Crosslinker (3)Sulfhydryl-carbonyl Crosslinker (1)Sulfhydryl-sulfhydryl Crosslinker (4)Other Reactive Crosslinkers (3)
Denaturants (2)
Surface Active Agent (2)
Detergents (18)
Amphoteric Surfactant (4)Anionic Surfactant (3)Cationic Surfactant (2)Nonionic Surfactant (6)Sulfonated Betaine (3)
Lipids (219)
Aliphatic Acyl (210)Glycerol Lipid (7)Sphingolipid (2)
Polypeptides (39)
Dipeptide and Tripeptide (36)Oligopeptide (3)
Steroids (2675)
Bile Acid (49)Cholestane (3)Estrogen (1)Plant Sterol (10)Steroidal Glycoside (3)Other Steroids (2)Others (2611)
Sugar and Derivatives (151)
Sugar (137)Sugar Alcohol (15)
Sweeteners (For Research Experiments) (18)
Artificial sweetener (6)Natural sweetener (12)
Cancer
Cancer Stem Cells (2475)
Cathepsin (98)CXCR (112)Hedgehog (32)IL (172)IL Receptor (9)Integrin (134)MIF (18)MMP (179)NF-κB (419)NOS (186)Notch (26)PDGFR (127)PPAR (193)STAT (160)TGF-beta/Smad (381)VEGFR (271)Wnt (104)YAP (28)
Tumor Development and Microenvironment Evolution (1825)
ALK (86)AP-1 (14)CAR (5)CCR (89)Complement System (45)COX (344)DDR1/DDR2 Receptor (22)ErbB (6)GABA Receptor (188)GSK-3 (126)IFNAR (24)IRAK (71)JAK (245)LAG-3 (1)NLR (73)Nrf2 (99)PD-1/PD-L1 (80)STING (98)Syk (40)TLR (163)TNF-alpha (30)TNK (4)
Tumor Epigenetics and Gene Regulation (2861)
Aminoacyl-tRNA Synthetase (18)ATM/ATR (67)DNA Methyltransferase (43)DNA/RNA Synthesis (620)Epigenetic Reader Domain (396)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)RNA polymerase 1 (2)Sirtuin (129)TET (8)Topoisomerase (271)
Tumor Growth, Proliferation and Apoptosis (2213)
Akt (207)Aurora Kinase (87)Bcl-2 (195)c-Met/HGFR (131)c-Myc (47)EGFR (403)ERK (166)HER2 (31)MEK (99)MLKL (4)mTOR (187)p53 (41)PI3K (340)PTEN (5)Raf (106)Ras (275)ROR (67)Telomerase (21)
Tumor Metabolism (1274)
ACC (22)ALDH (30)AMPK (105)Arginase (15)ATP Citrate Lyase (6)Dehydrogenase (156)FBPase (4)FTO (15)GLUT (32)Glutaminase (25)Hexokinase (8)IDH (37)IDO (70)MCT (17)MDH (3)NADPH Oxidase (32)OGT (2)P450 (261)PDHK (12)PHGDH (5)PKM2 (6)ROS (398)SHMT (7)SLC (6)SOD (4)SREBP (5)
Cell Biology
Cell Analysis (2)
Cell Proliferation and Cytotoxicity (2)
Cell Apoptosis/Death Detection (1419)
Apoptosis Inducer (1407)Apoptosis Inhibitor (2)Iron death Inhibitor (10)
Cell Culture (292)
Additive and Auxiliary Reagent (130)Cell Assay Reagents (9)Cell Staining (3)Organoid Culture Additive (90)Stem Cell Induction (83)
Enzymology
Enzyme Inhibitors (206)
Acetaldehyde Dehydrogenase Inhibitor (1)Acyltransferase Inhibitor (4)Alkaline Phosphatase Inhibitor (2)Angiotensin Converting Enzyme Inhibitor (4)ATP Enzyme Inhibitor (7)Calcineurin Inhibitor (1)Carbonic Acid Dehydratase Inhibitor (2)Caspase Inhibitor (2)Cyclooxygenase (COX) Inhibitor (47)DNA Topoisomerase II Inhibitor (11)Hypoxia Inducible Factor (HIF) Inhibitor (3)Inosine Monophosphate (IMP) Dehydrogenase Inhibitor (10)Leukotriene A4 Hydrolase Inhibitor (3)Lipoxygenase Inhibitor (11)Monoamine Oxidase Inhibitor (4)NADH Peroxidase Inhibitor (2)Pancreatic Lipase Inhibitor (2)Phosphodiesterase Inhibitor (20)Protease Inhibitor (20)Reverse Transcriptase Inhibitor (16)Starch Glucosidase Inhibitor (3)Thromboxane Synthase Inhibitor (2)Topoisomerase I Inhibitor (8)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)
Enzyme Preparation (63)
Cyclooxygenase (COX) (46)E3 Ubiquitin Ligase (2)Hydrolase (12)Nitric Oxide Metabolism (3)
Enzyme Substrates (4)
Peroxidase Substrate (2)β-Glucuronidase Substrate (2)
Fluorescent Probe / Staining
Cell Biology Fluorescent Dyes (61)
Apoptosis Dyes (6)BODIPY (21)Cytoplasm Dyes (5)Cytotoxicity Analysis Dyes (12)Endocytosis and pinocytosis Dyes (5)Endoplasmic Reticulum Dyes (2)Exosome Dyes (4)Lipid Droplet Dyes (3)Lysosome Dyes (4)Membrane Dyes (4)Mitochondrial Dyes (5)NOS Dyes (6)Nucleic Acid Dyes (1)Nucleus Dyes (10)PH Indicators (18)ROS Dyes (27)
Fluorescence Labeling Reagents (2848)
Anthocyanine (1)Boron Dipyrrole Methylene  (2)Coumarin (8)Danacyl (2)Fluoressin (7)Nitrobenzoxadiazole (NBD) (2)Pyrene (6)Other Fluorescence Labeling Reagents (213)Others (2611)
Fluorescent Dyes (2797)
Acridine Dye (8)Blood Dyes (2)Cancer Analysis Dyes (8)Coumarine Dye (57)Cyanine Dye (25)Neuroscience Analysis Dyes (33)Protein (3)Other Fluorescent Dyes (7)Others (2611)
Molecular Biology
Extraction and Analysis Of Nucleic Acid (5)
Hybridization Reagent (3)Probe (2)
Gene Cloning (21)
Buffer (21)
Nucleic Acid Electrophoresis (5)
Electrophoretic Buffer (3)Gelatin (2)
Natural Products
Acanthaceae (20)
Adhatoda (4)Andrographis (9)Justicia (4)Phlogacanthus (2)Strobilanthes (1)
Aceraceae (2)
Acer (2)
Adiantaceae (2)
Adiantum (2)
Alariaceae (76)
Acanthopanax (5)Aralia (8)Diplopanax (3)Eleutherococcus (3)Hedera (3)Oplopanax (1)Panax (53)
Alismataceae (2)
Alisma (2)
Amaranthaceae (5)
Achyranthes (3)Celosia (1)Cyathula (1)
Amaryllidaceae (23)
Agave (4)Allium (5)Curculigo (10)Lycoris (3)Narcissus (1)
Anacardiaceae (15)
Lannea (1)lodes (1)Mangifera (6)Rhus (4)Toxicodendron (3)
Annonaceae (19)
Annona (2)Fissistigma (6)Goniothalamus (4)Guatteria (1)Miliusa (1)Orophea (2)Polyalthia (2)Uvaria (1)
Apocynaceae (45)
Alstonia (3)Apocynum (1)Aspidosperma (1)Catharanthus (5)Cerbera (5)Kopsia (1)Nerium (10)Plumeria (2)Rauvolfia (9)Thevetia (3)Trachelospermum (4)Voacanga (1)
Aquifoliaceae (3)
Ilex (3)
Araceae (14)
Acorus (10)Eminium (2)Pinellia (2)
Aristolochiaceae (15)
Aristolochia (11)Asarum (3)Holostylis (1)
Asclepiadaceae (19)
Cryptolepis (3)Cynanchum (7)Marsdenia (5)Periploca (4)
Asparagaceae (11)
Eucomis (2)Muscari (1)Scilla (8)
Asteraceae (228)
Achillea (3)Ageratum (1)Ambrosia (2)Arctium (2)Arnica (1)Artemisia (25)Aster (2)Atractylodes (9)Aucklandia (5)Bellis (1)Blumea (4)Cacalia (1)Carpesium (1)Carthamus (7)Centaurea (5)Centipeda (4)Chrysactinia (4)Chrysanthemum (6)Cichorium (2)Cirsium (2)Conyza (1)Coreopsis (1)Cosmos (1)Crepis (3)Cynara (1)Dahlia (2)Dittrichia (1)Doronicum (1)Echinacea (2)Eclipta (6)Elephantopus (1)Erigeron (3)Eupatorium (20)Gnaphalium (1)Gynura (2)Helianthus (4)Heterotheca (1)Inula (8)Kalimeris (1)Laggera (13)Laurentia (1)Ligularia (4)Matricaria (2)Petasites (2)Pulicaria (4)Saussurea (3)Scorzonera (2)Senecio (9)Siegesbeckia (2)Silybum (5)Smallanthus (1)Stevia (10)Tagetes (4)Telekia (1)Tessaria (1)Tussilago (2)Verbesina (1)Vernonia (5)Wedelia (2)Xanthium (6)Zinnia (1)
Athyriaceae (1)
Cystopteris (1)
Balsaminaceae (5)
Impatiens (5)
Berberidaceae (37)
Berberis (3)Bongardia (1)Caulophyllum (2)Dysosma (3)Epimedium (26)Sinopodophyllum (2)
Betulaceae (11)
Alnus (6)Betula (1)Carpinus (1)Corylus (3)
Bignoniaceae (16)
Catalpa (8)Crescentia (2)Incarvillea (1)Kigelia (1)Macfadyena (1)Markhamia (1)Oroxylum (2)
Blechnaceae (1)
Woodwardia (1)
Boraginaceae (18)
Arnebia (2)Echium (1)Ehretia (1)Lithospermum (13)Tournefortia (1)
Burseraceae (11)
Boswellia (3)Canarium (5)Commiphora (3)
Buxaceae (3)
Buxus (3)
By Structure (5433)
Alkaloids (149)Coumarins (21)Lignans (36)Phenols (1786)Phenylpropanane (54)Quinones (35)Natural Products-Other Structure (3377)
Calophyllaceae (8)
Pseudostellaria (2)Stellaria (1)Vaccaria (5)
Campanulaceae (14)
Codonopsis (1)Lobelia (2)Platycodon (10)Sphenoclea (1)
Cannabaceae (11)
Cannabis (3)Humulus (8)
Caprifoliaceae (23)
Lonicera (20)Sambucus (1)Viburnum (2)
Celastraceae (16)
Celastrus (3)Euonymus (2)Maytenus (1)Tripterygium (10)
Cephalotaxaceae (10)
Cephalotaxus (10)
Chenopodiaceae (3)
Kochia (1)Spinacia (1)Suaeda (1)
Chloranthaceae (11)
Chloranthus (10)Sarcandra (1)
Clusiaceae (94)
Alliaria (1)Brassica (6)Calophyllum (6)Cratoxylum (2)Descurainia (1)Eruca (1)Garcinia (47)Hypericum (15)Isatis (2)Lepidium (4)Mammea (1)Mesua (1)Raphanus (3)Sinapis (3)Symphonia (1)
Combretaceae (6)
Calycopteris (1)Combretum (2)Terminalia (3)
Convolvulaceae (2)
Erycibe (1)Ipomoea (1)
Coriariaceae (2)
Coriaria (2)
Cornaceae (2)
Cornus (2)
Crassulaceae (12)
Rhodiola (7)Sedum (5)
Cucurbitaceae (44)
Bolbostemma (1)Bryonia (1)Cucumis (1)Cucurbita (1)Echinocystis (1)Gynostemma (4)Hemsleya (2)Herpetospermum (1)Lagenaria (3)Luffa (1)Momordica (9)Siraitia (17)Trichosanthes (2)
Cupressaceae (11)
Chamaecyparis (2)Juniperus (5)Platycladus (4)
Cyperaceae (5)
Carex (2)Cyperus (3)
Daphniphyllaceae (36)
Aquilaria (10)daphne (3)Daphniphyllum (1)Edgeworthia (1)Excoecaria (1)Pieris (2)Stellera (10)Wikstroemia (8)
Dennstaedtiaceae (1)
Dennstaedtia (1)
Dicksoniaceae (4)
Cibotium (4)
Dioscoreaceae (11)
Dioscorea (11)
Dipsacaceae (2)
Dipsacus (2)
Dryopteridaceae (4)
Dryopteris (4)
Elaeagnaceae (7)
Elaeagnus (2)Hippophae (5)
Equisetaceae (3)
Equisetum (3)
Erythroxylaceae (1)
Erythroxylum (1)
Eucommiaceae (12)
Eucommia (12)
Euphorbiaceae (46)
Breynia (1)Croton (7)Endospermum (1)Euphorbia (10)Excoecaria (1)Flueggea (1)Hevea (3)Jatropha (5)Macaranga (1)Mallotus (1)Phyllanthus (11)Suregada (2)Trigonostemon (2)
Fabaceae (348)
Abrus (1)Acacia (9)Adenanthera (1)Albizia (1)Ammothamnus (1)Antheroporum (1)Astragalus (23)Butea (1)Caesalpinia (18)Cajanus (3)Campylotropis (1)Cassia (26)Cicer (1)Crotalaria (5)Cytisus (3)Dalbergia (10)Derris (13)Desmodium (3)Erythrina (13)Flemingia (3)Genista (1)Glycine (22)Glycyrrhiza (41)Griffonia (1)Hedysarum (1)Lespedeza (5)Leucaena (3)Lotus (5)Lupinus (8)Maackia (4)Medicago (1)Millettia (6)Mimosa (1)Mucuna (2)Ononis (2)Parochetus (2)Phyllodium (1)Pisum (1)Pongamia (1)Prosopis (2)Psoralea (18)Pterocarpus (1)Pterolobium (1)Pueraria (25)Robinia (2)Saraca (1)Senna (1)Sophora (36)Spartium (1)Spatholobus (2)Styphnolobium (1)Trifolium (6)Trigonella (2)Vicia (2)Wisteria (2)
Fagaceae (2)
Castanea (1)Lithocarpus (1)
Gentianaceae (28)
Anthocleista (1)Canscora (1)Gentiana (16)Gentianella (1)Halenia (1)Swertia (8)
Geraniaceae (3)
Geranium (2)Pelargonium (1)
Gesneriaceae (1)
Lysionotus (1)
Ginkgoaceae (9)
Ginkgo (9)
Gnetaceae (4)
Gnetum (4)
Hamamelidaceae (2)
Hamamelis (1)Loropetalum (1)
Hernandiaceae (129)
Ammi (2)Angelica (32)Bupleurum (13)Centella (4)Cnidium (9)Cuminum (1)Ferula (3)Heracleum (13)Hernandia (2)Ledebouriella (1)Ligusticopsis (1)Ligusticum (9)Notopterygium (7)Oenanthe (1)Petroselinum (2)Peucedanum (20)Pimpinella (1)Saposhnikovia (7)Seseli (1)
Hippocastanaceae (5)
Aesculus (5)
Illiciaceae (7)
Illicium (7)
Iridaceae (19)
Belamcanda (8)Crocus (6)Eleutherine (3)Iris (2)
Juglandaceae (6)
Diospyros (2)Engelhardtia (1)Juglans (1)Sesamum (2)
Juncaceae (5)
Juncus (5)
Lamiaceae (140)
Ajuga (2)Ballota (1)Clinopodium (3)Coleus (2)Dracocephalum (3)Elsholtzia (1)Isodon (5)Lamiophlomis (1)Leonurus (9)Marrubium (2)Mentha (4)Mosla (2)Perilla (4)Phlomis (1)Plectranthus (1)Pogostemon (1)Rosmarinus (5)Salvia (45)Scutellaria (40)Stachys (2)Tectona (1)Thymus (5)
Lauraceae (22)
Cinnamomum (7)Cryptocarya (3)Endlicheria (1)Laurus (1)Lindera (4)Litsea (1)Nectandra (2)Ocotea (3)
Lepidoziaceae (1)
Lepidozia (1)
Lichenes (1)
Usnea (1)
Liliaceae (78)
Aloe (4)Anemarrhena (9)Asparagus (1)Dracaena (11)Fritillaria (3)Hosta (1)Lilium (3)Liriope (3)Ophiopogon (28)Paris (8)Polygonatum (3)Smilax (1)Trillium (1)Tupistra (1)Veratrum (1)
Linaceae (2)
Linum (2)
Loganiaceae (5)
Buddleja (2)Gelsemium (1)Strychnos (2)
Loranthaceae (1)
Taxillus (1)
Lycopodiaceae (3)
Lycopodium (3)
Lygodiaceae (1)
Lygodium (1)
Lythraceae (11)
Lawsonia (4)Punica (7)
Magnoliaceae (24)
Liriodendron (4)Magnolia (19)Michelia (1)
Malvaceae (5)
Abelmoschus (1)Gossypium (1)Guazuma (2)Hibiscus (1)
Meliaceae (24)
Aglaia (12)Amoora (2)Aphanamixis (3)Melia (4)Walsura (3)
Menispermaceae (13)
Cocculus (2)Diploclisia (1)Menispermum (1)Stephania (5)Tinospora (3)Triclisia (1)
Moraceae (69)
Artocarpus (2)Broussonetia (13)Cudrania (16)Morus (37)Trilepisium (1)
Moringaceae (7)
Moringa (7)
Musaceae (13)
Musa (10)Musella (3)
Myricaceae (6)
Morella (6)
Myristicaceae (7)
Myristica (7)
Myrsinaceae (1)
Ardisia (1)
Myrtaceae (27)
allspice (1)Eucalyptus (16)Psidium (6)Rhodomyrtus (1)Syzygium (3)
Nartheciaceae (4)
Narthecium (1)Philydrum (1)Xanthorrhoea (2)
Nelumbonaceae (3)
Nelumbo (3)
Nyctaginaceae (33)
Atropa (1)Boerhavia (3)Capsicum (5)Datura (7)Lycium (3)Mirabilis (1)Nicotiana (2)Physalis (4)Solanum (6)Withania (1)
Nyssaceae (52)
Camptotheca (6)Gaultheria (1)Pyrola (2)Rhododendron (5)Vaccinium (38)
Oleaceae (37)
Abeliophyllum (1)Forsythia (12)Fraxinus (4)Jasminum (6)Ligustrum (11)Olax (1)Osmanthus (1)Syringa (1)
Orchidaceae (28)
Anoectochilus (1)Bletilla (2)Cremastra (2)Dendrobium (7)Gastrodia (3)Gymnadenia (8)Pholidota (3)Vanda (1)Vanilla (1)
Orobanchaceae (10)
Cistanche (10)
Paeoniaceae (6)
Paeonia (6)
Palmae (6)
Areca (4)Euterpe (1)Trachycarpus (1)
Pandanaceae (3)
Pandanus (3)
Papaveraceae (26)
Chelidonium (10)Corydalis (8)Glaucium (1)Hylomecon (1)Hypecoum (1)Macleaya (2)Papaver (1)Sanguinaria (2)
Parmeliaceae (4)
Parmelia (4)
Passifloraceae (2)
Passiflora (2)
Pentaphylacaceae (1)
Adinandra (1)
Phyllanthaceae (4)
Securinega (3)Uapaca (1)
Phytolaccaceae (6)
Microtea (1)Phytolacca (5)
Pinaceae (35)
Abies (2)Cedrus (4)Larix (1)Pinus (18)Pseudolarix (9)Tsuga (1)
Piperaceae (28)
Piper (28)
Pittosporaceae (1)
Pittosporum (1)
Plantaginaceae (2)
Picrorhiza (1)Plantago (1)
Plumbaginaceae (2)
Limoniastrum (1)Plumbago (1)
Poaceae (14)
Avena (2)Coix (1)Hordeum (2)Leptochloa (1)Oryza (1)Phyllostachys (1)Poa (2)Saccharum (1)Secale (2)Zea (1)
Podocarpaceae (8)
Podocarpus (8)
Polygalaceae (32)
Polygala (31)Securidaca (1)
Polygonaceae (40)
Atraphaxis (2)Fallopia (3)Polygonum (9)Rheum (22)Rumex (4)
Polypodiaceae (2)
Phymatopteris (2)
Pontederiaceae (1)
Monochoria (1)
Portulacaceae (1)
Talinum (1)
Primulaceae (4)
Lysimachia (3)Primula (1)
Proteaceae (4)
Grevillea (1)Helicia (3)
Ranunculaceae (45)
Aconitum (2)Anemone (6)Cimicifuga (9)Clematis (3)Coptis (7)Delphinium (2)Hydrastis (2)Pulsatilla (10)Semiaquilegia (1)Thalictrum (3)
Resedaceae (1)
Reseda (1)
Rhamnaceae (16)
Hovenia (1)Rhamnus (11)Ziziphus (4)
Rhizophoraceae (3)
Cassipourea (1)Kandelia (2)
Rosaceae (31)
Agrimonia (4)Crataegus (4)Exochorda (5)Filipendula (2)Malus (1)Photinia (1)Potentilla (1)Pourthiaea (1)Prunus (3)Rosa (3)Rubus (3)Sanguisorba (1)Sorbus (1)Spiraea (1)
Rubiaceae (69)
Borreria (1)Cinchona (2)Coffea (3)Emmenopterys (1)Galium (5)Gardenia (11)Hedyotis (8)Knoxia (2)Mitragyna (1)Morinda (4)Mussaenda (1)Nauclea (2)Paederia (5)Pausinystalia (2)Pentas (1)Rubia (14)Uncaria (6)
Rutaceae (162)
Aegle (1)Boenninghausenia (2)Cedrelopsis (1)Citrus (38)Clausena (7)Dictamnus (8)Euodia (1)Evodia (13)Flindersia (1)Fortunella (1)Glycosmis (3)Haplophyllum (3)Melicope (1)Micromelum (11)Murraya (21)Phebalium (2)Phellodendron (8)Ptaeroxylon (1)Ruta (3)Skimmia (1)Tetradium (1)Toddalia (14)Zanthoxylum (20)
Salicaceae (2)
Populus (2)
Santalaceae (3)
Thesium (3)
Sapindaceae (10)
Dodonaea (10)
Saururaceae (6)
Houttuynia (1)Saururus (5)
Saxifragaceae (11)
Astilbe (1)Bergenia (1)Dichroa (3)Hydrangea (5)Penthorum (1)
Schisandraceae (18)
Kadsura (5)Schisandra (13)
Scrophulariaceae (33)
Bacopa (6)Euphrasia (1)Limnophila (1)Linaria (2)Melampyrum (1)Paulownia (1)Pedicularis (2)Picria (3)Rehmannia (12)Scrophularia (4)
Selaginellaceae (3)
Selaginella (3)
Simaroubaceae (32)
Ailanthus (8)Brucea (8)Eurycoma (1)Picrasma (14)Quassia (1)
Sinopteridaceae (17)
Onychium (4)Pteridium (3)Pteris (10)
Stemonaceae (1)
Stemona (1)
Sterculiaceae (4)
Casearia (1)Gynocardia (2)Hydnocarpus (1)
Styracaceae (3)
Styrax (3)
Tamaricaceae (1)
Tamarix (1)
Taxaceae (8)
Taxus (7)Torreya (1)
Taxodiaceae (5)
Cryptomeria (2)Sequoia (3)
Theaceae (9)
Camellia (9)
Tiliaceae (2)
Microcos (1)Tilia (1)
Toricelliaceae (3)
Toricellia (3)
Tropaeolaceae (1)
Tropaeolum (1)
Typhaceae (4)
Typha (4)
Ulmaceae (1)
Ulmus (1)
Valerianaceae (19)
Nardostachys (4)Patrinia (5)Valeriana (10)
Verbenaceae (39)
Callicarpa (10)Clerodendrum (7)Duranta (1)Gmelina (1)Lippia (1)Stachytarpheta (1)Verbena (2)Vitex (16)
Violaceae (7)
Viola (7)
Viscaceae (2)
Viscum (2)
Vitaceae (18)
Ampelopsis (4)Turpinia (2)Vitis (12)
Winteraceae (4)
Drimys (4)
Zingiberaceae (79)
Aframomum (1)Alpinia (25)Amomum (1)Boesenbergia (2)Curcuma (33)Kaempferia (1)Zingiber (16)
Zygophyllaceae (6)
Peganum (4)Tribulus (2)
Pharmaceutical Research
Animal Modeling Agents (46)
Cardio-cerebrovascular Disease Model (2)Diabete Model (1)Inflammation Model (21)Lifestyle-related Disease Model (10)Nervous System Model (5)Pain and Pruritus Model (8)Tumor Model (6)Other Modeling Agents (6)
Classical Positive Drugs (61)
Cardiovascular System (20)Diabete (30)Digestive System (11)
Drug Analysis (663)
Drug Standard (208)Plant Standard (457)
Drug Delivery (560)
Cationic Lipids (119)Cholesterol (10)Fluorescent Lipids (1)Pegylated Lipids (11)Phospholipids (175)
Pharmacy Related (27)
Biomaterial (2)Classical Raw Material Drug (2)Cosolvents (12)Medicinal Excipient (14)
Small Molecule Positive Drugs (2843)
Anti-allergy (5)Anti-inflammation (30)Anti-osteoporosis (2)Anti-rheumatoid Arthritis (6)Anti-tumor (7)Antivirus (62)Depressurization (18)Diabete (30)Neurotransmitter (32)Reduce Blood Lipid (6)Other Compounds (66)Others (2611)
PROTACS
E3 Ligand-Linker Conjugate (166)
CRBN Ligand-Linkers (117)VHL Ligand-Linkers (49)
E3 Ligands (72)
CRBN Inactive Ligand (4)CRBN Ligand (56)IAP Ligand (2)MDM2 Ligand (2)VHL Ligand (8)
Molecular Glue (31)
Bcl-6/PROTAC (3)Casein Kinase 1α/PROTAC (2)Cyclin K/PROTAC (5)GSPT1/PROTAC (5)IKZF1/3/PROTAC (7)mHTT/PROTAC (2)PDE6D/PROTAC (2)RBM39/PROTAC (4)β-catenin/PROTAC (1)
Warhead (1)
Bcr-Abl/Warhead Ligand (1)
Vesicle
Exosome (2591)
ApoE (1)ARF (2)Calcium Channel (269)Ceramidase (4)FGF (2)HBV (151)HIV (447)HSP (161)HSV (75)Integrin (134)LPL Receptor (118)MicroRNA (16)mTOR (187)Neurotransmitter (32)p53 (41)PD-1/PD-L1 (80)Phospholipase (108)Ras (275)STAT (160)TGF-beta/Smad (381)
Parkinson'S Disease and Alzheimer'S Disease (5789)
Akt (207)AMPAR (54)Apoptosis (2143)Caspase (170)CDK (475)CREB (5)Dopamine Receptor (170)Dopamine β-hydroxylase (8)ERK (166)Glucagon Receptor (50)GPCR (203)GSK-3 (126)IL (172)JAK (245)JNK (79)LRRK2 (32)MyD88 (6)NF-κB (419)Notch (26)p53 (41)PI3K (340)PKA (59)PTEN (5)RAGE (3)Ras (275)Rho (14)ROCK (90)ROS (398)Secretase (112)STAT (160)STING (98)Tau Protein (28)TLR (163)TNF (22)Tyrosinase (100)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)Wnt (104)α-synuclein (1)β-catenin (71)
Zoology and Botany
Pesticide Composition (103)
Fungicide (60)Herbicide (17)Insecticide (27)
Home Cart Sign in  
/
Inhibitors/Agonists
/
Apoptosis
/
Apoptosis Inducer
/
Oxaliplatin
/
Inhibitors/Agonists
/
Apoptosis
Other Inhibitors/Agonists DNA Damage Cell Cycle
/
Apoptosis Inducer
Anti-tumor DNA Alkylator/Crosslinker DNA/RNA Synthesis
/
Chemical Structure| 61825-94-3 Chemical Structure| 61825-94-3

Structure of Oxaliplatin
CAS No.: 61825-94-3

Chemical Structure| 61825-94-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Oxaliplatin inhibits DNA synthesis by conforming DNA adducts.

Synonyms: Lipoxal; RP 54780; LOHP

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of Oxaliplatin Purity: 98% SDS Specification
COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Marlhoux, Léna ; Arnaud, Alexandre ; Hervieu, Céline ; Makulyte, Gabriela ; Martinasso, Charlotte ; Mularoni, Angélique , et al.

DOI: PubMed ID:

Abstract: Casein kinase 2 (CK2) has emerged as a promising therapeutic target across a broad spectrum of malignancies, including pediatric and orphan cancers. The identification of a ligandable allosteric αD pocket on the CK2α subunit has enabled the development of bivalent inhibitors, which bind simultaneously to both the adenosine triphosphate (ATP) site and the allosteric pocket. Here, we report the discovery and pharmacological characterization of KDX1381, a structure-guided bivalent CK2α inhibitor with low-nanomolar potency and high selectivity, confirmed by cocrystal structures. In mice, KDX1381 suppressed CK2-driven tumor growth as a monotherapy and enhanced therapeutic efficacy when combined with vascular endothelial growth factor receptor (VEGFR) inhibitors or DNA-damaging agents in hepatocellular carcinoma and glioma models. These findings support bivalent CK2α inhibition as a differentiated therapeutic strategy with broad applicability in CK2-dependent cancers.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ;

Lopez-Hernandez, Javier E. ; Nayeem, Nazia ; Ceron-Carrasco, Jose P. ; Ahad, Afruja ; Hafeez, Aiman ; Leon, Ignacio E. , et al.

DOI: PubMed ID:

Abstract: New heterometallic binuclear and trinuclear platinum(IV)-gold(I) compounds of the type [Pt(L)n Cl2 (OH){(OOC-4-C6 H4 -PPh2 )AuCl}x ] (L=NH3 , n=2; x=1, 2; L=diaminocyclohexane, DACH, n=1; x=2) are described. These compounds are cytotoxic and selective against a small panel of renal, bladder, ovarian, and breast cancer cell lines. We selected a trinuclear PtAu2 compound containing the PtIV core based on oxaliplatin, to further investigate its cell-death pathway, cell and organelle uptake and anticancer effects against the triple-negative breast cancer (TNBC) MDA-MB-231 cell line. This compound induces apoptosis and accumulates mainly in the nucleus and mitochondria. It also exerts remarkable antimigratory and antiangiogenic properties, and has a potent cytotoxic effect against TNBC 3D spheroids. Trinuclear compounds do not seem to display relevant interactions with calf thymus (CT) DNA and plasmid (pBR322) even in the presence of reducing agents, but inhibit pro-angiogenic enzyme thioredoxin reductase (TrxR) in TNBC cells.

Keywords: Chemotherapeutics ; TNBC ; gold ; heterometallic phosphanes ; platinum

Purchased from AmBeed: ;

Alternative Products

Product Details of Oxaliplatin

CAS No. :61825-94-3
Formula : C8H14N2O4Pt
M.W : 397.29
SMILES Code : O=C1O[Pt]2([NH2][C@@H]3CCCC[C@H]3[NH2]2)OC1=O
Synonyms :
Lipoxal; RP 54780; LOHP
MDL No. :MFCD00866327
InChI Key :DRMCATBEKSVAPL-BNTLRKBRSA-N
Pubchem ID :9887053

Safety of Oxaliplatin

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H317-H318-H334-H341-H351-H360-H362-H372
Precautionary Statements:P201-P202-P260-P263-P264-P270-P272-P280-P284-P302+P352-P304+P340-P305+P351+P338+P310-P308+P313-P333+P313-P342+P311-P405-P501

Related Pathways of Oxaliplatin

DNA

Isoform Comparison

Biological Activity

Target

  • DNA synthesis

In Vitro:

Cell Line
Concentration Treated Time Description References
CRC PDOs 0 to 100 μM 7 days To evaluate the sensitivity of Oxaliplatin to CRC PDOs, the results showed that Oxaliplatin significantly inhibited the growth of PDOs PMC8980070
HCT116 cells 40 µM 24 h To evaluate the effect of NFS1 deficiency combined with oxaliplatin on cell death, the results showed that NFS1 deficiency significantly enhanced the antitumor effect of oxaliplatin and induced PANoptosis (apoptosis, necroptosis, pyroptosis, and ferroptosis). PMC8882671
DLD1 cells 80 µM 24 h To evaluate the effect of NFS1 deficiency combined with oxaliplatin on cell death, the results showed that NFS1 deficiency significantly enhanced the antitumor effect of oxaliplatin and induced PANoptosis (apoptosis, necroptosis, pyroptosis, and ferroptosis). PMC8882671
Human neuroglioma H4 cells 10, 25, 50 μM 6 h To evaluate the effect of ISO on autophagy, the results showed that ISO induced the formation of GFP-LC3 puncta, indicating the activation of autophagy. PMC7690654
Human osteosarcoma U2OS cells 25 μM 6 h To evaluate the effect of ISO on autophagy, the results showed that ISO induced the formation of GFP-LC3 puncta, and this effect was abolished in ATG5 knockout cells, indicating that ISO acts through the autophagy pathway. PMC7690654
HT29 0.1 μM to 1.0 μM 2–3 months To generate oxaliplatin-resistant CRC cell lines and evaluate their sensitivity to oxaliplatin. Results showed that oxaliplatin-resistant cell lines had reduced sensitivity to oxaliplatin. PMC9596403
HT29-OR 1.0 μM To evaluate the tumor sphere formation ability of oxaliplatin-resistant cell lines in a 3D environment and analyze their protein kinase phosphorylation levels. Results showed that the phosphorylation level of CHK2 at Thr68 was significantly elevated in HT29-OR cells. PMC9596403
RKO cells 62.5 µg/mL 24 h To evaluate the effect of oHA on oxaliplatin sensitivity, results showed that the combination of oHA with oxaliplatin significantly increased the apoptosis rate. PMC8118506
RKO cells 125 µg/mL 24 h To evaluate the effect of oHA on oxaliplatin sensitivity, results showed that the combination of oHA with oxaliplatin significantly increased the apoptosis rate. PMC8118506
RKO cells 250 µg/mL 24 h To evaluate the effect of oHA on oxaliplatin sensitivity, results showed that the combination of oHA with oxaliplatin significantly increased the apoptosis rate. PMC8118506
HT29-OR cells 10 μM 4 hours To evaluate the effect of BML-277 on CHK2 activity and protein PARylation, results showed that BML-277 attenuated CHK2 activity, protein PARylation and FANCD2 monoubiquitination. PMC9596403

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice CRC xenograft tumors intraperitoneal injection 5 mg/kg once a week for 14 days To evaluate the therapeutic effect of Oxaliplatin on CRC xenograft tumors, the results showed that Oxaliplatin significantly inhibited tumor growth PMC8980070
Mice Oxaliplatin-induced neuropathic pain model Intraperitoneal injection 2.4 mg/kg Days 1, 2, 5-9, 12-14, total of 10 injections To evaluate the pain response in the oxaliplatin-induced neuropathic pain model in mice and validate the analgesic effects of drugs through behavioral tests. PMC8007106
Nude mice CRC xenograft model Intraperitoneal injection 7.5 mg/kg Every 3 days for 30 days To evaluate the effect of NFS1 deficiency combined with oxaliplatin on tumor growth, the results showed that NFS1 deficiency significantly enhanced the antitumor effect of oxaliplatin and reduced tumor volume and weight. PMC8882671
Mice MCA205 fibrosarcoma model Intraperitoneal injection 10 mg/kg Not specified To evaluate the effect of ISO combined with oxaliplatin on tumor growth, the results showed that the combination treatment significantly inhibited tumor growth, and this effect depended on the immune system. PMC7690654
nude mice HCC xenograft model intraperitoneally 5 mg/kg 3 times per week for 2 weeks Oxaliplatin treatment inhibited the growth of HCC xenograft tumors PMC9895048
NOD/SCID mice HT29 cell xenograft model Intraperitoneal injection 5 mg/kg Once a week for 3 weeks To evaluate the anti-tumor effect of oxaliplatin on HT29 cell xenograft models. Results showed that oxaliplatin significantly inhibited the growth of tumors carrying the empty vector, but had a lesser effect on tumors expressing CHK2-WT or CHK2-TD. PMC9596403
Nude mice RKO cell tumor model Tail vein injection 5 mg/kg Every 3 days for 5 times To evaluate the in vivo antitumor effect of oHA-Lipid-Oxa, results showed that oHA-Lipid-Oxa significantly inhibited tumor growth and reduced side effects. PMC8118506

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01157052 Neoplasms, Colorectal ... More >> Colorectal Cancer Colorectal Carcinoma Less << Phase 1 Unknown September 2015 Canada, Alberta ... More >> Cross Cancer Institute Not yet recruiting Edmonton, Alberta, Canada, T6G 1Z2 Sub-Investigator: Judith Meza-Junco, MD Less <<
NCT00005856 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Maryland ... More >> New Approaches to Brain Tumor Therapy Consortium Baltimore, Maryland, United States, 21231-1000 Less <<
NCT01795027 Gastric Cancer Phase 3 Unknown June 2018 China, Guangdong ... More >> the central hospital of Chaozhou Chaozhou, Guangdong, China the 1st people's hospital of Foshan Foshan, Guangdong, China cancer center of Guangzhou medical college Guangzhou, Guangdong, China cancer center of Sun yat-sen University Guangzhou, Guangdong, China Guangdong Traditional Medical Hospital Guangzhou, Guangdong, China the 1st affliated hospital of Guangdong pharmacuetic college Guangzhou, Guangdong, China the 1St Affliated Hospital of Guangzhou Medical College Guangzhou, Guangdong, China the 6th affliated hospital of Sun-yat-sen University Guangzhou, Guangdong, China the 1st hospital of Shantou University Shantou, Guangdong, China the cental hospital of Shantou Shantou, Guangdong, China YUE-BEI people's hospital Shaoguan, Guangdong, China the 2nd people's hospital of Shenzhen Shenzhen, Guangdong, China the 5th hospital of Sun-yat-sen University Zhuhai, Guangdong, China Less <<
NCT01178944 - Completed - -
NCT01178944 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Undifferentiated Carcinoma Gastric Adenocarcinoma Gastric Squamous Cell Carcinoma Recurrent Esophageal Adenocarcinoma Recurrent Esophageal Squamous Cell Carcinoma Recurrent Gastric Carcinoma Stage IIIB Esophageal Adenocarcinoma Stage IIIB Esophageal Squamous Cell Carcinoma Stage IIIB Gastric Cancer Stage IIIC Esophageal Adenocarcinoma Stage IIIC Esophageal Squamous Cell Carcinoma Stage IIIC Gastric Cancer Stage IV Esophageal Adenocarcinoma Stage IV Esophageal Squamous Cell Carcinoma Stage IV Gastric Cancer Undifferentiated Gastric Carcinoma Less << Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Rochester General Hospital Rochester, New York, United States, 14621 Less <<
NCT00585078 Pancreatic Cancer Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less <<
NCT00217282 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Florida ... More >> Mount Sinai Medical Center Miami Beach, Florida, United States, 33140 Less <<
NCT00612677 Lung Cancer Phase 2 Terminated(slow accrual - the ... More >>1 patient accrued did not go on treatment) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00585078 - Completed - -
NCT01442155 - Completed - Slovakia ... More >> Banska Bystrica, Slovakia, 975 17 Bratislava, Slovakia, 812 50 Bratislava, Slovakia, 833 10 Kosice, Slovakia, 04001 Martin, Slovakia, 036 59 Nitra, Slovakia, 950 01 Poprad, Slovakia, 058 01 Presov, Slovakia, 081 81 Ruzomberok, Slovakia, 03426 Less <<
NCT00612677 - Terminated(slow accrual - the ... More >>1 patient accrued did not go on treatment) Less << - -
NCT01450163 Pain Neuropat... More >>hic Pain Polyneuropathy Less << Phase 3 Completed - Brazil ... More >> Instituto do Câncer do Estado de São Paulo ICESP São Paulo, Brazil, 01246-000 Less <<
NCT00504192 Advanced Biliary Tract Adenoca... More >>rcinoma Gemcitabine Oxaliplatin Combination Chemotherapy Efficacy Less << Phase 2 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Kyunggi, Korea, Republic of, 420-767 Less <<
NCT01222312 Non Small Cell Lung Cancer Phase 2 Completed - Germany ... More >> Krankenhaus Nordwest Frankfurt/Main, Germany, 60488 Less <<
NCT00338988 Cancer of the Gallbladder ... More >> Cancer of the Biliary Tract Less << Phase 2 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00611962 Neoplasms, Germ Cell and Embry... More >>onal Less << Phase 2 Completed - France ... More >> Sanofi-Aventis Lyon, France Less <<
NCT00338988 - Completed - -
NCT00692900 Ovarian Cancer ... More >> Peritoneal Cancer Fallopian Tube Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Magee-Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01524575 Metastatic Pancreatic Cancer ... More >> ERCC1 Less << Phase 2 Unknown January 2014 United States, Hawaii ... More >> University of Hawaii Recruiting Honolulu, Hawaii, United States, 96813 Contact: Jared D Acoba, MD    808-531-8521    jacoba@hawaii.edu Less <<
NCT00354887 - Completed - -
NCT00354887 Gastrointestinal Cancer Phase 2 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01351597 Recurrent Breast Cancer ... More >> Metastatic Breast Cancer Less << Phase 2 Unknown September 2013 Korea, Republic of ... More >> Department of Surgery, Breast Cancer Center, Inje University Paik Hospital Recruiting Seoul, Korea, Republic of, 139-707 Contact: Sehwan Han, MD. PhD.    82-2-950-1018    hanse@paik.ac.kr Less <<
NCT03159143 - Completed - -
NCT00831571 - Active, not recruiting December 2019 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT03159143 Metastatic Transitional Cell C... More >>ancer of the Urothelial Tract Less << Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00861783 Hepatoma Adva... More >>nced Solid Tumor Less << Phase 1 Completed - United States, New York ... More >> Mount Sinai Medical Center New York, New York, United States, 10029 Less <<
NCT00101270 Childhood Burkitt Lymphoma ... More >> Childhood Central Nervous System Germ Cell Tumor Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Liver Cancer Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Malignant Germ Cell Tumor Recurrent Childhood Medulloblastoma Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway Glioma Recurrent Colon Cancer Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Melanoma Recurrent Nasopharyngeal Cancer Recurrent Neuroblastoma Recurrent Osteosarcoma Recurrent Wilms Tumor and Other Childhood Kidney Tumors Recurrent/Refractory Childhood Hodgkin Lymphoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> COG Phase I Consortium Arcadia, California, United States, 91006-3776 Less <<
NCT00142467 Hepatocellular Carcinoma Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01149122 Unresectable, Metastatic Bilia... More >>ry Tract Carcinoma Less << Phase 3 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01180153 Biliary Tract Cancer Phase 2 Unknown August 2012 China, Beijing ... More >> Chin Beijing Cancer Hospital Not yet recruiting Beijing, Beijing, China, 100004 Contact: Jie Li, Doctor    010-88121122 ext 321    xiaotong10241@sin.com    Contact: Yi Shen    010-59714220    ian97@163.com    Principal Investigator: Lin Shen, Professor Less <<
NCT03153280 Colorectal Neoplasms ... More >> Stomach Neoplasm Esophageal Neoplasms Less << Phase 1 Not yet recruiting August 2021 Ireland ... More >> Cork University Hospital Not yet recruiting Cork, Ireland Principal Investigator: Prof Seamus O'Reilly          St James's Hospital, James's Street Not yet recruiting Dublin 8, Ireland Principal Investigator: Dr Sinead Cuffe          Beaumont Hospital Not yet recruiting Dublin, Ireland, Dublin 7 Principal Investigator: Dr Liam Grogan Less <<
NCT02720926 Colorectal Cancer ... More >> Gastric Cancer Less << Phase 1 Terminated(Unafavourable toxic... More >>ity profile) Less << - Singapore ... More >> National Cancer Centre singapore Singapore, Singapore Less <<
NCT03722680 Oxaliplatin-induced Peripheral... More >> Neuropathy Less << Phase 2 Not yet recruiting August 31, 2022 -
NCT00430027 Esophageal Adenocarcinoma Not Applicable Terminated(This study was term... More >>inated due slow accrual.) Less << - United States, Colorado ... More >> University of Colorado at Denver and Health Science Center Aurora, Colorado, United States, 80045 Less <<
NCT00250029 Colonic Diseases|Cancer COMPLETED 2025-03-06 Hematology Oncology Associates... More >>, Albuquerque, New Mexico, 87102-3661, United States|Lovelace Sandia Health Systems Dept of Hematology, Albuquerque, New Mexico, 87108, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, 87131, United States|New Mexico Veterans Administration Health Care System, Albuquerque, New Mexico, United States Less <<
NCT00430027 - Terminated(This study was term... More >>inated due slow accrual.) Less << - -
NCT02435927 Solid Tumors Phase 1 Recruiting June 2020 Singapore ... More >> National Cancer Centre Recruiting Singapore, Singapore, 169610 Less <<
NCT01233505 Adenocarcinoma of the Pancreas... More >> Adenocarcinoma of the Stomach BRCA1 Mutation Carrier BRCA2 Mutation Carrier Ovarian Mucinous Cystadenocarcinoma Recurrent Breast Cancer Recurrent Colon Cancer Recurrent Gastric Cancer Recurrent Ovarian Epithelial Cancer Recurrent Ovarian Germ Cell Tumor Recurrent Pancreatic Cancer Recurrent Rectal Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Stage IV Colon Cancer Stage IV Gastric Cancer Stage IV Ovarian Epithelial Cancer Stage IV Ovarian Germ Cell Tumor Stage IV Pancreatic Cancer Stage IV Rectal Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00463840 - Terminated(Due to slow accrual... More >>) Less << - -
NCT00463840 Pancreatic Cancer Phase 1 Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, New York ... More >> Bellevue Hospital New York, New York, United States, 10016 NYU Cancer Institute New York, New York, United States, 10016 Less <<
NCT01528826 Breast Cancer Phase 2 Unknown July 2013 China, Shanghai ... More >> Fudan University Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Leiping Wang, MD    +862164175590    leipingwang@163.com Less <<
NCT01531452 Stomach Neoplasms Phase 2 Completed - China, Beijing ... More >> cancer hospital & Institute,Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 Less <<
NCT00568529 Gastric Cancer Phase 2 Suspended(There are not enough... More >> patients enrolled.) Less << February 2010 China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT01522989 Advanced Solid Tumor Malignanc... More >>ies Less << Phase 1 Active, not recruiting September 2019 United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Washington, District of Columbia, United States, 20007 Less <<
NCT00611754 Head and Neck Cancer Phase 2 Completed - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT03294252 Digestive Cancer Phase 1 Phase 2 Recruiting June 7, 2021 France ... More >> ICO René Gauducheau Recruiting Saint-Herblain, France, 44805 Contact: DUMONT Frédéric, MD    +33 2 40 67 99 00    frederic.dumont@ico.unicancer.fr Less <<
NCT01935778 Gastric Cancer, Adjuvant Chemo... More >>therapy, XO Less << Phase 3 Recruiting September 2022 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Yoon-Koo Kang, M.D., Ph.D.    +82-2-3010-3230    ykkang@amc.seoul.kr    Principal Investigator: Yoon-Koo Kang, M.D., Ph.D.          Sub-Investigator: Ryoo Back-Yeol, MD,PhD          Sub-Investigator: Ryu Min-Hee, MD,PhD          Sub-Investigator: Park Sook-Ryun, MD,PhD Less <<
NCT00871169 Pancreatic Cancer Phase 2 Completed - United States, New Mexico ... More >> University of New Mexico Cancer Center @ Lovelace Medical Center Albuquerque, New Mexico, United States, 87102 Hematology Oncology Associates Albuquerque, New Mexico, United States, 87106 Cancer Center at Presbyterian Hospital Albuquerque, New Mexico, United States, 87110 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131-0001 Memorial Medical Center- Cancer Center Las Cruces, New Mexico, United States, 88011 Less <<
NCT00871169 - Completed - -
NCT01364493 Gastric Cancer Phase 2 Completed - China, Beijing ... More >> Lin Shen Beijing, Beijing, China, 100142 Less <<
NCT02548195 Cholangiocarcinoma Phase 3 Unknown December 2018 China, Shanghai ... More >> Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Mei-Ling Li    +86 21 64041990    livercongress@zs-hospital.sh.cn    Principal Investigator: Hui-Chuan Sun Less <<
NCT01442155 - Completed - -
NCT02105350 Biliary Tract Carcinoma ... More >> Gallbladder Carcinoma Less << Phase 1 Withdrawn(Study was never init... More >>iated) Less << - -
NCT03342937 Gastric Cancer ... More >> Esophagus Cancer Less << Phase 2 Recruiting December 2022 United States, North Carolina ... More >> Duke Cancer Center, Duke Uniersity Recruiting Durham, North Carolina, United States, 27710 Principal Investigator: Hope Uronis, MD Less <<
NCT02089633 Hepatocellular Carcinoma Phase 2 Completed - Hong Kong ... More >> The University of Hong Kong, Queen Mary Hospital Hong Kong, Hong Kong Less <<
NCT00145418 - Terminated(low enrollment) - -
NCT02833753 Colorectal Cancer|Appendix Can... More >>cer|Peritoneal Carcinomatosis Less << PHASE1 COMPLETED 2025-02-22 UMass Memorial Medical Center ... More >>- University Campus, Worcester, Massachusetts, 01655, United States Less <<
NCT00458809 Carcinoma of the Appendix ... More >> Colorectal Cancer Primary Peritoneal Cavity Cancer Less << Phase 1 Completed - United States, North Carolina ... More >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00256269 Esophageal Cancer ... More >> Gastroesophageal Cancer Less << Phase 2 Terminated(Study was terminate... More >>d by funding entity) Less << - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT01942200 - Completed - Germany ... More >> Practice Elstra, Germany, 01920 Practice Leipzig, Germany, 04277 Practice Naunhof, Germany, 04683 Less <<
NCT00145418 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated(low enrollment) - United States, Illinois ... More >> Oncology Specialists, SC Park Ridge, Illinois, United States, 60068 Less <<
NCT01213238 Advanced Cancers Phase 1 Active, not recruiting September 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00256308 - Terminated(Halted prematurely ... More >>due to slow accrual) Less << - -
NCT01092481 Colon Cancer Phase 3 Recruiting December 2019 Korea, Republic of ... More >> Hallym University Medical Center Recruiting Anyang, Gyeonggi, Korea, Republic of, 431-070 Contact: Dae Young Zang, M.D., Ph.D    82-31-380-3871    fhdzang@hallym.or.kr    Principal Investigator: Dae Young Zang, M.D., Ph.D          Soon Chun Hyang University Hospital Bucheon Recruiting Bucheon, Gyeonggi, Korea, Republic of, 420-767 Contact: Dae Sik Hong, M.D., Ph.D    82-32-621-5104    dshong@schbc.ac.kr    Principal Investigator: Dae Sik Hong, M.D., Ph.D          National Cancer Center Recruiting Goyang, Gyeonggi, Korea, Republic of, 410-768 Contact: Sun Young Kim, M.D., Ph.D    82-31-920-1661    cathykimmd@gmail.com    Principal Investigator: Sun Young Kim, M.D., Ph.D          School of Medicine, CHA University Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-712 Contact: Doyeun Oh, M.D., Ph.D    82-31-780-5217    doh@cha.ac.kr    Principal Investigator: Doyeun Oh, M.D., Ph.D          Sungkyunkwan University Masan Samsung Hospital Recruiting Masan, Gyeongsangnam, Korea, Republic of, 630-522 Contact: Kyung Tae Park, M.D., Ph.D    82-55-290-6007    pkt@unitel.co.kr    Principal Investigator: Kyung Tae Park, M.D., Ph.D          Pusan National University Yangsan Hospital Recruiting Yangsan, Gyeongsangnam, Korea, Republic of, 626-770 Contact: Seong - Geun Kim, M.D., Ph.D    82-55-360-1424    patheny@nate.com    Principal Investigator: Seong - Geun Kim, M.D., Ph.D          Chonnam National University Hwasun Hospital Recruiting Hwasun, Jeollanam, Korea, Republic of, 519-809 Contact: Ik Joo Chung, M.D., Ph.D    82-61-379-7632    ijchung@jnu.ac.kr    Principal Investigator: Ik Joo Chung, M.D., Ph.D          Kosin Medical Center Recruiting Busan, Korea, Republic of, 602-702 Contact: Seong-Hoon Shin, M.D., Ph.D    82-51-990-6107    ssh1533@hanmail.net    Principal Investigator: Seong-Hoon Shin, M.D., Ph.D          Dong-A University Medical Center Recruiting Busan, Korea, Republic of, 602-715 Contact: Hyuk-Chan Kwon, M.D., Ph.D    82-51-240-2887    hckwon@dau.ac.kr    Principal Investigator: Hyuk-Chan Kwon, M.D., Ph.D          Gachon University Gil Hospital Recruiting Incheon, Korea, Republic of, 405-760 Contact: Dong Bok Shin, M.D., Ph.D    82-32-460-2187    dbs@ghil.com    Principal Investigator: Dong Bok Shin, M.D., Ph.D          Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 120-752 Contact: Joong Bae Ahn, M.D., Ph.D    82-2-2228-8134    vvswm513@yuhs.ac    Principal Investigator: Joong Bae Ahn, M.D., Ph.D          Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Young Suk Park, M.D.,Ph.D.    82-2-3410-3459    pys27hmo@skku.edu    Sub-Investigator: Ho-Kyung Chun, M.D., Ph.D          Sub-Investigator: Woo Yong Lee, M.D., Ph.D          Sub-Investigator: Seong Hyeon Yun, M.D., Ph.D          Sub-Investigator: Hee Cheol Kim, M.D., Ph.D          Sub-Investigator: Yong Beom Cho, M.D.          Sub-Investigator: Haeran Yun, M.D.          Sub-Investigator: Won Ki Kang, M.D., Ph.D          Sub-Investigator: Ho Yeong Lim, M.D., Ph.D          Sub-Investigator: Joon Oh Park, M.D., Ph.D          Sub-Investigator: Se Hoon Park, M.D., Ph.D          Sub-Investigator: Jeeyun Lee, M.D., Ph.D          Seoul St. Mary's hospital, Catholic Univerisity Recruiting Seoul, Korea, Republic of, 137-701 Contact: Myung Ah Lee, M.D., Ph.D    82-2-2258-6044    angelamd@catholic.ac.kr    Principal Investigator: Myung Ah Lee, M.D., Ph.D          Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Tae Won Kim, M.D., Ph.D    82-2-3010-3210    twkimmd@amc.seoul.kr    Principal Investigator: Tae Won Kim, M.D., Ph.D          Soonchunhyang University Hospital Recruiting Seoul, Korea, Republic of, 140-210 Contact: Nam Su Lee, M.D., Ph.D    82-2-709-9287    mdnslee@hosp.sch.ac.kr    Principal Investigator: Nam Su Lee, M.D., Ph.D          SMG-SNU Boramae Medical Center Recruiting Seoul, Korea, Republic of, 156-707 Contact: In Sil Choi, M.D., Ph.D    82-2-870-2231    hmoischoi@hanmail.net    Principal Investigator: In Sil In Sil, M.D., Ph.D          Chung-Ang University College of Medicine Recruiting Seoul, Korea, Republic of, 156-755 Contact: Joung Soon Jang, M.D., Ph.D    82-2-6299-1427    alsaba@hanmail.net    Principal Investigator: Joung Soon Jang, M.D., Ph.D Less <<
NCT00256308 Head and Neck Cancer Phase 2 Terminated(Halted prematurely ... More >>due to slow accrual) Less << - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT01980407 Gastric Cancer Phase 2 Unknown March 2016 China, Jilin ... More >> Jilin Provincial Tumor Hospital Recruiting Changchun, Jilin, China Less <<
NCT02867839 Gastric Cancer Phase 3 Recruiting February 10, 2024 China, Beijing ... More >> Cancer Hospital Chinese Acadamy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Dongbing Zhao, MD          Contact: Lin Yang, MD          Peking University First Hospital Not yet recruiting Beijing, Beijing, China, 100034 Contact: Xin Wang, MD    13691478989    wangxin_guo@hotmail.com    Contact: Tao Wu, MD    13671063600    drwutao@aliyun.com    Peking University People's Hospital Not yet recruiting Beijing, Beijing, China, 100044 Contact: Yingjiang Ye, MD    13911133682    yeyingjiang@pkuph.edu.cn    Contact: Jing Zhou, MD       zhoujing-rmyy@126.com    Beijing Friendship Hospital Not yet recruiting Beijing, Beijing, China, 100050 Contact: Zhongtao Zhang, MD    13801060364    zhangzht@medmail.com.cn    Xuanwu Hospital Not yet recruiting Beijing, Beijing, China, 100053 Contact: Fei Li, MD       fli36@hotmail.com    Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jiafu Ji, MD    0086-01-88196391    jiafuj@hotmail.com    Contact: Biao Fan, MD, PhD    0086-01-88196970    fanbiao1986@163.com    Principal Investigator: Jiafu Ji, MD          Sub-Investigator: Zhaode Bu, MD          Sub-Investigator: Biao Fan, MD          Beijing Hospital Not yet recruiting Beijing, Beijing, China, 100730 Contact: Gang Xiao, MD       xgbj@sina.com    Chinese PLA General Hospital Not yet recruiting Beijing, Beijing, China, 100853 Contact: Lin Chen, MD    13801290395    chenlinbj@vip.sina.com    China, Hubei Zhongnan Hospital of Wuhan University Not yet recruiting Wuhan, Hubei, China, 430071 Contact: Bin Xiong, MD    13886029351    binxiong1961@163.com    China, Jiangsu Nanjing General Hospital Not yet recruiting Nanjing, Jiangsu, China, 210002 Contact: Guoli Li, MD    13851559752    13851559752@163.com    China, Liaoning The First Affiliated Hospital of Daliang Medical University Recruiting Daliang, Liaoning, China, 116011 Contact: Xiang Hu, MD       sunnyliangpin@163.com    China, Shandong Qilu Hospital of Shandong University Not yet recruiting Jinan, Shandong, China, 250012 Contact: Qingsi He, MD    13791122955    13791122955@163.com    Contact: Lian Liu, MD       tounao@126.com    China, Zhejiang Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Yian Du, MD       duyajim@126.com    The First Affiliated Hospital of Wenzhou Medical University Recruiting Wenzhou, Zhejiang, China, 325000 Contact: Xiaolei Chen, MD    15888405786    99953095@qq.com    Contact: Wenyi Wu, MD    15888405786    99953095@qq.com    The Second Affiliated Hospital of Wenzhou Medical University Not yet recruiting Wenzhou, Zhejiang, China, 325000 Contact: Xian Shen, MD    13968888872    13968888872@163.com Less <<
NCT03255434 Stage III Colon Cancer Phase 2 Recruiting April 2022 France ... More >> Institut regional du Cancer - Val d Aurelle Recruiting Montpellier, France, 34298 Contact: Bleuse Jean Pierre    +33467612344    jean-pierre.bleuse@icm.unicancer.fr    Principal Investigator: assenat eric Less <<
NCT00476086 Mixed Mullerian Tumors of the ... More >>Uterus Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT01693445 Gastrointestinal Neoplasms Phase 1 Completed - Korea, Republic of ... More >> Hallym University Medical Center Anyang, Korea, Republic of Less <<
NCT00557557 Colorectal Liver Metastases Phase 1 Completed - United States, Pennsylvania ... More >> UPMC Cancer Centers Network Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02694718 - Completed - -
NCT00476086 - Completed - -
NCT01019863 Non-Hodgkin Lymphoma Phase 2 Unknown October 2011 Canada, Quebec ... More >> CHA Hôpital de l'Enfant-Jésus Recruiting Québec, Quebec, Canada, G1J 1Z4 Contact: Linda Vallée, RN    418-649-0252 ext 3115    linda.vallee.cha@ssss.gouv.qc.ca    Principal Investigator: Jean-François Larouche, MD          CHUS Hopital Fleurimont Recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: Anick Champoux, Research coordinator    819-346-1110 ext 12811    achampoux.chus@ssss.gouv.qc.ca    Principal Investigator: Rami Kotb, MD Less <<
NCT00452374 - Completed - -
NCT02694718 Rectal Cancer Phase 2 Completed - Switzerland ... More >> Basel, Switzerland, 4031 Chur, Switzerland, 7000 Luzern, Switzerland, 6004 St. Gallen, Switzerland, 9007 Zürich, Switzerland, 8037 Zürich, Switzerland, 8063 Less <<
NCT00452374 Leukemia Phase 1 Phase 2 Completed - United States, California ... More >> University of California-San Diego La Jolla, California, United States, 92093 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00525005 Stomach Neoplasms Phase 2 Completed - Korea, Republic of ... More >> Hallym University Medical Center Anyang, Korea, Republic of, 431-070 Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT03585673 Esophagus Squamous Cell Carcin... More >>oma (SCC) Metastatic Cancer Less << Phase 2 Recruiting March 30, 2021 Korea, Republic of ... More >> Dong-A University Hospital Recruiting Busan, Korea, Republic of, 49201 Contact: Sung Yong Oh, MD    +82512402808    drosy@dau.ac.kr    Contact: EunKyung Lee, RN    +82512405044    dongahicrc12@naver.com Less <<
NCT02191566 Stomach Cancer Phase 2 Recruiting February 2020 Korea, Republic of ... More >> Kangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of, 110-746 Contact: Dong-Hoe Koo, MD,PhD    +82-2-2001-8330    d.h.koo@samsung.com Less <<
NCT00923637 Non Small Cell Lung Cancer Phase 2 Unknown June 2015 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical College Recruiting Guangzhou, Guangdong, China, 510120 Contact: Daoyuan Wang, MD    +86-20-83337792    ghealth2008@gmail.com    Contact: Wenlong Shao, MD    +86-20-83337792    myfriends2003@126.com    Principal Investigator: Jianxing He, MD, FACS Less <<
NCT00674206 - Terminated(Sponsor funding sto... More >>pped) Less << - -
NCT00674206 Breast Cancer Phase 2 Terminated(Sponsor funding sto... More >>pped) Less << - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01090505 Gastric Cancer Phase 2 Unknown December 2015 China, Beijing ... More >> China PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Fu xing road 28#    86-10-66938328 Less <<
NCT00677443 Colorectal Cancer Phase 3 Completed - Korea, Republic of ... More >> National Cancer Center Goyang, Gyeonggi, Korea, Republic of, 410-769 Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of Chonnam National University Hospital Hwasun, Jeollanamdo, Korea, Republic of, 519-809 Yeungnam University Daegu, Korea, Republic of, 705-717 Gachon University Gil Medical Center Inchon, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Korea Cancer Center Hospital Seoul, Korea, Republic of, 139-706 Soon Chun Hyang University Hospital Seoul, Korea, Republic of, 140-743 Seoul National University Hospital Seoul, Korea, Republic of Yonsei University Seoul, Korea, Republic of Less <<
NCT00183898 Gastric Cancer ... More >> Esophageal Cancer Less << Phase 2 Active, not recruiting June 28, 2019 United States, California ... More >> U.S.C./Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT03427021 GI Patients on Oxaliplatin Con... More >>taining Regimen Less << EARLY_PHASE1 TERMINATED 2018-10-23 Abramson Cancer Center of the ... More >>University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States Less <<
NCT02368860 Pancreatic Cancer Phase 1 Recruiting June 2019 Singapore ... More >> National Cancer Centre Recruiting Singapore, Singapore, 169610 Contact: Lanying Wang    64368267    nctwly@nccs.com.sg Less <<
NCT03567629 mCRC Phase 2 Active, not recruiting December 30, 2023 China, Beijing ... More >> Beijing Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT03026803 Liver Cancer ... More >>Hepatocellular Cancer Less << Phase 2 Terminated(Due to Sorafenib be... More >>came first line treatment for HCC, the designed treatment became less competitive. The company Sanofi decided not to continue to support) Less << - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT02604615 Stage III Esophageal Squamous ... More >>Cell Carcinoma Esophageal Neoplasms Less << Phase 3 Recruiting December 2020 China, Henan ... More >> The First Affiliated Hospital of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Contact: shegan gao, doctor    0379 64811906    gsg112258@163.com    Contact: tanyou shan, master    0379 64815350    shantanyou@163.com Less <<
NCT01106066 Phase I: To Determine the Maxi... More >>mum Tolerated Dose (MTD) Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/Oxaliplatin Less << Phase 1 Phase 2 Terminated(Difficulties in rec... More >>ruiting patients) Less << - Korea, Republic of ... More >> Samsung Cancer Center Seoul, Korea, Republic of Less <<
NCT01067053 Metastatic Colorectal Cancer Phase 2 Unknown March 2014 Spain ... More >> Hospital de L´Hospitalet Hospitalet de Llobregat, Barcelona, Spain, 08906 Hospital de Gran Canaria Doctor Negrin Las Palmas de Gran Canaria, Las Palmas, Spain, 35010 Hospital Infanta Sofía San Sebastián de los Reyes, Madrid, Spain, 28702 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Hospital Lluis Alcanyis Játiva, Valencia, Spain, 46800 Hospital Clinic i Provincial Barcelona, Spain, 08036 Hospital General Yagüe Burgos, Spain, 09005 Hospital Arnau de Vilanova Lérida, Spain, 25198 Hospital Universitario la Paz Madrid, Spain, 28046 Hospital Quirón de Madrid Madrid, Spain, 28223 Hospital Morales Meseguer Murcia, Spain, 30008 Hospital La Fe de Valencia Valencia, Spain, 46009 Hospital General de Valencia Valencia, Spain, 46014 Hospital Doctor Peset Valencia, Spain, 46017 Hospital Xeral Cies de Vigo Vigo, Spain, 36204 Less <<
NCT02557490 Colon Cancer Liver Metastasis Phase 4 Unknown December 2017 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Zhu Xu, Master    0086-10-88195476    zhux387@263.net    Principal Investigator: Zhu Xu, Master Less <<
NCT02527785 Stomach Neoplasm Phase 2 Completed - Korea, Republic of ... More >> Hallym university medical center Anyang, Gyunggi, Korea, Republic of Less <<
NCT02527824 Biliary Tract Neoplasm Phase 2 Active, not recruiting September 2017 Korea, Republic of ... More >> Hallym university medical center Anyang, Gyunggi, Korea, Republic of Less <<
NCT01370876 Cancer of the Head and Neck|Ne... More >>oplasms, Head and Neck Less << PHASE2 TERMINATED 2025-05-12 Taipei Mackay Memorial Hospita... More >>l, Taipei, 104, Taiwan Less <<
NCT03528785 Pancreatic Adenocarcinoma Phase 2 Recruiting January 2020 Italy ... More >> Centro Ricerche Cliniche Recruiting Verona, Italy, 37134 Contact: Stefano Milleri, Dr.    +390458126619    stefano.milleri@crc.vr.it    Contact: Giorgia Barbiero, Dr.    +390458126562    giorgia.barbiero@crc.vr.it    Principal Investigator: Davide Melisi, Dr Less <<
NCT02347904 Esophageal Cancer Phase 1 Recruiting January 2019 Netherlands ... More >> Academic Medical Center, Medical Oncology Recruiting Amsterdam, Netherlands, 1100 DD Contact: H WM van Laarhoven, MD, PhD, PhD    31 20 5665955    h.vanlaarhoven@amc.uva.nl    Contact: E. H. vandaalen    31 20 5668229    trialmedonc@amc.uva.nl    Principal Investigator: H. WM van Laarhoven, MD, PhD, PhD          Sub-Investigator: S O. van der Woude, MD Less <<
NCT02289378 Docetaxel, Oxaliplatin and Flu... More >>orouracil Less << Phase 2 Unknown October 2017 China, Guangdong ... More >> The Sixth Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Jian Xiao, Ph D    86-2038250745    xiao_jian@139.com    Principal Investigator: Ping Lan, Ph D Less <<
NCT03254394 Neuropathy, Painful ... More >> Chemotherapy-induced Peripheral Neuropathy Colorectal Cancer Less << Phase 1 Phase 2 Recruiting June 1, 2019 United States, Missouri ... More >> Washington University School of Medicine/Barnes Jewish Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Karen Frey, BS    314-454-5980    freyk@anest.wustl.edu    Principal Investigator: Simon Haroutounian, PhD          Sub-Investigator: Mathias Leinders, PhD Less <<
NCT02486198 Neurotoxicity Phase 3 Completed - China, Tianjin ... More >> TianjinCIH Tianjin, Tianjin, China, 300060 Less <<
NCT01608646 Gastrointestinal Cancer Phase 2 Unknown August 2018 China, Shanxi ... More >> Xijing hospital of the fourth military medical univercity Recruiting Xijing, Shanxi, China, 710031 Contact: WENCHAO LIU, Professor    029-84775407    liuch@FMMU.edu.cn    Principal Investigator: WENCHAO LIU, Professor Less <<
NCT00954005 Indolent Lymphoma Phase 1 Phase 2 Terminated(Predefined terminat... More >>ion criterion of > 10 patients without CR or PR was matched.) Less << - Germany ... More >> Klinikum Ludwigshafen Ludwigshafen, Germany, 67063 Less <<
NCT02557503 Advanced Adult Primary Liver C... More >>ancer Less << Phase 4 Unknown December 2017 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Zhu Xu, Master    0086-10-88195476    zhux387@263.net    Principal Investigator: Zhu Xu, Master Less <<
NCT03172416 Peritoneal Carcinomatosis Phase 1 Recruiting January 2019 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119228 Contact: Jimmy So, MBChB    +65 6772 5555 ext 24236    sursbyj@nus.edu.sg    Contact: Guowei Kim, MBBS    +65 6772 5555 ext 28830    guo_wei_kim@nuhs.edu.sg Less <<
NCT01042691 Unresectable Colorectal Liver ... More >>Metastases Less << PHASE1 COMPLETED 2025-11-11 UPMC Presbyterian, Pittsburgh,... More >> Pennsylvania, 15213, United States|UPMC Cancer Centers, Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|UPMC Shadyside, Pittsburgh, Pennsylvania, 15232, United States Less <<
NCT02970526 Colorectal Cancer Survivors|Ox... More >>aliplatin Regimen|Adult Less << COMPLETED 2019-08-29 CHU Clermont-Ferrand, Clermont... More >>-Ferrand, 63003, France Less <<
NCT03026803 - Terminated(Due to Sorafenib be... More >>came first line treatment for HCC, the designed treatment became less competitive. The company Sanofi decided not to continue to support) Less << - -
NCT02630043 Neuroblastoma Phase 1 Recruiting December 2020 United States, Arkansas ... More >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Janet Storment, RN    501-364-2760    StormentJanetS@uams.edu    Principal Investigator: Kathleen Neville, MD          United States, California Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: Mehrzad Milburn    858-966-8155       Principal Investigator: William Roberts, MD          United States, Connecticut Connecticut Children's Hospital Not yet recruiting Hartford, Connecticut, United States, 06106 Contact: Sharon Huie-White    860-545-9337    shuie@connecticutchildrens.org    Principal Investigator: Michael Isakoff, MD          United States, Hawaii Kapiolani Medical Center for Women and Children Recruiting Honolulu, Hawaii, United States, 96813 Contact: Andrea Siu, MPH    808-535-7169    andrea.siu@kapiolani.org    Principal Investigator: Randal Wada, MD          United States, Michigan Helen DeVos Children's Hospital Recruiting Grand Rapids, Michigan, United States, 49503 Contact: Shannon MacKeigan, R    616-267-1162    shannon.mackeigan@helendevoschildrens.org    Principal Investigator: Deanna Mitchell, MD          Principal Investigator: Giselle Sholler, MD          United States, Missouri Cardinal Glennon Children's Medical Center Recruiting Saint Louis, Missouri, United States, 63104 Contact: Katherine Maxwell, RN    314-268-4000       Principal Investigator: William Ferguson, MD          United States, North Carolina Levine Children's Hospital Recruiting Charlotte, North Carolina, United States, 28204 Contact: Nicole Turner, RN    980-442-2355    felisha.turner@carolinashealthcare.org    Principal Investigator: Javier Oesterheld, MD          United States, Pennsylvania Penn State Milton S. Hershey Medical Center and Children's Hospital Not yet recruiting Hershey, Pennsylvania, United States, 17033 Contact: Suzanne Treadway       streadway@hmc.psu.edu    Principal Investigator: Valerie Brown, MD          United States, South Carolina Medical University of South Carolina Not yet recruiting Charleston, South Carolina, United States, 29425 Contact: Liz Shewfelt    843-792-2957    shewfelt@musc.edu    Principal Investigator: Jaqueline Kraveka, MD Less <<
NCT02077998 Stage IV Breast Cancer Early Phase 1 Completed - United States, California ... More >> UC Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 Less <<
NCT02062749 Colorectal Cancer PHASE1 COMPLETED 2018-06-27 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT02284529 Stage-Ⅱ Colorectal Cancer Phase 4 Completed - Taiwan ... More >> Taichung Veterans General Hospital Taichung, Taiwan, 40705 Less <<
NCT03726021 Overall Survival Phase 2 Recruiting January 31, 2020 China ... More >> Qingdao Central Hospital Recruiting Qingdao, China, 266042 Contact: youxin ji, M.D.    8653268665078    mdji001@gmail.com    Sub-Investigator: ketao lan, M.D.          Sub-Investigator: chunling zhang, M.D.          Principal Investigator: youxin ji, M.D. Less <<
NCT03263741 Gastric Cancer Phase 2 Recruiting September 1, 2020 China, Qinghai ... More >> Affiliated Hospital of Qinghai University Recruiting Xining, Qinghai, China, 810000 Contact: Jiuda Zhao, M.D.    +8613327661976    jiudazhao@126.com    Contact: Dengfeng Ren, M.D.    +8613086297659    dengfeng1104@126.com Less <<
NCT02569723 Colon Adenocarcinoma Not Applicable Recruiting December 2020 United States, California ... More >> University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Thomas J. Semrad    916-734-3771    tsemrad@ucdavis.edu    Principal Investigator: Thomas J. Semrad Less <<
NCT01558453 Relapsed Solid Tumor|Refractor... More >>y Solid Tumor Less << PHASE2 UNKNOWN 2025-12-13 Santa Marcelina Hospital, Sao ... More >>Paulo, SP, 08270070, Brazil Less <<
NCT00296816 Ovarian Cancer Phase 2 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Less <<
NCT01652976 Pancreatic Cancer Metastatic Phase 2 Active, not recruiting January 2019 United States, Florida ... More >> UF Health Cancer Center Gainesville, Florida, United States, 32610 Less <<
NCT01267344 Cholangiocarcinoma ... More >> Adenocarcinoma of Gallbladder Less << Phase 2 Completed - Taiwan ... More >> National Institute of Cancer Research, Taiwan Cooperative Oncology Group Zhunan, Miaoli County, Taiwan, 350 Less <<
NCT00957905 Recurrent Extragonadal Seminom... More >>a Recurrent Malignant Extragonadal Germ Cell Tumor Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor Recurrent Malignant Testicular Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor Stage III Testicular Cancer Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor Stage IV Extragonadal Seminoma Stage IV Ovarian Germ Cell Tumor Less << Phase 2 Completed - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211-1850 City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania UPMC-Presbyterian Hospital Pittsburgh, Pennsylvania, United States, 15213 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin Riverview Hospital Wisconsin Rapids, Wisconsin, United States, 54494 Less <<
NCT00957905 - Completed - -
NCT00394992 Colorectal Cancer ... More >> Liver Metastases Less << Phase 3 Terminated(Data from the C08 s... More >>tudy and Avant study) Less << - Netherlands ... More >> Universitair Medisch Centrum Utrecht Utrecht, Netherlands, 3508 GA Less <<
NCT01583361 Gastric Adenocarcinoma Phase 3 Unknown January 2017 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Tao Li, MD,PhD    0086-10-66938328    litbj301@sina.com Less <<
NCT01716949 Rectal Cancer Phase 1 Phase 2 Recruiting June 2023 Germany ... More >> Klinik Bad Trissl, Innere Medizin Recruiting Bad Trissl, Germany, 83080 Principal Investigator: Bernhard Weber, MD          Sub-Investigator: Friedemann Peschke, MD          University Hospital Recruiting Duesseldorf, Germany, 40225 Sub-Investigator: Christiane Matuschek, MD          Universitätsklinikum Erlangen, Strahlenklinik Recruiting Erlangen, Germany, 91054 Principal Investigator: Oliver Ott, MD          Sub-Investigator: Rainer Fietkau, MD          LMU München, Campus Großhadern, Medizinische Klinik III, Hyperthermie Recruiting München, Germany, 81377 Principal Investigator: Rolf Issels, MD          Sub-Investigator: Katharina Lechner, MD          Schlossbergklinik Recruiting Oberstaufen, Germany, 87534 Principal Investigator: Thomas Licht, MD          Sub-Investigator: Blair Wolfgang, MD          Universitätsklinikum Tübingen, Radioonkologie Recruiting Tübingen, Germany, 72076 Principal Investigator: Daniel Zips, MD          Sub-Investigator: Johanna Gellermann, MD Less <<
NCT03472365 Gastric Cancer ... More >> GastroEsophageal Cancer Less << Phase 2 Recruiting December 30, 2019 China, Anhui ... More >> The First Affiliated Hospital of Anhui Medical University Recruiting Hefei, Anhui, China Contact: Kangsheng Gu, MD          China, Beijing Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: Lin Shen, MD          Sub-Investigator: Zhi Peng, MD          China, Guangdong The sixth affliated hospital of Sun Yat-Sen Unversity Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanhong Deng, MD          China, Heilongjiang Harbin Tumor Hospital Recruiting Harbin, Heilongjiang, China Contact: Yanqiao Zhang, MD          China, Henan The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China Contact: Qingxia Fan, MD          China, Hubei Tongji Hospital of Tongji Medical College, Huangzhong University of Science & Technology Recruiting Wuhan, Hubei, China Contact: Xianglin Yuan, MD          China, Jiangsu Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China Contact: Jia Wei, MD          China, Jilin Jilin Cancer Hospital Recruiting Changchun, Jilin, China Contact: Ying Chen, MD          China, Shanxi The First Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China Contact: Juxiang Xiao, MD          China, Zhejiang Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China Contact: Jieer Ying, MD Less <<
NCT01364376 Stomach Neoplasms Not Applicable Completed - China, Shandong ... More >> Qilu Hospital of Shandong University Jinan, Shandong, China Shandong Provincial Hospital Jinan, Shandong, China China, Zhejiang Sir Run Run Shaw Hospital Hangzhou, Zhejiang, China The First Affiliated Hospital of Medical School of Zhejiang University Hangzhou, Zhejiang, China The Second Affiliated Hospital of Medical School of Zhejiang University Hangzhou, Zhejiang, China Jiaxing First Hospital Jiaxing, Zhejiang, China Ningbo Medical Treatment Center Lihuili Hospital Ningbo, Zhejiang, China The second affiliated hospital of Wenzhou medical college Wenzhou, Zhejiang, China Less <<
NCT00525915 Esophageal Cancer ... More >> Gastroesophageal Cancer Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01311050 - Unknown - Saudi Arabia ... More >> Kfsh & Rc Recruiting Riyadh, Saudi Arabia Less <<
NCT00453115 Lung Cancer Phase 2 Unknown May 2011 Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-dog, Korea, Republic of, 411-769 Less <<
NCT00086996 Esophageal Cancer Phase 2 Completed - -
NCT00831181 - Completed - -
NCT00532909 Anal, Colon, and Rectal Cancer... More >>s Colorectal Neoplasms Colon/Rectal Cancer Less << Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00296816 - Completed - -
NCT00356122 Non-Small Cell Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Less <<
NCT00525915 - Completed - -
NCT00356122 - Completed - -
NCT00831181 Colorectal Cancer Phase 2 Completed - United States, New York ... More >> Beth Israel Medical Center - Philipps Ambulatory Care Center New York, New York, United States, 10003 St. Luke's-Roosevelt Hospital Center - Roosevelt Division New York, New York, United States, 10019 Less <<
NCT00278694 Rectal Cancer Phase 2 Completed - Norway ... More >> RRHF Oslo, Norway, 0027 Less <<
NCT02380131 HER-2 Positive Gastric Cancer ... More >> Liver Metastasis Less << Phase 4 Unknown December 2017 China, Hebei ... More >> Department of Internal Medicine-Oncology Recruiting Shijiazhuang, Hebei, China, 050011 Contact: Qun Zhao, Doctor    +8613930162111    zhaoqun516@126.com    Principal Investigator: Qun Zhao, Dortor Less <<
NCT00446290 Stomach Cancer Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00733616 Gastric Cancer Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain Less <<
NCT00263354 Stomach Neoplasms PHASE2 COMPLETED 2025-07-06 -
NCT00086996 - Completed - -
NCT00512681 Stomach Neoplasms Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center Korea Goyang, Gyeonggi, Korea, Republic of Less <<
NCT00112528 Pancreatic Cancer Phase 2 Completed - -
NCT01022541 Metastatic Colorectal Cancer Phase 2 Completed - United Kingdom ... More >> David Cunningham Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00186277 Bladder Cancer Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01542294 Gastric Cancer Phase 1 Phase 2 Unknown April 2017 China ... More >> Department of Medical Oncology,Cancer hospital and Institute,CAMS Beijing, China, 100021 Less <<
NCT00446290 - Completed - -
NCT01399190 - Completed - -
NCT01396707 Metastatic or Recurrent Gastri... More >>c Adenocarcinoma Her-2 Positive Gastric Cancer Less << Phase 2 Active, not recruiting November 2018 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT02266355 Colon Cancer Phase 1 Recruiting March 2018 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06519 Contact: Nataliya Uboha, MD, PhD    475-202-9827    nataliya.uboha@yale.edu Less <<
NCT00202774 Colorectal Cancer Phase 3 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD) Madrid, Spain, 28046 Less <<
NCT00418093 - Terminated(THe study was termi... More >>nated early due to a lack of accural) Less << - -
NCT01399190 - Completed - Slovakia ... More >> Banska Bystrica, Slovakia, 975 17 Bratislava, Slovakia, 812 50 Bratislava, Slovakia, 833 10 Kosice, Slovakia, 04001 Martin, Slovakia, 036 59 Nitra, Slovakia, 950 01 Poprad, Slovakia, 058 01 Presov, Slovakia, 081 81 Ruzomberok, Slovakia, 03426 Less <<
NCT01499940 Neurotoxicity Phase 2 Terminated(Research cancelled ... More >>- no funding identified.) Less << - United States, West Virginia ... More >> West Virginia University Hospitals Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States, 26506 Less <<
NCT01193517 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00418093 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << Phase 2 Terminated(THe study was termi... More >>nated early due to a lack of accural) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00226941 - Terminated(The response rate o... More >>bserved in the phase 1 portion of the study did not merit further evaluation in phase 2 portion of the study.) Less << - -
NCT03448835 Stomach Cancer ... More >> Gastro Esophageal Junction Cancer Less << Phase 2 Recruiting January 1, 2021 Netherlands ... More >> Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066CX Contact: Elvira Nuijten, MSc    +3120512 ext 2671    e.nuijten@nki.nl Less <<
NCT00591149 Head and Neck Cancer ... More >> Carcinoma, Squamous Less << Phase 2 Terminated(Study was stopped d... More >>ue to termination of funding) Less << - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT00226941 Rectal Cancer ... More >> Colo-rectal Cancer Less << Phase 1 Phase 2 Terminated(The response rate o... More >>bserved in the phase 1 portion of the study did not merit further evaluation in phase 2 portion of the study.) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02079220 Metastatic Colorectal Cancer Phase 2 Withdrawn(Funding for the stud... More >>y was withdrawn, no participants were ever recruited.) Less << March 2018 United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00444678 Colorectal Cancer ... More >> Neoplasm Metastasis Less << Phase 2 Completed - United States, New York ... More >> Bellevue Hospital New York, New York, United States, 10016 New York University Langone Medical Center New York, New York, United States, 10016 Less <<
NCT01523574 Peripheral Neuropathy Phase 2 Completed - Brazil ... More >> Faculdade de Medicina do ABC Santo Andre, Sao Paulo, Brazil, 09060-870 Faculdade de Medicina do ABC Santo André, São Paulo, Brazil, 09060-870 Less <<
NCT03382600 Gastric Cancer Phase 2 Recruiting August 17, 2020 Japan ... More >> National Cancer Center Hospital East ( Site 0001) Recruiting Kashiwa, Chiba, Japan, 277-8577 Contact: Study Coordinator    +81471331111       National Hospital Organization Shikoku Cancer Center ( Site 0024) Recruiting Matsuyama, Ehime, Japan, 791-0280 Contact: Study Coordinator    +81899991111       Gunma Prefectural Cancer Center ( Site 0005) Recruiting Ohta, Gunma, Japan, 373-8550 Contact: Study Coordinator    +81276380771       Hokkaido University Hospital ( Site 0006) Recruiting Sapporo, Hokkaido, Japan, 060-8648 Contact: Study Coordinator    +81117161161       Hyogo Cancer Center ( Site 0016) Recruiting Akashi, Hyogo, Japan, 673-8558 Contact: Study Coordinator    +81789291151       Kobe City Medical Center General Hospital ( Site 0015) Recruiting Kobe, Hyogo, Japan, 650-0047 Contact: Study Coordinator    +81783024321       Ibaraki Prefectural Central Hospital ( Site 0018) Recruiting Kasama, Ibaraki, Japan, 309-1793 Contact: Study Coordinator    +81296771121       Kitasato University Hospital ( Site 0019) Recruiting Sagamihara, Kanagawa, Japan, 252-0375 Contact: Study Coordinator    +81427788111       Kanagawa Cancer Center ( Site 0003) Recruiting Yokohama, Kanagawa, Japan, 241-8515 Contact: Study Coordinator    +81455202222       Tohoku University Hospital ( Site 0023) Recruiting Sendai, Miyagi, Japan, 980-8574 Contact: Study Coordinator    +81227177000       Kindai University Hospital ( Site 0013) Recruiting Osakasayama, Osaka, Japan, 589-8511 Contact: Study Coordinator    +81723660221       Osaka University Hospital ( Site 0010) Recruiting Suita, Osaka, Japan, 565-0871 Contact: Study Coordinator    +81668795111       Saitama Cancer Center ( Site 0004) Recruiting Kitaadachi-gun, Saitama, Japan, 362-0806 Contact: Study Coordinator    +81487221111       Shizuoka Cancer Center Hospital and Research Institute ( Site 0020) Recruiting Sunto-gun, Shizuoka, Japan, 411-8777 Contact: Study Coordinator    +81559895222       Jichi Medical University Hospital ( Site 0009) Recruiting Shimotsuke, Tochigi, Japan, 329-0498 Contact: Study Coordinator    +81285442111       Chiba Cancer Center ( Site 0012) Recruiting Chiba, Japan, 260-8717 Contact: Study Coordinator    +81432645431       National Hospital Organization Kyushu Cancer Center ( Site 0017) Recruiting Fukuoka, Japan, 811-1395 Contact: Study Coordinator    +81925413231       Kyushu University Hospital ( Site 0014) Recruiting Fukuoka, Japan, 812-8582 Contact: Study Coordinator    +81926411151       Gifu University Hospital ( Site 0021) Recruiting Gifu, Japan, 501-1194 Contact: Study Coordinator    +81582306000       Kochi Health Sciences Center ( Site 0022) Recruiting Kochi, Japan, 781-8555 Contact: Study Coordinator    +81888373000       Kumamoto University Hospital ( Site 0002) Recruiting Kumamoto, Japan, 860-8556 Contact: Study Coordinator    +81963442111       Osaka International Cancer Institute ( Site 0011) Recruiting Osaka, Japan, 541-8567 Contact: Study Coordinator    +81669451181       National Cancer Center Hospital ( Site 0025) Recruiting Tokyo, Japan, 104-0045 Contact: Study Coordinator    +81335422511       Tokyo Metropolitan Komagome Hospital ( Site 0008) Recruiting Tokyo, Japan, 113-8677 Contact: Study Coordinator    +81338232101       The Cancer Institute Hospital of JFCR ( Site 0007) Recruiting Tokyo, Japan, 135-8550 Contact: Study Coordinator    +81335200111 Less <<
NCT00591149 - Terminated(Study was stopped d... More >>ue to termination of funding) Less << - -
NCT03122886 Advanced Malignant Neoplasm Not Applicable Recruiting April 2020 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Aminah Jatoi Less <<
NCT02527772 Hepatocellular Carcinoma Phase 2 Phase 3 Unknown September 2018 -
NCT00094965 Gastrointestinal Cancer Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6307 Less <<
NCT00335959 - Terminated(Closed due to slow ... More >>accrual) Less << - -
NCT00920868 Solid Tumor M... More >>etastatic Colorectal Cancer Less << Phase 1 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, North Carolina Duke Univeristy Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00335959 Gastric Cancer Phase 2 Terminated(Closed due to slow ... More >>accrual) Less << - -
NCT01611155 Peripheral Neuropathy Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00422773 Metastatic Colorectal Cancer Phase 1 Phase 2 Completed - Germany ... More >> Universitaetsklinikum Carl Gustav Carus, Medizinische Klinik Dresden, Sachsen, Germany, 01307 Westdeutsches Tumorzentrum, Universitaetsklinikum Essen Essen, Germany, 45112 Universitaetsklinik Mannheim GmbH, III. Medizinische Klinik Mannheim, Germany, 68167 Less <<
NCT00120172 Colorectal Cancer ... More >> Neoplasm Metastasis Less << Phase 2 Terminated(positive results fr... More >>om a larger study with same regimen was released.) Less << - United States, California ... More >> Mission Hills, California, United States, 91345 United States, District of Columbia Washington, District of Columbia, United States, 20007 United States, Florida Inverness, Florida, United States, 34452 New Port Richey, Florida, United States, 34652 United States, Idaho Coeur D'Alene, Idaho, United States, 83814 Less <<
NCT00675012 Colon Cancer Phase 2 Completed - Italy ... More >> Azienda Ospedaliera Universitaria San Martino Genoa, Italy, 16132 Less <<
NCT00184028 Carcinoma of the Head and Neck Phase 2 Terminated(Insufficient Accrua... More >>l) Less << - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT02987699 HepatoCellular Carcinoma Phase 2 Unknown May 2017 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD.       shiming@sysu.edu.cn    Principal Investigator: shi Ming, MD. Less <<
NCT01270724 CNS Germ Cell Tumor Phase 2 Recruiting December 2018 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Girish Dhall, MD    323-361-8589    gdhall@chla.usc.edu    Principal Investigator: Girish Dhall, MD Less <<
NCT00208546 Colorectal Cancer Phase 3 Completed - Netherlands ... More >> University Medical Center Nijmegen Nijmegen, Gelderland, Netherlands Less <<
NCT00070265 Liver Metastases ... More >> Recurrent Colon Cancer Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Texas ... More >> University of Texas Houston, Texas, United States, 77030 Less <<
NCT00184028 - Terminated(Insufficient Accrua... More >>l) Less << - -
NCT00205322 Metastatic Colorectal Cancer Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT03166553 Advanced Primary Liver Cancer Not Applicable Recruiting November 27, 2019 China, Beijing ... More >> 302 Military Hospital of China Not yet recruiting Beijing, Beijing, China, 100039 Contact: Yinying Lu          China, Gansu The First Hospital of Lanzhou University Not yet recruiting Lanzhou, Gansu, China, 730000 Contact: Da Zhao          China, Hebei The First Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050000 Contact: Yonghui An          China, Heilongjiang Harbin Medical University Cancer Hospital Not yet recruiting Harbin, Heilongjiang, China, 150000 Contact: Yuxian Bai          China, Henan Henan Medical University Cancer Hospital Not yet recruiting Zhengzhou, Henan, China, 450000 Contact: Huaimin Liu          China, Hubei Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Not yet recruiting Wuhan, Hubei, China, 430000 Contact: Xianglin Yuan          Xiehe University of Science and Technology Affiliate Tongji Hospital Not yet recruiting Wuhan, Hubei, China, 43000 Contact: Tao Zhang          China, Shandong Jinan Military General Hospital Not yet recruiting Jinan, Shandong, China, 250000 Contact: Baochen Wang          The Affiliated Hospital of Qindao University Not yet recruiting Qindao, Shandong, China, 266000 Contact: Wensheng Qiu          China, Shanghai Shanghai Oriental Hospital Not yet recruiting Shanghai, Shanghai, China, 200000 Contact: Jin Li Less <<
NCT00057863 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Carcinoma Stage IVA Cervical Cancer Stage IVB Cervical Cancer Less << Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467-2490 Less <<
NCT00084617 Adenocarcinoma of the Gastroes... More >>ophageal Junction Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Recurrent Gastric Cancer Stage IIIA Gastric Cancer Stage IIIB Gastric Cancer Stage IIIC Gastric Cancer Stage IV Gastric Cancer Less << Phase 2 Completed - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT03321643 Recurrent Diffuse Large B-Cell... More >> Lymphoma Recurrent Transformed Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Transformed Non-Hodgkin Lymphoma Richter Syndrome Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Less << Phase 1 Recruiting March 31, 2020 United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org    Principal Investigator: Alex F. Herrera          University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact    916-734-3089       Principal Investigator: Joseph M. Tuscano Less <<
NCT02885753 Colorectal Neoplasms Phase 3 Recruiting June 2023 France ... More >> CHU Not yet recruiting Angers, France Contact: Antoine BOUVIER          Institut de cancérologie de l'Ouest Not yet recruiting Angers, France Contact: Véronique GUERIN-MEYER          Institut Sainte Catherine Not yet recruiting Avignon, France Contact: Laurent MINEUR          Polyclinique Bordeaux Nord Not yet recruiting Bordeaux, France Contact: Cedric LECAILLE          Centre Hospitalier Sud Francilien Not yet recruiting Corbeil-essonnes, France Contact: Samy LOUAFI          Chu Le Bocage Not yet recruiting Dijon, France Contact: Sylvain MANFREDI          CHU Not yet recruiting Grenoble, France Contact: Victoire GRANGER          Chd Vendee Not yet recruiting La Roche Sur Yon, France Contact: Roger FAROUX          Not yet recruiting Longjumeau, France Contact: Samy LOUAFI          Hôpital du Scorff Not yet recruiting Lorient, France Contact: Joëlle EGRETEAU          Hopital Europeen Not yet recruiting Marseille, France Contact: Yves RINALDI          Hopital Saint Joseph Not yet recruiting Marseille, France Contact: Hervé PERRIER          Centre d'Imagerie médicale du Confluent- IRIS GRIM Not yet recruiting Nantes, France Contact: Jean-Marie PASQUIER          CHU Not yet recruiting Nantes, France Contact: Yann TOUCHEFEU          Hôpial Privé du Confluent Le Confluent Centre Catherine de Sienne Not yet recruiting Nantes, France Contact: Hélène CASTANIE          CHR Not yet recruiting Orleans, France Contact: Jean-Paul LAGASSE          Ch de Bicetre Not yet recruiting Paris, France Contact: Anne THIROT BIDAULT          Gh La Pitie Salpetriere Not yet recruiting Paris, France Contact: Olivier DUBREUIL          HEGP Recruiting Paris, France Contact: Simon PERNOT          Hopital St Joseph Not yet recruiting Paris, France Contact: Nabil BABA HAMED          Hôpital Cochin Not yet recruiting Paris, France Contact: Romain CORIAT          Hôpital Europeen G Pompidou Not yet recruiting Paris, France Contact: Julien TAIEB          Saint Louis Not yet recruiting Paris, France Contact: Thomas APARICIO          CH Not yet recruiting Perpignan, France Contact: Faiza KHEMISSA          CHU Not yet recruiting Pessac, France Contact: Denis SMITH          CHU Not yet recruiting Poitiers, France Contact: David TOUGERON          Centre Eugène Marquis Not yet recruiting Rennes, France Contact: Samuel LE SOURD          CHU Not yet recruiting Rouen, France Contact: Alice GANGLOFF          Saint Gregoire - Chp Not yet recruiting Saint Gregoire, France Contact: Laurent MIGLIANICO          Saint- Etienne Chu Not yet recruiting Saint- Etienne, France Contact: Jean Marc PHELIP          Chu Rangueil Not yet recruiting Toulouse, France Contact: Rosine GUIMBAUD          GR Not yet recruiting Villejuif, France Contact: Michel DUCREUX          Hôpital Paul BROUSSE Not yet recruiting Villejuif, France Contact: Mohamed BOUCHAHDA Less <<
NCT00713687 Cholangiocarcinoma Phase 2 Withdrawn(recruiting failed) - Germany ... More >> Technical University of Munich at the Klinikum rechts der Isar II. Medizinische Klinik Ismaninger Str. 22 Munich, Germany, 81675 Less <<
NCT02035072 Unresectable Pancreatic Cancer... More >> Nonmetastatic Pancreatic Cancer Locally Advanced Pancreatic Cancer Less << Phase 2 Completed - Italy ... More >> Radiotherapy Unit, IRCCS IRST Meldola, FC, Italy, 47014 Less <<
NCT00177307 Cancer Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00398398 Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Korea Cancer Center Hospital Seoul, Korea, Republic of Seoul Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00084617 - Completed - -
NCT03162510 Gastric Cancer in Situ ... More >> Pancreatic Cancers Biliary Cancers Less << Phase 1 Recruiting October 2019 Taiwan ... More >> Taiwan Cooperative Oncology Group, National Health Research Institutes Recruiting Taipei, Taiwan Contact: Tsang-Wu Liu, MD    +886-2-26534401 ext 25150    walter@nhri.org.tw    Principal Investigator: Li-Tzong Chen, MD PHD          Principal Investigator: Nai-Jung Chiang, MD Less <<
NCT00057863 - Completed - -
NCT00177307 - Completed - -
NCT02426450 Hepatocellular Carcinoma Phase 2 Unknown April 2017 China, Guangdong ... More >> Zhen-Wei Peng Guangzhou, Guangdong, China, 510080 Less <<
NCT00040859 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, Iowa ... More >> Siouxland Hematology-Oncology Associates, LLP Sioux City, Iowa, United States, 51101 Mercy Medical Center - Sioux City Sioux City, Iowa, United States, 51104 St. Luke's Regional Medical Center Sioux City, Iowa, United States, 51104 United States, South Dakota Avera Cancer Institute Sioux Falls, South Dakota, United States, 57105 Medical X-Ray Center, PC Sioux Falls, South Dakota, United States, 57105 Sanford Cancer Center at Sanford USD Medical Center Sioux Falls, South Dakota, United States, 57117-5039 Less <<
NCT00398398 - Completed - -
NCT01470742 Gastric Cancer Phase 3 Unknown December 2015 Korea, Republic of ... More >> Samsung medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT03364530 Cholangiocarcinoma Non-resecta... More >>ble Non-metastatic Less << Phase 2 Not yet recruiting January 2023 France ... More >> Uhmontpellier Montpellier, France, 34295 Less <<
NCT01946061 Advanced Gastric Cancer Phase 2 Terminated(This study was stop... More >>ped because of difficulties of supplying the drug.) Less << - Korea, Republic of ... More >> Severnace Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT00996385 Mesothelioma Phase 2 Unknown September 2014 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Principal Investigator: Robert N Taub, MD, PhD          Sub-Investigator: Alain C Borczuk, MD Less <<
NCT00987766 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Liver Cancer Pancreatic Cancer Periampullary Adenocarcinoma Small Intestine Cancer Less << Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00557206 Neoplasms Hea... More >>d and Neck Neoplasms Less << Phase 2 Terminated(Funding was termina... More >>ted) Less << - United States, Minnesota ... More >> VA Medical Center Minneapolis, Minnesota, United States, 55417 Less <<
NCT00227734 Colorectal Cancer Phase 2 Completed - Switzerland ... More >> Kantonspital Aarau Aarau, Switzerland, 5001 Hirslanden Klinik Aarau Aarau, Switzerland, CH-5001 Praxis Dr. Streit Baden, Switzerland, 5404 Kantonsspital Baden Baden, Switzerland, CH-5404 Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Spitaeler Chur AG Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Kantonsspital Liestal, Switzerland, CH-4410 Ospedale Civico Lugano, Switzerland, CH-6900 Praxis Dr. Beretta Rheinfelden, Switzerland, 4310 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 City Hospital Triemli Zurich, Switzerland, 8063 Stadtspital Waid Zurich, Switzerland, CH-8037 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT00744640 Locally Advanced Pancreatic Ca... More >>ncer Metastatic Pancreatic Cancer Less << Phase 1 Phase 2 Completed - Switzerland ... More >> Cantonal Hospital Bruderholz Bruderholz, BL, Switzerland Cantonal Hospital Liestal Liestal, BL, Switzerland St. Clara Hospital Basel, Switzerland University Hospital Basel Basel, Switzerland Cantonal Hospital Lucerne Lucerne, Switzerland City Hospital Triemli Zurich, Switzerland Oncocenter Hirslanden Zurich, Switzerland University Hospital Zurich, Switzerland Less <<
NCT01048320 Advanced Pancreatic Cancer Phase 1 Completed - United Kingdom ... More >> Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00363831 Nasopharyngeal Neoplasms PHASE2 UNKNOWN - Sanofi-aventis, Hong Kong, Hon... More >>g Kong Less <<
NCT01061515 Carcinoma Phase 1 Recruiting May 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Benjamin Tan, M.D.    314-362-9115    btan@wustl.edu    Sub-Investigator: Matthew Mutch, M.D.          Sub-Investigator: Andrea Wang-Gillam, M.D., Ph.D.          Sub-Investigator: Caron Rigden, M.D.          Sub-Investigator: Elisa H Birnbaum, M.D.          Sub-Investigator: Tanya Wildes, M.D.          Sub-Investigator: Rama Suresh, M.D.          Sub-Investigator: Manik Amin, M.D.          Sub-Investigator: Eric Knoche, M.D.          Sub-Investigator: Kian-Huat Lim, M.D.          Sub-Investigator: Daniel Morgensztern, M.D.          Sub-Investigator: Michael Naughton, M.D.          Sub-Investigator: Peter Oppelt, M.D.          Sub-Investigator: Haeseong Park, M.D.          Sub-Investigator: Joel Picus, M.D.          Sub-Investigator: Matthew Powell, M.D.          Sub-Investigator: Lee Ratner, M.D.          Sub-Investigator: Paul Wise, M.D.          Sub-Investigator: Olivia Aranha, M.D., Ph.D. Less <<
NCT02002195 - Unknown May 2016 Italy ... More >> Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore Recruiting Pesaro, PU, Italy, 61122 Principal Investigator: Vincenzo Catalano, MD          Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio San Salvatore, Recruiting Pesaro, Italy, 61122 Contact: Vincenzo Catalano, MD    0039072136 ext 4001    catalano_v@yahoo.it    Principal Investigator: Vincenzo Catalano, MD Less <<
NCT01962376 Gastric Cancer ... More >> Liver Metastasis Less << Phase 4 Unknown April 2015 China, Hebei ... More >> Department of Internal Medicine-Oncology Recruiting Shijiazhuang, Hebei, China, 050011 Contact: Yan Zhang, Doctor    +8613315978336    13315978336@163.com    Principal Investigator: Yan Zhang, Doctor Less <<
NCT03691454 Gastric Adenocarcinoma Phase 2 Phase 3 Active, not recruiting June 30, 2023 China, Beijing ... More >> Beijing Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT02808624 Peripheral Neuropathy ... More >> Cancer Less << Phase 1 Phase 2 Completed - Egypt ... More >> Cairo University Cairo, Kasr el Aini, Egypt Less <<
NCT00004190 Pancreatic Cancer Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Saskatchewan Cancer Agency Regina, Saskatchewan, Canada, S4S 6X3 Less <<
NCT01208103 Ampulla of Vater Adenocarcinom... More >>a Small Intestinal Adenocarcinoma Stage III Ampulla of Vater Cancer AJCC v8 Stage III Small Intestinal Adenocarcinoma AJCC v8 Stage IIIA Ampulla of Vater Cancer AJCC v8 Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 Stage IIIB Ampulla of Vater Cancer AJCC v8 Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 Stage IV Ampulla of Vater Cancer AJCC v8 Stage IV Small Intestinal Adenocarcinoma AJCC v8 Less << Phase 2 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00527930 Breast Neoplasms Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00732745 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Cancer Less << Phase 1 Terminated(Lost funding for Ph... More >>ase II portion of study) Less << - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02216149 Esophagus Cancer ... More >> Stomach Cancer Small Bowel Cancer Colon Cancer Rectum Cancer Less << Phase 2 Terminated(Slow accrual) - Finland ... More >> Helsinki University Central Hospital Helsinki, Finland, 00029 Less <<
NCT03399110 Gastric Cancer Phase 3 Recruiting December 1, 2025 China, Anhui ... More >> Anqing Municipal Hospital Recruiting Anqing, Anhui, China Contact: Yaming Zhang          Contact: Daibin Tang    13865176528       Anhui Provincial Hospital Recruiting Hefei, Anhui, China Contact: Xuhui Zhao    18963789289       Contact: Yifu He    13485691976       First Affiliated Hospital of Wannan Medical College Recruiting Wuhu, Anhui, China Contact: Lianghui Shi    13956159006       China, Guangdong Cancer Center of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Dazhi Xu    86(020)87343737    xudzh@sysucc.org.cn    Contact: Youqing Zhan    86(020)87343910    Zhanyq@sysucc.org.cn    Yuebei People's Hospital Recruiting Guangzhou, Guangdong, China Contact: Tao Tao Zhang    13500206389       Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China Contact: Ligang Xia    13602679058       China, Jiangxi Jiangxi Provincial Cancer Hospital Recruiting Nanchang, Jiangxi, China Contact: Huamin Rao    13879100685       China, Zhejiang Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting Hangzhou, Zhejiang, China Contact: Li Chen    13958092350       Lishui Hospital of Zhejiang University Recruiting Lishui, Zhejiang, China Contact: Hongtao Xu    15024622762       China Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, China Contact: Rupeng Zhang    13920561244 Less <<
NCT01099449 Chemotherapeutic Agent Toxicit... More >>y Colorectal Cancer Neuropathy Neurotoxicity Less << Phase 3 Completed - -
NCT01129310 Gastrointestinal Neoplasm ... More >> Gastric Adenocarcinoma Less << Phase 2 Unknown January 2018 Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT02896803 Pancreatic Neoplasms Phase 2 Recruiting August 2018 Brazil ... More >> Instituto do Câncer do Estado de São Paulo Recruiting São Paulo, Brazil, 01246-000 Contact: Tiago Castria, MD PhD    +5511 3893-2000    tiagobiachi@yahoo.com.br Less <<
NCT00952003 Gastric Cancer ... More >> Unresectable Less << Phase 2 Active, not recruiting April 2018 Austria ... More >> Universitätsklinik Innsbruck Innsbruck, Austria, A-6020 A.ö. Landeskrankenhaus Leoben Leoben, Austria, A-8700 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 Universitätsklinik Wien Vienna, Austria, 1090 Klinikum Wels-Grieskirchen GmbH Wels, Austria, A-4600 BKH Zams Zams, Austria, A-6511 Less <<
NCT00123851 Colorectal Cancer ... More >> Neoplasm Metastasis Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02340403 Neuropathy Pa... More >>inful Less << Not Applicable Unknown December 2016 France ... More >> CHU de Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Principal Investigator: Denis PEZET Less <<
NCT00266097 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Pancreatic Cancer Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00378066 Metastatic Colorectal Cancer Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center Goyang, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Yonsei University Hospital Seoul, Korea, Republic of Bundang Seoul National University Hospital Sungnam, Korea, Republic of Less <<
NCT01262482 Advanced or Metastatic Gastric... More >> or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) Less << Phase 2 Completed - Spain ... More >> Hospital Clinic de Barcelona Barcelona, Spain Hospital Sant Pau Barcelona, Spain H. Josep Trueta Girona, Spain Centro Oncológico M.D. Anderson Spain Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital La Paz Madrid, Spain Hospital Althaia Manresa, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital General de Valencia Valencia, Spain Less <<
NCT03493061 Colo-rectal Cancer ... More >> Liver Metastases Less << Phase 2 Recruiting December 30, 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Li Yuhong, MD    020-87342487    liyh@sysucc.org.cn    Principal Investigator: Li Yuhong, MD Less <<
NCT00507585 Liver Cancer ... More >>Advanced Solid Tumors Less << Phase 1 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00006094 Adenocarcinoma of the Rectum ... More >> Stage II Rectal Cancer Stage III Rectal Cancer Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT01505413 Pancreatic Cancer Phase 2 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi, Korea, Republic of, 420-767 Less <<
NCT00470405 Lymphoma Soli... More >>d Tumor Less << Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT02251977 Colorectal Cancer ... More >> Chemotherapy-induced Neutropenia Less << Phase 3 Recruiting August 2018 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yuhong Li, MD       liyh@sysucc.org.cn    Principal Investigator: Yuhong Li, MD Less <<
NCT00408564 - Completed - -
NCT01389414 Biliary Carcinoma Phase 2 Completed - Italy ... More >> Centro di Riferimento Oncologico INT di Aviano Aviano, Pordenone, Italy, 33081 Ircc Candiolo Candiolo, Torino, Italy, 10060 AOU S.Luigi Gonzaga Orbassano, Torino, Italy, 10043 AOU Ospedali Riuniti di Ancona Ancona, Italy, 60020 UO Oncologia Medica Spedali Civili di Brescia Brescia, Italy, 25123 I.R.S.T. Meldola, Italy, 47014 San Raffaele Scientific Institute Milano, Italy, 20132 Ospedale Niguarda " Ca'-Granda" Milano, Italy, 20162 Istituto Nazionale per lo studio e la cura dei Tumori-Fondazione Pascale Napoli, Italy, 80131 SC Oncologia Medica Ospedale S.Maria della Misericordia Perugia, Italy, 06132 A.O.U S.Giovanni Battista Torino, Italy, 10126 A.O.U S.Maria della Misericordia Udine, Italy, 33100 Less <<
NCT00193128 Esophagus Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Tower Oncology Beverly Hills, California, United States, 90211 United States, Florida Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 United States, Georgia Atlanta Cancer Care Atlanta, Georgia, United States, 30342 Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT00193128 - Completed - -
NCT00275210 Colonic Neoplasms Phase 3 Completed - -
NCT00156975 Colorectal Neoplasms ... More >> Liver Metastases Less << Phase 3 Unknown - Germany ... More >> Universitaetsklinikum Carl Gustav Carus, Medizinische Klinik Dresden, Sachsen, Germany, 011307 Universitaetsklinikum Essen, Klinik für Allgemein- und Transplantationschirurgie OPZ II Essen, Germany, 45122 Klinik für Allgemein- und Gefäßchirurgie , J. W. Goethe Universität Frankfurt Am Main, Germany, 60590 Less <<
NCT00080951 Colorectal Cancer Phase 2 Completed - -
NCT00272051 Metastases Co... More >>lorectal Neoplasms Colorectal Carcinoma Less << Phase 3 Completed - -
NCT00354224 - Terminated(due to low accrual) - -
NCT00448552 Head and Neck Cancer Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Less <<
NCT00816543 Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Less <<
NCT00354224 Gastric Cancer Phase 2 Terminated(due to low accrual) - United States, South Carolina ... More >> Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02086656 Colorectal Cancer Liver Metast... More >>ases Less << Phase 2 Active, not recruiting December 2017 Italy ... More >> Fondazione IRCCS Istituto Nazionale Tumori Milan, Mi, Italy, 20133 Less <<
NCT00483405 Liver Cancer Phase 2 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00408564 Pancreatic Cancer Phase 2 Completed - United States, South Carolina ... More >> Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT00087802 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT00483405 - Completed - -
NCT00961077 Elderly S-1 ... More >> Oxaliplatin First-Line Gastric Cancer Less << Phase 2 Unknown August 2012 -
NCT01196260 Colorectal Cancer Phase 2 Phase 3 Recruiting December 2020 China, Shaanxi ... More >> State Key Laboratory of Cancer Biology Recruiting Xi'an, Shaanxi, China, 710032 Contact: Dake Chu, M.D.    86-29-84774516    chudake@hotmail.com Less <<
NCT02442362 Gastric Cancer Phase 2 Phase 3 Completed - -
NCT00506571 Colorecal Neoplasms ... More >> Secondary Less << Phase 2 Unknown June 2010 Korea, Republic of ... More >> National Cancer Center Korea Recruiting Goyang, Gyeonggi, Korea, Republic of, 410-769 Contact: Kyung Hae Jung, M.D.Ph.D    +82-31-920-1611    khjung@ncc.re.kr    Contact: Hwa Jeong Kim    +82-31-920-1145    ncccoloonco@hanmail.net    Sub-Investigator: Yong Sang Hong, M.D.          Sub-Investigator: Sun Young Kim, M.D.          Sub-Investigator: Hye Suk Han, M.D.          Sub-Investigator: Seung-Yong Jeong, M.D.Ph.D          Sub-Investigator: Hyo Seong Choi, M.D.          Sub-Investigator: Seok-Byung Lim, M.D.          Sub-Investigator: Hee Jin Chang, M.D.Ph.D.          Sub-Investigator: Jun Yong Jeong, M.D. Less <<
NCT01121848 Pancreatic Neoplasms Phase 3 Completed - Canada ... More >> Investigational Site Number 124015 Abbotsford, Canada, V2S0C2 Investigational Site Number 124018 Brampton, Canada, L6V1B4 Investigational Site Number 124014 Burnaby, Canada, V5G2X6 Investigational Site Number 124006 Calgary, Canada, T2N 4N2 Investigational Site Number 124011 Greenfield Park, Canada, J4V2H1 Investigational Site Number 124010 Hamilton, Canada, L8V5C2 Investigational Site Number 124-016 New Glasgow, Canada Investigational Site Number 124013 Oshawa, Canada, L1G2B9 Investigational Site Number 124012 Ottawa, Canada, K1Y0W9 Investigational Site Number 124004 Sherbrooke, Canada, J1H 5N4 Investigational Site Number 124008 Sudbury, Canada, P3E5J1 Investigational Site Number 124007 Surrey, Canada, V3V1Z2 Investigational Site Number 124003 Toronto, Canada, M4N3M5 Investigational Site Number 124002 Toronto, Canada, M5G2M9 Investigational Site Number 124001 Vancouver, Canada, N5Z4E6 Less <<
NCT02620800 Metastatic Pancreas Adenocarci... More >>noma Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Tufts - New England Medical Center Boston, Massachusetts, United States, 02111 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48103 Karmanos Cancer Center Wayne State University Detroit, Michigan, United States, 48201 United States, New York Cornell University Weill Medical College New York, New York, United States, 10065 United States, South Carolina Gibbs Cancer Center and Research Institute Spartanburg, South Carolina, United States, 29303 United States, Washington Virginia Mason Cancer Center Seattle, Washington, United States, 98101 Less <<
NCT00307723 Pancreatic Cancer ... More >> Pancreatic Ductal Adenocarcinoma Less << Phase 1 Phase 2 Terminated(poor accrual) - -
NCT01516944 Gastric Cancer Phase 2 Phase 3 Active, not recruiting December 2018 China, Hebei ... More >> Department of General Surgery Shijiazhuang, Hebei, China, 050011 Less <<
NCT00005836 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT00127595 Carcinoma, Transitional Cell Phase 2 Terminated - France ... More >> Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT01215539 Colorectal Cancer Phase 2 Completed - Greece ... More >> General Hospital of Athens "Hippokratio", 2nd Dept of Internal Medicine Athens, Greece, 11527 Sotiria General Hospital, 3rd Dept of Medicine, Oncology Unit Athens, Greece, 11527 General Peripheral Hospital of Athens "Alexandra" Athens, Greece, 11528 Agii Anargiri Cancer Hospital, Oncology Dept Athens, Greece, 14564 Hygeia Hospital, 2nd Dept of Medical Oncology Athens, Greece, 15123 Hygeia Hospital, 3rd Dept of Medical Oncology Athens, Greece, 15123 Metropolitan Hospital, 1st Dept of Medical Oncology Athens, Greece, 18547 Metropolitan Hospital, 2nd Dept of Medical Oncology Athens, Greece, 18547 Chania General Hospital Chania, Greece, 73100 Ioannina University Hospital, Dept of Medical Oncology Ioannina, Greece, 45110 Rio University Hospital, Dept of Oncology Patras, Greece, 26500 Papageorgiou General Hospital, Dept of Medical Oncology Thessaloniki, Greece, 56429 Less <<
NCT00004126 Lung Cancer Phase 2 Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 Louis A. Weiss Memorial Hospital Chicago, Illinois, United States, 60640 Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States, 62526 Evanston Northwestern Health Care Evanston, Illinois, United States, 60201 Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61602 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States, 46885-5099 Michiana Hematology/Oncology P.C. South Bend, Indiana, United States, 46617 United States, Ohio Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT02504229 Gastric Cancer Phase 2 Unknown - China, Beijing ... More >> Chinese Academy of Medical Sciences Tumor Hospital Recruiting Beijing, Beijing, China Contact: jinwan Wang       lyang69@sina.com    Contact: lin Yang       lyang69@sina.com    Principal Investigator: jinwan Wang          Principal Investigator: lin Yang Less <<
NCT00399750 Colorectal Cancer Phase 2 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT01017809 Ovarian Cancer Not Applicable Withdrawn(NYU 03-67 reached ac... More >>crual prior to this study opening.) Less << December 2013 United States, New York ... More >> NYU Clinical Cancer Center New York, New York, United States, 10016 Less <<
NCT01338792 - Completed - -
NCT01348412 Colorectal Cancer ... More >> Liver Metastases Less << Phase 2 Completed - France ... More >> Centre Georges François Leclerc Dijon, France, 21000 Less <<
NCT00075543 Ovarian Cancer Phase 1 Phase 2 Unknown - France ... More >> Intercommunal Hospital Montfermeil, France, 93370 Hopital Saint Antoine Paris, France, 75012 Hopital Tenon Paris, France, 75970 Polyclinique De Courlancy Reims, France, F-51100 C.H. Senlis Senlis, France, 60309 Less <<
NCT00159458 Recurrent Breast Cancer ... More >> Metastastic Breast Cancer Less << Phase 2 Terminated(Insufficient Accrua... More >>l) Less << - United States, California ... More >> Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Premiere Oncology Santa Monica, California, United States, 90404 Less <<
NCT00006121 Breast Cancer Phase 2 Terminated(low accrual) - Austria ... More >> Kaiser Franz Josef Hospital Vienna (Wien), Austria, A-1100 Belgium Institut Jules Bordet Brussels (Bruxelles), Belgium, 1000 France CHU de la Timone Marseille, France, 13385 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Centre Eugene Marquis Rennes, France, 35064 Germany Universitats-Krankenhaus Eppendorf Hamburg, Germany, D-20246 Israel Rambam Medical Center Haifa, Israel, 31096 Schneider Children's Medical Center of Israel Petah-Tikva, Israel, 49202 Slovenia Institute of Oncology, Ljubljana Ljubljana, Slovenia, Sl-1000 United Kingdom Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT01338792 Hormone-resistant Prostate Can... More >>cer Recurrent Prostate Cancer Less << Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00183820 Testicular Cancer ... More >> Germ Cell Neoplasm Less << Phase 2 Completed - United States, California ... More >> Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00964457 Rectum Cancer Phase 2 Unknown July 2017 Denmark ... More >> Herlev Hospital Active, not recruiting Herlev, Denmark, 2730 Less <<
NCT02607982 Esophageal Cancer ... More >> Concurrent Chemoradiotherapy Oxaliplatin Paclitaxel Less << Phase 2 Completed - -
NCT00398320 Neuroendocrine Tumors Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00398320 - Completed - -
NCT00040820 Colorectal Cancer Not Applicable Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01481701 Ovarian Carcinoma ... More >> Relapse Less << Phase 2 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Less <<
NCT01081262 Borderline Ovarian Mucinous Tu... More >>mor Ovarian Mucinous Cystadenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Stage IA Fallopian Tube Cancer Stage IA Ovarian Cancer Stage IB Fallopian Tube Cancer Stage IB Ovarian Cancer Stage IC Fallopian Tube Cancer Stage IC Ovarian Cancer Stage IIA Fallopian Tube Cancer Stage IIA Ovarian Cancer Stage IIB Fallopian Tube Cancer Stage IIB Ovarian Cancer Stage IIC Fallopian Tube Cancer Stage IIC Ovarian Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Less << Phase 3 Active, not recruiting - -
NCT00244348 Colorectal Cancer ... More >> Metastasis Liver Cancer Less << Phase 1 Phase 2 Withdrawn(Investigator has lef... More >>t institution) Less << - United States, Wisconsin ... More >> Medical College of Wisconsin/ Froedtert Hospital Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00017082 Colorectal Cancer Phase 2 Completed - United States, District of Col... More >>umbia Washington Cancer Institute Washington, District of Columbia, United States, 20010 United States, Florida Comprehensive Cancer Care Specialists of Boca Raton Boca Raton, Florida, United States, 33428 United States, Kentucky Kentuckiana Cancer Institute Louisville, Kentucky, United States, 40202 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 United States, New York Veterans Affairs Medical Center - Albany Albany, New York, United States, 12208 United States, North Carolina Southeastern Medical Oncology Center Goldsboro, North Carolina, United States, 27534 Raleigh Hematology/Oncology Associates - Wake Practice Raleigh, North Carolina, United States, 27609 United States, Pennsylvania Pinnacle Health Hospitals Harrisburg, Pennsylvania, United States, 17105-8700 University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 United States, Tennessee Memphis Cancer Center Memphis, Tennessee, United States, 38119 Less <<
NCT00005837 Cervical Cancer Phase 2 Completed - -
NCT03451370 - Recruiting March 2021 Italy ... More >> Istituto Oncologico Veneto IRCCS Recruiting Padua, Italy, 35128 Contact: Federica Buggin       federica.buggin@iov.veneto.it    Principal Investigator: Sara Lonardi, MD          Sub-Investigator: Fotios Loupakis, MD Less <<
NCT00849550 Unspecified Adult Solid Tumor,... More >> Protocol Specific Cancer Less << Phase 1 Completed - United States, Illinois ... More >> Ingalls Cancer Research Center Harvey, Illinois, United States, 60426 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT00166439 Lymphoma Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00005077 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 Beckman Research Institute, City of Hope Los Angeles, California, United States, 91010 University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, District of Columbia Walter Reed Army Medical Center Washington, District of Columbia, United States, 20307-5000 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT03771846 Intrahepatic Cholangiocarcinom... More >>a Less << Phase 3 Recruiting August 1, 2022 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn    Ming Shi Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    (8620)-87343938    shiming@sysucc.org.cn Less <<
NCT02512380 Gastric Adenocarcinoma Phase 3 Recruiting July 2021 China ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China, 100021 Contact: Xi Wang, M.D Less <<
NCT01429961 Advanced Hepatocellular Carcin... More >>oma Less << Phase 2 Unknown December 2013 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Tae-You Kim    +82-2-2072-3943 Less <<
NCT01769508 - Terminated(Study closed due to... More >> slow accrual.) Less << - -
NCT01769508 HER2 Positive Esophagogastric ... More >>Cancer Less << Phase 2 Terminated(Study closed due to... More >> slow accrual.) Less << - United States, Florida ... More >> Florida Cancer Specialists - South Fort Myers, Florida, United States, 33916 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists-North St. Petersburg, Florida, United States, 33705 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT00001835 Kidney Disease|Neoplasm|Neopla... More >>sm Metastasis Less << PHASE1 COMPLETED 2025-12-01 National Cancer Institute (NCI... More >>), Bethesda, Maryland, 20892, United States Less <<
NCT00506207 Colorectal Neoplasm ... More >> Gastric Neoplasm Secondary Less << Phase 1 Unknown December 2009 Korea, Republic of ... More >> National Cancer Center Korea Goyang, Gyeonggi, Korea, Republic of, 410-769 Less <<
NCT00005035 Head and Neck Cancer Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Louis A. Weiss Memorial Hospital Chicago, Illinois, United States, 60640 Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States, 62526 Evanston Northwestern Health Care Evanston, Illinois, United States, 60201 Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61602 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States, 46885-5099 Saint Joseph's Regional Medical Center South Bend, Indiana, United States, 46634-1935 United States, Ohio Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 Less <<
NCT02387138 Digestive Cancer Phase 1 Recruiting December 2020 France ... More >> Institut du Cancer de Montpellier - Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Emmanuelle SAMALIN, MD    +33467613102    emmanuelle.samalin@icm.unicancer.fr    Principal Investigator: Emmanuelle SAMALIN, MD Less <<
NCT00353457 Rectal Cancer Phase 2 Completed - -
NCT01016639 Stomach Cancer ... More >> Gall Bladder Cancer Bile Ductus Cancer Pancreas Cancer Colorectal Cancer Less << Phase 1 Phase 2 Completed - Sweden ... More >> Centralsjukhuset, Dept of Oncology Karlstad, Sweden University Hospital Lund Lund, Sweden University Hospital Malmö, Dept of Oncology Malmö, Sweden Karolinska University Hospital Stockholm, Sweden Akademiska Sjukhuset Uppsala, Sweden Less <<
NCT00005844 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-2794 Less <<
NCT02436044 - - May 2020 China, Guangdong ... More >> Minimally Invasive Interventional Division, Medical Imaging Center, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, doctor    +86 020 87343272    zhaoming@sysucc.org.cn Less <<
NCT01748773 Gastric Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 2 Completed - Turkey ... More >> Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology Adana, Turkey, 01250 Ankara Numune Hospital; Onkoloji Ankara, Turkey, 06100 Ankara Oncology Hospital; Oncology Ankara, Turkey, 06200 Baskent University Medical Faculty; Internal Medicine Ankara, Turkey, 06490 Gaziantep University Medical Faculty, Medical Oncology Department Gaziantep, Turkey, 27310 Marmara Uni Faculty of Medicine; Medical Oncology Istanbul, Turkey, 34890 Ege Uni Medical Faculty; Oncology Dept Izmir, Turkey, 35100 Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases Konya, Turkey, 42080 Hacettepe Uni Medical Faculty Hospital; Oncology Dept Sıhhiye, ANKARA, Turkey, 06100 Less <<
NCT00853684 Advanced Colorectal Cancer Phase 2 Unknown March 2011 China, Shanghai ... More >> Department of Oncology, Ruijin Hospital, Medical School of Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200035 Contact: Daoyuan Wang, MD    +86-13601628114    ghealth2008@gmail.com    Principal Investigator: Weiguo Cao, MD Less <<
NCT03750786 Colo-rectal Cancer Phase 3 Not yet recruiting January 31, 2023 -
NCT01467921 Curatively-resected, Node-posi... More >>tive Esophageal Squamous Cell Carcinoma Less << Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Mi yeon kwon, RN    +82-2-3410-1248    miyeon.kwon@samsung.com Less <<
NCT00634751 Pancreatic Neoplasms ... More >> Bile Duct Neoplasms Less << Phase 1 Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00634751 - Completed - -
NCT00985556 Gastric Cancer Phase 2 Unknown - Korea, Republic of ... More >> Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 120-752 Contact: Hyun C. Chung, MD, PhD    82-2-2019-3297    unchung8@yuhs.ac Less <<
NCT00623805 - Completed - -
NCT00941499 Advanced Cancers Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00623805 Colorectal Cancer Phase 3 Completed - Turkey ... More >> Ankara, Turkey, 06100 Ankara, Turkey, 06500 Ankara, Turkey, 06590 Gaziantep, Turkey, 27310 Istanbul, Turkey, 34300 Istanbul, Turkey, 34390 Istanbul, Turkey, 34890 Izmir, Turkey, 35100 Izmir, Turkey, 35340 S?hhiye, ANKARA, Turkey, 06100 Less <<
NCT00238849 Previously Treated Metastatic ... More >>Non-Small Cell Lung Cancer Less << PHASE2 UNKNOWN - Integrated Community Oncology ... More >>Network, Jacksonville, Florida, 32256, United States|Integrated Community Oncology Network, Orange Park, Florida, 32073, United States Less <<
NCT00006062 Liver Disease Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT02415829 Colorectal Cancer Phase 2 Unknown - China, Shanghai ... More >> Department of Colorectal Surgery Fudan University Shanghai Caner Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Ye Xu, M.D    +86-21-6417-5590    xu_shirley021@163.com Less <<
NCT00517829 Gastric Cancer Adenocarcinoma ... More >>Metastatic Less << Phase 2 Completed - -
NCT00353145 Unknown Primary Neoplasms Phase 2 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00268151 Carcinoma, Non-Small Cell Lung Phase 1 Terminated(Study was terminate... More >>d due to lack of funding.) Less << - United States, Kentucky ... More >> James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 Less <<
NCT00061815 Colorectal Cancer Phase 3 Completed - -
NCT00660725 Advanced Incurable Solid Malig... More >>nancy Less << Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute / Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00472849 - Completed - -
NCT00071929 Endometrial Cancer Phase 2 Completed - -
NCT00517829 - Completed - -
NCT03111732 Biliary Tract Neoplasms ... More >> Cholangiocarcinoma Bile Duct Cancer Liver Cancer Gallbladder Cancer Less << Phase 2 Recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00290615 Colorectal Cancer Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00290615 - Completed - -
NCT00316914 Colorectal Cancer ... More >> Neurotoxicity Less << Phase 3 Completed - United States, Georgia ... More >> MBCCOP - Medical College of Georgia Cancer Center Augusta, Georgia, United States, 30912 United States, Iowa Mercy Capitol Hospital Des Moines, Iowa, United States, 50307 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309 John Stoddard Cancer Center at Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates at John Stoddard Cancer Center Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates at Mercy Cancer Center Des Moines, Iowa, United States, 50314 Mercy Cancer Center at Mercy Medical Center - Des Moines Des Moines, Iowa, United States, 50314 John Stoddard Cancer Center at Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316 United States, North Dakota Bismarck Cancer Center Bismarck, North Dakota, United States, 58501 Medcenter One Hospital Cancer Care Center Bismarck, North Dakota, United States, 58501 Mid Dakota Clinic, PC Bismarck, North Dakota, United States, 58501 United States, South Dakota Avera Cancer Institute Sioux Falls, South Dakota, United States, 57105 Medical X-Ray Center, PC Sioux Falls, South Dakota, United States, 57105 Sanford Cancer Center at Sanford USD Medical Center Sioux Falls, South Dakota, United States, 57117-5039 Less <<
NCT00472849 Richter's Transformation ... More >> Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00636883 Pancreatic Cancer Phase 2 Terminated(slow accrual rate) - Saudi Arabia ... More >> National Guard Health Affairs Riyadh, Saudi Arabia, 9661 Less <<
NCT00316914 - Completed - -
NCT01471132 Gastric Cancer ... More >> Metastases to Perineum Less << Phase 2 Unknown September 2015 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Less <<
NCT01497041 Carcinoma, Non-Small-Cell Lung... More >> Carcinoma, Squamous Carcinoma, Large Cell Less << Phase 2 Unknown December 2013 Korea, Republic of ... More >> Soonchunhyang University Cheonan Hospital Recruiting Cheonan, Korea, Republic of Contact: Sang Byung Bae, M.D.    +82-41-570-3667    baesan@schmc.ac.kr    Principal Investigator: Sang Byung Bae, M.D.          Sub-Investigator: Han Jo Kim, M.D.          Sub-Investigator: Kyu Taek Lee, M.D.          Chungbuk National University Hospital Recruiting Cheongju, Korea, Republic of Contact: Ki Hyeong Lee    +82-43-269-6015    kihlee@chungbuk.ac.kr    Sub-Investigator: Hye Suk Han          Principal Investigator: Ki Hyeong Lee          Chungnam National University Hospital Recruiting Daejeon, Korea, Republic of Contact: Hwan Jung Yun    +82-42-280-7157    hjyun@cnuh.co.kr    Principal Investigator: Hwan Jung Yun          Sub-Investigator: Sam Yong Kim          Sub-Investigator: Hyo Jin Lee          The Catholic University of Korea Daejeon ST. Mary's Hospital Recruiting Daejeon, Korea, Republic of Contact: Suk Young Park    +82-42-220-9832    sypark1011@hotmail.com    Principal Investigator: Suk Young Park          Sub-Investigator: Young Joon Yang          Sub-Investigator: Ji Chan Park          Chonbuk National University Hospital Recruiting Jeonju, Korea, Republic of Contact: Eun-Kee Song    +82-63-254-1609    eksong@jbnu.ac.kr    Principal Investigator: Eun-Kee Song          Sub-Investigator: Chang-Yeol Yim          Sub-Investigator: Na-Ri Lee Less <<
NCT00125034 Neoplasm Metastasis ... More >> Colorectal Cancer Less << Phase 2 Completed - -
NCT03468231 Hepatocellular Carcinoma Phase 3 Recruiting March 9, 2020 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    86-2087343115    shiming@mail.sysu.edu.cn    Principal Investigator: Ming Shi, MD          The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People 's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT00436800 Nasopharyngeal Neoplasms Phase 2 Completed - Hong Kong ... More >> Sanofi-Aventis Administrative Office Hong Kong, Hong Kong Less <<
NCT00125034 - Completed - -
NCT00667420 Esophageal Adenocarcinoma ... More >> Gastric Adenocarcinoma Less << Phase 1 Phase 2 Terminated(Closed due to slow ... More >>accrual) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 DFCI Boston, Massachusetts, United States, 02115 Less <<
NCT00667420 - Terminated(Closed due to slow ... More >>accrual) Less << - -
NCT02129322 Hepatocellular Carcinoma Phase 2 Not yet recruiting December 2019 China ... More >> First affiliated hospital, Zhejiang University Not yet recruiting Hangzhou, China Contact: Weijiafang fang          Principal Investigator: Weijia fang, MD Less <<
NCT02506842 Stage ⅠA Pancreatic Cancer ... More >> Stage ⅠB Pancreatic Cancer Stage ⅡA Pancreatic Cancer Stage ⅡB Pancreatic Cancer Less << Phase 3 Recruiting June 2019 China, Guangdong ... More >> Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center,Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Sheng-Ping Li, M.D PH.D    020-87343088    lishengp@mail.sysu.edu.cn    Principal Investigator: Sheng-Ping Li, M.D PH.D          China, Shanghai Department of Biliary Pancreatic Surgery, Shanghai Changzheng Hospital, The Second Military Medical University Recruiting Shanghai, Shanghai, China, 200003 Contact: Cheng-Hao Shao, M.D PH.D    021-81886999    schhao88@gmail.com    Principal Investigator: Cheng-Hao Shao, M.D PH.D          Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Xian-Jun Yu, M.D., Ph.D.    +86-21-6417-5590    yuxianjun@fudanpci.org    Contact: Wen-Quan Wang, M.D., Ph.D.    +86-21-6417-5590    wangwenquan@fudanpci.org    Principal Investigator: Xianjun Yu, M.D., Ph.D.          Department of Biliary Pancreatic Surgery, Huadong Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200040 Contact: Wei Wang, M.D PH.D    021-62483180    wangw2003cn@hotmail.com    Principal Investigator: Wei Wang, M.D PH.D          Department of Pancreatic Surgery, Huashan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200040 Contact: De-Liang Fu, M.D PH.D    021-52889999    surgeonfu@163.com    Principal Investigator: De-Liang Fu, M.D PH.D          China, Tianjin Department of Pancreatic Surgery, Cancer Institute & Hospital, Tianjin Medical University Recruiting Tianjin, Tianjin, China, 300060 Contact: Ji-Hui Hao, M.D PH.D    022-23340123    haojihui@tjmuch.com    Principal Investigator: Ji-Hui Hao, M.D PH.D          China, Zhejiang Department of General Surgery,Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310016 Contact: Yi-Ping Mou, M.D PH.D    0571-86090073    mouyp@srrsh.com    Principal Investigator: Yi-Ping Mou, M.D PH.D Less <<
NCT00251524 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Ohio ... More >> Veeda Oncology Columbus, Ohio, United States, 43215 Less <<
NCT00456599 - Completed - -
NCT02560974 Gastric Cancer Phase 3 Completed - China ... More >> Beijing, China, 100044 Beijing, China, 100142 Fujian, China, 350001 Guangzhou, China, 510060 Guangzhou, China, 510080 Shanghai, China, 200025 Shanghai, China, 200032 Shenyang, China, 110001 Tianjin, China, 300060 Korea, Republic of Bundang City, Korea, Republic of, 463-802 Busan, Korea, Republic of, 49267 Daegu, Korea, Republic of, 700-712 Daegu, Korea, Republic of, 702-210 Daegu, Korea, Republic of Gyeonggi-do, Korea, Republic of, 10408 Gyeonggi-do, Korea, Republic of, 443-380 Incheon, Korea, Republic of, 405-760 Jeollabuk-do, Korea, Republic of, 561-712 Jeollanam-do, Korea, Republic of, 58128 Seoul, Korea, Republic of, 03080 Seoul, Korea, Republic of, 120-752 Seoul, Korea, Republic of, 130-872 Seoul, Korea, Republic of, 134-791 Seoul, Korea, Republic of, 135-720 Seoul, Korea, Republic of, 139-709 Seoul, Korea, Republic of, 140-743 Seoul, Korea, Republic of, 152-703 Seoul, Korea, Republic of, 158-710 Seoul, Korea, Republic of Suwon, Korea, Republic of Taiwan Changhua, Taiwan, 500 Tainan, Taiwan, 704 Taipei, Taiwan, 00112 Taipei, Taiwan, 104 Taipei, Taiwan Taoyuan, Taiwan, 333 Less <<
NCT00349076 Rectal Neoplasms Phase 3 Completed - -
NCT00305188 Metastases Co... More >>lorectal Neoplasms Colorectal Carcinoma Less << Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Argentina Sanofi-Aventis Administrative Office Buenos Aires, Argentina Australia Sanofi-Aventis Administrative Office Macquarie Park, Australia Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Canada Sanofi-Aventis Administrative Office Laval, Canada Chile Sanofi-Aventis Administrative Office Santiago, Chile Germany Sanofi-Aventis Administrative Office Berlin, Germany Hungary Sanofi-Aventis Administrative Office Budapest, Hungary Italy Sanofi-Aventis Administrative Office Milano, Italy Poland Sanofi-Aventis Administrative Office Warszawa, Poland Portugal Sanofi-Aventis Administrative Office Porto Salvo, Portugal Spain Sanofi-Aventis Administrative Office Barcelona, Spain United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom Less <<
NCT00536874 - Completed - -
NCT00536874 Pancreatic Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065-0009 Less <<
NCT00456599 Pancreatic Cancer Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21231 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01485744 Pancreatic Cancer Phase 1 Active, not recruiting March 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02214 Less <<
NCT01300156 Hodgkin's Lymphoma Phase 2 Unknown December 2013 Korea, Republic of ... More >> National Cancer Center, Korea Recruiting Goyang, Korea, Republic of Contact: Hyewon Lee, MD    +82-31-920-1765    hwlee@ncc.re.kr    Principal Investigator: Hyeon Seok Eom, MD, PhD Less <<
NCT00003427 Anal Cancer C... More >>olorectal Cancer Esophageal Cancer Extrahepatic Bile Duct Cancer Gallbladder Cancer Gastric Cancer Gastrointestinal Carcinoid Tumor Liver Cancer Pancreatic Cancer Small Intestine Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00101075 Head and Neck Cancer Phase 2 Terminated(Slow Accrual) - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00012389 Colorectal Cancer Phase 3 Completed - -
NCT00096278 - Completed - -
NCT02870153 Colorectal Neoplasm Phase 2 Recruiting June 2019 China, Jiangsu ... More >> The First People's Hospital of Changzhou Recruiting Changzhou, Jiangsu, China, 213003 Contact: Liangrong Shi, M.D.    86-519-68871122    shiliangr@126.com Less <<
NCT00096278 Adenocarcinoma of the Colon ... More >> Stage IIA Colon Cancer Stage IIB Colon Cancer Stage IIC Colon Cancer Stage IIIA Colon Cancer Stage IIIB Colon Cancer Stage IIIC Colon Cancer Less << Phase 3 Completed - United States, Pennsylvania ... More >> National Surgical Adjuvant Breast and Bowel Project Pittsburgh, Pennsylvania, United States, 15212-5234 Less <<
NCT00006391 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 1 Completed - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT01880632 Gastric Adenocarcinoma Phase 2 Unknown August 2018 China, Shanghai ... More >> Zhongshan Hospital Affiliated to Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Tianshu Liu, doctor       liu.tianshu@zs-hospital.sh.cn    Sub-Investigator: Yiyi yu, Master Less <<
NCT03722498 Hepatocellular Carcinoma Phase 2 Recruiting November 1, 2018 China, Guangdong ... More >> Ming Shi Recruiting Guangzhou, Guangdong, China Contact: Ming Shi, MD    (8620)-87343938    shiming@sysu.edu.cn    Principal Investigator: Ming Shi, MD Less <<
NCT00977717 - Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135 710 Less <<
NCT01531712 Pancreatic Cancer Phase 2 Terminated(Due to a low recrui... More >>tment rate since start of recruitment period.) Less << - Spain ... More >> Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain, 08907 Less <<
NCT02821559 Metastatic Colorectal Cancer Phase 2 Completed - France ... More >> CHRU de Besançon Besançon, France Less <<
NCT00138177 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00345696 Metastatic Colorectal Cancer Phase 2 Completed - Spain ... More >> Hospital 12 de Octubre Madrid, Spain, 28041 Less <<
NCT01532804 Metastatic Colorectal Cancer Phase 2 Active, not recruiting December 2018 France ... More >> Val d'Aurelle Cancer Institute Montpellier, France, 34298 Less <<
NCT00868816 Colorectal Cancer Phase 4 Completed - China, Shanghai ... More >> Zhongshan Hospital, Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT00004173 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Unknown - United States, Ohio ... More >> Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 Less <<
NCT02288195 Rectal Neoplasms Phase 3 Recruiting June 2024 China, Guangdong ... More >> Sun Yat-sen University, Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Junzhong Lin, MD    000862087343124    linjzh@sysucc.org.cn    Principal Investigator: Peirong Ding, MD, Ph D          Sub-Investigator: Junzhong Lin, MD Less <<
NCT00004243 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 Beckman Research Institute, City of Hope Los Angeles, California, United States, 91010 University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT01851941 Advanced Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00263055 Colonic Neoplasms Phase 4 Completed - China ... More >> Sanofi-Aventis Beijing, China Hong Kong Sanofi-Aventis Hong Kong, Hong Kong Korea, Republic of Sanofi-aventis Seoul, Korea, Republic of Taiwan Sanofi-Aventis Taipei, Taiwan Thailand Sanofi-Aventis Bangkok, Thailand Less <<
NCT00004187 Colorectal Cancer Phase 1 Phase 2 Completed - Switzerland ... More >> Inselspital, Bern Bern, Switzerland, CH-3010 Less <<
NCT01775449 Neuropathy Di... More >>gestive Cancer System Less << Phase 3 Completed - France ... More >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63003 Less <<
NCT02109341 Metastatic Pancreatic Cancer Phase 1 Phase 2 Completed - Italy ... More >> Ospedale Sacro cuore di Gesù - FATEBENEFRATELLI Benevento, BN, Italy, 82100 IRCCS Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo, FG, Italy, 71013 SC Oncologia Medica 1 Florence, FI, Italy, 50134 Azienda Ospedaliera Istituti Ospedalieri di Cremona Cremona, Italy, 26100 Ospedale S. Chiara - Azienda Ospedaliero-Universitaria Pisana Pisa, Italy, 56126 Arcispedale Santa Maria Nuova Reggio Emilia, Italy, 42100 Regina Elena National Cancer Institute Rome, Italy, 00144 Ospedale Borgo Roma Verona, Italy, 37134 Less <<
NCT00074321 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00006117 Pancreatic Cancer Phase 2 Unknown - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 France Centre Paul Papin Angers, France, 49036 Centre Hospitalier Victor Dupouy Argenteuil, France, 95107 Hopital Beaujon Clichy, France, 92118 Hopital Drevon Dijon, France, 21000 Clinique Saint Jean Lyon, France, 69008 American Hospital of Paris Neuilly Sur Seine, France, F-92202 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Polyclinique De Courlancy Reims, France, F-51100 Less <<
NCT00784446 Stage IV Colorectal Cancer Phase 1 Phase 2 Completed - Germany ... More >> Medical Clinic for Haematology and Oncology Cologne, NRW, Germany, 50937 Städische Kliniken Esslingen Esslingen, Germany, 73730 Klinikum St. Georg gGmbH Leipzig, Germany, 04129 Johannes-Gutenberg-Universität Mainz Mainz, Germany, 55131 Klinikum Mannheim Mannheim, Germany, 68167 Prosper-Hospital Recklinghausen, Germany, 45659 Leopoldina Krankenhaus Schweinfurt, Germany, 97422 Universitätsklinik Ulm Ulm, Germany, 89081 Less <<
NCT00005839 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 Beckman Research Institute, City of Hope Los Angeles, California, United States, 91010 University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00721916 Colorectal Cancer Phase 2 Completed - Japan ... More >> Shizuoka Cancer Center Shimonagakubo Nagaizumi-cho Sunto-gun, Shizuoka, Japan, 411-8777 Less <<
NCT00058474 Colorectal Cancer Phase 3 Unknown May 2016 -
NCT00174616 Rectal Neoplasms Phase 2 Completed - Belgium ... More >> Sanofi-Aventis Administrative Office Diegem, Belgium France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Frankfurt, Germany Italy Sanofi-Aventis Administrative Office Milan, Italy Netherlands Sanofi-Aventis Administrative Office Pe Gouda, Netherlands Spain Sanofi-Aventis Administrative Office Barcelona, Spain United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom Less <<
NCT00578071 Cancer of the Esophagus Phase 1 Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00403988 Breast Neoplasms Phase 2 Terminated(The results of a sa... More >>me study design have shown low response with important side effects. Accordingly & ethicly, the study has been stopped.) Less << - Lebanon ... More >> AmericanUBMC Beirut, Lebanon Less <<
NCT00019773 Carcinoma of the Appendix ... More >> Colorectal Cancer Small Intestine Cancer Less << Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Less <<
NCT01434147 Rectal Cancer Phase 2 Completed - Austria ... More >> Hospital BHB St. Veit/Glan, Surgery St. Veit a. d. Glan, Carinthia, Austria, 9330 Medical University Graz, Oncology Graz, Styria, Austria, 8036 Medical University Innsbruck, Internal Medicine Innsbruck, Tyrol, Austria, 6020 Klinikum Wels-Grieskirchen Wels, Upper Austria, Austria, 4600 State Hospital Feldkirch, Radiotherapy Feldkirch, Vorarlberg, Austria, 6807 Paracelsus Medical University Salzburg - Oncology Salzburg, Austria, 5020 Medical University of Vienna, General Hospital Vienna, Austria, 1090 Less <<
NCT00058149 Pancreatic Cancer Phase 3 Completed - -
NCT00118105 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Withdrawn(Budget Constraints) - -
NCT01359397 Metastatic Gastric Cancer ... More >> Adenocarcinoma of the Gastro-oesophageal Junction Less << Phase 2 Unknown - Netherlands ... More >> Netherlands Cancer Institute Amsterdam, Netherlands Less <<
NCT03127124 Pancreatic Adenocarcinoma Meta... More >>static Less << Phase 1 Phase 2 Recruiting December 2018 United States, California ... More >> Chan Soon-Shiong Institutes for Medicine Recruiting El Segundo, California, United States, 90245 Contact: Nant Pharma Clinical Review Team    800-988-6083    clinical.trials@NantKwest.com Less <<
NCT00578071 - Completed - -
NCT02076594 Locally Advanced Unresectable ... More >>Gastric Cancer Metastatic Gastric Cancer Less << Phase 3 Recruiting December 2019 Italy ... More >> ASUR Zona territoriale 6 di Fabriano (AN) Withdrawn Fabriano, AN, Italy, 60044 Istituto Tumori Recruiting Bari, BA, Italy, 70124 Contact: Nicola Silvestris, MD    +39 080 5555419    n.silvestris@oncologico.bari.it    Principal Investigator: Nicola Silvestris, MD          Azienda Ospedaliera Papa Giovanni XXIII Recruiting Bergamo, BG, Italy, 24127 Contact: Roberto Labianca, MD    +39 035 2673691    rlabianca@hpg23.it    Principal Investigator: Roberto Labianca, MD          A.O. Treviglio-Caravaggio Recruiting Treviglio (bg), BG, Italy, 24047 Contact: Sandro Barni, MD    +39 036 3424 420       Contact       sandro.barni@ospedale.treviglio.bg.it    Principal Investigator: Sandro Barni, MD          Ospedale degli Infermi Withdrawn Biella, BI, Italy, 13900 ASDAA Bolzano Withdrawn Bolzano, BZ, Italy, 39100 Azienda Ospedaliera Universitaria di Cagliari Recruiting Monserrato, CA, Italy, 09042 Contact: Mario Scartozzi, MD    +39 0715963834    mscartozzi@medicina.unica.it    Azienda Ospedaliera Sant'Anna Recruiting Como, CO, Italy, 22020 Contact: Monica Giordano, MD          Principal Investigator: Monica Giordano, MD          Ospedale di Circolo A. Manzoni Recruiting Lecco, LC, Italy, 23900 Contact: Stefania Dell'Oro, MD    +39 0341 489155       Principal Investigator: Stefania Dell'Oro, MD          Azienda Ospedaliera Ospedale Maggiore Withdrawn Lodi, LO, Italy, 26900 Ospedale Santa Maria Goretti Latina Recruiting Latina, LT, Italy, 04100 Contact: Enzo Veltri, MD    07736553840    e.veltri@ausl.latina.it    Principal Investigator: Enzo Veltri, MD          A.O. Ospedale Versilia Recruiting Camaiore, LU, Italy, 55041 Contact: Domenico Amoroso, MD          Principal Investigator: Domenico Amoroso, MD          Azienda Ospedaliera San Gerardo di Monza, Withdrawn Monza, MB, Italy, 20900 P.O. "San Vincenzo" Taormina Recruiting Taormina, ME, Italy, 98039 Contact: Francesco Ferraù, MD    +39 0942 579322       Principal Investigator: Francesco Ferraù, MD          Osped. Di Circolo Serbelloni-Gorgonzola Recruiting Gorgonzola, MI, Italy, 20064 Contact: Maria C. Zavettieri, MD    +39 02 95707 317       Principal Investigator: Maria C. Zavettieri, MD          Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Withdrawn Milano, MI, Italy, 20122 Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milano, MI, Italy, 20133 Contact: Maria Di Bartolomeo, MD    +39 02 23902882    maria.dibartolomeo@istitutotumori.mi.it    Principal Investigator: Maria Di Bartolomeo, MD          IRCCS Istituto Europeo di Oncologia (IEO) Recruiting Milano, MI, Italy, 20141 Contact: Nicola Fazio, MD          Principal Investigator: Nicola Fazio, MD          Azienda Ospedaliera San Paolo Recruiting Milano, MI, Italy, 20142 Contact: Daris Ferrari, MD          Principal Investigator: Daris Ferrari, MD          Ospedale L. Sacco Recruiting Milano, MI, Italy, 20157 Contact: Sabrina Ferrario, MD          Principal Investigator: Sabrina Ferrario, MD          Ospedale di Carpi Recruiting Carpi, MO, Italy, 41012 Contact: Fabrizio Artioli, MD          Principal Investigator: Fabrizio Artioli, MD          AUSL di Piacenza Recruiting Piacenza, PC, Italy, 29100 Contact: Luigi Cavanna, MD    +39 0523 302697    l.cavanna@ausl.pc.it    Principal Investigator: Luigi Cavanna, MD          ASL Pescara Ospedale San Massimo Withdrawn Penne, PE, Italy, 65017 A.O. Ospedali Riuniti Marche Nord - Presidio S. Salvatore Muraglia Recruiting Pesaro, PE, Italy, 61122 Contact: Vincenzo Catalano, MD          Principal Investigator: Vincenzo Catalano, MD          A. O. di Pescara - Ospedale Civile Spirito Santo Recruiting Pescara, PE, Italy, 65124 Contact: Donato Natale, MD          Principal Investigator: Donato Natale, MD          Ospedale Misericordia e Dolce Recruiting Prato, PO, Italy, 59100 Contact: Andrea Ciarlo, MD          Principal Investigator: Andrea Ciarlo, MD          Azienda Ospedaliera Ospedale San Carlo Recruiting Potenza, PZ, Italy, 85100 Contact: Domenico Bilancia, MD          Principal Investigator: Domenico Bilancia, MD          Ospedale di S. Maria Nuova Recruiting Reggio Emilia, RE, Italy, 42100 Contact: Ermanno Rondini, MD          Principal Investigator: Ermanno Rondini, MD          Azienda Policlinico Umberto I Withdrawn Roma, RM, Italy, 00161 Ospedale Fatebenefratelli Recruiting Roma, RM, Italy, 00186 Contact: Domenico Cristiano Corsi, MD    +39 06 6837249       Principal Investigator: Domenico Cristiano Corsi, MD          Azienda Ospedaliera Valtellina e Valchiavenna - Ospedale Civile Withdrawn Sondrio, SO, Italy, 23100 Azienda Ospedaliera Città della Salute e della Scienza di Torino Withdrawn Torino, TO, Italy, 10126 Ospedale Generale Provinciale di Saronno Withdrawn Saronno, VA, Italy, 21047 Ospedale di Circolo e Fondazione Macchi di Varese Recruiting Varese, VA, Italy, 21100 Contact: Graziella Pinotti, MD          Principal Investigator: Graziella Pinotti, MD          Ospedale Sacro Cuore Don Calabria di Negrar Recruiting Negrar, VR, Italy, 37024 Contact: Massimo Cirillo, MD    +39 0456013472       Principal Investigator: Massimo Cirillo, MD          IRCCS Istituto Nazionale Tumori Fondazione Pascale Recruiting Napoli, Italy, 80131 Contact: Rosario Vincenzo , Iaffaioli          Principal Investigator: Rosario Vincenzo Iaffaioli, MD          Ospedale Policlinico G.B. Rossi (Borgo Roma) Di Verona Withdrawn Verona, Italy, 37134 Less <<
NCT01042028 Pancreatic Cancer Phase 1 Phase 2 Terminated(Emergence of FOLFIR... More >>INOX and slow recruitment) Less << - Denmark ... More >> Department of Oncology, Aarhus Hospital Aarhus, Denmark, 8000 Department of Oncology, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT01313377 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Liver Cancer Less << Phase 3 Completed - France ... More >> CHU - Hôpital Nord Amiens, France, 80054 Centre Paul Papin Angers, France, 49933 Institut Sainte Catherine Avignon, France, 84082 Centre hospitalier de la Côte Basque Bayonne, France, 64109 Hôpital Jean Minjoz Besancon, France, 25030 Hôpital Avicenne Bobigny, France, 93009 CHU Brest - Hôpital Morvan Brest, France, 29200 CHU Côte de Nacre Caen, France, 14000 CHU Estaing Clermont Ferrand, France, 63003 Hôpital Beaujon Clichy, France, 92118 Hôpital Henri Mondor Créteil, France, 94000 Hôpital Bocage Dijon, France, 21079 CHD Vendée La Roche Sur Yon, France, 85925 Centre Léon Bérard Lyon, France, 69008 Hôpital Privé Jean Mermoz Lyon, France, 69373 Hôpital Edouard Herriot Lyon, France, 69437 Hôpital Saint Joseph Marseille, France, 13008 Hôpital Nord Marseille, France, 13015 Institut Paoli Calmettes Marseille, France, 13273 CHU Timone Adulte Marseille, France, 13385 Centre Hospitalier Saint Eloi Montpellier, France, 34295 Centre René Gauducheau Nantes, France, 44805 Hôpital La Source Orléans, France, 45067 Hôpital Saint Antoine Paris, France, 75012 Institut Mutualiste Montsouris Paris, France, 75014 CHU Saint Louis Paris, France, 75475 Hôpital de la Pitié Salpétrière Paris, France, 75651 Hôpital Européen Georges Pompidou Paris, France, 75908 CHU de Poitiers Poitiers, France, 86021 Centre Eugene Marquis Rennes, France, 35042 CHU de Rouen - Hôpital Ch. Nicolle Rouen, France, 76031 CHU Sainte-Etienne - Hopital Nord Sainte-Etienne, France, 42255 Centre Paul Strauss Strasbourg, France, 67065 Hôpital de Hautepierre / Hôpital Civil Strasbourg, France, 67098 Hôpital Trousseau Tours, France, 37044 CHU Brabois Vandouevre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT00217737 Colon Mucinous Adenocarcinoma ... More >> Colon Signet Ring Cell Adenocarcinoma Lynch Syndrome Stage IIA Colon Cancer AJCC v7 Stage IIB Colon Cancer AJCC v7 Stage IIC Colon Cancer AJCC v7 Less << Phase 3 Active, not recruiting - -
NCT00544063 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Unknown - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Marc Ychou, MD, PhD    33-4-6761-3066    mychou@valdorel.fnclcc.fr Less <<
NCT00004220 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States, 91010-3000 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0804 University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00448838 Pancreatic Cancer Not Applicable Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT02241499 Adenocarcinoma of the Esophagu... More >>s or Esophagogastric Junction Less << Phase 2 Recruiting December 2018 Sweden ... More >> Lund University Hospital, Department of Oncology Recruiting Lund, Sweden, 221 85 Contact: David Borg, MD    +46 46 17 75 20    david.borg@skane.se    Contact: Jan Sundberg, RN    +46 46 17 70 34    jan.sundberg@skane.se    Principal Investigator: David Borg, MD Less <<
NCT03330964 Neurotoxicity ... More >> Gastrointestinal Neoplasms Less << Not Applicable Recruiting May 2018 China, Liaoning ... More >> Oncology Department，The First Affiliated Hospital of Dalian Medical University Recruiting Dalian, Liaoning, China, 116011 Contact: Xiaonan Cui, MD,PhD    +8618098876725    cxn23@sina.com    Contact: Weiwei Zhang, MM    +8613234062398    1650579799@qq.com    The First Affiliated Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116011 Contact: Xiaonan Cu, MD,PhD    +8618098876725    cxn23@sina.com    Contact: Weiwei Zhang, MM    +8613234062398    1650579799@qq.com Less <<
NCT00471965 Carcinoma, Hepatocellular Phase 3 Completed - China ... More >> Sanofi-Aventis Administrative Office Shanghai, China Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Thailand Sanofi-Aventis Administrative Office Bangkok, Thailand Less <<
NCT03192735 Safety and Effectiveness of Ap... More >>atinib Combined With SOX Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer Less << Phase 2 Recruiting June 30, 2024 China, Fujian ... More >> Fujian Medical University Union Hospital Recruiting Fuzhou, Fujian, China, 350000 Contact: Changming Huang, Professor    8613805069676    hcmlr2002@163.com    Contact: Ruhong Tu, M.D    8615980278081    794561137@qq.com Less <<
NCT00351195 Hepatocellular Carcinoma Phase 2 Terminated(Did not meet the cr... More >>iteria for continuation to second stage) Less << - Denmark ... More >> Århus Sygehus, Dept. of Oncology Århus, Denmark, 8000 C Less <<
NCT00955721 - Terminated(Lack of Funding) - -
NCT01572324 Biliary Tract Cancer Phase 2 Completed - China, Beijing ... More >> Peking University Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT00955721 Cholangiocarcinoma ... More >> Biliary Tract Cancer Gallbladder Cancer Less << Phase 1 Phase 2 Terminated(Lack of Funding) - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 Less <<
NCT00321100 Colorectal Neoplasms Phase 2 Terminated(Enrollment closed 1... More >>0/15/2008 based on data about KRAS.) Less << - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00350961 Cholangiocarcinoma Phase 1 Phase 2 Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 Vejle Sygehus Vejle, Denmark, 7100 Less <<
NCT01049620 Advanced Gastric Cancer Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00564720 Pancreatic Cancer Phase 2 Terminated(Due to poor accrual... More >> of the study) Less << - Greece ... More >> University General Hospital of Alexandroupolis, Department of Medical Oncology Alexandroupolis, Greece Air Forces Military Hospital of Athens Athens, Greece Errikos Ntynan General Hospital Athens, Greece IASO General Hospital of Athens, 1st Department of Medical Oncology Athens, Greece Laikon General Hospital, Medical Oncology Unit, Propedeutic Department of Internal Medicine Athens, Greece Metaxa's Anticancer Hospital of Piraeus, 1st Department of Medical Oncology Athens, Greece State General Hospital of Larissa Larissa, Greece Diabalkaniko General Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT01972503 Colorectal Neoplasms ... More >> Neoplasm Metastasis Liver Neoplasms Less << Phase 4 Unknown September 2015 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200000 Contact: jianmin Xu, PHD    008613501984869    xujmin@aliyun.com Less <<
NCT01183663 Advanced Cancers Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01314027 Pancreatic Cancer Phase 3 Unknown September 2014 Belgium ... More >> University Hospital of Gent Not yet recruiting Gent, Belgium Contact: Frederick Berrevoet, MD          France University Hospital of Marseille Not yet recruiting Marseille, France Contact: Jean-Robert Delpero, MD          University Hospital of Strasbourg Not yet recruiting Strasbourg, France Contact: Philippe Bachellier, MD          Germany University Hospital Mainz Not yet recruiting Mainz, Germany, 55131 Contact: Stefan Heinrich, MD    0049 6131 17 2738    stefan.heinrich@unimedizin-mainz.de    Sub-Investigator: Stefan Heinrich, MD          Switzerland University Hospital of Zurich Recruiting Zurich, Switzerland Contact: Pierre-Alain Clavien, MD, PhD    0041 44 255 3300    clavien@access.unizh.ch    Sub-Investigator: Mickael Lesurtel, MD          Sub-Investigator: Bernhard Pestalozzi, MD          Sub-Investigator: Stefan Heinrich, MD Less <<
NCT00096070 Adenocarcinoma of the Pancreas... More >> Stage II Pancreatic Cancer Stage III Pancreatic Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT00104689 Colorectal Cancer Phase 2 Unknown - France ... More >> Centre Regional Francois Baclesse Caen, France, 14076 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Hopital Europeen Georges Pompidou Paris, France, 75015 Polyclinique Francheville Perigueux, France, 24004 Institut Jean Godinot Reims, France, 51056 Centre Rene Huguenin Saint Cloud, France, 92210 C.H. Senlis Senlis, France, 60309 Institut Claudius Regaud Toulouse, France, 31052 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00220649 Pancreatic Neoplasms Phase 1 Completed - United States, New York ... More >> St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10019 Less <<
NCT00250835 Rectal Cancer Phase 2 Terminated(Low accrual) - United States, New Mexico ... More >> Hematology Oncology Associates Albuquerque, New Mexico, United States, 87106 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 New Mexico Cancer Care Associates Santa Fe, New Mexico, United States, 87505 Less <<
NCT00660426 Advanced Gastrointestinal Mali... More >>gnancies Solid Tumors Less << Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01245582 Hepatic Neoplasm Malignant Phase 3 Withdrawn August 2015 -
NCT02848079 Colorectal Neoplasms Phase 1 Phase 2 Recruiting December 2020 United States, Connecticut ... More >> Yale Cancer Center Recruiting New Haven, Connecticut, United States, 06510 Contact: Jeremy Kortansky, MD       Jeremy.kortmansky@yale.edu    Contact: Kamil Sadowski       kamil.sadowski@yale.edu Less <<
NCT00250835 - Terminated(Low accrual) - -
NCT00280618 Carcinoma, Hepatocellular PHASE2 COMPLETED - -
NCT00439179 Metastatic Pancreatic Cancer Phase 1 Completed - United States, Rhode Island ... More >> brown University oncology group Providence, Rhode Island, United States, 02912 Less <<
NCT00286013 Locally Advanced and Unresecta... More >>ble, But Non-Metastatic Pancreatic Adenocarcinoma or Cholangiocarcinoma Less << Phase 2 Suspended(Study suspended beca... More >>use of safety reasons) Less << - Belgium ... More >> Erasme University Hospital Brussels, Belgium, 1000 Jules Bordet Institute Brussels, Belgium, 1000 University Hospital Ghent Ghent, Belgium, 9000 CHU Sart-Tilman Luik, Belgium, 4000 Less <<
NCT00795301 Rectal Cancer Phase 2 Unknown - Singapore ... More >> National University Hospital Singapore, Singapore, 119074 Less <<
NCT00439179 - Completed - -
NCT00433550 - Completed - -
NCT00433550 Small Intestine Adenocarcinoma... More >> Recurrent Small Intestine Cancer Less << Phase 2 Completed - -
NCT02024191 Peripheral Neuropathy Phase 3 Unknown June 2015 Turkey ... More >> Ankara Numune Education and Research Hospital Recruiting Ankara, Turkey, 06230 Contact: Ozan Yazici, MD    +90 312 5084610    drozanyazici@gmail.com    Contact: Nuriye Ozdemir, MD    +90 312 5084601    nyozdemir@yahoo.com    Principal Investigator: Ozan Yazici, MD Less <<
NCT00274859 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 2 Unknown - France ... More >> C.H.G. Beauvais Beauvais, France, 60021 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Centre Hospitalier Docteur Duchenne Boulogne Sur Mer, France, 62200 Centre Jean Perrin Clermont-Ferrand, France, 63011 Intercommunal Hospital Montfermeil, France, 93370 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Polyclinique De Courlancy Reims, France, F-51100 Centre Rene Huguenin Saint Cloud, France, 92210 Centre Hospitalier de Saint-Quentin Saint-Quentin, France, 02321 C.H. Senlis Senlis, France, 60309 Centre Paul Strauss Strasbourg, France, 67065 Centre Hospitalier Intercommunal Toulon - La Seyne Sur Mer Toulon - Cedex, France, 83056 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00305786 Lung Cancer Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 Less <<
NCT03422601 - Active, not recruiting July 15, 2019 France ... More >> Hôpital Saint Antoine Paris, France Less <<
NCT03422523 Diffuse Large B Cell Lymphoma ... More >> Relapsed Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << Phase 2 Recruiting June 2023 United Kingdom ... More >> The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Contact: John Radford Less <<
NCT01087658 Colorectal Neoplasms Phase 3 Completed - Canada ... More >> Investigational Site Number 0001 Greenfield Park, Canada, J4V2H1 Investigational Site Number 124-005 Laval, Canada, H7M3L9 Investigational Site Number 124-007 London, Canada, N6A 4L6 Investigational Site Number 124-014 Moncton, Canada Investigational Site Number 124-006 Montreal, Canada, H1T 2M4 Investigational Site Number 124-004 Montreal, Canada, H2L 4M1 Investigational Site Number 124010 Montreal, Canada, H2W1S6 Investigational Site Number 124-011 Montreal, Canada, H2X 1P1 Investigational Site Number 124-015 Oshawa, Canada, L1G 2B9 Investigational Site Number 124-012 Ottawa, Canada, K1H8L6 Investigational Site Number 124-003 Quebec, Canada, G1R 2J6 Investigational Site Number 124-017 Rimouski, Canada, G5L5T1 Investigational Site Number 124-002 Toronto, Canada, M5G2M9 Investigational Site Number 124-016 Winnipeg, Canada, R2H2A6 Less <<
NCT00316433 Small Cell Lung Cancer Phase 2 Terminated - United States, Washington ... More >> Swedish Medical Center Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT00447967 Gastric Cancer Phase 2 Completed - Greece ... More >> University Hospital of Crete Heraklion, Crete, Greece, 71110 University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece 401 Military Hospital of Athens Athens, Greece Air Forces Military Hospital of Athens Athens, Greece State General Hospital of Larissa Larissa, Greece "Metaxa's" Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology Piraeus, Greece Less <<
NCT00276861 Colorectal Cancer Phase 2 Terminated(Low Accrual) - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Less <<
NCT00276861 - Terminated(Low Accrual) - -
NCT00627432 Bladder Cancer Phase 2 Suspended - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Less <<
NCT00767377 Gastric Cancer Phase 2 Completed - China ... More >> Fudan University Cancer Hospital Shanghai, China, 200032 Less <<
NCT00941967 Liver Cancer Phase 2 Unknown - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34295 Contact: Eric Assenat, MD    33-4-6761-2593 Less <<
NCT00452881 Lung Cancer Phase 2 Unknown December 2014 Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of, 411-769 Less <<
NCT03745170 Gastric Cancer Phase 3 Not yet recruiting February 1, 2022 -
NCT00274885 Cancer Phase 4 Unknown - France ... More >> CHU de Grenoble - Hopital Michallon Recruiting Grenoble, France, 38043 Contact: Christine Rebischung    33-4-7676-5451       Centre Hospital Universitaire Hop Huriez Recruiting Lille, France, 59037 Contact: Mohamed Hebbar, MD    33-3-2044-5461    m-hebbar@chru-lille.fr    Clinique Saint Jean Recruiting Lyon, France, 69008 Contact: Gerard Lledo    33-4-7878-1051       Hopital Saint Antoine Recruiting Paris, France, 75571 Contact: Olivier Rosmorduc, MD, PhD    33-1-4928-2382    olivier.rosmorduc@sat.aphp.fr    CHU Pitie-Salpetriere Recruiting Paris, France, 75651 Contact: Jean-Baptiste Meric, MD    33-1-4216-0471    jeanbaptiste.meric@psl.ap-hop-paris.fr    Hopital Tenon Recruiting Paris, France, 75970 Contact: Thierry Andre, MD    33-1-6177-0708    thierry.andre@tnn.ap-hop-paris.fr Less <<
NCT00081237 Colorectal Cancer Phase 1 Completed - Germany ... More >> Medizinische Hochschule Hannover Hannover, Germany, D-30625 United Kingdom Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT00828672 Advanced Colorectal Cancer Phase 2 Active, not recruiting March 2019 Belgium ... More >> Onze Lieve Vrouwziekenhuis Aalst, Belgium, 9300 ZNA Middelheim Antwerp, Belgium, ZNA Middelheim AZ St- Lucas Brugge, Belgium, 8310 Erasme Hospital Brussels, Belgium, 1070 Cliniques Universitaires St Luc Brussels, Belgium, 1200 AZ Groeninge Kortrijk, Belgium, 8500 C.H.U. Sart-Tilman Liege, Belgium, 4000 Clinique Sainte Elisabeth Namur, Belgium, 5000 H. Hartziekenhuis Roeselare, Belgium, 8800 Less <<
NCT01243775 Non-Small Cell Lung Cancer Phase 2 Completed - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-809 Less <<
NCT00220116 Colorectal Cancer Phase 2 Completed - United Kingdom ... More >> Royal Marsden Hospital Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00524706 Colorectal Cancer Phase 1 Phase 2 Unknown April 2011 Japan ... More >> Shizuoka Cancer Center Shizuoka, Japan, 411-8777 Less <<
NCT01503983 Stage IV Gastric Cancer With M... More >>etastasis Less << Phase 2 Completed - Spain ... More >> Hospital Lucus Augusti de Lugo Lugo, A Coruña, Spain, 27003 Hospital Provincial de Pontevedra Pontevedra, Vigo, Spain, 36001 Hospital Juan Canalejo A Coruña, Spain, 15006 Centro Oncológico de Galicia A Coruña, Spain, 15009 Hospital de Basurto Bilbao, Spain, 48013 Hospital Arnau de Vilanova de LLeida Lleida, Spain, 25198 Hospital Gregorio Marañon Madrid, Spain, 28009 Hospital La Paz Madrid, Spain, 28046 Hospital de Orense Orense, Spain, 32005 Hospital Universitario Cnetral de Asturias Oviedo, Spain, 33006 Hospital Universitario Marqués de Valdecilla Santander, Spain, 39008 Hospital Xeral Cies Vigo, Spain, 36204 Hospital de POVISA Vigo, Spain, 36211 Less <<
NCT01243775 - Completed - -
NCT00711412 Esophageal Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT01665274 Gastric Cancer Phase 2 Recruiting December 2022 China, Heilongjiang ... More >> Harbin Medical University Cancer Hospital Recruiting Ha Er Bin, Heilongjiang, China Contact: Yingwei Xue, Phd, MD       xyw801@163.com Less <<
NCT00411229 Stomach Neoplasms Phase 3 Completed - China ... More >> Sanofi-Aventis Beijing, China Korea, Republic of Sanofi-Aventis Seoul, Korea, Republic of Taiwan Sanofi-Aventis Taipei, Taiwan Less <<
NCT00169195 Diffuse Large Cell Lymphoma Phase 2 Completed - France ... More >> Hôpital Henri Mondor Créteil, France Service d'Hématologie Clinique - CHU Le Bocage Dijon, France Service des Maladies du Sang - CHRU de Lille Lille, France Centre Léon Bérard Lyon, France Hôpital Saint Louis Paris, France Service D'Hématologie Adulte - Hôpital Necker Paris, France Centre Henri Becquerel Rouen, France CHRU de Nancy Brabois Vandoeuvre les Nancy, France Less <<
NCT00711412 - Completed - -
NCT01331928 Gastric Cancer Phase 2 Unknown - Taiwan ... More >> Taipei veterans general hospital Recruiting Taipei, Taiwan, 112 Contact: Yee Chao, MD. PHD    +886-2-28712121 ext 7618    ychao@vghtpe.gov.tw    Principal Investigator: Yee Chao, MD.PHD          Sub-Investigator: Ming-Huang Chen, MD          Sub-Investigator: Chung-Pin Li, MD.PHD Less <<
NCT03366272 Lymphoma, Non-Hodgkin Phase 2 Phase 3 Recruiting November 2024 -
NCT00686166 Colorectal Cancer Phase 2 Completed - -
NCT00980239 Liver Cancer ... More >>Advanced Cancer Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00686166 - Completed - -
NCT01515748 Gastric Cancer Phase 3 Active, not recruiting January 2, 2020 Korea, Republic of ... More >> Administrative Office Seoul, Korea, Republic of Less <<
NCT00093652 Esophageal Cancer Phase 1 Phase 2 Terminated - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00004257 Esophageal Cancer Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT02965248 Locally Advanced Colorectal Ca... More >>ncer Less << Phase 3 Recruiting November 2023 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Guoxiang Cai, M.D. Ph.D.    +86 13611831623    gxcai@fudan.edu.cn Less <<
NCT02169908 Digestive Cancer ... More >> Gynecological Cancer Less << Not Applicable Completed - France ... More >> Groupe Hospitalier Paris Saint Joseph Paris, Ile de France, France, 75014 Less <<
NCT01216644 Gastric Cancer Phase 2 Phase 3 Active, not recruiting September 2018 Germany ... More >> Krankenhaus Nordwest Frankfurt, Germany, 60488 Less <<
NCT01247337 Cholangiocarcinoma Phase 2 Unknown March 2015 Denmark ... More >> Herlev Hospital Herlev, Denmark, 2730 Less <<
NCT03161041 Colorectal Carcinomatosis Phase 2 Withdrawn(CHU Lyon will join a... More >>s a participating center (and as national French coordinator) as a part of the BEV-IP study ongoing study EudraCT-number 2014-004257-14.) Less << - -
NCT03219502 Malignant Neoplasm ... More >> Neuropathy Less << Not Applicable Recruiting July 31, 2021 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Sarah Prinsloo    713-563-9627       Principal Investigator: Sarah Prinsloo Less <<
NCT01422993 Neuropathy Ga... More >>strointestinal Cancer Less << Not Applicable Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00470340 Liver Neoplasms ... More >> Liver Cirrhosis Carcinoma, Hepatocellular Recurrence Neoplasm Recurrence, Local Less << Phase 3 Terminated(during the study) - France ... More >> Urc La Pitie Salpetriere, Poissy, France, 75013 Less <<
NCT00761241 Pancreatic Cancer Phase 2 Completed - United States, Washington ... More >> Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT00552149 Advanced Biliary Cancer Phase 2 Completed - France ... More >> Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT01127555 Unresectable Biliary Tract Can... More >>cer Less << Phase 2 Completed - Korea, Republic of ... More >> Chung-Ang University Yongsan Hospital Yongsan, Seoul, Korea, Republic of, 140-757 Less <<
NCT00976768 Advanced Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan medical center Seoul, Korea, Republic of, 138-736 Less <<
NCT00591045 Stomach Neoplasms ... More >> Gastric Cancer Less << Phase 2 Unknown December 2012 China, Beijing ... More >> Peking University School of Oncology Not yet recruiting Beijing, Beijing, China, 100036 Contact: Jiafu Ji, M.D.    86-10-88196048    jiafuj@hotmail.com    Principal Investigator: Jiafu Ji, M.D. Less <<
NCT00086931 Colorectal Cancer Phase 1 Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00005050 Colorectal Cancer Phase 1 Phase 2 Completed - United States, New York ... More >> Kaplan Cancer Center New York, New York, United States, 10016 Less <<
NCT01387373 Metastatic Breast Cancer ... More >> Liver Metastases Less << Phase 2 Unknown December 2014 Denmark ... More >> Herlev Hospital Recruiting Herlev, Denmark, DK-2730 Contact: Dorte Nielsen, Professor    +4544884000 ext 82344    dornie01@heh.regionh.dk    Contact: Birgitte Krogh Jensen, Study nurse    +454488000 ext 89562    bikrje01@heh.regionh.dk    Principal Investigator: Dorte Nielsen, professor          Herlev Hospital Recruiting Herlev, Denmark, DK-2730 Contact: Dorte Nielsen    +4544884000 ext 82344       Principal Investigator: Dorte Nielsen, professor Less <<
NCT01216345 Unresectable ... More >>Locally Advanced Metastatic Less << Phase 2 Completed - Austria ... More >> KH Rudolfstiftung Vienna, Austria, 1030 Less <<
NCT03403101 Carcinoma, Pancreatic Ductal Phase 2 Recruiting December 31, 2019 China, Shanghai ... More >> Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Xianjun Yu, M.D., Ph.D.    +86 21 64175590    yuxianjun@fudanpci.org    China Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; 270 Dong An Road, Shanghai 200032, China Recruiting Shanghai, China, 200032 Contact: Xian-Jun Yu, M.D., Ph.D.    +86-21-64175590    yuxianjun88@hotmail.com    Contact: Liang Liu, M.D., Ph.D.    +86-21-64175590    liuliang.zlhospital@gmail.com    Principal Investigator: Xian-Jun Yu, M.D., Ph.D. Less <<
NCT00427713 Colorectal Cancer Phase 3 Completed - -
NCT00222469 Metastatic Pancreatic Cancer Phase 2 Completed - United States, Oklahoma ... More >> University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00321828 Colorectal Cancer Phase 2 Completed - -
NCT00601172 - Completed - -
NCT00321828 - Completed - -
NCT00601172 Nausea and Vomiting, Chemother... More >>apy-Induced Less << Phase 3 Completed - -
NCT00005860 Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00192075 Colorectal Cancer Phase 2 Completed - United States, Arizona ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States United States, California For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beverly Hills, California, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palm Springs, California, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stockton, California, United States United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kansas City, Kansas, United States United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Springfield, Massachusetts, United States United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lansing, Michigan, United States United States, Mississippi For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tupelo, Mississippi, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bronx, New York, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stonybrook, New York, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burlington, North Carolina, United States United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cincinnati, Ohio, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Springfield, Ohio, United States United States, Wisconsin For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marshfield, Wisconsin, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milwaukee, Wisconsin, United States Less <<
NCT01387295 Metastatic Breast Cancer ... More >> Liver Metastases Less << Phase 2 Unknown December 2014 Denmark ... More >> Herlev Hospital Recruiting Herlev, Denmark, DK-2730 Contact: Dorte Nielsen, Professor    +4544884000 ext 82344    dornie01@heh.regionh.dk    Contact: Birgitte Krogh Jensen, Study nurse    +454488000 ext 89562    bikrje01@heh.regionh.dk    Principal Investigator: Dorte Nielsen, professor Less <<
NCT00192075 - Completed - -
NCT01237665 Rectal Cancer Phase 2 Unknown December 2017 Canada, Ontario ... More >> The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT01558011 Gastric Adenocarcinoma Phase 2 Terminated(The budget issues.) - Taiwan ... More >> National Health Research Institutes Zhunan, Miaoli, Taiwan, 350 Less <<
NCT02244632 Colorectal Neoplasm Phase 1 Phase 2 Recruiting June 2019 Denmark ... More >> Odense University Hospital Recruiting Odense, Denmark Greece 251 General Airforce Hospital Recruiting Athens, Greece IASO General Hospital Recruiting Athens, Greece Medical School University of Athens, Aretaieio Hospital Recruiting Athens, Greece University Genral Hospital Attikon Recruiting Athens, Greece University General Hospital of Heraklion Recruiting Iráklion, Greece Norway Oslo University Hospital Completed Oslo, Norway Sweden Sahlgrenska University Hospital Recruiting Göteborg, Sweden, 461 85 Contact: Göran Carlsson, MD          Principal Investigator: Göran Carlsson, MD          Skaraborg hospital Recruiting Skövde, Sweden Less <<
NCT03164382 Liver Cancer ... More >>Hepatic Carcinoma Less << Phase 3 Recruiting December 31, 2022 China, Guangdong ... More >> Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 500060 Contact: Ming Zhao, MD    86-20-87343272    zhaoming@sysucc.org.cn Less <<
NCT00212615 C04.588.274.476.411.307 Phase 2 Phase 3 Unknown - Denmark ... More >> Department of Oncology, Esbjerg Hospital Esbjerg, Denmark, 6700 Department of Oncology, Herlev University Hospital Herlev, Denmark, 2730 Department of Oncology, Herning Hospital Herning, Denmark, 7400 Department of Oncology, Hilleroed Hospital Hilleroed, Denmark, 3400 Department of Oncology, Naestved Hospital Naestved, Denmark, 4700 Department of Oncology, Roskilde Hospital Roskilde, Denmark, 4000 Sweden Department of Oncology, Radiumhemmet Stockholm, Sweden, 100 26 Department of Oncology, Uppsala University Hospital Uppsala, Sweden, 751 85 Less <<
NCT01295086 Adenocarcinoma Not Applicable Unknown January 2018 Denmark ... More >> Aalborg University Hospital Recruiting Aalborg, Denmark, 9100 Contact: Mette Yilmaz, MD    +45 9932 1111       Principal Investigator: Mette Yilmaz, MD          Aarhus University Hospital Not yet recruiting Aarhus, Denmark, 8000 Contact: Morten Ladekarl, MD    +45 8949 4444       Principal Investigator: Morten Ladekarl, MD          Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Lene Bæksgaard, MD    +45 3545 3545       Principal Investigator: Lene Bæksgaard, MD          Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Katrine Rahbek Schoennemann, MD    +45 6541 2921    k.schoennemann@ouh.regionsyddanmark.dk    Principal Investigator: Katrine Rahbek Schoennemann, MD Less <<
NCT00304135 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Liver Cancer Less << Phase 2 Phase 3 Completed - France ... More >> Centre Hospitalier General Belfort, France, 90000 Centre Hospitalier Pierre Oudot Bourgoin-Jallieu, France, 38300 Hopital Louis Pasteur Colmar, France, 68024 Centre Hospitalier de Dax Dax, France, 40100 Hopital Du Bocage Dijon, France, 21034 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 C. H. Du Mans Le Mans, France, 72037 CHU de la Timone Marseille, France, 13385 Centre Hospitalier General de Mont de Marsan Mont-de-Marsan, France, 40000 CHR D'Orleans - Hopital de la Source Orleans, France, 45100 Hopital Bichat - Claude Bernard Paris, France, 75018 CHU Pitie-Salpetriere Paris, France, 75651 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Hopital Sebastopol, C.H.U. de Reims Reims, France, 51092 Centre Eugene Marquis Rennes, France, 35062 Hopital Charles Nicolle Rouen, France, 76031 Centre Hospitalier de Semur en Auxois Semur en Auxois, France, 21140 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Centre Hospitalier de Tarbes Tarbes, France, 65013 Less <<
NCT00416494 Colorectal Cancer Phase 2 Completed - -
NCT01071655 Colorectal Cancer Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain, 28046 Less <<
NCT00114231 Colorectal Cancer Phase 2 Completed - -
NCT00114231 - Completed - -
NCT00591123 Unresectable Adenocarcinoma of... More >> the Esophagus Metastatic Adenocarcinoma of the Esophagus Unresectable Adenocarcinoma of Gastric Cardia Metastatic Adenocarcinoma of Gastric Cardia Less << Phase 2 Completed - United States, California ... More >> Translational Oncology Research International (TORI) Network Los Angeles, California, United States, 90095 UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Less <<
NCT02604784 Peritoneal Carcinomatosis Phase 1 Phase 2 Recruiting October 2018 Italy ... More >> Department of Surgical Oncology - FPO-IRCCS Institute for Cancer Research and Treatment Recruiting Candiolo, Turin, Italy, 10060 Contact: Michele De Simone, MD    011993 ext 3673    michele.desimone@ircc.it    Contact: Marco Vaira, MD    011993 ext 3683    marco.vaira@ircc.it    Principal Investigator: Michele De Simone, MD          Sub-Investigator: Marco Vaira, MD          Sub-Investigator: Manuela Robella, MD Less <<
NCT00416494 - Completed - -
NCT00448682 - Terminated - -
NCT01896531 Gastric Cancer Phase 2 Active, not recruiting June 30, 2019 -
NCT03542136 Colorectal Cancer Not Applicable Recruiting December 2019 Sweden ... More >> Lund University Hospital Recruiting Lund, Sweden, 221 85 Contact: Jakob Eberhard, MD    +46 46 17 75 20    jakob.eberhard@med.lu.se    Contact: Muhammad Kadum, MD    +46 46 17 75 20    muhammad.kadum@skane.se    Principal Investigator: Jakob Eberhard, MD Less <<
NCT00338039 Pancreatic Cancer Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01670370 Diffuse Large B-cell Lymphoma Phase 2 Active, not recruiting December 2018 -
NCT00448682 Gastric Cancer Phase 2 Terminated - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00508872 Colorectal Liver Metastases Phase 2 Terminated(Slow accrual, study... More >> terminated.) Less << - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00508872 - Terminated(Slow accrual, study... More >> terminated.) Less << - -
NCT03246321 Colorectal Neoplasms ... More >> Cecal Neoplasms Peritoneal Metastases Peritoneal Carcinomatosis Less << Phase 1 Phase 2 Not yet recruiting October 1, 2019 Netherlands ... More >> Catharina Hospital Not yet recruiting Eindhoven, Netherlands, 5623 EJ Contact: Koen Rovers, MD    +31402396350    koen.rovers@catharinaziekenhuis.nl    Contact: Ignace de Hingh, MD, PhD    +31402397150    ignace.d.hingh@catharinaziekenhuis.nl    Principal Investigator: Ignace de Hingh, MD, PhD          Principal Investigator: Koen Rovers, MD          Sub-Investigator: Simon Nienhuijs, MD, PhD          Sub-Investigator: Geert-Jan Creemers, MD, PhD          Sub-Investigator: Maarten Deenen, PhD Less <<
NCT01023633 Colorectal Cancer Phase 4 Unknown July 2015 China, Jiangsu ... More >> The 1st Affiliated Hospital Of NanJing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Xiaofeng Chen, MD    86 25 83718836 ext 6428    xiaofengch198019@126.com    Principal Investigator: Yongqian Shu, MD          China, Zhejiang Zhejiang University affiliated sir run run shaw hospital Recruiting HangZhou, Zhejiang, China, 310016 Contact: Hongming Pan, MD    0571-86090073    panhongming@tom.com    Principal Investigator: Hongming Pan, MD Less <<
NCT00352755 Peritoneal Neoplasms Phase 2 Terminated(after interim analy... More >>sis it was determined that the risks were too great in comparision to the results) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00338039 - Completed - -
NCT01308840 Biliary Tract Cancer ... More >> Gallbladder Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber / Harvard Cancer Center Boston, Massachusetts, United States, 02215 United States, New York University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT01308840 - Completed - -
NCT00352755 - Terminated(after interim analy... More >>sis it was determined that the risks were too great in comparision to the results) Less << - -
NCT02024217 Gastric Cancer Phase 2 Unknown August 2015 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Guichao Li, MD       11111230012@fudan.edu.cn    Contact: Xiaowen Liu, MD       liuxw1129@hotmail.com    Principal Investigator: Zhen Zhang, MD Less <<
NCT00220051 Rectal Cancer Phase 2 Completed - -
NCT03676517 Locally Advanced Rectal Cancer Not Applicable Not yet recruiting August 31, 2019 Korea, Republic of ... More >> The Division of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Min Soo Cho, MD    82-2-2228-2107    nagase96@yuhs.ac Less <<
NCT03028155 Colorectal Peritoneal Carcinom... More >>atosis Less << Phase 3 Recruiting August 2018 Belgium ... More >> Ziekenhuis Oost-Limburg Recruiting Genk, Belgium, 3600 Contact: Lieselotte Lemoine, drs.       lieselotte.lemoine@uhasselt.be    Principal Investigator: Kurt Van der Speeten, prof. dr. Less <<
NCT00335595 Colorectal Cancer Phase 3 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain, 28046 Less <<
NCT00056446 Colorectal Neoplasms ... More >> Colonic Neoplasms Rectal Neoplasms Less << Phase 3 Completed - -
NCT02085005 Colorectal Cancer Metastatic Phase 2 Withdrawn August 2016 -
NCT01362374 Neoplasms Phase 1 Active, not recruiting June 30, 2019 United States, California ... More >> California Pacific Med Center San Francisco, California, United States, 94115 United States, Florida Florida Cancer Specialists - Sarasota Sarasota, Florida, United States, 34232 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan University Of Michigan Ann Arbor, Michigan, United States, 48109 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89128 United States, Tennessee SCRI Nashville, Tennessee, United States, 37203 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 France Institut Gustave Roussy; Departement Oncologie Medicale Villejuif, France, 94805 Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 United Kingdom The Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT Less <<
NCT00087334 Colorectal Cancer Phase 1 Phase 2 Terminated(Withdrawn due to po... More >>or/low accrual) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00056459 Colorectal Neoplasms ... More >> Colonic Neoplasms Rectal Neoplasms Less << Phase 3 Completed - -
NCT02827916 Peripheric Neuropathy ... More >> Chemo-induced Neuropathy Less << Not Applicable Completed - France ... More >> Groupe Hospitalier Paris Saint Joseph Paris, Ile-de-France, France, 75014 Less <<
NCT03641976 Unresectable Metastatic Right-... More >>sided Colon Cancer Starting First-line Combination Chemotherapy Unresectable Metastatic Right-sided Colon Cancer, Stage IV Less << Phase 2 Not yet recruiting August 31, 2022 Korea, Republic of ... More >> Yonsei Cancer Center, Severance Hospital, Yonsei University Health System Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Joong Bae Ahn, MD,PhD    82-2-2228-8134    vvswm513@yuhs.ac Less <<
NCT00256321 Gastric Carcinoma ... More >> Gastroesophageal Junction Carcinoma Less << Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT03007446 Gastric Cancer Phase 2 Recruiting November 2018 China ... More >> the chinese PLA General Hospital Recruiting Beijing, China, 100853 Contact: Lin Chen, Master    13801290395 Less <<
NCT00075452 Pancreatic Cancer Phase 3 Unknown - France ... More >> Centre Paul Papin Angers, France, 49036 C.H.G. Beauvais Beauvais, France, 60021 Hopital Saint Andre Bordeaux, France, 33075 CHU Ambroise Pare Boulogne Billancourt, France, F-92104 CMC Bligny Briis Sous Forges, France, 91640 Hopital Louis Pasteur Chartres, France, 28018 Chu-Hopital Gabriel Montpied Clermont Ferrand, France, F-63000 Hopital Beaujon Clichy, France, 92118 Hopital Louis Mourier Colombes, France, F-92701 Hopital Drevon Dijon, France, 21000 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 Hopital Saint - Louis La Rochelle, France, 17000 Centre Hospitalier de Lagny Lagny Sur Marne, France, 77405 Hopital Andre Mignot Le Chesnay, France, 78157 Centre Jean Bernard Le Mans, France, 72000 C. H. Du Mans Le Mans, France, 72037 Hopital Robert Boulin Libourne, France, 33500 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 Clinique Saint Jean Lyon, France, 69008 Hopital de la Croix Rousse Lyon, France, 69317 Hopital Notre-Dame de Bon Secours Metz, France, 57038 Intercommunal Hospital Montfermeil, France, 93370 American Hospital of Paris Neuilly Sur Seine, France, F-92202 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Bichat - Claude Bernard Paris, France, 75018 Hopital de la Croix St. Simon Paris, France, 75020 Hopital Saint-Louis Paris, France, 75475 Hopital Saint Antoine Paris, France, 75571 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Maison Medicale Marzet Pau, France, 64000 Hopital Haut Leveque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Clinique Ste - Marie Pontoise, France, 95300 Polyclinique De Courlancy Reims, France, F-51100 C. H. De Saumur Saumur, France, 49403 C.H. Senlis Senlis, France, 60309 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT01159171 - Completed - -
NCT00345761 Colorectal Cancer Phase 1 Phase 2 Completed - Japan ... More >> Hokkaido Region Hokkaido, Japan Kanto Region Kanto, Japan Kinki Region Kinki, Japan Tokai Region Tokai, Japan Less <<
NCT01997957 Hepatocellular Carcinoma Phase 4 Unknown - China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Zhu Xu, Master    0086-10-88195476    zhux387@263.net    Principal Investigator: Zhu Xu, Master Less <<
NCT01159171 Colorectal Cancer Phase 2 Completed - Italy ... More >> Aviano, Italy, 33081 Fano, Italy, 61032 Palermo, Italy, 90146 Rimini, Italy, 47900 Roma, Italy, 00135 Torino, Italy, 10126 Less <<
NCT00191568 Pancreatic Neoplasms Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Grenoble, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Lyon, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Marseille, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Montpellier, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Paris, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) MON-FRI 9 AM - 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Pierre Benite, France Less <<
NCT01761461 Gastric Cancer Phase 3 Recruiting December 2020 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Hyejin Jang, RN    3410-6859    hyejin1217.jang@samsung.com Less <<
NCT02688023 Colorectal Cancer Phase 2 Recruiting December 2019 China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China Contact: Jing Huang, M.D.    8610-87788103    huangjingwg@163.com    Principal Investigator: Zhixiang Zhou, M.D. Less <<
NCT03764553 Esophageal Cancer Phase 2 Not yet recruiting August 1, 2023 Netherlands ... More >> Academic Medical Center, Medical Oncology Amsterdam, Netherlands, 1100 DD Less <<
NCT02350686 Biliary Tract Cancer Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: sungju park       sungju6820.park@samsung.com Less <<
NCT00004931 Stage II Colon Cancer ... More >> Stage III Colon Cancer Less << Phase 3 Completed - United States, Pennsylvania ... More >> National Surgical Adjuvant Breast and Bowel Project Pittsburgh, Pennsylvania, United States, 15212-5234 Less <<
NCT00154791 Pancreatic Adenocarcinoma Phase 1 Phase 2 Completed - Taiwan ... More >> National Taiwan Univeristy Hospital Taipei, Taiwan, 100 Less <<
NCT02025036 Stage III Esophageal Squamous ... More >>Cell Carcinoma Stage II Esophageal Squamous Cell Carcinoma Less << Phase 3 Recruiting December 2020 China, Henan ... More >> The First Affiliated Hospital of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Contact: Shegan Gao, M.D Ph.D    +86(379)64811906    gsg112258@163.com    Contact: Tanyou Shan, master    +86(379)64815350    shantanyou@163.com    Sub-Investigator: Dan Zhou, M.D.M.S Less <<
NCT00538005 Melanoma (Skin) Phase 1 Phase 2 Unknown - United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD    760-452-3340    emcclay@pacificoncology.com Less <<
NCT03654729 Chemotherapy-induced Periphera... More >>l Neuropathy Less << Phase 3 Not yet recruiting September 2022 -
NCT01216124 - - - -
NCT01561014 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Adenocarcinoma of the Stomach Squamous Cell Carcinoma of the Esophagus Stage II Esophageal Cancer Stage II Gastric Cancer Stage III Esophageal Cancer Stage III Gastric Cancer Less << Phase 1 Completed - United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00199797 Colorectal Cancer Phase 1 Completed - Germany ... More >> Krankenhaus Nordwest Frankfurt, Germany, 60488 Switzerland UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT01905150 Pancreatic Cancer Phase 2 Active, not recruiting August 2018 United States, New York ... More >> Bruckner Oncology Bronx, New York, United States, 10469 Less <<
NCT00353262 Colorectal Cancer Phase 1 Completed - Canada, Ontario ... More >> Hamilton, Ontario, Canada, L8V 5C2 Ottawa, Ontario, Canada, K1H 8L6 Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00242190 Pancreatic Neoplasms Phase 1 Phase 2 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT00353262 - Completed - -
NCT00425425 Esophageal Cancer Phase 1 Phase 2 Unknown May 2015 Germany ... More >> Charite University Hospital - Campus Virchow Klinikum Berlin, Germany, D-13353 Universitaetsklinikum Giessen und Marburg GmbH - Marburg Marburg, Germany, D-35033 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Less <<
NCT00263029 Rectal Neoplasms Phase 2 Completed - -
NCT03478488 Biliary Tract Neoplasms Phase 3 Not yet recruiting June 30, 2022 China, Jiangsu ... More >> The Chinese people's liberation army (PLA) 81hospital Active, not recruiting Nanjing, Jiangsu, China, 210002 Less <<
NCT00060411 Mucinous Adenocarcinoma of the... More >> Colon Mucinous Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IIIA Colon Cancer Stage IIIA Rectal Cancer Stage IIIB Colon Cancer Stage IIIB Rectal Cancer Stage IIIC Colon Cancer Stage IIIC Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT00261092 Pancreatic Neoplasms PHASE2 COMPLETED - Sanofi-Aventis, Seoul, Korea, ... More >>Republic of Less <<
NCT00601705 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Unknown - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00824785 Oesophago-gastric Cancer Phase 3 Terminated(Lack of efficacy) February 2013 United Kingdom ... More >> Bournemouth Bournemouth, United Kingdom St Luke's Guildford Guildford, United Kingdom Royal Liverpool Liverpool, United Kingdom Royal Marsden NHS Foundation Trust London, United Kingdom, SW3 6JJ Newcastle Newcastle, United Kingdom Royal Marsden NHS Foundation Trust Sutton, United Kingdom Clatterbridge Oncology Centre Wirral, United Kingdom Less <<
NCT03388190 Colorectal Neoplasms Malignant Phase 2 Recruiting November 1, 2020 Norway ... More >> Haukeland University Hospital Not yet recruiting Bergen, Norway, 5021 Contact: Halfdan Sørbye, MD PhD       halfdan.sorbye@helse-bergen.no    Hospital of Southern Norway, Department of Oncology Not yet recruiting Kristiansand, Norway, 4604 Contact: Christian Kersten, MD PhD       Christian.Kersten@sshf.no    Oslo University Hospital Recruiting Oslo, Norway, 0424 Contact: Marianne G Guren, MD PhD       UXARUR@ous-hf.no    Sub-Investigator: Kjersti Flatmark, MD PhD          Akershus University Hospital Recruiting Oslo, Norway, 1478 Contact: Hanne M Hamre, MD PhD       hanne.m.hamre@ahus.no    Sub-Investigator: Christin Johansen, RN          Sub-Investigator: Anne Negård, MD PhD          Sub-Investigator: Jūratė Šaltytė Benth, PhD          Sub-Investigator: Sebastian Meltzer, MD PhD          Sub-Investigator: Eline Aas, PhD          Sub-Investigator: Anne H Ree, MD PhD          Sub-Investigator: Kathrine R Redalen, PhD          Sub-Investigator: Jonn Terje Geitung, MD PhD          St Olav's Hospital - Trondheim University Hospital Not yet recruiting Trondheim, Norway, 7006 Contact: Eva Hofsli, MD PhD       eva.hofsli@ntnu.no Less <<
NCT00004127 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, Connecticut ... More >> Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8028 United States, Illinois University of Illinois at Chicago Chicago, Illinois, United States, 60612 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Louis A. Weiss Memorial Hospital Chicago, Illinois, United States, 60640 Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States, 62526 Evanston Northwestern Health Care Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Columbia LaGrange Memorial Hospital LaGrange, Illinois, United States, 60525 Loyola University Medical Center Maywood, Illinois, United States, 60153 Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61602 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62701 United States, Indiana Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States, 46885-5099 Michiana Hematology/Oncology P.C. South Bend, Indiana, United States, 46617 United States, Kentucky Central Baptist Hospital Lexington, Kentucky, United States, 40503 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 Lakeland Medical Center - St. Joseph Saint Joseph, Michigan, United States, 49085 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Grant/Riverside Methodist Hospitals Columbus, Ohio, United States, 43214 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 Puerto Rico University of Puerto Rico School of Medicine Medical Sciences Campus San Juan, Puerto Rico, 00936-5067 Less <<
NCT00174564 Biliary Tract Neoplasms Phase 2 Completed - -
NCT02181218 Lymphoma, T-Cell, Cutaneous ... More >> Lymphoma, T-Cell, Peripheral Hodgkin Disease Lymphoma, Large B-Cell, Diffuse Less << Phase 1 Recruiting June 30, 2020 United States, California ... More >> University of California - San Francisco Not yet recruiting San Francisco, California, United States, 94143 Contact: Weiyun Ai, M.D., Ph.D.    415-353-4061    weiai@medicine.ucsf.edu    Principal Investigator: Weiyun Ai, M.D., Ph.D.          United States, Illinois University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Peter Riedell, M.D.    773-753-3288       Principal Investigator: Peter Riedell, M.D.          Sub-Investigator: Justin Kline, M.D.          Sub-Investigator: Sonali Smith, M.D.          Sub-Investigator: Kenneth Cohen, M.D.          Sub-Investigator: Michael Bishop, M.D.          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Neha Mehta-Shah, M.D.    314-747-7402    mehta-n@wustl.edu    Principal Investigator: Neha Mehta-Shah, M.D.          Sub-Investigator: Nancy Bartlett, M.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: Amanda Cashen, M.D.          Sub-Investigator: Brad Kahl, M.D.          Sub-Investigator: Peter Riedell, M.D. Less <<
NCT00950820 Colorectal Neoplasms Phase 2 Terminated(Recruitment rate to... More >> low; changed environment made protocol in its current state obsolete) Less << - Germany ... More >> AIO-Studien-gGmbH Berlin, Germany, 10623 Less <<
NCT03316326 Pancreatic Ductal Adenocarcino... More >>ma Less << Phase 2 Not yet recruiting December 31, 2021 -
NCT00422864 Rectal Cancer Phase 2 Completed - Australia, Victoria ... More >> Peter MacCaluum Cancer Centre Melbourne, Victoria, Australia, 3002 Less <<
NCT00470184 - Completed - -
NCT00403624 Rectal Neoplasms Phase 1 Phase 2 Completed - -
NCT00470184 Esophageal Cancer Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00555620 Stomach Neoplasms Phase 1 Completed - Korea, Republic of ... More >> Pfizer Investigational Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Goyang, Gyeonggi, Korea, Republic of, 410-769 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Less <<
NCT01744353 Metastatic Pancreatic Cancer Phase 1 Completed - United States, Rhode Island ... More >> Memorial Hospital Pawtucket, Rhode Island, United States, 02860 Rhode Island Hospital (including Newport and East Greenwich locations) Providence, Rhode Island, United States, 02903 The Miriam Hospital Providence, Rhode Island, United States, 02906 Less <<
NCT00689624 Metastatic Colorectal Cancer Phase 2 Completed - Greece ... More >> University Hospital of Crete Heraklion, Greece Less <<
NCT00296062 Colorectal Cancer ... More >> Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated(Trial did not move ... More >>to Phase II portion due to poor tolerance of treatment) Less << - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00782041 Uterine Neoplasms Phase 2 Terminated(protocol violation) - Thailand ... More >> Sanofi aventis administrative office Bangkok, Thailand Less <<
NCT01843829 Oesophageal Cancer Phase 2 Unknown May 2016 United Kingdom ... More >> Bristol Oncology and Haematology Centre Recruiting Bristol, United Kingdom Valindre NHS Recruiting Cardiff, United Kingdom Principal Investigator: Tom Crosby          University Hospitals Coventry and Warwickshire Recruiting Coventry, United Kingdom Royal Derby Hospital Not yet recruiting Derby, United Kingdom Principal Investigator: Rajendra Kulkarni          St James's Hospital Recruiting Leeds, United Kingdom Principal Investigator: Ganesh Radhakrishna          Leicester Royal Infirmary Recruiting Leicester, United Kingdom St Mary's Hopsital Recruiting London, United Kingdom The Christie Recruiting Manchester, United Kingdom Principal Investigator: Hamid Sheikh          Churchill Hospital Recruiting Oxford, United Kingdom Weston Park Hospital Recruiting Sheffield, United Kingdom Southampton General Hospital Recruiting Southampton, United Kingdom The Great Western Hospital Recruiting Swindon, United Kingdom Less <<
NCT01472029 Adenocarcinoma of the Gastroes... More >>ophageal Junction Adenocarcinoma of the Stomach Less << Phase 2 Completed - Germany ... More >> Tagestherapiezentrum am ITM & III. Medizinische Klinik Universitätsmedizin Mannheim Mannheim, Germany, D-68167 Less <<
NCT01744353 - Completed - -
NCT00069095 Colorectal Cancer Phase 3 Completed - -
NCT03244774 Gastric Adenocarcinoma Phase 1 Recruiting June 30, 2019 China, Fujian ... More >> Rongbo Lin Recruiting Fuzhou, Fujian, China, 350014 Contact: Rongbo Lin, MD    86+13705919382    rongbo_lin@163.com Less <<
NCT03311750 Advanced Colorectal Cancer Phase 2 Recruiting April 2020 Greece ... More >> Ioannina University Hospital Recruiting Ioánnina, Ioannina, Greece, 45500 Contact: George Pentheroudakis, MD,Ass.Prof    00302651099394    gpenther@otenet.gr    Agii Anargiri Cancer Hospital Recruiting Athens, Kalyftaki, Nea Kifisia, Greece, 14564 Contact: Gerasimos Aravantinos, MD    00302103501283    garavantinos@yahoo.gr    Agii Anargiri Cancer Hospital Recruiting Athens, Kalyftaki, Nea Kifisia, Greece, 14564 Contact: Joseph Sgouros, MD    00302103501273    josephsgouros@yahoo.co.uk    Metropolitan Hospital Recruiting Athens, Neo Faliro, Greece, 18547 Contact: Dimitrios Bafaloukos, MD    00302104809412    dimmp@otenet.gr    Metropolitan Hospital Recruiting Athens, Neo Faliro, Greece, 18547 Contact: Christos Christodoulou, MD    00302104809663    c_christodoulou@yahoo.gr    Euromedica General Clinic of Thessaloniki Recruiting Thessaloníki, Thessaloniki, Greece, 54645 Contact: George Fountzilas, Prof.Emer    00302310683136    fountzil@auth.gr Less <<
NCT02967289 Colon Cancer (High-risk Stage ... More >>III; pT4N1 or pT1 to 4 N2) Less << Phase 3 Recruiting June 2026 Canada, Prince Edward Island ... More >> The PEI Cancer Treatment Centre Queen Elizabeth Hospital Active, not recruiting Charlottetown, Prince Edward Island, Canada Canada, Quebec Hopital Charles LeMoyne Active, not recruiting Greenfield Park, Quebec, Canada Centre hospitalier de l'Université de Montréal Active, not recruiting Montréal, Quebec, Canada Canada, Saskatchewan Allan Blair Cancer Centre Active, not recruiting Regina, Saskatchewan, Canada France Institut de Cancérologie de l'Ouest -site Paul Papin Recruiting Angers, France Contact: Sandrine HIRET, MD          CHD de Vendée Active, not recruiting La Roche-sur-Yon, France Ch Emile Roux Recruiting Le Puy-en-Velay, France Contact: Kheir Eddine BENNMAMMAR          Hospices civils de Lyon - Hôpital Edouard Herriot Active, not recruiting Lyon, France Hôpital privé Jean Mermoz Recruiting Lyon, France Contact: Pascal ARTRU, MD          Icm Val D'Aurelle Recruiting Montpellier, France Contact: Thibault MAZARD          Institut de Cancérologie de l'Ouest -site René Gauducheau Recruiting Nantes, France Contact: Sandrine HIRET          Hôpital Européen Georges Pompidou Recruiting Paris, France Contact: Julien TAIEB, MD          Hôpital Saint Antoine Active, not recruiting Paris, France Centre Hospitalier Annecy Genevois Active, not recruiting Pringy, France Institut Jean Godinot Recruiting Reims, France Contact: ELISE DESOT          CHP Saint Grégoire Recruiting Saint Gregoire, France Contact: Laurent MIGLIANICO, MD          Clinique de la Côte d'Emeraude Active, not recruiting Saint-Malo, France Less <<
NCT00839111 Colorectal Neoplasms Phase 2 Unknown November 2010 China, Shanghai ... More >> Cancer Hospital,Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Yanfei Liu, Master    +862164175590 ext 1107 Less <<
NCT00940758 Metastatic Colorectal Cancer Phase 1 Completed - Taiwan ... More >> National Cheng Kung University Hospital Tainan, Taiwan, 704 Less <<
NCT03403296 - Completed - Korea, Republic of ... More >> Department of Surgery, Yonsei University College of Medicine Seoul, Korea, Republic of, 03722 Less <<
NCT00610948 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT02317471 Gastric Carcinoma Phase 1 Phase 2 Unknown December 2017 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Zheng Peng, MD    086-10-66938028    zihpeng@sina.com    Principal Investigator: Lin Chen, MD Less <<
NCT00501410 Colorectal Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03483038 Pancreatic Adenocarcinoma Phase 2 Recruiting December 2021 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32608 Contact: Chrystal Bailey          Principal Investigator: Thomas George, MD Less <<
NCT03389659 Vitamin D3 Phase 3 Not yet recruiting June 2022 -
NCT02716766 Carcinoma, Hepatocellular ... More >> Secondary Less << Phase 2 Active, not recruiting December 2020 Hong Kong ... More >> Queen Mary Hospital Hong Kong, Hong Kong Less <<
NCT00044343 Colorectal Cancer Phase 2 Completed - -
NCT00180960 Colon Tumors ... More >>Rectum Tumors Appendix Tumors Peritoneum Tumors Endocrine Tumors Less << Phase 2 Terminated - France ... More >> Institut Gustave-Roussy Villejuif, France, 94800 Less <<
NCT00069095 - Completed - -
NCT00969033 Metastatic Colorectal Cancer Phase 2 Terminated - United Kingdom ... More >> Broomfield Hospital Chelmsford, Essex, United Kingdom, CM1 7ET Mount Vernon Hospital Northwood, Middlesex, United Kingdom, HA6 2RN Nottingham City Hospital Nottingham, Notts, United Kingdom, NG5 1PB Chrichill Hospital Oxford, Oxon, United Kingdom, OX37LJ Royal Marsden Hospital Sutton, Surrey, United Kingdom, SM2 5PT Clatterbridge Hospital Bebington, Wirral, United Kingdom, CH634JY Royal United Hospital Bath Bath, United Kingdom, BA1 3NG Russels Hall Hospital Dudley, United Kingdom, DY1 2HQ Leicester Royal Infirmary Leicester, United Kingdom, LE1 5WW Less <<
NCT00204776 Metastatic Breast Cancer Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT01100801 Recurrent Gastric Cancer Phase 2 Unknown December 2018 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore Contact: Wei Peng Yong, MRCP, MB ChB    65 6772 4670    Wei_Peng_Yong@nuhs.edu.sg Less <<
NCT02494973 Colorectal Cancer Phase 2 Phase 3 Recruiting May 2028 France ... More >> Gustave Roussy Cancer Campus Grand Paris Recruiting Villejuif, Val De Marne, France, 94805 Contact: Diane Goéré, MD    0142115441 ext +33    diane.goéré@gustaveroussy.fr    Contact: Aurélie Abou Lovergne    0142113862 ext +33    aurelie.aboulovergne@gustaveroussy.fr    Principal Investigator: Diane Goéré, MD Less <<
NCT00603577 Colorectal Neoplasms Phase 3 Terminated(development of prod... More >>uct discontinued) Less << - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States Canada Sanofi-Aventis Administrative Office Québec, Canada France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Frankfurt, Germany Greece Sanofi-Aventis Administrative Office Kallithea, Greece Italy Sanofi-Aventis Administrative Office Milan, Italy Spain Sanofi-Aventis Administrative Office Barcelona, Spain United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom Less <<
NCT00303628 Adenocarcinoma of the Rectum ... More >> Stage II Rectal Cancer Stage III Rectal Cancer Less << Phase 3 Terminated(The study was termi... More >>nated before reaching its accrual goal due to slow accrual.) Less << April 2019 -
NCT00439426 Nasopharyngeal Cancer Phase 2 Completed - Morocco ... More >> Agadir, Morocco, 80000 Casablanca, Morocco, 20502 Marrakech, Morocco, 40000 Rabat, Morocco, 10000 Rabat, Morocco, 6213 Less <<
NCT02087475 Colorectal Neoplasms ... More >> Effects of Chemotherapy Surgery Metastasis Local Neoplasm Recurrence Less << Phase 3 Recruiting December 2024 China, Guangdong ... More >> The 6th Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Jian Xiao, MD    +8613711114566    xiao_jian@139.com    Sub-Investigator: Jian Xiao, MD Less <<
NCT02386397 Digestive Cancer Phase 1 Phase 2 Recruiting April 2019 France ... More >> Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Principal Investigator: Eric ASSENAT, MD Less <<
NCT01963702 Gastric Cancer Phase 2 Unknown December 2014 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: xiaodong Zhu, M.D    +862164175590 ext 5000    xddr001@163.com    Sub-Investigator: xiaodong Zhu, M.D Less <<
NCT01802645 Colorectal Cancer Phase 2 Recruiting July 2020 Germany ... More >> Universitätsklinikum der RWTH Aachen Recruiting Aachen, Germany, 52074 Contact: Ulf-Peter Neumann, Prof. Dr.    0241 8085660    chirurgie@ukaachen.de    Principal Investigator: Ulf-Peter Neumann, Prof. Dr.          Charité Campus Virchow Recruiting Berlin, Germany, 13353 Contact: Daniel Seehofer, PD Dr. med.    030/ 450 652062    daniel.seehofer@charite.de    Principal Investigator: Daniel Seehofer, PD Dr. med.          Überörtliche Gemeinschaftspraxis Hämatologie/ Onkologie Not yet recruiting Bocholt, Germany, 46397 Contact: Volker Burstedde, Dr. med.    02871/2182669    Dr.burstedde@gmx.de    Klinikum Coburg GmbH Not yet recruiting Coburg, Germany, 96450 Contact: Christof Lamberti, PD Dr. med.    09561 / 22-5413    christof.lamberti@klinikum-coburg.de    Onkologie Dülmen GbR Not yet recruiting Coesfeld, Germany, 48653 Contact: Manfred Glados, Dr. med.    02541/971893    onko-studien@glados.eu    Universitätsklinikum Carl Gustav Carus Recruiting Dresden, Germany, 01307 Contact: Gunnar Folprecht, PD Dr. med.    +49 351 458 4794    Gunnar.Folprecht@uniklinikum-dresden.de    Contact: Olga Schubert    +49 351 7965620    olga.schubert@uniklinikum-dresden.de    Principal Investigator: Gunnar Folprecht, PD Dr. med.          Klinikum der Johann Wolfgang Goethe Universität Frankfurt am Main Recruiting Frankfurt/ Main, Germany, 60590 Contact: Wolf Otto Bechstein, Prof. Dr.       wolf.bechstein@kgu.de    Universitätsmedizin Göttingen Recruiting Göttingen, Germany, 37075 Contact: Torsten Liersch, PD Dr. med.    0551/ 398323    tliersch@chirurgie-goettingen.de    Principal Investigator: Torsten Liersch, PD Dr. med.          Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Dirk Arnold, Prof. Dr.    040/ 7410 55489    d.arnold@uke.de    Principal Investigator: Dirk Arnold, Prof. Dr.          Klinikum Landshut gGmbH Recruiting Landshut, Germany, 84034 Contact: Florian Loehe, Prof. Dr.    0871 698 3338    florian.loehe@klinikum-landshut.de    University hospital Leipzig Recruiting Leipzig, Germany, 04103 Contact: Florian Lordick, Pr.    +49 341 97 12560    Florian.Lordick@medizin.uni-leipzig.de    Principal Investigator: Florian Lordick, Pr.          Johannes-Gutenberg-Universität Recruiting Mainz, Germany, 55131 Contact: Markus Möhler, PD Dr.    +49 6131 17 6863    markus.moehler@unimedizin-mainz.de    Principal Investigator: Markus Möhler, PD Dr.          Klinikum Oldenburg GmbH Recruiting Oldenburg, Germany, 26133 Contact: Claus-Henning Köhne, Prof. Dr.    +49 441 403-2610    onkologie@klinikum-oldenburg.de    Principal Investigator: Claus-Henning Köhne, Prof.          Rems-Murr-Klinikum Winnenden Not yet recruiting Winnenden, Germany, 71364 Contact: Markus Schaich, Prof. Dr.    07195-591 39240    Markus.Schaich@rems-murr-kliniken.de    Universitätsklinikum Würzburg Recruiting Würzburg, Germany, 97080 Contact: Volker Kunzmann, PD Dr. med.    0931/20140746    kunzmann_v@medizin.uni-wuerzburg.de    Principal Investigator: Volker Kunzmann, PD Dr. med. Less <<
NCT00268411 Pancreatic Cancer Phase 3 Unknown - France ... More >> Hopital Duffaut Avignon, France, 84902 C.H.G. Beauvais Beauvais, France, 60021 Hopital Drevon Dijon, France, 21000 Centre Hospitalier de Dreux Dreux, France, 28100 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 Hopital Saint - Louis La Rochelle, France, 17000 Hopital Louis Pasteur - Le Coudray Le Coudray, France, 28630 Clinique Victor Hugo Le Mans, France, F-72000 Polyclinique des Quatre Pavillons Lormont, France, 33310 Clinique Saint Jean Lyon, France, 69008 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Polyclinique De Courlancy Reims, France, F-51100 C.H. Senlis Senlis, France, 60309 Less <<
NCT00897819 - Completed - -
NCT03280511 Peritoneum Cancer ... More >> Peritoneal Carcinomatosis Peritoneal Metastases Colo-rectal Cancer Less << Phase 2 Recruiting March 1, 2025 Denmark ... More >> Odense PIPAC Center, Department of Surgery, Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Martin Graversen, MD    +45 30549497    martin.graversen@rsyd.dk    Principal Investigator: Martin Graversen, MD, Ph.D. Less <<
NCT02399410 Colorectal Neoplasms Phase 2 Recruiting January 2021 Belgium ... More >> Ghent University Hospital Recruiting Gent, Belgium, 9000 Contact: Wim Ceelen       wim.ceelen@ugent.be Less <<
NCT03355612 Gastric Carcinoma Phase 3 Not yet recruiting December 20, 2025 -
NCT00386828 Advanced Colorectal Cancer Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Centre for Southern Interior Kelowna, British Columbia, Canada BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada Canada, Ontario Sunnybrook Odette Cancer Centre Toronto, Ontario, Canada Less <<
NCT00072553 Colorectal Cancer Phase 2 Unknown - France ... More >> Hopital Tenon Paris, France, 75970 Less <<
NCT00630045 Colorectal Cancer ... More >> Resectable Liver Metastasis Less << Phase 3 Unknown June 2015 China, Beijing ... More >> Peking University, School of Oncology Recruiting Beijing, Beijing, China, 100036 Contact: Xiaotian Zhang, MD    86-10-88196561    zhangxt@yahoo.com    Contact: jifang gong, MD    86-10-88196088    goodjf@163.com    China Peking University, People's Hospital Recruiting Beijing, China, 100044 Contact: jing zhou, MD    86-10-66583821    zhoujing58@sohu.com Less <<
NCT03729687 Rectal Cancer Phase 2 Recruiting June 30, 2024 Sweden ... More >> Akademiska sjukhuset Recruiting Uppsala, Sweden, S-75185 Contact: Calin Radu, MD,PhD    +46 18 6110000    calin.radu@akademiska.se Less <<
NCT01658943 Pancreatic Acinar Cell Carcino... More >>ma Pancreatic Ductal Adenocarcinoma Recurrent Pancreatic Carcinoma Stage IV Pancreatic Cancer Less << Phase 2 Completed - -
NCT00303628 - Terminated(The study was termi... More >>nated before reaching its accrual goal due to slow accrual.) Less << - -
NCT03448549 Colorectal Cancer Stage III ... More >> Adjuvant Chemotherapy Less << Phase 3 Recruiting January 1, 2024 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Nan Chen, M.D.;Ph.D.    +86 18911956939    chennanpku@126.com    Principal Investigator: Aiwen Wu, M.D          Sub-Investigator: Nan Chen, M.D.;Ph.D. Less <<
NCT01658943 - Completed - -
NCT02879227 Esophagus Cancer Phase 2 Completed - -
NCT00561301 Lymphoma Phase 2 Unknown October 2009 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Yae-Eun Jang, nurse    82-2-3010-7290    redpin75@naver.com Less <<
NCT00430313 Liver Cancer ... More >>Liver Metastasis Less << Not Applicable Active, not recruiting January 2021 China ... More >> Fudan University Cancer Hospital Shanghai, China Less <<
NCT00314353 Colorectal Neoplasms Phase 2 Terminated(The study was close... More >>d early due to low enrollment and new information regarding the benefit of the study regimen.) Less << - United States, Pennsylvania ... More >> NSABP Operations Center Pittsburgh, Pennsylvania, United States, 15212 Less <<
NCT02080234 Lymphoma, Extranodal NK-T-Cell Phase 2 Unknown March 2017 China, Guangdong ... More >> Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Recruiting Guangzhou, Guangdong, China, 510060 Contact: Liang Wang, M.D.    0086-02087342438    wangliang@sysucc.org.cn    Principal Investigator: Jun Zh Xia, M.D. Less <<
NCT03484195 Colonic Neoplasms ... More >> Drug Therapy Less << Phase 2 Not yet recruiting April 1, 2021 -
NCT00314353 - Terminated(The study was close... More >>d early due to low enrollment and new information regarding the benefit of the study regimen.) Less << - -
NCT00499850 Advanced Colorectal Carcinoma Phase 1 Completed - Australia ... More >> Research Site East Melbourne, Australia Research Site Footscray, Australia Research Site Heidelberg, Australia Research Site Parkville, Australia Less <<
NCT03217097 Neuroendocrine Tumors Phase 4 Not yet recruiting October 2021 France ... More >> Hôpital Sud - CHU Amiens Not yet recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, MD          Principal Investigator: Vincent HAUTEFEUILLE, MD          CHU d'Angers Not yet recruiting Angers, France, 49933 Contact: Sandrine LABOUREAU, MD          Principal Investigator: Sandrine LABOUREAU, MD          Hôpital Beaujon - APHP Not yet recruiting Clichy, France, 92118 Contact: Olivia HENTIC, MD          Principal Investigator: Olivia HENTIC, MD          Hôpital François Mitterrand - CHU Dijon Bourgogne Not yet recruiting Dijon, France, 21000 Contact: Côme LEPAGE, MD          Principal Investigator: Côme LEPAGE, MD          Hôpital André Michalon - CHU Grenoble Alpes Not yet recruiting La Tronche, France, 38700 Contact: Victoire GRANGER, MD          Principal Investigator: Victoire GRANGER, MD          Centre Oscar Lambret Not yet recruiting Lille, France, 59020 Contact: Eric DANSIN, MD          Principal Investigator: Eric DANSIN, MD          Hôpital Claude Hurriet - CHRU Lille Not yet recruiting Lille, France, 59037 Contact: Christine DO CAO, MD          Principal Investigator: Christine DO CAO, MD          Hôpital Edouard Herriot - Hospices Civils de Lyon Not yet recruiting Lyon, France, 69003 Contact: Thomas WALTER, MD          Principal Investigator: Catherine LOMBARD BOHAS, MD          Sub-Investigator: Thomas WALTER, MD          Hôpital Privé Jean Mermoz Not yet recruiting Lyon, France, 69008 Contact: Jérôme DESRAMES, MD          Principal Investigator: Jérôme DESRAMES, MD          Centre Léon Bérard Not yet recruiting Lyon, France, 69373 Contact: Matthieu SARABI, MD          Principal Investigator: Matthieu SARABI, MD          Institut Paoli Calmettes Not yet recruiting Marseille, France, 13009 Contact: Patricia NICCOLI, MD          Principal Investigator: Patricia NICCOLI, MD          Hôpital Saint Eloi - CHU Montpellier Not yet recruiting Montpellier, France, 34090 Contact: Eric ASSENAT, MD          Principal Investigator: Eric ASSENAT, MD          Hôpital Saint Louis - APHP Not yet recruiting Paris, France, 75010 Contact: Thomas APARICIO, MD          Principal Investigator: Thomas APARICIO, MD          Hôpital Cochin - APHP Not yet recruiting Paris, France, 75014 Contact: Romain CORIAT, MD          Principal Investigator: Romain CORIAT, MD          CH Annecy Genevois Not yet recruiting Pringy, France, 74374 Contact: Mathieu BACONNIER, MD          Principal Investigator: Mathieu BACONNIER, MD          Hôpital Robert Debré - CHU Reims Not yet recruiting Reims, France, 51092 Contact: Guillaume CADIOT, MD          Principal Investigator: Guillaume CADIOT, MD          Hôpital Nord - CHU Saint Etienne Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Nicolas WILLIET, MD          Principal Investigator: Nicolas WILLIET, MD          Institut de Cancérologie de la Loire Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Léa SABAN-ROCHE, MD          Principal Investigator: Léa SABAN-ROCHE, MD          Hôpital Rangueil - CHU Toulouse Not yet recruiting Toulouse, France, 31059 Contact: Rosine GUIMBAUD, MD          Principal Investigator: Rosine GUIMBAUD, MD          Hôpital Trousseau - CHU Tours Not yet recruiting Tours, France, 37044 Contact: Thierry LECOMTE, MD          Principal Investigator: Thierry LECOMTE, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Eric BAUDIN, MD          Principal Investigator: Eric BAUDIN, MD Less <<
NCT03279289 Metastatic Colorectal Cancer Phase 2 Recruiting July 2021 Spain ... More >> Spanish Cooperative Group for Digestive Tumour Therapy (TTD) Recruiting Madrid, Spain, 28046 Contact: Inmaculada Ruiz de Mena, PhD    0034 91 378 82 75    ttd@ttdgroup.org Less <<
NCT01359007 - Terminated(The principal inves... More >>tigator terminated the study due to inactivity and low enrollment) Less << - -
NCT01937507 Metastatic Breast Cancer Phase 2 Terminated(PI Decision) - United States, Arizona ... More >> Western Regional Medical Center Inc Goodyear, Arizona, United States, 85338 Less <<
NCT01937507 - Terminated(PI Decision) - -
NCT01138904 Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Sung Yong Oh Busan, Korea, Republic of, 602-715 Less <<
NCT01359007 Adenocarcinoma of Pancreas Phase 2 Terminated(The principal inves... More >>tigator terminated the study due to inactivity and low enrollment) Less << - United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00938470 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Cancer Gastric Cancer Less << Phase 2 Completed - -
NCT00069121 Colorectal Cancer Phase 3 Completed - -
NCT00938470 - Completed - -
NCT00281944 Childhood Central Nervous Syst... More >>em Choriocarcinoma Childhood Central Nervous System Embryonal Tumor Childhood Central Nervous System Germ Cell Tumor Childhood Central Nervous System Germinoma Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Teratoma Childhood Central Nervous System Yolk Sac Tumor Recurrent Childhood Brain Stem Glioma Recurrent Childhood Central Nervous System Embryonal Tumor Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02631564 - Unknown December 2018 China, Shanghai ... More >> Fudan University Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Bo Zhou, M.D,Ph.D    8621-18616880602 Less <<
NCT00069121 - Completed - -
NCT01679340 Gastric Cancer Phase 2 Unknown June 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Shen Lin, Professor    010-88196561    xiaotong10241@sina.com    Principal Investigator: Shen Lin, professor Less <<
NCT00525785 Stomach Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03280407 Colorectal Neoplasm ... More >> Colorectal Cancer Rectal Neoplasms Chemotherapy Effect Intestinal Disease Intestinal Neoplasms Rectal Cancer Less << Phase 2 Recruiting December 31, 2024 Denmark ... More >> Vejle Hospital Recruiting Vejle, Denmark Contact: Lars Henrik Jensen, MD PhD       lars.henrik.jensen@rsyd.dk Less <<
NCT00115765 Colorectal Cancer Phase 3 Completed - -
NCT03578874 Hepatocellular Carcinoma Phase 2 Recruiting December 31, 2021 Hong Kong ... More >> Queen Mary Hospital Recruiting Hong Kong, Hong Kong Contact: Thomas Yau          Principal Investigator: Thomas Yau, MD Less <<
NCT00884767 Chemotherapeutic Agent Toxicit... More >>y Colorectal Cancer Neurotoxicity Less << Phase 2 Unknown - France ... More >> Centre Paul Papin Recruiting Angers, France, 49036 Contact: Erick Gamelin, MD    33-2-4135-2700    e.gamelin@unimedia.fr Less <<
NCT03607656 Gastric Cancer Stage IIIB ... More >> Gastric Cancer Stage IIIC Less << Phase 2 Phase 3 Recruiting November 30, 2021 China, Shanghai ... More >> Longhua Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Aiguang Zhao, M.D.,Ph D.    13661472241    2538312201@qq.com    Contact: Nida Cao, M.D.    13818949357    amandatsao77@163.com Less <<
NCT00383695 Colorectal Cancer Phase 2 Unknown - Spain ... More >> Vall d'Hebron University Hospital Barcelona, Spain, 08035 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Sweden Karolinska University Hospital - Solna Stockholm, Sweden, S-171 76 Uppsala University Hospital Uppsala, Sweden, S-75185 United Kingdom Royal Bournemouth Hospital NHS Trust Bournemouth, England, United Kingdom, BH7 7DW Sussex Cancer Centre at Royal Sussex County Hospital Brighton, England, United Kingdom, BN2 5BE Eastbourne District General Hospital Eastbourne, England, United Kingdom, BN21 2UD Cancer Research UK Clinical Groups at Guy's King's & St. Thomas' Hospitals London, England, United Kingdom, SE5 9NU Mid Kent Oncology Centre at Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Dorset Cancer Centre Poole Dorset, England, United Kingdom, BH15 2JB Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Less <<
NCT00305799 - Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Less <<
NCT01959061 Colorectal Cancer Metastatic Phase 4 Recruiting December 2017 China, Shanghai ... More >> Zhongshan Hospital Fudan University Recruiting Shanghai, Shanghai, China, 2000032 Contact: Jianhua Wang Less <<
NCT03488251 Non-hodgkin Lymphoma,B Cell ... More >> Refractory Diffuse Large B-Cell Lymphoma Relapsed Diffuse Large B-Cell Lymphoma Less << Phase 2 Recruiting February 15, 2022 United States, California ... More >> UC Irvine Health / Chao Family Comprehensive Cancer Center Recruiting Orange, California, United States, 92868 Contact: Michelle Perez    714-509-2414    michelrp@uci.edu    Principal Investigator: Elizabeth Brem, MD          United States, Indiana Indiana Blood and Marrow Transplantation Recruiting Indianapolis, Indiana, United States, 46237 Contact: Melanie Coleman    317-528-7298    melanie.coleman@franciscanalliance.org    Principal Investigator: Anand Tandra          United States, Ohio Good Samaritan Hospital Recruiting Cincinnati, Ohio, United States, 45220 Contact: Saulius Girnius, MD          Principal Investigator: Saulius Girnius Less <<
NCT00252564 Colorectal Cancer Metastatic Phase 3 Completed - -
NCT00115765 - Completed - -
NCT00016198 Colorectal Cancer Phase 2 Completed - -
NCT00131586 - Terminated - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT01503372 Advanced Gastric Cancer Phase 2 Unknown May 2015 Germany ... More >> Charite University medicine Recruiting Berlin, Germany, 13353 Contact: Mario Lorenz    + 49 30-450 553 889    magenkarzinom@charite.de    Contact: Daniela Bohnen    + 49 30-450 553 889    magenkarzinom@charite.de    Principal Investigator: Peter Thuss-Patience, Dr.          Sub-Investigator: Kirstin Breithaupt, Dr. Less <<
NCT01928524 First-line Treatment for Patie... More >>nts With Non-resectable Gastric Cancer or Cancer of the Esophagus or Less << Phase 1 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Less <<
NCT01487915 Advanced Urothelial Carcinoma Phase 2 Unknown - Korea, Republic of ... More >> Keimyeong University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Hong Seok Song, MD, PhD.          Contact: Jin Young Kim, MD          Chungnam University Hospital Recruiting Daejeon, Korea, Republic of, 301-721 Contact: Hyo Jin Lee, MD, PhD.          Korea University Anam Hospital Recruiting Seoul, Korea, Republic of, 136-705 Contact: Kyeong Hwa Park, MD, PhD          Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Jeong-Mi Ko, MSc       crnonc8@amc.seoul.kr    Principal Investigator: Jae-Lyun Lee, MD, PhD.          Sub-Investigator: Jin-Hee Ahn, MD, PhD.          Sub-Investigator: Hanjong Ahn, MD, PhD.          Sub-Investigator: Jun Hyuk Hong, MD, PhD.          Sub-Investigator: Cheryn Song, MD, PhD.          Sub-Investigator: Cheong Soo Kim, MD, PhD.          Chung Ang University Hospital Not yet recruiting Seoul, Korea, Republic of, 156-755 Contact: Hee Joon Kim, MD Less <<
NCT00252564 - Completed - -
NCT01955629 Colorectal Cancer Metastatic Phase 1 Phase 2 Terminated(The study enrollmen... More >>t was prematurely halted due to safety reasons.) Less << - Italy ... More >> Investigational Site Number 380-001 Genova, Italy, 16132 Investigational Site Number 380-002 Milano, Italy Less <<
NCT01489865 Metastatic Pancreatic Cancer Phase 1 Phase 2 Recruiting December 2019 United States, District of Col... More >>umbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Sarah Parenti    202-687-8350    sep88@georgetown.edu    Contact: Lisa Ley, RN MSN    202-687-6653    leyl@georgetown.edu    Principal Investigator: Michael Pishvaian, MD PhD Less <<
NCT01955629 - Terminated(The study enrollmen... More >>t was prematurely halted due to safety reasons.) Less << - -
NCT00006465 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02855788 Metastatic Gastric Cancer ... More >> Locally Advanced Gastric Cancer Less << Phase 2 Unknown October 2018 United States, Washington ... More >> Seattle Integrative Cancer Center Not yet recruiting Seattle, Washington, United States, 98188 Contact: Nick N Chen, M.D., Ph.D.    206-588-1722    nicknchenmd@gmail.com    Contact: Deb Ellifritt, BS    207-588-1722    debe@siccwa.com    Principal Investigator: Nick N Chen, M.D., Ph.D.          China, Shanghai Huashan Hospital Recruiting Shanghai, Shanghai, China, 200040 Contact: Zhongguang Luo, M.D.    021-5288237    luozg8@126.com    Contact: Jun Zhang, M.D.    021-5288237    archsteed@163.com    Principal Investigator: Jie Liu, M.D.          Principal Investigator: Nick N Chen, M.D., Ph.D. Less <<
NCT01521702 Pancreas Cancer Phase 3 Completed - France ... More >> Institut Paoli Calmettes Marseille, France, 13009 Less <<
NCT00555620 - Completed - -
NCT02539225 Metastatic Gastric Adenocarcin... More >>oma Gastroesophageal Junction Adenocarcinoma Less << Phase 2 Active, not recruiting November 2019 Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Akashi, Japan, 673-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bunkyo-Ku, Japan, 113-8677 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 260-8717 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gifu, Japan, 501-1194 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kochi, Japan, 781-8555 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Koto-ku, Japan, 135-8550 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Koto-ku, Japan, 135-8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 860-8556 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagoya, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagoya, Japan, 466-8560 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 534-0021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 541-8567 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 558-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sagamihara, Japan, 252-0375 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sakai, Japan, 593-8304 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sapporo, Japan, 060-8648 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shinjuku-Ku, Japan, 160-8582 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suita-shi, Japan, 565-0871 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Takatsuki, Japan, 569-8686 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Toyonaka, Japan, 560-8565 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Utsunomiya, Japan, 320-0834 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yokohama, Japan, 224-8503 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yokohama, Japan, 241-8515 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 03080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 03722 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 05505 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 06273 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 06351 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulsan-si, Korea, Republic of, 44033 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuei Shan Hsiang, Taiwan, 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 40447 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 10048 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 11217 Less <<
NCT00647530 Colorectal Cancer Phase 2 Phase 3 Active, not recruiting May 31, 2019 United Kingdom ... More >> Birmingham Clinical Trials Unit Birmingham,, England, United Kingdom, B15 2RR Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom, B15 2TH Queen Elizabeth Hospital Gateshead, England, United Kingdom, NE9 6SX Huddersfield Royal Infirmary Huddersfield, West Yorks, England, United Kingdom, HD3 3EA Royal Lancaster Infirmary Lancaster, England, United Kingdom, LA1 4RP Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Clatterbridge Centre for Oncology Merseyside, England, United Kingdom, CH63 4JY Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Southport and Formby District General Hospital Southport, England, United Kingdom, PR8 6PN Sandwell General Hospital West Bromwich, England, United Kingdom, B71 4HJ Less <<
NCT00559455 Carcinoma, Hepatocellular Phase 2 Completed - Korea, Republic of ... More >> Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Less <<
NCT01307592 Lymphoma Phase 2 Unknown - Puerto Rico ... More >> Centro de Cancer del Hospital Auxilio Mutuo Recruiting San Juan, Puerto Rico, 00936-2712 Contact: Clinical Trial Coordinator    787-771-7933 ext. 3569    iliboy@auxiliomutuo.com Less <<
NCT00227747 Colorectal Cancer Phase 3 Unknown - -
NCT00601198 Colorectal Cancer Phase 2 Terminated(Funding support wit... More >>hdrawn) Less << - United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT01415713 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT01862315 Intrahepatic Cholangiocarcinom... More >>a Peripheral Cholangiocarcinoma Cholangiolar Carcinoma Cholangiocellular Carcinoma Less << Phase 2 Recruiting May 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: William Jarnagin, MD    212-639-7601       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: William R. Jarnagin, MD    212-639-7601       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: William Jarnagin, MD    212-639-7601       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: William Jarnagin, MD    212-639-7601       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: William R Jarnagin, MD    212-639-7601       Contact: Nancy Kemeny, MD    646-888-4180       Principal Investigator: William R Jarnagin, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: William Jarnagin, MD    212-639-7601 Less <<
NCT02412683 - Completed - Sweden ... More >> Jenny Drott Linkoping, Sweden, 58183 Less <<
NCT01130337 Gastric Cancer Phase 2 Completed - Spain ... More >> Elche, Alicante, Spain, 03203 Oviedo, Asturias, Spain, 33006 Santander, Cantabria, Spain, 39008 San Sebastian, Guipuzcoa, Spain, 20014 Palma de Mallorca, Islas Baleares, Spain, 07198 Vigo, Pontevedra, Spain, 36204 La Laguna, Tenerife, Spain, 38320 Barakaldo, Vizcaya, Spain, 48903 Barcelona, Spain, 08003 Barcelona, Spain, 08035 Barcelona, Spain, 08036 Barcelona, Spain, 08907 Barcelona, Spain, 08916 Burgos, Spain, 09006 Cordoba, Spain, 14004 Granada, Spain, 18014 La Coruña, Spain, 15006 Leon, Spain, 24071 Lerida, Spain, 25198 Lugo, Spain, 27003 Madrid, Spain, 28007 Madrid, Spain, 28040 Madrid, Spain, 28041 Orense, Spain, 32005 Sevilla, Spain, 41013 Sevilla, Spain, 41014 Toledo, Spain, 45004 Valencia, Spain, 46009 Valencia, Spain, 46014 Zaragoza, Spain, 50009 Less <<
NCT02550119 Malignant Digestive System Neo... More >>plasm Nausea and Vomiting Less << Not Applicable Terminated(Insufficient accrua... More >>l) Less << - United States, California ... More >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT02428101 - Enrolling by invitation December 2018 Egypt ... More >> Ain Shams University hospitals Cairo, Abbasia, Egypt Less <<
NCT00544349 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - France ... More >> Hopital Saint Andre Bordeaux, France, 33075 Centre Regional Francois Baclesse Caen, France, 14076 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 CHU Pitie-Salpetriere Paris, France, 75651 Centre Eugene Marquis Rennes, France, 35062 Hopital Paul Brousse Villejuif, France, 94804 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00098982 Colorectal Cancer Phase 1 Completed - Italy ... More >> Istituto Nazionale per lo Studio e la Cura dei Tumori Naples, Italy, 80131 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Less <<
NCT00766155 Colorectal Cancer Phase 3 Completed - -
NCT00004206 Ovarian Cancer Phase 2 Unknown - United Kingdom ... More >> University Hospitals of Leicester Leicester, England, United Kingdom, LE1 5WW Less <<
NCT01130337 - Completed - -
NCT02071043 Advanced Gastric Cancer Phase 2 Completed - China, Shanghai ... More >> Zhongshan Hospital Affiliated to Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT02590367 Peripheral Neuropathy Phase 2 Phase 3 Unknown October 2017 China, Jiangsu ... More >> Jiangsu Province Hospital of Integrated Chinese and Western Medicine Recruiting Nanjing, Jiangsu, China, 210028 Contact: Huo Jie Ge, M.D.    +86 02585637121    hjg16688@126.com Less <<
NCT01494363 Biliary Tract Cancer Phase 2 Unknown December 2013 Korea, Republic of ... More >> Hyun Jung Kim Recruiting Bucheon, Korea, Republic of Contact: Hyun Jung Kim, M.D.    +82-32-621-5114    khjbless@schmc.ac.kr    Han Jo Kim Recruiting Cheonan, Korea, Republic of Contact: Han Jo Kim, M.D.    +82-41-570-3693    hzmd@schmc.ac.kr    Nam Su Lee Recruiting Seoul, Korea, Republic of Contact: Nam Su Lee, M.D.    +82-2-709-9114    mdnslee@schmc.ac.kr Less <<
NCT01164215 Colorectal Cancer ... More >> Diarrhea Neutropenia Less << Phase 1 Completed - United States, North Carolina ... More >> Cancer Care of Western North Carolina Asheville, North Carolina, United States, 28801 Moses Cone Regional Cancer Center at Wesley Long Community Hospital Greensboro, North Carolina, United States, 27403-1198 Leo W. Jenkins Cancer Center at ECU Medical School Greenville, North Carolina, United States, 27834 Rex Cancer Center at Rex Hospital Raleigh, North Carolina, United States, 27607 Marion L. Shepard Cancer Center Washington, North Carolina, United States, 27889 Less <<
NCT00643877 Colorectal Neoplasms Phase 3 Unknown December 2014 China ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, China, 200032 Principal Investigator: jianmin xu, MD Less <<
NCT01310972 - Completed - Saudi Arabia ... More >> Kfsh & Rc Riyadh, Saudi Arabia Less <<
NCT01571284 Colorectal Cancer Metastatic Phase 3 Completed - -
NCT02069041 Carcinoma, Hepatocellular Phase 1 Completed - Taiwan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 10048 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taoyuan City, Taiwan, 33305 Less <<
NCT01760252 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 2 Active, not recruiting December 2022 United States, New York ... More >> Mount Sinai Beth Israel New York, New York, United States, 10003 St-Lukes Roosevelt Hospital Medical Center New York, New York, United States, 10018 Beth Israel Comprehensive Care Center New York, New York, United States, 10025 Less <<
NCT01661270 Colorectal Cancer Metastatic Phase 3 Completed - China ... More >> Investigational Site Number 156003 Beijing, China, 100071 Investigational Site Number 156001 Beijing, China, 100142 Investigational Site Number 156002 Beijing, China, 100210 Investigational Site Number 156004 Beijing, China, 100853 Investigational Site Number 156016 Chengdu, China, 610041 Investigational Site Number 156020 Chongqing, China, 400038 Investigational Site Number 156021 Fuzhou, China, 350014 Investigational Site Number 156008 Guangzhou, China, 510060 Investigational Site Number 156010 Hangzhou, China, 310003 Investigational Site Number 156011 Hangzhou, China, 310009 Investigational Site Number 156009 Hangzhou, China, 310016 Investigational Site Number 156015 Harbin, China, 150081 Investigational Site Number 156012 Nanjing, China, 210002 Investigational Site Number 156013 Nanjing, China, 210029 Investigational Site Number 156006 Shanghai, China, 200032 Investigational Site Number 156007 Shanghai, China, 200032 Investigational Site Number 156014 Shenyang, China, 110001 Investigational Site Number 156005 Tianjin, China, 300060 Investigational Site Number 156019 Wuhan, China, 430022 Investigational Site Number 156018 Wuhan, China, 430030 Investigational Site Number 156017 Xi'An, China, 710032 Hong Kong Investigational Site Number 344002 Hong Kong, Hong Kong Investigational Site Number 344001 Shatin, Nt, Hong Kong Japan Investigational Site Number 392006 Amagasaki-Shi, Japan Investigational Site Number 392003 Bunkyo-Ku, Japan Investigational Site Number 392004 Bunkyo-Ku, Japan Investigational Site Number 392009 Gifu-Shi, Japan Investigational Site Number 392002 Kitaadachi-Gun, Japan Investigational Site Number 392001 Kobe-Shi, Japan Investigational Site Number 392005 Kochi-Shi, Japan Investigational Site Number 392007 Kumamoto-Shi, Japan Investigational Site Number 392008 Nagakute-Shi, Japan Investigational Site Number 392010 Takatsuki-Shi, Japan Singapore Investigational Site Number 702002 Singapore, Singapore, 119228 Investigational Site Number 702001 Singapore, Singapore, 169610 Taiwan Investigational Site Number 158003 Taipai, Taiwan, 10043 Investigational Site Number 158002 Taipei, Taiwan Less <<
NCT01558869 Pancreatic Adenocarcinoma Phase 2 Completed - Hong Kong ... More >> Queen Mary Hospital, The University of Hong Kong Hong Kong, Hong Kong Less <<
NCT01661270 - Completed - -
NCT01526135 Pancreatic Adenocarcinoma (Duc... More >>tal Adenocarcinoma) Less << Phase 3 Active, not recruiting September 2021 -
NCT00043121 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT01552967 Colorectal Adenocarcinoma Phase 2 Unknown February 2014 China, Guangdong ... More >> the Sixth Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yue Cai, Master    86-20-38250745    chilly8518@163.com Less <<
NCT02069041 - Completed - -
NCT01571284 - Completed - -
NCT01586611 Metastatic Pancreas Cancer Phase 3 Unknown June 2015 Canada, Alberta ... More >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Jennifer L Spratlin, MD FRCPC    780-432-8514    Jennifer.Spratlin@albertahealthservices.ca    Contact: Karen Mulder, MC FRCPC    780-432-8514    Karen.Mulder@albertahealthservices.ca    Sub-Investigator: Jennifer L Spratlin, MD FRCPC          Sub-Investigator: Karen Mulder, MD FRCPC          Principal Investigator: Karen King, MC FRCPC Less <<
NCT00016978 Colorectal Cancer Phase 2 Completed - -
NCT01339832 - Completed - Switzerland ... More >> Basel, Switzerland, 4031 Chur, Switzerland, 7000 Luzern, Switzerland, 6004 St. Gallen, Switzerland, 9007 Zürich, Switzerland, 8063 Less <<
NCT03487939 Colorectal Neoplasms ... More >> Drug Therapy Less << Phase 2 Not yet recruiting May 1, 2021 -
NCT02359968 Esophageal Neoplasms Phase 2 Unknown October 2018 France ... More >> University Hospital of Lille Recruiting Lille, France, 59000 Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Antoine ADENIS, MD Less <<
NCT01397019 Pancreatic Cancer Phase 2 Unknown January 2017 Denmark ... More >> Aalborg University Hospital Withdrawn Aalborg, Denmark, 9100 Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Morten Ladekarl, MD    +45 8949 2565       Principal Investigator: Morten Ladekarl, MD          Herlev University Hospital Recruiting Herlev, Denmark, 2730 Contact: Benny V Jensen, MD    +45 3868 3868    bevi@heh.regionh.dk    Principal Investigator: Benny V Jensen, MD          Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Jon K Bjerregaard, MD    +45 6541 3834    jon.bjerregaard@ouh.regionsyddanmark.dk    Contact: Per Pfeiffer, Professor    +45 6541 2921    per.pfeiffer@ouh.regionsyddanmark.dk    Principal Investigator: Per Pfeiffer, Professor          Sub-Investigator: Jon K Bjerregaard, MD          Sub-Investigator: Michael B Mortensen, MD Less <<
NCT00016952 Colorectal Cancer Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57104 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT01504256 Gastric Adenocarcinoma With Pe... More >>ritoneal Carcinomatosis Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis Less << Phase 2 Completed - Germany ... More >> Prof. Dr. F. Lordick Leipzig, Germany, 04103 Less <<
NCT02555358 Gastric Cancer Phase 3 Recruiting December 2017 China, Hebei ... More >> Fourth Affiliated Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050011 Contact: Qun Zhao, doctor    13930162111    zhaoqun516@126.com Less <<
NCT03484221 Rectal Neoplasms ... More >> Drug Therapy Radiation Less << Phase 2 Recruiting April 1, 2021 China ... More >> China Medical University Recruiting Shenyang, China Contact: Yuanhe Wang Less <<
NCT01339832 - Completed - -
NCT00615056 Colorectal Neoplasms Phase 2 Completed - -
NCT03702491 Gallbladder Carcinoma Phase 2 Recruiting August 10, 2020 China, Shanghai ... More >> xiao qing xiao qing Jiang Recruiting Shanghai, Shanghai, China Contact: xiao q xiao qing Jiang    13801603438 ext 13801603438    Jxq1225@sina.com Less <<
NCT00615056 - Completed - -
NCT00438737 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Unknown - France ... More >> Hopital Ambroise Pare Boulogne, France, F-92104 Less <<
NCT01646554 Colorectal Cancer Metastatic ... More >> Liver Metastases KRAS Mutated Colorectal Cancer Less << Phase 2 Phase 3 Withdrawn December 2016 -
NCT01060007 Rectal Neoplasms Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01747551 - Completed - -
NCT00008060 Colorectal Cancer Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT01747551 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT01060007 - Completed - -
NCT02394834 Colorectal Cancer Phase 3 Active, not recruiting May 31, 2020 -
NCT00384176 Colorectal Cancer Phase 2 Phase 3 Completed - -
NCT02301481 Stomach Neoplasms ... More >> Neoadjuvant Therapy Chemoradiotherapy Chemotherapy Less << Phase 2 Recruiting December 2018 China ... More >> Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Recruiting Beijing, China, 100021 Contact: Xin Wang, MD    +8613311583220    beryl_wx2000@163.com Less <<
NCT00384176 - Completed - -
NCT02497157 Metastatic Colorectal Cancer Phase 2 Active, not recruiting September 2018 Japan ... More >> Matsuyama Red Cross Hospital Matsuyama-city, Ehime-prefecture, Japan, 790-8524 Kagawa University Hospital Kita-gun, Miki-cho, Kagawa-prefecture, Japan, 761-0793 Kawasaki Medical School Hospital Kurashiki-city, Okayama-prefecture, Japan, 701-0192 Okayama Saiseikai General Hospital Okayama-city, Okayama-prefecture, Japan, 700-8511 Okayama University Hospital Okayama-city, Okayama-prefecture, Japan, 700-8558 Okayama Rosai Hospital Okayama-city, Okayama-prefecture, Japan, 702-8055 Tokushima Red Cross Hospital Komatsushima-city, Tokushima-prefecture, Japan, 773-8502 Less <<
NCT02080221 Metastatic Pancreatic Cancer Phase 2 Recruiting December 2019 United States, Massachusetts ... More >> Southcoast centers for cancer care Recruiting Fairhaven, Massachusetts, United States, 02179 Contact: Kayla Rosati, EdM    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: Elizabeth Blanchard, MD          United States, Rhode Island Memorial Hospital of Rhode Island Withdrawn Pawtucket, Rhode Island, United States, 02860 Lifespan Hospitals (The Miriam and RI Hospital, East Greenwich, Newport) Recruiting Providence, Rhode Island, United States, 02903 Contact: kayla rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: Howard Safran, MD          Sub-Investigator: Kevin Charpentier, MD Less <<
NCT01399684 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT01640405 Metastatic Colorectal Cancer Phase 3 Active, not recruiting November 2018 Spain ... More >> Spanish Cooperative Group for Digestive Tumour Therapy Madrid, Spain, 28046 Less <<
NCT03126071 Advanced Colorectal Cancer Phase 2 Recruiting February 15, 2020 China, Jiangsu ... More >> Jiangsu Cancer Institute & Hospital Recruiting Nanjing, Jiangsu, China, 210009 Contact: Liangjun Zhu    +8613905199123    zhulj98@foxmail.com    Contact: Yuejiao Zhong    +861370575447    zhongyuejiao@163.com    Nantong Tumor Hospital Active, not recruiting Nantong, Jiangsu, China, 226000 The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Chunrong Zhu, M.D.    +8613063870566    zcr050311@163.com    Contact: Feng Xiong    +8613270971002    greenlemontea@126.com    China, Shanghai Rui Jin Hospital Shanghai Jiao Tong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200025 Contact: Jun Zhang, M.D. Less <<
NCT01941953 Metastatic Colorectal Cancer Phase 2 Completed - Brazil ... More >> Instituto Do Cancer Do Estado de São Paulo Sao Paulo, Brazil, 01246-000 Less <<
NCT01163396 Colorectal Cancer Metastatic Phase 2 Completed - -
NCT00755534 Colorectal Cancer Phase 2 Terminated(Due to poor accrual... More >>) Less << - Greece ... More >> University Hospital of Heraklion, Dep of Medical Oncology Heraklion, Creta, Greece University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece 401 Military Hospital of Athens Athens, Greece Air Forces Military Hospital of Athens Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece State General Hospital of Larissa Larissa, Greece "Metaxa's" Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology Piraeus, Greece "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology Thessaloniki, Greece Interbalkan Hospital, division of Oncology, Pylaia, Thessaloniki Thessaloniki, Greece Less <<
NCT01229111 Adult Primary Cholangiocellula... More >>r Carcinoma Advanced Adult Primary Liver Cancer Cholangiocarcinoma of the Extrahepatic Bile Duct Cholangiocarcinoma of the Gallbladder Localized Unresectable Adult Primary Liver Cancer Periampullary Adenocarcinoma Recurrent Adult Primary Liver Cancer Recurrent Extrahepatic Bile Duct Cancer Recurrent Gallbladder Cancer Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer Less << Phase 2 Terminated(Lack of Drug Supply... More >>) Less << - United States, Ohio ... More >> Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Ireland Cancer Center Landerbrook Health Center Mayfield Heights, Ohio, United States, 44124 Lake University Ireland Cancer Center Mentor, Ohio, United States, 44060 UHHS-Chagrin Highlands Medical Center Orange Village, Ohio, United States, 44122 UH-Seidman Cancer Center at Saint John Medical Center Westlake, Ohio, United States, 44145 Less <<
NCT02028806 Metastatic Pancreatic Cancer Phase 2 Recruiting December 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Li Yuhong, MD, Ph D       liyh@sysucc.org.cn    Principal Investigator: Li Yuhong, MD, Ph D Less <<
NCT01229111 - Terminated(Lack of Drug Supply... More >>) Less << - -
NCT00039611 Colorectal Cancer Not Applicable Completed - -
NCT01666730 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 2 Active, not recruiting November 2018 United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT02060669 Metastatic Colorectal Cancer Phase 3 Terminated(others) - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01383707 Colorectal Cancer Phase 2 Completed - Italy ... More >> IRCCS Istituto Nazionale Tumori Fondazione Pascale; Oncologia Medica A Napoli, Campania, Italy, 80131 Azienda Ospedaliero-Universitaria S.Orsola-Malpighi; Unità Operativa Oncologia Medica Bologna, Emilia-Romagna, Italy, 40138 A.O. Universitaria Policlinico Di Modena; Ematologia Modena, Emilia-Romagna, Italy, 41100 Azienda Ospedaliera Sant' Antonio Abate; Divisione di Oncologia Gallarate, Lombardia, Italy, 21013 Irccs Ospedale San Raffaele;Oncologia Medica Milano, Lombardia, Italy, 20132 Irccs Istituto Europeo Di Oncologia (IEO); Oncologia Medica Milano, Lombardia, Italy, 20141 Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia Milano, Lombardia, Italy, 20162 Fondazione IRCCS Policlinico San Matteo Pavia, Lombardia, Italy, 27100 Ospedali Riuniti Di Ancona; Oncology Ancona, Marche, Italy, 60121 Az Ospedaliera Nuovo Garibaldi Quartiere Nesima; Oncologia Medica Catania, Sicilia, Italy, 95122 Centro Catanese Di Oncologia; Oncologia Medica Catania, Sicilia, Italy, 95126 Less <<
NCT02425930 - Completed - China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510000 Less <<
NCT02085655 Extranodal NK-T-Cell Lymphoma,... More >> Nasal and Nasal-Type Less << Phase 3 Unknown December 2018 China, Guangdong ... More >> Department of Medical Oncology, Sun Yat-sen University Cancer Center, Recruiting Guangzhou, Guangdong, China, 510060 Contact: HuiQiang Huang    86-020-87343350    huanghq@sysucc.org.cn Less <<
NCT02046538 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Less << Phase 2 Withdrawn(Investigator termina... More >>ted due to funding issues) Less << February 2018 United States, New York ... More >> Weill Cornell Medical College New York city, New York, United States, 10065 Less <<
NCT00112918 - Completed - -
NCT00165867 Colorectal Cancer Phase 2 Completed - France ... More >> Hôpitaux Civils de Colmar Colmar, France, F- 68024 CRLC Val d'Aurelle Montpellier, France, F-34298 Centre Antoine Lacassagne Nice, France, F-06189 United Kingdom Aberdeen Royal Infirmary Aberdeen, United Kingdom, AB25 2ZN Beatson Oncology Centre Glasgow, United Kingdom, G11 6NT Cookridge Hospital Leeds, United Kingdom, LS16 6QB Leicester Royal Infirmary Leicester, United Kingdom, LE1 5WW Less <<
NCT00112918 Colorectal Cancer Phase 3 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT01383707 - Completed - -
NCT01523457 Metastatic Pancreatic Cancer ... More >> Pancreatic Cancer Less << Phase 2 Completed - United States, Connecticut ... More >> Smilow Cancer Center New Haven, Connecticut, United States, 06510 Less <<
NCT01523457 - Completed - -
NCT00779454 Cholangiocarcinoma Phase 2 Completed - Denmark ... More >> Vejle Hospital, Dept. of Oncology Vejle, Denmark, DK-7100 Less <<
NCT02229682 Lymphoma, Non... More >>-Hodgkin Lymphoma, Extranodal NK/T-cell Lymphoma,Nasal-type, Less << Phase 2 Not yet recruiting October 2019 China, Guangdong ... More >> Dept. Radiation Oncology, Sun Yat-sen University Cancer Center Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Yujing Zhang, MD/PhD    86-20-87343702    zhangyj@sysucc.org.cn    Principal Investigator: Yujing Zhang, MD/PhD Less <<
NCT01858662 Metastatic Colorectal Cancer Phase 2 Terminated(due to poor recrutm... More >>ent) Less << - Belgium ... More >> Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium, 6000 clinique Saint Luc Bouge, Belgium, 5004 Cliniques universitaires Saint-Luc - UCL Brussels, Belgium, 1200 Centre Hospitalier Jolimont Lobbes La Louvière, Belgium, 7100 CHU liège (Sart Timan) Liège, Belgium, 4000 Clinique Saint Pierre Ottignies Ottignies, Belgium, 1340 CHU-UCL Dinant-Godinne Yvoir, Belgium, 5530 Less <<
NCT02842580 Colorectal Neoplasms Phase 2 Recruiting July 2021 France ... More >> CHU Robert DEBRE Recruiting Reims, France Contact: Olivier BOUCHE          Saint Etienne - Chu Recruiting Saint Etienne, France Contact: Jean Marc PHELIP Less <<
NCT00478946 Colorectal Cancer Phase 1 Phase 2 Unknown June 2010 Russian Federation ... More >> Leningrad Regional Oncology Center, Chemotherapy Department - Phase 2 Kuzmolovsky Village, Vsevolozhsk, Russian Federation, 188663 Regional Oncology Center - Phase 2 Astrakhan, Russian Federation, 414041 Chelyabinsk Regional Oncology Center - Phase 1 Chelyabinsk, Russian Federation, 454087 Regional Oncology Center, Chemotherapy Department - Phase 2 Engels, Russian Federation, 413115 Kazan Oncology Center Kazan, Russian Federation, 420111 Blokhin Russian Oncology Research Center - Phase 1 Moscow, Russian Federation, 115478 Semashko Central Clinical Hospital #2 - Phase 1 Moscow, Russian Federation, 129128 Medical Radiology Research Center of Russian Academy of Medical Sciences- Phase 1 Obninsk, Russian Federation, 249036 Republic Oncology Center of the Ministry of Healthcare of Karelia Republic - Phase 2 Petrozavodsk, Russian Federation, 185007 Rostov Research Institute of Oncology- Phase 2 Rostov-na-Dony, Russian Federation, 350086 St. Petersburg Academy of Postgraduate Education - Phase 2 St. Petersburg, Russian Federation, 194291 St. Petersburg Mechnikov State Medical Academy - Phase 2 St. Petersburg, Russian Federation, 195067 St. Petersburg City Oncology Center - Phase 1 St. Petersburg, Russian Federation, 198255 Regional Clinical Oncology Center - Phase 2 Ulyanovsk, Russian Federation, 432063 Voronezh Regional Clinical Oncology Center - Phase 2 Voronezh, Russian Federation, 394000 Yaroslavl Regional Oncology Center - Phase 1 Yaroslavl, Russian Federation, 150054 Less <<
NCT00737373 Gastric Cancer ... More >> Adenocarcinoma of the Esophagogastric Junction Less << Phase 2 Completed - Germany ... More >> Krankenhaus Nordwest Frankfurt, Germany, 60488 Less <<
NCT02359162 Lymphoma, Extranodal NK-T-Cell Phase 3 Terminated(The study is out of... More >> date) Less << - China, Guangdong ... More >> Sun Yat-sen University Cancer Center GuangZhou, Guangdong, China, 510060 Less <<
NCT02289547 Stomach Neoplasms Phase 3 Recruiting January 2019 Korea, Republic of ... More >> St. Vincent's Hospital Recruiting Suwon, Gyeonggi-do, Korea, Republic of, 442-723 Contact: Byoungyong Shim, Ph.D., M.D    82-31-249-8457       Principal Investigator: Byoungyong Shim, M.D., Ph.D          Buchon St. Mary's Hospital Recruiting Buchon, Korea, Republic of Contact: Cuk Jin Lee          Daejeon St. Mary's Hospital Recruiting Daejeon, Korea, Republic of Contact: Ji Chan Park          Incheon St. Mary's Hospital Recruiting Incheon, Korea, Republic of Contact: Jeo Ho Byen          Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Young Seon Hong          St. Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: In Sook Woo          Bundang Seoul National hospital Recruiting Sungnam, Korea, Republic of Contact: Keun Wook Lee          Ujeongbu St. Mary's Hospital Recruiting Ujeongbu, Korea, Republic of Contact: Yoon Ho Ko Less <<
NCT01560949 Pancreatic Cancer Phase 2 Active, not recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00852228 Metastatic Colorectal Cancer ... More >> Liver Metastases Hepatic Lesions Less << Phase 2 Unknown December 2015 Belgium ... More >> Clinique Saint-Joseph Liège, Belgium, 4000 France CHU de Bordeaux, Hôpital Saint-André Bordeaux, France, 33000 Hôpital Ambroise Paré Boulogne-Billancourt, France, 92100 Centre Jean Perrin Clermont-Ferrand, France, 63011 CHRU de Lille, Hôpital Claude Huriez Lille, France, 59037 Hôpital Cochin Paris, France, 75014 Hôpital Européen Georges Pompidou Paris, France, 75015 CHU Toulouse Toulouse, France, 31059 Chronotherapy Unit, Medical Oncology Department, Paul Brousse Hospital Villejuif, France, 94800 Institut Gustave Roussy Villejuif, France, 94800 Italy Università G. d'Annunzio Chieti, Italy, 66100 Azienda Ospedaliera S.Maria Degli Angeli Pordenone, Italy, 33170 Istituto Regina Elena Roma, Italy, 00144 Portugal Hospital Fernando Fonesca Amadora, Portugal, 27000 Less <<
NCT01051167 Metastatic Colorectal Cancer Phase 2 Completed - Germany ... More >> University of Duisburg-Essen Medical School Essen, Nordrhein-Westfalen, Germany, 45122 Alfried Krupp von Bohlen und Halbach Krankenhaus gGmbH Essen, Nordrhein-Westfalen, Germany, 45131 Prosper Hospital Recklinghausen Recklinghausen, Nordrhein-Westfalen, Germany, 45659 Less <<
NCT00541112 Colorectal Cancer Phase 2 Unknown - France ... More >> Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Marianne Fonck, MD    33-5-5633-3242       Centre de Lutte Contre le Cancer Georges-Francois Leclerc Recruiting Dijon, France, 21079 Contact: Philippe Maingon, MD    33-380-737-517    mcperrin@dijon.fnclcc.fr    Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Xavier Mirabel    33-3-2029-5521       Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Isabelle Martel Lafay, MD    33-4-7878-5166       Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: David Azria, MD, PhD    33-4-6761-3132    David.Azria@valdorel.fnclcc.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Eric Francois    33-4-9203-1613       Centre Hospitalier Lyon Sud Recruiting Pierre Benite, France, 69495 Contact: Jean-Christophe Saurin    33-4-7886-1289       Centre Rene Huguenin Recruiting Saint Cloud, France, 92210 Contact: Frederique B. Cvitkovic, MD    33-1-4711-1515    f.cvitkovic@stcloud-huguenin.org    Centre Alexis Vautrin Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Thierry Conroy, MD    33-3-8359-8460       Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Patrick Ezra, MD    33-1-4211-4125 Less <<
NCT00052962 - Completed - -
NCT00355888 Cancer Phase 1 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030-4009 Institute for Drug Development San Antonio, Texas, United States, 78245 Less <<
NCT00052962 Gastrointestinal Neoplasm Phase 3 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00513266 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Unknown - Switzerland ... More >> Kantonspital Aarau Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Hopital Regional de Sion-Herens-Conthey Sion, Switzerland, CH -1951 Less <<
NCT03125980 Locally Advanced Colon Cancer Phase 3 Recruiting May 2027 China, Shanghai ... More >> Department of Colorectal Surgery Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Sanjun Cai, M.D    +86-21-64175590 ext 81108    caisanjuncsj@163.com Less <<
NCT00719797 Colorectal Cancer Phase 3 Completed - Italy ... More >> Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica Alessandria, Italy, 15100 A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona - Ancona (An) Oncologia Medica Ancona, Italy, 60100 P.O. Zona Aretina - Ospedale S. Donato Di Arezzo - Arezzo (Ar) Oncologia Medica Arezzo, Italy, 52100 Irccs Centro Di Riferimento Oncologico (Cro) - Aviano (Pn) Oncologia Medica Aviano, Italy, 33081 Ospedale S. Orsola F.B.F. - Brescia - Brescia (Bs) Oncologia Medica Brescia, Italy, 25122 Istituto Ospedaliero Fondazione Poliambulanza Di Brescia - Brescia (Bs) Oncologia Medica Brescia, Italy, 25124 Stabilimento "Perrino" - Brindisi - Brindisi (Br) Oncologia Medica Brindisi, Italy, 72100 Azienda Ospedaliera S. Elia - Caltanissetta (Cl) Oncologia Medica Caltanissetta, Italy, 93100 Ausl 1 Di Massa E Carrara - Carrara (Ms) Oncologia Medica Carrara, Italy, 54033 Ospedale Cecina - Cecina (Li) Oncologia Medica Cecina, Italy, 57023 Istituti Ospitalieri - Cremona - Cremona (Cr) Oncologia Medica Cremona, Italy, 26100 Azienda Ospedaliera S. Croce E Carle Di Cuneo - Cuneo (Cn) Oncoematologia Cuneo, Italy, 12100 Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica Empoli, Italy, 50053 U.S.L.N.6 -Ospedale Civile 'E.Profili'-F - Fabriano (An) Oncologia Medica Fabriano, Italy, 60044 Ausl 10 Di Firenze - Firenze (Fi) Oncologia Medica Firenze, Italy, 50122 Irccs Istituto Nazionale Per La Ricerca Sul Cancro (Ist) - Genova (Ge) Oncologia Medica Genova, Italy, 16132 Ausl Le Di Lecce - Lecce (Le) Oncologia Medica Lecce, Italy, 73100 Aulss 21 Di Legnago (Vr) - Legnago (Vr) Oncologia Medica Legnano, Italy, 37045 Ausl 12 Di Viareggio (Lu) - Lido Di Camaiore (Lu) Oncologia Medica Lido di Camaiore, Italy, 55053 Ospedale Livorno - Livorno (Li), Oncologia Medica Livorno, Italy, 57100 Presidio Ospedaliero Piana Di Lucca - Lucca (Lu) Oncologia Medica Lucca, Italy, 25124 Irccs Fondazione Centro S. Raffaele Del Monte Tabor - Milano (Mi) Oncologia Medica Milano, Italy, 20132 Ospedale Ca` Granda-Niguarda - Milano - Milano (Mi) Oncologia Medica Milano, Italy, 20162 S.Gerardo - Monza - Monza (Mi) Oncologia Medica Monza, Italy, 20052 A.O. Universitaria Federico Ii Di Napoli Oncologia Medica Napoli, Italy, 80131 A.O. Universitaria Maggiore Della Carita' Di Novara Oncologia Medica Novara, Italy, 28100 A.O. Universitaria Di Parma Oncologia Medica Parma, Italy, 43100 Asl 1 Di Citta' Di Castello (Pg) - Citta' Di Castello (Pg) Oncologia Medica Perugia, Italy, 06012 A.O. Di Perugia - Ospedale S. Maria Della Misericordia (Ex Silvestrini) - Perugia (Pg) Oncologia Medica Perugia, Italy, 06156 Azienda Ospedaliera San Salvatore - Pesaro (Pu) Oncologia Medica Pesaro, Italy, 61100 Ospedale Della Valdinievole - Pescia (Pt) Oncologia Medica Pescia, Italy, 51017 Ospedale Piombino - Piombino (Li) Oncologia Medica Piombino, Italy, 57100 A.O. Universitaria Pisana Oncologia Medica Pisa, Italy, 56100 Ausl 5 Di Pisa - Pisa (Pi) Oncologia Medica Pisa, Italy, 56100 Alfredo Falcone A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica Pisa, Italy, 56126 Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica Pistoia, Italy, 51100 Ausl 4 Di Prato - Prato (Po) Oncologia Medica Prato, Italy, 59100 Ospedale Di S. Maria Nuova - Reggio Nell`Emilia (Re) Oncologia Medica Reggio Emilia, Italy, 42100 Policlinico Universitario Campus Bio-Medico Di Roma Oncologia Medica Rome, Italy, 00155 Policlinico Umberto I Di Roma Oncologia Medica Rome, Italy, 00161 Policlinico Universitario Gemelli Di Roma Oncologia Medica Rome, Italy, 00168 A.O. Universitaria Senese Oncologia Medica Siena, Italy, 53100 Ospedale Civile - Sondrio - Sondrio (So) Oncologia Medica Sondrio, Italy, 23100 A.O. Universitaria S. Giovanni Battista-Molinette Di Torino Oncologia Medica Torino, Italy, 10134 Less <<
NCT00321685 Rectal Adenocarcinoma ... More >> Stage II Rectal Cancer AJCC v7 Stage III Rectal Cancer AJCC v7 Less << Phase 2 Active, not recruiting May 1, 2020 -
NCT00153998 Colorectal Cancer ... More >> Liver Metastases Less << Phase 2 Completed - Austria ... More >> Medizinische Universitaet Wien, Universitaetsklinik für Chirurgie Wien, Austria, A-1090 Germany Kreiskrankenhaus Aschersleben Aschersleben, Germany, 06449 Charite-Campus Benjamin Franklin, Innere Medizin Berlin, Germany, 12200 Charite-Campus, Virchow-Klinikum, Innere Medizin Berlin, Germany, 13353 Allgemeines Krankenhaus Celle Celle, Germany, 29223 University Hospital "Carl Gustav Carus" Dresden, Germany, 01307 Florence-Nightingale-Krankenhaus Duesseldorf, Germany, 40489 Universitaet Erlangen-Nuernberg, Chirurgie Erlangen, Germany, 91054 Westdeutsches Tumorzentrum, Universitaetsklinikum Essen Essen, Germany, 45112 Johann Wolfgang Goethe Universitaet, Chirurgie Frankfurt Main, Germany, 60596 Westpfalz-Klinikum GmbH Innere Medizin I Kaiserslautern, Germany, 67653 UKSH Campus Kiel, II. Medizinische Klinik Kiel, Germany, 24116 Staedtisches Klinikum Magdeburg-Olvenstedt Magdeburg, Germany, 39130 Universitaetsklinik Mannheim gGmbH, III. Medizinische Klinik Mannheim, Germany, 68167 Klinikum Grosshadern, III. Medizinische Klinik Muenchen, Germany, 81377 Klinikum Oldenburg GmbH Oldenburg, Germany, 26133 Klinikum Passau, II. Medizinische Klinik Passau, Germany, 94032 Klinikum der Hansestadt Stralsund GmbH, Medizinische Klinik Stralsund, Germany, 18435 Krankenhaus der Barmherzigen Brueder Trier, Chirurgie Trier, Germany, 54292 Universitaetsklinikum Tuebingen Tuebingen, Germany, 72076 Universitaetsklinikum Wuerzburg, Chirurgie Wuerzburg, Germany, 97080 Less <<
NCT00321685 - Active, not recruiting - -
NCT01070290 Gastric Cancer Phase 2 Withdrawn - -
NCT00482222 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 3 Unknown - United Kingdom ... More >> Basildon University Hospital Recruiting Basildon, England, United Kingdom, SS16 5NL Contact: Pauline Leonard, MD    44-1702-435-555       Basingstoke and North Hampshire NHS Foundation Trust Recruiting Basingstoke, England, United Kingdom, RG24 9NA Contact: Charlotte Rees, MD    44-125-631-4793       Royal Bournemouth Hospital Recruiting Bournemouth, England, United Kingdom, BH7 7DW Contact: Tamas Hickish, MD    44-1202-303-626    tamas.hickish@rbch.nhs.uk    Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 0QQ Contact: Pippa Corrie, PhD, FRCP    44-1223-274-401    pippa.corrie@addenbrookes.nhs.uk    St. Luke's Cancer Centre at Royal Surrey County Hospital Recruiting Guildford, England, United Kingdom, GU2 7XX Contact: Sharadah Essapen, MD    44-1483-571-122       Aintree University Hospital Recruiting Liverpool, England, United Kingdom, L9 7AL Contact: Graeme J. Poston, MD    44-151-525-5980    graeme.poston@aintree.nhs.uk    Royal Liverpool University Hospital Recruiting Liverpool, England, United Kingdom, L9 7AL Contact: Paula Ghaneh, MD          Saint Bartholomew's Hospital Recruiting London, England, United Kingdom, EC1A 7BE Contact: Sarah Slater, MD    44-20-7601-8391       UCL Cancer Institute Recruiting London, England, United Kingdom, NW3 2PF Contact: Astrid Mayer, MD    44-207-794-0500    a.mayer@ucl.ac.uk    Royal Marsden - London Recruiting London, England, United Kingdom, SW3 6JJ Contact: David Cunningham, MD    44-20-8661-3156       Charing Cross Hospital Recruiting London, England, United Kingdom, W6 8RF Contact: Charles P. Lowdell, MD, BSc, MBBS, FRCP, FRCR    44-208-383-0576    charles.lowdell@imperial.nhs.uk    Clatterbridge Centre for Oncology Recruiting Merseyside, England, United Kingdom, CH63 4JY Contact: David Smith, MD    44-151-334-1155    david.smith@ccotrust.nhs.uk    St. Mary's Hospital Recruiting Newport, England, United Kingdom, PO30 5TG Contact: Christopher Baughan, MD    44-1983-524-081       Cancer Research Centre at Weston Park Hospital Recruiting Nottingham, England, United Kingdom, NG5 1PB Contact: J. Hornbuckle, MD    44-115-969-1169 ext. 47599       Dorset Cancer Centre Recruiting Poole Dorset, England, United Kingdom, BH15 2JB Contact: Tamas Hickish, MD    44-1202-442-532       Salisbury District Hospital Recruiting Salisbury, England, United Kingdom, SP2 8BJ Contact: Tim J. Iveson, MD    44-1722-336-262 ext. 4688       Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: John N. Primrose, MD    44-23-8079-6144    j.n.primrose@soton.ac.uk    Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: David Cunningham, MD    44-20-8661-3279    david.cunningham@rmh.nhs.uk    Southend University Hospital NHS Foundation Trust Recruiting Westcliff-On-Sea, England, United Kingdom, SS0 0RY Contact: Pauline Leonard, MD    44-1702-435-555       Worthing Hospital Recruiting Worthing, England, United Kingdom, BN11 2DH Contact: Andrew Webb, MD    44-1903-205-111       Velindre Cancer Center at Velindre Hospital Recruiting Cardiff, Wales, United Kingdom, CF14 2TL Contact: Timothy Maughan, MD    44-2920-316-904       University Hospital of Wales Recruiting Cardiff, Wales, United Kingdom, CF14 4XW Contact: Timothy Maughan, MD    44-2920-316-904 Less <<
NCT00005036 Mucinous Adenocarcinoma of the... More >> Colon Mucinous Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IIIA Colon Cancer Stage IIIA Rectal Cancer Stage IIIB Colon Cancer Stage IIIB Rectal Cancer Stage IIIC Colon Cancer Stage IIIC Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 3 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT03001726 Gastric Cancer Phase 3 Enrolling by invitation January 2022 China, Shanghai ... More >> Zhongshan hospital Shanghai, Shanghai, China, 200000 Less <<
NCT02048540 Locally Advanced Gastric Carci... More >>noma Less << Phase 1 Phase 2 Completed - China, Beijing ... More >> First Affiliated Hospital, Chinese PLA General Hospital Beijing, Beijing, China, 100048 Less <<
NCT00077233 Colorectal Cancer Phase 3 Terminated(Poor accrual) - -
NCT01763450 Liver Metastases ... More >> Colorectal Cancer Less << Phase 2 Unknown September 2014 China, Heilongjiang ... More >> Second Affiliated Hosptial of Harbin Medical University Harbin, Heilongjiang, China, 150086 China, Liaoning Liaoning Cancer Hospital&Institute Shenyang, Liaoning, China Less <<
NCT02350530 Metastatic Colorectal Cancer Phase 2 Recruiting January 2020 China, Guangdong ... More >> The Sixth Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanhong Deng, M.D.    008613925106525    13925106525@163.com Less <<
NCT02177552 Esophageal Neoplasms ... More >> Stomach Neoplasms Less << Phase 2 Recruiting November 2019 Denmark ... More >> Finsen Center, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Principal Investigator: Peter C Petersen, MD          Sub-Investigator: Lene Baeksgaard, MD Less <<
NCT00471484 Liver Cancer Phase 2 Unknown - Singapore ... More >> National Cancer Centre - Singapore Recruiting Singapore, Singapore, 169610 Contact: Donald Poon, MD    65-6-436-8000 Less <<
NCT03110926 Esophageal Carcinoma Phase 2 Recruiting June 2022 United States, New York ... More >> University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Tanya Smith, BS    585-275-5823    tanya_smith@urmc.rochester.edu    Contact: Mohamedtaki A Tejani, MD    585-275-5823    mohamed_tejani@urmc.rochester.edu Less <<
NCT00803647 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00803647 - Completed - -
NCT00003834 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT00066274 Colorectal Cancer Phase 2 Unknown - France ... More >> Centre Hospitalier de L' Agglomeration Montargoise Amilly, France, 45207 Pole Sante Sarthe et Loir Hopital Pierre Daguet Angers, France, 49036 Institut Bergonie Bordeaux, France, 33076 Centre Regional Francois Baclesse Caen, France, 14076 Clinique Sainte-Marguerite Hyeres, France, 83400 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 Centre Oscar Lambret Lille, France, 59020 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 CHR D'Orleans - Hopital de la Source Orleans, France, 45100 Polyclinique Francheville Perigueux, France, 24004 Centre Eugene Marquis Rennes, France, 35062 CHG Roanne Roanne, France, F-42300 Centre Hospitalier de Rodez Rodez, France, 12027 Centre Rene Huguenin Saint Cloud, France, 92210 Centre Hospitalier Regional Metz Thionville Thionville, France, 57126 Centre Hospitalier General Lucien Hussel Vienne, France, 38200 Less <<
NCT03504618 - Completed - Vietnam ... More >> Hanoi Medical University Hanoi, Vietnam, 10000 Less <<
NCT02394795 Colorectal Cancer Phase 3 Active, not recruiting March 1, 2020 -
NCT01618474 Stomach Cancer Phase 2 Unknown December 2016 China, Tianjin ... More >> Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Hospital Tianjin, Tianjin, China, 300060 Less <<
NCT02167321 Locally Advanced Rectal Cancer Phase 3 Recruiting May 2021 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Joong Bae Ahn, M.D., Ph.D.       vvswm513@yuhs.ac    Principal Investigator: Joong Bae Ahn, M.D., Ph.D. Less <<
NCT01858649 Metastatic Colorectal Cancer Phase 2 Recruiting May 2019 Belgium ... More >> Clinique Saint Luc Recruiting Bouge, Belgium, 5004 Contact: Laurence Jacqmin       laurence.jacqmin@slbo.be    CHIREC Recruiting Brussels, Belgium, 1180 Contact: sandrine roland, MD    02.434.46.64    roland_sandrine@yahoo.fr    Contact: eugene mucyo    02.434.46.64    datamanagercci@skynet.be    Cliniques universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Marc Van den Eynde, MD    0032764 ext 1041    marc.vandeneynde@uclouvain.be    Principal Investigator: Marc Van den Eynde, MD          Grand Hopital de Charleroi Recruiting Charleroi, Belgium, 6000 Contact: Javier Carrasco, MD PhD    00327110 ext 4701    javier.carrasco@ghdc.be    Principal Investigator: Javier Carrasco, MD PhD          AZ Groeninge Recruiting Kortrijk, Belgium, 8500 Contact: philippe vergauwe, MD       philippe.vergauwe@azgroeninge.be    Contact: Fien Verplancke    056 63 33 38    fien.verplancke@azgroeninge.be    Centre Hospitalier Jolimont Lobbes Recruiting La Louvière, Belgium, 7100 Contact: Benedicte Petit, MD    +32.64.23.39.87    benedicte.petit@entitejolimontoise.be    Principal Investigator: Benedicte Petit, MD          CHC Liège clinique Saint Joseph Recruiting Liège, Belgium, 4000 Contact: Gauthier Demolin, MD    +32.4.224.89.92    gauthier.demolin@chc.be    Principal Investigator: Gauthier Demolin, MD          CHU liège (Sart Timan) Recruiting Liège, Belgium, 4000 Contact: Daniel Van Daele, MD    +32.04.242.55.21    daniel.vandaele@chu.ulg.ac.be    Principal Investigator: Daniel Van Daele, MD          Clinique Maternité Saint Elisabeth Recruiting Namur, Belgium, 5000 Contact: Jean-Charles Goeminne, MD    +32.81.720.761    jeancharles.goeminne@cmsenamur.be    Principal Investigator: Jean-Charles Goeminne, MD          Clinique Saint Pierre Ottignies Recruiting Ottignies, Belgium, 1340 Contact: Jean-Charles Coche, MD    +32.10.437.479    jc.coche@skynet.be    Principal Investigator: Jean-Charles Coche, MD          CHU-UCL Dinant-Godinne Recruiting Yvoir, Belgium, 5530 Contact: Lionel D'hondt, MD PhD    +32.81.42.38.53    lionel.dhondt@uclouvain.be    Principal Investigator: Lionel D'Hondt, MD PhD Less <<
NCT00004242 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT01322178 Colorectal Cancer ... More >> Liver Metastases Less << Phase 2 Unknown December 2013 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China Contact: Wenhua Li, MD    8621-64175590    whliiris@hotmail.com Less <<
NCT00118755 Colorectal Cancer Phase 2 Completed - -
NCT01812148 - Completed - Canada, Quebec ... More >> Maisonneuve Rosemont Hospital Montréal, Quebec, Canada, H1T 2M4 Less <<
NCT00118755 - Completed - -
NCT00832637 Hepatocellular Carcinoma ... More >> Cholangiocellular Carcinoma Cholangiocarcinoma of the Extrahepatic Bile Duct Bile Duct Cancer Periampullary Adenocarcinoma Gallbladder Cancer Extrahepatic Bile Duct Cancer Less << Phase 2 Terminated(Low accrual) - United States, California ... More >> California Pacific Medical Center San Francisco, California, United States, 94115 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT00209703 Colorectal Cancer Phase 2 Terminated - Japan ... More >> Hokkaido University Hospital (Hokkaido University Graduate School of Medicine) Sapporo, Hokkaido, Japan, 060-8638 Less <<
NCT03530267 Colorectal Cancer Phase 2 Recruiting June 15, 2022 Germany ... More >> Phase Drei Not yet recruiting Aschaffenburg, Germany, 63739 Contact: Manfred Welslau, MD          HELIOS Klinikum Bad Saarow Not yet recruiting Bad Saarow, Germany, 15526 Contact: Daniel Pink, Dr.          Klinikum Bayreuth Not yet recruiting Bayreuth, Germany, 95445 Contact: Alexander Kiani, Prof. Dr.          MVZ Seestrasse Not yet recruiting Berlin, Germany, 13347 Contact: Alexander Schmittel, Dr.          Klinikum Bremen Nord Not yet recruiting Bremen, Germany, 28755 Contact: Ruben R. Plentz, Prof. Dr.          Kliniken Essen-Mitte Not yet recruiting Essen, Germany, 45136 Contact: Michael Stahl, Prof. Dr.          Agaplesion Markus Krankenhaus Not yet recruiting Frankfurt, Germany, 60431 Contact: Claus Bolling, MD          Krankenhaus Nordwest GmbH Recruiting Frankfurt, Germany, 60488 Contact: Thorsten O Goetze, PD Dr.          Klinikum Garmisch-Partenkirchen GmbH Not yet recruiting Garmisch-Partenkirchen, Germany, 82467 Contact: Till Seiler, MD          Nationales Centrum für Tumorerkrankungen (NCT) Not yet recruiting Heidelberg, Germany, 69120 Contact: Anne Berger, MD          Städtisches Klinikum Karlsruhe Not yet recruiting Karlsruhe, Germany, 76133 Contact: Margarethe Schmier, MD          DRK-Kliniken Nordhessen gGmbH Not yet recruiting Kassel, Germany, 34121 Contact: Mathias Kleiss, MD          Ortenau Klinikum Lahr Not yet recruiting Lahr, Germany, 77933 Contact: Matthias Egger, MD          Onkologisches Zentrum Not yet recruiting Lebach, Germany, 66822 Contact: Stefan Bauer, PD Dr.          Klinikum Ludwigshafen Not yet recruiting Ludwigshafen, Germany, 67063 Contact: Ralf Jakobs, Prof. Dr.          Klinikum Magdeburg gGmbH Not yet recruiting Magdeburg, Germany, 39130 Contact: Christoph Kahl, Prof. Dr.          Tagestherapiezentrum am ITM Universitätsmedizin Mannheim Recruiting Mannheim, Germany, 68167 Contact: Ralf D Hofheinz, Prof. Dr.          Kliniken Ostalb Not yet recruiting Mutlangen, Germany, 73557 Contact: Holger Hebart, Prof. Dr.          Klinikum der Universität München-Großhadern Not yet recruiting München, Germany, 81377 Contact: Volker Heinemann, Prof. Dr.          Kliniken des Landkreises Neumarkt in der Oberpfalz Not yet recruiting Neumarkt In Der Oberpfalz, Germany, 92318 Contact: Eva Horndasch          Studienzentrum Onkologie Ravensburg Recruiting Ravensburg, Germany, 88212 Contact: Tobias Dechow, Prof. Dr.          Clinical Research Stolberg GmbH Not yet recruiting Stolberg, Germany, 52222 Contact: Matthias Groschek          Klinikum Mutterhaus Trier Not yet recruiting Trier, Germany, 54290 Contact: Rolf Mahlberg, MD          Universitätsklinikum Tübingen Not yet recruiting Tübingen, Germany, 72076 Contact: Hans-Georg Kopp, Prof. Dr.          Klinikum Wilhelmshaven Not yet recruiting Wilhelmshaven, Germany, 26389 Contact: Tanja Trarbach, Dr. Less <<
NCT01125020 Liver Transplantation ... More >> Hepatocellular Carcinoma Tumor Recurrence and Metastasis Survival Adjuvant Chemotherapy Less << Not Applicable Unknown December 2010 China, Shanghai ... More >> Shanghai First People's Hospital Recruiting Shanghai, Shanghai, China, 200080 Contact: Zhi-Hai Peng, MD    0086-021-63240090 ext 3132    pengpzh@hotmail.com    Principal Investigator: Jun-Wei Fan, MD Less <<
NCT03199989 Adjuvant Chemotherapy Phase 3 Recruiting July 31, 2024 China ... More >> Beijing cancer hospital Recruiting Beijing, China Contact: Pengju Chen, M.D.          Principal Investigator: Aiwen Wu, M.D.          Sub-Investigator: Pengju Chen, M.D. Less <<
NCT02725424 Gastric Cancer Phase 2 Recruiting June 2019 China, Beijing ... More >> Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 10000 Contact: Ping Ai Zhou, PHD    13691161998    zhouap1825@126.com    Contact: liang Zhao, PHD    18611110507    drzhaoliang@126.com    Principal Investigator: Ping Ai Zhou, PHD Less <<
NCT00227617 Gastrointestinal Carcinoid Tum... More >>or Islet Cell Tumor Lung Cancer Neoplastic Syndrome Neuroendocrine Tumor Less << Phase 2 Phase 3 Unknown June 2016 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Kaiser Permanente Medical Center - Vallejo Vallejo, California, United States, 94589 Less <<
NCT00004102 Colorectal Cancer Phase 2 Completed - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT02839343 Pancreatic Adenocarcinoma ... More >> Borderline Resectable Adenocarcinoma of the Head of the Pancrease Less << Phase 2 Suspended(Interim analysis) - -
NCT01383538 Pancreatic Cancer ... More >> Adenocarcinoma Pancreatic Neoplasms Less << Phase 1 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT02217020 Rectal Cancer Phase 2 Unknown August 2017 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yatsen University Guangzhou, Guangdong, China, 510655 Less <<
NCT00832637 - Terminated(Low accrual) - -
NCT03577392 Quality of Life Phase 2 Phase 3 Not yet recruiting August 1, 2021 -
NCT00580073 Rectal Cancer Phase 2 Terminated(Loss of funding) - United States, Wisconsin ... More >> University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT02121405 Colorectal Neoplasm ... More >> Effects of Radiation Therapy Effects of Chemotherapy Surgery Less << Phase 3 Active, not recruiting December 2022 China, Fujian ... More >> Union Hospital Fujian Medical University Fuzhou, Fujian, China, 350001 China, Liaoning Liaoning Cancer Hospital Shenyang, Liaoning, China, 110042 China, Shanghai Zhongshan Hospital Fudan University Shanghai, Shanghai, China, 200032 China, Zhejiang The First Affiliated Hospital of College of Medicine Zhejiang University Hangzhou, Zhejiang, China, 310003 Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China, 310016 Jinhua People's Hospital Jinhua, Zhejiang, China, 321000 Yuyao People's Hospital Yuyao, Zhejiang, China, 315400 Less <<
NCT01775501 Hepatocellular Cancer Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02125 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT01672333 Gastric Cancer Phase 2 Completed - Iran, Islamic Republic of ... More >> Fayyazbakhsh hospital Tehran, Iran, Islamic Republic of Less <<
NCT01590719 Gastric Cancer Phase 2 Completed - -
NCT00448760 Esophageal Cancer Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00580073 - Terminated(Loss of funding) - -
NCT00374985 Esophageal Neoplasms ... More >> Stomach Neoplasms Less << Phase 1 Phase 2 Completed - Germany ... More >> Johannes-Gutenberg-Universität Mainz, Rheinland-Pfalz, Germany, 55131 Less <<
NCT00025142 Colorectal Cancer Phase 2 Completed - United States, California ... More >> Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305 Less <<
NCT01671891 - Unknown February 2013 China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Wenjie Sun, Master    86-21-64175590    ganjumedecin@hotmail.com    Principal Investigator: Zhen Zhang, PhD,MD          Sub-Investigator: Wenjie Sun, Master,MD Less <<
NCT01525069 Cholangiocarcinoma ... More >> Liver Neoplasms Less << Phase 1 Recruiting June 30, 2022 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: William Chapman, M.D.    314-362-7792    chapmanw@wustl.edu    Contact: Tracey Guthrie    314-747-4404    guthriet@wustl.edu    Sub-Investigator: William Chapman, M.D.          Sub-Investigator: M.B. Majella Doyle, M.D.          Sub-Investigator: William Hawkins, M.D.          Sub-Investigator: Jeffrey Lowell, M.D.          Sub-Investigator: Joel Picus, M.D.          Sub-Investigator: Steven Strasberg, M.D.          Sub-Investigator: Rama Suresh, M.D.          Sub-Investigator: Andrea Wang-Gillam, M.D., Ph.D.          Sub-Investigator: Kathryn J. Fowler, M.D.          Sub-Investigator: Benjamin Tan, M.D.          Sub-Investigator: John Kotyk, M.D. Less <<
NCT02845908 Malignant Neoplasm of Stomach ... More >>Stage IV Less << Phase 2 Enrolling by invitation March 2020 China, Fujian ... More >> Rongbo Lin Fuzhou, Fujian, China, 350014 Less <<
NCT00421824 Rectal Neoplasms Phase 2 Completed - Spain ... More >> Sanofi-Aventis Administrative Office Barcelona, Spain Less <<
NCT01711242 Gastric Cancer Phase 3 Unknown December 2017 China, Zhejiang ... More >> The First Affiliated Hospital of Wenzhou Medical College Recruiting Wenzhou, Zhejiang, China, 325000 Contact: congying xie, MD    86-0577-8806-9316    wzxiecongying@163.com Less <<
NCT00006050 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Unknown - France ... More >> Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00448760 - Completed - -
NCT01395667 Rectal Cancer Phase 1 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT01619423 - Completed - -
NCT03564912 Colorectal Cancer Phase 1 Phase 2 Recruiting May 28, 2021 China, Zhejiang ... More >> First afflicated hospital of zhejiang university Recruiting Hangzhou, Zhejiang, China, 310000 Contact: fang M weijia, doctor Less <<
NCT00941655 Gastric Cancer Phase 3 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00323583 Adenocarincoma of Pancreas ... More >> Stage III Pancreatic Cancer Stage IVA Pancreatic Cancer Stage IVB Pancreatic Cancer Less << Phase 2 Unknown - United States, Washington ... More >> Seattle Cancer Treatment and Wellness Center Recruiting Seattle, Washington, United States, 98112 Contact: Nick Chen, MD    206-292-2277    nickc@seattlecancerwellness.com    Contact: Jerry Kaufman    206-292-2277    jerryk@seattelcancerwellness.com Less <<
NCT01619423 Advanced Metastatic (Stage IV)... More >> Colorectal Cancer Less << Phase 1 Phase 2 Completed - -
NCT00865709 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00602602 Pancreatic Cancer Phase 2 Active, not recruiting - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00911170 Cancer Colon ... More >>Cancer Colorectal Cancer Fever Locally Advanced Metastatic Colorectal Cancer Neutropenia Rectal Cancer Less << Phase 3 Completed - -
NCT00865709 - Completed - -
NCT03349827 Peritoneal Metastases From Gas... More >>tric Cancer Less << Not Applicable Recruiting November 30, 2020 China, Hubei ... More >> Wuhan University Recruiting Wuhan, Hubei, China Contact: Bin Xiong    +86 27 67813152    jyn1983@163.com Less <<
NCT00941655 - Completed - -
NCT00973609 Colorectal Neoplasms Phase 3 Completed - Germany ... More >> AIO-Studien gGmbH Berlin, Germany, 10623 Less <<
NCT00039208 Colorectal Cancer Phase 2 Completed - Belgium ... More >> Centre Hospitalier Notre Dame - Reine Fabiola Charleroi, Belgium, 6000 Clinique Saint-Joseph Liege, Belgium, B 4000 CHU Liege - Domaine Universitaire du Sart Tilman Liege, Belgium, B-4000 Clinique Sainte Elisabeth Namur, Belgium, 5000 Centre Hospitalier Peltzer-La Tourelle Verviers, Belgium, B-4800 France Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospital Regional Universitaire de Limoges Limoges, France, 87042 Hopital Saint-Louis Paris, France, 75475 Centre Rene Huguenin Saint Cloud, France, 92211 Hopital Paul Brousse Villejuif, France, 94804 Italy Azienda Sanitaria di Bolzano Bolzano, Italy, 39100 Universita G.D'Annunzio Di Chieti Chieti, Italy, 66100 Ospedale San Carlo Borromeo Milano (Milan), Italy, 20153 Azienda Ospedale S. Luigi at University of Torino Orbassano, (Torino), Italy, 10043 Fondazione Salvatore Maugeri Pavia, Italy, I-27100 Ospedale Oncologico Regionale RIONERO in VULTURE, Italy, I-58028 Istituto Regina Elena Rome, Italy, 00161 Istituto Clinico Beato Matteo Vigevano, Italy, 27029 Portugal Hospital Fernando Fonseca Amadora, Portugal, P-2700 Less <<
NCT00055822 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Texas ... More >> San Antonio Cancer Institute San Antonio, Texas, United States, 78229-3264 Less <<
NCT03167112 Pancreatic Cancer Phase 2 Recruiting May 2018 Canada, Quebec ... More >> Jewish General Hospital Recruiting Montréal, Quebec, Canada, H3T 1E2 Contact: Petr Dr Kavan, MD    5143408222    petr.kavan@mcgill.ca Less <<
NCT02745639 Rectal Neoplasms Phase 2 Completed - -
NCT03714490 Rectal Neoplasms Phase 2 Recruiting September 30, 2024 China ... More >> Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Recruiting Beijing, China, 100021 Contact: Jing Jin, MD    +8613601365130    jingjin1025@163.com Less <<
NCT03398512 Peritoneal Metastases From Col... More >>orectal Cancer Less << Not Applicable Recruiting December 31, 2020 China, Hubei ... More >> Wuhan University Recruiting Wuhan, Hubei, China Contact: Bin Xiong    +86 27 67813152    jyn1983@163.com Less <<
NCT03084809 Colorectal Cancer ... More >> Cytokine-induced Killer Cells Postoperative Complications Survival Less << Phase 4 Completed - -
NCT00049101 Colorectal Cancer Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00911170 - Completed - -
NCT00531115 Metastatic Colorectal Cancer Phase 2 Terminated(According to the st... More >>udy design, in the first step the number of responses was lower than the number required (< 7).) Less << - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain, 28046 Less <<
NCT03406299 Biliary Tract Neoplasms Phase 2 Recruiting December 31, 2020 Taiwan ... More >> Taiwan Cooperative Oncology Group, National Health Research Institutes Recruiting Taipei, Taiwan Contact: Tsang-Wu Liu, MD    +886-2-26534401 ext 25150    walter@nhri.org.tw    Principal Investigator: Li-Tzong Chen, MD PHD          Principal Investigator: Nai-Jung Chiang, MD Less <<
NCT03773367 Resectable Gastric and Gastroe... More >>sophageal Junction Adenocarcinoma Less << Phase 2 Not yet recruiting January 15, 2026 Sweden ... More >> Lund University Hospital Not yet recruiting Lund, Sweden, 221 85 Contact: David Borg, MD    +46 46 17 75 20    david.borg@skane.se    Principal Investigator: David Borg, MD          Centrallasarettet i Växjö Not yet recruiting Växjö, Sweden, 352 34 Contact: Ulrika Pallenius, MD    +46 470 58 80 00    ulrika.pallenius@kronoberg.se    Principal Investigator: Ulrika Pallenius, MD Less <<
NCT00642603 Colorectal Cancer Phase 2 Terminated - -
NCT00642603 - Terminated - -
NCT02585479 Hepatocellular Carcinoma Phase 2 Phase 3 Unknown October 2017 -
NCT00777192 - Active, not recruiting August 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00059930 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 1 Active, not recruiting June 2019 United States, New Jersey ... More >> Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01219920 Metastatic Colorectal Cancer Phase 3 Completed - Italy ... More >> Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica Alessandria, Italy, 15100 A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona - Ancona (An) Oncologia Medica Ancona, Italy, 60100 Ausl Della Valle D' Aosta (Ao) - Aosta (Ao) Oncologia Medica Aosta, Italy, 11100 P.O. Zona Aretina - Ospedale S. Donato Di Arezzo - Arezzo (Ar) Oncologia Medica Arezzo, Italy, 52100 Azienda Ospedale `G.Rummo` - Benevento (Bn) Oncologia Medica Benevento, Italy, 82100 Ospedale Degli Infermi Di Biella - Biella (Bi) Oncologia Medica Biella, Italy, 13900 Ospedale S. Orsola F.B.F. - Brescia - Brescia (Bs) Oncologia Medica Brescia, Italy, 25122 Stabilimento "Perrino" - Brindisi - Brindisi (Br) Oncologia Medica Brindisi, Italy, 72100 Azienda Ospedaliera S. Elia - Caltanissetta (Cl) Oncologia Medica Caltanissetta, Italy, 93100 Ospedale Versilia - Camaiore (Lu) Oncologia Medica Camaiore, Italy, 55043 Ospedale Cecina - Cecina (Li) Oncologia Medica Cecina, Italy, 57023 Istituti Ospitalieri - Cremona - Cremona (Cr) Oncologia Medica Cremona, Italy, 26100 Azienda Ospedaliera S. Croce E Carle Di Cuneo - Cuneo (Cn) Oncologia Medica Cuneo, Italy, 12100 Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica Empoli, Italy, 50053 Asur - Zona Territoriale 6 Di Fabriano (An) - Fabriano (An) Oncologia Medica Fabriano, Italy, 60044 Ospedale Santa Croce Fano - Fano (Pu) Oncologia Medica Fano, Italy, 61032 Ausl 10 Di Firenze - Firenze (Fi) Oncologia Medica Firenze, Italy, 50122 A.O. Universitaria Careggi Di Firenze Oncologia Medica Firenze, Italy, 50134 E.O. Ospedali Galliera - Genova (Ge) Oncologia Medica Genova, Italy, 16128 Irccs Istituto Nazionale Per La Ricerca Sul Cancro (Ist) - Genova (Ge) Oncologia Medica Genova, Italy, 16132 Ospedale Sant`Andrea La Spezia - La Spezia (Sp) Oncologia Medica La Spezia, Italy, 19100 Ausl Le Di Lecce - Lecce (Le) Oncologia Chirurgica Lecce, Italy, 73100 Ospedale Per Acuti "Mater Salutis" Legn. - Legnago (Vr) Oncologia Medica Legnano, Italy, 37045 U.O. Oncologia Medica, Ospedale Civile Livorno, Italy, 57123 Presidio Ospedaliero Piana Di Lucca - Lucca (Lu) Oncologia Medica Lucca, Italy, 55100 Irccs Fondazione Centro S. Raffaele Del Monte Tabor - Milano (Mi) Oncologia Medica Milano, Italy, 20132 Ospedale Ca` Granda-Niguarda - Milano - Milano (Mi) Oncologia Medica Milano, Italy, 20162 Ospedale Civile Di Mirano - Mirano (Ve) Oncologia Medica Mirano, Italy, 30035 A.O. Universitaria Federico Ii Di Napoli Oncologia Medica Napoli, Italy, 80131 A.O. Universitaria Maggiore Della Carita' Di Novara Oncologia Medica Novara, Italy, 28100 A.O. Universitaria Di Parma Oncologia Medica Parma, Italy, 43100 Asl 1 Di Citta' Di Castello (Pg) - Citta' Di Castello (Pg) Oncologia Medica Perugia, Italy, 06012 A.O. Di Perugia - Ospedale S. Maria Della Misericordia (Ex Silvestrini) - Perugia (Pg) Oncologia Medica Perugia, Italy, 06156 Azienda Ospedaliera San Salvatore - Pesaro (Pu) Oncologia Medica Pesaro, Italy, 61100 Ospedale Piombino - Piombino (Li) Oncologia Medica Piombino, Italy, 57025 Ausl 5 Di Pisa - Pisa (Pi) Oncologia Medica Pisa, Italy, 56100 A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica Pisa, Italy, 56126 A.O. Universitaria Pisana Oncologia Medica Pisa, Italy, 56126 Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica Pistoia, Italy, 51100 Ospedali Riuniti Di Pistoia - Pistoia (Pt) Oncologia Medica Pistoia, Italy, 51100 Ospedale Di S. Maria Nuova - Reggio Nell`Emilia Reggio Emilia, Italy, 42100 Policlinico Universitario Campus Bio-Medico Di Roma Oncologia Medica Roma, Italy, 00128 Policlinico Umberto I Di Roma Oncologia Medica Roma, Italy, 00161 Policlinico Universitario Gemelli Di Roma Oncologia Medica Roma, Italy, 00168 A.O. Universitaria Senese Oncologia Medica Siena, Italy, 53100 Ausl 7 Di Siena - Siena (Si) Oncologia Medica Siena, Italy, 53100 Ospedale Civile - Sondrio - Sondrio (So) Oncologia Medica Sondrio, Italy, 23100 A.O. Universitaria S. Giovanni Battista-Molinette Di Torino Oncologia Medica Torino, Italy, 10134 Less <<
NCT00003287 Colorectal Cancer Phase 3 Completed - -
NCT02562716 Pancreatic Adenocarcinoma ... More >> Resectable Pancreatic Carcinoma Less << Phase 2 Recruiting October 2021 -
NCT00769405 Colorectal Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 3 Completed - France ... More >> Centre Paul Papin Angers, France, 49036 Hôpital Antoine Béclère Clamart, France, 92141 CHU Estaing Clermont Ferrand, France, 63003 Louis Mourier Hospital Colombes Cedex, France, 92701 Hopital Du Bocage Dijon, France, 21034 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Centre Leon Berard Lyon, France, 69373 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Hopital de l'Archet CHU de Nice Nice, France, F-06202 Institut Curie Paris, France, 75005 Hopital Lariboisiere Paris, France, 75010 Hôpital Lariboisière Paris, France, 75010 Hopital Tenon Paris, France, 75970 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Institut Jean Godinot Reims, France, 51056 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Centre Hospitalier Regional de Purpan Toulouse, France, 31059 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT02641691 Cancer of Rectum ... More >> Cancer of the Rectum Neoplasm, Rectum Rectal Cancer Rectum Cancer Rectum Neoplasms Adenocarcinoma of the Rectum Less << Phase 1 Recruiting July 31, 2019 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Hyun Kim, M.D.    314-362-8502    kim.hyun@wustl.edu    Sub-Investigator: Hyun Kim, M.D.          Sub-Investigator: Steven Hunt, M.D.          Sub-Investigator: Parag Parikh, M.D.          Sub-Investigator: Elisa Birnbaum, M.D.          Sub-Investigator: Sekhar Dharmarajan, M.D.          Sub-Investigator: Sean Glasgow, M.D.          Sub-Investigator: Kian-Huat Lim, M.D., Ph.D.          Sub-Investigator: Manik Amin, M.D.          Sub-Investigator: Matthew Mutch, M.D.          Sub-Investigator: Anna Roshal, M.D.          Sub-Investigator: Matthew Silviera, M.D.          Sub-Investigator: Rama Suresh, M.D.          Sub-Investigator: Benjamin R Tan, M.D.          Sub-Investigator: Paul Wise, M.D.          Sub-Investigator: Katrina Pederson, M.D.          Sub-Investigator: Michael Roach, M.D.          Sub-Investigator: Radhika Smith, M.D.          Sub-Investigator: Andrea Wang-Gillam, M.D., Ph.D.          Sub-Investigator: Haeseong Park, M.D.          Sub-Investigator: Nikolaos Trikalinos, M.D. Less <<
NCT02591667 Colorectal Cancer ... More >> Peritoneal Metastasis Less << Phase 2 Recruiting February 2020 Austria ... More >> Medical University of Vienna, Department of Internal Medicine I Recruiting Vienna, Austria, 1090 Contact: Gerald Prager, MD    +43-1-40400 ext 44240    gerald.prager@meduniwien.ac.at    Contact: Anja Grah    +43-1-40400 ext 44240    anja.grah@meduniwien.ac.at    Medical University of Vienna, Department of Surgery Recruiting Vienna, Austria, 1090 Contact: Thomas Bachleitner-Hofmann, MD    +43-1-40400 ext 56210    thomas.bachleitner-hofmann@meduniwien.ac.at    Contact: Daniela Truzla    +43-1-40400 ext 69430    carcinosis@meduniwien.ac.at Less <<
NCT00286130 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00112658 Pancreatic Cancer Phase 2 Phase 3 Unknown - -
NCT02143219 Pancreatic Metastatic Cancer ... More >> Toxicity Less << Phase 2 Recruiting July 2021 France ... More >> ICO Paul Papin Recruiting Angers, France, 49000 Contact: Olivier CAPITAIN, MD    +33 2 41 35 27 00    olivier.capitain@ico.unicancer.fr    Principal Investigator: Olivier CAPITAIN, MD          CH Vendée Not yet recruiting La Roche Sur Yon, France, 85925 Contact: Roger FAROUX, MD    02 51 44 61 68       Principal Investigator: Roger FAROUX, MD          Sub-Investigator: Cécile GARCEAU, MD          Sub-Investigator: Morgane AMIL, MD          Sub-Investigator: François DEWAELE, MD          Sub-Investigator: Jean-Pierre LAFARGUE, MD          Sub-Investigator: Matthieu SCHNEE, MD          Sub-Investigator: Vincent MACE, MD          Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Antoine ADENIS, MD    03.20.29.55.00       Principal Investigator: Antoine ADENIS, MD          Sub-Investigator: Farid EL HAJBI, MD          Sub-Investigator: Eric AMELA, MD          Sub-Investigator: Charlotte PEUGNIEZ, MD          ICM (Val d'Aurelle) Not yet recruiting Montpellier Cedex 5, France, 34298 Contact: Emmanuelle SAMALIN, MD    04 67 67 25 92       Sub-Investigator: Emmanuel SAMALIN, MD          Sub-Investigator: Blandine GALLET-SUCHET, MD          Sub-Investigator: Laurence DALSTEIN, MD          Sub-Investigator: Marc YCHOU, MD          ICO René Gauducheau Recruiting Nantes - St Herblain, France, 44805 Contact: Sandrine HIRET, MD    +33 2 40 67 99 00 ext 9357    sandrine.hiret@ico.unicancer.fr    Principal Investigator: Sandrine HIRET, MD          Sub-Investigator: Jean-Yves DOUILLARD, Pr          Sub-Investigator: Jaafar BENNOUNA, Pr          Sub-Investigator: Hélène SENELLART, MD          Centre Eugène marquis Not yet recruiting Rennes, France, 35042 Contact: Bérengère LECONTE, MD    02 99 28 54 65       Principal Investigator: Bérengère LECONTE, MD          Sub-Investigator: Evelyne BOUCHER, MD          Sub-Investigator: Sylvain MANFREDI, MD          Sub-Investigator: Julien EDELINE, MD Less <<
NCT02128100 Pancreatic Cancer Non-resectab... More >>le Less << Phase 2 Recruiting May 2018 United States, Kentucky ... More >> James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 Contact: Alicia A Lutz    502-562-3429    aalutz01@louisville.edu    Sub-Investigator: Shiao Woo, MD          Sub-Investigator: Craig Silverman, MD          Sub-Investigator: Moataz El-Ghamry, MD          Sub-Investigator: Vivek Sharma, MD          Sub-Investigator: Rebecca Redman, MD          Sub-Investigator: Charles Scoggins, MD          Sub-Investigator: Robert Martin, MD          James Graham Brown Cancer Center Not yet recruiting Louisville, Kentucky, United States, 40202 Contact: Alicia A Lutz    502-562-3429    aalutz@louisville.edu    Principal Investigator: Neal E Dunlap, MD Less <<
NCT02345460 - Terminated(Competing studies) - -
NCT01374425 Colorectal Cancer Phase 2 Completed - -
NCT02280070 Rectal Cancer Phase 2 Recruiting August 2020 Japan ... More >> Kyushu University Hospital Recruiting Fukuoka, Japan, 812-8582 Contact: Eiji Oki, MD, PhD    092-642-5466    okieiji@surg2.med.kyushu-u.ac.jp    Principal Investigator: Eiji Oki, MD, PhD          Kurume University Hospital Recruiting Kurume, Japan, 830-0011 Contact: Yoshito Akagi, MD, PhD          Principal Investigator: Yoshito Akagi, MD, PhD Less <<
NCT02345460 Pancreatic Adenocarcinoma ... More >> Poorly Differentiated Malignant Neoplasm Resectable Pancreatic Cancer Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Undifferentiated Pancreatic Carcinoma Less << Phase 2 Terminated(Competing studies) - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01212822 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Squamous Cell Carcinoma of the Esophagus Stage IA Esophageal Cancer Stage IA Gastric Cancer Stage IB Esophageal Cancer Stage IB Gastric Cancer Stage IIA Esophageal Cancer Stage IIA Gastric Cancer Stage IIB Esophageal Cancer Stage IIB Gastric Cancer Stage IIIA Esophageal Cancer Stage IIIA Gastric Cancer Stage IIIB Esophageal Cancer Stage IIIB Gastric Cancer Stage IIIC Esophageal Cancer Stage IIIC Gastric Cancer Less << Phase 2 Completed - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02128425 Metastatic Colorectal Cancer Phase 2 Unknown April 2018 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanhong Deng, M.D.    008613925106525    13925106525@163.com    Principal Investigator: Yanhong Deng, M.D. Less <<
NCT02298010 - Unknown December 2016 -
NCT01516216 Metastatic Colorectal Cancer Phase 2 Active, not recruiting - United States, Idaho ... More >> Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho, United States, 83712 Mountain States Tumor Institute- Fruitland Fruitland, Idaho, United States, 83619 Mountain States Tumor Institute - Meridian Meridian, Idaho, United States, 83642 Mountain States Tumor Institute- Nampa Nampa, Idaho, United States, 83686 Mountain States Tumor Institute- Twin Falls Twin Falls, Idaho, United States, 83301 United States, Illinois The Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Lowell General Hospital Lowell, Massachusetts, United States Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center Milford, Massachusetts, United States Newton-Wellesley Hospital Newton, Massachusetts, United States Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital South Weymouth, Massachusetts, United States United States, New Hampshire New Hampshire Oncology Hematology-P.A. Concord, New Hampshire, United States New Hampshire Oncology Hematology-P.A. Hooksett, New Hampshire, United States New Hampshire Oncology Hematology-P.A. Laconia, New Hampshire, United States Dana-Farber/New Hampshire Oncology-Hematology Londonderry, New Hampshire, United States United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT01374425 - Completed - -
NCT03515356 Colorectal Cancer Not Applicable Recruiting July 2020 United States, Michigan ... More >> The University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Grace Kanzawa-Lee, BSN, RN    734-623-9598    gracekan@umich.edu    Principal Investigator: Grace Kanzawa-Lee, BSN, RN          St. Joseph Mercy Hospital Recruiting Ann Arbor, Michigan, United States, 48197 Contact: Grace Kanzawa-Lee,, BSN, RN    734-623-9598    gracekan@umich.edu    Principal Investigator: Grace Kanzawa-Lee, BSN, RN          Principal Investigator: Philip Stella, MD          St. Joseph Mercy Brighton Health Center Recruiting Brighton, Michigan, United States, 48114 Contact: Grace Kanzawa-Lee    734-623-9598    gracekan@umich.edu    Brighton Center for Specialty Care Recruiting Brighton, Michigan, United States, 48116 Contact: Grace Kanzawa-Lee    734-623-9598    gracekan@umich.edu    St. Joseph Mercy Health System Recruiting Canton, Michigan, United States, 48188 Contact: Grace Kanzawa-Lee    734-623-9598    gracekan@umich.edu    St. Joseph Mercy Chelsea Cancer Center Recruiting Chelsea, Michigan, United States, 48118 Contact: Grace Kanzawa-Lee    734-623-9598    gracekan@umich.edu    The University of Michigan Northville Health Center Recruiting Northville, Michigan, United States, 48168 Contact: Grace Kanzawa-Lee    734-623-9598    gracekan@umich.edu Less <<
NCT02047474 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Stage I Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Less << Phase 2 Recruiting December 2020 United States, Connecticut ... More >> Yale University Recruiting New Haven, Connecticut, United States, 06520-8032 Contact: Kamil Sadowski    203-785-6661    kamil.sadowski@yale.edu    Principal Investigator: Jill Lacy Less <<
NCT01404156 Esophageal Cancer ... More >> Adenocarcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Less << Phase 2 Phase 3 Recruiting April 2021 Canada, Manitoba ... More >> Health Sciences Centre / CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada, R3A 1R9 Less <<
NCT02314182 Rectal Adenocarcinoma Phase 3 Completed - France ... More >> Service de Chirurgie Générale et Digestive, Centre hospitalier Lyon Sud Pierre Benite, France, 69495 Less <<
NCT02896907 Pancreatic Adenocarcinoma ... More >> Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Unresectable Pancreatic Carcinoma Less << Early Phase 1 Active, not recruiting January 1, 2019 United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01835041 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 1 Active, not recruiting January 2019 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02319304 Rectal Adenocarcinoma Phase 2 Recruiting December 2021 United States, Maryland ... More >> Ummc Msgcc Recruiting Baltimore, Maryland, United States, 21201 Contact: Jill Harper, RN, PhD    410-369-5350    jillharper@umm.edu    Principal Investigator: Shahed Badiyan, M.D. Less <<
NCT01175291 Metastatic Colorectal Cancer Phase 2 Withdrawn(treatment deemed ine... More >>ffective so accrual was closed) Less << July 2012 -
NCT03504423 Pancreatic Cancer Metastatic Phase 3 Recruiting March 2022 United States, North Carolina ... More >> Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Principal Investigator: Caio Max Rocha Lima, MD Less <<
NCT01413022 Pancreatic Neoplasms Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT03231722 Metastatic Colorectal Cancer Phase 3 Recruiting July 15, 2021 Italy ... More >> Fondazione IRCCS Istituto Nazionale Tumori Recruiting Milan, Italy, 20133 Contact: Filippo de Braud, MD          Fondazione IRCCS Istituto Oncologico Veneto Recruiting Padova, Italy, 35128 Contact: Sara Lonardi, MD          A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica Recruiting Pisa, Italy, 56126 Contact: Gianluca Masi, MD          Principal Investigator: Alfredo Falcone, MD          Azienda Ospedaliera Universitaria Integrata Verona Recruiting Verona, Italy, 37126 Contact: Giampaolo Tortora, MD Less <<
NCT02923921 Pancreatic Cancer Phase 3 Recruiting March 31, 2020 -
NCT03464968 Biliary Cancer Metastatic Phase 2 Recruiting December 25, 2020 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 13620 Contact: Jin Won Kim, MD, PhD    82-31-787-8209    jwkim@snubh.org Less <<
NCT03192618 Hepatocellular Carcinoma Phase 3 Recruiting December 31, 2024 China ... More >> Cancer Center of Sun Yat-Sen University Recruiting Guangzhou, China, +86 Contact: Shaohua Li, MD    +8615088064187    lishaoh@sysucc.org.cn Less <<
NCT03065478 - Completed - Germany ... More >> Praxis für interdisziplinäre Onkologie & Hämatologie Freiburg im Breisgau, Baden-Württemberg, Germany, 79110 Less <<
NCT02319018 Malignant Digestive System Neo... More >>plasm Less << Phase 1 Completed - United States, Connecticut ... More >> Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States, 06510 Yale University New Haven, Connecticut, United States, 06520 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT01782339 Germ Cell Tumour Phase 2 Recruiting January 2021 United Kingdom ... More >> St Bartholomew's Hospital Recruiting London, United Kingdom, EC1A 7BE Contact: GAMMA coordinator          Principal Investigator: Jonathan Shamash, MD FRCP Less <<
NCT02363374 Rectal Neoplasms ... More >> Rectal Cancer Stage II Rectal Cancer Stage III Less << Phase 2 Active, not recruiting June 2023 Germany ... More >> University Clinic Erlangen, Bavaria, Germany RWTH Aachen Aachen, Germany University Clinic Bochum, Germany Clinic for Radiotherapy Chemnitz, Germany Diacura Clinic for Radiotherapy Coburg, Germany Internist Practice Dresden, Germany University Clinic Dresden, Germany University Clinic Esslingen, Germany University Hospital Frankfurt Goethe University Frankfurt, Germany, 60590 University Clinic Freiburg, Germany University Clinic Göttingen, Germany University Clinic Heidelberg, Germany HELIOS Park-Klinikum Leipzig Leipzig, Germany University Clinic Leipzig, Germany University Clinic Mannheim, Germany Hospital Miria Hilf Moenchengladbach, Germany Pius Hospital Oldenburg Oldenburg, Germany University Clinic Oldenburg, Germany Hospital Barmherziger Brueder Regensburg, Germany University Clinic Regensburg, Germany University Clinic Rostock, Germany University Clinic Wuerzburg, Germany Less <<
NCT00312000 Advanced Colorectal Cancer Phase 3 Completed - -
NCT01959139 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Active, not recruiting October 2020 -
NCT01358812 Metastatic Colo-rectal Cancer Phase 2 Completed - Italy ... More >> P.O. Zona Aretina - Ospedale S. Donato Di Arezzo Arezzo, Italy Istituto Nazionale Per La Ricerca Sul Cancro Genova, Italy, 16132 IRCCS Ospedale San Raffaele Milano, Italy, 20132 Asl Olbia - Uo Oncologia Ospedale San Giovanni Di Dio Olbia, Italy, 07026 Istituto Oncologico Veneto (IOV) Padova, Italy, 35100 Polo Oncologico Area Vasta Nord-Ovest Pisa, Italy, 56126 Universita' Campus Bio-Medico Di Roma Roma, Italy, 00128 Asl Di Sassari - Ospedale S.S. Annunziata -U.O. Oncologia Medica Sassari, Italy, 07100 Ausl 7 Di Siena Siena, Italy, 53100 A.O. Universitaria S.Maria Della Misericordia Di Udine Udine, Italy, 33100 Less <<
NCT01821729 Pancreatic Cancer Phase 2 Active, not recruiting July 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02856867 Esophagogastric Adenocarcinoma... More >> Metastatic Disease No Previous Chemotherapy for Metastatic Esophagogastric Cancer Less << Phase 2 Withdrawn - -
NCT01913639 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Active, not recruiting July 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Less <<
NCT02178709 Resectable Pancreatic Ductal A... More >>denocarcinoma Less << Phase 2 Recruiting June 30, 2019 United States, Indiana ... More >> Indiana University Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Safi Shahda, M.D.    317-278-4688    shahdas@iu.edu    Contact: Janet Flynn, R.N.    317-274-0972    janflynn@iupui.edu    Principal Investigator: Safi Shahda, M.D.          Sub-Investigator: Janet Flynn, R.N. Less <<
NCT03516708 Rectal Cancer Phase 1 Phase 2 Not yet recruiting August 31, 2022 United States, Missouri ... More >> Washington University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Haeseong Park, M.D., M.P.H.    314-747-7401    guebertk@wustl.edu    Principal Investigator: Haeseong Park, M.D., M.P.H.          Sub-Investigator: Manik Amin, M.D.          Sub-Investigator: Olivia Aranha, M.D., Ph.D.          Sub-Investigator: Salman Chaudhry, M.D.          Sub-Investigator: Matthew Ciorba, M.D.          Sub-Investigator: Eric Knoche, M.D.          Sub-Investigator: Kian-Huat Lim, M.D.          Sub-Investigator: Peter Oppelt, M.D.          Sub-Investigator: Parag Parikh, M.D.          Sub-Investigator: Katrina Pedersen, M.D.          Sub-Investigator: Joel Picus, M.D.          Sub-Investigator: Timothy Rearden, M.D.          Sub-Investigator: Caron Rigden, M.D.          Sub-Investigator: Anna Roshal, M.D.          Sub-Investigator: Rama Suresh, M.D.          Sub-Investigator: Benjamin Tan, M.D.          Sub-Investigator: Nikolaos Trikalinos, M.D.          Sub-Investigator: Andrea Wang-Gillam, M.D., Ph.D. Less <<
NCT03283761 Gastro-Esophageal Junction Ade... More >>nocarcinoma Gastric Cancer Less << Phase 2 Recruiting June 30, 2020 United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Victoria Maurer    312-695-3818    victoria.maurer@northwestern.edu    Principal Investigator: Al Benson, MD          Univeristy of Illinois Cancer Center Recruiting Chicago, Illinois, United States, 60612 Contact: Alyssa Secreto    312-413-1069    asecre2@uic.edu    Principal Investigator: Rozina Chowdhery, MD          Northwestern Medicine Lake Forest Hospital Recruiting Lake Forest, Illinois, United States, 60045 Contact: Valerie Nelson    847-582-2134    cancertrials@northwestern.edu    United States, Michigan Michigan State University Recruiting Lansing, Michigan, United States, 48910 Contact: Kimberly Wright    517-975-9532    Kimberly.Wright@hc.msu.edu    Principal Investigator: Jatin Rana, MD          United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53705 Contact: Erin Clements    608-265-2857    eclements@wisc.edu    Principal Investigator: Nataliya Uboha, MD Less <<
NCT02767375 Hepatocellular Carcinoma Phase 2 Phase 3 Recruiting December 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Guang Cao, Doctor    86-138-1165-2497    caoguang1207@bjmu.edu.cn    Contact: Wei Liu, Doctor    86-138-1083-9736    huoxinglaotai@163.com    Sub-Investigator: Guang Cao, Doctor          Sub-Investigator: Wei Liu, Doctor Less <<
NCT00786058 - - - -
NCT01420874 Colorectal Cancer ... More >> Cancer of Pancreas Pancreatic Neoplasm Malignant Neoplasm of Large Intestine Malignant Tumor of Colon Colon Carcinoma Cancer of Colon Pancreatic Cancer Less << Phase 1 Active, not recruiting June 2019 United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48601 Less <<
NCT03300544 Rectal Adenocarcinoma ... More >> Stage III Rectal Cancer AJCC v7 Stage IIIA Rectal Cancer AJCC v7 Stage IIIB Rectal Cancer AJCC v7 Stage IIIC Rectal Cancer AJCC v7 Stage IV Rectal Cancer AJCC v7 Stage IVA Rectal Cancer AJCC v7 Stage IVB Rectal Cancer AJCC v7 Less << Phase 1 Recruiting July 31, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact    877-312-3961       Principal Investigator: Nageshwara V. Dasari Less <<
NCT01111604 Colon Cancer ... More >>Rectal Cancer Less << Phase 2 Completed - United States, Ohio ... More >> ImClone Investigational Site Cincinnati, Ohio, United States, 45242 United States, South Carolina ImClone Investigational Site Columbia, South Carolina, United States, 29210 United States, Tennessee ImClone Investigational Site Nashville, Tennessee, United States, 37232 Canada, Alberta ImClone Investigational Site Calgary, Alberta, Canada, T2N 4N2 ImClone Investigational Site Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia ImClone Investigational Site Kelowna, British Columbia, Canada, V1Y 5L3 ImClone Investigational Site Surrey, British Columbia, Canada, V3V 1Z2 ImClone Investigational Site Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Nova Scotia ImClone Investigational Site Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario ImClone Investigational Site Hamilton, Ontario, Canada, L8V 5C2 ImClone Investigational Site London, Ontario, Canada, N6A 4L6 ImClone Investigational Site Mississauga, Ontario, Canada, L5M 2N1 ImClone Investigational Site Oshawa, Ontario, Canada, L1G 2B9 ImClone Investigational Site Ottawa, Ontario, Canada, K1H 8L6 ImClone Investigational Site Toronto, Ontario, Canada, M5G 2M9 ImClone Investigational Site Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec ImClone Investigational Site Montreal, Quebec, Canada, H2W 156 Less <<
NCT00909987 Rectum Cancer Phase 2 Completed - Spain ... More >> Hospital General Universitario de Elche Elche, Alicante, Spain, 03203 Complejo Sanitario Parc Taulí Sabadell, Barcelona, Spain, 08208 Hospital del Mar Barcelona, Spain, 08003 Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08025 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Arnau de Vilanova Lérida, Spain, 25198 Hospital La Paz Madrid, Spain, 28046 Hospital de Navarra Pamplona, Spain, 31008 Hospital La Fe Valencia, Spain, 46009 Instituto Valenciano de Oncología (IVO) Valencia, Spain, 46009 Hospital General de Valencia Valencia, Spain, 46014 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT01205711 Colorectal Cancer Phase 2 Completed - United Kingdom ... More >> Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Centre for Cancer Research and Cell Biology at Queen's University Belfast Belfast, Northern Ireland, United Kingdom, BT9 7AB Wales Cancer Trials Unit Cardiff, Wales, United Kingdom, CF11 9LJ Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT00364013 Metastatic Colorectal Cancer Phase 3 Completed - -
NCT03006705 Gastric Cancer Phase 3 Recruiting - -
NCT01643499 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Adenocarcinoma of the Gallbladder Adenocarcinoma of Unknown Primary Adult Primary Cholangiocellular Carcinoma Advanced Adult Primary Liver Cancer Cholangiocarcinoma of the Extrahepatic Bile Duct Cholangiocarcinoma of the Gallbladder Diffuse Adenocarcinoma of the Stomach Duct Cell Adenocarcinoma of the Pancreas Intestinal Adenocarcinoma of the Stomach Localized Unresectable Adult Primary Liver Cancer Metastatic Carcinoma of Unknown Primary Metastatic Extrahepatic Bile Duct Cancer Mixed Adenocarcinoma of the Stomach Mucinous Adenocarcinoma of the Colon Mucinous Adenocarcinoma of the Rectum Newly Diagnosed Carcinoma of Unknown Primary Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage III Pancreatic Cancer Stage IIIA Colon Cancer Stage IIIA Gallbladder Cancer Stage IIIA Gastric Cancer Stage IIIA Rectal Cancer Stage IIIB Colon Cancer Stage IIIB Gallbladder Cancer Stage IIIB Gastric Cancer Stage IIIB Rectal Cancer Stage IIIC Colon Cancer Stage IIIC Gastric Cancer Stage IIIC Rectal Cancer Stage IV Gastric Cancer Stage IV Pancreatic Cancer Stage IVA Colon Cancer Stage IVA Gallbladder Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Gallbladder Cancer Stage IVB Rectal Cancer Unresectable Extrahepatic Bile Duct Cancer Less << Phase 1 Active, not recruiting August 2020 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Evanston CCOP-NorthShore University HealthSystem Evanston, Illinois, United States, 60201 Less <<
NCT00609622 Colorectal Neoplasms Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01160419 Gastric Cancer Phase 2 Unknown May 2014 Germany ... More >> University of Munich, Klinikum Grosshadern Munich, Germany Less <<
NCT00849615 Gastric Cancer ... More >> Adenocarcinoma of the Esophagogastric Junction Less << Phase 2 Completed - Germany ... More >> Krankenhaus Nordwest Frankfurt, Germany, 60488 Less <<
NCT02416609 Pancreatic Cancer Not Applicable Recruiting November 2019 Italy ... More >> Azienda Ospedaliero-Universitaria Policlinico di Modena Recruiting Modena, MO, Italy, 41121 Contact: Bruno Meduri, MD    +393388878319    brunomeduri@gmail.com    Principal Investigator: Bruno Meduri, MD Less <<
NCT02414009 Metastatic Colorectal Cancer Phase 2 Unknown September 2017 Italy ... More >> Fondazione IRCCS Istituto Nazionale Tumori Recruiting Milan, Mi, Italy, 20133 Contact: Filippo Pietrantonio, MD    00390223903807    filippo.pietrantonio@istitutotumori.mi.it    Contact       trialcenter@istitutotumori.mi.it    Principal Investigator: Filippo de Braud, MD          Sub-Investigator: Filippo Pietrantonio, MD Less <<
NCT00364013 - Completed - -
NCT02270606 Mucinous Adenocarcinoma of the... More >> Rectum Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Rectum Rectal Adenocarcinoma Stage IIA Rectal Cancer Stage IIB Rectal Cancer Stage IIC Rectal Cancer Stage IIIA Rectal Cancer Stage IIIB Rectal Cancer Stage IIIC Rectal Cancer Less << Phase 1 Active, not recruiting May 14, 2023 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23219 Less <<
NCT03271255 Colorectal Neoplasms ... More >> Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Less << Phase 2 Not yet recruiting December 31, 2022 China, Guang Dong ... More >> Shenzhen People's Hospital Not yet recruiting Shenzhen, Guang Dong, China Contact: Ruilian Xu, MD    +8613923889123    xuruilian@126.com    Contact: Wan He, MD,PhD    +8618823719462    hewanshenzhen@hotmail.com Less <<
NCT00006015 Colorectal Cancer Phase 2 Terminated(lack of sufficient ... More >>accrual) Less << - -
NCT01670721 - Completed - -
NCT03013010 Stomach Neoplasm ... More >> GastroEsophageal Cancer Adenocarcinoma Locally Advanced Cancer Chemoradiation Less << Phase 3 Recruiting December 2023 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Zhen Zhang, M.D.    (86)13661738625    zhenzhang6@gmail.com    Contact: Xiaowen Liu, M.D.    (86)13636698200    liuxw1129@hotmail.com Less <<
NCT01670721 Colorectal Cancer Metastatic Phase 3 Completed - France ... More >> Administrative office Paris, France Less <<
NCT03043729 Rectal Cancer ... More >> Rectosigmoid Cancer Less << Phase 2 Recruiting February 2022 Germany ... More >> Tagestherapiezentrum am ITM & III. Med. Klinik Recruiting Mannheim, Germany, 68167 Contact: Ralf-Dieter Hofheinz, Prof. Dr. med. Less <<
NCT03428958 Colorectal Cancer ... More >> Colorectal Neoplasms Colorectal Carcinoma Colorectal Tumors Neoplasms, Colorectal Less << Phase 1 Recruiting December 2019 United States, Tennessee ... More >> Vanderbilt University Not yet recruiting Nashville, Tennessee, United States, 37232 Principal Investigator: Kristen Ciombor, MD          Principal Investigator: Jordan Berlin, MD          United States, Washington Seattle Cancer Center Not yet recruiting Seattle, Washington, United States, 98109-1023 Principal Investigator: Andrew Coveler, MD          United Kingdom The Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 0YN Principal Investigator: Jeff Evans, MB BS MD          Principal Investigator: Janet Graham, MBChB, MRCP          University of Oxford Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Sarah Blagden, PhD, FRCP Less <<
NCT00954876 Metastatic Colorectal Cancer Phase 2 Withdrawn(Study has been termi... More >>nated due to lack of accrual.) Less << - United States, Washington ... More >> Evergreen Hematology & Oncology Spokane, Washington, United States, 99218 Less <<
NCT03748680 Colorectal Cancer ... More >> Circulating Tumor DNA Adjuvant Chemotherapy Progression Free Survival Less << Phase 2 Recruiting October 1, 2025 Denmark ... More >> Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 Contact: Karen-Lise G Spindler, Prof.    +457846 2535    k.g.spindler@rm.dk    Contact: Line M Sparvath, CRN    457846 2610    linspa@rm.dk    Sub-Investigator: Søren Lauerberg, Prof.          Sub-Investigator: Claus L Andersen, Prof. Less <<
NCT02017704 Rectal Cancer Phase 2 Active, not recruiting October 2021 United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33607 United States, Georgia Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Maryland The SKCCC at Johns Hopkins Baltimore, Maryland, United States, 21287 United States, New York Beth Israel Hospital New York, New York, United States, 10003 Less <<
NCT00609622 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01472601 - Recruiting April 2018 Korea, Republic of ... More >> Samsung medical Center Recruiting Seoul, Korea, Republic of Contact: mi yeon kwon, RN    +82-2-3410-1248    miyeon.kwon@samsung.com    Principal Investigator: YOUNG SUK PARK, MD Less <<
NCT02366819 Esophageal Adenocarcinoma ... More >> Gastric Adenocarcinoma Stage IIB Gastric Cancer Stage IIIA Esophageal Adenocarcinoma Stage IIIA Gastric Cancer Stage IIIB Esophageal Adenocarcinoma Stage IIIB Gastric Cancer Stage IIIC Esophageal Adenocarcinoma Stage IIIC Gastric Cancer Less << Phase 4 Recruiting January 2019 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Recruiting Chicago, Illinois, United States, 60637 Contact: Daniel V. Catenacci    773-702-7596    dcatenac@medicine.bsd.uchicago.edu    Principal Investigator: Daniel V. Catenacci          Kellogg Cancer Center - Evanston Hospital Recruiting Evanston, Illinois, United States, 60201 Contact: Robert d. Marsh    847-570-2112    rmarsh@northshore.org    Principal Investigator: Robert d. Marsh          NorthShore University HealthSystem Recruiting Evanston, Illinois, United States, 60201 Contact: Mark S. Talamonti    847-570-2560    mtalamonti@northshore.org    Principal Investigator: Mark S. Talamonti Less <<
NCT02636088 Esophageal Neoplasm Phase 2 Active, not recruiting January 2019 -
NCT00149578 Pancreatic Cancer Phase 2 Unknown October 2008 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 333 Contact: Hsiu-Po Wang, M.D.    886-2-23123456    whp@ha.mc.ntu.edu.tw    Principal Investigator: Jen-Shi Chen, M.D.          Chang Gung Memorial Hospital Recruiting Tao-Yuan, Taiwan Contact: Jen-Shi Chen , M.D.    886-3-3286778    fong0301@ms18.hinet.net    Principal Investigator: Hue-Chang Tsai, M.D.          Principal Investigator: Pin-Wen Lin, M.D.          Principal Investigator: Cheng-Chung Wu, M.D. Less <<
NCT00089635 Colorectal Cancer ... More >> Metastases Less << Phase 2 Completed - -
NCT01498289 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Cancer Gastric Cancer Less << Phase 2 Active, not recruiting March 2019 -
NCT00660582 Metastatic Colorectal Cancer Phase 2 Completed - Denmark ... More >> Department of Oncology, Aalborg University Hospital Aalborg, Denmark, 9800 Department of Oncology, Herlev University Hospital Herlev, Denmark, 2630 Department of Oncology, Odense University Hospital Odense, Denmark, 5000 Norway Department of Oncology, Haukeland University Hospital Bergen, Norway Kreftsenteret, Ullevaal University Hospital Oslo, Norway, 0407 Sweden Section of Oncology, Uppsala University Hospital Uppsala, Sweden, 751 85 Less <<
NCT00932438 Colon Cancer With Metastases t... More >>o the Liver Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> Clearview Cancer Center Huntsville, Alabama, United States, 35805 United States, California Radiology Associates of Sacramento/Sutter Cancer Center Sacramento, California, United States, 95816 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 Northside Hospital/GA Cancer Specialists Atlanta, Georgia, United States, 30342 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Mississippi Hematology and Oncology Assoc. at Bridgeport Tupelo, Mississippi, United States, 38801 United States, Missouri Washington University/Alvin J. Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Oregon Providence Portland Medical Center/Providence Cancer Center Portland, Oregon, United States, 97213 United States, Wisconsin Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Argentina Hospital Italiano de Buenos Aires Buenos Aires, Argentina Less <<
NCT00268398 Colorectal Cancer ... More >> Metastatic Cancer Chemotherapy Less << Phase 3 Completed - France ... More >> Institut Sainte Catherine Avignon, France, 84000 Hopital Duffaut Avignon, France, 84902 C.H.G. Beauvais Beauvais, France, 60021 Hopital Saint Andre Bordeaux, France, 33075 Centre Hospitalier Docteur Duchenne Boulogne Sur Mer, France, 62200 Hopital Ambroise Pare Boulogne-Billancourt, France, F-92104 Centre Hospitalier de Briey Briey, France, 54151 Centre Regional Francois Baclesse Caen, France, 14076 Hopital Louis Pasteur Chartres, France, 28018 Hopital Beaujon Clichy, France, 92118 Louis Mourier Hospital Colombes Cedex, France, 92701 Clinique du Parc Croix, France, 59170 Hopital Drevon Dijon, France, 21000 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 Hopital Saint - Louis La Rochelle, France, 17000 Hopital Robert Boulin Libourne, France, 33500 Polyclinique Du Bois Lille, France, 59000 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 Polyclinique des Quatre Pavillons Lormont, France, 33310 Hopital Saint Joseph Marseille, France, 13008 Hopital Notre-Dame de Bon Secours Metz, France, 57038 Centre Hospitalier Intercommunal Le Raincy - Montfermeil Montfermeil, France, 93370 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Saint Antoine Paris, France, 75571 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Hopital Haut Leveque Pessac, France, 33604 Polyclinique De Courlancy Reims, France, F-51100 Clinique Specialise du Littoral-Cote d'Opale Saint Martin Boulogne, France, 62280 Clinique Charcot Sainte Foy Les Lyon, France, 69110 C.H. Senlis Senlis, France, 60309 Hopital Foch Suresnes, France, 92151 Less <<
NCT01566942 Colorectal Cancer Phase 3 Unknown June 2017 China, Guangdong ... More >> the first affiliated hospital of Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China, 510080 Contact: JIANJUN PENG, PhD    86-20-87332200 ext 8211    aidigua@hotmail.com Less <<
NCT01588964 Ovarian Epithelial Cancer Recu... More >>rrent Less << Phase 2 Completed - -
NCT00089635 - Completed - -
NCT03603834 Cholangiocarcinoma Phase 2 Recruiting December 2023 Thailand ... More >> Jarin Chindaprasirt Recruiting Khon Kaen, Thailand, 40002 Contact: Jaruda Sringam, Master    6643366592    talnurse8@gmail.com    Principal Investigator: Jarin Chindaprasirt, MD          Sub-Investigator: Aumkhae Sookprasert, MD          Sub-Investigator: Kosin Wirasorn, MD          Sub-Investigator: Attapol Titapun, MD          Sub-Investigator: Kulyada Somsap, MD          Sub-Investigator: Watcharin Loilome, MD          Sub-Investigator: Narong Kuntikheo, MD Less <<
NCT00881504 Biliary Tract Cancer Phase 2 Terminated(It was not possible... More >> to get insurance companies to cover bevacizumab.) Less << - United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Less <<
NCT03279237 GastroEsophageal Cancer Phase 1 Recruiting October 31, 2024 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Jill McElroy    617-724-3744    jsmcelroy@mgh.harvard.edu    Principal Investigator: Theodore S. Hong, MD Less <<
NCT02529774 Resected Liver Metastases From... More >> Colorectal Cancer Less << Phase 2 Phase 3 Not yet recruiting September 2021 China, Shanghai ... More >> Fudan University Shanghai Cancer Center China Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Ye Xu, Dr.    +86 21 64175590    xu_shirley021@163.com    Contact: Hongtu Zheng, Dr.    +86 180 1731 7711    zht5863@126.com Less <<
NCT00646607 Colon Cancer Phase 3 Completed - -
NCT00454116 Colorectal Cancer Phase 2 Completed - United States, Michigan ... More >> Research Site Ann Arbor, Michigan, United States United States, New York Research Site New York, New York, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Utah Research Site Salt Lake City, Utah, United States Argentina Research Site Buenos Aires, Argentina Research Site Ramos Mejia, Argentina Research Site Rosario, Argentina Research Site Santa Fe, Argentina Research Site Vicente Lopez, Argentina Korea, Republic of Research Site Seoul, Korea, Republic of Norway Research Site Bergen, Norway Research Site Oslo, Norway Research Site Stavanger, Norway Spain Research Site A Coruna, Spain Research Site Barcelona, Spain Research Site Jaen, Spain Research Site Lerida, Spain Research Site Lleida, Spain United Kingdom Research site Belfast, Northern Ireland, United Kingdom Research Site Aberdeen, United Kingdom Research Site Leicester, United Kingdom Research Site Manchester, United Kingdom Less <<
NCT00454116 - Completed - -
NCT00300027 Gastrointestinal Neoplasms Phase 1 Terminated - United States, Arkansas ... More >> Local Institution Little Rock, Arkansas, United States United States, California Local Institution Los Angeles, California, United States United States, District of Columbia Local Institution Washington, District of Columbia, United States United States, Iowa Local Institution Iowa City, Iowa, United States United States, North Carolina Local Institution Durham, North Carolina, United States United States, Texas Local Institution Temple, Texas, United States Less <<
NCT01928290 Stomach Neoplasms ... More >> Esophageal Neoplasms Less << Phase 2 Active, not recruiting July 23, 2021 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01554059 Rectal Adenocarcinoma Phase 2 Completed - China, Guangdong ... More >> Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510600 Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510655 Less <<
NCT00881504 - Terminated(It was not possible... More >> to get insurance companies to cover bevacizumab.) Less << - -
NCT02625610 Unresectable, Locally Advanced... More >> or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction Less << Phase 3 Active, not recruiting March 11, 2024 -
NCT02934464 Stomach Neoplasms Phase 3 Recruiting October 2019 Italy ... More >> Maria Di Bartolomeo Recruiting Milan, Italy, 20133 Contact: MARIA DI BARTOLOMEO, MD    +390223902882    maria.dibartolomeo@istitutotumori.mi.it    Contact: SILVIA LAZZATI    +3923903835    trialcenter@istitutotumori.mi.it Less <<
NCT02423278 Gastric Cancer ... More >> Surgery Effects of Chemotherapy Less << Phase 2 Phase 3 Recruiting December 2020 China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Yulong He, MD    +86 13602839886    yulongh.sysu@gmail.com Less <<
NCT02980510 Metastatic Colorectal Cancer Phase 2 Recruiting January 2024 France ... More >> Institut Sainte Catherine Not yet recruiting Avignon, France Contact: Laurent MINEUR       l.mineur@isc84.org    Principal Investigator: Laurent MINEUR, Dr          Centre Léon Berard Not yet recruiting Lyon, France Contact: Christelle DE LA FOUCHARDIERE       christelle.delafouchardiere@lyon.unicancer.fr    Principal Investigator: Christelle DE LA FOUCHARDIERE, Dr          Chu Saint Eloi Not yet recruiting Montpellier, France Contact: Eric ASSENAT       e-assenat@chu-montpellier.fr    Principal Investigator: Eric ASSENAT, Dr          ICM Val D'Aurelle Recruiting Montpellier, France Contact: Thibault MAZARD       Thibault.Mazard@icm.unicancer.fr    Principal Investigator: Thibault MAZARD, Dr          Institut de Cancérologie de Lorraine Not yet recruiting Nancy, France Contact: Céline GAVOILLE       c.gavoille@nancy.unicancer.fr    Principal Investigator: Céline GAVOILLE, Dr          CHU Carémeau - Institut de Cancérologie du Gard Not yet recruiting Nimes, France Contact: Stéphane OBLED       stephane.obled@chu-nimes.fr    Principal Investigator: Stéphane OBLED, Dr Less <<
NCT00070434 Colorectal Cancer Phase 2 Withdrawn(poor accrual) - -
NCT02339116 Metastatic Colorectal Cancer Phase 3 Active, not recruiting February 2021 Italy ... More >> Polo Oncologico - AOUP Pisa, PI, Italy, 56126 Less <<
NCT03443661 Locally Advanced Rectal Cancer Phase 2 Recruiting November 1, 2018 China ... More >> National Cancer Center/Cancer Hospital, Chinese ACademy of Medical Sciences and Peking Union Medical College Recruiting Beijing, China, 100021 Contact: Aiping Zhou, Doctor    +86 13691161998    zhouap1825@126.com    Principal Investigator: Aiping Zhou, Doctor Less <<
NCT01786538 Metastatic Colorectal Cancer Phase 3 Withdrawn May 2017 Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138736 Less <<
NCT00008281 Colorectal Cancer Phase 3 Unknown - -
NCT00005068 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03203525 Liver Cancer Phase 1 Not yet recruiting December 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       siqingfu@mdanderson.org Less <<
NCT00006468 Colorectal Cancer Phase 3 Unknown - France ... More >> Hopital Saint Antoine Paris, France, 75571 Less <<
NCT03121807 Metastatic Gastric Cancer Not Applicable Recruiting December 1, 2019 Taiwan ... More >> Chung-Ho Memorial Hospital, Kaohsiung Medical University: Recruiting Kaohsiung, Taiwan, 807 Contact: Jaw-Yuan Wang, PhD       cy614112@ms14.hinet.net    Contact: Cheng-Jen Ma, MD       kmu880402@gmail.com    Principal Investigator: Jaw-Yuan Wang, Ph.D.          Sub-Investigator: Cheng-Jen Ma, MD Less <<
NCT03415763 Rectal Neoplasms Phase 3 Recruiting December 2025 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Xinxiang Li, MD,PhD    86-13918176716    lxx1149@163.com    Contact: Qingguo Li, MD,PhD    86-18918298120    13111230016@fudan.edu.cn    Principal Investigator: Xinxiang Li, MD,PhD Less <<
NCT03675737 Stomach Neoplasms Phase 3 Recruiting February 2, 2024 United States, Maryland ... More >> Greater Baltimore Medical Center ( Site 0102) Recruiting Baltimore, Maryland, United States, 21204 Contact: Study Coordinator    443-849-3122       United States, Minnesota Minnesota Oncology Hematology, PA ( Site 8000) Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Study Coordinator    281-863-4643       United States, Virginia Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care ( Site 8001) Recruiting Roanoke, Virginia, United States, 24014 Contact: Study Coordinator    281-863-4643       United States, Washington Wenatchee Valley Clinic [Wenatchee, WA] ( Site 0116) Recruiting Wenatchee, Washington, United States, 98801 Contact: Study Coordinator    509-665-5800       Australia, New South Wales Southern Medical Day Care Centre ( Site 2303) Recruiting Wollongong, New South Wales, Australia, 4020 Contact: Study Coordinator          Canada, Quebec McGill University Health Centre ( Site 0208) Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Study Coordinator    5149341934       France C.H.R.U. de Brest - Hopital Morvan ( Site 1007) Recruiting Brest, France, 29200 Contact: Study Coordinator    +33298223428       Israel Rabin Medical Center ( Site 1302) Recruiting Petah Tikva, Israel, 4941492 Contact: Study Coordinator    +97239378077       Chaim Sheba Medical Center ( Site 1304) Recruiting Ramat Gan, Israel, 5262000 Contact: Study Coordinator    +97235307776       Sourasky Medical Center ( Site 1306) Recruiting Tel Aviv, Israel, 6423906 Contact: Study Coordinator    +97236973082       Korea, Republic of Seoul National University Hospital ( Site 2803) Recruiting Seoul, Korea, Republic of, 03080 Contact: Study Coordinator    +82220720701       Severance Hospital Yonsei University Health System ( Site 2800) Recruiting Seoul, Korea, Republic of, 03722 Contact: Study Coordinator    +82222288132       Asan Medical Center ( Site 2802) Recruiting Seoul, Korea, Republic of, 05505 Contact: Study Coordinator    +82230103230       Samsung Medical Center ( Site 2801) Recruiting Seoul, Korea, Republic of, 06351 Contact: Study Coordinator    +82234101779       Switzerland Luzern Kantonsspital ( Site 1904) Recruiting Luzern, Switzerland, 6000 Contact: Study Coordinator    +41412055875       Taiwan National Cheng Kung University Hospital ( Site 2901) Recruiting Tainan, Taiwan, 704 Contact: Study Coordinator    +886623535354559 Less <<
NCT02337946 Colorectal Carcinoma Phase 2 Completed - -
NCT00268333 Colorectal Cancer Phase 2 Completed - France ... More >> Institut Sainte Catherine Avignon, France, 84082 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Hopital Drevon Dijon, France, 21000 Hopital Robert Boulin Libourne, France, 33500 Polyclinique des Quatre Pavillons Lormont, France, 33310 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Tenon Paris, France, 75970 Polyclinique De Courlancy Reims, France, F-51100 C.H. Senlis Senlis, France, 60309 Less <<
NCT00387387 Neoplasms, Colorectal Phase 1 Completed - India ... More >> GSK Investigational Site Hyderabad, Andhra Pradesh, India, 500482 GSK Investigational Site Parel, India, 400012 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2QQ GSK Investigational Site Oxford, Oxfordshire, United Kingdom, OX3 7LJ GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT01006369 Colorectal Cancer Phase 2 Completed - United States, New Jersey ... More >> Cooper Hospital/University Medical Center Camden, New Jersey, United States, 08103 Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States, 08690 Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 New Jersey Medical School/The University Hospital Cancer Center Newark, New Jersey, United States, 07103 Less <<
NCT03391843 Rectal Cancer Stage III Phase 2 Active, not recruiting December 31, 2027 China, S ... More >> Department of Radiation Oncology,Renji Hospital affiliated to Medical School, Shanghai Jiaotong University Shanghai, S, China, 2 Less <<
NCT03653507 Locally Advanced Unresectable ... More >>Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer Metastatic Gastric Adenocarcinoma or Cancer Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma Less << Phase 3 Recruiting April 2023 United States, California ... More >> Pacific Cancer Care Recruiting Monterey, California, United States, 93940 United States, New Mexico New Mexico Oncology Hematology Recruiting Albuquerque, New Mexico, United States, 87109 Korea, Republic of Site KR82002 Recruiting Daegu, Korea, Republic of Site KR82007 Recruiting Gyeonggi-do, Korea, Republic of Site KR82008 Recruiting Hwasungun, Korea, Republic of Site KR82010 Recruiting Jeonju-si, Korea, Republic of Site KR82001 Recruiting Seoul, Korea, Republic of Site KR82003 Recruiting Seoul, Korea, Republic of Site KR82009 Recruiting Suwon, Korea, Republic of Less <<
NCT01876927 Gastric Cancer ... More >> Locally Advanced Malignant Neoplasm Less << Phase 2 Completed - Italy ... More >> Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - GM Lancisi Ancona, AN, Italy USL 8 Arezzo - Presidio Ospedaliero Zona Casentino - Ospedale di Bibbiena Bibbiena, AR, Italy USL 8 Arezzo - Ospedale "Santa Maria alla Gruccia" Valdarno (Montevarchi), AR, Italy UO Oncologia , Spedali Civili di Brescia Brescia, BS, Italy, 25123 Ospedale Bufalini Cesena, FC, Italy UO oncologia medica IRCCS IRST Meldola (FC), FC, Italy, 47014 UOC Oncologia , Azienda USL 11 Empoli, FI, Italy, 50053 Ospedale Careggi Firenze, FI, Italy UO ONCOLOGIA , Istituto Europeo di Oncologia Milano, MI, Italy, 20141 Istituto Clinico Humanitas Rozzano, MI, Italy Azienda Ospedaliera Universitaria Pisana Pisa, PI, Italy UO Oncologia, Fondazione Policlinico San Matteo Pavia, PV, Italy, 27100 UO Oncologia Medica, PO Rimini, AUSL della Romagna Rimini, RI, Italy, 47923 UO Oncologia , Casa di Cura Tortorella Salerno, SA, Italy, 84122 Policlinico Le Scotte Siena, SI, Italy UO Oncologia, Azienda Ospedaliero Treviglio Treviglio, TV, Italy, 24047 UO Oncologia Medica, azienda Ospedaliera di Varese Varese, VA, Italy, 21100 Azienda Ospedaliera di Perugia - Ospedale S. Maria della Misericordia Perugia, Italy Ospedale San Filippo Neri Roma, Italy Ospedale Borgo Trento Verona, Italy Less <<
NCT00436280 Lymphoma, Large Cell, Diffuse Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Creteil, France, 94010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dijon, France, 21079 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France, 59037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nice, France, 06202 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nimes, France, 30029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75475 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pessac, France, 33604 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pierre Benite, France, 69495 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rouen, France, 76038 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, D-12203 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bremen, Germany, 28205 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, D-4600 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20099 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kassel, Germany, 34125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kiel, Germany, 24116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55131 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 125167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 198255 Less <<
NCT00885950 - Completed - Netherlands ... More >> Department of Surgery; Maastricht University Medical Centre Maastricht, Netherlands Less <<
NCT00845039 Colon Cancer ... More >>Rectal Cancer Less << Phase 2 Terminated(Study terminated ea... More >>rly 22Feb2010 with only 4 participants due to business reasons.) Less << - United States, California ... More >> ImClone Investigational Site Vallejo, California, United States, 94589 United States, North Carolina ImClone Investigational Site Greenville, North Carolina, United States, 27834 United States, Pennsylvania ImClone Investigational Site Scranton, Pennsylvania, United States, 18510 Less <<
NCT02942563 Rectal Cancer Phase 2 Recruiting September 30, 2022 China, Shanghai ... More >> Ethics Committee of Renji Hospital, School of Medicine,Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200127 Contact: Ming Ye, Master    +862168383459    renjiyeming@163.com    Contact: Qi Lu, Master    +862158752345 ext 33364    luqi@renji.com Less <<
NCT01362361 Colorectal Cancer Phase 2 Unknown December 2013 Germany ... More >> Universitätsklinikum Halle Recruiting Halle, Sachsen-Anhalt, Germany, 06120 Contact: Thomas Seufferlein, MD          Principal Investigator: Thomas Seufferlein, MD          Sub-Investigator: Thomas J. Ettrich, MD          Schwerpunktpraxis für Hämatologie und Onkologie Bottrop und Dorsten Recruiting Bottrop, Germany Principal Investigator: Carla V. Hannig, MD          Universitätsklinikum Greifswald -Klinik für Innere Medizin A Recruiting Greifswald, Germany Principal Investigator: Julia Mayerle, MD          Gemeinschaftspraxis und Tagesklinik Onkologie und Gastroenterologie - Halle Recruiting Halle, Germany Principal Investigator: Stefanie Frank-Gleich, MD          Klinikum Karlsruhe, Medizinische Klinik III Recruiting Karlsruhe, Germany Principal Investigator: Margarethe Schmier, MD          Kliniken der Stadt Köln gGmbH - Krankenhaus Holweide Recruiting Köln, Germany Principal Investigator: Claudia Lang, MD          Universitätsmedizin Mannheim - TTZ am Interdisziplinären Tumorzentrum Recruiting Mannheim, Germany Principal Investigator: Ralf Hofheinz, MD          Joh. Wesling Klinikum Minden Recruiting Minden, Germany Principal Investigator: Hans-Joachim Tischler, MD          Stauferklinikum Schwäbisch Gmünd - Mutlangen - Zentrum Innere Medizin Recruiting Mutlangen, Germany Principal Investigator: Holger Hebart, MD          Klinikum der Universität München-Großhadern - Medizinische Klinik und Poliklink III Recruiting München, Germany Principal Investigator: Volker Heinemann, MD          Leopoldina-Krankenhaus Schweinfurt - Medizinische Klinik 2 Recruiting Schweinfurt, Germany Principal Investigator: Stephan Kanzler, MD          Universitätsklinikum Ulm - Klinik für Innere Medizin I Recruiting Ulm, Germany Principal Investigator: Götz von Wichert, MD Less <<
NCT00845039 - Terminated(Study terminated ea... More >>rly 22Feb2010 with only 4 participants due to business reasons.) Less << - -
NCT00399035 - Completed - -
NCT00479752 Colorectal Cancer Phase 2 Completed - Austria ... More >> LKH Leoben, Abt. für Innere Medizin Leoben, Steiermark, Austria, 8700 Medical University of Vienna Vienna, Austria Bosnia and Herzegovina Institute of Oncology Sarajevo Sarajevo, Bosnia and Herzegovina Bulgaria SBALO National Oncology Center Sofia, Bulgaria, 1754 Croatia University Hospital Centre Rijeka Rijeka, Croatia, 51000 University Hospital for Tumors Zagreb, Croatia University Hospital Rebro Zagreb, Croatia Estonia Noth estonian Regional Oncology Hospital Tallin, Estonia, 13419 Greece AHEPA Hospital University Hospital Papageorgiou Athens, Greece General Hospital of Athens Athens, Greece Hungary Semmelweis Univ. Radiology Clinic Budapest, Hungary, 1082 National Medical Center Budapest, Hungary, 1135 Markusovsy Hospital Szombathely, Hungary, 39700 Israel Meir Medical Center Kfar Saba, Israel Oncology Division Sourasky Medical Center Tel Aviv, Israel, 64239 Latvia P. Stradins University Hospital Riga, Latvia, 1020 latvian Center of Oncology Riga, Latvia, 1079 Romania Institutul Oncologic Bucuresti Bucuresti, Romania Institutul Oncologic Ion Chiricuta Cluj Napoca, Romania Serbia Institute of Oncology and Radiology of Serbia Belgrade, Serbia, 11000 Institute of Oncology of Vojvodina Sremska Kamenica, Serbia, 21204 Slovakia National Cancer Institute Bratislava, Slovakia, 83310 National Institute of Oncology Bratislava, Slovakia Slovenia Institute of Oncology Ljubljana, Slovenia, 1000 Less <<
NCT00399035 Metastatic Colorectal Cancer Phase 3 Completed - -
NCT01688336 Pancreatic Cancer Phase 2 Terminated(Results unlikely to... More >> impact treatment patterns. Time to complete not justified.) Less << - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01688336 - Terminated(Results unlikely to... More >> impact treatment patterns. Time to complete not justified.) Less << - -
NCT02817425 Gastric Cancer Phase 2 Phase 3 Recruiting May 2019 China, Gansu ... More >> Second Hospital Affiliated to Lanzhou University Recruiting LanZhou, Gansu, China, 0931 Contact: WEN QIU    0931-8487117    qiuwenmm@sina.com    Principal Investigator: XIAO CHEN, Professor Less <<
NCT03368131 Gastroesophageal Junction Aden... More >>ocarcinoma Less << Phase 2 Active, not recruiting December 2019 China, Hebei ... More >> Fourth Affiliated Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050011 Less <<
NCT00514020 Gastric Cancer Phase 2 Completed - United States, Missouri ... More >> Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis, Missouri, United States, 63110 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 United States, Tennessee Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00126256 Colorectal Cancer ... More >> Metastasis Less << Phase 3 Completed - France ... More >> Institut Gustave-Roussy Villejuif, France, 94805 Less <<
NCT01658033 Metastatic Breast Cancer Phase 2 Completed - China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT03000374 Rectal Cancer Phase 2 Recruiting October 2020 Spain ... More >> Hospital General Universitario de Elche Not yet recruiting Elche, Alicante, Spain, 3203 Contact: Javier Gallego Plazas, MD       j.gallegoplazas@gmail.com    Hospital de Sabadell Active, not recruiting Sabadell, Barcelona, Spain, 08208 Hospital de Sant Joan Despí Moisés Broggi Active, not recruiting Sant Joan Despí, Barcelona, Spain, 08970 Complejo Hospitalario de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: Ruth Vera Garcia, MD       ruth.vera.garcia@cfnavarra.es    Hospital de la Santa Creu i Sant Pau Active, not recruiting Barcelona, Spain, 08025 Hospital Universitari Vall d'Hebrón Not yet recruiting Barcelona, Spain, 08035 Contact: Jaume Capdevila, MD       jacapdevila@vhebron.net    Hospital Clinic i Provincial Active, not recruiting Barcelona, Spain, 08036 Hospital Universitario La Paz Active, not recruiting Madrid, Spain, 28046 Hospital Universitario Virgen del Rocío Not yet recruiting Sevilla, Spain, 41013 Contact: Manuel Valladares, MD       mvalaye@icloud.com    Fundación Instituto Valenciano de Oncología Active, not recruiting Valencia, Spain, 46009 Consorcio Hospital General Universitario de Valencia Active, not recruiting Valencia, Spain, 46014 Hospital Politécnico Universitario La Fe Not yet recruiting Valencia, Spain, 46026 Contact: Jorge Aparicio Urtasun, MD          Contact       japariciou@seom.org Less <<
NCT03399253 Gastric Cancer Phase 2 Phase 3 Recruiting December 1, 2025 China, Anhui ... More >> Anqing Municipal Hospital Recruiting Anqing, Anhui, China Contact: Yaming Zhang          Contact: Daibin Tang    13865176528       Anhui Provincial Hospital Recruiting Hefei, Anhui, China Contact: Xuhui Zhao    18963789289       Contact: Yifu He    13485691976       The First Affiliated Hospital of Anhui Medical University Recruiting Hefei, Anhui, China Contact: Aman Xu    13705695470       Contact: Fei Zhong    18226616729       First Affiliated Hospital of Wannan Medical College Recruiting Wuhu, Anhui, China Contact: Lianghui Shi    13956159006       China, Guangdong Cancer Center of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Dazhi Xu    86(020)87343737    xudzh@sysucc.org.cn    Contact: Youqing Zhan    86(020)87343910    Zhanyq@sysucc.org.cn    Yuebei People's Hospital Recruiting Guangzhou, Guangdong, China Contact: Tao Tao Zhang    13500206389       China, Jiangxi Jiangxi Provincial Cancer Hospital Recruiting Nanchang, Jiangxi, China Contact: Huamin Rao    13879100685       China, Zhejiang Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting Hangzhou, Zhejiang, China Contact: Li Chen    13958092350       China Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, China Contact: Rupeng Zhang    13920561244 Less <<
NCT01366118 Rectal Cancer Not Applicable Completed - Spain ... More >> Centro Integral Oncológico Clara Campal Madrid, Spain, 28050 Less <<
NCT02864849 Rectal Cancer Phase 2 Recruiting April 2023 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Lin Wang, M.D.    +86 139 1097 5011       Principal Investigator: Aiwen Wu, M.D.          Sub-Investigator: Lin Wang, M.D. Less <<
NCT01815853 Gastric Cancer Phase 3 Recruiting December 2025 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Wei Wang, M.D, Ph.D    0086-20-87343910    wangwei@sysucc.org.cn    Principal Investigator: Zhi-wei Zhou, MD,PhD Less <<
NCT01679327 Colorectal Cancer Phase 2 Unknown September 2014 China ... More >> Cancer Institute&Hospital Chinese Academy of Medical Sciences Recruiting Beijing, China Contact: Yihebali Chi, MD    8610-87788145    Yihebalichi@yahoo.com Less <<
NCT01270438 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 2 Withdrawn - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT02648711 Solid Tumors Phase 1 Active, not recruiting December 2017 United States, Michigan ... More >> START Midwest/Cancer & Hematology Centers of Western Michigan, PC Grand Rapids, Michigan, United States, 49503 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 South Texas Accelerated Research Therapeutics (START), LLC San Antonio, Texas, United States, 78229 Less <<
NCT01271166 Advanced Colorectal Cancer Phase 1 Terminated - Australia ... More >> Novarts Investigative Site Melbourne, Australia Less <<
NCT02648841 Gastric Cancer Phase 3 Recruiting June 2022 China, Beijing ... More >> Cancer Hospital, Chinese academy of medical sciences Recruiting Bejing, Beijing, China, 100021 Contact: Ning Li, MD    +86-87788280    lee_ak@163.com Less <<
NCT02195180 Pancreatic Adenocarcinoma Meta... More >>static Less << Phase 2 Completed - France ... More >> Saint Catherine Institute Avignon, France, 84918 Institut de Cancerologie Brest, France, 29609 Hopital Beaujon Clichy, France, 92118 Hospital Henri Mondor Creteil, France, 94010 Groupe Hospitalier Mutualiste Grenoble Grenoble, France, 38028 Centre Hospitalier Departemental Vendee - Les Oudairies La Roche-sur-Yon, France, 85925 Centre Oscar Lambret Lille, France, 59020 Cnetre Leon Berard Lyon, France, 69373 Institut Regional du Cancer-Montpellier Val d'Aurelle Montpellier, France, 34298 Institute Mutualiste Montsouris Paris, France, 75014 Hospital Saint Antoine Paris, France, 75571 Hospital Pitie Salpetriere Paris, France, 75651 CHU de Poitiers Poitiers, France, 42109 CHU Reims Reims, France, 51100 CHU Toulouse - Rangueil Toulouse, France, 31059 CHU de Tours Tours, France, 37044 Less <<
NCT01867892 Pancreatic Cancer Phase 2 Enrolling by invitation May 2019 -
NCT01918527 Colon Cancer Phase 3 Recruiting February 2025 Denmark ... More >> Aalborg University Hospital Recruiting Aalborg, Denmark Contact: Mette N Yilmaz, MD       m.yilmaz@rn.dk    Principal Investigator: Mette N Yilmaz, MD          Rigshospitalet Recruiting Copenhagen, Denmark Contact: Lone Nørgaard, MD       Lone.Noergaard.Petersen@regionh.dk    Principal Investigator: Lone Nørgaard, MD          Herlev Hospital Recruiting Herlev, Denmark Contact: Ole Larsen, MD       ole.larsen@regionh.dk    Principal Investigator: Ole Larsen, MD          Hilleroed Hospital Recruiting Hillerød, Denmark Contact: Kell Østerlind, MD       kell.oesterlind@regionh.dk    Principal Investigator: Keld Østerlind, MD          Roskilde Hospital Recruiting Roskilde, Denmark Contact: Jim S Larsen, MD       JSLA@regionsjaelland.dk    Principal Investigator: Jim S Larsen, MD          Sygehus Sønderjylland Recruiting Sønderborg, Denmark Contact: Daniela Zitnjak, MD       Daniela.Zitnjak@rsyd.dk    Principal Investigator: Daniela Zitnjak, MD          Vejle Hospital Recruiting Vejle, Denmark Contact: Anders Jakobsen, DMSc       anders.jakobsen@rsyd.dk    Contact: Henrik Jensen, MD, PhD       lars.henrik.jensen@rsyd.dk    Principal Investigator: Henrik Jensen, MD, PhD          Sub-Investigator: John Ploen, MD          Norway Haukeland University Hospital Recruiting Bergen, Norway Contact: Olav Dahl, MD       olav.dahl@helse-bergen.no    Principal Investigator: Olav Dahl, MD          Sweden Sahlgrenska University Hospital Recruiting Göteborg, Sweden Contact: Göran Carlssen, MD       goran.u.carlsson@vgregion.se    Principal Investigator: Göran Carlsson, MD Less <<
NCT00720512 Colorectal Cancer Phase 3 Terminated - Italy ... More >> Universita Politecnica Delle Marche Ancona, Italy, 60100 Azienda Usl 8 Arezzo Arezzo, Italy, 52100 Ospedale degli Infermi - ASL 12 Biella, Italy, 13900 A. Perrino Hospital Brindisi, Italy, 72100 Azienda Ospedaliera S. Elia Caltanissetta, Italy, 93100 Ospedale Santa Croce Cuneo, Italy, 12100 Ospedale San Giuseppe Empoli, Italy, 50053 Ospedale E. Profili Fabriano, Italy, 60044 Ospedale Civile S. Croce Fano, Italy, 61032 Azienda Ospedaliera di Firenze Florence, Italy, 50011 Azienda Ospedaliero Careggi Florence, Italy, 50139 Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Ospendale S. Andrea EST La Spezia, Italy, 19100 Azienda Ospedaliera Vito Fazzi Lecce, Italy, 73100 Azienda USL12 Versilia Lido di Camaiore, Italy, 55043 Ospedale Campo Di Marte Lucca Lucca, Italy, 55100 Azienda Ospedaliera Maggiore Della Carita Novara, Italy, 28100 Azienda Ospedaliera Pisana Pisa, Italy, 56126 Arcispedale S. Maria Nuova Reggio Emilia, Italy, 42100 Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 Dipartimento Oncologico Siena, Italy, 53100 Less <<
NCT02320448 Peritoneal Carcinomatosis Phase 2 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Less <<
NCT02997228 Colorectal Adenocarcinoma ... More >> Mismatch Repair Deficiency Stage IV Colorectal Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Less << Phase 3 Recruiting April 30, 2022 -
NCT00385021 Colorectal Neoplasms Phase 2 Terminated - United States, Oklahoma ... More >> Cancer Treatment Centers of America at Southwestern Regional Medical Center, Inc. Tulsa, Oklahoma, United States, 74133 Less <<
NCT03287375 Peritoneum; Carcinomatosis ... More >> Peritoneal Neoplasms Peritoneal Metastases Chemotherapy Effect Chemotherapeutic Toxicity Quality of Life Histologic Progression Less << Phase 2 Recruiting December 1, 2020 Denmark ... More >> Department of Surgery, Odense University Hospital Recruiting Odense, Denmark, 5000 Principal Investigator: Michael B Mortensen, MD, Ph.D. Less <<
NCT01821612 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage II Pancreatic Cancer Stage III Pancreatic Cancer Less << Early Phase 1 Completed - United States, California ... More >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 United States, Kentucky The James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky, United States, 40202 United States, Louisiana Ochsner Medical Center Jefferson New Orleans, Louisiana, United States, 70121 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45267 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 University Pointe West Chester, Ohio, United States, 45069 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00571740 Colorectal Cancer Phase 2 Withdrawn(The study was not ac... More >>tivated) Less << - -
NCT00322712 - Completed - United States, New Mexico ... More >> University of New Mexico Albuquerque, New Mexico, United States, 87131 Less <<
NCT00322712 - Completed - -
NCT03117972 Metastatic Colorectal Cancer Phase 2 Recruiting October 2021 France ... More >> Centre Hospitalier Universitaire de Besançon Recruiting Besançon, France, 25000 Contact: Marine JARY, PH          Centre Hospitalier de Boulogne sur Mer Recruiting Boulogne-sur-Mer, France Contact: Vincent BOURGEOIS, Dr          CH de Colmar Recruiting Colmar, France Principal Investigator: Gilles BREYSACHER, Dr          Institut de Cancérologie de Bourgogne Recruiting Dijon, France, 21000 Contact: Ariane Darut-Jouve, Dr          CHRU de LILLE Recruiting Lille, France, 59037 Contact: Anthony TURPIN, Dr          Hôpital Nord Franche-Comté Recruiting Montbéliard, France, 25209 Contact: Stefano Kim, Dr          Institut de Cancérolgie de Montpellier- ICM Not yet recruiting Montpellier, France, 34070 Contact: Emmanuelle SAMALIN, Dr          CHU de REIMS, Hôpital Robert Debré Recruiting Reims, France Contact: Olivier BOUCHE, Pr          Clinique Sainte Anne Recruiting Strasbourg, France, 67000 Contact: Louis-Marie Dourthe, Dr          Centre Paul Strauss Recruiting Strasbourg, France, 67065 Contact: Meher Benabdelghani, Dr          CHU de Tours Recruiting Tours, France, 37044 Contact: Thierry Lecomte, Pr          CHI de Haute-Saône Not yet recruiting Vesoul, France, 70014 Contact: Denis Cleau, Dr Less <<
NCT01443065 Malignant Neoplasm of Esophagu... More >>s Malignant Neoplasm of Stomach Less << Phase 2 Active, not recruiting January 2019 France ... More >> Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT02746796 Gastric Cancer Phase 2 Phase 3 Active, not recruiting - -
NCT03349866 Gastroesophageal Junction Aden... More >>ocarcinoma Less << Phase 2 Recruiting June 2020 China, Hebei ... More >> The Fourth Hospital of Hebei Medical University Recruiting ShiJiaZhuang, Hebei, China Contact: Qun Zhao    13930162111    Zhaoqun516@126.com Less <<
NCT02584556 Hepatocellular Carcinoma Phase 2 Phase 3 Unknown October 2017 -
NCT00958737 Colorectal Cancer Phase 3 Active, not recruiting September 2017 France ... More >> GERCOR Groupe Cooperateur Multidisciplinaire en Oncologie Paris, France, 75011 Less <<
NCT02578368 Gastric Cancer Phase 3 Recruiting December 2021 Germany ... More >> Krankenhaus Nordwest Recruiting Frankfurt am Main, Germany, 60488 Contact: Salah-Eddin Al-Batran, MD    +496976014420    albatran@aol.com    Contact: Claudia Pauligk, PhD    +496976013906    pauligk.claudia@khnw.de    Principal Investigator: Salah-Eddin Al-Batran, MD Less <<
NCT02949258 Stomach Neoplasms ... More >> Gastric Cancer Less << Phase 2 Not yet recruiting January 2021 China, Jiangsu ... More >> Research institue of general surgery, Jinling hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Guoli Li, M.D.    +86-13851559752 Less <<
NCT02021422 Pancreas Cancer Phase 1 Active, not recruiting December 2017 United States, Texas ... More >> Baylor Sammons Cancer Center Dallas, Texas, United States, 75246 Less <<
NCT00868569 Liver Metastasis ... More >> Colorectal Cancer Less << Phase 4 Unknown December 2010 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: jianmin xu, MD, PHD    008613501984869    xujmin@yahoo.com.cn    Principal Investigator: jianmin xu, MD, PHD Less <<
NCT01523015 Adenocarcinoma of the Gastroes... More >>ophageal Junction Less << Phase 2 Phase 3 Recruiting December 2020 Poland ... More >> Second Department of General & Gastrointestinal Surgery & Oncological Surgery of the Alimantary Tract, Medical University of Lublin Recruiting Lublin, Lubelskie, Poland, 20-081 Contact: Tomasz Skoczylas, MD, PhD    +48 81 5328810    tomskocz@yahoo.com    Principal Investigator: Tomasz Skoczylas, MD, PhD          Principal Investigator: Grzegorz Wallner, Professor          Principal Investigator: Andrzej Dąbrowski, Professor          Sub-Investigator: Witold Zgodziński, MD, PhD          Sub-Investigator: Marek Majewski, MD, PhD Less <<
NCT00008294 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01191697 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02141295 Colorectal Cancer Phase 2 Completed - -
NCT02291744 Metastatic Colon Cancer Phase 2 Unknown October 2017 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting ShangHai, Shanghai, China, 200032 Contact: Wei Jian Guo, PHD Less <<
NCT02545504 Gastric Adenocarcinoma Phase 3 Active, not recruiting December 2023 -
NCT01231399 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Recurrent Esophageal Cancer Recurrent Gastric Cancer Stage IV Esophageal Cancer Stage IV Gastric Cancer Less << Phase 1 Phase 2 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 South Pasadena Cancer Center South Pasadena, California, United States, 91030 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01064999 Rectal Cancer Phase 2 Phase 3 Unknown December 2014 China, Shanghai ... More >> Cancer Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Principal Investigator: Zhen Zhang, MD          Sub-Investigator: Ji Zhu, MD Less <<
NCT01508000 Colorectal Cancer Metastatic ... More >> Liver Metastases KRAS Wild Type Colorectal Cancer Less << Phase 2 Terminated(Low or poor accrual... More >>) Less << - Austria ... More >> Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, A-1090 Belgium Hopital Universitaire Brugmann Brussels, Belgium Universitair Ziekenhuis Gent Gent, Belgium AZ Groeninge Kortrijk - Campus Kennedylaan Kortrijk, Belgium AZ Turnhout - Campus Sint Elisabeth Turnhout, Belgium Centre Hospitalier Peltzer-La Tourelle Verviers, Belgium France Institut Sainte Catherine Avignon, France Institut Bergonie Bordeaux, France CHU Ambroise Pare Boulogne Billancourt, France, F-92104 Assistance Publique - Hôpitaux de Paris - Hopital De Bicetre AP-HP Le Kremlin Bicetre, France Centre Hospitalier Saint Joseph Saint Luc Lyon, France Centre Leon Berard Lyon, France Hopital Prive Jean Mermoz Lyon, France Centre Antoine Lacassagne Nice, France Hopital Europeen Georges Pompidou Paris, France, 75015 Groupe Hospitalier Diaconesses Croix Saint-Simon - Site Reuilly Paris, France CHU de Lyon - Centre Hospitalier Lyon Sud Pierre-Benite (lyon), France CHU de Reims - Hôpital Robert Debré Reims, France Hopital Charles Nicolle Rouen, France CHU Saint-Etienne - CHU de Saint-Etienne - Hopital Nord Saint Priest en Jarez, France Centre Hospitalier Privé Saint-Grégoire Saint-Gregoire, France CHU d'Amiens - CHU Amiens - Hopital Sud Salouel, France Netherlands The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis Amsterdam, Netherlands Spain Hospital General Vall D'Hebron Barcelona, Spain Switzerland Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie Geneve, Switzerland Less <<
NCT01529164 Colorectal Cancer Phase 2 Unknown September 2014 China, Beijing ... More >> Cancer hospital & Institute,Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Wen Zhang, MD    86-10-87788145    wenwen0605@163.com    Contact: Lin Yang, MD    86-10-87788118    lyang69@sina.com.cn    Principal Investigator: Lin Yang, MD Less <<
NCT01818973 Rectal Cancer Phase 2 Recruiting March 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center (SYSUCC) Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yuan-hong Gao    +86-20-87343385       Principal Investigator: Yuan-hong Gao Less <<
NCT00462501 Colorectal Cancer Not Applicable Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01231399 - Completed - -
NCT00462501 - Completed - -
NCT03300609 Colorectal Adenocarcinoma ... More >> RAS Wild Type Stage III Colorectal Cancer AJCC v7 Stage IIIA Colorectal Cancer AJCC v7 Stage IIIB Colorectal Cancer AJCC v7 Stage IIIC Colorectal Cancer AJCC v7 Stage IV Colorectal Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Less << Phase 3 Recruiting February 27, 2023 United States, California ... More >> USC/Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Dana Agafitei    323-865-0467    Raluca.Agafitei@med.usc.edu Less <<
NCT02580253 Hepatocellular Carcinoma Phase 2 Not yet recruiting December 2018 China, Zhejiang ... More >> First affiliated hospital, Zhejiang University Hangzhou, Zhejiang, China, 310006 Less <<
NCT01897454 Pancreatic Adenocarcinoma ... More >> Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer Less << Phase 2 Unknown - United States, New York ... More >> Montefiore Medical Center-Weiler Hospital Recruiting Bronx, New York, United States, 10461 Contact: Jennifer W. Chuy    718-405-8404    JCHUY@montefiore.org    Principal Investigator: Jennifer W. Chuy Less <<
NCT01867697 Metastatic Colorectal Cancer Phase 2 Active, not recruiting March 2020 Denmark ... More >> Aalborg University Hospital Aalborg, Denmark, 9100 Aarhus University Hospital Aarhus, Denmark, 8000 Rigshospitalet Copenhagen, Denmark, 2100 Sydvestjysk Hospital Esbjerg, Denmark, 6700 Herlev University Hospital Herlev, Denmark, 2730 Herning Hospital Herning, Denmark Naestved Hospital Naestved, Denmark, 4700 Odense University Hospital Odense, Denmark, 5000 Roskilde Hospital Roskilde, Denmark, 4000 Norway Haukeland University Hospital Bergen, Norway, 5021 Trondheim University Hospital Trondheim, Norway Sweden Akademiska University Hospital Uppsala, Sweden, 751 85 Less <<
NCT02774187 Hepatocellular Carcinoma Phase 3 Active, not recruiting August 2018 China, Guangdong ... More >> Dongguan People 's Hospital Dongguan, Guangdong, China, 523059 Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Guangzhou Twelfth People 's Hospita Guangzhou, Guangdong, China, 510620 The Kaiping Center's Hospital Kaiping, Guangdong, China, 529300 China, Hunan First Affiliated Hospital of University Of South China Hengyang, Hunan, China, 421001 China, Shanxi First Affiliated Hospital Of Xi'an Jiaotong University Xi'an, Shanxi, China, 710061 Less <<
NCT01524094 Colorectal Peritoneal Carcinom... More >>atosis Less << Phase 3 Completed - Sweden ... More >> Akademiska Sjukhuset (Uppsala University Hospital) Uppsala, Sweden, SE-751 85 Less <<
NCT02582970 Colorectal Cancer Phase 4 Completed - Taiwan ... More >> Chai Yi, Taiwan, 613 Kaohsiung, Taiwan, 00833 Kaohsiung, Taiwan, 807 Taichung, Taiwan, 404 Taichung, Taiwan, 407 Tainan, Taiwan, 704 Tainan, Taiwan, 710 Taipei, Taiwan, 104 Less <<
NCT01611857 - Completed - -
NCT02338518 Stomach Neoplasms ... More >> Gastric Cancer Less << Phase 3 Unknown December 2018 China, Jiangsu ... More >> Jinling Hospital Recruiting Nanjing, Jiangsu, China Contact: Kun Liu    +86-18068770627    liushen1022@163.com Less <<
NCT00003594 Colorectal Cancer Phase 3 Completed - -
NCT02715531 Solid Tumor Phase 1 Recruiting January 28, 2021 -
NCT02582970 - Completed - -
NCT02735239 Esophageal Cancer Phase 1 Phase 2 Recruiting April 2022 United Kingdom ... More >> Research Facility Recruiting Dundee, United Kingdom, DD1 9SY Research Facility Not yet recruiting Nottingham, United Kingdom, NG5 1PB Research Facility Recruiting Oxford, United Kingdom, OX3 9DU Research Facility Recruiting Southampton, United Kingdom, SO16 6YD Less <<
NCT01975454 Metastatic Colorectal Cancer Phase 1 Phase 2 Completed - China, Chongqing ... More >> Chongqing Three Gorges Central Hospital Chongqing, Chongqing, China, 404000 China, Shanghai Longhua Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT00707889 Advanced Colorectal Cancer ... More >> Adenocarcinoma of the Colon Adenocarcinoma of the Rectum Less << Phase 2 Completed - -
NCT00602329 Colorectal Cancer Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104-4283 Contact: Clinical Trials Office - Abramson Cancer Center of the Univers    800-474-9892 Less <<
NCT02193594 Gastroesophageal Junction Aden... More >>ocarcinoma Less << Phase 2 Phase 3 Recruiting May 2020 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Haidian District, Beijing, China, 100142 Contact: Shuangxi Li, M.D.       lishuangxi@outlook.com    Principal Investigator: Jiafu Ji, M.D.          Sub-Investigator: Ziyu Li, M.D.          Sub-Investigator: Shuangxi Li, M.D. Less <<
NCT01611857 Malignant Solid Tumour ... More >> Gastroesophageal Cancer Less << Phase 1 Phase 2 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Florida Cancer Specialists-Sarasota Sarasota, Florida, United States, 34232 Florida Cancer Specialists-North St. Petersburg, Florida, United States, 33705 United States, Oklahoma Oklahoma University Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology - Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 Less <<
NCT01386346 Esophageal Cancer ... More >> Malignant Neoplasm of Cardio-esophageal Junction of Stomach Less << Phase 1 Completed - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT00127036 - Terminated(drug now on market) - -
NCT02476045 Metastatic Colorectal Cancer Phase 2 Unknown July 2018 Italy ... More >> Fondazione IRCCS Istituto Nazionale dei tumori Recruiting Milano, MI, Italy, 20133 Contact: Filippo Pietrantonio, MD    +39022390 ext 3807    filippo.pietrantonio@istitutotumori.mi.it Less <<
NCT00316745 Metastatic Colorectal Cancer Phase 3 Suspended(Because of approval ... More >>of Bevacizumab, it was difficult to perform clinical study in 1st line setting.) Less << March 2009 Japan ... More >> Hokkaido University Hospital (Hokkaido University Graduate School of Medicine / School of Medicine) Sapporo, Hokkaido, Japan, 060-8638 Less <<
NCT01363843 Colon Cancer ... More >>Rectal Cancer Less << Phase 2 Completed - United States, Rhode Island ... More >> Memorial Hospital Pawtucket, Rhode Island, United States, 02860 The Miriam Hospital Providence, Rhode Island, United States, 02903 Rhode Island Hospital Providence, Rhode Island, United States, 02906 Less <<
NCT00308516 - Completed - -
NCT02340949 Rectal Cancer Phase 2 Active, not recruiting February 2020 -
NCT02413853 Colorectal Adenocarcinoma ... More >> Stage IVA Colorectal Cancer Stage IVB Colorectal Cancer Less << Phase 2 Withdrawn(Study drug supply is... More >>sues) Less << November 2018 United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01320683 Liver Metastases ... More >> Recurrent Colon Cancer Recurrent Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 2 Terminated(Slow accrual.) - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT01320683 - Terminated(Slow accrual.) - -
NCT00861094 Esophageal Cancer Phase 2 Phase 3 Completed - France ... More >> CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 Hopital Saint Andre Bordeaux, France, 33075 Institut Bergonie Bordeaux, France, 33076 Hopital Ambroise Pare Boulogne-Billancourt, France, F-92104 Polyclinique Du Parc Caen, France, 14052 Centre Regional Francois Baclesse Caen, France, 14076 Hopital Du Bocage Dijon, France, 21034 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Centre Hospital Regional Universitaire de Limoges Limoges, France, 87042 Centre Leon Berard Lyon, France, 69373 CHU de la Timone Marseille, France, 13385 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Saint-Louis Paris, France, 75475 Hopital Tenon Paris, France, 75970 CHU Poitiers Poitiers, France, 86021 Institut Jean Godinot Reims, France, 51056 CHU - Robert Debre Reims, France, 51092 Centre Eugene Marquis Rennes, France, 35042 Hopital Charles Nicolle Rouen, France, 76031 Clinique Armoricaine De Radiologie Saint Brieuc, France, F-22015 Centre Paul Strauss Strasbourg, France, 67065 Institut Claudius Regaud Toulouse, France, 31052 Clinique Du Parc Toulouse, France, 31078 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT01660711 Pancreatic Adenocarcinoma Phase 2 Active, not recruiting July 2018 United States, Illinois ... More >> NorthShore University HealthSystem Evanston, Illinois, United States, 60201 Less <<
NCT01363843 - Completed - -
NCT00127036 Adenocarcinoma ... More >> Colon Cancer Less << Phase 2 Terminated(drug now on market) - United States, Florida ... More >> North Broward Medical Center Deerfield Beach, Florida, United States, 33064 Broward General Medical Center Fort Lauderdale, Florida, United States, 33316 Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 Center for Cancer Care & Research - Watson Clinic Lakeland, Florida, United States, 33805 Fawcett Memorial Hospital Port Charlotte, Florida, United States, 33592 Martin Memorial Stuart, Florida, United States, 34994 Tallahassee Memorial Hospital Tallahassee, Florida, United States, 32308 Bay Area Oncology Tampa, Florida, United States, 33607 H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Space Coast Medical Associates Titusville, Florida, United States, 32796 United States, Georgia St. Joseph's Candler Health System Savannah, Georgia, United States, 31405 United States, Nebraska Southeast Nebraska Cancer Center Lincoln, Nebraska, United States, 68510 Less <<
NCT03500874 Colorectal Cancer ... More >> Liver Metastases HAI Less << Phase 3 Recruiting December 31, 2024 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yuhong Li, MD    +86(20)87343135    kyk@sysucc.org.cn    Contact: Yuhong Li, MD    +86(20)87342490    liyh@sysucc.org.cn Less <<
NCT02296671 Esophagogastric Cancer Phase 2 Withdrawn(Was unable to accrue... More >> any patients) Less << February 2022 -
NCT02782182 Pancreatic Ductal Adenocarcino... More >>ma (PDAC) Less << Not Applicable Active, not recruiting August 2019 United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Less <<
NCT00308516 Rectal Cancer ... More >> Cancer of the Rectum Colorectal Cancer Less << Phase 2 Completed - United States, Alabama ... More >> Northeast Alabama Regional Medical Center Anniston, Alabama, United States, 36207 United States, Arkansas Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Pennsylvania Consultants in Medical Oncology and Hematology Drexel Hill, Pennsylvania, United States, 19026 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37205 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT00982592 Adenocarcinoma of the Gastroes... More >>ophageal Junction Adenocarcinoma of the Stomach Recurrent Gastric Cancer Stage IIIA Gastric Cancer Stage IIIB Gastric Cancer Stage IIIC Gastric Cancer Stage IV Gastric Cancer Less << Phase 2 Completed - United States, California ... More >> University of California at Davis Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 Cancer Care Center of Decatur Decatur, Illinois, United States, 62526 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Crossroads Cancer Center Effingham, Illinois, United States, 62401 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Loyola University Medical Center Maywood, Illinois, United States, 60153 Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Illinois Oncology Research Association CCOP Peoria, Illinois, United States, 61615 Memorial Medical Center Springfield, Illinois, United States, 62781-0001 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne, Indiana, United States, 46845 Indiana University Medical Center Indianapolis, Indiana, United States, 46202 United States, Michigan University of Michigan University Hospital Ann Arbor, Michigan, United States, 48109 University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Saint John's Mercy Medical Center Saint Louis, Missouri, United States, 63141 United States, New York New York Cancer Consortium Bronx;, New York, United States, 10461 Albert Einstein College of Medicine Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467-2490 Beth Israel Medical Center New York, New York, United States, 10003 New York University Langone Medical Center New York, New York, United States, 10016 Saint Luke's Roosevelt Hospital Center - Saint Luke's Division New York, New York, United States, 10025 Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT00982592 - Completed - -
NCT00006115 Colorectal Cancer Phase 2 Unknown - France ... More >> Hopital Drevon Dijon, France, 21000 Centre Jean Bernard Le Mans, France, 72000 Centre Hospital Universitaire Hop Huriez Lille, France, 59000 Clinique Saint Jean Lyon, France, 69008 CH Meulan Meulan, France, 78250 Intercommunal Hospital Montfermeil, France, 93370 Centre Hospitalier de Mulhouse Mulhouse, France, 68051 American Hospital of Paris Neuilly Sur Seine, France, F-92202 Hopital Bichat-Claude Bernard Paris, France, 75018 Hopital Saint Antoine Paris, France, 75571 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Hopital Claude Gallien Quincy Sous Senart, France, 91480 Polyclinique De Courlancy Reims, France, F-51100 C.H. Senlis Senlis, France, 60300 Clinique de l'Orangerie Strasbourg, France, 67010 Less <<
NCT02705300 Colorectal Cancer Phase 2 Recruiting March 2025 Denmark ... More >> Department of Oncology, Vejle Hospital Recruiting Vejle, Denmark, DK-7100 Contact: Lars H Jensen, PhD       lars.henrik.jensen@rsyd.dk    Principal Investigator: Louise R Larsen, MD Less <<
NCT02015169 HER2-positive Gastric Cancer P... More >>atients With Liver Metastasis Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Korea, Republic of, 135-720 Less <<
NCT02912559 Colon Adenocarcinoma ... More >> DNA Repair Disorder Lynch Syndrome Stage III Colon Cancer AJCC v7 Stage IIIA Colon Cancer AJCC v7 Stage IIIB Colon Cancer AJCC v7 Stage IIIC Colon Cancer AJCC v7 Less << Phase 3 Recruiting July 1, 2020 -
NCT03604614 Stage IV Gastric Cancer With M... More >>etastasis Hyperthermic Intraperitoneal Chemotherapy Exploratory Behavior Less << Phase 2 Recruiting August 24, 2020 China, Guangdong ... More >> Guangdong Province Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine Recruiting Guangzhou, Guangdong, China, 510120 Contact: Wei Wang, M.D.,PH.D.    +86-13922255515    wangwei16400@163.com    Contact: Wenjun Xiong, M.D.    +86-15920553177    xiongwj1988@163.com    Principal Investigator: Wei Wang          Principal Investigator: Jin Wan          Principal Investigator: Wen jun Xiong          Principal Investigator: De chang Diao          Principal Investigator: Yan sheng Zheng          Principal Investigator: Hong ming Li          Principal Investigator: Yao bin He          Principal Investigator: Li jie Luo Less <<
NCT01198548 - Terminated(Lack of funding) - -
NCT01198548 Stage IV Colon Cancer ... More >> Stage IV Rectal Cancer Less << Phase 2 Terminated(Lack of funding) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT03161574 Rectal Cancer Phase 2 Enrolling by invitation June 1, 2022 China, Guangxi Autonomous Regi... More >>on Affiliated Tumor Hospital of Guangxi Medical University Nanning, Guangxi Autonomous Region, China, 530021 Less <<
NCT01650428 Rectal Cancer Phase 2 Active, not recruiting February 2019 United Kingdom ... More >> Blackpool Victoria Hospital Blackpool, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, United Kingdom Charing Cross Hospital London, United Kingdom Guy's and St Thomas' Hospital London, United Kingdom Hammersmith Hospital London, United Kingdom North MiddlesexHospital London, United Kingdom Royal Marsden Hospitals NHS Foundation Trust London, United Kingdom UCLH London, United Kingdom Mount Vernon Hospital Middlesex, United Kingdom Wexham Park Hospital Slough, United Kingdom Lister Hospital Stevenage, United Kingdom Less <<
NCT01030042 Metastatic Colorectal Cancer Phase 3 Completed - Italy ... More >> Ospedale Profili Fabriano, AN, Italy, 60044 Usl 11 Ospedale Murri Fermo, AP, Italy, 63023 A.O. Treviglio-Caravaggio, P.le Ospedale n1 Treviglio, Bergamo, Italy, 24047 Spedali Civili Brescia, BS, Italy, 25100 AUSL di Lanciano-Vasto Lanciano, CH, Italy, 66034 Istituto Oncologico del Mediterraneo Catania, CT, Italy, 95029 ASL 11 Empoli, FI, Italy, 50010 Università Firenze, FI, Italy, 50139 Ospedale Maggiore Lodi, LO, Italy, 26900 Ospedale S.Vincenzo Taormina, ME, Italy, 98039 Ospedale Serbelloni Gorgonzola, MI, Italy, 20064 Istituto di Ricerca S.Raffaele Milano, MI, Italy, 20100 Ospedale Fatebenefratelli Milano, MI, Italy, 20100 A.O. S.Gerardo Monza, MI, Italy, 20052 Istituto Oncologico Veneto Padova, PD, Italy, 35124 A.O. S.Salvatore Pesaro, PS, Italy, 61100 Ospedale Civile Urbino, PS, Italy, 61029 Azienda Ospedaliera San Carlo Potenza, PZ, Italy, 85100 Università Policlinico Umberto I Roma, RM, Italy, 00186 Ospedale Sant'Andrea Roma, RM, Italy, 00189 AULSS 18 di Rovigo Rovigo, RO, Italy, 45100 Ospedale Morelli Sondalo, SO, Italy, 23100 Università degli Studi Candiolo, TO, Italy, 10060 Ospedale Mater Salutis Legnago, VR, Italy, 37045 A.O. Ospedale Umberto I - Università - Località Torretta Ancona, Italy, 60020 Ospedali Riuniti, Largo Barozzi, 1 Bergamo, Italy, 24128 Fondazione Poliambulanza, Via Bissolati 57 Brescia, Italy, 25100 A.O. Ospedale S.Anna Como, Italy, 22100 A.O. Carlo Poma - Via Albertoni, 1 Mantova, Italy, 46100 Istituto Tumori - Fondazione Pascale Napoli, Italy, 80131 Università Campus Biomedico, Via Emilio Longoni, 83 Roma, Italy, 00155 A.O. S.Giovanni Calabita Fatebenefratelli Roma, Italy, 00186 Less <<
NCT02661971 Stomach Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 2 Phase 3 Recruiting October 2019 Germany ... More >> Institute for Clinical Cancer Research Krankenhaus Nordwest Recruiting Frankfurt, Germany, 60488 Contact: Salah-Eddin Al-Batran, Prof    +496976014420       Contact: Ulli S Bankstahl    +496976014596       Italy Università degli studi della Campania "Luigi Vanvitelli" Not yet recruiting Napoli, Campania, Italy Contact: Ferdinando De Vita, Prof.          Contact    +39 081 5666713 Less <<
NCT00182715 Colorectal Cancer Phase 3 Unknown - -
NCT02102789 Metastatic Colorectal Cancer Phase 3 Recruiting December 2024 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yu-hong Li, MD, Ph D       liyh@sysucc.org.cn    Principal Investigator: Yu-hong Li, MD, Ph D Less <<
NCT03636893 Gastric Cancer ... More >> Chemotherapy Effect Less << Phase 2 Not yet recruiting March 2020 China, Shanghai ... More >> Ruijin Hospital Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200025 Contact: Birendra K Sah, Ph D    008613817516354    byahut@hotmail.com    Contact: Li Chen, Ph D    008613916632699    rjsurgeon@hotmail.com    Sub-Investigator: Birendra K Sah, PH D Less <<
NCT01626664 - Completed - -
NCT01626664 Adult T-cell Leukemia-Lymphoma Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Florida University of Miami / Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Memorial Sloan Kettering New York, New York, United States, 10021 Columbia Presbyterian New York, New York, United States, 10032 Weill Cornell Medical College New York, New York, United States, 10065 Belgium Cliniques Universitaires Saint-Luc Bruxelles, Belgium, 1200 Brazil Hospital Universitario Professor Edgard Santos- UFBA Salvador, Bahia, Brazil, 40110-060 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo- SP, Brazil, CEP 05403-000 France CHU de Fort de France Fort De France Cedex, France, BP 632 97261 Hospital Necker Paris, France, 75743 Peru Hospital Nacional Edgardo Rebagliati Martins Lima, Peru, Lima11 Instituto Oncologico Miraflores Lima, Peru, Lima18 United Kingdom Guy's Hospital London, United Kingdom, SE1 9RT Imperial College London, United Kingdom, W2 1PG Sandwell General Hospital West Midlands, United Kingdom, B71 4HJ Less <<
NCT00006479 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 3 Unknown - -
NCT02984501 Pancreatic Cancer Phase 2 Completed - -
NCT02221700 Gastrointestinal Cancer Not Applicable Active, not recruiting April 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00862784 Colorectal Carcinoma Phase 2 Completed - Canada, Ontario ... More >> ImClone Investigational Site Ottawa, Ontario, Canada, K1H 8L6 ImClone Investigational Site Toronto, Ontario, Canada, M5G-2M9 Canada, Quebec ImClone Investigational Site Montreal, Quebec, Canada, H2L 4M1 Spain ImClone Investigational Site Barcelona, Spain ImClone Investigational Site Santander, Spain ImClone Investigational Site Seville, Spain ImClone Investigational Site Valencia, Spain Less <<
NCT00749450 Colorectal Cancer Phase 3 Completed - United Kingdom ... More >> Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Less <<
NCT00862784 - Completed - -
NCT03776487 Clinical Stage 0 Gastric Cance... More >>r AJCC v8 Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage I Gastric Cancer AJCC v8 Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IIB Gastric Cancer AJCC v8 Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IVA Gastric Cancer AJCC v8 Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Gastric Adenocarcinoma Localized Gastric Carcinoma Localized Gastroesophageal Junction Adenocarcinoma Pathologic Stage 0 Gastric Cancer AJCC v8 Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage I Gastric Cancer AJCC v8 Pathologic Stage IA Gastric Cancer AJCC v8 Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IB Gastric Cancer AJCC v8 Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IIA Gastric Cancer AJCC v8 Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IIB Gastric Cancer AJCC v8 Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IIIA Gastric Cancer AJCC v8 Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Less << Phase 1 Phase 2 Not yet recruiting March 1, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Mariela Blum    713-792-2828       Principal Investigator: Mariela Blum Less <<
NCT00514020 - Completed - -
NCT00556413 Colorectal Cancer Phase 2 Completed - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Less <<
NCT02395640 Gastric Cancer Phase 3 Unknown March 2018 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting ShangHai, Shanghai, China, 200032 Contact: Wei Jian Guo, PHD       guoweijian1@sohu.com Less <<
NCT02452853 Hepatocellular Carcinoma Phase 2 Unknown May 2018 -
NCT00835185 Metastatic Colorectal Cancer Phase 2 Completed - Belgium ... More >> ImClone Investigational Site Brussels, Belgium, 1000 ImClone Investigational Site Haine Saint-Paul, Belgium, 7100 Spain ImClone Investigational Site Barcelona, Spain, 08035 ImClone Investigational Site Madrid, Spain, 28040 ImClone Investigational Site Valencia, Spain, 46010 Less <<
NCT01565109 Gastric Adenocarcinoma Phase 2 Unknown March 2018 France ... More >> Institut Sainte Catherine Recruiting Avignon, France, 84000 Contact: LAURENT MINEUR, DOCTOR    04.90.27.62.68    l.mineur@isc84.org Less <<
NCT02845986 Stomach Neoplasms Phase 2 Active, not recruiting August 2021 China, Beijing ... More >> Beijing Cancer Hospital Haidian, Beijing, China, 100142 China, Chongqing Southwest Hospital Shapingba, Chongqing, China, 400038 China, Fujian Fujian Medical University Union Hospital Fuzhou, Fujian, China, 350001 Fujian Provincial Hospital Fuzhou, Fujian, China, 350001 Longyan First Hospital Longyan, Fujian, China, 364000 The First Hospital of Putian City Putian, Fujian, China, 351100 The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China, 361003 Zhangzhou Municipal Hospital of Fujian Province Zhangzhou, Fujian, China, 363000 China, Guangdong Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Guangdong Provincial Hospital of Traditional Chinese Medicine Guangzhou, Guangdong, China, 510120 Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China, 510515 Meizhou People's Hospital Meizhou, Guangdong, China, 514031 China, Jiangsu Jiangsu province hospital Nanjing, Jiangsu, China, 210029 China, Jilin The Second Hospital of Jilin University Changchun, Jilin, China, 130041 China, Qinghai Qinghai University Affiliated Hospital Xining, Qinghai, China, 810001 China, Shanghai Renji Hospital, Shanghai Jiao Tong University School of Medicine Pudong, Shanghai, China, 200135 Shanghai Zhongshan Hospital Xuhui, Shanghai, China, 200032 China, Shanxi The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shanxi, China, 710061 China, Sichuan West China Hospital, Sichuan University Chengdu, Sichuan, China, 610041 China, Xinjiang The First Affiliated Hospital of Xinjiang Medical University Xinjiang, Xinjiang, China, 830054 Less <<
NCT00408772 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Withdrawn(Lack of accrual) - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00835185 - Completed - -
NCT00515216 Stomach Neoplasms ... More >> Esophageal Neoplasms Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00515216 - Completed - -
NCT01263171 Colorectal Cancer Phase 2 Completed - United Kingdom ... More >> Walsgrave Hospital Coventry, England, United Kingdom, CV2 2DX Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Christie Hospital Manchester, England, United Kingdom, M20 4BX Rosemere Cancer Centre at Royal Preston Hospital Preston, England, United Kingdom, PR2 9HT Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Glan Clwyd Hospital Rhyl, Denbighshire, Wales, United Kingdom, LL 18 5UJ Less <<
NCT03365765 Apatinib Phase 3 Recruiting December 31, 2022 China ... More >> Huashan Hospital Affiliated to Fudan University Recruiting Shanghai, China, 200040 Contact: Jianbin Xiang, doctor    86-21-52887333    68875417@qq.com    Contact: Xiaodong Gu, doctor    86-21-52887333    gxdgxd737@sohu.com    Principal Investigator: Jianbin Xiang, doctor Less <<
NCT01307956 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Adenocarcinoma Stage IIA Esophageal Cancer Stage IIB Esophageal Cancer Less << Phase 2 Terminated(Drug manufacturer -... More >> Amgen requested, per DSMB observation in POWER trial.) Less << - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT01307956 - Terminated(Drug manufacturer -... More >> Amgen requested, per DSMB observation in POWER trial.) Less << - -
NCT00785122 Colorectal Carcinoma Phase 1 Phase 2 Completed - -
NCT02392377 - Terminated(Slow accrual) - -
NCT02392377 Stage IB Esophageal Adenocarci... More >>noma Stage IIA Esophageal Adenocarcinoma Stage IIB Esophageal Adenocarcinoma Stage IIIA Esophageal Adenocarcinoma Stage IIIB Esophageal Adenocarcinoma Stage IIIC Esophageal Adenocarcinoma Less << Phase 2 Terminated(Slow accrual) - United States, Ohio ... More >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00065117 Colorectal Neoplasms ... More >> Metastases, Neoplasm Less << Phase 2 Terminated - United States, California ... More >> Research Site Los Angeles, California, United States Research Site San Francisco, California, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Louisiana Research Site New Orleans, Louisiana, United States United States, Maryland Research Site Baltimore, Maryland, United States United States, Missouri Research Site St. Louis, Missouri, United States United States, New York Research Site New York, New York, United States United States, North Carolina Research Site Chapel Hill, North Carolina, United States Research Site Durham, North Carolina, United States United States, Pennsylvania Research Site Pittsburgh, Pennsylvania, United States Less <<
NCT01260415 Colorectal Cancer ... More >> Liver Metastases Less << Phase 2 Completed - Canada, Ontario ... More >> London Regional Cancer Centre London, Ontario, Canada The Ottawa Hospital Cancer Center Ottawa, Ontario, Canada Mount Sinai Hospital Toronto, Ontario, Canada Princess Margaret Hospital Toronto, Ontario, Canada Less <<
NCT01409005 Metastatic or Recurrent Colore... More >>ctal Cancer Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan Salvage Chemotherapy Less << Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi-do, Korea, Republic of, 463-707 Seoul National University Hospital Seoul, Korea, Republic of SMG-SNU Boramae Medical Center Seoul, Korea, Republic of Less <<
NCT01063192 Locally Advanced Pancreatic Ca... More >>ncer Less << Phase 2 Unknown September 2016 -
NCT00419159 Colorectal Cancer Phase 2 Completed - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less <<
NCT00419159 - Completed - -
NCT03645876 Metastatic Colorectal Cancer Phase 2 Recruiting May 2019 China, Guangdong ... More >> Cancer Center of Sun-Yat Sen University (CCSYSU) Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ruihua Xu Less <<
NCT02148549 Pancreatic Cancer. Phase 1 Unknown February 2017 Japan ... More >> Nagoya University Nagoya, Aichi, Japan Kobe University Kobe, Hyogo, Japan Nara Prefectual Medical University Kashihara, Nara, Japan Kansai Medical University Hirakata, Osaka, Japan Osaka University Suita, Osaka, Japan Hiroshima University Hiroshima, Japan Osaka City University Osaka, Japan Osaka Medical Center for Cancer and CVD Osaka, Japan Wakayama Medical University Wakayama, Japan, 641-8510 Less <<
NCT00890188 Colon Cancer Phase 2 Unknown June 2011 Taiwan ... More >> National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Peng Chan Lin, MD    +886-06-2353535 ext 4559    pengchanlin@yahoo.com.tw    Principal Investigator: Peng Chan Lin, MD Less <<
NCT01889680 Colorectal Cancer ... More >> Metastatic Colorectal Cancer Less << Phase 2 Withdrawn May 2018 -
NCT00253370 Adenocarcinoma of the Gastroes... More >>ophageal Junction Metastatic Gastric Cancer Advanced Unresectable Gastric Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00327119 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00253370 - Completed - -
NCT02316496 Colorectal Cancer Metastatic Phase 2 Terminated - France ... More >> Hôpital Beaujon Clichy, France Centre hospitalier Alpes Leman Contamine sur Arve, France Centre Georges François Leclerc Dijon, France CHD Vendée La Roche/ Yon, France Hôpital Privé Jean Mermoz Lyon, France Hôpital Européeen Marseille, France Institut Paoli-Calmettes Marseille, France CHU Caremeau Nîmes, France CHU Cochin Paris, France Hôpital Pitié Salpêtrière Paris, France Hôpital Saint Antoine Paris, France Hôpital Saint Louis Paris, France Hôpital Tenon Paris, France Clinique Armoricaine de Radiologie Saint Brieuc, France Groupe hospitalier Public du Sud de l'Oise -site de Senlis Senlis, France Centre de radiothérapie - Clinique Sainte Anne Strasbourg, France Hôpital Foch Suresnes, France Hôpitaux du Léman Thonon les Bains, France CHU Tours - Hôpital Trousseau Tours, France Clinique Générale Valence, France Less <<
NCT01197560 - Completed - -
NCT00891930 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT02842294 - Unknown February 2018 France ... More >> CHRU Besançon Recruiting Besançon, Franche Comté, France, 25030 Contact: ikram es saad, msc    0370632181 ext 0033    iessaad@chu-besancon.fr Less <<
NCT00865189 - Completed - -
NCT03387098 Pancreatic Cancer Phase 1 Phase 2 Active, not recruiting December 2019 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT01197560 Diffuse Large B-cell Lymphoma Phase 2 Phase 3 Completed - -
NCT01964287 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Recruiting March 2020 France ... More >> Institut regional du Cancer - Val d Aurelle Recruiting Montpellier, France, 34298 Contact: Bleuse Jean Pierre    +33467612344    jean-pierre.bleuse@icm.unicancer.fr    Principal Investigator: assenat eric Less <<
NCT00159445 Colorectal Cancer ... More >> Colon Cancer Less << Phase 2 Completed - United States, California ... More >> U.S.C./Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT03329248 Pancreatic Cancer Phase 1 Phase 2 Active, not recruiting December 2019 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT03099265 Pancreatic Cancer Phase 2 Recruiting August 2022 United States, Connecticut ... More >> Smilow Cancer Hospital Recruiting New Haven, Connecticut, United States, 06510 Less <<
NCT03169790 Non Hodgkin Lymphoma Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT00625573 Colorectal Cancer Phase 2 Completed - United States, Florida ... More >> Mount Sinai Medical Center Miami Beach, Florida, United States, 33140 Less <<
NCT03641183 Pancreas Cancer Phase 1 Phase 2 Recruiting March 31, 2020 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Ravikumar Paluri, MD    205-934-2992    rpaluri@uabmc.edu    Principal Investigator: Ravikumar Paluri, MD Less <<
NCT03197584 Ovarian Cancer Phase 1 Phase 2 Not yet recruiting April 2019 -
NCT02767674 Diffuse Large B Cell Lymphoma Phase 3 Recruiting July 2019 China, Hubei ... More >> Tongji Medical College of HUST Recruiting Wuhan, Hubei, China, 430030 Contact: Jianfeng Zou          China, Jiangsu The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital) Recruiting NanJing, Jiangsu, China, 21002 Contact: Huayuan Zhu, M.D., Ph.D.    +86 68136034    huayuan.zhu@hotmail.com    Principal Investigator: Wei Xu, M.D., Ph.D.          China, Shandong QiLu Hospital of Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Luqun Wang, M.D., Ph.D.          Shandong Province Hospital Recruiting Jinan, Shandong, China, 250021 Contact: Xin Wang, M.D., Ph.D.          China, Shanghai Rui Jin Hospital Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Weili Zhao, M.D., Ph.D.          Sudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200433 Contact: Ye Guo, M.D., Ph.D. Less <<
NCT00865189 Rectal Cancer Phase 2 Completed - France ... More >> ICO Paul Papin; Oncologie Medicale. Angers, France, 49055 Angers, France, 49055 HOPITAL JEAN MINJOZ; Oncologie Besancon, France, 25030 Besancon, France, 25030 Hopital Saint Andre; Département de Radiothérapie Et D'Oncologie Médicale Bordeaux, France, 33075 Bordeaux, France, 33075 Centre Georges Francois Leclerc; Oncologie 3 Dijon, France, 21079 Dijon, France, 21079 Hopital Albert Michallon; Radiotherapie La Tronche, France, 38700 La Tronche, France, 38700 Centre Oscar Lambret; Radiotherapie Lille, France, 59020 Lille, France, 59020 Centre Hospitalier Andre Boulloche; Departement D'Oncologie Montbeliard, France, 25209 Montbeliard, France, 25209 Centre Val Aurelle Paul Lamarque; Radiotherapie Montpellier, France, 34928 Montpellier, France, 34928 Polyclinique Gentilly; CHIMIOTHERAPIE AMBULATOIRE Nancy, France, 54100 Nancy, France, 54100 Centre Antoine Lacassagne; Hopital De Jour A2 Nice, France, 06189 Nice, France, 06189 Hopital Saint Louis; Radiotherapie Oncologie Paris, France, 75475 Paris, France, 75475 Ch Pitie Salpetriere; Oncologie Medicale Paris, France, 75651 Paris, France, 75651 HOPITAL TENON; Cancerologie Medicale Paris, France, 75970 Paris, France, 75970 Ch Lyon Sud; Radiotherapie Sct Jules Courmont Pierre Benite, France, 69495 Pierre Benite, France, 69495 Chu La Miletrie; Radiotherapie Poitiers, France, 86021 Poitiers, France, 86021 Ico Rene Gauducheau; Oncologie Saint Herblain, France, 44805 Saint Herblain, France, 44805 Centre Paul Strauss; Oncologie Medicale Strasbourg, France, 67065 Strasbourg, France, 67065 Polyclinique Du Parc; Centre De Hautes Energies Toulouse, France, 31078 Toulouse, France, 31078 Hopital Bretonneau; Clinique D'Oncologie & de Radiotherapie Tours, France, 37044 Tours, France, 37044 Centre Alexis Vautrin; Oncologie Medicale Vandoeuvre Les Nancy, France, 54511 Vandoeuvre Les Nancy, France, 54511 Less <<
NCT01899118 Locally Advanced Rectal Cancer Phase 2 Unknown - China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Jialin Luo, MD    0086-571-88122062       Principal Investigator: Yuan Zhu, PhD Less <<
NCT00507091 Metastatic Co... More >>lorectal Adenocarcinoma Less << Phase 1 Completed - Belgium ... More >> Research Site Gent, Belgium United Kingdom Research Site Belfast, United Kingdom Research Site Manchester, United Kingdom Less <<
NCT00889343 Colorectal Neoplasms Phase 2 Terminated - -
NCT00891930 - Completed - -
NCT03192644 Hepatocellular Carcinoma Phase 3 Recruiting December 31, 2024 China ... More >> Cancer Center of Sun Yat-Sen University Recruiting Guangzhou, China Contact: Shaohua Li, MD       lishaoh@sysucc.org.cn Less <<
NCT02415699 Colorectal Cancer Phase 2 Phase 3 Not yet recruiting July 2020 -
NCT02419495 Advanced Cancers Phase 1 Recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT03042780 - Terminated(Slow accrual) - -
NCT01771146 Pancreas Cancer ... More >> Localized Pancreas Cancer Non-metastatic Pancreas Cancer Less << Not Applicable Active, not recruiting September 2020 United States, Texas ... More >> Baylor University Medical Center - Texas Oncology Dallas, Texas, United States, 75246 Less <<
NCT03042780 Gastro-enteropancreatic Neuroe... More >>ndocrine Tumor Pancreatic Cancer Neuroendocrine Carcinomas of Pancreas Islet Cell Carcinoma Less << Phase 2 Terminated(Slow accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01729481 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 2 Active, not recruiting December 2017 Germany ... More >> University of Munich Munich, Germany, 81377 Less <<
NCT01288339 Metastatic Colorectal Cancer Phase 2 Completed - Spain ... More >> Hospital General Universitario de Elche Elche, Alicante, Spain, 03203 Hosptial General de l'Hospitalet de Barcelona Hospitalet de Llobregat, Barcelona, Spain, 08906 Corporació Sanitaria Parc Taulí de Barcelona Sabadell, Barcelona, Spain, 08208 Hospital de l'Esperit Sant Santa Coloma De Gramenet, Barcelona, Spain, 08923 Consorcio Hospitalario Provincial de Castellon Castellón De La Plana, Castellon, Spain, 12002 Hospital Son Espases de Mallorca Palma De Mallorca, Illes Balears, Spain, 07010 Hosptial Son Llatzer de Mallorca Palma De Mallorca, Illes Balears, Spain, 07198 Hosptial de Logroño Logroño, La Rioja, Spain, 26006 Hospital Universitario La Paz de Madrid Madrid, Madrdi, Spain, 28046 Clínica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Hospital Xeral Cies de Vigo Vigo, Pontevedra, Spain, 36204 Hospital Clínic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital de la Santa Creu i Sant Pau de Barcelona Barcelona, Spain, 08041 Complejo Asitencia de Burgos. Hospital General Yague Burgos, Spain, 09005 Hospital General de Ciudad Real Ciudad Real, Spain, 13005 Institut Català d'Oncologia (ICO) de Girona Girona, Spain, 17007 Centro Oncológico de Galícia La Coruña, Spain, 15009 Hosptial Dr. Negrin de Las Palmas de Gran Canaria Las Palmas de Gran Canaria, Spain, 35010 Hospital Arnau de Vilanova de Lleida Lleida, Spain, 25198 Hospital Infanta Sofía de Madrid Madrid, Spain, 28072 Hospital Universitario Puerta de Hierro de Madrid Madrid, Spain, 28222 Hospital de Fuenlabrada de Madrid Madrid, Spain, 28942 Hospital Morales Meseguer Murcia, Spain, 30008 Hosptial de Sant Pau i Santa Tecla de Tarragona Tarragona, Spain, 43003 Hospital La Fe de Valencia Valencia, Spain, 46009 Instituto Valenciano de Oncología de Valencia Valencia, Spain, 46009 Hospital General de Valencia Valencia, Spain, 46014 Hospital Dr. Peset de Valencia Valencia, Spain, 46017 Hospital Miguel Servet de Zaragoza Zaragoza, Spain, 50009 Less <<
NCT00557713 Rectal Neoplasms ... More >> Locally Advanced Rectal Adenocarcinoma Less << Phase 2 Unknown October 2013 Spain ... More >> ACROSS Recruiting Barcelona, Spain, 08021 Contact: Inmaculada Portal, MD       inmaportal@teleline.es    Principal Investigator: Miquel Nogué, MD          Principal Investigator: Bernardo Queralt, MD          Principal Investigator: Carles Pericay, MD          Principal Investigator: Ferran Losa, MD          Principal Investigator: Isabel Moreno, MD          Principal Investigator: José María Roca, MD          Principal Investigator: Pilar Vicente, MD          Principal Investigator: Christian Rolfo, MD          Principal Investigator: Inmaculada Guasch, MD          Principal Investigator: Antonio Arriví, MD          Principal Investigator: Enrique Cabrera, MD          Principal Investigator: María José Safont, MD          Principal Investigator: Gaspar Esquerdo, MD          Principal Investigator: Ana Ruiz, MD          Principal Investigator: Antonieta Salud, MD Less <<
NCT01276379 Colorectal Cancer Phase 2 Completed - Spain ... More >> Hospital Provincial de Castellón Castelló de la Plana, Castellón, Spain Hospital Son Espases Palma, Malllorca, Spain Hospital Son Llàtzer Palma, Mallorca, Spain Hospital Sant Joan de Reus Reus, Tarragona, Spain Complejo Hospitalario Universitario de Albacete Albacete, Spain Hospital Infanta Cristina de Badajoz Badajoz, Spain Hospital de Barbastro Barbastro, Spain Hospital Clínic de Barcelona Barcelona, Spain Hospital General Yagüe Burgos, Spain Hospital Sant Jaume de Calella Calella, Spain Hospital San Pedro de Alcántara Cáceres, Spain Hospital General Universitario de Elche Elche, Spain Hospital de Jaén Jaén, Spain Hospital Universitario de Gran Canaria Dr. Negrín Las Palmas de Gran Canaria, Spain Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain Fundación Jimenez Díaz Madrid, Spain Hospital de Móstoles Madrid, Spain Hospital Universitario la Paz Madrid, Spain Hospital de Mataró Mataró, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital de Navarra Pamplona, Spain Hospital de Sagunto Sagunto, Spain Mutua de Terrassa Terrassa, Spain Hospital Virgen de la Salud Toledo, Spain Instituto Valenciano de Oncología Valencia, Spain Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain Hospital Miguel Servet Zaragoza, Spain Less <<
NCT01506167 - Completed - United Kingdom ... More >> Royal United Hospital Bath; Diabetes and Lipid Research, Wolfson Centre Bath, United Kingdom, BA1 3NG Wexham Park Hospital; Oncology Berkshire, United Kingdom, SL2 4HL Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH Birmingham Heartlands Hospital; Dept of Oncology Birmingham, United Kingdom, B9 5SS Bishop Auckland Hospital;Oncology Department Bishop Auckland, United Kingdom, DL14 6AD University Hospital of North Staffordhire Blackpool, United Kingdom, FY3 8NR Bradford Royal Infirmary; Dept of Medical Oncology C/O Ward15 Bradford, United Kingdom, BD9 6RJ Bristol Haematology and Oncology Centre Bristol, United Kingdom, BS2 8ED West Suffolk Hospital Nhs Trust; Gi Corridor Bury St Edmunds, United Kingdom, IP33 2QZ Kent & Canterbury Hospital Canterbury, United Kingdom, CT1 3NG Cumberland Infirmary; Oncology Department Carlisle, United Kingdom, CA2 7HY Broomfield Hospital; Oncology Chelsmford, United Kingdom, CM1 7ET University Hospital North Tees Cleveland, United Kingdom, TS19 8PE Castle Hill Hospital; Academic Oncology Cottingham, United Kingdom, HU16 5JQ Darlington Memorial Hospital Darlington, United Kingdom, DL3 6HX Russells Hall Hospital; Dept of Hematology Dudley, United Kingdom, DY1 2HQ University Hospital of North Durham; Oncology Durham, United Kingdom, DH15TW Harrogate Hospital Harrogate, United Kingdom, HG2 8AY Northhwick Park Hospital;Oncology Department Harrow, United Kingdom, HA1 3UJ Ipswich Hospital; Oncology Pharmacy Ipswich, United Kingdom, IP4 5PD Kidderminster Hospital; Oncology Dept Kidderminster, United Kingdom, DY11 6RJ Royal Free Hospital; Dept of Oncology London, United Kingdom, NW3 2QG Guys Hosp./Med. Onc./3rd Fl. T; Clinical Trial Office London, United Kingdom, SE1 9RT Queen Elizabeth Hospital London, United Kingdom, SE18 4QH Macclesfield District General Hospital Macclesfield, United Kingdom, SK10 3BL Maidstone & Tonbridge Wells Hospital; Kent Oncology Center Maidstone, United Kingdom, ME16 9QQ The James Cook University Hospital Middlesborough, United Kingdom, TS4 3BW Freeman Hospital Newcastle upon Tyne, United Kingdom, NE7 7DN North Tyneside General Hospital North Shields, United Kingdom, NE29 8NH Mount Vernon Cancer Centre Northwood, United Kingdom, HA6 2RN Nottingham University Hospitals City Campus Nottingham, United Kingdom, NG5 1PB Peterborough City Hospital, Edith Cavell Campus; Oncology Department Peterborough, United Kingdom, PE3 9GZ Derriford Hospital; Gastroenterology Plymouth, United Kingdom, PL6 8DH Queen's Hospital Romford, United Kingdom, RM7 0AG Scunthorpe General Hospital; Dept of Oncology Scunthorpe, United Kingdom, DN16 7BH Stafford Hospital; Oncology Department Stafford, United Kingdom, ST16 3SA The Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT Great Western Hospital, Swindon Cancer Research Unit; Osprey Unit Level 3 Swindon, United Kingdom, SN3 6BB Torbay Hospital; Oncology Torquay, United Kingdom, TQ2 7AA Royal Cornwall Hospital; Dept of Clinical Oncology Truro, United Kingdom, TR1 3LJ Walsall Manor Hospital Walsall, United Kingdom, WS2 9PS Royal Hampshire County Hospital; Winchester & Andover Breast Unit Winchester, United Kingdom, SO22 5DG The Royal Wolverhampton Hospitals NHS Trust Wolverhampton, United Kingdom, WV10 0QP Less <<
NCT01906008 Colorectal Cancer Phase 2 Active, not recruiting May 2019 United States, Texas ... More >> LBJ Hospital Houston, Texas, United States, 77030 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00228189 Colorectal Cancer ... More >> Liver Metastases Less << Phase 1 Phase 2 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Center, dept. of Medical Oncology Nijmegen, Netherlands, P.O. box 9101 6500 HB Less <<
NCT00778830 Metastatic Colorectal Cancer Phase 1 Phase 2 Completed - Singapore ... More >> Research Site Singapore, Singapore Less <<
NCT00642746 Metastatic Colorectal Cancer Phase 2 Terminated(Terminated due to p... More >>oor enrollment and grade 3 toxicities noted during an interim analysis.) Less << - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT01845337 Gastrointestinal Cancer ... More >> Cancer of Unknown Primary Site Pancreatic Cancer Bile Duct Neoplasms Less << Phase 2 Recruiting December 31, 2018 United Kingdom ... More >> Edinburgh Cancer Centre Recruiting Edinburgh, Scotland, United Kingdom, EH4 2XU Contact: Sally Clive, MBChB    0131 777 350       Principal Investigator: Sally Clive, MBChB MD          Sub-Investigator: Alan Christie, MBChB Less <<
NCT00778830 - Completed - -
NCT01442649 Colorectal Cancer Phase 2 Active, not recruiting December 2018 France ... More >> Centre rené Gauducheau Saint-herblain, France, 44805 Less <<
NCT02158988 Malignant Neoplasm of Stomach ... More >> Secondary Malignant Neoplasm of Peritoneum Secondary Malignant Neoplasm of Other and Unspecified Sites Less << Phase 3 Recruiting September 2020 Germany ... More >> Klinik für Allgemein-, Visceral-, Gefäß- und ThoraxchirurgieCharité Campus Mitte Recruiting Berlin, Germany, 10117 Contact: Beate Rau    +49 (0)30 450 622 ext 214    beate.rau@charite.de Less <<
NCT03045770 Advanced Gastric Cancer Adenoc... More >>arcinoma of Esophagogastric Junction Less << Not Applicable Not yet recruiting December 30, 2019 China, Fujian ... More >> Jianwei Yang Enrolling by invitation Fuzhou, Fujian, China, 350000 Less <<
NCT01515787 Colorectal Cancer Phase 2 Phase 3 Recruiting - -
NCT00642746 - Terminated(Terminated due to p... More >>oor enrollment and grade 3 toxicities noted during an interim analysis.) Less << - -
NCT03577704 Advanced Solid Tumors Phase 1 Phase 2 Recruiting October 30, 2021 China, Shanghai ... More >> Shanghai East Hospital Recruiting Shanghai, Shanghai, China, 200123 Contact: Jin E Li, Phd    （021）38804518 ext 22228    lijin@csco.org.cn    Contact: Jin E Li       lijin@csco.org.cn    Principal Investigator: Jin Li, PhD          Sub-Investigator: Ye Guo, PhD Less <<
NCT02233205 Gastrointestinal Neoplasms Phase 1 Phase 2 Unknown June 2016 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Wei Yang, Doctor    0086-10-88196195    13681408183@163.com    Contact: Yanjie Wang, Doctor    0086-10-88196941    philinsss@163.com    Sub-Investigator: Yan Li, Doctor          Sub-Investigator: Wei Yang, Doctor          Sub-Investigator: Jifang Gong, Doctor Less <<
NCT02581215 Pancreatic Cancer Phase 2 Recruiting October 2019 United States, Arizona ... More >> Mayo Clinic-Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Tanios Bekaii-Saab, MD          United States, Georgia Emory University: Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Walid Shaib, M.D.          United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Ahmad Al-Hader       aalhader@iu.edu    Principal Investigator: Bert O'Neil, MD          Community Healthcare System Recruiting Munster, Indiana, United States, 46321 Contact: Mary Shields    219-836-6879    mshields@comhs.org    Principal Investigator: Erwin Robin, MD          United States, Kentucky University of Louisville, James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 Contact: James Graham Brown Cancer Center    502-562-4673       Principal Investigator: Rebecca Redman, MD          United States, Nebraska Nebraska Methodist Hospital Recruiting Omaha, Nebraska, United States, 68114 Contact: Marlene Watson    402-354-5831    Marlene.Watson@nmhs.org    Principal Investigator: Timothy Huyck, MD          United States, Pennsylvania Gettysburg Cancer Center Recruiting Gettysburg, Pennsylvania, United States, 17325 Contact: Vanessa Hardman    717-334-4033    vhardman@gettysburgoncology.com    Principal Investigator: Tina Khair          Thomas Jefferson University Kimmel Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Jessica DePue    215-964-0260    jessica.depue@jefferson.edu    Principal Investigator: Ashwin Sama, MD, MS Less <<
NCT00381706 Esophageal Cancer Phase 2 Completed - -
NCT02287129 Adenocarcinoma of the Esophago... More >>gastric Junction Less << Phase 2 Active, not recruiting June 2019 Germany ... More >> 2nd department of the Medical Clinic of the Technical University Munich Munich, Bavaria, Germany, 81675 Less <<
NCT01992705 Resectable Pancreatic Cancer Early Phase 1 Recruiting December 2020 United States, Maryland ... More >> University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Sub-Investigator: William Regine, MD          Sub-Investigator: Yixing Jiang, MD          Sub-Investigator: Nader Hanna, MD          Sub-Investigator: H. Richard Alexander, MD          Sub-Investigator: Navesh Sharma, DO, PhD          Sub-Investigator: Mark Mishra, MD Less <<
NCT03475615 Gastric Cancer ... More >> Stomach Neoplasms Less << Phase 3 Recruiting December 31, 2020 China ... More >> Fudan University Cancer Hospital Recruiting Shanghai, China, 200032 Contact: xiaodong Zhu, M.D    862164175590 ext 1105    xddr001@163.com    Sub-Investigator: xiaodong Zhu, M.D Less <<
NCT01715363 Patients With Colorectal Cance... More >>r With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated Less << Phase 2 Terminated(Recruitment difficu... More >>lties) Less << - France ... More >> Institut Gustave Roussy Villejuif, Val de Marne, France, 94805 Less <<
NCT01135498 Colorectal Cancer Phase 2 Completed - Spain ... More >> Sabadell, Barcelona, Barcelona, Spain, 08208 Terrassa, Barcelona, Spain, 08221 Santander, Cantabria, Spain, 39008 Palma de Mallorca, Islas Baleares, Spain, 07198 Logroño, La Rioja, Spain, 26006 Barakaldo, Vizcaya, Spain, 48903 Burgos, Spain, 09006 Huesca, Spain, 22004 Jaen, Spain, 23007 Lerida, Spain, 25198 Teruel, Spain, 44002 Zaragoza, Spain, 50009 Less <<
NCT03671252 Rectal Cancer Phase 3 Recruiting September 25, 2028 China, Guangdong ... More >> Cancer center of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Rui-Hua Xu, MD, PhD    86-020-87343333    ruihxu@163.com    Principal Investigator: Rui-hua Xu, MD, PhD          Medical Oncology,Sun Yat-sen University Cancer Center Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Ruihua Xu, M.D,Ph.D    8613922206676    ruihxu@163.com    Contact: Zhizhong Pan    8613719388166    panzhzh@sysucc.org.cn Less <<
NCT02931890 Gastric Cancer Phase 2 Recruiting October 2022 Netherlands ... More >> Medisch Centrum Leeuwarden Not yet recruiting Leeuwarden, Friesland, Netherlands, 8901BR Contact: Marco B Polee, MD,PhD    +31 58 286 6963       Radiotherapeutisch Instituut Friesland Not yet recruiting Leeuwarden, Friesland, Netherlands, 8934AD Contact: Vera Oppedijk, MD       v.oppedijk@skf-rif.nl    Gelre Ziekenhuizen Withdrawn Apeldoorn, Gelderland, Netherlands, 7334DZ Gelre Ziekenhuizen Withdrawn Zutphen, Gelderland, Netherlands, 7207AE Zuyderland Medisch Centrum Not yet recruiting Sittard-Geleen, Limburg, Netherlands, 6162 BG Contact: Frank PJ Peters, MD    +31 88 459 7777    f.peters@zuyderland.nl    Elkerliek Not yet recruiting Deurne, Noord Brabant, Netherlands, 5751 CB Contact: Jeroen Vincent, MD    +31 493 32 88 88    j.vincent@elkerliek.nl    Catharina Ziekenhuis Recruiting Eindhoven, Noord Brabant, Netherlands, 5602 ZA Contact: Grard AP Nieuwenhuijzen, MD, PhD    +31 40 239 66 00    grard.nieuwenhuijzen@catharinaziekenhuis.nl    Maxima Medisch Centrum Not yet recruiting Eindhoven, Noord Brabant, Netherlands, 5631 BM Contact: Lieke HJ Simkens, MD, PhD    +31 40 8885320    l.simkens@mmc.nl    St. Anna Zorggroep Not yet recruiting Geldrop, Noord Brabant, Netherlands, 5664 EH Contact: Arno EM Smals, MD, PhD    +31 40 286 4040    a.smals@st‐anna.nl    Elkerliek Not yet recruiting Helmond, Noord Brabant, Netherlands, 5707 HA Contact: Jeroen Vincent, MD    +31 492 59 55 55    j.vincent@elkerliek.nl    Instituut Verbeten Not yet recruiting Tilburg, Noord Brabant, Netherlands, 5022 GC Contact: Tom Rozema, MD    +31 13 594 77 77    rozema.t@bvi.nl    Bernhoven Not yet recruiting Uden, Noord Brabant, Netherlands, 5406 PT Contact: Allert H Vos, MD    +31 413 - 40 19 41    a.vos@bernhoven.nl    Maxima Medisch Centrum Not yet recruiting Veldhoven, Noord Brabant, Netherlands, 5504 DB Contact: Lieke HJ Simkens, MD, PhD    +31 40 8885320    l.simkens@mmc.nl    Ziekenhuisgroep Twente Not yet recruiting Almelo, Overijssel, Netherlands, 7609 PP Contact: Ronald Hoekstra, MD, PhD    +31 88 708 4087    r.hoekstra@zgt.nl    Deventer Ziekenhuis Not yet recruiting Deventer, Overijssel, Netherlands, 7416 SE Contact: Lonneke L.W. Kessels, MD    +31 57 053 6437    researchoncologie@dz.nl    Medisch Spectrum Twente Not yet recruiting Enschede, Overijssel, Netherlands, 7512 KZ Contact: Leonie J.M Mekenkamp, MD, PhD    +31 53 487 2000    l.mekenkamp@mst.nl    Leids Universitair Medisch Centrum Recruiting Leiden, Zuid Holland, Netherlands, 2333 ZA Contact: Henk H Hartgrink, MD, PhD    +31 71 526 4005    h.h.hartgrink@lumc.nl    Reinier de Graaf Gasthuis Not yet recruiting Delft, Zuid-Holland, Netherlands, 2625 AD Contact: Annelie J.E. Vulink, MD, PhD    +31 15 260 3107    a.vulink@rdgg.nl    Netherlands Cancer Instituut Recruiting Amsterdam, Netherlands, 1066CX Contact: Marcel Verheij, MD, PhD    +31 20 512 9111    m.verheij@nki.nl    Contact: Edwin Jansen, MD, PhD    +31 20 512 9111    epm.jansen@nki.nl    Academisch Medisch Centrum Recruiting Amsterdam, Netherlands, 1105AZ Contact: Hanneke van Laarhoven, MD, PhD    +31 20 566 5955    h.vanlaarhoven@amc.uva.nl    Contact: Maarten C Hulshof, MD, PhD    +31 20 566 5955    m.c.hulshof@amc.uva.nl    Universitair Medisch Centrum Groningen Not yet recruiting Groningen, Netherlands, 9713 GZ Contact: Boudewijn van Etten, MD, PhD    +31 50 361 2317    b.van.etten@umcg.nl    Spaarne Gasthuis Not yet recruiting Hoofddorp, Netherlands, 2130AT Contact: Aart Beeker, MD    +31 23 2240065    abeeker@spaarnegasthuis.nl    Ziekenhuis St Antonius Not yet recruiting Nieuwegein, Netherlands, 3435CM Contact: Maartje Los, MD, PhD    +31 88 320 3000    m.los@antoniusziekenhuis.nl    Elisabeth Tweesteden Ziekenhuis Not yet recruiting Tilburg, Netherlands, 5022GC Contact: Laurens Beerepoot, MD, PhD    +31 13 221 00 00    l.beerepoot@elisabeth.nl    Universitair Medisch Centrum Utrecht Not yet recruiting Utrecht, Netherlands, 3508 GA Contact: Richard van Hillergersberg, MD, PhD    +31 88 75 580 74    r.vanhillergersberg@umcutrecht.nl Less <<
NCT01991873 Metastatic Colorectal Cancer Phase 2 Recruiting June 2018 Germany ... More >> St.-Antonius-Hospital Eschweiler Recruiting Eschweiler, Germany, 52249 Contact: Schlegel, Dr. med.    02403/76-1281       Zentrum für Tumorbiologie und Integrative Medizin, Klinikum Wilhelmshaven Not yet recruiting Wilhelmshaven, Germany, 26389 Contact: Dr. Tanja Trarbach Less <<
NCT02486601 Cancer of Stomach Phase 2 Recruiting June 2022 France ... More >> Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Recruiting Besancon, France, 25030 Contact    33-3-8166-8393       Principal Investigator: Stéphano KIM          Centre Hospitalier Universitaire Henri Mondor Recruiting Creteil, France, 94000 Contact    33-1-4981-2579       Principal Investigator: Christophe TOURNIGAND          Centre Léon Bérard Recruiting Lyon, France Contact: E          Principal Investigator: Christelle de la FOUCHARDIERE          Hôpital Privé Jean Mermoz Recruiting Lyon, France Principal Investigator: Gérard LLEDO          CHU Pitie-Salpetriere Recruiting Paris, France, 75651 Contact    33-1-42-16-00-00       Principal Investigator: Jean-Baptiste BACHET          Hopital Saint Antoine Recruiting Paris, France Principal Investigator: Thierry ANDRE          Institut Mutualiste Montsouris Recruiting Paris, France Contact: Christophe , PhD          Principal Investigator: Christophe LOUVET, PhD Less <<
NCT00381706 - Completed - -
NCT00673673 - Completed - -
NCT01661088 Pancreatic Cancer Phase 2 Active, not recruiting February 2019 United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00673673 Gastroesophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, Connecticut ... More >> Medical Oncology & Hematology PC Hamden, Connecticut, United States Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT01765582 Colorectal Neoplasms Phase 2 Terminated - -
NCT01765582 - Terminated - -
NCT00500292 Colorectal Ca... More >>ncer Less << Phase 2 Completed - France ... More >> Research Site Lille Cedex, France Research Site Toulouse Cedex 9, France Hungary Research Site Budapest, Hungary Research Site Debrecen, Hungary Research Site Szeged, Hungary Korea, Republic of Research Site Seoul, Korea, Republic of Slovakia Research Site Bratislava, Slovakia Research Site Poprad, Slovakia Research Site Trnava, Slovakia Research Site Zilina, Slovakia Spain Research Site Hospitalet deLlobregat, Spain Research Site Oviedo, Spain Research Site Santander, Spain Taiwan Research Site Taipei, Taiwan Research Site Tao-Yuan, Taiwan Less <<
NCT01135498 - Completed - -
NCT01661088 - Active, not recruiting - -
NCT03504397 Locally Advanced Unresectable ... More >>Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer Metastatic Gastric Adenocarcinoma or Cancer Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma Less << Phase 3 Recruiting September 2022 -
NCT01197118 Gastric Cancer Phase 2 Unknown May 2011 China, Hubei ... More >> Tongji Cancer Center,Tongji Hospital Not yet recruiting Wuhan, Hubei, China, 430030 Contact: Qiang Fu, Master    86-27-83663342    yunr777@yahoo.com.cn    Contact: Shiying Yu, Master    86-27-83663342    syyu@tjh.tjmu.edu.cn    Principal Investigator: Shiying Yu, Master          Sub-Investigator: Qiang Fu, Master Less <<
NCT02022033 Pancreatic Cancer Phase 2 Recruiting June 2019 United States, Rhode Island ... More >> Rhode Island Hospital (East Greenwich and Newport Hospital) Recruiting Providence, Rhode Island, United States, 02903 Contact: kayla Rosati    401-863-3000    Kayla_Rosati@brown.edu    Principal Investigator: Howard Safran, MD          The Miriam Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: kayla rosati    401-863-3000    kayla_rosati@brown.edu    Contact       kayla_rosati@brown.edu    Principal Investigator: Howard Safran, MD Less <<
NCT00500292 - Completed - -
NCT03364907 - Recruiting January 30, 2019 Netherlands ... More >> Radboudumc Recruiting Nijmegen, Netherlands Contact: Loek de jong Less <<
NCT01384994 Colorectal Cancer ... More >> KRAS Wildtype After Resection of Liver Metastases Less << Phase 2 Unknown August 2014 Germany ... More >> Ludwig-Maximilians - University of Munich Recruiting Munich, Germany, 81377 Contact: Volker Heinemann, Prof. Dr. med.    +49 89 7095 ext 0    volker.heinemann@med.uni-muenchen.de    Contact: Clemens Giessen, Dr. med.    +49 89 7095 ext 0    clemens.giessen@med.uni-muenchen.de    Principal Investigator: Volker Heinemann, Prof. Dr. med. Less <<
NCT02162563 Colorectal Cancer ... More >> Liver Metastases Less << Phase 3 Recruiting July 2025 -
NCT00100841 Adenocarcinoma of the Rectum ... More >> Mucinous Adenocarcinoma of the Colon Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Less <<
NCT01718873 Colorectal Cancer Phase 3 Active, not recruiting June 2018 Italy ... More >> Istituto Nazionale Tumori Fondazione G. Pascale Napoli, Italy Less <<
NCT02172976 Resectable Prancreas Carcinoma Phase 2 Phase 3 Active, not recruiting January 2019 Germany ... More >> Institute of Clinical Cancer Research (IKF), UCT - University Cancer Center, Frankfurt, Germany Frankfurt, Germany, 60488 Less <<
NCT00100841 - Completed - -
NCT02860234 - Recruiting April 2023 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Lin Wang, MD    +86 139 1097 5011       Principal Investigator: Aiwen Wu, M.D.          Sub-Investigator: Lin Wang, M.D. Less <<
NCT01930942 Rectal Neoplasms Phase 2 Unknown December 2017 China ... More >> Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Recruiting Beijing, China, 100021 Contact: Jing Jin, MD    +8613601365130    jingjin1025@163.com Less <<
NCT03618758 Gastric Cancer Stage IV ... More >> Peritoneal Carcinomatosis Intraperitoneal Paclitaxel mFOLFOX6 Less << Phase 1 Phase 2 Recruiting July 29, 2021 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 Contact: Sa-Hong Min, M.D.          Principal Investigator: Hyung-Ho Kim, M.D., PhD.          Sub-Investigator: Do Joong Park, M.D., PhD.          Sub-Investigator: Sang-Hoon Ahn, M.D.          Sub-Investigator: Young Suk Park, M.D.          Sub-Investigator: Yo Seok Cho, M.D. Less <<
NCT03443492 Locally Advanced or Metastatic... More >> Pancreatic Cancer Less << Phase 2 Enrolling by invitation December 2020 Taiwan ... More >> National Institute of Cancer Research Miaoli, Taiwan Less <<
NCT00551213 Colorectal Cancer Phase 2 Completed - -
NCT00778102 Colorectal Cancer Phase 2 Completed - Austria ... More >> Wien, Austria, 1090 France Bordeaux, France, 33075 Creteil, France, 94010 Le Mans, France, 72037 Lille, France, 59037 Lyon, France, 69373 Montpellier, France, 34298 Villejuif, France, 94804 Spain San Sebastian, Guipuzcoa, Spain, 20080 Palma de Mallorca, Islas Baleares, Spain, 07198 Santiago de Compostela, La Coruña, Spain, 15706 Girona, Spain, 17007 Madrid, Spain, 28007 Madrid, Spain, 28046 Valencia, Spain, 46026 United Kingdom London, United Kingdom, WC1E 6DD Manchester, United Kingdom, M20 4QL Sutton, United Kingdom, SM2 5PT Wirral, United Kingdom, CH63 4JY Less <<
NCT00551213 - Completed - -
NCT02904031 Elderly Metastatic Colorectal ... More >>Cancer Patients Less << Phase 2 Recruiting March 2019 Italy ... More >> Istituto Oncologico Veneto IRCCS Recruiting Padua, Italy, 35128 Contact: Federica Buggin       federica.buggin@iov.veneto.it    Principal Investigator: Sara Lonardi, MD          Principal Investigator: Fotios Loupakis, MD Less <<
NCT00778102 - Completed - -
NCT00103298 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00262808 Colorectal Cancer Phase 2 Completed - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT02954536 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Recruiting November 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Yelena Janjigian, MD    646-888-4186       Principal Investigator: Yelena Janjigian, MD          Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Yelena Janjigian, MD    646-888-4186       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Yelena Janjigian, MD    646-888-4186       Principal Investigator: Yelena Janjigian, MD          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Yelena Janjigian, MD    646-888-4186       Memorial Sloan Kettering Cancer Center 1275 York Avenue Recruiting New York, New York, United States, 10065 Contact: Yelena Janjigian, MD    646-888-4186       Contact: David Ilson, MD, PhD    646-888-4183       Principal Investigator: Yelena Janjigian, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Yelena Janjigian, MD    646-888-4186       Principal Investigator: Yelena Janjigian, MD          United States, Texas Md Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Mariela Blum Murphy, MD    713-792-2828       Principal Investigator: Mariela Blum Murphy, MD Less <<
NCT00578201 Esophageal Cancer Stage III Phase 2 Completed - France ... More >> Clinique Saint Jean Lyon, France, 69008 Less <<
NCT02295930 Metastatic Colorectal Cancer Phase 2 Completed - Italy ... More >> Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica Alessandria, Italy, 15100 Irccs Centro Di Riferimento Oncologico (Cro) - Aviano (Pn) Aviano, Italy, 33081 A.O.Universitaria Policlinico S.Orsola-Malpighi Di Bologna (Oncologia Medica) Bologna, Italy, 40138 Istituto Ospedaliero Fondazione Poliambulanza Di Brescia - Brescia (Bs) Oncologia Medica Brescia, Italy, 25124 Pres.Ospedal.Spedali Civili Brescia - Brescia (Bs) Oncologia Medic Brescia, Italy, 25125 Ospedale Armando Businco - Cagliari (Ca) Oncologia Medica Cagliari, Italy, 09121 Azienza Ospedaliera S. Croce E Carle Cuneo, Italy, 12100 AUSL DI FROSINONE - FROSINONE (FR) ONCOLOGIA MEDICA U.O. Oncologia Medica Frosinone, Italy, 03100 IRCCS ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO (IST) - GENOVA (GE) ONCOLOGIA MEDICA Oncologia Medica A Genova, Italy, 16132 Ausl 12 Di Viareggio (Lu) - Lido Di Camaiore (Lu) Oncologia Medica Lucca, Italy, 50053 Irccs Istituto Oncologico Veneto (Iov) - Padova (Pd) Oncologia Medica Padova, Italy, 35128 AZIENDA OSPEDALIERA DI PERUGIA - OSPEDALE S. MARIA DELLA MISERICORDIA - PERUGIA (PG) ONCOLOGIA MEDICA U.O. Oncologia Medica Perugia, Italy, 06156 Polo Oncologico Area Vasta Nord Ovest Pisa, Italy, 56100 AUSL 5 DI PISA - PISA (PI) ONCOLOGIA MEDICA oncologia medica Osp Lotti Pontedera Pontedera, Italy, 56100 Ospedale Di S. Maria Nuova - Reggio Nell`Emilia (Re) Oncologia Medica Reggio Emilia, Italy, 42100 Policlinico Universitario Campus Bio-Medico Di Roma - Roma (Rm) Oncologia Medica Roma, Italy, 00128 POLICLINICO UMBERTO I DI ROMA - ROMA (RM) ONCOLOGIA MEDICA oncologia Medica Roma, Italy, 00161 Ospedale Fatebenefratelli Roma, Italy, 00186 Ospedale San Pietro Fatebenefratelli - Roma (Rm) Oncologia Medica Roma, Italy, 00189 Ospedale Civile Di Sondrio Sondrio, Italy, 23100 A.O. Universitaria S. Giovanni Battista-Molinette Di Torino - Torino (to) Oncologia Medica Torino, Italy, 10134 A.O. UNIVERSITARIA S. MARIA DELLA MISERICORDIA DI UDINE - UDINE (UD) ONCOLOGIA MEDICA U.O. Oncologia Medica Udine, Italy, 33100 Less <<
NCT03368651 Hepatocellular Carcinoma Phase 3 Recruiting December 31, 2028 China, Guangdong ... More >> Cancer Center of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, +86 Contact: Shaohua Li, MD    +8615088064187    lishaoh@sysucc.org.cn Less <<
NCT03401294 Metastatic Colorectal Cancer Phase 2 Not yet recruiting August 31, 2021 -
NCT00483080 Colorectal Cancer (CRC) Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy Azienda Ospedaliera Universitaria "San Martino" Genoa, Italy Fondazione San Raffaele del Monte Tabor Milan, Italy Less <<
NCT00766142 Colorectal Cancer ... More >> Peritoneal Cavity Cancer Less << Phase 2 Unknown - France ... More >> Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Serge Evrard    33-556-333-333 Less <<
NCT02829385 Colorectal Neoplasms Phase 2 Unknown September 2018 China, Gansu ... More >> Cancer Cnter,The First Hospital of Lanzhou University Recruiting Lanzhou, Gansu, China, 730000 Contact: Shoucheng Ma, Master    (86)13893453504    mashoucheng@medmail.com.cn Less <<
NCT00819780 - Completed - -
NCT03515941 Gastrointestinal Cancer Early Phase 1 Recruiting January 1, 2027 United States, Texas ... More >> Baylor Clinic Recruiting Houston, Texas, United States, 77030 Contact: Brandon Smaglo, MD    713-798-3752    smaglo@bcm.edu    Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Brandon Smaglo, MD       smaglo@bcm.edu    Sub-Investigator: Benjamin Musher, MD          Sub-Investigator: Yvonne Sada, MD          Sub-Investigator: Courtney Miller-Chism, MD          Sub-Investigator: Henry Mok, MD          Sub-Investigator: Eugene Choi, MD          Baylor St. Lukes Medical Center Recruiting Houston, Texas, United States, 77030 Contact: Brandon Smaglo    713-798-3752    smaglo@bcm.edu    Harris Health System- Smith Clinic Recruiting Houston, Texas, United States, 77054 Contact: Brandon Smaglo, MD    713-798-3752    smaglo@bcm.edu Less <<
NCT00869271 Unresectable Liver Metastasis ... More >>of Colorectal Cancer Less << Phase 4 Completed - China, Shanghai ... More >> Zhongshan Hospital, Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT03692429 Colorectal Cancer Phase 1 Recruiting October 18, 2033 Belgium ... More >> Institut Jules Bordet Not yet recruiting Brussels, Belgium, 1000 Contact: Michel Dubuisson          Principal Investigator: Leila Shaza, MD          UZ Antwerpen Recruiting Edegem, Belgium, 2650 Contact: Hans Prenen, MD          Principal Investigator: Hans Prenen, MD          UZ Leuven Active, not recruiting Leuven, Belgium, 3000 United Kingdom Guy's and St Thomas' NHS Foundation Trust Not yet recruiting London, United Kingdom, SE1 9RT Contact: Sophie Papa, MD          Principal Investigator: Sophie Papa, MD          The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, M20 4BX Contact: Fiona Thistlethwaite, MD          Principal Investigator: Fiona Thistlethwaite, MD Less <<
NCT00964080 Gastric Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma Less << Phase 1 Phase 2 Unknown April 2015 United States, Texas ... More >> Mary Crowley Medical Research Center Dallas, Texas, United States, 76201 MD Anderson Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Georgia A.Gvamichava National Center of Cancer Tbilisi, Georgia, 0177 Medulla Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia, 0186 Less <<
NCT00819780 Colon Cancer ... More >>Colorectal Cancer Rectal Cancer Metastatic Colorectal Cancer Less << Phase 2 Completed - -
NCT00833131 Rectal Cancer Phase 3 Unknown November 2015 Poland ... More >> M. Sklodowska-Curie Memorial Cancer Centre Recruiting Warsaw, Poland, 02-781 Contact: Krzysztof Bujko, Prof.    +48226439287    bujko@coi.waw.pl    Principal Investigator: Krzysztof Bujko, Prof. Less <<
NCT02246049 Colorectal Neoplasms Phase 2 Completed - Japan ... More >> EPS Corporation Shinjuku, Tokyo, Japan, 162-0814 Less <<
NCT02830139 Malignant Neoplasm of Colorect... More >>um Less << Phase 2 Not yet recruiting July 2021 -
NCT01719926 Colorectal Neoplasms ... More >> Esophageal Neoplasms Ovarian Neoplasms Less << Phase 1 Completed - Netherlands ... More >> Meander Medisch Centrum Amersfoort, Utrecht, Netherlands, 3813TZ the Netherlands Cancer Institute Amsterdam, Netherlands, 1066 CX UMC Utrecht Utrecht, Netherlands, 3584CX Switzerland Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Less <<
NCT00537823 - Terminated(Poor accrual.) - -
NCT00537823 Colorectal Cancer ... More >> Metastases Less << Phase 2 Terminated(Poor accrual.) - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01047293 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Utah Cancer Specialists Salt Lake City, Utah, United States Less <<
NCT01372202 Esophageal Cancer Phase 2 Active, not recruiting June 2019 United States, Maryland ... More >> Ronan Kelly, M.D. Baltimore, Maryland, United States, 21287 Less <<
NCT01047293 - Completed - -
NCT02453490 Colorectal Cancer ... More >> Liver Metastasis Less << Phase 3 Recruiting September 2018 China, Guangdong ... More >> The Affiliated Tumor Hospital of Zhongshan University Not yet recruiting Guangzhou, Guangdong, China, 510060 Principal Investigator: Zhi-Zhong Pan, MD/PHD          China, Hubei Wuhan Union Hospital Not yet recruiting Wuhan, Hubei, China, 430022 Principal Investigator: Kai-Xiong Tao, MD/PHD          Zhongnan Hospital Affiliated to Wuhan University Not yet recruiting Wuhan, Hubei, China, 430071 Principal Investigator: Bing Xiong, MD          China, Shanghai Changhai Hospital of Shanghai Recruiting Shanghai, Shanghai, China, 200433 Principal Investigator: Wei Zhang, MD          China, Zhejiang The First Affiliated Hospital of College of Medicine Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310003 Principal Investigator: Jianjiang Lin, M.D.          Second Affiliated Hospitalof Zhejiang University School of Medicine Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Ke-Feng Ding, PhD/MD    86-571-87784827    dingkefeng@zju.edu.cn    Principal Investigator: Ke-Feng Ding, PhD/MD          Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Recruiting Hangzhou, Zhejiang, China, 310016 Principal Investigator: Xuefeng Huang, M.D.          Jinhua People's Hospital Recruiting Jinhua, Zhejiang, China, 321000 Principal Investigator: Jinlin Du, M.D.          The second hospital of Ningbo City Recruiting Ningbo, Zhejiang, China, 315010 Principal Investigator: Xiao-Yu Dai, MD Less <<
NCT03533582 Childhood Hepatocellular Carci... More >>noma Childhood Malignant Liver Neoplasm Elevated Alpha-Fetoprotein Hepatoblastoma SMARCB1 Gene Mutation Less << Phase 2 Phase 3 Recruiting March 31, 2025 -
NCT02240524 Advanced Gastric Adenocarcinom... More >>a Less << Phase 3 Recruiting July 2019 China, Guangdong ... More >> Department of Abdominal Surgery (Section 2), Affiliated Tumor Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510095 Contact: zhiyuan fang, Ph.D    86020666736662012    fangjnu@gmail.com    Principal Investigator: shuzhong cui, Ph.D Less <<
NCT01328171 Metastatic Colorectal Cancer Phase 2 Active, not recruiting January 2022 Germany ... More >> Klinikum Esslingen Esslingen, Baden-Württemberg, Germany, 73730 SLK-Kliniken Heilbronn GmbH Heilbronn, Baden-Württemberg, Germany, 74078 Ortenau Klinikum Lahr, Baden-Württemberg, Germany, 77933 Klinikum Ludwigsburg Ludwigsburg, Baden-Württemberg, Germany, 71640 Universitätsklinikum Mannheim Mannheim, Baden-Württemberg, Germany, 68135 Klinikum Schwäbisch Gmünd Mutlangen, Baden-Württemberg, Germany, 73557 Kreiskliniken Esslingen gGmbH Klinik Nürtingen Nürtingen, Baden-Württemberg, Germany, 72622 Schwerpunktpraxis und Tagesklinik Onkologie Hämatologie Gastroenterologie Palliativmedizin Drs. Höring, Respondek, Schwinger, Thunert Stuttgart, Baden-Württemberg, Germany, 70190 Universitätsklinikum Ulm Zentrum für Innere Medizin Ulm, Baden-Württemberg, Germany, 89081 Klinikum Augsburg Augsburg, Bayern, Germany, 86156 Leopoldina-Krankenhaus der Stadt Schweinfurth gGmbH Schweinfurt, Bayern, Germany, 97422 Klinikum der J.W. Goethe-Universität Frankfurt Frankfurt, Hessen, Germany, 60590 Universitätsklinikum Gießen und Marburg GmbH Marburg, Hessen, Germany, 35043 Franziskus Hospital Niels-Stensen-Kliniken Klinik für Internistische Onkologie und Hämatologie Georgsmarienhütte, Niedersachsen, Germany, 49124 Marienhospital Osnabrück Niels-Stensen-Kliniken Klinik für Innere Medizin Osnabrück, Niedersachsen, Germany, 49074 St. Vincenz-Krankenhaus Paderborn, Nordrhein-Westfalen, Germany, 33098 Klinikum Mutterhaus der Borromäerinnen gGmbH Trier, Rheinland-Pfalz, Germany, 54290 Universitätsklinikum Halle Halle, Sachsen-Anhalt, Germany, 6120 Universitätsklinikum Jena Jena, Thüringen, Germany, 7740 Less <<
NCT01372202 - Active, not recruiting - -
NCT03611556 Carcinoma Met... More >>astatic Pancreatic Adenocarcinoma Less << Phase 1 Phase 2 Recruiting May 25, 2021 -
NCT01280643 Metastatic Colorectal Cancer Not Applicable Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT01246960 Stomach Cancer ... More >> Esophageal Cancer Less << Phase 2 Completed - -
NCT03421288 Gastric Cancer ... More >> Gastroesophageal Junction Adenocarcinoma Less << Phase 2 Recruiting February 2025 Germany ... More >> Kranken Recruiting Frankfurt, Germany, 60488 Contact: Salah-Eddin Al-Batran, Prof    +496976014420    albatran@khnw.de    Contact: Thorsten Goetze    +496976014187    goetze.thorsten@khnw.de Less <<
NCT02918747 Lymphoma Phase 3 Recruiting December 2021 China, Hunan ... More >> Hunan Cancer Hospital Recruiting Changsha, Hunan, China, 4100013 Contact: Pingyong Yi, MD.    (86-0731)89762281    yipingy1964@163.com    Principal Investigator: Pingyong Yi, MD. Less <<
NCT02548169 Pancreatic Cancer Phase 1 Unknown April 2018 United States, Texas ... More >> Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 Contact: Grace Townsend    214-818-8382    grace.townsend@baylorhealth.edu    Contact: Gaby Ethington    214-818-8326    gabriele@BaylorHealth.edu    Principal Investigator: Carlos Becerra          Sub-Investigator: Scott Celinski Less <<
NCT01246960 - Completed - -
NCT00851084 - Completed - -
NCT01097265 Colorectal Cancer Phase 2 Phase 3 Unknown - Netherlands ... More >> Jeroen Bosch Ziekenhuis Recruiting 's-Hertogenbosch, Netherlands, 5211 NL Contact: Contact Person    31-73-699-2701    k.bosscha@jbz.nl    Vrije Universiteit Medisch Centrum Recruiting Amsterdam, Netherlands, 1007 MB Contact: Contact Person    31-20-444-4300       Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Recruiting Amsterdam, Netherlands, 1066 BE Contact: Contact Person    31-20-512-9111       Academisch Medisch Centrum at University of Amsterdam Recruiting Amsterdam, Netherlands, 1105 AZ Contact: Contact Person    31-20-566-9111       Catharina Ziekenhuis Recruiting Eindhoven, Netherlands, 5602 ZA Contact: Contact Person    31-40-239-9111       University Medical Center Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Contact Person    31-50-361-2317       Leiden University Medical Center Recruiting Leiden, Netherlands, 2300 RC Contact: Contact Person    31-71-526-2309    c.j.h.van_de_velde@lumc.nl    Academisch Ziekenhuis Maastricht Recruiting Maastricht, Netherlands, 6202 AZ Contact: Contact Person    31-43-387-7025       Universitair Medisch Centrum St. Radboud - Nijmegen Recruiting Nijmegen, Netherlands, NL-6500 HB Contact: Contact Person    31-24-361-0353    c.punt@onco.umcn.nl    University Medical Center Rotterdam at Erasmus Medical Center Recruiting Rotterdam, Netherlands, 3000 CA Contact: Contact Person    31-10-463-5995    w.r.schouten@erasmusmc.nl    University Medical Center Utrecht Recruiting Utrecht, Netherlands, 3584 CX Contact: Contact Person    31-30-250-9111 Less <<
NCT01183780 Colorectal Cancer Phase 3 Completed - -
NCT00851084 Colorectal Neoplasms ... More >> Neoplasm Metastasis Less << Phase 2 Completed - -
NCT01183780 - Completed - -
NCT00077987 Colorectal Neoplasms Phase 2 Completed - -
NCT02969681 Colorectal Neoplasms Phase 3 Recruiting December 2020 China, Guangdong ... More >> Medical Oncology,Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Feng Wang, M.D,Ph.D    86-18620880867    wangfeng@sysucc.org.cn    Principal Investigator: Ruihua Xu, M.D,Ph.D          Sub-Investigator: Feng Wang, M.D,Ph.D Less <<
NCT00215722 Colorectal Carcinoma Phase 2 Unknown July 2008 Portugal ... More >> Hospital Garcia de Orta Almada, Portugal, 2800 Hospital Distrital do Barreiro Barreiro, Portugal, 2830 Hospital Distrital de Beja Beja, Portugal, 7800-309 Hospital de São Marcos Braga, Portugal, 4700 Hospitais da Universidade de Coimbra Coimbra, Portugal, 3000-075 IPO - Coimbra Coimbra, Portugal, 3000 Centro Hospitalar do Funchal Funchal, Portugal, 9000-514 Hospital Pedro Hispano Matosinhos, Portugal, 4454-509 Hospital do Divino Espírito Santo Ponta Delgada, Portugal, 9500-370 IPO - Porto Porto, Portugal, 4200 Less <<
NCT00291785 Colorectal Cancer Phase 1 Phase 2 Completed - Italy ... More >> Policlinico Universitario "A.Gemelli" Rome, Italy Istituto Clinico Humanitas Rozzano, Italy Less <<
NCT01286818 Colorectal Carcinoma Phase 1 Completed - Japan ... More >> ImClone Investigational Site Chiba, Japan, 277-8577 ImClone Investigational Site Osaka, Japan, 569-8686 ImClone Investigational Site Shizuoka, Japan, 411-8777 Less <<
NCT01286818 - Completed - -
NCT02624492 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 2 Completed - Belgium ... More >> UNIV UZ Gent Gent, Belgium, 9000 Jessa Ziekenhuis - Campus Virga Jesse Hasselt, Belgium, 3500 Italy Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Italy, 20133 Istituto Clinico Humanitas Rozzano (MI), Italy, 20089 A. O. S. Maria della Misericordia Udine, Italy, 33100 Spain Hospital Germans Trias i Pujol Badalona, Spain, 08916 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital La Paz Madrid, Spain, 28046 Less <<
NCT01479465 Colorectal Cancer Phase 2 Completed - -
NCT00403052 Colorectal Neoplasms Phase 1 Terminated(Administrative reas... More >>ons) Less << - United States, California ... More >> Premiere Oncology Santa Monica, California, United States, 90404 United States, District of Columbia Lombardi Comprehensive Cancer Center, Georgetown University Washington, District of Columbia, United States, 20007 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 Less <<
NCT03719924 Squamous Cell Carcinoma Phase 2 Not yet recruiting April 15, 2022 -
NCT03616574 Advanced or Metastatic Solid T... More >>umors Advanced or Metastatic Colorectal Cancer (mCRC) Less << Phase 1 Not yet recruiting June 2021 -
NCT02624726 Metastatic Colorectal Cancer Phase 2 Recruiting January 2019 Greece ... More >> University Hospital of Heraklion Crete Recruiting Heraklion, Crete, Greece, 71110 Contact: Ioannis Athanasakis    +302810392783    dclintrials@gmail.com    Principal Investigator: Athanasios Kotsakis, MD          251 Air Forces Military Hospital of Athens Recruiting Athens, Greece Contact: Nikolaos Kentepozidis, MD       kentenik@hotmail.com    Principal Investigator: Nikolaos Kentepozidis, MD          Anicancer Hospital of Athens "Agios Savvas" Recruiting Athens, Greece Principal Investigator: Alexandros Ardavanis, MD          Anticanscer Hospital of Athens "Agios Savvas" Recruiting Athens, Greece Principal Investigator: George Koumakis, MD          Athens Hospital "Mitera" Hygia Polis Recruiting Athens, Greece Principal Investigator: Ilias Athanasiadis, MD          General Hospital of Athens "Aretaieio" Recruiting Athens, Greece Principal Investigator: Christos Papadimitriou, MD, hD          General Hospital of Athens "Sotiria" Recruiting Athens, Greece Principal Investigator: Konstantinos Syrigos, Professor          IASO General Hospital Recruiting Athens, Greece Contact: Panagiotis Katsaounis, MD    +302106502639       Principal Investigator: Panagiotis Katsaounis, MD          University Hospital of Patras-Rio Recruiting Rio-Patra, Greece Contact: Charalampos Kalofonos, Professor          Principal Investigator: Charalampos Kalofonos, Professor          Thessaloniki Bioclinic Recruiting Thessaloniki, Greece Contact: Ioannis Boukovinas, MD          Principal Investigator: Ioannis Boukovinas, MD Less <<
NCT03348150 Stomach Neoplasm ... More >> Peritoneal Carcinomatosis Less << Phase 3 Recruiting October 1, 2022 Netherlands ... More >> Antoni van Leeuwenhoek/ Netherlands Cancer institute Recruiting Amsterdam, Netherlands, 1066CZ Contact: Willem Koemans, MSc    +31 20 512 2954    w.koemans@nki.nl Less <<
NCT01333033 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Cancer Less << Phase 2 Active, not recruiting - -
NCT03377842 Colorectal Cancer ... More >> Neoadjuvant Therapy Less << Phase 2 Not yet recruiting September 1, 2020 -
NCT01167725 Colorectal Cancer Phase 3 Unknown - United States, Maryland ... More >> St. Agnes Hospital Cancer Center Baltimore, Maryland, United States, 21229 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00202787 Colorectal Cancer Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD) Madrid, Spain, 28046 Less <<
NCT01591733 Pancreatic Cancer Phase 2 Active, not recruiting January 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00114946 Colorectal Cancer Phase 4 Terminated - -
NCT00994864 Colon Cancer Not Applicable Active, not recruiting December 2022 Belgium ... More >> Clinique St-Luc Bouge Bouge, Belgium, 5004 Hôpital Erasme Brussels, Belgium, 1000 Jules Bordet Institute Brussels, Belgium, 1000 CHU Brugmann Brussels, Belgium, 1020 IRIS Etterbeek-Ixelles Brussels, Belgium, 1050 Clin Université St-Luc Bruxelles Brussels, Belgium, 1200 HIS IZZ Bracops Brussels, Belgium Grand Hôpital Charleroi Charleroi, Belgium UZ Antwerp Edegem, Belgium, 2650 UZ Gent Gent, Belgium, 9000 AZ Groeninge Kortrijk, Belgium, 8500 CHR Citadelle de Liege Liege, Belgium, 4000 CHU De Liège Liège, Belgium, 4000 Clinique St-Joseph Liège, Belgium, 4000 ZNA - Jan Palfijin Merksem, Belgium, 2170 CHU Ambroise Paré Mons, Belgium, 7000 CHR Namur Namur, Belgium, 5000 AZ Damiaan Oostende, Belgium, 8400 clinique St Pierre Ottignies Ottignies, Belgium AZ Turnhout Turnhout, Belgium Clinique Universites UCL Mont-Godinne Yvoir, Belgium, 5530 Less <<
NCT02876224 Colorectal Cancer Phase 1 Active, not recruiting August 28, 2019 United States, Colorado ... More >> University Of Colorado Aurora, Colorado, United States, 80045 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Inst. Nashville, Tennessee, United States, 37203 United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Spain Hospital Universitario Vall d'Hebron Barcelona, Spain, 08035 START Madrid. Centro Integral Oncologico Clara Campal; CIOCC Madrid, Spain, 28050 Less <<
NCT00361842 Colorectal Neoplasms Phase 2 Completed - United States, California ... More >> California Cancer Center Greenbrae, California, United States, 94904 United States, District of Columbia Lombardi Comprehensive Cancer Research Institute, Georgetown University Medical Center Washington DC, District of Columbia, United States, 20057 United States, Florida NW Oncology & Hematology Associates Coral Springs, Florida, United States, 33065 Broward Oncology Associates Fort Lauderdale, Florida, United States, 33308 United States, Georgia St. Joseph's/Candler Health System Inc. Savannah, Georgia, United States, 31405 United States, North Carolina Presbyterian Hospital Charlotte,, North Carolina, United States, 28204 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Oklahoma Cancer Care Oklahoma Oklahoma City, Oklahoma, United States Cancer Care Oklahoma Tulsa, Oklahoma, United States United States, South Carolina South Carolina Oncology Association Columbia, South Carolina, United States, 29210 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Canada, Alberta Cross Cancer Institute Edmonton, Alberta, Canada, T6G1Z2 Canada, Quebec Sir Mortimer B. Davis Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT01591733 - Active, not recruiting - -
NCT01498458 - Completed - -
NCT01498458 Metastatic Breast Cancer Phase 1 Completed - Germany ... More >> GBG Forschungs GmbH Neu-Isenburg, Germany, 63263 Less <<
NCT02776683 Colorectal Neoplasms Phase 3 Completed - -
NCT02887313 Rectal Cancer Phase 2 Recruiting November 2019 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yatsen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanhong Deng, PhD    0086-020-38250745    dengyanh@mail.sysu.edu.cn    Principal Investigator: Yanhong Deng, Phd Less <<
NCT00874406 Colorectal Cancer Phase 4 Unknown December 2009 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: jianmin xu, MD, PHD    008613501984869    xujmin@yahoo.com.cn    Principal Investigator: jianmin xu, MD, PHD Less <<
NCT03426904 Colon Cancer Phase 3 Not yet recruiting February 28, 2026 -
NCT02209441 - - - -
NCT03427268 Advanced Colorectal Cancer Phase 2 Active, not recruiting October 2019 United States, California ... More >> US017 Los Angeles, California, United States, 90089-9181 Canada, Ontario CA001 Toronto, Ontario, Canada, ON M5G 2M9 Spain ES001 Barcelona, Spain, 08035 ES009 Madrid, Spain, 28041 ES002 Valencia, Spain, 46010 Less <<
NCT01379482 Peritoneal Carcinomatosis ... More >> Gastric Cancer Less << Phase 2 Completed - Sweden ... More >> Uppsala University Uppsala, Sweden Less <<
NCT01943786 - Unknown December 2015 Spain ... More >> Centro Integral Oncólógico Clara Campal (Madrid Norte Sanchinarro University Hospital) Madrid, Spain, 28050 Less <<
NCT02539537 Pancreatic Cancer ... More >> Carcinoma Less << Phase 3 Recruiting March 2022 France ... More >> CHU Amiens - Hôpital Nord Recruiting Amiens, France Principal Investigator: Vincent HAUTEFEUILLE, Dr          Institut de cancérologie de l'Ouest - Site Paul Papin Active, not recruiting Angers, France, 49933 Centre hospitalier d'Auxerre Recruiting Auxerre, France Contact: Anne-Laure VILLING, Dr          Centre hospitalier Henri Duffaut Recruiting Avignon, France Contact: Thibault BROTELLE, Dr          Hôpital Avicenne Active, not recruiting Bobigny, France, 93000 Institut Bergonié Active, not recruiting Bordeaux, France, 33076 Polyclinique Bordeaux Nord Active, not recruiting Bordeaux, France, 33077 CH Boulogne sur Mer Active, not recruiting Boulogne sur Mer, France, 62321 CHU Côte de Nacre Active, not recruiting Caen, France, 14033 Centre François Baclesse Active, not recruiting Caen, France, 14076 Hôpital Trousseau Recruiting Chambray-les-tours, France Principal Investigator: Thierry LECOMTE, Dr          Hôpitaux civils de Colmar Recruiting Colmar, France Contact: Gilles BREYSACHER, Dr          CHD Vendée Active, not recruiting La Roche Sur Yon, France, 85925 Centre Hospitalier de Laon Active, not recruiting Laon, France, 02000 Centre Oscar Lambret Recruiting Lille, France, 59020 Principal Investigator: Antoine ADENIS, Pr          Hôpital Privé Jean Mermoz Active, not recruiting Lyon, France, 69008 Hôpital Edouard Herriot - Lyon Recruiting Lyon, France, 69437 Principal Investigator: Julien FORESTIER, Dr          Hôptal Européen Active, not recruiting Marseille, France, 13003 Hôpital De La Timone Active, not recruiting Marseille, France, 13365 Centre Hospitalier de Meaux Active, not recruiting Meaux, France, 77000 CHU Hotel Dieu Recruiting Nantes, France Contact: Yann TOUCHEFEU, Dr          Centre Antoine Lacassagne Recruiting Nice, France Principal Investigator: Philippe FOLLANA, Dr          Hôpital Saint Antoine Active, not recruiting Paris, France, 75571 Groupe hospitalier Paris Saint Joseph Recruiting Paris, France Principal Investigator: Nabil BABA HAMED, Dr          Groupe hospitalier Pitié Salpétrière Recruiting Paris, France Contact: Jean-Baptiste BACHET, Dr          CHU - Robert Debre Recruiting Reims, France, 51092 Principal Investigator: Olivier BOUCHE, Dr          CHU Rouen Recruiting Rouen, France Principal Investigator: Frédéric DI FIORE, Dr          Hôpital Privé des Côtes d'Armor Active, not recruiting Saint Brieuc, France, 22190 Centre Regional René Gauducheau Recruiting Saint Herblain, France Principal Investigator: Olivier CAPITAIN, Dr          Centre Hospitalier de Saint Malo Active, not recruiting Saint Malo, France, 35403 Institut de cancérologie Lucien Neuwirth Active, not recruiting Saint Priest En Jarez, France, 42271 Clinique mutualiste de l'Estuaire Recruiting Saint-Nazaire, France Principal Investigator: Catherine LIGEZA, Dr          Hôpital privé Saint Claude Recruiting Saint-quentin, France Principal Investigator: Pierre VANELSLANDER, Dr          Centre Hospitalier de Soissons Recruiting Soissons, France, 02209 Principal Investigator: Sarah MONTEMBAULT, Dr          Centre Hospitalier de Rangueil Recruiting Toulouse, France, 31059 Principal Investigator: Rosine GUIMBAUD, Pr          Institut de Cancérologie de Lorraine Active, not recruiting Vandoeuvre Les Nancy, France, 54519 Gustave Roussy Recruiting Villejuif, France Principal Investigator: Michel DUCREUX, Pr Less <<
NCT01673607 Resectable Hepatic Metastases ... More >>of Colorectal Cancer Less << Phase 2 Unknown - France ... More >> Poitiers University Hospital Recruiting Poitiers, France, 86021 Contact: David TOUGERON, MD    33.5.49.44.37.51    david.tougeron@chu-poitiers.fr Less <<
NCT00063141 Colorectal Cancer Phase 3 Completed - -
NCT03031444 Colorectal Cancer Stage IV ... More >> Metastasis Less << Phase 2 Phase 3 Recruiting December 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Kun Wang, MD    86-010-88196559    wang-kun@vip.sina.com    Sub-Investigator: Kemin Jin, MD          Sub-Investigator: Da Xu, MD          Sub-Investigator: Jian Li, MD          Sub-Investigator: Yunfeng Yao, MD          Sub-Investigator: Ming Liu, MD          Sub-Investigator: Baocai Xing, MD          China, Sichuan West China Hospital, Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: Meng Qiu, MD          China, Yunnan First Affiliated Hospital of Kunming Medical University Recruiting Kunming, Yunnan, China, 650032 Contact: Wenliang Li, MD          China, Zhejiang Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Jieer Ying, MD Less <<
NCT03693846 Mucinous Neoplasm ... More >> Colorectal Tumor Appendiceal Tumor Less << Phase 2 Not yet recruiting November 2023 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Peter O'Dwyer    855-216-0098    penncancertrials@emergingmed.com    Principal Investigator: Peter O'Dwyer, MD Less <<
NCT01653301 Rectal Cancer Phase 3 Unknown - Italy ... More >> Catholic University of Sacred Heart Recruiting Rome, Italy, 00168 Contact: Vincenzo Valentini, MD    +390630155226    vvalentini@rm.unicatt.it    Principal Investigator: Vincenzo Valentini, MD Less <<
NCT00113763 Colorectal Cancer ... More >> Metastases Less << Phase 3 Completed - -
NCT03563144 Metastatic Pancreatic Cancer Phase 2 Not yet recruiting December 30, 2019 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT00498407 Advanced Colorectal Cancer ... More >> Colorectal Cancer Less << Phase 2 Completed - United Kingdom ... More >> Aberdeen Royal Infirmary, Foresterhill, Aberdeen, United Kingdom, AB25 2ZN The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN Medical Oncology Dept. of Cancer Studies and Molecular Medicine, Leicester Royal Infirmary Leicester, United Kingdom, LEI 5WW Macmillan Lead Clinician in Gastro-intestinal Cancer Mount Vernon Cancer Centre Northwood, United Kingdom, HA6 2RN Less <<
NCT00492999 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Active, not recruiting May 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Less <<
NCT00113763 - Completed - -
NCT00362102 Colorectal Carcinoma Phase 2 Completed - -
NCT02720068 Advanced Cancer Phase 1 Recruiting July 2, 2021 United States, Arizona ... More >> Call for Information (Investigational Site 0021) Recruiting Phoenix, Arizona, United States, 85054 United States, California Call for Information (Investigational Site 0008) Recruiting Encinitas, California, United States, 92024 Call for Information (Investigational Site 0009) Recruiting Fresno, California, United States, 93720 United States, Colorado Call for Information (Investigational Site 0019) Recruiting Denver, Colorado, United States, 80218 United States, Florida Call for Information (Investigational Site 0022) Recruiting Jacksonville, Florida, United States, 32224 United States, Michigan Call for Information (Investigational Site 0012) Recruiting Detroit, Michigan, United States, 48201 Call for Information (Investigational Site 0003) Recruiting Grand Rapids, Michigan, United States, 49503 United States, Minnesota Call for Information (Investigational Site 0020) Recruiting Rochester, Minnesota, United States, 55905 United States, Tennessee Call for Information (Investigational Site 0002) Recruiting Nashville, Tennessee, United States, 37203 United States, Texas Call for Information (Investigational Site 0017) Recruiting Houston, Texas, United States, 77030 Call for Information (Investigational Site 0001) Recruiting San Antonio, Texas, United States, 78229 Canada, Quebec Merck Canada Recruiting Kirkland, Quebec, Canada, H9H 4M7 Contact: Medical Information Centre Centre d'information medicale Merck Canada Inc.    514-428-8600 / 1-800-567-2594       Germany MSD Sharp & Dohme GmbH Recruiting Haar, Germany Contact: German Medical Information Center    49 800 673 673 673       Israel Merck Sharp & Dohme Co. Ltd. Recruiting Hod Hasharon, Israel Contact: Dan Goldstaub    972-9-9533326       Korea, Republic of MSD Korea LTD Recruiting Seoul, Korea, Republic of, 4130 Contact: TaeYoun Jo    8223312313       Poland MSD Polska Sp. Z o.o. Recruiting Warsaw, Poland Contact: Thomas J. Johansson    48224784324       Spain Merck Sharp and Dohme de Espana S.A. Recruiting Madrid, Spain Contact: Lourdes Lopez-Bravo    (0034) 913210654 Less <<
NCT01302613 Stage II Rectal Cancer ... More >> Stage III Rectal Cancer Less << Phase 1 Phase 2 Terminated(Drug shortage) - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00612586 Colorectal Cancer Phase 2 Completed - United States, Tennessee ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38138 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States, 77030 United States, Utah For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salt Lake City, Utah, United States, 84106 Austria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Innsbruck, Austria, 6020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Krems, Austria, 3500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vienna, Austria, 1100 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brest, France, 29609 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Caen, France, 14076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Clichy, France, 92118 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France, 59020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marseille, France, 13385 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75015 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Augsburg, Germany, D-86150 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, D-60431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, D-69120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Luebeck, Germany, 23562 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Muenchen, Germany, 81925 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munich, Germany, 81377 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Weiden, Germany, 92637 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bari, Italy, 70126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy, 50139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Livorno, Italy, 57128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Puerto Rico, 00918 Less <<
NCT03042000 Rectal Cancer, Adenocarcinoma ... More >> Neoadjuvant Chemoradiation Less << Not Applicable Not yet recruiting December 2021 -
NCT01926197 Pancreatic Cancer Phase 3 Recruiting September 2019 United States, California ... More >> UCLA Recruiting Los Angeles, California, United States, 60153 Contact: Jackie Hernandez    559-624-3015    JHernandez@mednet.ucla.edu    Stanford University, School of Medicine Recruiting Stanford, California, United States, 94305 Contact: Samantha Wong    650-498-8495    swong8@stanford.edu    Principal Investigator: Daniel T Chang          United States, Illinois Loyola University Recruiting Maywood, Illinois, United States, 60153 Contact: Beth Chiappetta, RN    708-216-2568    BCHIAPPETTA@lumc.edu    United States, Texas University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Patrick Brooks    214-645-2250    Patrick.Brooks@UTSouthwestern.edu    Canada, British Columbia BC Cancer Agency Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Sonya Lam    604-877-6000 ext 6006    Sonya.Lam@bccancer.bc.ca    Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada Contact: Sonca Lengoc    416-946-4501 ext 4820    sonca.lengoc@rmp.uhn.ca Less <<
NCT00838578 Colorectal Cancer Phase 1 Phase 2 Terminated(Per protocol, the s... More >>tudy was terminated based on interim analysis results) Less << - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, Arizona Arizona Clinical Research Center Tucson, Arizona, United States, 85715 United States, California USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, District of Columbia Lombardi Comprehensive Cancer Center, Georgetown University Hospital Washington, District of Columbia, United States, 20007-2113 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33916 University of Florida COllege of Medicine/Shands Cancer Center Gainesville, Florida, United States, 32610 University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Georgia Emory University - Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Greater Baltimore Medical Center Baltimore, Maryland, United States, 21204 United States, New York NYU Clinical Trials Office, New York University Cancer Institute New York, New York, United States, 10016 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00104676 Extragonadal Germ Cell Tumor ... More >> Teratoma Testicular Germ Cell Tumor Less << Phase 3 Unknown - United States, Texas ... More >> M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U    713-792-3245       France Centre Paul Papin Recruiting Angers, France, 49100 Contact: Remy Delva    33-49-800-918-507       Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Nguyen Binh Bui, MD    33-5-5633-3813       C.H.U. de Brest Recruiting Brest, France, 29609 Contact: Jean-Pierre Malhaire, MD    33-298-223-333 ext. 233-95       Centre Regional Francois Baclesse Recruiting Caen, France, 14076 Contact: Emmanuel Sevin, MD    33-2-3145-5000    e.sevin@baclesse.fr    CHU de Grenoble - Hopital de la Tronche Recruiting Grenoble, France, 38043 Contact: Francois Ringeisen    33-4-7676-5537       Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Armelle Caty, MD    33-32-029-5959    acaty@o-lambret.fr    Centre Leon Berard Recruiting Lyon, France, 69008 Contact: Aude Flechon    33-4-78-78-26-45       Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Gwenaelle Gravis, MD    33-4-9122-3740    gravisg@marseille.fnclcc.fr    Hopital Notre-Dame de Bon Secours Recruiting Metz, France, 57038 Contact: Christian Platini, MD    33-3-8755-3554    cplatini@chr-metz-thionville.fr    Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Stephane Culine, MD    33-4-6761-3755    stculine@valdorel.fnclcc.fr    CRLCC Nantes - Atlantique Recruiting Nantes-Saint Herblain, France, 44805 Contact: Frederic Rolland, MD    33-2-40-67-99-76    F-rolland@nantes.fnclcc.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Antoine Thyss, MD    33-04-9203-1538    antoine.thyss@cal.nice.fnclcc.fr    Hopital Europeen Georges Pompidou Recruiting Paris, France, 75015 Contact: Stephane Oudard, MD, PhD    33-1-56-093-476    stephane.oudard@hop.egp.ap-hop-paris.fr    Hopital Tenon Recruiting Paris, France, 75970 Contact: Jean-Pierre Lotz, MD    33-1-5601-6058    jean-pierre.lotz@tnn.ap-hop-paris.fr    Institut Jean Godinot Recruiting Reims, France, 51056 Contact: Jean-Christophe Eymard, MD    33-03-2650-4444    jc.eymard@reims.fnclcc.fr    Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Pierre Kerbrat, MD, PhD    33-299-253-280    kerbrat@rennes.fnclcc.fr    Centre Hospitalier de Rodez Recruiting Rodez, France, 12027 Contact: Laurent Mosser    33-05-6575-1212       Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Paule Chinet-Charrot    33-2-3208-2222       Institut Claudius Regaud Recruiting Toulouse, France, 31052 Contact: Christine Chevreau-Dalbianco, MD    33-56-142-4114    chevreau.christine@claudiusregaud.fr    Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Claude Linassier, MD, PhD    33-2-4747-3827    linassier@med.univ-tours.fr    Centre Alexis Vautrin Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Lionnel Geoffrois, MD    33-3-8359-8400       Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Karim Fizazi, MD, PhD    33-1-4211-4559    fizazi@igr.fr    Slovakia National Cancer Institute - Bratislava Recruiting Bratislava, Slovakia, 833 10 Contact: Maria Reckova, MD    421-2-5937-8366    maria.reckova@nou.sk Less <<
NCT02384850 Colorectal Neoplasm Phase 1 Completed - Belgium ... More >> University Hospital Antwerpen Antwerpen, Belgium, 1200 Germany University Hospital Hamburg Hamburg, Germany, 20246 Less <<
NCT00838578 - Terminated(Per protocol, the s... More >>tudy was terminated based on interim analysis results) Less << - -
NCT02149771 Hepatocellular Carcinoma ... More >> Hepatic Portal Vein Tumor Invasion Less << Phase 3 Withdrawn(Insufficient funding... More >>) Less << - China, Shanghai ... More >> Department of Interventional Radiology, Zhongshan Hospital, Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT00986440 Colorectal Cancer Phase 2 Completed - -
NCT02509286 Esophageal Adenocarcinoma (UIC... More >>C TNM7) Adenocarcinoma of the Esophagogastric Junction Less << Phase 3 Recruiting June 2024 Germany ... More >> Uniklinik RWTH Aachen Recruiting Aachen, Germany Principal Investigator: Ulf Peter Neumann, Professor          Sub-Investigator: Christian Klink, PD Dr.          Charité Berlin - Campus Benjamin Franklin (CBF) Recruiting Berlin, Germany, 12203 Contact: Severin Daum, PD Dr.          Principal Investigator: Severin Daum, PD Dr.          Sub-Investigator: Hendrik Seeliger, PD Dr.          Charité Berlin Campus Virchow-Klinikum (CVK) Recruiting Berlin, Germany, 13353 Principal Investigator: Peter Thuß-Patience, PD Dr.          Sub-Investigator: Matthias Biebl, PD Dr.          Klinikum Dortmund gGmbH Recruiting Dortmund, Germany, 44137 Contact: Maximilian Schmeding, Prof.          Principal Investigator: Maximilian Schmeding, Prof.          Sub-Investigator: Michael Heike, Prof.          Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Recruiting Dresden, Germany, 03107 Principal Investigator: Gunnar Folprecht, PD Dr.          Sub-Investigator: Thilo Welsch, Prof.          Universitätsklinikum Düsseldorf Recruiting Düsseldorf, Germany Principal Investigator: Matthias Schauer, PD Dr.          Sub-Investigator: Wolfram Knoefel, Prof.          Universitätsklinikum Erlangen Recruiting Erlangen, Germany, 91054 Contact: Robert Grützmann, Prof.          Principal Investigator: Robert Grützmann, Prof.          Sub-Investigator: Dimitrios Raptis, Dr.          Universitätsklinikum Frankfurt Recruiting Frankfurt am Main, Germany, 60590 Contact: Detlef Imhoff, Dr.          Principal Investigator: Detlef Imhoff, Dr.          Sub-Investigator: Christian Keller, Dr.          Universitätsklinikum Freiburg Recruiting Freiburg, Germany Principal Investigator: Jens Hoeppner, Professor          Sub-Investigator: Ralph Fritsch, Dr.          Universitätsmedizin Göttingen Recruiting Göttingen, Germany, 37099 Principal Investigator: Jochen Gaedcke, PD Dr.          Sub-Investigator: Alexander König, Dr.          Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany Principal Investigator: Jakob R. Izbicki, Professor          Sub-Investigator: Cordula Petersen, Professor          Universitätsklinikum des Saarlandes Recruiting Homburg, Germany, 66421 Contact: Frank Lammert, Prof.          Principal Investigator: Frank Lammert, Prof.          Sub-Investigator: Simone Zimmermann          Universitätsklinikum Schleswig-Holstein, Campus Kiel Recruiting Kiel, Germany Principal Investigator: Thomas Becker, Professor          Sub-Investigator: Benedikt Reichert, Dr.          Uniklinik Köln Recruiting Köln, Germany, 50937 Contact: Christiane Bruns, Prof.          Principal Investigator: Christiane Bruns, Prof.          Sub-Investigator: Thomas Zander, PD Dr.          Sub-Investigator: Armin Tuchscherer, Dr.          Universitätsklinikum Leipzig Recruiting Leipzig, Germany Principal Investigator: Ines Gockel, Professor          Sub-Investigator: Orestis Lyros, Dr.          Universitätsklinikum Schleswig-Holstein, Campus Lübeck Recruiting Lübeck, Germany Principal Investigator: Tobias Keck, Professor          Sub-Investigator: Ralf Bouchard, Dr.          Universitätsklinikum Magdeburg Recruiting Magdeburg, Germany Principal Investigator: Frank Benedix, Prof.          Sub-Investigator: Marino Venerito, Dr.          Universitätsmedizin Mainz Recruiting Mainz, Germany Principal Investigator: Peter Grimminger, PD Dr.          Sub-Investigator: Stefan Heinrich, PD Dr.          Johannes Wesling Klinikum Minden Recruiting Minden, Germany, 32429 Contact: Kai Wille, Dr.          Principal Investigator: Kai Wille, Dr.          Sub-Investigator: Emil Sagynaliev, Dr.          Klinikum der Universität München (LMU) Recruiting München, Germany Principal Investigator: Jens Werner, Professor          Sub-Investigator: Martin Angele, Professor          Universitätsklinikum Münster Recruiting Münster, Germany Principal Investigator: Andreas Pascher, Professor          Sub-Investigator: Mike Laukötter, PD Dr.          Ruppiner Kliniken GmbH Recruiting Neuruppin, Germany, 16816 Contact: Andreas Loew, Dr.          Principal Investigator: Andreas Loew, Dr.          Sub-Investigator: Christoph Löschner, Dr.          Sana Klinikum Offenbach GmbH Recruiting Offenbach, Germany, 63069 Principal Investigator: Thomas Haist, Dr.          Sub-Investigator: Mate Knabe, Dr.          Universitätsklinikum Regensburg Recruiting Regensburg, Germany, 93053 Contact: Felix Steger, Dr.          Principal Investigator: Felix Steger, Dr.          Sub-Investigator: Matthias Hautmann, Dr.          Universitätsmedizin Rostock Recruiting Rostock, Germany, 18059 Contact: Guido Hildebrandt, Prof.          Principal Investigator: Guido Hildebrandt, Prof.          Sub-Investigator: Marcella Szücs, Dr.          Klinikum Stuttgart Recruiting Stuttgart, Germany, 70174 Contact: Gerald Illerhaus, Professor          Principal Investigator: Gerald Illerhaus, Gerald, Prof., Professor          Sub-Investigator: Pascale Regincos, Dr.          Robert-Bosch-Krankenhaus Stuttgart Recruiting Stuttgart, Germany, 70376 Contact: Annette Steckkönig, Dr.          Principal Investigator: Annette Steckkönig, Dr.          Sub-Investigator: Anette Hoferer, Dr.          Klinikum Mutterhaus Recruiting Trier, Germany, 54290 Contact: Rolf Mahlberg, Dr.          Principal Investigator: Rolf Mahlberg, Dr.          Sub-Investigator: Stefan Heidel, Dr.          Universitätsklinikum Würzburg Recruiting Würzburg, Germany Principal Investigator: Burkhard von Rahden, PD Dr.          Principal Investigator: Volker Kunzmann, Professor Less <<
NCT00408551 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Unknown - United States, Indiana ... More >> Center for Cancer Care at Goshen General Hospital Recruiting Goshen, Indiana, United States, 46526 Contact: Clinical Trials Office - Center for Cancer Care at Goshen Gene    574-535-2858 Less <<
NCT01380600 Carcinoma, Colorectal Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01418742 Colorectal Carcinoma Phase 2 Terminated(Recruitement did no... More >>t meet expectations. Prev. differentiation of RAS-wild-type and mutated RAS are not in accordance with the scientific rank anymore.) Less << - Germany ... More >> DRK Kliniken Berlin / Köpenick, Klinik für Chirurgie Berlin, Germany, 12559 Onkologische Schwerpunktpraxis Berlin, Germany, 13055 Medizinisches Versorgungszentrum Ärzteforum Seestraße Berlin, Germany, 13347 Charité Campus Virchow Klinikum (CVK), Centrum für Tumormedizin, Medizinische Klinik mit Schwerpunkt Hämatologie u. Onkologie Berlin, Germany, 13355 Ärzteforum Bernau Bernau, Germany, 16321 Onkologische Schwerpunktpraxis Brandenburg, Germany, 14770 Städtisches Klinikum Dessau, Hömatologie und Internistische Onkologie Dessau, Germany, 06847 St. Georg Klinikum Eisenach gGmbH, Klinik für Innere Medizin 2 Eisenach, Germany, 99817 Krankenhaus St. Elisabeth u. St. Barbara, Klinik für Allgemein- u. Visceralchirurgie Halle, Germany, 06110 Ärzteforum Hennigsdorf Hennigsdorf, Germany, 16761 eps-early phase GmbH Jena, Germany, 07743 Klinikum Dorothea Christiane Erxleben Quedlinburg gGmbH, Klinik f. Allgemein, Vizeral- und Gefäßchirurgie Quedlinburg, Germany, 06484 Less <<
NCT02425683 Colorectal Neoplasms ... More >> Adenocarcinoma of the Colon Adenocarcinoma of the Rectum Less << Phase 2 Terminated(insufficient accrua... More >>l) Less << - United States, Florida ... More >> 24 Sites Including Dallas, TX, Ocala, FL, Denver, CO, Florida, United States Less <<
NCT01080547 Length of Stay ... More >> Complications Adverse Drug Event Quality of Life Hospital Costs Less << Phase 3 Completed - China, Zhejiang ... More >> Second Affiliated Hospital Zhejiang University College of Medicine Hangzhou, Zhejiang, China, 310999 People's Hospital of Shaoxing Shaoxing, Zhejiang, China, 312000 Less <<
NCT02619435 Advanced Colorectal Cancer Phase 2 Recruiting November 2018 Italy ... More >> AO G. Rummo Not yet recruiting Benevento, Italy Istituto Nazionale Tumori Fondazione G. Pascale Recruiting Napoli, Italy Seconda Università di Napoli Not yet recruiting Napoli, Italy AO S. Carlo Not yet recruiting Potenza, Italy Less <<
NCT00403130 - Completed - -
NCT00116506 Colorectal Cancer ... More >> Neoplasm Metastasis Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusett General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01802684 Unresectable Metastatic Colore... More >>ctal Cancer Less << Phase 2 Completed - France ... More >> Polyclinique de Bordeaux Nord Bordeaux, France, 33300 Hôpital Henri Mondor Créteil, France, 94010 CHU Dupuytren Limoges, France, 87042 Hôpital Privé Jean Mermoz Lyon, France, 69008 CH Mont de Marsan Paris, France, 40000 Hôpital Saint-Antoine Paris, France, 75012 Hôpital Pitié Salpêtrière Paris, France, 75013 Institut Mutualiste Montsouris Paris, France, 75014 Less <<
NCT00826800 Colon Cancer Not Applicable Terminated(Lack of accrual) - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT00403130 Breast Cancer ... More >> Metastatic Breast Cancer Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02355379 Colonic Adenocarcinoma Phase 3 Recruiting August 2025 -
NCT00826800 - Terminated(Lack of accrual) - -
NCT02243358 Pancreas Neoplasm Malignant Re... More >>sectable Less << Phase 2 Unknown - United States, Michigan ... More >> Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Tiffany Pearce, BS    313-916-1784    tpearce1@hfhs.org    Contact: Jennifer Carabio, BS    313-916-1827    jcarabi1@hfhs.org    Principal Investigator: Gazala Kahn, MD Less <<
NCT03631615 Gastric Adenocarcinoma Phase 2 Not yet recruiting October 2020 China, Shanghai ... More >> Zhongshan Hospital Affiliated to Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Tianshu Liu, Doctor       liu.tianshu@zs-hospital.sh.cn    Sub-Investigator: Yiyi Yu, master Less <<
NCT02460198 Colorectal Carcinoma Phase 2 Active, not recruiting September 9, 2019 -
NCT03405272 Metastatic Colorectal Cancer Phase 2 Not yet recruiting December 1, 2019 -
NCT01035437 Esophageal Neoplasm Not Applicable Withdrawn(no accrual) - -
NCT02231723 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Active, not recruiting - United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, Georgia Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Nevada Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 United States, Ohio The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Tennessee The University of Tennessee Medical Center Knoxville, Tennessee, United States, 37920 United States, Texas Texas Oncology - Austin Midtown Austin, Texas, United States, 78705 Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas, Texas, United States, 75246 Texas Oncology - SAT&BC San Antonio, Texas, United States, 78216 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 Less <<
NCT02921256 Rectal Adenocarcinoma ... More >> Stage II Rectal Cancer AJCC v7 Stage III Rectal Cancer AJCC v7 Less << Phase 2 Recruiting - -
NCT00539617 - Terminated(For slow accrual) - -
NCT02102022 Advanced Gastrointestinal (GI)... More >> Malignancies Hepatocellular Carcinoma Gastric Cancer Colorectal Cancer Less << Phase 1 Phase 2 Recruiting October 2019 United States, California ... More >> California Pacific Medical Center Recruiting San Francisco, California, United States, 94115 Contact: Ari Baron, MD          Principal Investigator: Ari Baron, MD          United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Mehmet Akce, MD          Principal Investigator: Mehmet Akce, MD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Benjamin Tan, MD          Principal Investigator: Benjamin Tan, MD          United States, New York Memorial Sloan-Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: James Harding, MD          Principal Investigator: James Harding, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Gina Vaccaro, MD          Principal Investigator: Gina Vaccaro, MD          United States, Washington University of Washington Recruiting Seattle, Washington, United States, 98109 Contact: Stacey Cohen          Principal Investigator: Stacey Cohen, MD          Taiwan Chang Gung Medical Foundation - Kaohsiung Recruiting Kaohsiung, Taiwan, 833 Contact: Kung-Ming Rau, M.D.          National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Chia-Jui Yen, M.D.          Mackay Memorial Hospital Recruiting Taipei, Taiwan, 10491 Contact: Tsang-En Wang, M.D.          Taipei Veterans General Hospital Recruiting Taipei, Taiwan Contact: Yee Chao, M.D.          Tri-Service General Hospital Recruiting Taipei, Taiwan Contact: Yee Chao, MD          Chang Gung Medical Foundation - Linkou Recruiting Taoyuan, Taiwan Contact: Tsai-Sheng Yang, MD          United Kingdom Royal Free Hospital Recruiting London, United Kingdom, NW3 2QG Contact: Timothy Meyer, MD Less <<
NCT03061058 Stomach Neoplasms ... More >> Chemotherapy Effect Chemotherapeutic Toxicity Less << Phase 3 Recruiting December 2019 China, Anhui ... More >> Ma'anshan People's Hospital Recruiting Ma'anshan, Anhui, China Contact: Fenglin Zhang, MD          Contact: Fangbo Cui, MD          China, Jiangsu Jiangyin People's Hospital Recruiting Jiangyin, Jiangsu, China Contact: Weisheng Shen, MD          Contact: Lei Xi, MD          Nanjing Gaochun People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Rongfu Wei, MD          Contact: Yajun Xin, MD          Nanjing Lishui People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Chunlan Nie, MD          Contact: Hui Xu, MD          The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang, MD,PhD,MSCR    0086-18602568379    wing_young7@hotmail.com    Contact: Baorui Liu, MD, PhD    0086-13770621908    baoruiliu07@163.com    Suqian People's Hospital Recruiting Suqian, Jiangsu, China Contact: Chuanwen You, MD          Contact: Qing Zhu, MD          Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China Contact: Sanyuan Sun, MD          Contact: Yuan Yuan, MD          Affiliated Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China Contact: Xiaoqing Li, MD          Contact: Meilian Cheng, MD Less <<
NCT03376958 Relapsed /Refractory Diffuse L... More >>arge B Cell Lymphoma Less << Phase 4 Recruiting February 1, 2019 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com Less <<
NCT00539617 Esophageal Cancer Phase 2 Terminated(For slow accrual) - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT03487016 Metastatic Pancreatic Cancer Phase 2 Not yet recruiting June 2023 -
NCT00265811 Colorectal Cancer Phase 3 Completed - France ... More >> Hopital Duffaut Avignon, France, 84902 CHU de Caen Caen, France, 14033 Hopital Robert Boulin Libourne, France, 33500 Hopital Bichat - Claude Bernard Paris, France, 75018 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Centre Hospitalier Yves Le Foll Saint Brieuc Cedex 1, France, BP 2367 Nouvelle Clinique Generale Valence, France, 26000 Less <<
NCT03221426 Gastric Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 3 Recruiting July 26, 2023 -
NCT02125136 Ductal Adenocarcinoma of the P... More >>ancreas Less << Phase 2 Recruiting October 2020 Germany ... More >> Universitätsklinikum Würzburg/Comprehensive Cancer Center Mainfranken Recruiting Würzburg, Bayern, Germany, 97080 Contact: Volker Kunzmann, Prof. Dr.       kunzmann_v@medizin.uni-wuerzburg.de    Principal Investigator: Volker Kunzmann, Prof. Dr. Less <<
NCT00406302 Carcinoma, Non-small-cell Lung Phase 2 Completed - Austria ... More >> University Hospital, Internal Medicine Innsbruck, Tirol, Austria, A-6020 Hosptial Kufstein Kufstein, Tirol, Austria, A-6330 Hospital Natters Natters, Tirol, Austria, A-6161 Hospital Zams Zams, Tirol, Austria, A-6511 Prim. Dr. Bolitschek Linz, Austria, A-4010 Prim. Dr. H. Schinko Linz, Austria, A-4020 OA Dr. Rainer Kolb Wels, Austria, A-4600 Less <<
NCT02862535 Gastric Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Less << Phase 1 Active, not recruiting July 2019 Japan ... More >> Nagoya, Japan Osaka, Japan Tokyo, Japan Less <<
NCT01417494 Colorectal Cancer Phase 2 Completed - France ... More >> Hôpital Avicenne Bobigny, France, 93000 Less <<
NCT01878422 Metastatic Colorectal Cancer Phase 3 Completed - Italy ... More >> Dipartimento Oncologia Ematologia - Policlinico S.Orsola-Malpighi - Università di Bologna Bologna, BO, Italy Ist. di Ematologia e Oncologia Medica "L. e A. Seragnoli" - Università di Bologna Bologna, BO, Italy Ospedale Bellaria-Maggiore, AUSL Città di Bologna Bologna, BO, Italy P.O. San lazzaro Alba, CN, Italy Ospedale Buffalini - ASL Cesena Cesena, FC, Italy Irccs Irst Meldola (FC), FC, Italy, 47014 Azienda Ospedaliero - Università di Ferrara Ferrara, FE, Italy Ospedale Vito Fazzi Lecce, LE, Italy Ospedale Ramazzini - ASL Modena Carpi, MO, Italy Centro Oncologico Modenese - Policlinico di Modena Modena, MO, Italy Ospedale degli Infermi - AUSL di Ravenna Faenza, RA, Italy Ospedale Civile di Lugo -AUSL di Ravenna Lugo, RA, Italy Ospedale S.Maria delle Croci Ravenna, RA, Italy ospedale Civile Cattolica Cattolica, RN, Italy Ospedale Infermi - Azienda USL di Rimini Rimini, RN, Italy AOU S.Giovanni Battista di Torino (Molinette) Presidio San Lazzaro Torino, TO, Italy Azienda Sanitaria Ospedaliera S. Giovanni Battista - Molinette Torino, TO, Italy Ospedale Cardinal Massaia Asti, Italy Azienda ULSS 1 di Belluno Belluno, Italy Ospedale A.Perrino Brindisi, Italy Azienda Osp. Maggiore della Carità Novara, Italy Azienda Ospedaliero Universitaria di Parma Parma, Italy Ospedale di Piacenza, ASL Piacenza Piacenza, Italy Less <<
NCT00442637 Colorectal Cancer Metastatic Phase 3 Unknown December 2013 Netherlands ... More >> University Medical Center Nijmegen Nijmegen, Gelderland, Netherlands Less <<
NCT02613221 Colorectal Cancer Phase 1 Phase 2 Completed - Japan ... More >> Nagoya, Aichi, Japan Kashiwa, Chiba, Japan Matsuyama, Ehime, Japan Kitakyushu, Fukuoka, Japan Kurume, Fukuoka, Japan Hakodate, Hokkaido, Japan Kushiro, Hokkaido, Japan Sapporo, Hokkaido, Japan Amagasaki, Hyogo, Japan Kobe, Hyogo, Japan Tsukuba, Ibaragi, Japan Kasama, Ibaraki, Japan Miki-cho, Kagawa, Japan Sagamihara, Kanagawa, Japan Osaki, Miyagi, Japan Matsumoto, Nagano, Japan Sasebo, Nagasaki, Japan Yamatotakada, Nara, Japan Takatsuki, Osaka, Japan Ina, Saitama, Japan Shizuoka, Shizioka, Japan Nagaizumi, Shizuoka, Japan Kouto-ku, Tokyo, Japan Minato-ku, Tokyo, Japan Chiba, Japan Fukui, Japan Fukuoka, Japan Kumamoto, Japan Okayama, Japan Okinawa, Japan Osaka, Japan Toyama, Japan Less <<
NCT00735241 Colorectal Carcinoma ... More >> Liver Metastases Less << Phase 2 Phase 3 Withdrawn(Withdrawn by the stu... More >>dy sponsor.) Less << March 2009 United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28208 United States, Washington Sacred Heart Medical Center Spokane, Washington, United States, 99204 Less <<
NCT00813137 Colorectal Neoplasms Phase 2 Unknown October 2010 China, Jiangsu ... More >> The Affiliated Changzhou Tumor Hospital of Suzhou University Recruiting Changzhou, Jiangsu, China, 213000 Contact: Joe, M.D.       joeton@21cn.com    Principal Investigator: Yang Ling, M.D, Ph.D          The Affiliated Zhongda Hospital of Southeast University Active, not recruiting Nanjing, Jiangsu, China Less <<
NCT02741388 B-cell Lymphoma Phase 1 Recruiting June 2020 Belgium ... More >> Institut Jules Bordet Recruiting Bruxelles, Belgium Contact: Marie MAEREVOET, MD    +32 25 41 32 12       Principal Investigator: Marie MAEREVOET, MD          France CHU Dijon Recruiting Dijon, France Contact: Olivier CASASNOVAS, MD    +33380295041       Principal Investigator: Olivier CASASNOVAS, MD          CHRU de Lille - Hôpital Claude Huriez Recruiting Lille, France Contact: Franck MORSCHHAUSER, MD    +33320445713       Principal Investigator: Franck MORSCHHAUSER, MD          CHU Montpellier - Hôpital Saint Eloi Recruiting Montpellier, France Contact: Guillaume CARTRON, MD    +33467338079       Principal Investigator: Guillaume CARTRON, MD          CHU Nancy - Hôpital de Brabois Recruiting Nancy, France Contact: Pierre FEUGIER, MD    +33383153282       Principal Investigator: Pierre FEUGIER, MD          Hôpital Saint-Louis Recruiting Paris, France Contact: Catherine THIEBLEMONT, MD    +33142499236       Principal Investigator: Catherine THIEBLEMONT, MD          CHU Bordeaux - Centre François Magendie Recruiting Pessac, France Contact: Kamal BOUABDALLAH    +33557656511       Principal Investigator: Kamal BOUABDALLAH, MD          Centre Henri Becquerel Recruiting Rouen, France Contact: Hervé TILLY, MD    +33232082202       Principal Investigator: Hervé TILLY, MD Less <<
NCT03563248 Pancreatic Cancer Phase 2 Recruiting December 31, 2025 United States, Colorado ... More >> University of Colorado Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Wells Messersmith, MD       wells.messermith@ucdenver.edu    Principal Investigator: Wells Messersmith, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Theodore S. Hong, MD    617-724-4000    tshong1@mgh.harvard.edu    Principal Investigator: Theodore S. Hong, MD          Brigham and Women's Hospital Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Brian M. Wolpin, MD       bwolpin@partners.org    Principal Investigator: Brian M. Wolpin, MD          Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Brian M Wolpin, MD       bwolpin@partners.org    Principal Investigator: Brian M Wolpin, MD          Newton Wellesley Hospital Recruiting Newton, Massachusetts, United States, 02462 Contact: Lawrence Blaszkowsky, MD       lblaszkowsky@partners.org    Principal Investigator: Lawrence Blaszkowsky, MD          United States, New York New York University Langone Medical Center Recruiting New York, New York, United States, 10016 Contact: Paul Oberstein, MD       paul.oberstein@nyulangone.org    Principal Investigator: Paul Oberstein, MD Less <<
NCT01839877 Colorectal Cancer With Non Res... More >>ectable Hepatic Metastasis Less << Phase 2 Active, not recruiting January 2019 France ... More >> Hopital Saint André Bordeaux, France, 33075 CHU Dijon, France CHU-Hôpital Michallon Grenoble, France Hôpital Prive Jean Mermoz Lyon, France, 69008 Centre Léon Berard Lyon, France, 69373 Hôpital Edouard Herriot Lyon, France Institut Paoli Calmette Marseille, France, 13273 CHU de la TIMONE Marseille, France, 13385 Hôpital Europeen G Pompidou Paris, France, 75015 Cochin Paris, France Hôpital Saint Joseph Paris, France Hôpital de la Milétrie Poitiers, France, 86021 CHU Charles Nicolle Rouen, France, 76031 Hôpital Rangueil Toulouse, France, 31059 Less <<
NCT03469557 Esophageal, Gastric, or Gastro... More >>esophageal Junction Carcinoma Less << Phase 2 Recruiting March 23, 2019 China, Beijing ... More >> The 307th Hospital of Military Chinese People's Liberation Army Recruiting Beijing, Beijing, China, 100071 Contact: Jinchao Hu, BS    86-10-66947797    jgb947797@163.com    Principal Investigator: Jianming Xu, MD          China, Heilongjiang The Tumor Hospital Affiliated to Harbin Medical University Recruiting Ha'erbin, Heilongjiang, China, 150006 Contact: Weilu Liu, BS    86-451-86298104    sylcyj609@163.com    Principal Investigator: Yuxian Bai, MD          China, Hubei Tongji Medical College Huanzhong University of Science&Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Chang Shu, BS    86-27-83663625    lsjhe12345@163.com    Principal Investigator: Xianglin Yuan, MD          China, Jiangsu Clinical Medical School, Yangzhou University Affliated Hospital to Yangzhou University Recruiting Yangzhou, Jiangsu, China, 225001 Contact: Hua Zhu, BS    86-1805106131    yzsbhgcp@163.com    Principal Investigator: Buhai Wang, MD          China, Shanxi The First Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710000 Contact: Mingying Lu, BS    86-29-85324094    Lumy3215@163.com    Principal Investigator: Xiaoen Li, MD          China, Zhejiang The First Affiliated Hospital, Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 Contact: Lihua Wu, BS    86-571-87236560    zyct79@163.com    Principal Investigator: Nong Xu, MD Less <<
NCT02211443 Metastatic Colorectal Cancer Phase 1 Unknown December 2015 -
NCT03152370 Neoadjuvant Therapy in Rectal ... More >>Cancer Less << Phase 1 Recruiting January 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 United States, New York Weill Cornell Recruiting New York, New York, United States, 10065 Poland Marie-Skodowska Curie Cancer Centre Recruiting Warsaw, Poland United Kingdom The Christie Recruiting Manchester, United Kingdom Mount Vernon Hospital Recruiting Northwood, United Kingdom Less <<
NCT02620865 Metastatic Pancreatic Adenocar... More >>cinoma Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 1 Phase 2 Active, not recruiting December 2018 United States, Michigan ... More >> Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT03607643 Cancer of Pancreas ... More >> Cancer of Liver Cancer of Rectum Cancer of Colon Cancer, Gall Bladder Myeloma Multiple Glioblastoma Multiforme Less << Phase 1 Phase 2 Not yet recruiting December 15, 2020 United States, Florida ... More >> Southwest Cancer Center Not yet recruiting Orlando, Florida, United States, 32806 Contact: Sarah Katta, DO    407-426-8660    sarahfk1978@yahoo.com    Contact: Philip Arlen, PhD    407-443-0656    parlen@leafvertical.com Less <<
NCT01972490 Colorectal Neoplasms Phase 4 Unknown March 2016 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200000 Contact: jianmin xu, MD    008613501984869    xujmin@aliyun.com Less <<
NCT01564810 Colorectal Neoplasms ... More >> Neoplasm Metastasis Liver Neoplasms Less << Phase 4 Unknown September 2015 China, Shanghai ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200000 Contact: jianmin xu , doctor    008613501984869    xujmin@yahoo.com.cn Less <<
NCT00081289 Colorectal Cancer Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Florida Baptist-South Miami Regional Cancer Program Miami, Florida, United States, 33176 United States, Illinois Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 United States, New Jersey Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton Marlton, New Jersey, United States, 08053 United States, Pennsylvania Northeast Radiation Oncology Center Dunmore, Pennsylvania, United States, 18512 Less <<
NCT03563157 Colorectal Cancer Metastatic ... More >> mCRC Less << Phase 1 Phase 2 Recruiting December 30, 2021 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Less <<
NCT03721653 Metastatic Colorectal Cancer Phase 2 Not yet recruiting April 15, 2021 Italy ... More >> Francesca Vannini Not yet recruiting Pisa, Italia, Italy, 56126 Contact: Francesca Vannini, Biology    050992192    vannini.fr@gmail.com    Principal Investigator: Chiara Cremolini, MD Less <<
NCT03136406 Pancreatic Cancer Phase 1 Phase 2 Active, not recruiting December 2018 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT00890305 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00081289 - Completed - -
NCT00911222 - Completed - Germany ... More >> iOMEDICO AG Freiburg, Baden-Württemberg, Germany, 79108 Less <<
NCT03586869 Pancreatic Cancer Phase 1 Phase 2 Recruiting May 2020 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Less <<
NCT01108107 Colon Cancer Phase 2 Completed - Denmark ... More >> Department of Oncology, Herlev Hospital Herlev, Denmark, DK-2730 Dept. of Oncology, Hilleroed Hospital Hilleroed, Denmark, 3400 Department of Oncology, Vejle Hospital Vejle, Denmark, DK-7100 Less <<
NCT00454636 Gastric Cancer Phase 2 Completed - -
NCT02445209 HER2 Negative Gastric Cancer Phase 3 Completed - -
NCT03169738 Non-small Cell Lung Cancer Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT00609336 - Completed - -
NCT00609336 Adenocarcinoma of the Pancreas... More >> Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00809796 Colorectal Cancer Phase 1 Phase 2 Completed - Canada, Quebec ... More >> Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT02226380 Gastric Cancer ... More >> Effects of Chemotherapy Surgery Less << Phase 2 Unknown - China, Beijing ... More >> Department of Oncology and Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100032 Contact: Xiang Wang, Master    +86(10)69158315    wangxiang5123@126.com    Principal Investigator: Xiao yi Li, Doctor          Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100032 Contact: Xiao yi Li, Mater    +86(10)69154910    li.xiaoyi@263.net Less <<
NCT00454636 - Completed - -
NCT01588990 Colorectal Neoplasms Phase 4 Completed - Australia, Australian Capital ... More >>Territory Canberra Hospital Garran, Australian Capital Territory, Australia, 2605 Australia, New South Wales Macarthur Cancer Therapy Centre Campbelltown, New South Wales, Australia, 2560 Chris O'Brien Lifehouse Camperdown, New South Wales, Australia, 2050 St Vincent'S Hospital; Clinical Oncology Darlinghurst, New South Wales, Australia, 2010 Mid North Coast Cancer Institute Port Macquarie, New South Wales, Australia, 2444 Royal North Shore Hospital; Department of Medical Oncology St Leonards, New South Wales, Australia, 2065 Sydney Adventist Hospital; Clinical Trial Unit Sydney, New South Wales, Australia, 2076 Australia, Queensland Royal Brisbane Hospital Brisbane, Queensland, Australia, 4029 Rockhampton Hospital Rockhampton, Queensland, Australia, 4700 The Townsville Hospital; Townsville Cancer Centre Townsville, Queensland, Australia, 4812 Australia, South Australia Lyell McEwin Hospital; Oncology Clinical Trials, Chemotherapy Day Unit Elizabeth Vale, South Australia, Australia, 5112 Calvary North Adelaide; North Adeliade Oncology Centre North Adelaide, South Australia, Australia, 5006 Australia, Tasmania Launceston General Hospital Launceston, Tasmania, Australia, 7250 Australia, Victoria Austin Hospital; Medical Oncology Heidelberg, Victoria, Australia, 3084 Sunshine Hospital; Oncology Research St Albans, Victoria, Australia Australia, Western Australia St John of God Murdoch Hospital; Oncology West Murdoch, Western Australia, Australia, 6150 St John of God Hospital; Bendat Cancer Centre Subiaco, Western Australia, Australia, 6008 Less <<
NCT02909478 Chemotherapy-induced Nausea an... More >>d Vomiting Colorectal Cancer Less << Phase 3 Unknown - -
NCT03169777 Colorectal Cancer Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT01490866 - Completed - -
NCT00003260 Colorectal Cancer Phase 3 Unknown - France ... More >> Hopital Saint Antoine Paris, France, 75571 Less <<
NCT03646591 - Completed - China, Shanhgai ... More >> Ruijin Hospital Shanghai, Shanhgai, China, 200025 Less <<
NCT01822444 - Active, not recruiting - Germany ... More >> Private Practice Oncology Speyer, Rhineland-Palatinate, Germany Medizinische Klinik III, Universitaetsklinikum Aachen, Germany Onkologisches Zentrum Deggendorf, Germany University Hospital Saarland Homburg, Germany Gemeinschaftspraxis Haematologie/Onkologie Lebach, Germany Kilnikum Ludwigsburg Ludwigsburg, Germany Medizinische Klinik and Poliklinik Mainz Mainz, Germany Univeritaetsmedizin Mannheim Mannheim, Germany Ireland Bon Secours Hospital Cork, Ireland Cork University Hospital Cork, Ireland St Vincent's University Hospital Dublin, Ireland, D4 Beaumont Hospital Dublin, Ireland St James Hospital Dublin, Ireland The Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland Galway University Hospital Galway, Ireland Sligo General Hospital Sligo, Ireland Waterford Regional Hospital Waterford, Ireland Less <<
NCT02704520 Rectal Cancer Phase 2 Phase 3 Recruiting December 2021 United Kingdom ... More >> Hampshire Hospitals NHS Foundation Trust Recruiting Basingstoke, Hampshire, United Kingdom, RG24 9NA Contact: Megan Topping    01256 313918    megan.topping@hhft.nhs.uk    Contact: Caroline Palmer    01256 313918    caroline.palmer@hhft.nhs.uk    Principal Investigator: Brendan Moran, MD          Sub-Investigator: Mit Dattani, MD          Salisbury NHS Foundation Trust Recruiting Salisbury, Wiltshire, United Kingdom, SP2 8BJ Contact: Sophia Strong-Sheldrake    01722 336262 ext 4191    sophia.strong-sheldrake@salisbury.nhs.uk    Contact: Julie Attlee    01722 336262 ext 4191    julie.attlee@salisbury.nhs.uk    Principal Investigator: Graham Branagan, MD          Sub-Investigator: Alaaeldin Shablak, MD          Bristol Royal Infirmary Recruiting Bristol, United Kingdom, BS2 8ED Contact: Robert Hollister    +44 1173426742    robert.hollister@uhbristol.nhs.uk    Principal Investigator: Stephen Falk, MD          Colchester General Hospital Recruiting Colchester, United Kingdom, CO4 5JL Contact: Lucy Thorogood    +44 1206 745 355    lucy.thorogood@colchesterhospital.nhs.uk    Contact: Celine Driscoll    +44 1206 745 355    celine.driscoll@colchesterhospital.nhs.uk    Principal Investigator: Bruce Sizer, MD          NHS Lanarkshire - Hairmyres Hospital Recruiting East Kilbride, United Kingdom, G75 8RG Contact: Louise Devlin    +44 1355 585329    louise.devlin@lanarkshire.scot.nhs.uk    Contact: Angela Scullion    +44 1355 585 329    angela.scullion@lanarkshire.scot.nhs.uk    Principal Investigator: Cindy Chew, MD          Diana Princess of Wales Hospital Recruiting Grimsby, United Kingdom, DN33 2BA Contact: Jonathan Hatton    +44 3033 303555    jonathan.hatton@nhs.net    Principal Investigator: Rajarshi Roy, MD          University Hospital of North Tees Recruiting Stockton-on-Tees, United Kingdom, TS19 8PE Contact: Helen Wilson    +44 1642 383 277    Helen.Wilson2@nth.nhs.uk    Contact: Lynda Poole    +44 1642 383 277    Lynda.Poole@nth.nhs.uk    Principal Investigator: David Wilson, MD          Royal Marsden NHS Foundation Trust Recruiting Sutton, United Kingdom, SM2 5PT Contact: Michelle Frost    44 (0) 208 915 6067    michelle.frost@rmh.nhs.uk    Contact: Ceri Evans    44 (0)208 642 6011 ext 4280    ceri.evans@rmh.nhs.uk    Principal Investigator: Sheela Rao, MD Less <<
NCT00974389 Colorectal Cancer Phase 2 Unknown - Japan ... More >> Osaka Medical College Recruiting Takatsuki, Osaka, Japan, 569-8686 Contact: Hiroya Takiuchi, MD, PhD    81-72-683-1221 Less <<
NCT01882868 Colorectal Cancer Metastatic Phase 2 Completed - Japan ... More >> Investigational Site Number 392011 Chiba-Shi, Japan Investigational Site Number 392018 Chuo-Ku, Japan Investigational Site Number 392016 Fukuoka-Shi, Japan Investigational Site Number 392017 Fukuoka-Shi, Japan Investigational Site Number 392001 Kashiwa-Shi, Japan Investigational Site Number 392019 Kawasaki-Shi, Japan Investigational Site Number 392015 Matsuyama-Shi, Japan Investigational Site Number 392013 Mitaka-Shi, Japan Investigational Site Number 392004 Nagoya-Shi, Japan Investigational Site Number 392006 Osaka-Shi, Japan Investigational Site Number 392014 Sagamihara-Shi, Japan Investigational Site Number 392008 Sapporo-Shi, Japan Investigational Site Number 392003 Sendai-Shi, Japan Investigational Site Number 392009 Shimotsuke-Shi, Japan Investigational Site Number 392012 Shinjuku-Ku, Japan Investigational Site Number 392005 Suita-Shi, Japan Investigational Site Number 392002 Sunto-Gun, Japan Investigational Site Number 392010 Tsukuba-Shi, Japan Investigational Site Number 392007 Yufu-Shi, Japan Less <<
NCT01490866 Colorectal Cancer Phase 2 Completed - United States, Arkansas ... More >> NEA Baptist Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists-North St. Petersburg, Florida, United States, 33705 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Oncology Hematology of SW Indiana Newburgh, Indiana, United States, 47630 Hope Cancer Center Terre Haute, Indiana, United States, 47802 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New Jersey Atlantic Health System Summit, New Jersey, United States, 07901 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Texas Health Physician Group Dallas, Texas, United States, 75243 Less <<
NCT03511963 Metastatic Colorectal Cancer (... More >>mCRC) Less << Phase 3 Recruiting April 30, 2020 China, Jiangsu ... More >> Nanjing Bayi Hospital Ethics Committee Recruiting Nanjing, Jiangsu, China, 210002 Contact: Linhua Luo    86-025-80864362    luolinhua0513@163.com    Principal Investigator: Shukui Qin Less <<
NCT01362127 Carcinoma, Squamous Cell ... More >> Adenocarcinoma of the Esophagus and Gastric Cardia Less << Phase 2 Active, not recruiting June 2018 Sweden ... More >> Gastrocentrum. Department of surgery, Karolinska University Hospital Stockholm, Sweden, 14186 Less <<
NCT00494221 Metastatic Colorectal Cancer Phase 1 Phase 2 Completed - Japan ... More >> Research Site Osaka, Japan Research Site Saitama, Japan Less <<
NCT01882868 - Completed - -
NCT00335816 Colorectal Cancer Phase 2 Active, not recruiting December 2019 United States, California ... More >> Cancer Care Center at John Muir Health - Concord Campus Concord, California, United States, 94524-4110 City of Hope Medical Center Duarte, California, United States, 91010-3000 St. Joseph Hospital Regional Cancer Center - Orange Orange, California, United States, 92868-3849 Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States, 92868 UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, District of Columbia Washington Cancer Institute at Washington Hospital Center Washington, District of Columbia, United States, 20010 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, Nebraska Colon and Rectal Surgery, Incorporated Omaha, Nebraska, United States, 68114 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 United States, Vermont Vermont Cancer Center at University of Vermont Burlington, Vermont, United States, 05405-0110 Canada, Alberta Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Less <<
NCT01077739 Colorectal Cancer Phase 2 Completed - Belgium ... More >> Aalst, Belgium, 9300 Arlon, Belgium, 6700 Assebroek, Belgium, 8310 AYE, Belgium, 6900 Bonheiden, Belgium, 2820 Brasschaat, Belgium, 2930 Brugge, Belgium, 8000 Bruxelles, Belgium, 1020 Bruxelles, Belgium, 1180 Bruxelles, Belgium, 1200 Charleroi, Belgium, 6000 Dendermonde, Belgium, 9200 Edegem, Belgium, 2650 Genk, Belgium, 3600 Gent, Belgium, 9000 Hasselt, Belgium, 3500 Kortrijk, Belgium, 8500 Mechelen, Belgium, 2800 Merksem, Belgium, 2170 Mont-godinne, Belgium, 5530 Montigny-le-Tilleul, Belgium, 6110 Namur, Belgium, 5000 Oostende, Belgium, 8400 Sint-Niklaas, Belgium, 9100 Tournai, Belgium, 7500 Turnhout, Belgium, 2300 Verviers, Belgium, 4800 Wilrijk, Belgium, 2610 Less <<
NCT01344304 Colorectal Cancer Not Applicable Unknown March 2014 Japan ... More >> Kansai Rosai Hospital Recruiting Amagasaki, Hyogo, Japan, 6600064 Contact: Rei Suzuki          Kinki Central Hospital Recruiting Itami, Hyogo, Japan, 6640872 Contact: Takamichi Komori          Kawasaki Hospital Recruiting Kobe, Hyogo, Japan, 6520042 Contact: Toshihiro Kimura          Nara Hospital Kinki University Faculty of Medicine Recruiting Ikoma, Nara, Japan, 6300293 Contact: Kotaro Kitani          Higashiosaka City General Hospital Recruiting Higashi-Osaka, Osaka, Japan, 5788588 Contact: Masaki Okuyama          Saito Yukoukai Hospital Recruiting Ibaraki, Osaka, Japan, 5670085 Contact: Taro Hayashi    0726416898       Rinku General Medical Center Recruiting Izumisano, Osaka, Japan, 5988577 Contact: Hitoshi Mizuno          Kaizuka City Hospital Recruiting Kaizuka, Osaka, Japan, 5970015 Contact: Hiroshi Nakano          Hannan Chuo Hospital Recruiting Matsubara, Osaka, Japan, 5800023 Contact: Isao Arai          Minoh City Hospital Recruiting Minoo, Osaka, Japan, 5620014 Contact: Yasuhiro Miyake          Sakai City Hospital Recruiting Sakai, Osaka, Japan, 5900064 Contact: Hiroyoshi Takemoto          Osaka Rosai Hospital Recruiting Sakai, Osaka, Japan, 5918025 Contact: Hajime Hirose          Suita Municipal Hospital Recruiting Suita, Osaka, Japan, 5640082 Contact: Takashi Yoshino          Saiseikai Senri Hospital Recruiting Suita, Osaka, Japan, 5650862 Contact: Hirofumi Ota          Graduate School of Medicine / Faculty of Medicine, Osaka University Recruiting Suita, Osaka, Japan Contact: Junichi Nishimura       jnishimura@gesurg.med.osaka-u.ac.jp    Toyonaka Municipal Hospital Recruiting Toyonaka, Osaka, Japan, 5608565 Contact: Taishi Hata          Yao Municipal Hospital Recruiting Yao, Osaka, Japan, 5810069 Contact: Yoshihito Ide          Kenporen Osaka Central Hospital Recruiting Osaka, Japan, 5300001 Contact: Masato Yoshikawa    0647955505       Iseikai Hospital Recruiting Osaka, Japan, 5330022 Contact: Takahiko Tanigawa          Osaka Medical Center for Cancer and Cardiovascular Diseases Recruiting Osaka, Japan, 5378511 Contact: Tatsushi Shingai          National Hospital Organization Osaka National Hospital Recruiting Osaka, Japan, 5400006 Contact: Masayoshi Yasui          NTT West Osaka Hospital Recruiting Osaka, Japan, 5430042 Contact: Katsuki Danno          Nissay Hospital Recruiting Osaka, Japan, 5500012 Contact: Shohei Maeda          Tane General Hospital Recruiting Osaka, Japan, 5500024 Contact: Atsuhiro Ogawa          Osaka Seninhoken Hospital Recruiting Osaka, Japan, 5520021 Contact: Yasunori Watanabe          Osaka Koseinenkin Hospital Recruiting Osaka, Japan, 5530003 Contact: Makoto Fujii    06-6441-5451       Osaka General Medical Center Recruiting Osaka, Japan, 5588558 Contact: Hiroshi Tamagawa Less <<
NCT01077739 - Completed - -
NCT00494221 - Completed - -
NCT02654639 - Terminated(Principal investiga... More >>tor left the institution) Less << - -
NCT02269904 DSF Phase 2 Unknown June 2018 China, Heilongjiang ... More >> Heilongjiang Cancer Hospital Recruiting Harebin, Heilongjiang, China, 150000 Contact: Chunfeng Li, Doctor    18745787187    lichunfeng007@163.com    Principal Investigator: Yingwei Xue, Doctor Less <<
NCT00631410 Colorectal Neoplasms Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Suntougun, Shizuoka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan Less <<
NCT02654639 Metastatic Colorectal Cancer Phase 2 Terminated(Principal investiga... More >>tor left the institution) Less << - United States, District of Col... More >>umbia Georgetown University Washington, District of Columbia, United States, 20007 Less <<
NCT00631410 - Completed - -
NCT03374852 Pancreatic Ductal Adenocarcino... More >>ma Less << Phase 2 Withdrawn(PI Left institution ... More >>on 8/6/2018 and study has been final reported with IRB. Never opened to accrual) Less << October 2020 -
NCT01870791 Esophageal Neoplasm ... More >> Gastric Neoplasm Less << Phase 2 Terminated(Interim analysis) - United Kingdom ... More >> University Hospitals of Leicester NHS Trust Leicester, Leicestershire, United Kingdom, LE1 5WW Less <<
NCT02581462 Stomach Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 2 Phase 3 Active, not recruiting March 2021 Germany ... More >> Institute for Clinical Cancer Research Krankenhaus Nordwest Frankfurt, Germany, 60488 Less <<
NCT03167268 Colorectal Cancer Metastatic ... More >> Skin Toxicity Less << Phase 2 Recruiting November 30, 2019 Italy ... More >> Marco Pirovano Recruiting Milano, Italy, 20153 Contact: Marco Pirovano, MD    +390240222108    marco.pirovano@asst-santipaolocarlo.it Less <<
NCT03565029 Colo-rectal Cancer Phase 2 Recruiting December 31, 2022 Italy ... More >> ASST GOM Niguarda Recruiting Milano, Italy, 20162 Contact: Salvatore Siena, MD    +39026444 ext 2291    salvatore.siena@ospedaleniguarda.it    Contact: Silvia ghezzi, Biologist    +39026444 ext 3695    silvia.ghezzi@ospedaleniguarda.it Less <<
NCT03686254 Colorectal Neoplasms Malignant Phase 2 Phase 3 Recruiting October 1, 2023 China, Guangdong ... More >> Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Wangjun Liao    62787731 ext 008620    nfyyliaowj@163.com    Contact: Na Huang    62787736 ext 008620    lala343@126.com Less <<
NCT03414983 Colorectal Cancer Phase 2 Phase 3 Recruiting August 18, 2022 -
NCT01310478 Colorectal Neoplasm Phase 1 Unknown - China, Shanghai ... More >> Shanghai Cancer Center Recruiting Shanghai, Shanghai, China Contact: Zhiyu Chen, MD          Principal Investigator: Jin Li, MD Less <<
NCT03601988 Gastric Cancer Phase 3 Recruiting July 28, 2022 China, Hubei ... More >> Tongji hospital of Tongji Medical College, Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Xianglin Yuan, MD,PHD    8627-83663406 ext 1    xlyuan1020@163.com    Contact: Ping Peng, MD,PHD    8627-83663407 ext 1    pengpingtj@163.com    Principal Investigator: Xianglin Yuan, MD,PHD          Sub-Investigator: Ping Peng, MD,PHD Less <<
NCT03666832 Metastatic Pancreatic Cancer Phase 1 Phase 2 Not yet recruiting December 30, 2019 -
NCT01900717 Metastatic Colorectal Adenocar... More >>cinoma Less << Phase 2 Completed - France ... More >> CHU de Dijon Dijon, France, 21079 Less <<
NCT03590275 - Completed - Italy ... More >> Oncologia ASL BI Ponderano, Biella, Italy, 13875 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Meldola, Forlì Cesena, Italy, 47014 Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia FPO - IRCSS Candiolo, Torino, Italy, 10060 ASL VCO, Ospedale Castelli Verbania Verbania, Torino, Italy, 28922 A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica Pisa, Italy, 56012 P.O. Molinette Oncologia 1 Torino, Italy, 10126 A.O. Ordine Mauriziano Torino, Italy, 10128 Less <<
NCT03412994 Colorectal Neoplasms Phase 2 Not yet recruiting February 28, 2021 -
NCT01991080 Colon Cancer Not Applicable Recruiting December 2018 Israel ... More >> Oncology Institute, Rambam Health Care Campus Recruiting Haifa, Israel, 31096 Contact: Gil Bar Sela, Prof    +972-4-8542791    g_barsela@rambam.health.gov.il    Principal Investigator: Gil Bar Sela, Prof Less <<
NCT01683422 Pancreatic Cancer Phase 2 Recruiting December 2024 United States, California ... More >> Loma Linda University Medical Center Recruiting Loma Linda, California, United States, 92354 Contact: Gary Yang, MD    909-558-4280    gyang@llu.edu    Contact: Proton Referral    1 800 496-4966       Principal Investigator: Gary Yang, MD Less <<
NCT03281369 Gastric Adenocarcinoma or Gast... More >>roesophageal Junction Adenocarcinoma Less << Phase 1 Phase 2 Recruiting November 13, 2021 -
NCT03009058 Metastatic Cancer Phase 1 Phase 2 Terminated(Commercial reasons) - France ... More >> Centre Léon Bérard, Dpt Medecine & INSERM Lyon, France, 69373 Gustave Roussy Cancer Center Villejuif, France, 94805 United Kingdom St George's University of London, Institute of Infection and Immunity London, United Kingdom, SW17 0RE Royal Marsden Hospital Foundation Trust London, United Kingdom, SW3 6JJ Less <<
NCT02000050 Rectal Carcinoma Phase 2 Active, not recruiting July 2019 Italy ... More >> UO Oncologia Medica IRCCS IRST Meldola, FC, Italy, 47014 Oncologia Medica PO RAVENNA; FAENZA; LUGO Ravenna, RA, Italy, 48121 Less <<
NCT00112996 Neurotoxicity ... More >> Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 3 Completed - United States, Arkansas ... More >> Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States, 72913 United States, Indiana Horizon Oncology Center Lafayette, Indiana, United States, 47905 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana Cabrini Center for Cancer Care at Christus St. Frances Cabrini Hospital Alexandria, Louisiana, United States, 71301 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Minnesota CCOP - Metro-Minnesota St. Louis Park, Minnesota, United States, 55416 United States, Missouri Cancer Research for the Ozarks Springfield, Missouri, United States, 65804 United States, Oregon CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 United States, Pennsylvania CCOP - Main Line Health Wynnewood, Pennsylvania, United States, 19096 United States, South Carolina CCOP - Greenville Greenville, South Carolina, United States, 29615 United States, Texas University of Texas M.D. Anderson CCOP Research Base Houston, Texas, United States, 77030-4009 CCOP - Scott and White Hospital Temple, Texas, United States, 76508 United States, Wisconsin Marshfield Clinic - Marshfield Center Marshfield, Wisconsin, United States, 54449 Less <<
NCT01206218 Advanced Gastric Cancer Phase 2 Phase 3 Unknown - -
NCT00172159 Colorectal Cancer Phase 2 Unknown June 2005 Taiwan ... More >> Department of Surgery, National Taiwan University Hospital, No.7, Chung-Shan South Road, Taipei, TAIWAN, R.O.C. Recruiting Taipei, Taiwan, 100 Contact: Jin-Tung Liang, M.D., Ph.D.    886-2-23562068 Less <<
NCT03206073 Colorectal Cancer ... More >> Colorectal Carcinoma Colorectal Adenocarcinoma Refractory Cancer Colorectal Neoplasms Less << Phase 1 Phase 2 Recruiting December 31, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02027363 Colorectal Neoplasms ... More >> Neoplasms Metastasis Less << Phase 2 Unknown June 2014 China, Guangdong ... More >> Medical Oncology,Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT01632722 Colorectal Cancer ... More >> Liver Metastasis Less << Phase 2 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT00772694 Testicular Cancer Phase 2 Unknown December 2011 Poland ... More >> Chemotherapy Unit, Dept of Urology, Instituite of Oncology Recruiting Warsaw, Poland, 02781 Principal Investigator: Iwona A Skoneczna, MD          Sub-Investigator: Agnieszka Chaladaj-Kujawska, MD Less <<
NCT01750918 Cancer Phase 2 Active, not recruiting April 30, 2019 United States, Arizona ... More >> Novartis Investigative Site Scottsdale, Arizona, United States, 85259 United States, California Novartis Investigative Site San Francisco, California, United States, 94115 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, New York Novartis Investigative Site New York, New York, United States, 10065 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Paris cedex 12, France, 75571 Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Milano, Lombardia, Italy, 20162 Novartis Investigative Site Candiolo (TO), Piemonte, Italy, 10060 Japan Novartis Investigative Site Aichi, Japan, 464-8681 Novartis Investigative Site Chiba, Japan, 277-8577 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Utrecht, Netherlands, 3584 CX Spain Novartis Investigative Site Barcelona, Spain, 08035 United Kingdom Novartis Investigative Site Birmingham, United Kingdom, B15 2TH Less <<
NCT02578732 Locally Advanced Pancreatic Ca... More >>ncer Pancreatic Cancer Less << Phase 2 Recruiting July 2020 United States, Rhode Island ... More >> Rhode Island Hospital and The Miriam Hospital Recruiting Providence, Rhode Island, United States, 02903/02906 Contact: Kayla Rosati, EdM    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: Howard Safran, MD Less <<
NCT00540735 Cholangiocarcinoma Phase 3 Terminated(Big difficulties to... More >> enroll patients) Less << - France ... More >> UH Amiens Amiens, France, 80 000 UH Angers Angers, France, 49933 H Beaujon Clichy, France, 92 118 UH Henri Mondor Créteil, France, 94 010 UH Kremlin Bicêtre Le Kremlin Bicêtre, France, 94 275 UH Claude Huriez Lille, France, 59 037 Clinique Sainte Anne Lyon, France, 69 003 UH La Timone Marseille, France, 13 385 UH Marseille Nord Marseille, France, 13 915 H Metz-Thionville Metz, France, 57 038 UH Nantes Nantes, France, 44 000 Clinique du Trocadéro Paris, France, 75 116 UH Cochin Paris, France, 75 679 UH La Milétrie Poitiers, France, 86 021 UH Charles Nicolle Rouen, France, 76 031 UH Hôpital Civil Strasbourg, France, 67 091 UH Purpan Toulouse, France, 31 059 UH Rangueil Toulouse, France, 31 059 Less <<
NCT02758951 Colorectal Cancer ... More >> Colorectal Neoplasms Colorectal Carcinoma Colorectal Adenocarcinoma Colorectal Cancer Metastatic Peritoneal Carcinoma Peritoneal Neoplasms Peritoneal Cavity Cancer Peritoneal Carcinomatosis Peritoneal Metastases Less << Phase 2 Phase 3 Recruiting August 1, 2026 Netherlands ... More >> Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute Recruiting Amsterdam, Netherlands Contact: Arend G Aalbers, MD, PhD    +31205129111    a.aalbers@nki.nl    Contact: Henk Boot, MD, PhD    +31205129111    h.boot@nki.nl    Principal Investigator: Arend G Aalbers, MD, PhD          Sub-Investigator: Henk Boot, MD, PhD          VU University Medical Centre Recruiting Amsterdam, Netherlands Contact: Jurriaan B Tuynman, MD, PhD    +31204444444    j.tuynman@vumc.nl    Contact: Henk M Verheul, MD, PhD    +31204444444    h.verheul@vumc.nl    Principal Investigator: Jurriaan B Tuynman, MD, PhD          Sub-Investigator: Henk M Verheul, MD, PhD          Catharina Hospital Recruiting Eindhoven, Netherlands Contact: Ignace H de Hingh, MD, PhD    +31402397150    ignace.d.hingh@catharinaziekenhuis.nl    Contact: Geert-Jan J Creemers, MD, PhD    +31402396622    geert-jan.creemers@catharinaziekenhuis.nl    Principal Investigator: Ignace H de Hingh, MD, PhD          Sub-Investigator: Geert-Jan J Creemers, MD, PhD          Medisch Spectrum Twente Not yet recruiting Enschede, Netherlands Contact: Eino B van Duyn, MD, PhD    +31534873440    e.vanduyn@mst.nl    Contact: Leonie M Mekenkamp, MD, PhD    +31534872440    j.mekenkamp@mst.nl    Principal Investigator: Eino B van Duyn, MD, PhD          Sub-Investigator: Leonie M Mekenkamp, MD, PhD          University Medical Centre Groningen Recruiting Groningen, Netherlands Contact: Patrick H Hemmer, MD    +31503616161    p.h.j.hemmer@umcg.nl    Contact: Derk Jan J de Groot, MD, PhD    +31503616161    d.j.a.de.groot@umcg.nl    Principal Investigator: Patrick H Hemmer, MD          Sub-Investigator: Derk Jan J de Groot, MD, PhD          St. Antonius Hospital Recruiting Nieuwegein, Netherlands Contact: Marinus J Wiezer, MD, PhD    +31883201900    r.wiezer@antoniusziekenhuis.nl    Contact: Maartje Los, MD, PhD    +31883205700    m.los@antoniusziekenhuis.nl    Principal Investigator: Marinus J Wiezer, MD, PhD          Sub-Investigator: Maartje Los, MD, PhD          Radboud University Medical Centre Recruiting Nijmegen, Netherlands Contact: Sandra A Radema, MD, PhD    +31243618800    sandra.radema@radboudumc.nl    Contact: Johannes H de Wilt, MD, PhD    +31243613808    hans.dewilt@radboudumc.nl    Principal Investigator: Sandra A Radema, MD, PhD          Sub-Investigator: Johannes H de Wilt, MD, PhD          Erasmus Medical Centre Recruiting Rotterdam, Netherlands Contact: Jacobus W Burger, MD, PhD    +31107041506    j.burger@erasmusmc.nl    Contact: Esther van Meerten, MD, PhD    +31107040704    e.vanmeerten@erasmusmc.nl    Principal Investigator: Jacobus W Burger, MD, PhD          Sub-Investigator: Esther van Meerten, MD, PhD          University Medical Centre Utrecht Recruiting Utrecht, Netherlands Contact: Wilhelmina M van Grevenstein, MD, PhD    +31887556901    w.m.u.vangrevenstein@umcutrecht.nl    Contact: Miriam Koopman, MD, PhD    +31887556308    m.koopman-6@umcutrecht.nl    Principal Investigator: Wilhelmina M van Grevenstein, MD, PhD          Sub-Investigator: Miriam Koopman, MD, PhD Less <<
NCT02906800 Head and Neck Cancer Phase 1 Phase 2 Recruiting May 2019 France ... More >> Hopital Europeen Georges Pompidou Recruiting Paris, Île-de-France, France, 75015 Contact: Stephane Hans, MD       stephane.hans@aphp.fr    Principal Investigator: Stephane Hans, MD Less <<
NCT03693807 Colorectal Cancer ... More >> Cholangiocarcinoma Less << Phase 2 Recruiting September 2020 United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Nancy Kemeny, MD    646-888-4180       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Nancy Kemeny, MD    646-888-4180       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Nancy Kemeny, MD    646-888-4180       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Nancy Kemeny, MD, PhD    646-888-4180       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Nancy Kemeny, MD    646-888-4180       Principal Investigator: Nancy Kemeny, MD          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Nancy Kemeny, MD    646-888-4180       Principal Investigator: Nancy Kemeny, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Nancy Kemeny, MD    646-888-4180 Less <<
NCT01163305 - Completed - Hong Kong ... More >> Department of Clinical Oncology, Prince of Wales Hospital Hong Kong, Hong Kong Less <<
NCT02502370 Small Bowel Adenocarcinoma ... More >> Adjuvant Chemotherapy for SBA Less << Phase 3 Not yet recruiting - France ... More >> CHU du Bocage Not yet recruiting Dijon, France, 21079 Contact: Côme LEPAGE    33 3 80 39 34 86    ome.lepage@u-bourgogne.fr Less <<
NCT02738697 Carcinoma, Hepatocellular Phase 3 Recruiting December 2021 China, Guangdong ... More >> SUN YAT-SEN University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Rong-Ping Guo, M.D.    00862087342266    guorp@sysucc.org.cn    Contact: Wei Wei, Ph.D. M.D.    00862087343790    weiwei@sysucc.org.cn Less <<
NCT03179579 Gastric Cancer ... More >> Peritoneal Carcinomatosis Less << Phase 3 Not yet recruiting August 1, 2022 China, Guangdong ... More >> Department of Abdominal Surgery (Section 2), Affiliated Tumor Hospital of Guangzhou Medical University Not yet recruiting Guangzhou, Guangdong, China, 510095 Contact: Xianzi Yang, M.D    8602066673666    7097359@qq.com    Principal Investigator: shuzhong cui, M.D Less <<
NCT03666442 Rectal Cancer Phase 2 Recruiting June 1, 2022 China, Sichuan ... More >> Guoxue Road 37#,West China Hospital Recruiting Chengdu, Sichuan, China, 610041 Contact: Ziqiang Wang, MD    18980602028    wangtrial@163.com Less <<
NCT03528876 Metastatic Gastro-esophageal A... More >>denocarcinoma Less << Phase 2 Recruiting June 30, 2023 Canada, Saskatchewan ... More >> Allan Blair Cancer Center Recruiting Regina, Saskatchewan, Canada, S4T7T1 Contact: Haji Chalchal, MD    (306) 766-2213    haji.chalchal@saskcancer.ca    Saskatoon Cancer Center Not yet recruiting Saskatoon, Saskatchewan, Canada, S7N4H4 Contact: Shahid Ahmed, MD, PhD    3066552710    shahid.ahmed@saskcancer.ca    Contact: Lynn Dwernychuck, MSc       lynn.dwernychuck@saskcancer.ca Less <<
NCT01394120 Carcinoma, Pancreatic Ductal Phase 2 Unknown December 2013 Spain ... More >> Centro Integral Oncologico Clara Campal Recruiting Madrid, Spain, 28050 Contact: Manuel Hidalgo, MD, PhD       mhidalgo@cnio.es    Sub-Investigator: Jesus Rodriguez-Pascual          Sub-Investigator: Antonio Cubillo          Sub-Investigator: Pia Morelli          Sub-Investigator: Elena Garcia          Sub-Investigator: Barbara Angulo          Sub-Investigator: Ulpiano Lopez de la Guardia          Sub-Investigator: Emilio de Vicente          Sub-Investigator: Eduardo Garcia-Rico          Sub-Investigator: Ignacio Juez          Sub-Investigator: Ana Ruiz Less <<
NCT01661114 Pancreatic Cancer ... More >> Biliary Cancer Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT03772132 Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << Phase 2 Recruiting December 2021 China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: yingbin liu    13918803900    laoniulyb@163.com Less <<
NCT01253057 - Unknown December 2011 Taiwan ... More >> Taipei Medical University WanFang Hospital Taipei, Taiwan Less <<
NCT01558921 Rectal Cancer Phase 3 Active, not recruiting June 8, 2022 -
NCT00072748 Colorectal Neoplasms ... More >> Colonic Neoplasms Rectal Neoplasms Less << Phase 2 Completed - -
NCT03701373 Gastric Cancer Stage IV ... More >> Cancer of Stomach Less << Phase 2 Recruiting December 2018 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Rui-hua Xu    +86-20-87343295    xurh@sysucc.org.cn    Contact: Ming-ming He, MD    +86-13632350737    hemm@sysucc.org.cn Less <<
NCT01661114 - Completed - -
NCT03470350 Colorectal Cancer Metastatic Phase 1 Phase 2 Recruiting June 1, 2020 Netherlands ... More >> Antoni van Leeuwenhoek (NKI-AVL) Recruiting Amsterdam, Noord-Holland, Netherlands, 1066 CX Contact: S Huijberts, MD    +31 (0)20-5129111    s.huijberts@nki.nl    Contact: N Steeghs, MD    +31 (0)20-5129111    n.steeghs@nki.nl    Principal Investigator: N Steeghs, Dr.          Sub-Investigator: S Huijberts, MD Less <<
NCT02843191 Rectal Cancer Phase 3 Recruiting November 2021 Korea, Republic of ... More >> Inje University Busan Paik hospital Recruiting Busan, Korea, Republic of, 47392 Contact: Min Sung An, MD    82-10-2863-8283    gsams@paik.ac.kr    Contact: Ki Beom Bae, MD    82-10-4557-5643    bkbsur@daum.net    Principal Investigator: Ki Beom Bae, MD          Sub-Investigator: Min Sung An, MD          Chuncheon Sacred Heart Hospital, Hallym University College of Medicine Recruiting Chuncheon, Korea, Republic of, 24253 Contact: Byung Mo Kang, MD    82-10-8586-6963    kbm0728@yahoo.co.kr    Principal Investigator: Byung Mo Kang, MD          Keimyung University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 41931 Contact: Woon Kyung Jeong, MD    82-10-2535-8440    shinycloud@daum.net    Contact: Seong Kyu Baek, MD    82-10-8745-2317    sgbeak@dsmc.or.kr    Principal Investigator: Seong Kyu Baek, MD          Sub-Investigator: Woon Kyung Jeong, MD          Chungnam National University Hospital Recruiting Daejeon, Korea, Republic of, 35015 Contact: Jin Soo Kim, MD    82-10-8887-7562    jskim7562@gmail.com    Contact: Ji Yeon Kim, MD    82-10-9414-6909    jkim@cnu.ac.kr    Principal Investigator: Ji Yeon Kim, MD          Sub-Investigator: Jin Soo Kim, MD          Wonkwang University Hospital Recruiting Iksan, Korea, Republic of, 54538 Contact: Won Cheol Park, MD    82-10-2926-5977    parkwc@wonkwang.ac.kr    Principal Investigator: Won Cheol Park, MD          Inje University Sanggye Paik Hospital Recruiting Seoul, Korea, Republic of, 01757 Contact: Byung-Noe Bae, MD    82-10-6215-6566    bnbae1@naver.com    Principal Investigator: Byung-Noe Bae, MD          Gangnam Severance Hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 06273 Contact: Seung Hyuk Baik, MD    82-10-2443-7275    whitenoja@yuhs.ac    Principal Investigator: Seung Hyuk Baik, MD          Uijeongbu St. Mary's Hospital, The Catholic University College of Medicine Recruiting Uijeongbu, Korea, Republic of, 11765 Contact: Jae-Im Lee, MD    82-10-8550-0958    lji96@catholic.ac.kr    Contact: Seong-Taek Oh, MD    82-10-9191-1923    stoh@catholic.ac.kr    Principal Investigator: Seong-Taek Oh, MD          Sub-Investigator: Jae-Im Lee, MD          Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine Recruiting Wonju, Korea, Republic of, 26426 Contact: Ik Yong Kim, MD    82-10-4644-5508    iykim@yonsei.ac.kr    Principal Investigator: Ik Yong Kim, MD          Pusan National University Yangsan Hospital Recruiting Yangsan, Korea, Republic of, 50612 Contact: Gyung Mo Son, MD    82-10-7523-8056    skm171@naver.com    Principal Investigator: Gyung Mo Son, MD Less <<
NCT03344328 - Not yet recruiting September 30, 2018 France ... More >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermmontferrand.fr    Principal Investigator: David BALAYSSAC Less <<
NCT01413295 Colorectal Neoplasms Phase 2 Completed - Spain ... More >> Hospital Clínic Barcelona Barcelona, Spain, 08036 Less <<
NCT01659424 Rectal Cancer Phase 2 Withdrawn(No participants were... More >> enrolled) Less << - United States, New York ... More >> Beth Isael Medical Center New York, New York, United States, 10003 St-Lukes Roosevelt Hospital Medical Center New York, New York, United States, 10018 Less <<
NCT02872779 Circulating Markers ... More >> Metastatic Colorectal Cancer Less << Not Applicable Recruiting August 2020 France ... More >> Rouen University Hospital Recruiting Rouen, France Sub-Investigator: Pierre MICHEL, Pr Less <<
NCT02960061 Survival Phase 3 Not yet recruiting December 2019 China, Guangdong ... More >> The sixth affliated hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510655 Less <<
NCT03067792 Inoperable Gastric Cancer Phase 3 Completed - -
NCT02114359 Gastric Cancer Phase 3 Recruiting February 2020 Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Recruiting Anyang, Korea, Republic of, 431-796 Contact: ZANG, M.D.       fhdzang@hallym.ac.kr    Principal Investigator: ZANG, M.D.          Inje University Haeundae Paik Hospital Recruiting Busan, Korea, Republic of Contact: LEE, M.D.          Principal Investigator: LEE, M.D.          Chungbuk National University Hospital Not yet recruiting Cheongju, Korea, Republic of, 361-711 Contact: HAN, M.D.          Principal Investigator: HAN, M.D.          Kyungpook National University Medical Center Recruiting Daegu, Korea, Republic of, 702-210 Contact: KIM, M.D.          Principal Investigator: KIM, M.D.          Yeongnam University Medical Center Recruiting Daegu, Korea, Republic of Contact: KOH, M.D.          Principal Investigator: KOH, M.D.          National Cancer Center Recruiting Goyang, Korea, Republic of, 410-769 Contact: PARK, M.D.       youngiee@dreamwiz.com    Principal Investigator: PARK, M.D.          Gachon University Gil Medical Center Not yet recruiting Incheon, Korea, Republic of, 400-713 Contact: SIM, M.D.          Principal Investigator: SIM, M.D.          Inje University Pusan Paik Hospital Recruiting Pusan, Korea, Republic of, 614-735 Contact: KIM, M.D.          Principal Investigator: KIM, M.D.          Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 463-707 Contact: LEE, M.D.       hmodoctor@hanmail.net    Principal Investigator: LEE, M.D.          Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: RYU, M.D.          Principal Investigator: RYU, M.D.          SMG-SNU Boramae Medical Center Recruiting Seoul, Korea, Republic of, 156-707 Contact: CHOI, M.D.          Principal Investigator: CHOI, M.D.          Inje University Sanggye Paik Hospital Recruiting Seoul, Korea, Republic of Contact: SOHN, M.D.          Principal Investigator: SOHN, M.D.          Kangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of Contact: KOO, M.D.          Principal Investigator: KOO, M.D.          The Catholic University of Korea Uijeongbu St. Mary's Hospital Recruiting Uijeongbu, Korea, Republic of Contact: KO, M.D.          Principal Investigator: KO, M.D. Less <<
NCT01675999 Colon Cancer ... More >>Locally Advanced Malignant Neoplasm Less << Phase 2 Recruiting February 2021 France ... More >> Hopital Henri Mondor Recruiting Paris, France, 94010 Contact: Mehdi KAROUI, PH    +33 (0) 1 42 17 56 11    mehdi.karoui@gmail.com Less <<
NCT03751176 Colorectal Cancer Metastatic Phase 2 Recruiting December 2021 Spain ... More >> ICO Girona Dr. Josep Trueta Recruiting Gerona, Barcelona, Spain, 17007 Contact: Xavier Hernández, MD       xhernandez@iconcologia.net    Hospital de Granollers Recruiting Granollers, Barcelona, Spain, 08402 Contact: Rosa Gallego, MD       mrgallego@fhag.es    Hospital Mutua de Terrassa Recruiting Terrassa, Barcelona, Spain, 08221 Contact: Julén Fernández, MD       julenfernandez@mutuaterrassa.cat    Hospital General Universitario de Elche Recruiting Alicante, Elche, Spain, 03203 Contact: Javier Gallego, MD       j.gallegoplazas@gmail.com    Hospital Universitario Fundación Alcorcón Recruiting Alcorcón, Madrid, Spain, 28922 Contact: Juan Carlos Cámara       jccamara@fhalcorcon.es    H. Universitari Sant Joan de Reus Recruiting Reus, Tarragona, Spain, 43204 Contact: Féliz Muñoz, MD       felix.munoz@grupsagessa.com    Hospital de La Ribera de Alzira Recruiting Alzira, Valencia, Spain, 46600 Contact: Teresa Taberner, MD       mttb2@hotmail.com    Hospital Universitario Vall d`Hebron Recruiting Barcelona, Spain, 08035 Contact: Jaume Capdevila, MD       jacapdevila@vhebron.net    Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Joan Maurel, MD       JMAUREL@clinic.cat    Hospital de la Santa Creu I Sant Pau Recruiting Barcelona, Spain, 08041 Contact: Anna Virgili, MD       avirgili@santpau.cat    Hospital Universtiario la Paz Recruiting Madrid, Spain, 28046 Contact: Nuria Rodriguez, MD       nuria.rodriguez@salud.madrid.org    CIOCC Sanchinarro Recruiting Madrid, Spain, 28050 Contact: Rafaél Álvarez, MD       ralvarezgallego@hmhospitales.com    Complejo Hospitalario de Navarra Recruiting Navarro, Spain, 31008 Contact: Ruth Vera, MD       ruth.vera.garcia@cfnavarra.es    Corporació Sanitaria Parc Taulí Recruiting Sabadell, Spain, 08208 Contact: ismael Macías, Md       imacias@tauli.cat    Fundación Instituto Valenciano de Oncología Not yet recruiting Valencia, Spain, 46009 Contact: Carlos Fernandez-Martos, MD          Hospital Universitario Dr. Peset Recruiting Valencia, Spain, 46017 Contact: Carles Bosch, MD       bosch_car@gva.es    Hospital Universitario y Politécnico La Fe Not yet recruiting Valencia, Spain, 46026 Contact: Jorge Aparicio, MD       japariciou@seom.org Less <<
NCT00934882 Colorectal Neoplasms Phase 1 Completed - Germany ... More >> Freiburg, Baden-Württemberg, Germany, 79106 Heidelberg, Baden-Württemberg, Germany, 69120 Mannheim, Baden-Württemberg, Germany, 68167 Oldenburg, Niedersachsen, Germany, 26133 Herne, Nordrhein-Westfalen, Germany, 44625 Köln, Nordrhein-Westfalen, Germany, 50937 Dresden, Sachsen, Germany, 01307 Less <<
NCT03291951 Resistance Training ... More >> Colon Cancer Chemotherapy Effect Less << Not Applicable Enrolling by invitation May 2022 United States, California ... More >> Kaiser Permanente Division of Research Oakland, California, United States, 94612 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Pennsylvania Penn State Cancer Institute Hershey, Pennsylvania, United States, 17033 Less <<
NCT00931840 Metastatic Colorectal Cancer Phase 2 Unknown January 2012 -
NCT03611985 Breast Cancer Phase 1 Phase 2 Not yet recruiting January 2022 United States, Florida ... More >> University of Florida Not yet recruiting Gainesville, Florida, United States, 32608 Contact: Allison Allegra, MPH    352-273-5079    allisonallegra3@ufl.edu    Principal Investigator: Coy Heldermon Less <<
NCT00068289 Lung Cancer Phase 2 Completed - -
NCT03418038 High Grade B-Cell Lymphoma Wit... More >>h MYC and BCL2 or BCL6 Rearrangements Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Recurrent Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Lymphoma Less << Phase 2 Recruiting March 15, 2024 United States, Arizona ... More >> Mayo Clinic in Arizona Not yet recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Craig B. Reeder          United States, Florida Mayo Clinic in Florida Not yet recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Taimur Sher          United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Umar Farooq       umar-farooq@uiowa.edu    Principal Investigator: Umar Farooq          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Thomas E. Witzig Less <<
NCT00921661 Colorectal Neoplasms ... More >> Neoplasm Metastasis Less << Phase 1 Completed - Japan ... More >> Sanofi-Aventis Administrative Office Tokyo, Japan Less <<
NCT01804790 Cancer of the Rectum Phase 3 Active, not recruiting January 2022 France ... More >> Centre hospitalier Universitaire d'Amiens Amiens, France ICO - Site Paul Papin Angers, France Centre hospitalier d'Auxerre Auxerre, France Centre Hospitalier de Beauvais Beauvais, France Institut de Cancérologie de Franche Comté Besancon, France Centre Hospitalier de Blois Blois, France Hopital Avicenne Bobigny, France Clinique Tivoli Bordeaux, France Hopital Saint Andre Bordeaux, France Institut Bergonie Bordeaux, France Centre Francois Baclesse Caen, France Chd de La Roche Sur Yon - Les Oudairies La Roche-sur-yon, France Centre Bourgogne Lille, France Centre Oscar Lambret Lille, France Centre Léon Bérard Lyon, France Hopital Prive Jean Mermoz Lyon, France Ap Hm - Hopital de La Timone - Adultes Marseille, France Institut de Cancérologie de Franche Comté Montbeliard, France Centre Azuréen de cancérologie Mougins, France Hopital Emile Muller Mulhouse, France centre Alexis Vautrin Nancy, France Polyclinique de Gentilly Nancy, France Centre Antoine Lacassagne Nice, France Groupe Hospitalier La Pitie-Salpetriere Paris, France Institut Mutualiste Montsouris Paris, France Hopital Haut Leveque Pessac, France Centre Hospitalier Regional D'Annecy Pringy, France Hopital Robert Debre Reims, France Institut Jean Godinot Reims, France Clinique Armoricaine de Radiologie Saint-brieuc, France Hopital Saint Gregoire Saint-gregoire, France Clinique Mutualiste de L'Estuaire Saint-nazaire, France Centre Hospitalier de la Réunion - Site du GHSR Saint-pierre, France ICO - Site René Gauducheau St Herblain, France Centre Paul Strauss Strasbourg, France Gustave Roussy Villejuif, France Less <<
NCT02456714 Cholangiocarcinoma Phase 2 Active, not recruiting December 1, 2018 Netherlands ... More >> Academic medical center Amsterdam Amsterdam, Netherlands, 1105AZ Less <<
NCT02514278 Rectal Cancer Phase 3 Recruiting March 2022 France ... More >> Service de Chirurgie Digestive, CHU Amiens Picardie Recruiting Amiens, France Contact: Jean-Marc REGIMBEAU       regimbeau.jean-marc@chu-amiens.fr    Service de Chirurgie Digestive, CHU de Besançon Recruiting Besançon, France Contact: Georges MANTION       georges.mantion@chu-besancon.fr    Service de Chirurgie Digestive, Hôpital Saint-André - CHU de Bordeaux Recruiting Bordeaux, France Contact: Eric RULLIER       eric.rullier@chu-bordeaux.fr    Service de Chirurgie Digestive, Institut Bergonié Not yet recruiting Bordeaux, France Contact: Serge EVRARD       S.Evrard@bordeaux.unicancer.fr    Service de Chirurgie Digestive, CHU Estaing - CHRU Clermont Ferrand Recruiting Clermont-Ferrand, France Contact: Denis PEZET       dpezet@chu.clermontferrand.fr    Service de Chirurgie Digestive, Hôpital Beaujon - APHP Not yet recruiting Clichy, France Contact: Yves PANIS       yves.panis@bjn.aphp.fr    Service de Chirurgie Digestive, Centre Georges François Leclerc - Dijon Recruiting Dijon, France Contact: David ORRY       dorry@cgfl.fr    Service de Chirurgie Digestive, Hôpital Albert Michallon - CHU de Grenoble Not yet recruiting La Tronche, France Contact: Jean-Luc FAUCHERON       JLFaucheron@chu-grenoble.fr    Service de Chirurgie Digestive, Centre Oscar Lambret - Lille Not yet recruiting Lille, France Contact: Mehrad JAFARI       m-jafari@o-lambret.fr    Service de Chirurgie Digestive, CHRU de Lille Not yet recruiting Lille, France Contact: Christophe MARIETTE       christophe.mariette@chru-lille.fr    Service de Chirurgie Digestive, Centre Léon Bérard - Lyon Recruiting Lyon, France Contact: Michel RIVOIRE       rivoire@lyon.fnclcc.fr    Service de Chirurgie Digestive, Hôpital Lyon Sud - CHU Lyon Recruiting Lyon, France Contact: Eddy COTTE       eddy.cotte@chu-lyon.fr    Service de Chirurgie Digestive, CHU de la Timone - Marseille Not yet recruiting Marseille, France Contact: Igor SIELEZNEFF       Bernard.Sastre@mail.ap-hm.fr    Service de Chirurgie Digestive, Institut Paoli Calmette - Marseille Not yet recruiting Marseille, France Contact: Bernard LELONG       lelongb@ipc.unicancer.fr    Service de Chirurgie Digestives, Hôpital Européen de Marseille Recruiting Marseille, France Contact: Antoine CAMERLO       a.camerlo@hopital-europeen.fr    Service de Chirurgie Digestive, CHU Saint-Eloi - Montpellier Not yet recruiting Montpellier, France Contact: Jean-Michel FABRE       jm-fabre@chu-montpellier.fr    Service de Chirurgie Digestive, Institut du Cancer de Montpellier Recruiting Montpellier, France Contact: Philippe ROUANET       phillipe.rouanet@montpellier.unicancer.fr    Service d'Oncologie et Radiothérapie, Centre Azuréen de Cancérologie Not yet recruiting Mougins, France Contact: Philippe RONCHIN       ronchinp@yahoo.fr    Service de Chirurgie Digestive,Institut de Cancérologie de Lorraine Recruiting Nancy, France Contact: Frédéric MARCHAL       f.marchal@nancy.unicancer.fr    Service de Chirurgie Digestive, Hôtel Dieu - CHU de Nantes Not yet recruiting Nantes, France Contact: Guillaume MEURETTE       guillaume.meurette@chu-nantes.fr    Service de Chirurgie Digestive, CHU Carémeau - Nîmes Recruiting Nîmes, France Contact: Michel PRUDHOMME       michel.prudhomme@chu-nimes.fr    Service de Chirurgie Digestive et Oncologique, Hôpital Bicêtre - APHP Recruiting Paris, France Contact: Stéphane BENOIST       stephane.benoist@aphp.fr    Service de Chirurgie Digestive, Hôpital les Diaconnesses Recruiting Paris, France Contact: Henri MOSNIER       hmosnier@hopital-dcss.org    Service de Chirurgie Digestive, Hôpital Pitié Salpetrière - APHP Not yet recruiting Paris, France Contact: Medhi KAROUI       medhi.karoui@psl.aphp.fr    Service de Chirurgie Digestive, Hôpital Saint-Antoine - APHP Recruiting Paris, France Contact: Emmanuel TIRET       emmanuel.tiret@sat.aphp.fr    Service de Chirurgie Digestive, Hôpital Saint-Louis - APHP Paris Not yet recruiting Paris, France Contact: Mircea CHIRICA       mircea.chirica@sls.aphp.fr    Service de Chirurgie Digestive, Hôpital Pontchaillou - CHU Rennes Recruiting Rennes, France Contact: Bernard MEUNIER       bernard.meunier@chu-rennes.fr    Service de Chirurgie Digestive, Hôpital Charles Nicolle - CHU de Rouen Recruiting Rouen, France Contact: Jean-Jacques TUECH       jean-jacques.tuech@chu-rouen.fr    Service de Chirurgie Digestive, Hôpital Purpan - CHU de Toulouse Not yet recruiting Toulouse, France Contact: Guillaume PORTIER       portier.g@chu-toulouse.fr    Service de chirurgie digestive, CHRU de Nancy -Hôpital de Brabois Recruiting Vandœuvre-lès-Nancy, France Contact: Adeline GERMAIN       a.germain@chru-nancy.fr    Département de chirurgie digestive, Institut Gustave Roussy Not yet recruiting Villejuif, France Contact: Léonor BENHAIM       leonor.benhaim@gustaveroussy.fr Less <<
NCT01243047 Metastatic Colorectal Cancer Phase 2 Completed - Hong Kong ... More >> Department of Clinical Oncology, Prince of Wales Hospital Hong Kong, Hong Kong Less <<
NCT02394951 Neuropathy Pa... More >>in Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine/Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 Less <<
NCT03743428 Colorectal Neoplasms Not Applicable Recruiting December 31, 2022 China, Guang Dong ... More >> Shenzhen People's Hospital Recruiting Shenzhen, Guang Dong, China Contact: Wan He, PhD,MD Less <<
NCT01937715 Metastatic Colorectal Carcinom... More >>a Less << Phase 1 Phase 2 Terminated(B2151007 was premat... More >>urely discontinued due to Pfizer's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction) Less << - -
NCT01937715 - Terminated(B2151007 was premat... More >>urely discontinued due to Pfizer's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction) Less << - -
NCT01248299 Squamous Cell Carcinoma of Eso... More >>phagus Less << Phase 2 Unknown September 2016 France ... More >> CHU Brest Brest, France, 29200 Centre François BACLESSE Caen, France, 14076 Centre Georges François Leclerc Dijon, France, 21079 CHU Dijon Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 CHU Lille Lille, France, 59035 CHU La Timone Marseille, France, 13385 Centre Val d'Aurelle Montpellier, France, 34298 Centre René Gauducheau Nantes Saint-herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Centre Eugène Marquis Rennes, France, 35042 Clinique de la Theuillerie Ris Orangis, France, 91130 CHU Rouen Rouen, France, 76031 Clinique de l'Armoricaine St-Brieuc, France, 22000 Centre Paul Strauss Strasbourg, France, 67000 Centre Alexis Vautrin Vandoeuvre-les-nancy, France, 54511 Centre Hospitalier Intercommunal Villeneuve St Georges, France, 94190 Less <<
NCT03314935 Biliary Tract Cancer (BTC) ... More >> Colorectal Cancer (CRC) Endometrial Cancer Gastroesophageal Cancer (GC) Ovarian Cancer Solid Tumors Less << Phase 1 Phase 2 Recruiting May 27, 2020 United States, Alabama ... More >> University of Alabama Not yet recruiting Birmingham, Alabama, United States, 35294-3300 USA Mitchell Cancer Center Recruiting Mobile, Alabama, United States, 36604 United States, California UC Davis - Comprehensive Cancer Centre Not yet recruiting Sacramento, California, United States, 95817 United States, Georgia Northwest Georgia Oncology Centers Recruiting Marietta, Georgia, United States, 30060 United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 START San Antonio Recruiting San Antonio, Texas, United States, 78229 Belgium Grand Hopital de Charleroi - Department of Medical Oncology Not yet recruiting Brussels, Belgium, 6000 Institut Jules Bordet - Clinical Trials Conduct Unit Recruiting Brussels, Belgium, B-1000 United Kingdom University of Liverpool Not yet recruiting Liverpool, United Kingdom, L69 3BX UCL Cancer Institute Recruiting London, United Kingdom, WC1E 6BT The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Less <<
NCT03307941 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Squamous Cell Carcinoma of the Esophagus Less << Phase 1 Phase 2 Withdrawn(Suspended collaborat... More >>ion with the company providing the study drug) Less << - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Less <<
NCT00066768 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00659269 Cancer Phase 3 Completed - United States, New Mexico ... More >> University of New Mexico Cancer Center @ Lovelace Medical Center Albuquerque, New Mexico, United States, 87102 Hematology Oncology Associates Albuquerque, New Mexico, United States, 87106 Cancer Center at Presbyterian Hospital Albuquerque, New Mexico, United States, 87110 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 New Mexico Cancer Care Associates Santa Fe, New Mexico, United States, 87505 Less <<
NCT03667170 Solid Tumor Phase 2 Recruiting July 1, 2021 China, Beijing ... More >> Peking University Cancer Hospital, Peking University Recruiting Beijing, Beijing, China, 100010 Contact: Lin Shen, MD    86-010-88196340    doctorshenlin@sina.cn Less <<
NCT01252628 Incurable Metastatic Colorecta... More >>l Carcinoma Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Less << Phase 1 Phase 2 Completed - -
NCT02951156 Diffuse Large B-Cell Lymphoma Phase 3 Active, not recruiting May 29, 2021 -
NCT00659269 - Completed - -
NCT01454180 Advanced Pancreatic Carcinoma Phase 2 Completed - Spain ... More >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Universitario Madrid Sanchinarro Madrid, Spain, 28050 Less <<
NCT01655823 Pain Peripher... More >>al Neuropathy Neuropathic Pain Less << Phase 2 Terminated(Interim analysis co... More >>mpleted and decided to terminate and proceed to Phase 3 trial.) Less << - -
NCT01152437 Colorectal Neoplasms Phase 2 Completed - United Kingdom ... More >> 1200.74.44001 Boehringer Ingelheim Investigational Site Bournemouth, United Kingdom 1200.74.44005 Boehringer Ingelheim Investigational Site Bristol, United Kingdom 1200.74.44006 Boehringer Ingelheim Investigational Site Cambridge, United Kingdom 1200.74.44003 Boehringer Ingelheim Investigational Site Glasgow, United Kingdom 1200.74.44009 Boehringer Ingelheim Investigational Site London, United Kingdom 1200.74.44012 Boehringer Ingelheim Investigational Site Manchester, United Kingdom 1200.74.44007 Boehringer Ingelheim Investigational Site Northwood, United Kingdom 1200.74.44013 Boehringer Ingelheim Investigational Site Nottingham, United Kingdom 1200.74.44011 Boehringer Ingelheim Investigational Site Poole, United Kingdom 1200.74.44010 Boehringer Ingelheim Investigational Site Sheffield, United Kingdom 1200.74.44008 Boehringer Ingelheim Investigational Site Southampton, United Kingdom 1200.74.44004 Boehringer Ingelheim Investigational Site Sutton, Surrey, United Kingdom 1200.74.44002 Boehringer Ingelheim Investigational Site Truro, United Kingdom Less <<
NCT01136031 Advanced Gastric Cancer Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01152437 - Completed - -
NCT01636947 Nausea Vomiti... More >>ng Less << Phase 4 Completed - -
NCT01655823 - Terminated(Interim analysis co... More >>mpleted and decided to terminate and proceed to Phase 3 trial.) Less << - -
NCT02664077 Stage III (IIIB or IIIC) Colon... More >> Cancer Less << Phase 3 Active, not recruiting October 2019 -
NCT01636947 - Completed - -
NCT01803282 Tumors Pancre... More >>atic Cancer Non-small Cell Lung Cancer Esophagogastric Cancer Colorectal Cancer Breast Cancer Less << Phase 1 Active, not recruiting February 2019 United States, Alabama ... More >> Alabama Oncology Birmingham, Alabama, United States, 35213 United States, Arizona Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 United States, California Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 San Diego Pacific Oncology and Hematology Associates, Inc. Encinitas, California, United States, 92024 University of Southern California (USC) Los Angeles, California, United States, 90033 California Pacific Medical Center San Francisco, California, United States, 94115 UCLA Medical Center Santa Monica, California, United States, 90404 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Cornell University New York, New York, United States, 10021 United States, South Carolina Greenville Health System, Institute for Translational Oncology Research Greenville, South Carolina, United States, 29605 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt Nashville, Tennessee, United States, 37212 United States, Texas UT Southwestern Dallas, Texas, United States, 75390 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 Less <<
NCT02817178 Metastatic Colorectal Cancer Not Applicable Active, not recruiting March 2020 France ... More >> Centre Hospitalier Régional Universitaire de Besançon Besançon, France Polyclinique de Franche-Comté Besançon, France Hôpitaux Civils de Colmar Colmar, France Centre Georges François Leclerc Dijon, France Hôpital Nord Franche-Comté Montbéliard, France Institut de Cancérologie de Lorraine Nancy, France Hôpital Européen Georges Pompidou Paris, France Centre Paul Strauss Strasbourg, France Centre Hospitalier Universitaire de Tours Tours, France Less <<
NCT02024607 Advanced Gastrointestinal Canc... More >>er Less << Phase 1 Phase 2 Active, not recruiting - United States, Arizona ... More >> Mayo Clinic Campus in Arizona Phoenix, Arizona, United States, 85054 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33916 United States, Georgia Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Indiana University Health Arnett Hospital Lafayette, Indiana, United States, 47905 Indiana University Health Ball Memorial Hospital Muncie, Indiana, United States, 47303 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55901 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Institute for Translational Oncology Research, Greenville Health System Greenville, South Carolina, United States, 29605 United States, Tennessee Tennessee Oncology - Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology - Nashville Nashville, Tennessee, United States, 37203 Canada, Ontario Ottawa Hospital Cancer Center Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT00418938 Cancer Colon ... More >>Cancer Colorectal Cancer Metastatic Cancer Rectal Cancer Metastatic Colorectal Cancer Less << Phase 2 Completed - -
NCT02199171 FIGO Stage IIC-IV Ovarian Carc... More >>inoma Fallopian Tube Carcinoma Peritoneal Carcinoma Less << Phase 1 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT02008656 Rectal Cancer Phase 2 Recruiting November 2019 -
NCT00418938 - Completed - -
NCT00349336 Colorectal Cancer Phase 3 Completed - Australia ... More >> Box Hill, Australia, 3128 Fitzroy, Australia, 3065 Sydney, Australia, 2031 Canada, Ontario Brampton, Ontario, Canada, L6R 3J7 Hamilton, Ontario, Canada, L8V 5C2 Toronto, Ontario, Canada, M5G 2M9 New Zealand Christchurch, New Zealand Less <<
NCT02162914 Cholangiocarcinoma Phase 2 Unknown December 2016 Belgium ... More >> CH Jolimont Active, not recruiting Haine-Saint-Paul, Hainaut, Belgium, 7100 University Hospitals of Antwerp Not yet recruiting Antwerp, Belgium, 2650 Contact: Marc Peeters, MD, PhD    +32(0)38213954    marc.peeters@uza.be    Contact: Iris Verhaegen    +32(0)8215681    iris.verhaegen@uza.be    Principal Investigator: Marc Peeters, MD, PhD          AZ St-Lucas Brugge Not yet recruiting Brugge, Belgium, 8310 Contact: Joris Arts, MD    +32(0)50 36 57 11    joris.arts@stlucas.be    Contact: Hilde Nevens, Mrs    +32(0)50 36 57 11    hilde.nevens@stlucas.be    Principal Investigator: Joris Arts, MD          Erasme University Hospital Recruiting Brussels, Belgium, 1070 Contact: Anne Demols, MD, PhD    +32(0)25555867    anne.demols@erasme.ulb.ac.be    Principal Investigator: Anne Demols, MD, PhD          Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Ivan Borbath, MD, PhD    +32 (0)2 764 4213    ivan.borbath@uclouvain.be    Contact: Antonino Ceratti, Mr    +32 (0)2 764 4213    antonino.ceratti@uclouvain.be    Principal Investigator: Ivan Borbath, MD, PhD          Grand Hôpital de Charleroi Active, not recruiting Charleroi, Belgium, 6000 AZ St-Lucas Gent Not yet recruiting Gent, Belgium, 9000 Contact: Johan Van Ongeval, MD    +32(0)9/2246111    johan.VanOngeval@AZSTLUCAS.be    Contact: Koen De Graeve, Mr    +32(0)9/224 62 27    koen.degraeve@azstlucas.be    Principal Investigator: Johan Van Ongeval, MD          UZ Gent Not yet recruiting Gent, Belgium, 9000 Contact: Stéphanie Laurent, MD, PhD    09/3322371       Contact: Roxane Van Vynckt, Mrs    +32(0)9/3322378    roxane.vanvynckt@uzgent.be    Principal Investigator: Stéphanie Laurent, MD, PhD          CHC St-Joseph Active, not recruiting Liège, Belgium, 4000 Hôpital Ambroise Paré Not yet recruiting Mons, Belgium, 7000 Contact: Stephane Holbrechts, MD    +32(0)65/39 39 39    stephane.holbrechts@hap.be    Contact: Melissa Canzurlo, Mrs    +32(0)65/39 39 39    melissa.canzurlo@hap.be    Principal Investigator: Stephane Holbrechts, MD          AZ Delta Not yet recruiting Roeselare, Belgium, 8800 Contact: Jochen Decaestecker, MD    +32(0)51/237111    jdecaestecker@azdelta.be    Contact: Sophie Adriaens, Mrs    +32(0)51/237111    sadriaens@azdelta.be    Principal Investigator: Jochen Decaestecker, MD Less <<
NCT01652482 Colorectal Cancer Phase 2 Completed - -
NCT01490996 Colonic Cancer ... More >> Metastasis Less << Phase 1 Phase 2 Active, not recruiting February 2019 United Kingdom ... More >> Dept Oncology, Leicester Royal Infirmary Leicester, United Kingdom, LE1 2WW Less <<
NCT00813605 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00786006 Metastatic Pancreatic Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT00349336 - Completed - -
NCT02973685 HepatoCellular Carcinoma Phase 3 Recruiting October 2019 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn    The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan The First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT03048123 Hepatocellular Carcinoma Phase 2 Completed - China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT02045030 Metastatic Colorectal Cancer Phase 2 Terminated(Drug (Aflibercept) ... More >>no longuer available for the study) Less << - Canada, Quebec ... More >> CSSS Champlain-Charles-Le Moyne Greenfield Park, Quebec, Canada, J4V 2H1 Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada, H1T 2M4 Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Hôpital du Sacré-Coeur de Montréal Montréal, Quebec, Canada, H4J 1C5 Less <<
NCT01543412 Pancreatic Adenocarcinoma Phase 2 Completed - Italy ... More >> A.O. Treviglio-Caravaggio, P.le Ospedale n1 Treviglio, Bergamo, Italy, 24047 Azienda Ospedaliera "Di Liegro" Gaeta, Latina, Italy, 04024 A.O. Ospedale S.Paolo Milano, MI, Italy, 20100 A.O. S.Salvatore Pesaro, PS, Italy, 61100 Ospedale Morelli Sondalo, SO, Italy, 23100 Ospedali Riuniti Umberto I - GM Lancisi-G Salesi Ancona, Italy, 60126 Ospedali Riuniti, Largo Barozzi, 1 Bergamo, Italy, 24128 Fondazione Poliambulanza, Via Bissolati 57 Brescia, Italy, 25100 A.O. Carlo Poma - Via Albertoni, 1 Mantova, Italy, 46100 Less <<
NCT01442935 Colorectal Cancer Phase 2 Active, not recruiting February 2019 France ... More >> Centre Val d'Aurelle Montpellier, France, 34298 Less <<
NCT00497497 Colorectal Cancer Phase 1 Completed - -
NCT01889303 Gastric Cancer Phase 2 Recruiting December 2019 China, Hubei ... More >> Zhongnan Hospital of Wuhan University Recruiting Wuhan, Hubei, China, 430071 Contact: F X Zhou, PHD    86-27-67813155    happyzhoufx@sina.com    Contact: Y F Zhou, PHD    86-27-67823096    yfzhouwhu@163.com Less <<
NCT01281761 Metastatic Colorectal Cancer Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT03010722 - Recruiting July 2017 United Kingdom ... More >> The Royal Marsden NHS Foundation Trust London and Surrey Recruiting Carshalton, Surrey, United Kingdom, SM2 5PT Contact: Claire Saffery    02086613637    claire.saffery@rmh.nhs.uk    Contact: Dr Khurum Khan    02086426011 ext 1123    khurum.khan@rmh.nhs.uk Less <<
NCT00118261 Colorectal Cancer Phase 1 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 Less <<
NCT00439517 Previously Untreated Metastati... More >>c Colorectal Cancer Less << Phase 2 Completed - -
NCT00311610 Colorectal Cancer Phase 2 Completed - United States, California ... More >> Kaiser Permanente Medical Office -Vandever Medical Office San Diego, California, United States, 92120 United States, Delaware Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Maryland Union Hospital Cancer Program at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Nevada University Medical Center of Southern Nevada Las Vegas, Nevada, United States, 89102 CCOP - Nevada Cancer Research Foundation Las Vegas, Nevada, United States, 89106 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Kinston Medical Specialists Kinston, North Carolina, United States, 28501 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210-1240 Less <<
NCT00439517 - Completed - -
NCT01652196 Mucinous Adenocarcinoma of the... More >> Colon Mucinous Adenocarcinoma of the Rectum Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 2 Active, not recruiting December 31, 2018 United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 United States, New York Montefiore Medical Center Bronx, New York, United States, 10461 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT03698461 Colorectal Neoplasms ... More >> Neoplasm Metastasis Colonic Neoplasms Rectal Neoplasms Less << Phase 2 Not yet recruiting November 2021 Korea, Republic of ... More >> Asan Medical Center Not yet recruiting Seoul, Songpa-gu, Korea, Republic of, 05505 Contact: SunYoung Kim, Ph.D    82-2-3010-3204    sunyoungkim@amc.seoul.kr Less <<
NCT01490749 Esophageal Cancer ... More >> Neoplasms, Esophageal Less << Phase 1 Active, not recruiting May 2020 United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT02352337 Metastatic Pancreatic Cancer Phase 2 Active, not recruiting February 2019 -
NCT02785146 Colorectal Cancer Phase 3 Unknown June 2018 China, Guangdong ... More >> Sixth Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Xiaojian Wu, Ph.D.    +86-13760608396    wuxjian@mail.sysu.edu.cn Less <<
NCT00425841 Pancreatic Cancer Phase 2 Completed - Germany ... More >> Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Less <<
NCT02359058 Stomach Neoplasms Phase 1 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Aichi, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Chiba, Japan, 277-8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Ehime, Japan, 791-0280 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician Osaka, Japan, 565-0871 Less <<
NCT02503150 Metastatic Colorectal Cancer Phase 3 Not yet recruiting December 2020 -
NCT02359058 - Completed - -
NCT00854854 Advanced Gastric Cancer Phase 1 Phase 2 Unknown July 2010 Korea, Republic of ... More >> The catholic University of korea Banpo-Dong, Seoul, Korea, Republic of, 137-701 Less <<
NCT00208260 Colorectal Cancer ... More >> Liver Metastases Chemotherapy Less << Phase 2 Phase 3 Completed - France ... More >> CRLC Val d'Aurelle Montpellier, France, 34298 Less <<
NCT01787539 Gastric Cancer Phase 2 Phase 3 Recruiting February 2022 Poland ... More >> Second Department of General & Gastrointestinal Surgery & Surgical Oncology of the Alimentary Tract, Medical University of Lublin Recruiting Lublin, Lubelskie, Poland, 20-081 Contact: Tomasz Skoczylas, MD, PhD    +48 81 5328810    tomskocz@yahoo.com    Principal Investigator: Grzegorz Wallner, Professor          Principal Investigator: Andrzej Dąbrowski, Professor          Sub-Investigator: Witold Zgodziński, MD, PhD          Sub-Investigator: Marek Majewski, MD, PhD          Sub-Investigator: Krzysztof Zinkiewicz, MD, PhD          Sub-Investigator: Witold Krupski, Professor          Sub-Investigator: Justyna Szumiło, Professor          Sub-Investigator: Jadwiga Sierocińska-Sawa, MD, PhD          St. John's Cancer Center Recruiting Lublin, Lubelskie, Poland, 20-090 Contact: Tomasz Kubiatowski, MD, PhD    +48 81 7477511 ext 129       Principal Investigator: Elżbieta Starosławska, MD, PhD          Principal Investigator: Tomasz Kubiatowski, MD, PhD          Sub-Investigator: Bożena Kukiełka-Budny, MD, PhD Less <<
NCT03331640 Metastatic Pancreatic Ductal A... More >>denocarcinoma Less << Phase 2 Recruiting January 2023 Germany ... More >> Praxis für Innere Medizin Recruiting Friedrichshafen, Germany Contact: Helmut Oettle, Prof. Dr. Less <<
NCT01269229 Rectal Cancer Phase 2 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT03017326 Hepatoblastoma ... More >> Carcinoma, Hepatocellular Less << Phase 3 Recruiting December 2022 United Kingdom ... More >> Royal Aberdeen Children's Hospital Recruiting Aberdeen, United Kingdom, AB25 2ZG Contact: Hugh Bishop, MBChB          Addenbrooke's Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Amos Burke, MB ChB       amos.burke@addenbrookes.nhs.uk Less <<
NCT03732235 - Recruiting December 2021 Italy ... More >> Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore Recruiting Pesaro, PU, Italy, 61122 Contact: Giammaria Fiorentini, MD    +390721364124    giammaria.fiorentini@ospedalimarchenord.it    Principal Investigator: Giammaria Fiorentini, MD Less <<
NCT02305615 - Completed - Hungary ... More >> Szent Margit Hospital Budapest, Hungary, 1032 Semmelweis Egyetem Onkologiai Központ Budapest, Hungary, 1083 Szent Imre Hospital Budapest, Hungary, 1115 Orszagos Onkologiai Intezet; B Belgyogyaszati Osztaly Budapest, Hungary, 1122 Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika Budapest, Hungary, 1125 Fövárosi Önkormányzat uzsoki utcai Kórház Budapest, Hungary, 1145 Kenezy Korhaz Rendelointezet Debrecen, Hungary, 4031 Debreceni Egyetem Klinikai Kozpont ; Department of Oncology Debrecen, Hungary, 4032 Petz Aladar Megyei Oktato Korhaz Gyor, Hungary, 9024 Békés Megyei Pándy Kálmán Kórház; Onkologiai tanszek Gyula, Hungary, 5703 Kaposi Mor Teaching Hospital Kaposvár, Hungary, 7400 Bacs-Kiskun Megyei Korhaz, SZTE AOK Oktato Korhaza, Onkoradiologiai Kozpont Kecskemet, Hungary, 6000 Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly Miskolc, Hungary, 3501 Josa Andras Korhaz; Dept of Oncoradiology Nyíregyháza, Hungary, 4400 Pécsi Tudományegyetem Áok; Onkoterapias Intezet Pecs, Hungary, 7624 Szegedi Tudomanyegyetem, AOK, Szent-Gyorgyi Albert Klinikai Kozpont, Onkoterapias Klinika Szeged, Hungary, 6720 Szent Gyorgy Korhaz;Fejer Megyei Szekesfehervar, Hungary, 8000 Tolna Megyei Onkormanyzat Balassa Janos Korhaz Szekszard, Hungary, 7100 Markusovszky Hospital Szombathely, Hungary, 9700 Szent Borbala Korhaz Tatabánya, Hungary, 2800 Veszprem Megyei Csolnoky; Ferenc Korhaz Veszprem, Hungary, 8200 Zala megyei Önkormányzat Kórház és Rendelõintézet Zalaegerszeg, Hungary, 8900 Less <<
NCT00479583 Cancer Phase 1 Completed - United States, Alabama ... More >> University Of Alabama At Birmingham Birmingham, Alabama, United States, 35294 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 France Local Institution Saint-Herblain Cedex, France, 44805 Local Institution Villejuif, France, 94805 Less <<
NCT02312284 - Completed - China ... More >> Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, China, 100021 Less <<
NCT03612544 Smoking Cessation ... More >> Toxicity Less << Not Applicable Recruiting June 2020 Switzerland ... More >> Policlinique Médicale Universitaire, Université de Lausanne Not yet recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Jacques Cornuz, Prof.Dr.med       Jacques.Cornuz@chuv.ch    University Clinic for General Internal Medicine, Bern University Hospital Recruiting Bern, Switzerland, 3010 Contact: Nicolas Rodondi, Prof.Dr.med       Nicolas.Rodondi@insel.ch    Département de médecine interne, Hôpitaux universitaires de Genève Not yet recruiting Geneva, Switzerland, 1211 Contact: Jean-Paul Humair, PD Dr.med.       Jean-Paul.Humair@hcuge.ch Less <<
NCT03680261 Gastric Cancer Phase 3 Not yet recruiting September 30, 2023 China, Shanghai ... More >> ZhongShan hospital FuDan university Shanghai, Shanghai, China, 200032 Less <<
NCT01540344 Peritoneal Carcinomatosis ... More >> Colorectal Cancer Metastatic Less << Phase 2 Terminated(Slow recruitment.) - Germany ... More >> Charité Campus Mitte, Humboldt-University Berlin Berlin, Germany, 10117 Medical Center of the Friedrich-Alexander-University Erlangen- Nürnberg Erlangen, Germany, 91054 Cologne-Merheim Medical Center, University Witten/Herdecke Koeln, Germany, 51058 University Hospital Regensburg Regensburg, Germany, 93042 St. John of God Hospital Regensburg Regensburg, Germany, 93049 University Hospital, University of Tuebingen Tuebingen, Germany, 72076 University Hospital Wuerzburg, Julius-Maximilians University Wuerzburg, Germany, 97080 Less <<
NCT03615326 Gastric Neoplasms ... More >> Gastroesophageal Junction Adenocarcinoma Less << Phase 3 Recruiting March 20, 2024 -
NCT01836432 Pancreatic Cancer ... More >> Pancreatic Carcinoma Non-resectable Locally Advanced Malignant Neoplasm Less << Phase 3 Unknown June 2017 -
NCT02758925 Diffuse Large B Cell Lymphoma Phase 2 Unknown December 2018 -
NCT01327612 Advanced Solid Tumors ... More >> Carcinoid Colorectal Cancer Locally Advanced Lymphoma Metastatic Cancer Non-Small Cell Lung Cancer Sarcoma Solid Tumors Less << Phase 2 Active, not recruiting November 6, 2019 United States, California ... More >> Research Site Duarte, California, United States, 91010 Research Site La Jolla, California, United States, 92093-0957 United States, Colorado Research Site Denver, Colorado, United States, 80218 United States, Florida Research Site Tampa, Florida, United States, 33612 United States, Michigan Research Site Ann Arbor, Michigan, United States, 48109 United States, New York Research Site Buffalo, New York, United States, 14263 United States, Tennessee Research Site Memphis, Tennessee, United States, 38120 United States, Texas Research Site Houston, Texas, United States, 77030 Research Site San Antonio, Texas, United States, 78229 United States, Utah Research Site Ogden, Utah, United States, 84403 Poland Research Site Szczecin, Poland, 70-891 Spain Research Site Barcelona, Cataluña, Spain, 08035 Less <<
NCT03022734 Rectal Cancer, Metastatic Phase 2 Recruiting January 2019 Korea, Republic of ... More >> Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of, 03722 Contact: Sang Joon Shin    82-2-2228-8130 Less <<
NCT02563002 Colorectal Carcinoma Phase 3 Active, not recruiting September 19, 2019 -
NCT01703390 Metastatic Colorectal Cancer Phase 2 Recruiting August 2018 Austria ... More >> AKH Linz, Innere Medizin 3, Zentrum für Hämatologie und medizinische Onkologie Recruiting Linz, Oberösterreich, Austria, 4021 Principal Investigator: Michael Fridrik, MD          A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie Recruiting Kufstein, Tirol, Austria, 6330 Principal Investigator: August Zabernigg, MD          LKH Feldkirch, Interne E Recruiting Feldkirch, Vorarlberg, Austria, 6807 Principal Investigator: Thomas Winder, MD          LKH Bludenz Innere Medizin Recruiting Bludenz, Austria, 6700 Principal Investigator: Othmar Thurnes, MD          LKH Bregenz Recruiting Bregenz, Austria, 6900 Principal Investigator: Franz X Schmid, Dr          KH Dornbirn, Innere Medizin Recruiting Dornbirn, Austria, 6850 Principal Investigator: Guntram Winder, MD          Universitätsklinikum Graz Recruiting Graz, Austria, 8036 Principal Investigator: Helmuth Samonigg, MD          LKH Hohenems, Interne Intensivmedizin Recruiting Hohenems, Austria, 6845 Principal Investigator: Günter Höfle, MD          Krankenhaus d. Barmherzigen Schwestern Linz Recruiting Linz, Austria, A-4010 Principal Investigator: Andreas Petzer, MD          Universitätsklinik für Innere Medizin III mit Hämatologie, internistischer Onkologie, Infektologie, Rheumatologie und Onkologisches Zentrum Recruiting Salzburg, Austria, 5020 Principal Investigator: Richard Greil, MD          Medizinische Universität Wien, Univ.Klinik für Innere Medizin I, Abteilung für Onkologie Recruiting Vienna, Austria, 1090 Principal Investigator: Gerald Prager, MD Less <<
NCT03398291 Pancreatic Cancer ... More >> Liver Metastases Surgery Less << Phase 3 Recruiting June 1, 2025 China, Shanghai ... More >> Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: XianJun Yu, M.D., Ph.D.    +86-21-6417-5590    yuxianjun@fudanpci.org    Contact: Si Shi, M.D.    +86-21-6417-5590    shisi@fudanpci.org    Principal Investigator: Xianjun Yu, M.D., Ph.D. Less <<
NCT00854971 Advanced Colorectal Cancer Phase 1 Phase 2 Unknown January 2010 Korea, Republic of ... More >> The Catholic University of Korea Seoul, Banpo-dong, Korea, Republic of, 137-701 Less <<
NCT01322815 Colon Cancer Phase 2 Terminated(Poor accrual rate) - United States, District of Col... More >>umbia Georgetown University Washington, District of Columbia, United States, 20007 Less <<
NCT03768375 Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << Phase 2 Recruiting December 30, 2021 China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: Yingbin Liu, PHD    13918803900    laoniulyb@163.com    Principal Investigator: yingbin liu, PHD Less <<
NCT01910610 Colorectal Cancer Metastatic Phase 3 Recruiting December 2019 -
NCT01322815 - Terminated(Poor accrual rate) - -
NCT00381862 - Completed - -
NCT00381862 Colorectal Cancer ... More >> Nausea and Vomiting Less << Phase 2 Completed - United States, Georgia ... More >> St. Josephs/Cander Hospital Savannah, Georgia, United States, 31405 United States, Hawaii Kaiser Permanente Hilo, Hawaii, United States, 86720 United States, Illinois Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 United States, Missouri Kansas City Cancer Center Kansas City, Missouri, United States, 64104 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 United States, Texas Texas A & M university / Scott and White Clinic Temple, Texas, United States, 76508 Less <<
NCT00460603 Colorectal Neoplasms Phase 1 Phase 2 Completed - -
NCT02918162 Gastric Cancer ... More >> Adenocarcinoma of the Gastroesophageal Junction Less << Phase 2 Recruiting June 30, 2020 United States, New York ... More >> Weill Cornell Medical College/ NewYork-Presbyterian Not yet recruiting New York, New York, United States, 10021 Contact: Manish Shah, MD       mas9313@med.cornell.edu    Principal Investigator: Manish Shah, MD          Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Paul Oberstein, MD    646-317-6085    po2178@cumc.columbia.edu    Principal Investigator: Paul Oberstein, MD Less <<
NCT01206530 Rectal Cancer ... More >> Colon Cancer Metastasis Adenocarcinoma Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03034473 Locally Advanced Rectal Cancer Not Applicable Active, not recruiting October 2020 Germany ... More >> University Medical Center Goettingen Gottingen, Lower Saxony, Germany, 37075 Less <<
NCT03469479 Hepatocellular Carcinoma Phase 3 Recruiting March 2, 2023 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn    The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan The First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT01836653 Liver Only Metastasis From KRA... More >>S Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer Less << Phase 2 Completed - Japan ... More >> EPS Corporation Shinjuku-ku, Tokyo, Japan, 162-0814 Less <<
NCT02220088 Hepatocellular Carcinoma Phase 2 Phase 3 Completed - China, Guangdong ... More >> Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT02215837 Gastric Cancer ... More >> Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Gastrointestinal Diseases Less << Phase 2 Unknown May 2018 China, Guangdong ... More >> Affiliated Tumor Hospital of Guangzhou Medical University Immunotherapy center Guangzhou, Guangdong, China, 510000 China, Hubei Jingzhou Central Hospital Immunotherapy center Jingzhou, Hubei, China, 434020 Less <<
NCT00943137 Cancer (Advanced Stage) Phase 2 Unknown June 2017 Singapore ... More >> National University Hospital Singapore, Singapore, 119074 Less <<
NCT03633734 Pancreatic Adenocarcinoma Meta... More >>static Chemotherapy Effect Less << Phase 1 Phase 2 Recruiting December 31, 2024 China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Qi Zhang, MD    8613819137113 Less <<
NCT01834014 Liver Metastasis ... More >> Colorectal Cancer Less << Not Applicable Completed - Japan ... More >> EPS Corporation Shinjuku-ku, Tokyo, Japan, 162-0814 Less <<
NCT03511183 Colorectal Neoplasms ... More >> Chemotherapy Less << Phase 2 Recruiting June 1, 2020 China, Heilongjiang ... More >> Harbin Medical University Recruiting Harbin, Heilongjiang, China Contact: Yu Han, doctor Less <<
NCT01740648 Recurrent Rectal Cancer ... More >> Stage IIA Rectal Cancer Stage IIB Rectal Cancer Stage IIC Rectal Cancer Stage IIIA Rectal Cancer Stage IIIB Rectal Cancer Stage IIIC Rectal Cancer Less << Phase 1 Active, not recruiting December 31, 2022 United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63110 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States Less <<
NCT02405585 Pancreatic Cancer ... More >> Pancreatic Carcinoma Non-resectable Less << Phase 2 Terminated - United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40292 United States, Massachusetts Lahey Clinic Burlington, Massachusetts, United States United States, New Mexico New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States, 87106 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT00460603 - Completed - -
NCT02592395 Pancreatic Adenocarcinoma Phase 1 Withdrawn(PI transferred to an... More >>other institution and did not take this study with him.) Less << October 2017 -
NCT01531595 Metastatic Colorectal Cancer Phase 2 Recruiting December 2025 Finland ... More >> Department of Oncology Recruiting Helsinki, Finland Contact: Pia Osterlund, MD    +358-9-4711    pia.osterlund@hus.fi    Principal Investigator: Pia Osterlund, MD          Principal Investigator: Helena Isoniemi, MD Less <<
NCT02836847 Cholangiocarcinoma of the Extr... More >>ahepatic Bile Duct Gallbladder Cancer Less << Phase 2 Recruiting December 2020 China, Shanghai ... More >> Xinhua Hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: yingbin liu    13918803900    laoniulyb@163.com Less <<
NCT03503630 Locally Advanced Rectal Cancer Phase 2 Recruiting May 13, 2023 Jordan ... More >> King Hussein Cancer Center Not yet recruiting Amman, Jordan Contact: Rim Turfa, M.D.    +96265300460 ext 1656    rturfa@khcc.jo    Lebanon American University of Beirut Medical Center Recruiting Beirut, Lebanon Contact: Ali I Shamseddine, M.D.    00961-1-350000 ext 5390    as04@aub.edu.lb    Hôtel Dieu de France Not yet recruiting Beirut, Lebanon Contact: Joseph Kattan, M.D.    +9611615300 ext 8013    kattan62@hotmail.com Less <<
NCT03549494 Stomach Neoplasm ... More >> Gastrointestinal Neoplasms Digestive System Neoplasm Esophageal Neoplasms Head and Neck Neoplasms Gastrointestinal Disease Digestive System Disease Esophageal Diseases Stomach Diseases Esophagogastric Junction Disorder Less << Phase 2 Not yet recruiting October 1, 2019 Cuba ... More >> National Institute of Oncology and Radiobiology (INOR) Not yet recruiting Havana, La Habana, Cuba, 10400 Contact: Luis E. Alsina Tul, Dr.    +53-78388589    lealsina@infomed.sld.cu    Principal Investigator: Luis E. Alsina Tul, Dr.          Sub-Investigator: Yanelys Mir Espinosa, Dr.          Sub-Investigator: Giselle Álvarez Pérez, BSc          Sub-Investigator: Karelia Silvera Candó, BSc          Sub-Investigator: Zaida Lastre Sosa, BSc          Sub-Investigator: Janet Lamadrid García, Dr.          Sub-Investigator: Danay Corrales Otero, Dr.          Sub-Investigator: Marta Lugioyo Lugo, BSc          Sub-Investigator: Juan J. Lence Anta, Dr. Less <<
NCT02271464 Metastatic Colorectal Cancer Phase 2 Completed - Italy ... More >> Istituto Ospedaliero Fondazione Poliambulanza Di Brescia Brescia, Italy, 25124 Pres.Ospedaliero Spedali Civili Brescia Brescia, Italy, 25125 Istituti Ospitalieri Di Cremona Cremona, Italy, 26100 Azienda Ospedaliera S. Croce E Carle Di Cuneo Cuneo, Italy, 12100 A.O. Universitaria Arcispedale S.Anna Di Ferrara Ferrara, Italy, 44100 Ausl Di Frosinone - Frosinone, Italy, 03100 E.O. Ospedali Galliera Genova, Italy, 16128 Ospedale Per Acuti Mater Salutis Di Legnago Legnago, Italy, 37045 Oncologia AUSL 2 Lucca Lucca, Italy Irccs Fondazione Centro S. Raffaele Del Monte Tabor Milano, Italy, 20132 A.O. Universitaria Federico Ii Di Napoli Napoli, Italy, 80131 Irccs Istituto Oncologico Veneto (Iov) Padova, Italy, 35128 Polo Oncologico Area Vasta Nord Ovest Pisa, Italy, 56100 Ausl 5 Di Pisa Pontedera, Italy, 56100 Ospedale Mesericordia E Dolce Prato, Italy, 59100 Ospedale S. Maria Nuova Reggio Emilia, Italy, 42100 Ospedale San Giovanni Calibita Fatebenefratelli Roma, Italy, 00186 Ospedale San Pietro Fatebenefratelli Di Roma Roma, Italy, 00189 Campus Biomedico Roma, Italy A.O. Universitaria S. Maria Della Misericordia Udine, Italy, 33100 Less <<
NCT03720678 GastroEsophageal Cancer ... More >> Colorectal Cancer Less << Phase 1 Recruiting July 30, 2021 United States, North Carolina ... More >> Huntersville, NC Recruiting Huntersville, North Carolina, United States, 28078 Contact: Principal Investigator          Principal Investigator: Principal Investigator          Australia, New South Wales Sydney, Australia Recruiting Sydney, New South Wales, Australia, 2010 Contact: Principal Investigator          Principal Investigator: Principal Investigator Less <<
NCT03229096 Chemotherapy Effect ... More >> Chemotherapeutic Toxicity Gastric Cancer Less << Phase 2 Recruiting December 1, 2021 China, Shanghai ... More >> ZhongShan hospital FuDan university Recruiting Shanghai, Shanghai, China, 200032 Contact: Yi-Hong Sun, MD    86-13701735406    sun.yihong@zs-hospital.sh.cn    Principal Investigator: Yi-Hong Sun, MD Less <<
NCT02268825 Advanced GI Cancer Phase 1 Terminated(Merck requested to ... More >>change MK-3475 dosing schedule; PI decided to close instead) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT03139435 Peripheral Neuropathy ... More >> Stage 0 Breast Cancer Stage I Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage III Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Not Applicable Recruiting March 2019 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Roy E. Strowd    336-716-6777    rstrowd@wakehealth.edu    Principal Investigator: Roy E. Strowd Less <<
NCT03511170 Colorectal Neoplasms ... More >> Chemotherapy Less << Phase 2 Recruiting June 1, 2020 China, Heilongjiang ... More >> Harbin Medical University Recruiting Harbin, Heilongjiang, China Contact: Yu Han, doctor Less <<
NCT01453257 Progression Free Survival Phase 2 Completed - Spain ... More >> Centro Integral Oncológico Clara campal Madrid, Spain, 28050 Less <<
NCT03100708 - Recruiting April 2021 Germany ... More >> Universitätsklinikum Leipzig - AöR Recruiting Leipzig, Sachsen, Germany, 04103 Less <<
NCT01437618 - Completed - Italy ... More >> Azienda Ospedaliero-Universitaria Pisana Pisa, Italy, 56126 Less <<
NCT03038256 Rectal Cancer ... More >> Pathological Complete Response Disease Free Survival Less << Phase 2 Not yet recruiting December 1, 2022 -
NCT02533271 Cancer, Rectum Phase 3 Recruiting August 2025 China, Beijing ... More >> Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Recruiting Beijing, Beijing, China Contact: Yang Tang    +86-15011304945    tangyuan82@126.com    Contact: Jing Jin    +86-13601365130    jingjin1025@163.com Less <<
NCT02826837 Advanced Colorectal Cancer Phase 1 Phase 2 Not yet recruiting February 1, 2022 -
NCT01362582 Pancreatic Cancer Phase 3 Terminated - Germany ... More >> Onkologische Schwerpunktpraxis und Tagesklinik Bad Soden, Germany, 65812 Krankenhaus Nordwest Frankfurt Frankfurt am Main, Germany, 60488 University Hospital of Heidelberg / National Center for Tumordiseases Heidelberg, Germany, 69120 Asklepios Klinik Weißenfels Weißenfels, Germany, 06667 Less <<
NCT03251612 Colorectal Cancer Metastatic Phase 2 Recruiting December 2020 Denmark ... More >> Department of Oncology, Aalborg University Hospital Not yet recruiting Aalborg, Denmark Contact: Mette Yilmaz, MD       m.yilmaz@rn.dk    Department of Oncology, Rigshospitalet Not yet recruiting Copenhagen, Denmark Contact: Lone N Petersen, MD       Lone.Noergaard.Petersen@regionh.dk    Departmen of Oncology, Vejle Hospital Recruiting Vejle, Denmark Contact: Lars H Jensen, MD       lars.henrik.jensen@rsyd.dk    Germany Universitätsklinikum Hamburg - Eppendorf, Universitäres Cancer Center Hamburg (UCCH) Not yet recruiting Hamburg, Germany Contact: Andreas Block, MD       block@uke.de Less <<
NCT01540435 Colon Cancer Liver Metastasis Phase 2 Withdrawn(insufficient recruit... More >>ment) Less << - -
NCT01161316 Metastatic Colorectal Cancer Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain, 28046 Less <<
NCT03455205 Digestive Tract Not Applicable Recruiting December 30, 2019 China, Guangdong ... More >> First affiliated hospital of guangzhou university of traditional Chinese medicine Recruiting Guangzhou, Guangdong, China Contact: lin lizhu, Dr.    13501505588    13501505588@163.com Less <<
NCT02749136 Pancreatic Adenocarcinoma Phase 2 Recruiting June 2019 Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 05505 Contact: Changhoon Yoo, MD    +82-2-3010-1727    yooc@amc.seoul.kr Less <<
NCT03426371 Metastatic Colorectal Cancer Phase 3 Recruiting December 2023 China, Beijing ... More >> 307 Hospital of PLA Recruiting Beijing, Beijing, China, 100071 Contact: Jianming Xu    010-56943977    Hjc1126@sina.com Less <<
NCT01505166 Colon Cancer Phase 2 Terminated(Terminated (Busines... More >>s Decision to pursue other indications)) Less << - United States, Texas ... More >> Mary Crowley Cancer Research Centers Dallas, Texas, United States, 75230 Less <<
NCT02748772 Colorectal Neoplasms Phase 3 Unknown December 2018 China, Anhui ... More >> Anhui Cancer Hospital Recruiting Hefei, Anhui, China, 230000 Contact: CHANGLU HU, Bachelor    +8613955116061    huchanglu@csco.org.cn    Anhui Jimin Cancer Hospital Recruiting Hefei, Anhui, China, 230000 Contact: AIGUO LIU, Doctor    +8613805512862    lag5912@163.com    The First People's Hospital of Hefei Recruiting Hefei, Anhui, China, 230000 Contact: FU DAI, Master    +8613705609377    hfsyydf@sina.com    Contact: YANGYI BAO, Bachelor    +8618655168357    Dr_yangyibao@hotmail.com Less <<
NCT00975897 Colorectal Cancer Phase 2 Phase 3 Completed - United Kingdom ... More >> Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Belfast City Hospital Trust Incorporating Belvoir Park Hospital Belfast, Northern Ireland, United Kingdom, BT8 8JR Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT01206049 Cholangiocarcinoma Phase 2 Completed - Denmark ... More >> Department of Oncology, Vejle Hospital Vejle, Denmark, DK-7100 Less <<
NCT01472250 - Completed - China, Beijing ... More >> Lin Shen Beijing, Beijing, China, 100142 Less <<
NCT01505166 - Terminated(Terminated (Busines... More >>s Decision to pursue other indications)) Less << - -
NCT03174405 Metastatic Colorectal Cancer Phase 2 Active, not recruiting August 2021 Germany ... More >> Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany Less <<
NCT03228043 Apatinib Outc... More >>ome, Fatal Colorectal Cancer Surgery Adjuvant Chemotherapy Less << Not Applicable Recruiting March 1, 2023 China, Sichuan ... More >> Yunhong Tian Recruiting Nanchong, Sichuan, China, 637000 Contact: Yunhong Tian, Doctor    +8613508087719    drtianyunhong@126.com Less <<
NCT02055924 B-cell Lymphoma Phase 1 Terminated(ANSM decision due t... More >>o veino occlusive disease (security alert)) Less << - Belgium ... More >> Universite Catholique de Louvain Saint Luc Bruxelles, Belgium CHU de Liège Liège, Belgium, 04000 CHU UCL Namur asbl Yvoir, Belgium, 5530 France Centre François Baclesse Caen, France, 14076 Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon - Hôpital le Bocage Dijon, France, 21034 CHRU de Lille - Hôpital Claude Huriez Lille, France, 59037 Centre Léon Bérard Lyon, France, 69373 CHU Montpellier Montpellier, France, 34295 CHU de Nantes Nantes, France, 44093 Hôpital Saint Louis Paris, France, 75475 Centre François Magendie - Hôpital du Haut Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Bénite, France, 69495 CHU Pontchaillou Rennes, France, 35003 Centre Henri Becquerel Rouen, France, 76038 Less <<
NCT03399071 Gastric Adenocarcinoma ... More >> Oesophageal Adenocarcinoma Less << Phase 2 Recruiting August 15, 2025 United Kingdom ... More >> The Royal Marsden Hospital Recruiting London, United Kingdom, SW3 6JJ Contact: Marco Gerlinger, MD, FRCP    02071535234    marco.gerlinger@icr.ac.uk Less <<
NCT01298570 Colorectal Cancer Metastatic Phase 2 Active, not recruiting February 2019 United States, Colorado ... More >> Rocky Mountain Cancer Centers Denver, Colorado, United States, 80218 United States, Florida Mount Sinai Medical Center-Miami Miami, Florida, United States, 33140 Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 Georgia Cancer Specialists Atlanta, Georgia, United States, 30341 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Kentucky University of Louisville James Brown Cancer Center Louisville, Kentucky, United States, 40202 United States, New York North Shore Long Island Jewish Health System Manhasset, New York, United States, 11030 New York University Langone Medical Center New York, New York, United States, 10016 United States, North Carolina Seby B. Jones Cancer Center Boone, North Carolina, United States, 28607 University of North Carolina Chapel Hill, North Carolina, United States, 27599 Carolinas HealthCare System Charlotte, North Carolina, United States, 28262 Southeast Medical Oncology Center Goldsboro, North Carolina, United States, 27534 The Moses Cone Regional Cancer Center Greensboro, North Carolina, United States, 27403 Leo W. Jenkins Cancer Center at ECU Medical School Greenville, North Carolina, United States, 27834 First Health of the Carolinas, Moore Regional Hospital Pinehurst, North Carolina, United States, 28374 Rex Cancer Center at Rex Hospital Raleigh, North Carolina, United States, 27607 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio University of Cincinnati Cincinnati, Ohio, United States, 45267 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43221 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22903 Portsmouth Naval Medical Center Portsmouth, Virginia, United States, 23708 United States, Washington Multicare Regional Cancer Center Tacoma, Washington, United States, 98405 Ireland Ireland Cooperative Clinical Research Group Dublin, Ireland Less <<
NCT01298570 - Active, not recruiting - -
NCT03524287 Stomach Neoplasms Phase 1 Phase 2 Enrolling by invitation August 31, 2022 China, Fujian ... More >> Fujian Medical University Union Hospital Fuzhou, Fujian, China, 350001 Less <<
NCT03435107 Metastatic Colorectal Cancer Phase 2 Recruiting May 31, 2022 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Contact: TaeWon Kim, PhD Less <<
NCT01493713 Colorectal Cancer ... More >> Hepatic Metastasis Less << Phase 4 Completed - Spain ... More >> Hospital de Donostia San Sebastián, Guipúzcoa, Spain, 20014 Hospital Universitario Fundación Alcorcón Alcorcón, Madrid, Spain, 28922 Hospital Universitario Puerta de Hierro de Majadahonda Majadahonda, Madrid, Spain, 28222 Hospital Son Llatzer Palma de Mallorca, Mallorca, Spain, 07198 Hospital Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain, 30120 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Hospital del Mar Barcelona, Spain, 08003 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clìnic Barcelona, Spain, 08036 Complejo Hospitalario Xeral Calde Lugo, Spain, 27004 Hospital Universitario Arnau de Vilanova de Lleida Lérida, Spain, 25198 Hospital General Universitario Gregorio Marañón Madrid, Spain, 28009 Hospital Universitario La Paz Madrid, Spain, 28046 Complejo Hospitalario Universitario de Ourense Orense, Spain, 32005 Hospital Universitario Central de Asturias Oviedo, Spain, 33006 Hospital de Sabadell Sabadell, Spain, 08208 Hospital General Universitario de Valencia Valencia, Spain, 46014 Hospital Arnau de Vilanova de Valencia Valencia, Spain, 46015 Hospital Universitario y Politécnico La Fe Valencia, Spain, 46026 Complejo Hospitalario Universitario de Vigo Vigo, Spain, 36036 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT02241551 Borderline Resectable Pancreat... More >>ic Cancer Less << Phase 2 Terminated(Study was terminate... More >>d with the IRB ended early as logistical concerns of the SBRT) Less << - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02241551 - Terminated(Study was terminate... More >>d with the IRB ended early as logistical concerns of the SBRT) Less << - -
NCT03336216 Advanced Pancreatic Cancer Phase 2 Recruiting December 15, 2020 -
NCT00737438 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center Commack, New York, United States Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT03193190 Pancreatic Adenocarcinoma Phase 1 Phase 2 Recruiting September 19, 2020 -
NCT00737438 - Completed - -
NCT00832299 - Terminated(terminated for lack... More >> of enrollment) Less << - -
NCT02996617 Lymphoma,Non-Hodgkin Phase 4 Unknown December 2018 China, Shandong ... More >> Department of Hematology, Provincial Hospital Affiliated to Shandong University Recruiting Jin'an, Shandong, China, 250012 Contact: Xin Wang, MD, PHD    86-531-68778331    xinw007@126.com    Contact: changqing zhen, MD    86-531-68778331    zcq1521@163.com Less <<
NCT03085914 Solid Tumors ... More >>Colorectal Cancer (CRC) Adenocarcinoma (PDAC) Lung Cancer UC (Urothelial Cancer) Head and Neck Cancer Less << Phase 1 Phase 2 Active, not recruiting January 2020 United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, California University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States, 92093 The Angeles Clinic and Research Institute Los Angeles, California, United States, 90025 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Carolina Bio-Oncology Institute, PLLC Huntersville, North Carolina, United States, 28078 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Health System Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15237 United States, Tennessee Tennessee Oncology - Nashville; The Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt University; Henry Joyce Cancer Clinic Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT02009449 Melanoma Pros... More >>tate Cancer Ovarian Cancer Renal Cell Carcinoma Colorectal Carcinoma Pancreatic Carcinoma Non-small Cell Lung Carcinoma Solid Tumors Breast Cancer Less << Phase 1 Active, not recruiting March 2020 United States, California ... More >> UCLA Medical Hematology & Oncology Los Angeles, California, United States, 90024 UCSF San Francisco, California, United States United States, Colorado Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists & Research Institute Sarasota, Florida, United States, 34232 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Oklahoma Stephenson Cancer Center at Oklahoma University TSET Phase 1 Program Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less <<
NCT00832299 Rectal Neoplasms Phase 2 Terminated(terminated for lack... More >> of enrollment) Less << - United States, New York ... More >> Beth Israel Medical Center New York, New York, United States, 10003 St. Luke's Roosevelt Hospital Center New York, New York, United States, 10019 Less <<
NCT03503604 Solid Tumors Phase 1 Not yet recruiting March 1, 2019 China, Shanghai ... More >> Shanghai East Hospital Not yet recruiting Shanghai, Shanghai, China, 200120 Contact: Jin Li, MD,Phd    86-13761222111    lijin@csco.org.cn    Principal Investigator: Jin Li, Professor          Sub-Investigator: Ye Guo, Professor Less <<
NCT01791361 - Completed - -
NCT01209962 - Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT02962063 Esophageal Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Less << Phase 2 Recruiting November 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Geoffrey Ku, MD    646-888-4588       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Geoffrey Yu, MD    646-888-4588       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Geoffrey Yu, MD    646-888-4588       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Geoffrey Ku, MD    646-888-4588       Principal Investigator: Geoffrey Ku, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Geoffrey Yu, MD    646-888-4588 Less <<
NCT00717990 Metastatic Colorectal Cancer Phase 2 Terminated(Poor Accrual) - Greece ... More >> University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Less <<
NCT00486460 Pancreatic Cancer Phase 3 Unknown - Israel ... More >> Sourasky Medical Center Recruiting Tel Aviv, Israel, 64239 Contact: Nadir Arber, M.D, MSc, MHA    03-6953179    nadir@tasmc.health.gov.il Less <<
NCT02912052 Colon Cancer Phase 3 Not yet recruiting October 2023 China, Jiangsu ... More >> Jiangsu province hospital Nanjing, Jiangsu, China, 210029 Less <<
NCT01134666 - Terminated(The study was disco... More >>ntinued due to slow recruitment and subjects not completing follow up period.) Less << - India ... More >> Indo- American Cancer Institute & Research Centre Hyderabad, Andhra Pradesh, India, 500034 NVS Ramakrishna's Clinic Hyderabad, Andhra Pradesh, India, 500063 Dr. Nikhil's Clinic Secunderabad, Andhra Pradesh, India, 500025 Nikhil Gharyalpatil's Clinic Secunderabad, Andhra Pradesh, India, 500025 Ravi Kumar's Clinic Hyderabad, Andrapradesh, India, 500001 Ambaa Hospitals Hyderabad, Andrapradesh, India, 500008 Swarna Sai Hospital Hyderabad, Andrapradesh, India, 500059 Manipal Centre For Clinical Research Mangalore, Bangalore, India, 575 001 Medical College Calicut Kerala, Calicut, India, 673016 Hemato Oncology Clinic Ahmedabad, Gujarat, India, 380009 Kattimani Oncology Clinic Hubli, Karnataka, India, 580020 SKIMS Srinagar, Kashmir, India, 190001 S. K. I. M. S. Srinagar, Kashmir, India, 190010 Dr. T. P. Sahoo's Clinic Bhopal, Madhya Pradesh, India, 462001 BND Onco Centre Mumbai, Maharashtra, India, 400014 Joy Hospital Mumbai, Maharashtra, India, 400071 Ruby Hall Clinic Pune, Maharashtra, India, 411001 Grace Nursing Home Aizwal, Mizoram, India, 796 009 Lilavati Hospital Bandra, Mumbai, India, 400050 S.L.Raheja Hospital Mahim, Mumbai, India, 400016 Apollo Cancer Institute Delhi, New Delhi, India, 110044 Rajiv Gandhi Cancer Institute & Research Delhi, New Delhi, India, 110085 Fortis Escorts Hospital Amritsar, Punjab, India, 143004 Dr. Rajeev Bedi's Clinic Chandigarh, Punjab, India, 160101 D.M.C Hospital Ludhiana, Punjab, India, 141001 IVY Hospital Mohali, Punjab, India, 160071 Cancer Clinic Jaipur, Rajasthan, India, 302004 SMS Hospital Jaipur, Rajasthan, India, 302004 Bhagwan Mahaveer Cancer Hospital Jaipur, Rajasthan, India, 302006 Bhagwan Mahaveer Cancer Hospital & Research Centre Jaipur, Rajasthan, India, 302030 Vyas Cancer Care Jodhpur, Rajasthan, India, 3420003 TC 14/ 764 Sreemangalam Trivandrum, Tamilnadu, India, 695011 Shati Gopal Hospital Ghaziabad, Uttar Pradesh, India, 201014 Annapurna Medical and Cancer Relief Society Lucknow, Uttar Pradesh, India, 226007 Chittaranjan National Cancer Institute Kolkata, West Bengal, India, 700026 Apollo Gleneagles Cancer Hospital Kolkata, West Bengal, India, 700054 Nothern Railway Central Hospital Delhi, India, 110055 Indraprastha Apollo Hospital Delhi, India, 110076 Shanti Mukand Hospital Delhi, India, 110092 Dharamshila Cancer Hospital & Research Centre Delhi, India, 110096 Less <<
NCT01460589 Colon Cancer Phase 3 Recruiting December 2018 Korea, Republic of ... More >> Kyungpook National University Hospital Recruiting Daegu, Korea, Republic of, 700-721 Contact: Jun seok Park, M.D.    +82-53-420-6555    caumed5@naver.com    Gyu seog Choi Recruiting Daegu, Korea, Republic of Contact: Jun seok Park, M.D.    +82-53-200-2166    caumed5@naver.com Less <<
NCT01679054 - Completed - Hong Kong ... More >> Princess Margaret Hospital Kowloon, Hong Kong Less <<
NCT01035385 Colorectal Cancer ... More >> Liver Metastasis Less << Phase 3 Unknown December 2015 China, Guangdong ... More >> Guangdong General Hospital Recruiting Guangzhou, Guangdong, China Contact: Yong Li, Dr       yongyongsamrt@yahoo.cn    Sub-Investigator: Yong Li Less <<
NCT00044863 Colorectal Neoplasms ... More >> Metastases, Neoplasm Less << Phase 2 Completed - United States, Missouri ... More >> ImClone Investigational Site St. Charles, Missouri, United States, 63301 Less <<
NCT02510469 Gastric Cancer Phase 2 Phase 3 Recruiting July 2018 China, Hebei ... More >> Fourth Affiliated Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050011 Principal Investigator: Zhao Qun, MD Less <<
NCT01630083 CLDN18.2-positive Adenocarcino... More >>ma of the Gastroesophageal Junction CLDN18.2-positive Adenocarcinoma of Esophagus CLDN18.2-positive Gastric Adenocarcinoma Less << Phase 2 Active, not recruiting December 2018 -
NCT01757366 Self Efficacy Phase 2 Unknown December 2016 China, Hebei ... More >> Hebei Tumor Hospital Recruiting Shijiazhuang, Hebei, China, 050011 Contact: Baoen Shan    13803343508    15931166600@126.com    Principal Investigator: Wei Liu Less <<
NCT02972541 Colorectal Cancer ... More >> Neoadjuvant Chemotherapy Stent Obstruction Less << Not Applicable Recruiting December 2020 -
NCT01308086 CRC Phase 3 Active, not recruiting December 2017 Greece ... More >> University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Less <<
NCT01632306 Pancreatic Cancer Phase 1 Phase 2 Terminated(Study has been term... More >>inated due to slow enrollment.) Less << - United States, Florida ... More >> Mayo Clinic of Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01760694 Pancreatic Cancer Not Applicable Terminated(Lack of enrollment) - United States, Oklahoma ... More >> Southwestern Regional Medical Center, Inc. Tulsa, Oklahoma, United States, 74133 Less <<
NCT01632306 - Terminated(Study has been term... More >>inated due to slow enrollment.) Less << - -
NCT02037048 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Adenocarcinoma of the Gastric Cardia Stage IIIA Esophageal Cancer Stage IIIB Esophageal Cancer Stage IIIC Esophageal Cancer Less << Phase 2 Recruiting April 2019 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Michael J. McNamara    216-444-5110    mcnamam@ccf.org    Principal Investigator: Michael J. McNamara Less <<
NCT01283204 Recurrent or Metastatic Gastri... More >>c Cancer Less << Phase 2 Unknown August 2016 Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT00724503 Colorectal Cancer ... More >> Colorectal Carcinoma Liver Metastases Less << Not Applicable Completed - -
NCT03006432 OESOPHAGO-GASTRIC CARCINOMA Phase 3 Recruiting August 2022 -
NCT02440958 Pancreatic Ductal Adenocarcino... More >>ma Less << Phase 2 Unknown February 2017 -
NCT03015675 Gastric Cancer Phase 3 Recruiting December 2019 China, Guangdong ... More >> Medical Oncology,Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Feng Wang, M.D,Ph.D    86-18620880867    wangfeng@sysucc.org.cn Less <<
NCT02515734 Colorectal Cancer Phase 2 Not yet recruiting June 2020 -
NCT03222089 Metastatic Colorectal Cancer Phase 2 Withdrawn(Another study enroll... More >>ing the similar group of patient are ongoing) Less << July 20, 2020 China, Fujian ... More >> Rongbo Lin Fuzhou, Fujian, China, 350014 Less <<
NCT03374254 Metastatic Colorectal Cancer Phase 1 Recruiting November 26, 2021 United States, California ... More >> City of Hope National Medical Center ( Site 0102) Recruiting Duarte, California, United States, 91010 Contact: Study Coordinator    626-471-9200       United States, Colorado Anschutz Medical Campus, Anschutz Cancer Pavilion ( Site 0106) Recruiting Aurora, Colorado, United States, 80045 Contact: Study Coordinator    303-724-3532       United States, Connecticut Yale Cancer Center ( Site 0108) Recruiting New Haven, Connecticut, United States, 06520 Contact: Study Coordinator    203-785-6661       United States, Florida Moffitt Cancer Center ( Site 0111) Recruiting Tampa, Florida, United States, 33612 Contact: Study Coordinator    813-745-2742       United States, Illinois University of Chicago ( Site 0105) Recruiting Chicago, Illinois, United States, 60637 Contact: Study Coordinator    773-702-7763       United States, New Jersey Rutgers Cancer Institute of New Jersey ( Site 0107) Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Study Coordinator    732-235-2465       United States, Pennsylvania UPMC Cancer Center/Hillman Cancer Center ( Site 0113) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Study Coordinator    412-623-2677       United States, Texas Baylor Scott and White ( Site 0110) Recruiting Temple, Texas, United States, 76508 Contact: Study Coordinator    254-724-3796       United States, Washington Seattle Cancer Care Alliance ( Site 0104) Recruiting Seattle, Washington, United States, 98109 Contact: Study Coordinator    206-288-6248       Northwest Medical Specialties, PLLC ( Site 0101) Recruiting Tacoma, Washington, United States, 98405 Contact: Study Coordinator    253-428-8738       Canada, Alberta Cross Cancer Institute ( Site 0123) Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Study Coordinator    7804328248       Canada, Ontario Princess Margaret Cancer Centre ( Site 0122) Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Study Coordinator    4169462263       Canada, Quebec Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0124) Recruiting Montreal, Quebec, Canada, H2X 0C1 Contact: Study Coordinator    514890800025381       Jewish General Hospital ( Site 0121) Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Study Coordinator    5143408222 Less <<
NCT00866944 Liver Metastases ... More >> Colorectal Cancer Less << Phase 2 Completed - France ... More >> Centre Paul Strauss Strasbourg, France, 67065 Germany Zentralklinikum Augsburg Augsburg, Germany, 86156 Klinikum am Bruderwald, Sozialstiftung Bamberg Bamberg, Germany, 96049 Charité Campus Virchow Klinikum Berlin, Germany, 13353 Klinikum der Heinrich-Heine Universität Düsseldorf, Germany, 40489 J.W. Goethe-Universität Frankfurt, Germany, 60590 Martin-Luther Universität Halle, Germany, 06120 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitätsklinikum Leipzig Leipzig, Germany, 04103 Klinikum Magdeburg gGmbH Magdeburg, Germany, 39130 Klinikum der Johannes-Gutenberg Universität Mainz, Germany, 55131 Klinikum Mannheim GmbH Universitätsklinikum Mannheim, Germany, 68167 Universitätsklinikum der LMU Grosshadern München, Germany, 81377 Städtisches Klinikum Neuperlach München, Germany, 81737 Klinikum Oldenburg gGmbH Oldenburg, Germany, 26133 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Less <<
NCT01016028 - Withdrawn(Study assessment too... More >>l development delayed.) Less << - -
NCT00873756 Metastatic Colorectal Cancer Phase 1 Completed - United States, California ... More >> Los Angeles, California, United States, 90095 San Francisco, California, United States, 94115 United States, Colorado Aurora, Colorado, United States, 80045 Fort Collins, Colorado, United States, 80528 United States, Illinois Harvey, Illinois, United States, 60426 United States, New Mexico Albuquerque, New Mexico, United States, 87131 United States, North Carolina Chapel HIll, North Carolina, United States, 27599 Less <<
NCT01622543 Colorectal Cancer Phase 2 Active, not recruiting June 2018 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT03645187 Colon Cancer Stage Phase 4 Recruiting December 2025 Egypt ... More >> Amira Roushdy Recruiting Tanta, Elgharbia, Egypt, 35111 Contact: amira roushdy, msc    00201095159522 Less <<
NCT01926769 Previously Treated Advanced Co... More >>lorectal Cancer Less << Phase 2 Terminated(Slow accrual rate) - Korea, Republic of ... More >> Gachon University Gil Medical Center Incheon, Korea, Republic of Less <<
NCT00718354 Gastric Cancer ... More >> Gastroesophageal Cancer Less << Phase 3 Completed - India ... More >> Mahatma Gandhi Cancer Hospital & Research Institute ,1/7 M.V.P. Colony, - ,, . Vishakhapattanam, Andhra Pradesh, India, 530017 Mahavir Cancer Sansthan,Phulwari Sharif Patna, Bihar, India, 801505 Gujarat Cancer Research Institute, Civil Hospital Campus,Asarwa, , Ahmedabad, Gujarat,, India, 380016 Department Of Radiotherapy,S.S.G. Hospital, - Baroda,Vadodara, Gujarat,, India, 390 001 Gokula Curie Cancer Centre,M.S.Ramaiah Memorial Hospital,MSR Nagar, MSRIT Post Bangalore, Karnataka, India, 560054 Madhavan J.P. Trivandrum, Kerala,, India, 695011 MGM Medical College & MY Hospital, Indore, M.P, India, 452005 Curie Manavta Cancer Centre, Opp.Hotel Sandeep Naka,Nashik Mumbai, Maharashtra,, India, 425004 Ruby Hall Clinic,Cancer Building,40 sassoon Road, , , Pune, Maharashtra, India, 411001 Cancer Hospital & Research Institute, Cancer Hill Gwalior, MP, India, 474009 Acharya Tulsi Regional Cancer Treatment & Research Institute Bikaner, UP, India B.P.Poddar Hospital & Medical Research Ltd,71/1, Humayun Kabir Sarani,, Block-G, New Alipore Kolkata, west Bangol, India, 700053 Biswajit Sanyal Calcutta, West Bengal, India Chittaranjan National Cancer Institute,37, S.P.Mukhurjee Road Kolkata, West Bengal, India, 700026 Dr. BRA IRCH,all India Institute of Medical Sciences,Ansari Nagar, New Delhi, India, 110029. Less <<
NCT01394939 Colorectal Carcinoma ... More >> CRC Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States, 85259-5499 United States, California UCSD Moores Cancer Center La Jolla, California, United States, 92093 United States, Montana Billings Clinic Cancer Center Billings, Montana, United States, 59101 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599-1651 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States The Ohio State University Columbus, Ohio, United States, 43210 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Ottawa Hospital and Research Institute (OHRI) Ottawa, Ontario, Canada, K1H 8L6 France Hôpital Saint Antoine Paris, France, 75012 Hôpital Hautepierre Strasbourg, France, 67098 Institut Claudius Regaud Toulouse, France, 31052 Less <<
NCT03714555 Metastatic Pancreatic Cancer Phase 2 Not yet recruiting November 1, 2020 -
NCT02291289 Colorectal Cancer Phase 2 Suspended(Following iDMC revie... More >>w of cohort 4 data a temporary recruitment halt to the whole study and a temporary halt to randomisation into cohort 4 has been undertaken) Less << December 29, 2021 -
NCT03170960 Urothelial Carcinoma ... More >> Renal Cell Carcinoma Non-Small Cell Lung Cancer Castration-resistant Prostate Cancer Triple Negative Breast Cancer Ovarian Cancer Endometrial Cancer Hepatocellular Carcinoma Gastric Cancer Gastroesophageal Junction Adenocarcinoma Colorectal Cancer Head and Neck Cancer Differentiated Thyroid Cancer Less << Phase 1 Phase 2 Recruiting December 2020 -
NCT03186326 Metastatic Colorectal Cancer ... More >> MSI Less << Phase 2 Recruiting March 31, 2025 -
NCT01343901 - Completed - -
NCT02605265 Locally Advanced Rectal Cancer Phase 3 Recruiting December 2020 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Ji Zhu, MD       leo.zhu@126.com    Principal Investigator: Zhen Zhang, MD          Sub-Investigator: Ji Zhu, MD Less <<
NCT01488552 Stage IV Pancreatic Cancer Phase 1 Phase 2 Completed - United States, Arizona ... More >> TGen Clinical Research Services (TCRS) Scottsdale, Arizona, United States, 85258 United States, California Disney Family Cancer Center Burbank, California, United States, 91505 United States, Minnesota Virginia Piper Cancer Institute (VPCI) Minneapolis, Minnesota, United States, 55407 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Evergreen Hematology and Oncology Spokane, Washington, United States, 99218 Less <<
NCT01343901 - Completed - -
NCT03716518 Colon Cancer Phase 3 Not yet recruiting December 31, 2020 China, Beijing ... More >> Beijing Chao Yang Hospital Not yet recruiting Beijing, Beijing, China, 100020 Contact: Minzhe Li, M.D.          Oncology Department of Xiyuan Hospital of China Academy of Chinese Medical Sciences Not yet recruiting Beijing, Beijing, China, 100091 Contact: Yun Xu, M.D.    86 10 62835355    xyxiao78@163.com    Contact: Yufei Yang, M.D.    86 10 62835355    yyfwdbwyy@126.com    Peking University Third Hospital Not yet recruiting Beijing, Beijing, China, 100191 Contact: Tao Sun, M.D.          China, Guangzhou Guangdong Provincial Hospital of Traditional Chinese Medicine Guangdong, Guangzhou, China, 510120 China, Jiangsu Jiangsu Province Hospital of Traditional Chinese Medicine Not yet recruiting Nanjing, Jiangsu, China, 210029 Contact: Peng Shu, M.D.          China, Shanghai Shanghai Zhongshan Hospital Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Tianshu Liu, M.D.          China, Tianjin Tianjin Union Medical Center Not yet recruiting Tianjin, Tianjin, China, 300121 Contact: Huaqing Wang, M.D. Less <<
NCT03463837 Nicotine Dependence, Other Tob... More >>acco Product Tobacco Use Smoking, Tobacco Less << Not Applicable Active, not recruiting March 2019 United States, Nebraska ... More >> Celerion Lincoln, Nebraska, United States, 68502 Less <<
NCT01048463 Gastric Cancer ... More >> Colorectal Cancer Chemotherapy Less << Phase 3 Unknown January 2012 China, Guangdong ... More >> First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Han-ping Shi, MD, PhD    86-0-13802741263    shihp38@hotmail.com Less <<
NCT01333709 Locally Advanced Malignant Neo... More >>plasm Rectal Carcinoma Less << Phase 2 Completed - France ... More >> CRLC Val d'Aurelle-Paul Lamarque Montpellier, France, 34298 Less <<
NCT03253575 - Recruiting December 15, 2019 -
NCT01792934 Multi-organ Metastatic Colorec... More >>tal Cancer Less << Not Applicable Recruiting December 2020 Netherlands ... More >> Noordwest Ziekenhuis Groep Recruiting Alkmaar, Netherlands Contact: MP Hendriks, Dr          Principal Investigator: MP Hendriks, Dr          Ziekenhuisgroep Twente Recruiting Almelo, Netherlands Contact: R Hoekstra, R          Principal Investigator: R Hoekstra, R          Meander Medisch Centrum Recruiting Amersfoort, Netherlands Contact: HJ Bloemendal, HJ          Principal Investigator: HJ Bloemendal, Dr          Amstelveen Ziekenhuis Recruiting Amstelveen, Netherlands Contact: AA van Zweeden, Drs          Principal Investigator: AA van Zweeden, Drs          VU Medical Center Recruiting Amsterdam, Netherlands, NL-1081 HV Contact: H.M.W. Verheul, MD, PhD    0031-20-4444321    h.verheul@vumc.nl    Principal Investigator: H.M.W. Verheul, MD, PhD          Academisch Medisch Centrum Recruiting Amsterdam, Netherlands Contact: PJ Tanis, Dr          Principal Investigator: PJ Tanis, Dr          Onze Lieve Vrouwe Gasthuis Not yet recruiting Amsterdam, Netherlands Contact: JM Meerum Terwogt, Dr          Principal Investigator: JM Meerum Terwogt, Dr          Amphia Ziekenhuis Recruiting Breda, Netherlands Contact: A Ten Tije, Dr          Principal Investigator: A Ten Tije, Dr          Medisch Centrum Haaglanden Recruiting Den Haag, Netherlands Contact: HH Helgason, Dr          Principal Investigator: HH Helgason, Dr          Deventer Ziekenhuis Recruiting Deventer, Netherlands Contact: H Torrenga, Dr          Principal Investigator: H Torrenga, Dr          Albert Schweizer ziekenhuis Recruiting Dordrecht, Netherlands Contact: M Trajkovic, MD          Principal Investigator: M Trajkovic, MD          Maxima Medisch Centrum Recruiting Eindhoven, Netherlands Contact: G Vreugdenhil, Dr          Principal Investigator: G Vreugdenhil, Dr          Universitair Medisch Centrum Groningen Recruiting Groningen, Netherlands Contact: GAP Hospers, Prof Dr          Principal Investigator: GAP Hospers, Dr          Spaarne ziekenhuis Recruiting Hoofddorp, Netherlands Contact: A Beeker, Drs.          Principal Investigator: A Beeker, Drs          Medisch Centrum Leeuwarden Recruiting Leeuwarden, Netherlands Contact: M Polee, Dr          Principal Investigator: M Polee, Dr          Academisch ziekenhuis Maastricht Recruiting Maastricht, Netherlands Contact: RLH Jansen, Dr          Principal Investigator: RLH Jansen, Dr          Sint Antonius Ziekenhuis Recruiting Nieuwegein, Netherlands Contact: M Los, Dr          Principal Investigator: M Los, Dr          UMC Sint Radboud Recruiting Nijmegen, Netherlands Contact: SA Radema, Dr          Principal Investigator: SA Radema, Dr          Bravis ziekenhuis Recruiting Roosendaal, Netherlands Contact: Troost          Principal Investigator: Troost          Erasmus University Medical Center Recruiting Rotterdam, Netherlands, NL-3075 EA Contact: C. Verhoef, MD PhD    0031 (0)10 7040704    c.verhoef@erasmusmc.nl    Principal Investigator: C. Verhoef, MD PhD          Franciscus Gasthuis Recruiting Rotterdam, Netherlands Contact: P Hamberg, Dr          Principal Investigator: P Hamberg, Dr          IJsselland ziekenhuis Recruiting Rotterdam, Netherlands Contact: Vermaas          Principal Investigator: Vermaas          Maasstadziekenhuis Recruiting Rotterdam, Netherlands Contact: TC Kok, Dr          Principal Investigator: TC Kok, Dr          Elisabeth Tweesteden Ziekenhuis Recruiting Tilburg, Netherlands Contact: L Beerepoot, Dr          Principal Investigator: L Beerepoot, Dr          Diakonessenhuis Utrecht Recruiting Utrecht, Netherlands Contact: D Ten Bokkel Huinink, Dr          Principal Investigator: D Ten Bokkel Huinink, Dr          Universitait Medisch Centrum Utrecht Not yet recruiting Utrecht, Netherlands Contact: IHM Borel Rinkes, Prof Dr          Principal Investigator: IHM Rinkes, IHM          Admiraal de Ruyter Hospital Recruiting Vlissingen, Netherlands Contact: van Halteren          Principal Investigator: van Halteren          Jeroen Bosch Ziekenhuis Not yet recruiting Zaltbommel, Netherlands Contact: JFM Pruijt, Dr          Principal Investigator: JFM Pruijt, Dr          Isala Klinieken Recruiting Zwolle, Netherlands Contact: JWB de Groot, Dr          Principal Investigator: JWB de Groot, Dr Less <<
NCT03692078 Tobacco Use Not Applicable Completed - United States, Missouri ... More >> QPS Bio-Kinetic Clinical Applications, LLC Springfield, Missouri, United States, 65802 United States, New Jersey Inflamax - Hill Top Research Neptune, New Jersey, United States, 07753 Less <<
NCT01726582 Pancreatic Adenocarcinoma Phase 2 Active, not recruiting December 2021 United States, Ohio ... More >> University of Cincinnati Cancer Center Cincinnati, Ohio, United States, 45221 United States, Wisconsin Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03571724 Tobacco Use Phase 1 Recruiting March 28, 2019 United States, Nebraska ... More >> Celerion Recruiting Lincoln, Nebraska, United States, 68502 Contact: Philip Matthew, MD    402-476-2811    philip.matthew@celerion.com    Principal Investigator: Philip Matthew, MD          United States, North Carolina High Point Clinical Trials Recruiting High Point, North Carolina, United States, 27265 Contact: Melanie Fein, MD    336-841-0700 ext 2530    mfein@HighPointCTC.com    Principal Investigator: Melanie Fein, MD Less <<
NCT00440310 - Completed - -
NCT02082886 - Recruiting January 2034 United States, Illinois ... More >> Elmhurst Memorial Health Care Recruiting Elmhurst, Illinois, United States, 60126 Contact: Kathy Seymour, BSN    630-646-6072    Kathy.Seymour@EEHealth.org    Principal Investigator: George I Salti, MD          Edward Hospital Recruiting Naperville, Illinois, United States, 60540 Contact: Kathy Seymour, BSN    630-646-6072    Kathy.Seymour@EEHealth.org    Principal Investigator: George I Salti, MD Less <<
NCT00440310 Liver Metastases ... More >> Colorectal Neoplasms Neoplasm Metastasis Neoplasm Recurrence, Local Less << Phase 3 Completed - -
NCT03210298 - Recruiting May 2019 Argentina ... More >> Roffo Cancer Institute Recruiting Buenos Aires, Argentina Contact: Laura Lay, MD       lauralay@ymail.com    Australia Peter MacCallum Cancer Centre Recruiting Melbourne, Australia Contact: Craig Lynch, MD          Belgium University Hospital Gent (UZ Gent) Recruiting Gent, Belgium, 9000 Contact: Woulter Willaert, MD       wouter.willaert@ugent.be    Denmark University Hospital Odense Recruiting Odense, Denmark Contact: Martin Graversen, MD       martin.graversen@rsyd.dk    France Hospices civils de Lyon Recruiting Lyon, France Contact: Olivier Glehen, MD    +33 478862371       Hôpital Lariboisière Recruiting Paris, France, 75010 Contact: Clarisse Eveno, MD    +33 1 49 95 25 80       Germany University Hospital Tübingen Recruiting Tübingen, Germany, 72076 Contact: Verena Schlaich    +4970712986722    pipac@med.uni-tuebingen.de    India Fortis Hospital Recruiting Bengaluru, India Contact: Aditi Bhatt, MD          Italy IRCC Torino Candiolo Recruiting Turin, Italy Contact: Marco Vaira, MD       marco.vaira@ircc.it    Poland F. Łukaszczyk Oncology Centre Recruiting Bydgoszcz, Poland Contact: Maciej Nowacki, MD       maciej.s.nowacki@gmail.com    Russian Federation Gersten Institute for Cancer Research Recruiting Moscow, Russian Federation Contact: Vladimir Khomyakov, MD       vladimirkhom@mail.ru    Singapore National University Hospital Recruiting Singapore, Singapore Contact: Janelle Phua       niam_sin_phua@nuhs.edu.sg    Spain Hospital de Pilar Recruiting Barcelona, Spain Contact: Juan Torrent, MD       juanjotorrent@yahoo.es    Switzerland University Hospital Lausanne CHUV Recruiting Lausanne, Switzerland, 1011 Contact: Martin Huebner, MD       chv.carcinose@chuv.ch Less <<
NCT01208545 - Unknown - United States, California ... More >> Santa Clara Valley Health and Hospital System Santa Clara, California, United States, 95128 Less <<
NCT01266187 Liver Metastasis Not Applicable Terminated(Recruitment difficu... More >>lities) Less << - Germany ... More >> Department of Surgery, University Hospital Aachen Aachen, NRW, Germany, 52074 Less <<
NCT01775254 - Completed - United States, Washington ... More >> Deaconess Hospital Spokane, Washington, United States, 99204 Sacred Heart Medical Center Spokane, Washington, United States, 99204 Holy Family Hospital Spokane, Washington, United States, 99208 Valley Hospital Spokane, Washington, United States, 99216 Less <<
NCT00587145 Stomach Neoplasms Phase 2 Unknown May 2009 Korea, Republic of ... More >> National Cancer Center Korea Recruiting Goyang,, Gyeonggi, Korea, Republic of Contact: Sook Ryun Park, M.D    +82-31-920-1609    sukryun73@ncc.re.kr    Contact: So Yun Park, MS    +82-31-920-2307    tomongmong@naver.com    Sub-Investigator: Noe Kyeong Kim, M.D          Sub-Investigator: Young Iee Park Park, M.D.Ph.D          Sub-Investigator: Young Woo Kim,, M.D          Sub-Investigator: Keun Won Ryu, M.D          Sub-Investigator: Jun Ho Lee, M.D          Sub-Investigator: Il Ju Choi, M.D          Sub-Investigator: Chan Gyoo Kim, M.D          Sub-Investigator: Jong-Yeul Lee, M.D          Sub-Investigator: Jong Seok Lee, M.D          Sub-Investigator: Myeong-Cherl Kook Kook, M.D          Sub-Investigator: Hyeong-Seok Lim, M.D Less <<
NCT03690323 Locally Advanced Pancreatic Ca... More >>ncer Less << Not Applicable Recruiting May 2020 Netherlands ... More >> Amsterdam UMC Recruiting Amsterdam, Noord-Holland, Netherlands, 1105 ZA Contact: MGH Besselink, Prof. Dr.          Regionaal Academisch Kankercentrum Utrecht Recruiting Utrecht, Netherlands, 3508 GA Contact: IQ Molenaar, Prof. Dr. Less <<
NCT03126435 FOLFIRINOX Pa... More >>ncreas Cancer Pancreatic Adenocarcinoma Less << Phase 3 Recruiting July 2020 -
NCT01827553 Pancreatic Cancer Phase 3 Recruiting April 2022 -
NCT03034850 - Completed - -
NCT00625651 Metastatic Colorectal Cancer ... More >> Colon Cancer Colorectal Cancer Rectal Cancer Less << Phase 1 Phase 2 Completed - -
NCT03413514 Gastric Cancer Not Applicable Recruiting January 3, 2023 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Ziyu Li, M.D.    86-010-8819-6605    ligregory@outlook.com    Contact: Yinkui Wang, M.D.    86-010-8819-6598    wykchangfeng@163.com    Principal Investigator: Ziyu Li, M.D.          Sub-Investigator: Fei Shan, M.D.          Sub-Investigator: Yinkui Wang, M.D.          Sub-Investigator: Shuangxi Li, M.D.          Sub-Investigator: Yongning Jia, M.D.          Sub-Investigator: Hui Ren, M.M.          Sub-Investigator: Yingai Li, M.B.          Sub-Investigator: Xiangji Ying, M.S., M.P.H.          Sub-Investigator: Fei Pang, M.M.          Principal Investigator: Jiafu Ji, M.D., P.H.D Less <<
NCT00959647 Ovarian Cancer ... More >> Basal Cell Carcinoma Metastatic Colorectal Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Scottsdale, Arizona, United States, 85258 United States, California Oakland, California, United States, 94609 Palm Springs, California, United States, 92262 Stanford, California, United States, 94305 United States, Maryland Baltimore, Maryland, United States, 21231 United States, Michigan Ann Arbor, Michigan, United States, 48109-0934 Detroit, Michigan, United States, 48201 United States, Nevada Las Vegas, Nevada, United States, 89106 United States, Ohio Cincinnati, Ohio, United States, 45242 United States, Texas Houston, Texas, United States, 77030 Less <<
NCT01202409 Gastrointestinal Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00658671 Advanced Cancer Phase 1 Completed - United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Massachusetts Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States Less <<
NCT02969122 Stomach Neoplasm Not Applicable Recruiting December 2023 China, Beijing ... More >> Gastrointestinal Cancer Center, Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Rulin Miao, M.D.    86-10-88196598    miaorulin@outlook.com    Principal Investigator: Jiafu Ji, M.D.          Sub-Investigator: Ziyu Li, M.D.          Sub-Investigator: Rulin Miao, M.D. Less <<
NCT00959647 - Completed - -
NCT01053104 - Completed - United Kingdom ... More >> Oxford Cancer Centre, Churchill Hospital Oxford, United Kingdom, OX3 7LJ Less <<
NCT02446093 Pancreatic Adenocarcinoma Phase 1 Phase 2 Recruiting December 2020 United States, Florida ... More >> Cape Coral Hospital Not yet recruiting Cape Coral, Florida, United States, 33990 Contact: Rachel Piacente    239-430-3263    Rachel.Piacente@21co.com    Sub-Investigator: Brian Rajca, MD          Lee Memorial Hospital Not yet recruiting Fort Myers, Florida, United States, 33901 Contact: Rachel E Piacente    239-430-3263    Rachel.Piacente@21co.com    Principal Investigator: Mark Bloomston, MD          21st Century Oncology Not yet recruiting Fort Myers, Florida, United States, 33966 Contact: Rachel E Piacente    239-430-3263    Rachel.Piacente@21co.com    Principal Investigator: Mark Bloomston, M.D          United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Hamida Umar    614-685-6406    Hamida.Umar@osumc.edu    Principal Investigator: Mary Dilhoff, MD          Mexico Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Recruiting Mexico City, Mexico, 14080 Contact: Luis Uscanga, M.D    +52 (55)54870900 ext 4401    luis.uscangad@gmail.com Less <<
NCT02676349 Pancreatic Carcinoma Phase 2 Recruiting January 2024 France ... More >> Institut Bergonié Recruiting Bordeaux, France Contact: BECHADE Dominique, MD          Polyclinique Bordeaux Nord Recruiting Bordeaux, France Contact: LECAILLE Cédric, MD          CHU Morvan Not yet recruiting Brest, France Contact: METGES Jean-Philippe, MD          Hôpital Beaujon Recruiting Clichy, France, 92110 Contact: HAMMEL Pascal, PR          Chu Colmar Recruiting Colmar, France Contact: Gilles Breysacher, MD          Hôpital Henri Mondor (APHP) Recruiting Creteil, France Contact: BAUMGAERTNER Isabelle, MD          CH Bicêtre (APHP) Not yet recruiting Le Kremlin-Bicêtre, France Contact: THIROT-BIDAULT Anne, MD          Centre Oscar Lambret Recruiting Lille, France Contact: Xavier Mirabel, MD          Chru Lille Recruiting Lille, France Contact: PIESSEN Guillaume, MD          Infirmerie Protestante de Lyon Not yet recruiting Lyon, France Contact: TAVAN David, MD          Hopital européen Marseille Recruiting Marseille, France Contact: RINALDI Yves, MD          Hôpital La Timone Recruiting Marseille, France Contact: DAHAN Laëtitia, MD          Institut Paoli CALMETTES Recruiting Marseille, France Contact: DELPERO Jean-Robert, MD          Institut du Cancer de Montpellier Recruiting Montpellier, France Contact: PORTALES Fabienne, MD          Chu Nantes Recruiting Nantes, France Contact: Nicolas REGENET, MD          Hôpital Cochin (APHP) Recruiting Paris, France Contact: CORIAT Romain, MD          Institut Mutualiste Montsouris Recruiting Paris, France Contact: LOUVET Christophe, MD          Pitié Salpêtrière (APHP) Recruiting Paris, France Contact: BACHET Jean-Baptiste, MD          Hôpital Haut-Lévêque Recruiting Pessac, France Contact: VENDRELY Véronique, MD          CHU Reims Recruiting Reims, France Contact: BOUCHE Olivier, MD          Centre Eugène Marquis Recruiting Rennes, France Contact: SULPICE Laurent, MD          Chu Rouen Recruiting Rouen, France Contact: SCHWARZ Lillian          CHP Saint Grégoire Recruiting Saint Grégoire, France Contact: MIGLIANO Laurent, MD          Institut de Cancérologie de l'Ouest Recruiting Saint-Herblain, France Contact: THIBAUDEAU Emilie, MD          Chru Tours Recruiting Tours, France Contact: LECOMTE Thierry, MD          Chru Nancy Recruiting Vandoeuvre-les-nancy, France Contact: AYAV Ahmet, MD          Institut de Cancérologie de Lorraine Recruiting Vandoeuvre-les-nancy, France Contact: CONROY Thierry, MD Less <<
NCT02754856 Colorectal Cancer ... More >> Liver Metastases Less << Phase 1 Recruiting July 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02063412 - Withdrawn(Slow recruitment pac... More >>e) Less << - -
NCT02358863 Esophageal Cancer ... More >> Gastric Cancer Less << Not Applicable Terminated(Issues with recruit... More >>ment.) Less << - United States, District of Col... More >>umbia Georgetown University Washington, District of Columbia, United States, 20057 Less <<
NCT02358863 - Terminated(Issues with recruit... More >>ment.) Less << - -
NCT02658214 Small Cell Lung Carcinoma ... More >> Carcinoma, Squamous Cell of Head and Neck Stomach Neoplasms Triple Negative Breast Neoplasms Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms Esophagogastric Junction Neoplasms Carcinoma, Pancreatic Ductal Esophageal Squamous Cell Carcinoma Less << Phase 1 Recruiting June 28, 2019 United States, Georgia ... More >> Research Site Withdrawn Augusta, Georgia, United States, 30912 United States, Pennsylvania Research Site Withdrawn Pittsburgh, Pennsylvania, United States, 15232 Japan Research Site Recruiting Chuo-ku, Japan, 104-0045 Research Site Recruiting Kashiwa, Japan, 277-8577 Korea, Republic of Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 135-710 Less <<
NCT00779311 Metastatic Colorectal Cancer Phase 1 Terminated(Dose limiting toxic... More >>ity at the lowest planned dose level.) Less << - United States, Georgia ... More >> Central Georgia Cancer Care Macon, Georgia, United States, 31201 United States, Montana Hematology Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Less <<
NCT01595321 Pancreatic Cancer Not Applicable Active, not recruiting June 2020 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00502567 Advanced Solid Tumor Phase 1 Completed - United States, Michigan ... More >> Research Site Ann Arbor, Michigan, United States Research Site Detroit, Michigan, United States United States, Tennessee Research Site Nashville, Tennessee, United States Less <<
NCT00779311 - Terminated(Dose limiting toxic... More >>ity at the lowest planned dose level.) Less << - -
NCT03662659 Gastric Cancer ... More >> Cancer of the Stomach Esophagogastric Junction Less << Phase 2 Recruiting July 1, 2023 -
NCT01923987 Rectal Cancer ... More >> Liver Metastasis Lung Metastasis Less << Phase 2 Recruiting August 2019 Korea, Republic of ... More >> Kyung Hee University Gangdong Hospital Active, not recruiting Seoul, Korea, Republic of, 134-727 Korea Cancer Center Hospital Recruiting Seoul, Korea, Republic of, 139-706 Contact: Sun Mi Moon, MD, PhD    82-2-970-1237    msm386@yahoo.co.kr    Contact: Won Il Jang, MD, MS    82-2-970-1262    zzang11@kirams.re.kr    Principal Investigator: Sun Mi Moon, MD, PhD          Sub-Investigator: Ui Sup Shin, MD, PhD          Sub-Investigator: Won Il Jang, MD, MS          Sub-Investigator: Sun Hee Ji, MD Less <<
NCT01505530 Pancreatic Cancer Phase 2 Completed - United States, District of Col... More >>umbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington, District of Columbia, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tyler, Texas, United States United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wenatchee, Washington, United States Canada, Alberta For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jerusalem, Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kfar Saba, Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Petah Tiqva, Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tel Hashomer, Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tel-Aviv, Israel Norway For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oslo, Norway For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trondheim, Norway United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cambridge, Cambridgeshire, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, England, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Southampton, Hants, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Acton, London, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nottingham, Nottinghamshire, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edinburgh, Scotland, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cardiff, South Glamorgan, United Kingdom Less <<
NCT03130790 Gastric Cancer Phase 2 Phase 3 Active, not recruiting September 2022 Estonia ... More >> 2 Sites Tallinn, Estonia Hong Kong 1 Site Hong Kong, Hong Kong Korea, Republic of 2 Sites Daegu, Korea, Republic of 1 Site Incheon, Korea, Republic of 1 Site Jeongnam, Korea, Republic of 11 Sites Seoul, Korea, Republic of 2 Sites Suwon, Korea, Republic of Lithuania 2 Sites Kaunas, Lithuania 1 Site Vilnius, Lithuania Malaysia 2 Sites Kuala Lumpur, Malaysia Singapore 1 Site Singapore, Singapore Taiwan 1 Site Kaohsiung, Taiwan 1 Site Taichung, Taiwan 1 Site Taipei, Taiwan Thailand 1 Site Khon Kaen, Thailand 1 Site Pathum Thani, Thailand Less <<
NCT02468557 Pancreatic Ductal Adenocarcino... More >>ma Less << Phase 1 Terminated - United States, Arizona ... More >> Scottsdale Healthcare Clinical Research Institute Scottsdale, Arizona, United States, 85258 United States, California Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, District of Columbia Georgetown University Washington, District of Columbia, United States, 20007 United States, Indiana Indiana University Goshen Center for Cancer Care Goshen, Indiana, United States, 46506 United States, Massachusetts Dana Farber/ Harvard Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, South Carolina Greenville Hospital System Greenville, South Carolina, United States, 29605 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75230 Less <<
NCT01478594 Colorectal Cancer Phase 2 Completed - -
NCT01703910 Adenocarcinoma of Colon ... More >> Adenocarcinoma of Rectum Metastatic Disease Less << Phase 2 Completed - Spain ... More >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Less <<
NCT02644408 Stage III Esophageal Squamous ... More >>Cell Carcinoma Stage II Esophageal Squamous Cell Carcinoma Less << Phase 3 Recruiting December 2020 China, Henan ... More >> The First Affiliated Hospital of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Contact: shegan gao, doctor    0379 64811906    gsg112258@163.com    Contact: tanyou shan, master    0379 64815350    shantanyou@163.com Less <<
NCT01505530 - Completed - -
NCT01839799 Pancreatic Adenocarcinoma Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02404753 Gastric Cancer Phase 2 Active, not recruiting November 25, 2022 China, Beijing ... More >> Peking University Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT02510118 Colon Cancer Phase 2 Phase 3 Unknown June 2018 China, Jiangsu ... More >> Jiege Huo Recruiting Nanjing, Jiangsu, China Contact: Jiege Huo Jiege Huo, Dr    15852031176    Jiegehuo@163.com Less <<
NCT03329183 Colorectal Cancer Phase 2 Recruiting November 2021 China, Shanghai ... More >> Shanghai Changzheng Hospital Recruiting Shanghai, Shanghai, China, 200433 Contact: Yuan-sheng Zang, Prof.    +8613816584620    doctorzangys@163.com Less <<
NCT01929499 Colonic Neoplasms Phase 2 Not yet recruiting August 2019 China, Guangdong ... More >> Guangdong Provincial Hospital of Chinese Medicine Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: Yanjuan Zhu    (+86)13902260217    zyjsophy@hotmail.com    Contact: Haibo Zhang    (+86)13724123615    haibozh@aliyun.com    Principal Investigator: Haibo Zhang, MD          Sub-Investigator: Yanjuan Zhu          Sub-Investigator: Yong Li          Sub-Investigator: Jianping Bai          Sub-Investigator: Lirong Liu          Sub-Investigator: Yihong Liu          Sub-Investigator: Yanchun Qu          Sub-Investigator: Xin Qu          Sub-Investigator: Jin Wan Less <<
NCT01478594 - Completed - -
NCT03071198 Rectum Cancer Not Applicable Recruiting September 30, 2021 China, Heilongjiang ... More >> Cancer Hospital Affiliated to Harbin Medical University Recruiting Harbin, Heilongjiang, China, 150000 Contact: binbin cui Less <<
NCT01989858 Gastric Adenocarcinoma Phase 3 Terminated(lack of clinical ca... More >>ses) Less << - Italy ... More >> Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24128 A. O. Ospedale Treviglio-Caravaggio Treviglio, BG, Italy, 24047 A.O. Sant'Orsola Malpighi Bologna, BO, Italy, 40138 Policlinico Sant'Orsola Malpighi Bologna, BO, Italy, 40138 A.O. Santa Croce e Carle Cuneo, CN, Italy, 12100 Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele" Catania, CT, Italy, 95123 Policlinico Universitario Mater Domini Catanzaro, CZ, Italy, 88100 Azienda Ospedaliero- Universitaria Careggi - Firenze Firenze, FI, Italy, 50141 A.O. Ospedale San Gerardo Monza, MB, Italy, 20052 Azienda Ospedaliera di Desio e Vimercate Vimercate, MB, Italy, 20059 Fondazione IRCCS Ospedale Maggiore Policlinico Milano, MI, Italy, 20122 Istituto Nazionale per la Cura e lo Studio dei Tumori Milano, MI, Italy, 20133 Istituto Oncologico Europeo Milano, MI, Italy, 20141 Azienda Ospedaliera "San Paolo" Milano, MI, Italy, 20142 Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Casa di Cura MultiMedica Sesto San Giovanni, MI, Italy, 20099 A. O. "Carlo Poma" Mantova, MN, Italy, 46100 Ospedale "Ramazzini " di Carpi Carpi, MO, Italy, 41012 Ospedale "Guglielmo da Saliceto" Piacenza, PC, Italy, 29100 IRCCS Istituto Oncologico Veneto Padova, PD, Italy, 35128 Ospedale Misericordia e Dolce - USL 4 Prato, PO, Italy, 59100 Ospedale Santa Croce Fano Fano, PU, Italy, 61032 Azienda Ospedaliera 'San Carlo' Potenza, PZ, Italy, 85100 Arcispedale S. Maria Nuova Azienda Ospedaliera Reggio Emilia, RE, Italy, 42100 Università "Campus Bio-Medico" Roma, RM, Italy, 00128 Policlinico Universitario A. Gemelli Roma, RM, Italy, 00168 A.O. della Valtellina e della Valchiavenna - "Ospedale E. Morelli" Sondalo, SO, Italy, 23100 IRCC/FPO -Istituto per la Ricerca e la Cura del Cancro di Candiolo Candiolo, TO, Italy, 10060 A. O. "Ospedale di Circolo di Busto Arsizio" - Busto Arsizio (VA) Busto Arsizio, VA, Italy, 21052 A. O. Busto Arsizio - P.O. Saronno Saronno, VA, Italy, 21047 A.O. Ospedale di Circolo e Fondazione Macchi Varese, VA, Italy, 21100 Fondazione "G. Pascale" Istituto Tumori di Napoli Napoli, Italy, 80131 Less <<
NCT01677884 Colorectal Neoplasms Phase 2 Completed - France ... More >> Institut Gustave Roussy Villejuif, Val de Marne, France, 94805 Less <<
NCT03668418 - Recruiting May 31, 2022 Italy ... More >> Azienda Ospedaliero-Universitaria Pisana Recruiting Pisa, Italy, 56124 Contact: Luca Morelli, Prof       luca.morelli@unipi.it    Sub-Investigator: Vittoria Raffa, Prof          Sub-Investigator: Enrico Vasile, Dr          Sub-Investigator: Gregorio Di Franco, MD          Sub-Investigator: Alice Usai, MSc Less <<
NCT03176264 Metastatic Colorectal Cancer Phase 1 Completed - Australia, New South Wales ... More >> Novartis Investigative Site St Leonards, New South Wales, Australia, 2065 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT02202928 Colorectal Cancer ... More >> Neoplasms Intestinal Neoplasms Digestive System Neoplasms Gastrointestinal Diseases Less << Phase 2 Unknown December 2017 China, Hubei ... More >> Jingzhou Central Hospital Immunotherapy center Jingzhou, Hubei, China, 434020 Less <<
NCT03050814 Colorectal Tumors ... More >> Colorectal Neoplasms Colorectal Carcinoma Colorectal Adenocarcinoma Colorectal Cancer Less << Phase 2 Recruiting August 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02528110 Malignant Neoplasm of Stomach Phase 2 Not yet recruiting July 2020 -
NCT00790816 Neoplasms, Breast Phase 1 Completed - -
NCT03366155 Colorectal Cancer ... More >> Liver Metastases Colorectal Adenocarcinoma Colorectal Cancer With Hepatic Metastases Colorectal Carcinoma Less << Phase 2 Not yet recruiting December 30, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center Not yet recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00510627 Metastatic Liver Cancer ... More >> Secondary Liver Cancer Liver Neoplasm Less << Phase 4 Withdrawn(Boston Scientific ha... More >>s decided to close the Study.) Less << December 2010 United States, New York ... More >> New York University New York, New York, United States, 10016 United States, Ohio The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT03775395 Hepatocellular Carcinoma Phase 3 Recruiting December 1, 2021 China, Guangdong ... More >> Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn Less <<
NCT02856126 Hepatocellular Carcinoma Phase 3 Recruiting August 2018 China, Guangdong ... More >> Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Wusheng Yu, MD    13827285010    yuwusheng1998@126.com    Cancer Center Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD    8620-87343115    shiming@mail.sysu.edu.cn    The First Affiliated Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Guosheng Tan, MD    13725254145    tgs1976@163.com    Guangzhou Twelfth People 's Hospital Recruiting Guangzhou, Guangdong, China, 510620 Contact: Yuanmin Zhou, MD    15521278919    13430288977@139.com    Principal Investigator: Jinghua Chen, MD          Kaiping Central Hospital Recruiting Kaiping, Guangdong, China, 529300 Contact: Shijie Zhang, MD    13717287622    Shijie_9262511@163.com    China, Hunan The First Affiliated Hospital of University Of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Xiaoping Wu, MD    13975486015    wxp19730806@sina.com    China, Shanxi The First Affiliated Hospital Of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710061 Contact: Xin Zheng, MD    13649265446    183421344@qq.com Less <<
NCT03532711 - Completed - -
NCT00559676 Colorectal Cancer Phase 4 Completed - France ... More >> Centre Hospital Regional Universitaire de Limoges Limoges, France, 87042 Less <<
NCT00640081 Colorectal Cancer Phase 2 Completed - Cyprus ... More >> Bank of Cyprus Oncology Centre Nicosia, Cyprus United Kingdom Bradford Royal Infirmary Bradford, England, United Kingdom, BD9 6RJ Gloucestershire Oncology Centre at Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Essex County Hospital Colchester, England, United Kingdom, C03 3NB Dorset County Hospital Dorchester, England, United Kingdom, DT1 2JY St. Luke's Cancer Centre at Royal Surrey County Hospital Guildford, England, United Kingdom, GU2 7XX Hammersmith Hospital London, England, United Kingdom, W12 OHS St. Mary's Hospital London, England, United Kingdom, W2 1NY Churchill Hospital Oxford, England, United Kingdom, OX3 7LJ Peterborough Hospitals Trust Peterborough, England, United Kingdom, PE3 6DA University Hospital of North Staffordshire Stoke-On-Trent, England, United Kingdom, ST4 7LN Singleton Hospital Swansea, Wales, United Kingdom, SA2 8QA Royal United Hospital Bath, United Kingdom Royal Bournemouth Hospital Bournemouth, United Kingdom Addenbrookes Hospital Cambridge, United Kingdom Darent Valley Hospital Dartford, United Kingdom Hereford County Hospital Hereford, United Kingdom Charing Cross Hospital London, United Kingdom Guys and St Thomas' hospitals London, United Kingdom Dorset Cancer Centre, Poole Hospital Poole, United Kingdom Weston Park Sheffield, United Kingdom, S10 2SJ Southport and Ormskirk Southport, United Kingdom St Helens and Whiston hospitals St Helens, United Kingdom Warrington and Halton Hospitals Warrington, United Kingdom Worcestershire Royal Hospital Worcester, United Kingdom Less <<
NCT02128243 Unresectable, Locally Advanced... More >> or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction Gastric Neoplasm Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma Gastric Adenocarcinoma Esophageal Neoplasms Less << Phase 2 Recruiting September 2018 Germany ... More >> NCT-Med. Onkologie Recruiting Heidelberg, Baden-Württemberg, Germany, 69120 Contact: Georg Martin Haag, Dr.    +49-6221 ext 5637630    GeorgMartin.Haag@med.uni-heidelberg.de Less <<
NCT02042391 Posttransplant Lymphoprolifera... More >>tive Disorder Less << Phase 2 Recruiting December 2022 Germany ... More >> Uniklinik RWTH Aaachen Klinik für Onkologie, Hämatologie und Stammzell-transplantation Med. Klinik IV Recruiting Aachen, Germany, 52074 Charite Universitätsmedizin Berlin Campus Mitte, Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie Recruiting Berlin, Germany, 10117 Charité - Universitätsmedizin Berlin CCM Medizinische Klinik m. S. Nephrologie Recruiting Berlin, Germany, 10117 Universitätsklinikum Bonn Med. Klinik III/ZIM Hämatologie/Onkologie Recruiting Bonn, Germany, 53105 DIAKO Bremen gGmbH, Klinik für Hämatologie und Onkologie Recruiting Bremen, Germany, 28239 Universitätsklinikum Erlangen Med. Klinik 5 Hämatologie und Intern. Onkologie Recruiting Erlangen, Germany, 91054 Universitätsklinikum Essen Klinik für Hämatologie Recruiting Essen, Germany, 45147 Malteser Krankenhaus St. Franziskus-Hospital Med. Klinik 1 Recruiting Flensburg, Germany, 24939 Universitätsklinikum Frankfurt Med. Klinik III, Nephrologie Recruiting Frankfurt/Main, Germany, 60590 Universitätsklinikum Gießen Med. Klinik IV Recruiting Gießen, Germany, 35385 Universitätsmedizin Göttingen, Klinik für Hämatologie und medizinische Onkologie Not yet recruiting Göttingen, Germany, 37075 Nephrologisches Zenrtum Niedersachsen Not yet recruiting Hann-Münden, Germany, 34346 Medizinische Hochschule Hannover Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation Recruiting Hannover, Germany, 30625 Medizinische Universitätsklinik Heidelberg Abteilung Innere Medizin V Recruiting Heidelberg, Germany, 69120 II. Medizinische Klinik, Universitätsklinikum Schleswig-Holstein Campus Kiel Recruiting Kiel, Germany, 24105 Universitätsmedizin der Johannes-Gutenberg-Universität III. Medizinische Klinik Recruiting Mainz, Germany, 55101 Klinikum der Universität München-Großhadern Med. Klinik III Recruiting München, Germany, 81377 Klinikum Oldenburg gGmbH Klinik für Innere Medizin II Recruiting Oldenburg, Germany, 26133 Klinikum Passau II. Med. Klinik Recruiting Passau, Germany, 94032 Universitätsmedizin Rostock Klinik für Innere Medizin III Hämatologie, Onkologie, Palliativmedizin Not yet recruiting Rostock, Germany, 18057 Klinikum Stuttgart Klinik für Hämatologie und int. Onkologie Recruiting Stuttgart, Germany, 70174 Less <<
NCT01652833 - Completed - -
NCT00885885 Colorectal Cancer Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain, 28046 Less <<
NCT03584711 Metastatic Colorectal Cancer Phase 2 Recruiting December 2020 France ... More >> Clinique Trenel Recruiting Sainte Colombe, Lyon, France, 69560 Contact: Ivan GRABER, Dr       graber.trenel@gmail.com    Clinique Claude Bernard Recruiting Albi, France, 81030 Contact: Yann Berge, Dr       berge@claude-bernard-albi.com    Hopital Sud Recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, Dr       hautefeuille.vincent@chu-amiens.fr    Clinique de L'Europe Recruiting Amiens, France, 80090 Contact: Michel Gozy, Dr       michelgozy@gmail.com    Chu D'Angers Recruiting Angers CEDEX 9, France, 49933 Contact: Carole VITELLIUS, Dr       carole.vitellius@chu-angers.fr; carole.vitellius@wanadoo.fr; cvitellius@gmail.com    Hopital Prive D'Antony Recruiting Antony, France, 92166 Contact: Anne THIROT BIDAULT, Dr       a.t.bidault@gmail.com    Hopital Les Bonnettes Recruiting Arras CEDEX, France, 62012 Contact: Bruno HUGUENIN, Dr       drbhuguenin@orange.fr    Centre Marie Curie Recruiting Arras, France, 62000 Contact: Anne-Sophie BLANC-GUERINEAU       drblanc@radiopole-artois.com    Ch Cote Basque Recruiting Bayonne CEDEX, France, 64109 Contact: Franck AUDEMAR, Dr       faudemar@ch-cotebasque.fr    Ch de Beauvais Recruiting Beauvais, France, 60021 Contact: Fayçal HOCINE, Dr       f.hocine@ch-beauvais.fr ; fayoncologie@yahoo.fr    Polyclinique Saint Privat Recruiting Boujan-sur-Libron, France, 34760 Contact: Michaël HUMMELSBERGER, Dr       michael.hummelsberger@orange.fr    Cmco Cote D'Opale Recruiting Boulogne-sur-Mer, France, 62222 Contact: Laurent GASNAULT, Dr       laurent.gasnault@sfr.fr    Hopital Duchenne Recruiting Boulogne-sur-Mer, France, 62321 Contact: Vincent BOURGEOIS, Dr       vincebourgeois@hotmail.com    Hopital Morvan - Chu Recruiting Brest, France, 29609 Contact: Jean-Philippe METGES, Dr       jean-philippe.metges@chu-brest.fr    Ch de Beziers Cedex Recruiting Béziers, France, 34525 Contact: Mohamed RAMDANI, Dr       mohamed.ramdani@ch-beziers.fr    Centre Francois Baclesse Recruiting Caen, France, 14076 Contact: Stéphane CORBINAIS, Dr       s.corbinais@baclesse.unicancer.fr    Ch Cahors Recruiting Cahors, France, 46000 Contact: Nadia LEVASSEUR, Dr       nadia.levasseur@ch-cahors.fr    Ch de Cholet Recruiting Cholet, France, 49325 Contact: Frédérique ALABERT, Dr       frederique.alabert@ch-cholet.fr    Centre Hospitalier General Recruiting Châlons-en-Champagne, France, 51005 Contact: ROCH ANICET OSSENDZA, Dr       rochossendza@yahoo.fr    Hopitaux Civils de Colmar Recruiting Colmar, France, 68024 Contact: Gilles BREYSACHER, Dr       gilles.breysacher@ch-colmar.fr    Service de Medecine Recruiting Digne-les-Bains, France, 04000 Contact: Gilbert BORDES, Dr       gbordes@ch-digne.fr    CH Recruiting Dunkerque CEDEX 01, France, 59385 Contact: Tatiana CEBAN RUDIC, Dr       tatiana.ceban@ch-dunkerque.fr    Hopital Jacques Monod Recruiting Flers CEDEX, France, 61104 Contact: Pierre-Emmanuel HENNERESSE, Dr       pierre-emmanuel.henneresse@ch-flers.fr ; netpeh@orange.fr; p.e.henneresse@wanadoo.fr    Chi de Frejus Saint-Raphael Recruiting Fréjus, France, 83600 Contact: Bruno VALENZA, Dr       valenza-b@chi-frejus-saint-raphael.fr;oncologie-sec@chi-fsr.fr; brunovalenza@msn.com    Polyclinique de Blois - 3Eme Etage Recruiting La Chaussee St Victor, France, 41260 Contact: Philippe LAPLAIGE, Dr       dr.laplaige@wanadoo.fr    Chd Vendee Recruiting La Roche-sur-Yon, France, 85925 Contact: Roger FAROUX, Dr       roger.faroux@chd-vendee.fr    Ch Du Mans Recruiting Le Mans CEDEX 9, France, 72037 Contact: Oana COJOCARASU, Dr       ocojocarasu@ch-lemans.fr; oanaalexa@hotmail.com    Centre Hospitalier Schaffner Recruiting Lens, France, 62307 Contact: Alice PHAM-BECKER, Dr       apham@ch-lens.fr    Chru Hopital Claude Huriez 4Eme Est Recruiting Lille, France, 59037 Contact: Anthony TURPIN, Dr       turpin.anth@yahoo.fr; anthony.turpin@chru-lille.fr    Ch St Joseph-St Luc Recruiting Lyon, France, 69365 Contact: Denis PERE VERGE, Dr       dpereverge@ch-stjoseph-stluc-lyon.fr; fannydenis@sfr.fr    Hopital Europeen Marseille Recruiting Marseille, France, 13331 Contact: Yves RINALDI, Dr       y.rinaldi@hopital-europeen.fr; yrinaldi@wanadoo.fr    Ch de Meaux Recruiting Meaux, France, 77100 Contact: Christophe LOCHER, Dr       c-locher@ch-meaux.fr    Hopital Layne Recruiting Mont-de-Marsan, France, 40024 Contact: Jérôme DAUBA, Dr       jerome.dauba@ch-mt-marsan.fr    Polyclinique de Gentilly Recruiting Nancy, France, 54100 Contact: Fabien BROCARD, Dr       f.brocard@oncog.fr    Hopital Prive Du Confluent Sas Recruiting Nantes, France, 44277 Contact: Benjamin LINOT, Dr       benjamin.linot@groupeconfluent.fr    Ch de Niort - Sce D'Oncologie Recruiting Niort CEDEX, France, 79021 Contact: Albert ALEBA, Dr       albert.aleba@ch-niort.fr    Groupe Hospitalier Pitie-Salpetriere Recruiting Paris CEDEX 13, France, 75651 Contact: Jean-Baptiste BACHET, Dr       jean-baptiste.bachet@aphp.fr    Chu Cochin Recruiting Paris, France, 75014 Contact: Romain CORIAT, Pr       romain.coriat@aphp.fr    Groupe Hospitalier Pitie-Salpetriere Recruiting Paris, France Contact: Jean-Baptiste Bachet, Pr          Polyclinique de Courlancy Recruiting Reims, France, 51100 Contact: Karinne PRULHIER-CORVIOLE, Dr       kpulhiere@iccreims.fr    Centre Hospitalier Recruiting Saint-Quentin CEDEX, France, 02321 Contact: Innocenti DADAMESSI, Dr       I.dadamessi@ch-stquentin.fr;dadamessi@gmail.com    Clinique Ste Anne Recruiting Strasbourg, France, 67000 Contact: Louis-Marie DOURTHE, Dr       lm.dourthe@solcrr.org    Centre Paul Strauss Recruiting Strasbourg, France, 67065 Contact: Meher BEN ABDELGHANI, Dr       mbenabdelghani@strasbourg.unicancer.fr    Polyclinique de L'Ormeau Recruiting Tarbes, France, 65000 Contact: Philippe AYELA, Dr       Payela@ch-lourdes.fr ; philippe.ayela@sfr.fr ; nathaliemonteiro@wanadoo.fr    Clinique Pasteur Recruiting Toulouse, France, 31076 Contact: Mathilde MARTINEZ, Dr       m.martinez@clinique-pasteur.com    Martinique Chu de Fort de France Recruiting Fort-de-France, Martinique, 97261 Contact: Nathalie GROSSAT BERNADOU, Dr       nathalie.grossat-bernadou@chu-martinique.fr Less <<
NCT02697838 Malignant Neoplasm of Stomach ... More >>Stage II Less << Phase 2 Active, not recruiting October 31, 2018 China, Fujian ... More >> Rongbo Lin Fuzhou, Fujian, China, 350014 Less <<
NCT03561142 Rectal Cancer ... More >> Rectal Neoplasms Rectal Cancer Stage II Rectal Cancer Stage III Less << Phase 2 Recruiting April 16, 2024 Germany ... More >> University Hospital Erlangen Not yet recruiting Erlangen, Germany Contact: Oliver Ott, Prof.          University Hospital Frankfurt Not yet recruiting Frankfurt, Germany Contact: Claus Rödel, Prof.          University Hospital Tübingen Recruiting Tübingen, Germany Contact: Cihan Gani, Dr.          University Hospital Würzburg Not yet recruiting Würzburg, Germany Contact: Bülent Polat, Dr. Less <<
NCT02942706 Colorectal Cancer Phase 2 Phase 3 Not yet recruiting October 2019 -
NCT02730546 Gastric Cardia Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Stage IB Gastric Cancer AJCC v7 Stage II Gastric Cancer AJCC v7 Stage IIA Gastric Cancer AJCC v7 Stage IIB Gastric Cancer AJCC v7 Stage IIIA Gastric Cancer AJCC v7 Stage IIIB Gastric Cancer AJCC v7 Less << Phase 1 Phase 2 Recruiting April 15, 2021 United States, Arizona ... More >> Mayo Clinic Hospital Recruiting Phoenix, Arizona, United States, 85054 Contact: Clinical Trials Referral Office    866-776-0015       Principal Investigator: Daniel H. Ahn          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Harry H. Yoon Less <<
NCT02972372 Esophagus Cancer Not Applicable Recruiting June 2021 China, Henan ... More >> Anyang Tumor Hospital Recruiting Anyang, Henan, China Contact: Fuyou Zhou, MD,PhD    +86 13939998799    jiaruinuo@163.com    The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Contact: Shegan Gao, MD, PhD    +86 18638859977    gsg112258@163.com    Contact: Ruinuo Jia, MD    +86 18537950766    jiaruinuo@163.com    Principal Investigator: Ruinuo Jia, MD          Sub-Investigator: Xinshuai Wang, MD, PhD          Sub-Investigator: Guoqiang Kong, MD          Sub-Investigator: Baoping Chang, MD, PhD          Sub-Investigator: Jiachun Sun, MD, PhD          Sub-Investigator: Xiaozhi Yuan, MD          Sub-Investigator: Dan Zhou, MD          Sub-Investigator: Ruina Yang, MD          Sub-Investigator: Jing Ren, MD          Sub-Investigator: Shuoguo Li, MD          Sub-Investigator: Wei Wang, MD          Sub-Investigator: Shiyuan Song, MD          Sub-Investigator: Weijiao Yin, MD Less <<
NCT00879385 Colorectal Cancer Phase 1 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00101894 Rectal Cancer ... More >> Colon Cancer Less << Phase 1 Completed - -
NCT03635021 Colorectal Cancer Phase 3 Recruiting September 15, 2024 Spain ... More >> Spanish Cooperative Group for the Treatment of Digestive Tumors Recruiting Madrid, Spain, 28007 Contact: Inmaculada Ruiz de Mena, PhD    00913788275    ttd@ttdgroup.org Less <<
NCT03599752 Colorectal Adenocarcinoma ... More >> Colorectal Carcinoma Metastatic in the Lung Stage IV Colorectal Cancer AJCC v8 Stage IVA Colorectal Cancer AJCC v8 Stage IVB Colorectal Cancer AJCC v8 Stage IVC Colorectal Cancer AJCC v8 Less << Phase 2 Recruiting January 31, 2023 United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Raphael Bueno    713-745-4530       Principal Investigator: Raphael Bueno          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Dennis A. Wigle    713-745-4530       Principal Investigator: Dennis A. Wigle          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Benjamin D. Kozower    713-745-4530       Principal Investigator: Benjamin D. Kozower          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: David R. Jones    713-745-4530       Principal Investigator: David R. Jones          United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: David H. Harpole    713-745-4530       Principal Investigator: David H. Harpole          United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Arjun Pennathur    713-745-4530       Principal Investigator: Arjun Pennathur          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       mbantonoff@mdanderson.org    Canada, Ontario University Health Network Princess Margaret Cancer Center P2C Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Thomas K. Waddell    713-745-4530       Principal Investigator: Thomas K. Waddell          Canada, Quebec University of Montreal Recruiting Montreal, Quebec, Canada, H3T 1J7 Contact: Moishe Liberman    713-745-4530       Principal Investigator: Moishe Liberman Less <<
NCT02978313 Colorectal Cancer Phase 2 Phase 3 Not yet recruiting November 2019 -
NCT02919787 Pancreatic Cancer Phase 2 Phase 3 Recruiting October 2022 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway, N- 0424 Contact: Svein Dueland, MD, PhD Less <<
NCT03085992 Rectal Cancer Phase 2 Completed - Italy ... More >> Irccs Istituto Oncologico Veneto Padova, Italy, 35128 Polo Oncologico Area Vasta Nord Ovest Pisa, Italy, 56100 ausl5 di Pisa Pontedera, Italy, 56100 Dipartimento Oncologico AUSL 7 Siena, Italy, 53100 Less <<
NCT01863420 - Unknown October 2015 China, Beijing ... More >> Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Recruiting Beijing, Beijing, China, 100021 Contact: Jianyang Wang, MD    +86-13810095191    pkucell@163.com    Contact: Jing Jin, MD    +86-10-87788122    jingjin1025@163.com Less <<
NCT01606098 Colon Cancer ... More >>Primary Tumour Rectal Cancer Less << Phase 3 Recruiting August 2020 -
NCT03238404 Gastric Cancer Not Applicable Completed - China, Jiangsu ... More >> Jinling Hospital, Medical School of Nanjing University Nanjing, Jiangsu, China, 210002 Less <<
NCT02375672 Colorectal Cancer Phase 2 Active, not recruiting December 2019 United States, Georgia ... More >> Emory University: Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Ohio The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00343408 Colorectal Cancer ... More >> Lung Cancer Less << Phase 1 Completed - Canada, Ontario ... More >> Ottawa Hospital Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Jewish General Hospital - Montreal Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT00089024 Pancreatic Cancer Phase 2 Unknown - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT01274962 Operable T2-3N+M0 Rectal Cance... More >>r (Stage III) Less << Phase 2 Active, not recruiting December 2020 Canada, Quebec ... More >> Hôpital de Gatineau Gatineau, Quebec, Canada, J8T 8R2 Hôpital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 Centre Hospitalier Pierre-Boucher Longueuil, Quebec, Canada, J4M 2A5 Sir Mortimer B. Davis - Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 CHUM-Hôpital St-Luc Montréal, Quebec, Canada, H2X 3J4 Hôpital Honoré-Mercier Saint-Hyacinthe, Quebec, Canada, J2S 4Y8 Hôpital du Suroît Salaberry-De-Valleyfield, Quebec, Canada, J6T 6C1 Canada CHUQ - Hôtel-Dieu de Québec Québec, Canada, G1R 2J6 Less <<
NCT00159484 Colon Cancer ... More >>Colorectal Cancer Less << Phase 1 Phase 2 Active, not recruiting December 2017 United States, California ... More >> U.S.C./Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00043004 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Terminated(low accrual) - -
NCT01888978 Pancreatic Cancer Phase 2 Completed - United States, District of Col... More >>umbia Georgetown University- Lombardi Comprehensive Cancer Center Washington, District of Columbia, United States, 20007 United States, Maryland MedStar Montgomery Medical Center Olney, Maryland, United States, 20832 Less <<
NCT02941562 Rectal Cancer, Radiotherapy Phase 2 Not yet recruiting - -
NCT01237912 - Completed - United Kingdom ... More >> Stephen Smith Belfast, Northern Ireland, United Kingdom, BT96AD Less <<
NCT03409848 Gastric Cancer ... More >> Esophageal Cancer Adenocarcinoma Gastric HER2 Positive Gastric Cancer Metastatic Gastric Cancer GastroEsophageal Cancer Less << Phase 2 Recruiting January 2022 Germany ... More >> Universitätsklinikum Hamburg-Eppendorf Hubertus Wald Tumorzentrum - UCCH II. Medizinische Klinik und Poliklinik (Onkologie, Hämatologie, KMT mit Sektion Pneumologie) Recruiting Hamburg, Germany, 20246 Contact: Alexander Stein, Dr.       a.stein@uke.de Less <<
NCT01628211 Colorectal Cancer Phase 2 Recruiting June 2018 Italy ... More >> Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico Recruiting Napoli, Italy, 80131 Less <<
NCT02813096 Carcinoma, Hepatocellular Not Applicable Unknown July 2018 -
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01481545 Rectal Cancer Phase 2 Unknown July 2018 -
NCT02022852 Rectal Cancer Phase 2 Unknown January 2018 China, Heilongjiang ... More >> Harbin Medical University Cancer Hospital Recruiting Harbin, Heilongjiang, China, 150081 Contact: Binbin Cui, MD    13351112888    13351112888@163.com    Principal Investigator: Binbin Cui, MD Less <<
NCT01936974 Ovarian Carcinoma ... More >> Fallopian Tube Carcinoma Peritoneal Carcinoma Less << Phase 2 Terminated(PI Decision) - United States, Arizona ... More >> Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT03437200 Inoperable ?sophageal Cancer Phase 2 Not yet recruiting April 15, 2022 -
NCT01936974 - Terminated(PI Decision) - -
NCT01226719 Colorectal Cancer Phase 2 Completed - United States, Arkansas ... More >> NEA Baptist Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Florida Cancer Specialists St. Petersburg, Florida, United States, 33705 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Hope Cancer Center Terre Haute, Indiana, United States, 47802 Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, New Hampshire Portsmouth Regional Hospital Portsmouth, New Hampshire, United States, 03801 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care, Inc Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 United States, Texas The Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 Less <<
NCT01749956 Rectal Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33916 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 Florida Cancer Specialists St. Petersburg, Florida, United States, 33705 Space Coast Cancer Center Titusville, Florida, United States, 32796 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, Oklahoma Oklahoma University Oklahoma City, Oklahoma, United States, 71304 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology - Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23230 Less <<
NCT02069704 Metastatic Colorectal Cancer Phase 1 Completed - Argentina ... More >> Hospital de Gastroenterologia "Dr. Carlos Bonorino Udaondo" Buenos Aires, Argentina Instituto Oncológico de Rosario Rosario, Argentina Brazil Fundaçáo Pio XII - Hospital do Cancer de Barretos Barretos, Brazil Hospital Caridade Ijui, Brazil Hospital Sao Lucas da Pucrs Porto Alegre, Brazil Centro de Pesquisa do Instituto Brasileiro de Controle do Câncer - IBCC São Paulo, Brazil Hosp. A.C Camargo São Paulo, Brazil Instituto do Cancer del estado de S. Paulo (ICEPS ) São Paulo, Brazil India M S Patel Cancer Centre- Shree Krishna Hospital Karamsad, Gujarat, India, 388 325 Sri Ramachandra Hospital Chennai, India Tata Hospital Mumbai, India Central India Canter Research Institute Nagpur, India Curie Manavta Cancer Center Nashik, India Regional Cancer Center & Medical College Thiruvananthapuram, India Spain Centro Oncológico Clara Campal Madrid, Spain Ukraine Dnipropetrovsk City Multiple-discipline Clinical Hospital №4 Dnipropetrovsk, Ukraine Kharkiv Regional Clinical Oncology Center Kharkiv, Ukraine Danylo Halytskiy Lviv National Medical University Lviv, Ukraine Less <<
NCT01832948 Metastatic Colorectal Cancer Phase 2 Unknown January 2015 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China Contact: Liming Zhu, MD    0571-88122222       Principal Investigator: Liming Zhu, MD Less <<
NCT03485027 Metastatic Colorectal Cancer ... More >> Chemotherapy Effect Less << Phase 2 Recruiting January 24, 2021 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Chenchen Wang, M.D Less <<
NCT00940303 Colorectal Cancer Phase 2 Completed - Germany ... More >> Berlin, Germany, 10117 Berlin, Germany, 13347 Bochum, Germany, 44791 Celle, Germany, 29221 Celle, Germany, 29223 Dessau-Roßlau, Germany, 06847 Freiburg, Germany, 79106 Fulda, Germany, 36043 Hamburg, Germany, 20246 Hamburg, Germany, 22087 Hannover, Germany, 30171 Leer, Germany, 26789 Magdeburg, Germany, 39120 Magdeburg, Germany, 39130 Nürnberg, Germany, 90419 Stade, Germany, 21680 Villingen-Schwenningen, Germany, 78052 Less <<
NCT02356276 Gastric Cancer Phase 3 Recruiting January 2022 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Zheng Peng, M.D    0086-137-0132-3669    pengzheng301@sina.com    Principal Investigator: Zheng Peng, M.D          China, Guangdong Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhi-Wei Zhou, M.D    0086-139-0222-2859    zhouzhw@sysucc.org.cn    Contact: Xiao-Xi Zhu, M.B    0086-138-0881-5489    zhuxx@sysucc.org.cn    Principal Investigator: Zhi-Wei Zhou, M.D          Guangdong General Hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact: Yong Li, M.D    0086-138-2217-7479    yuan821007@126.com    Contact: Ze-Jian Lv, M.M    0086-137-9819-1490    648593454@qq.com    Principal Investigator: Yong Li, M.D          Affiliated Tumor Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510095 Contact: shuzhong cui, M.D    0086-138-0251-3800    cuishuzhong@126.com    Contact: Zhen Tang, M.M    0086-159-2081-9128    57932181@qq.com    Principal Investigator: shuzhong cui, M.D          Guangdong Provincial Hospital of Traditional Chinese Medicine Recruiting Guangzhou, Guangdong, China, 510120 Contact: Jin Wang, M.D    0086-136-0283-8202    gdphtcmwanjin@163.com    Contact: Wen-Jun Xiong, M.M    0086-159-2055-3177    xiongwj1988@163.com    Principal Investigator: Jin Wang, M.D          Nanfang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Guo-Xin Li, M.D    0086-138-0277-1450    gzliguoxin@163.com    Contact: Hao Liu, M.D    0086-138-2215-8578    liuhaofbi@163.com    Principal Investigator: Guo-Xin Li, M.D          China, Hebei The Second Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050000 Contact: Bao-Jun Zhou, M.M    0086-136-0311-7586    zhoubaojun67@hotmail.com    Contact: Shao-Wei Ma, M.M    0086-137-3331-4055    13733314055@163.com    Principal Investigator: Bao-Jun Zhou, M.M          Hebei Medical University Fourth Hospital Recruiting Shijiazhuang, Hebei, China, 050011 Contact: Yong Li, M.D    0086-311-8609-5678    li_yong_hbth@126.com    Contact: Qing-Wei Liu, M.M    0086-159-3105-9506    liuqingwei_10@163.com    Principal Investigator: Yong Li, M.D          China, Heilongjiang Harbin Medical University Cancer Hospital Recruiting Harbin, Heilongjiang, China, 150081 Contact: Kuan Wang, M.D    0086-139-3624-3918    88008008@sina.com    Contact: Guan-Yu Zhu, M.D    0086-187-4612-6777    zhuguanyu001@163.com    Principal Investigator: Kuan Wang, M.D          China, Henan Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450008 Contact: Guang-Sen Han    0086-138-0381-8006    hnhanguangsen@126.com    Contact: Wei Yang, M.M    0086-151-3893-9753    294859420@qq.com    Principal Investigator: Guang-Sen Han          China, Hubei Wuhan Union Hospital, China Recruiting Wuhan, Hubei, China, 430030 Contact: Kai-Xiong Tao, M.D    0086-135-0715-5452    tao_kaixiong@163.com    Contact: Ke Wu, M.D    0086-135-4524-8289    wuke201288@126.com    Principal Investigator: Kai-Xiong Tao, M.D          China, Hunan The second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Hong-Liang Yao, M.D    0086-138-0845-2603    Yaohl0326@163.com    Contact: San-Lin Lei, M.D    0086-139-7499-1477    13974991477@163.com    Principal Investigator: Hong-Liang Yao, M.D          China, Tianjin Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Han Liang, M.M    0086-130-1138-3125    tjlianghan@126.com    Contact: Xue-Jun Wang, M.D    0086-    wxjsimon@163.com    Principal Investigator: Han Liang, M.M          China, Zhejiang Zhejiang Cancer Hospital Recruiting Hanzhou, Zhejiang, China, 310022 Contact: Xin-Bao Wang, M.D    0086-139-0652-3036    wangxb@zjcc.org.cn    Contact: Chao Hu, M.D    0086-137-3589-3334    huchao1987pj@126.com    Principal Investigator: Xin-Bao Wang, M.D Less <<
NCT01226719 - Completed - -
NCT02024412 Colorectal Cancer Phase 3 Unknown December 2017 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: YI BA, MD PHD    +8602223340123-1051    zhoubaling123@163.com    Sub-Investigator: Likun Zhou, MD          Principal Investigator: yi ba, MD PHD Less <<
NCT03038217 Rectal Cancer, Adenocarcinoma ... More >> Neoadjuvant Chemoradiation Less << Phase 3 Not yet recruiting December 2021 -
NCT02024438 Gastric Cancer Phase 3 Unknown December 2017 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: YI BA, MD PHD    +8602223340123-1051    zhoubaling123@163.com    Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: YI BA, MD PHD    +8602223340123-1051    zhoubaling123@163.com    Sub-Investigator: Likun Zhou, MD          Principal Investigator: yi ba, MD PHD Less <<
NCT03600623 Locally Advanced Pancreatic Ca... More >>ncer Borderline Pancreatic Inoperable Cancer Pancreatic Cancer Less << Early Phase 1 Recruiting July 2021 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Anna Messer, RN, BSN, MS    205-975-0370    amesser@uabmc.edu    Contact: Ravi K Paluri, MD    205-975-2477    rpaluri@uabmc.edu Less <<
NCT01749956 - Completed - -
NCT01640444 Colorectal Cancer Metastatic Phase 2 Active, not recruiting November 2018 Spain ... More >> Spanish Cooperative Group for Digestive Tumour Therapy Madrid, Spain, 28046 Less <<
NCT00200200 Hepatic Metastases ... More >> Colon Cancer Rectal Cancer Less << Phase 2 Active, not recruiting November 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, New York, United States, 10021 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Less <<
NCT03343301 Gastrointestinal Cancer ... More >> Gastrointestinal Cancer Metastatic Gastric Cancer Less << Phase 1 Active, not recruiting February 28, 2019 United States, California ... More >> Marin Cancer Care Greenbrae, California, United States, 94904 Innovative Clinical Research Institute Whittier, California, United States, 90603 Less <<
NCT03493048 Colo-rectal Cancer ... More >> Liver Metastases Less << Phase 2 Recruiting December 30, 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Li Yuhong, MD    020-87342487    liyh@sysucc.org.cn    Principal Investigator: Li Yuhong, MD Less <<
NCT00659022 Colorectal Neoplasms ... More >> Liver Neoplasms Less << Phase 2 Unknown April 2014 Netherlands ... More >> The Netherlands Cancer Institute/ Antoni van Leeuwenhoek Hospital Recruiting Amsterdam, Netherlands, 1066 CX Contact: Theo Ruers, PhD    +31-20-5122538    t.ruers@nki.nl    Radboud University Nijmegen Medical Center Recruiting Nijmegen, Netherlands, 6500 HB Contact: Kees Punt, PhD    +31-24-3610353    C.Punt@onco.umcn.nl Less <<
NCT03601156 Rectal Cancer Not Applicable Recruiting November 2020 China, Chongqing ... More >> Daping Hospital, Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Dong Wang, PH.D.    86-23-68757151    dongwang64@hotmail.com    Principal Investigator: Dong Wang, PH.D.          Chongqing Zhongshan Hospital Recruiting Chongqing, Chongqing, China Contact: Zhixiang Yang, M.D.    86-13032372491       Principal Investigator: Zhixiang Yang, M.D.          Jiangjin Central Hospital Recruiting Chongqing, Chongqing, China Contact: Debing Xiang, M.D.    86-13320336639       Principal Investigator: Debing Xiang, M.D. Less <<
NCT03647969 Adenocarcinoma of the Stomach ... More >> GastroEsophageal Cancer Less << Phase 2 Recruiting December 2022 Germany ... More >> Krankenhaus Nordwest Recruiting Frankfurt, Germany, 60488 Contact: Salah-Eddin Al-Batran    +496976014420    albatran@ikf-khnw.de    Contact: Claudia Pauligk    +496976013906    pauligk.claudia@ikf-khnw.de Less <<
NCT01633970 Cancer Phase 1 Active, not recruiting December 31, 2018 United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, District of Columbia Georgetown University Medical Center Lombardi Cancer Center Washington, District of Columbia, United States, 20007 United States, Illinois Uni of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital. Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02215 Dana Farber Can Ins Boston, Massachusetts, United States, 02215 United States, New York Laura and ISAAC Perlmutter Cancer Center at NYU Langone. New York, New York, United States, 10016 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 Carolina BioOncology Institute; Can Therapy & Res Ctr Huntersville, North Carolina, United States, 28078 United States, Tennessee Sarah Cannon Research Inst. Nashville, Tennessee, United States, 37203 Less <<
NCT01801085 - Terminated(Slow recruitment pa... More >>ce) Less << - Hong Kong ... More >> Princess Margaret Hospital Kowloon, Hong Kong Queen Elizabeth Hospital Kowloon, Hong Kong Less <<
NCT02572141 Colon Cancer Phase 3 Recruiting October 2022 China, Guangdong ... More >> The Sixth Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanhong Deng, M.D.    008613925106525    13925106525@163.com Less <<
NCT03711240 Colorectal Cancer Phase 2 Not yet recruiting October 30, 2020 Taiwan ... More >> National Cheng-Kung University Hospital Not yet recruiting Tainan, Taiwan Contact: Jean Yang          Principal Investigator: Shang Hung Chen Less <<
NCT00636610 - Completed - -
NCT03177382 Total Neoadjuvant Treatment ... More >> Chemoradiotherapy Local Advanced Rectal Cancer High Risk Factors Less << Phase 3 Recruiting May 30, 2023 China, Sichuan ... More >> West China Hospital Recruiting Chengdu, Sichuan, China, 610041 Contact: Ziqiang Wang, MD          China, Zhejiang The Second Affiliated Hospital of Zhejiang University Not yet recruiting Hanzhou, Zhejiang, China, 310009 Contact: Kefeng Ding, MD Less <<
NCT01473303 Pancreatic Cancer Phase 1 Phase 2 Withdrawn(CALGB 81003 closed a... More >>bout a week after it was activated because of withdrawal of support. No patients were registered on this study.) Less << - -
NCT00636610 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT02063529 Metastatic Colorectal Cancer Phase 2 Recruiting February 2020 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanhong Deng, M.D.    008613925106525    13925106525@163.com Less <<
NCT01571024 Advanced Solid Tumors ... More >> Metastatic Colorectal Cancer Metastatic Pancreatic Cancer Less << Phase 1 Completed - United States, North Carolina ... More >> University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT03237507 - Active, not recruiting June 1, 2020 China, Heilongjiang ... More >> Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China, 150081 Less <<
NCT03750669 Pancreatic Adenocarcinoma Rese... More >>ctable Neoadjuvant Chemotherapy Less << Phase 2 Recruiting October 20, 2024 China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China Contact: Qi Zhang, MD    8613819137113    zhangqi86@zju.edu.cn Less <<
NCT02231086 Colorectal Neoplasms ... More >> Peritoneal Neoplasms Less << Phase 3 Active, not recruiting April 2022 Netherlands ... More >> Academic Medical Center Amsterdam, Netherlands, 1105 AZ Antoni van Leeuwenhoek hospital Amsterdam, Netherlands Free University Medical Center Amsterdam, Netherlands Catharina hospital Eindhoven, Netherlands University Medical Centre Groningen Groningen, Netherlands Antonius hospital Nieuwegein, Netherlands Radboud University Medical Center Nijmegen, Netherlands Erasmus Medical Center Rotterdam, Netherlands University Medical Center Utrecht Utrecht, Netherlands Less <<
NCT00274872 Colorectal Cancer Phase 2 Phase 3 Unknown - France ... More >> Institut Sainte Catherine Avignon, France, 84082 Hopital Duffaut Avignon, France, 84902 Infirmerie Protestante Caluire, France, 69300 Hopital Drevon Dijon, France, 21000 Centre Hospitalier de Dreux Dreux, France, 28100 Hopital Louis Pasteur - Le Coudray Le Coudray, France, 28630 Clinique Victor Hugo Le Mans, France, F-72000 Hopital Robert Boulin Libourne, France, 33500 Clinique Saint Jean Lyon, France, 69008 Intercommunal Hospital Montfermeil, France, 93370 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Polyclinique De Courlancy Reims, France, F-51100 C.H. Senlis Senlis, France, 60309 Clinique des Jockeys Senlis, France, 60309 Centre Medico-Chirurgical Foch Suresnes, France, 92151 Less <<
NCT02031939 Advanced Rectal Cancer Phase 3 Recruiting January 2023 China, Guangdong ... More >> Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhen-Hai Lu, Prof.    +86 20 87343584    luzhh@sysucc.org.cn    Contact: Rong-Xin Zhang, M.D.    +86 20 87343456    zhangrx@sysucc.org.cn    Principal Investigator: Zhen-Hai Lu, Prof.          Sub-Investigator: Rong-Xin Zhang, M.D.          Sub-Investigator: Fu-Long Wang, M.D.          Sub-Investigator: Yuan-Hong Gao, M.D.          Sub-Investigator: Yu-Jing Fang, PhD.          Sub-Investigator: Xiao-Jun Wu, M.D.          Sub-Investigator: Zhi-Zhong Pan, M.D.          Sub-Investigator: Gong Chen, M.D.          Sub-Investigator: Pei-Rong Ding, M.D.          Sub-Investigator: Zhi-Fan Zeng, M.D.          Sub-Investigator: Jun-Zhong Lin, M.D.          Sub-Investigator: Qing Liu, M.D.          Sub-Investigator: De-Sen Wan, Prof. Less <<
NCT02038621 Advanced Gastric Cancer Phase 2 Unknown December 2017 -
NCT03488667 Gastro Esophageal Junction Can... More >>cer Stomach Cancer Adenocarcinoma Less << Phase 2 Recruiting April 30, 2021 United States, Kansas ... More >> The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States, 66205 Contact: Kerry Hepler, RN    913-945-7552    ctnursenav@kumc.edu Less <<
NCT01013805 Rectal Cancer Phase 2 Completed - Australia, Victoria ... More >> Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 8006 Less <<
NCT02575508 Colon Adenocarcinoma ... More >> Metastatic Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma Pancreatic Ductal Adenocarcinoma Rectal Adenocarcinoma Stage III Pancreatic Cancer Stage IIIA Colon Cancer Stage IIIA Rectal Cancer Stage IIIB Colon Cancer Stage IIIB Rectal Cancer Stage IIIC Colon Cancer Stage IIIC Rectal Cancer Stage IV Pancreatic Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 1 Phase 2 Withdrawn(drug supply issues) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT03707639 Gastric Adenocarcinoma Phase 2 Not yet recruiting November 2020 China, Fujian ... More >> Rongbo Lin Fuzhou, Fujian, China, 350014 Less <<
NCT03368859 Cancer Phase 2 Recruiting August 21, 2020 -
NCT01228734 Metastatic Colorectal Cancer Phase 3 Completed - China, Fujian ... More >> Fujian Province Cancer Hospital Fuzhou, Fujian, China, 350014 Fuzhou General Hospital Fuzhou, Fujian, China, 350025 China, Guangdong First Hospital Affiliated to Guangzhou University of Chinese Medicine Guangzhou, Guangdong, China, 510405 Nanfang Hospital Guangzhou, Guangdong, China, 510515 China, Heilongjiang The Tumor Hospital of Harbin Medical University Harbin, Heilongjiang, China, 150040 China, Hubei Union Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China, 430023 China, Jilin Jilin Cancer Hospital Changchun, Jilin, China, 130012 First Affiliated Hospital of Jilin University Changchun, Jilin, China, 130021 China, Shandong The Affiliated Hospital of Medical College Qingdao University Qingdao, Shandong, China, 266003 China, Zhejiang The First Affiliated Hospital of College of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310009 Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310016 China 307 Hospital of PLA Beijing, China, 100071 The General Hospital of the People's Liberation Army Beijing, China, 100853 Affiliated Hospital of Bengbu Medical College Bengbu, China, 233004 The Xiangya 2nd Hospital of Central South University Changsha, Hunan, China, 410011 Southwest Hospital Chongqing, China, 400038 Yunnan Provincial Tumor Hospital KunMing, Yunnan, China, 650118 The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China, 330006 Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, China, 200025 Fudan University Shanghai Cancer Center Shanghai, China, 200032 Shanghai First People's Hospital Shanghai, China, 200080 Fudan University Zhongshan Hospital Shanghai, China The First Affiliated Hospital of Soochow University Shuzhou, Jiangsu, China, 215006 Tianjin People's Hospital Tianjin, China, 30000 Xijing Hospital the 4th Military Medical University of PLA Xi'an, China, 710032 Less <<
NCT01228734 - Completed - -
NCT01511146 Liver Metastasis Phase 2 Unknown July 2016 Denmark ... More >> Herlev Hospital Recruiting Herlev, Denmark, 2730 Contact: Ole Larsen, ph.d., MD    +4538682329    olelar02@heh.regionh.dk    Principal Investigator: Ole Larsen, ph.d., MD Less <<
NCT00068692 Rectal Mucinous Adenocarcinoma... More >> Rectal Signet Ring Cell Adenocarcinoma Recurrent Rectal Carcinoma Stage IIA Rectal Cancer AJCC v7 Stage IIB Rectal Cancer AJCC v7 Stage IIC Rectal Cancer AJCC v7 Stage IIIA Rectal Cancer AJCC v7 Stage IIIB Rectal Cancer AJCC v7 Stage IIIC Rectal Cancer AJCC v7 Stage IVA Rectal Cancer AJCC v7 Stage IVB Rectal Cancer AJCC v7 Less << Phase 3 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT01487720 Prostate Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00680901 - Active, not recruiting - -
NCT01748851 Gastric Carcinoma Stage IV Phase 3 Terminated(Poor enrollment of ... More >>patients) Less << - Korea, Republic of ... More >> Dong-A University Hospital Busan, Korea, Republic of, 602-715 Less <<
NCT00680901 Neoplasms, Gastrointestinal Tr... More >>act Less << Phase 3 Active, not recruiting December 31, 2020 -
NCT01941979 Rectal Cancer Phase 3 Unknown September 2016 Brazil ... More >> ICESP Recruiting Sao Paulo, SP, Brazil, 01246000 Contact: Rachel SP Riechelmann, MD    55 11 38932000    pesquisa.clinica@icesp.org.br    Principal Investigator: Rachel SP Riechemann, MD Less <<
NCT00068692 - Completed - -
NCT01211210 Rectal Cancer Phase 2 Phase 3 Active, not recruiting June 2020 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yatsen University Guangzhou, Guangdong, China, 510655 Less <<
NCT02355119 Pancreatic Cancer Phase 3 Unknown December 2018 Italy ... More >> Azienda Ospedaliero-Universitaria Pisana Recruiting Pisa, PI, Italy, 56126 Contact: Enrico Vasile, MD, PhD    +39 050 992466    envasile@tin.it    Principal Investigator: Enrico Vasile, MD, PhD Less <<
NCT02808091 Extranodal NK-T-CELL LYMPHOMA Phase 2 Terminated(Slow recruitment) - Singapore ... More >> National Cancer Centre Singapore, Singapore, 169610 Less <<
NCT03730558 - Recruiting November 8, 2021 France ... More >> Institut Sainte-Catherine Recruiting Avignon, Vaucluse, France, 84000 Contact: Laurent Mineur, Doctor    04 90 27 62 68    l.mineur@isc84.org    Principal Investigator: Laurent Mineur, Doctor          Institut Sainte Catherine Recruiting Avignon, France, 84000 Contact: RANIA BOUSTANY    0490276161    r.boustany@isc84.org Less <<
NCT01332604 Solid Cancers Phase 1 Completed - United States, California ... More >> Los Angeles, California, United States, 90095 United States, Colorado Aurora, Colorado, United States, 80045 United States, Minnesota Rochester, Minnesota, United States, 55905 Spain Barcelona, Spain, 08035 Less <<
NCT01581307 Liver Cancer ... More >>Pancreatic Cancer Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00599924 Colorectal Neoplasms ... More >> Neoplasms Less << Phase 1 Completed - United States, Colorado ... More >> Pfizer Investigational Site Aurora, Colorado, United States, 80045 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75246 Less <<
NCT01581307 - Completed - -
NCT00599924 - Completed - -
NCT00275119 Pancreatic Cancer Phase 2 Unknown - France ... More >> Institut Sainte Catherine Avignon, France, 84082 Hopital Saint Andre Bordeaux, France, 33075 Clinique Tivoli Bordeaux, France, F-33000 Hopital Drevon Dijon, France, 21000 CHU de Grenoble - Hopital de la Tronche Grenoble, France, F-38043 Hopital Saint - Louis La Rochelle, France, 17000 Clinique Victor Hugo Le Mans, France, F-72000 Clinique Saint Jean Lyon, France, 69008 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13009 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Less <<
NCT00265850 Colorectal Cancer Phase 3 Active, not recruiting December 2017 -
NCT02981498 Hepatocellular Carcinoma Phase 2 Recruiting April 2017 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD       Shiming@sysu.edu.cn Less <<
NCT03253133 Colorectal Cancer Phase 1 Recruiting January 2018 France ... More >> Institut réginal du Cancer de Montpellier Recruiting Montpellier, France, 34298 Contact: Olivia SGARBURA    0033467613102    olivia.sgarbura@icm.unicancer.fr Less <<
NCT02402972 Colorectal Cancer ... More >> Metastasis Less << Phase 3 Recruiting February 2022 China ... More >> Zhongshan Hospital, Fudan University Recruiting Shanghai, China, 200032 Contact: Wenju Chang, MD    86-21-13764476150       Principal Investigator: jianmin xu, MD Less <<
NCT02836977 Stage III Colon Cancer Not Applicable Active, not recruiting February 29, 2024 Taiwan ... More >> Chung-Ho Memorial Hospital, Kaohsiung Medical University: Kaohsiung, Taiwan, 807 Less <<
NCT00025337 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 3 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00265850 - Active, not recruiting - -
NCT03606928 Gastric Cancer Phase 1 Phase 2 Recruiting July 1, 2024 China ... More >> Department of Oncology, Ruijin Hospital Recruiting Shanghai, China, 200025 Contact: Jun Zhang, MD & Ph. D    +86-13818332497    junzhang10977@sjtu.edu.cn    Contact: Chenfei Zhou, MD & Ph. D    +86-13761618390    raining_grayday@hotmail.com    Principal Investigator: Jun Zhang, MD & Ph. D Less <<
NCT00271271 Non Small Cell Lung Cancer Phase 2 Completed - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT00254137 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT01596634 Colorectal Cancer ... More >> Dysgeusia Oral Complications of Chemotherapy Less << Not Applicable Completed - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00873275 Colorectal Cancer Phase 1 Active, not recruiting September 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT03213444 Colon Cancer ... More >>Adjuvant Chemotherapy Less << Not Applicable Recruiting July 2019 Brazil ... More >> Sociedade Beneficente de Senhoras Hospital Sírio-Libanês Recruiting São Paulo, Brazil, 01.409-000 Contact: Raphaela V Groehs, PhD    +551126615099    rapha_vilar@hotmail.com Less <<
NCT01662869 Gastric Cancer Phase 3 Completed - -
NCT00577031 - Completed - -
NCT00700570 Colorectal Cancer Phase 2 Completed - Taiwan ... More >> Kaohsiung, Taiwan, 00833 Kaohsiung, Taiwan, 807 Taichung, Taiwan, 407 Taipei, Taiwan, 00112 Taipei, Taiwan, 112 Taoyuan County, Taiwan, 333 Less <<
NCT00056030 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - -
NCT00577031 Colorectal Cancer Phase 4 Completed - Italy ... More >> Bologna, Italy, 40138 Brescia, Italy, 25122 Cagliari, Italy, 09100 Cagliari, Italy, 09121 Caserta, Italy, 81100 Catanzaro, Italy, 88100 Cefalu, Italy, 90015 Fano, Italy, 61032 Firenze, Italy, 50139 Frattaminore, Italy, 80026 Grosseto, Italy, 58100 Ivrea, Italy, 10015 Latisana, Italy, 33053 Lecce, Italy, 73100 Legnago, Italy, 37045 Legnano, Italy, 20025 Macerata, Italy, 62100 Napoli, Italy, 80131 Negrar, Italy, 37024 Orbassano, Italy, 10043 Padova, Italy, 35128 Palermo, Italy, 90127 Palermo, Italy, 90146 Pavia, Italy, 27100 Reggio Calabria, Italy, 89100 Reggio Emilia, Italy, 42100 Rionero in Vulture, Italy, 85028 Roma, Italy, 00152 Roma, Italy, 00184 Roma, Italy, 00186 Roma, Italy, 00189 Salerno, Italy, 84131 San Giovanni Rotondo, Italy, 71013 Sondrio, Italy, 23100 Taormina, Italy, 98030 Torino, Italy, 10125 Torino, Italy, 10153 Verbania, Italy, 28921 Less <<
NCT02860429 Gastrointestinal Neoplasms Phase 4 Unknown - China, Liaoning ... More >> The First Affiliated Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Xiaonan Cui    +8618098876725    cxn23@sina.com    Liaoning Cancer Hospital Not yet recruiting Shenyang, Liaoning, China, 110000 Contact: Rui Zhang    +8613898872185    zzzrrr1234@sina.com Less <<
NCT03486678 Biliary Tract Cancer ... More >> Cholangiocarcinoma Less << Phase 2 Recruiting April 8, 2020 China, Jiangsu ... More >> Jiangsu Province Hospital Recruiting Nanjing, Jiangsu, China, 210029 Contact: Yongqian Shu, PhD    00862568306428    shuyongqian@csco.org.cn    Contact: Xiaofeng Chen, PhD    008613585172006    xiaofengch198019@126.com Less <<
NCT03505320 Pharmacokinetics of Zolbetuxim... More >>ab Gastric Cancer Gastro-esophageal Junction (GEJ) Cancer Pharmacokinetics of Oxaliplatin Pharmacokinetics of Fluorouracil Bolus (5-FU) Less << Phase 2 Recruiting July 2020 United States, California ... More >> The Angeles Clinic and Research Institute Recruiting Los Angeles, California, United States, 90025 United States, Indiana Indiana University Cancer Center Recruiting Indianapolis, Indiana, United States, 46077 United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 United States, New York Weill Cornell Medical College Recruiting New York, New York, United States, 10065 United States, South Dakota Sanford Cancer Center Recruiting Sioux Falls, South Dakota, United States, 57104 United States, Virginia Virginia Cancer Specialists Recruiting Fairfax, Virginia, United States, 22031 France Site FR33011 Recruiting Brest, France Italy Site IT39005 Recruiting Milano, Italy Site IT39002 Recruiting Napoli, Italy Site IT39004 Recruiting Padova, Italy Site IT39003 Recruiting Pisa, Italy Korea, Republic of Site KR82002 Recruiting Seongnam-si, Korea, Republic of Site KR82001 Recruiting Seoul, Korea, Republic of Taiwan Site TW88601 Recruiting Taichung, Taiwan Less <<
NCT01562990 Diffuse Large B-Cell Lymphoma Phase 1 Phase 2 Completed - Belgium ... More >> AZ Sint Jan Bruges, Belgium, 8000 University Hospital Gent Gent, Belgium, 9000 CHU Mont-Godinne Yvoir, Belgium France Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon Dijon, France, 21000 CHRU de Lille Lille, France, 59037 CHU Lyon - Sud Lyon, France, 69495 CHU Hôtel Dieu Nantes, France, 44093 CHU Pontchaillou Rennes, France, 35003 Centre Henri Becquerel Rouen, France, 76038 CHU Brabois Vandoeuvre les nancy, France, 54511 Less <<
NCT01321957 Metastatic Colorectal Cancer Phase 2 Completed - -
NCT00700570 - Completed - -
NCT01643070 Rectal Cancer ... More >> Liver Metastases Less << Phase 2 Unknown December 2016 Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa, Korea, Republic of, 138736 Less <<
NCT03009461 HepatoCellular Carcinoma ... More >> Portal Vein Thrombosis Less << Phase 2 Recruiting December 2019 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Xiaodong Wang, MD    008610-88196476    wangxde@gmail.com    Sub-Investigator: Guang Cao, MD          Sub-Investigator: Hui Chen, MD          Sub-Investigator: Jianhai Guo, MD          Sub-Investigator: Haifeng Xu, MD          Sub-Investigator: Peng Liu, MD          Sub-Investigator: Jungang Hu, MD Less <<
NCT03599778 Gastric Carcinoma Phase 1 Phase 2 Not yet recruiting January 30, 2025 China, Anhui ... More >> Anhui Provincial Cancer Hospital Hefei, Anhui, China, 230000 Less <<
NCT00496704 Colorectal Cancer Phase 1 Phase 2 Unknown - Korea, Republic of ... More >> Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 120-752 Contact: Joong B. Ahn, MD    82-2-2228-8134 Less <<
NCT03146377 Colorectal Cancer Phase 2 Completed - Hong Kong ... More >> Queen Mary Hospital, The University of Hong Kong Hong Kong, Hong Kong Less <<
NCT02974556 Colon Cancer ... More >>Intraperitoneal Rectal Cancer Less << Phase 3 Not yet recruiting September 2025 Italy ... More >> ASST Nord Milano P.O. Città di Sesto S. Giovanni Not yet recruiting Milano, PD, Italy, 35031 Contact: Gianandrea Baldazzi, MD       gbaldazzi@hotmail.com    Principal Investigator: Gianandrea Baldazzi, MD          Sub-Investigator: Diletta Cassini, MD          ASO S. Croce e Carle Not yet recruiting Cuneo, Italy, 12100 Contact: Felice Borghi, MD       borghi.f@ospedale.cuneo.it    Principal Investigator: Felice Borghi, MD          Sub-Investigator: Maria Carmela Giuffrida, MD          Azienda Ospedaliera dei Colli Napoli, Italy, 80131 Istituto Nazionale Tumori IRCCS Fondazione Pascale di Napoli Napoli, Italy, 80131 Ospedale di Rimini Not yet recruiting Rimini, Italy, 47923 Contact: Gianluca Garulli, MD       lucagarulli@gmail.com    Principal Investigator: Gialuca Garulli, MD          Sub-Investigator: Basilio Pirrera, MD          University of Rome Sapienza Not yet recruiting Roma, Italy, 00161 Contact: Paolo Sammartino, MD PhD    336615632 ext +39    paolo.sammartino@uniroma1.it    Contact: Tommaso Cornali, MD    3489012376 ext +39    tommaso.cornali@uniroma1.it    Principal Investigator: Paolo Sammartino, MD PhD          Sub-Investigator: Tommaso Cornali, MD          Sub-Investigator: Fabio Accarpio, MD PhD          Sub-Investigator: Daniele Biacchi, MD Phd          Ospedale Sant'Eugenio Not yet recruiting Rome, Italy, 00144 Contact: Massimo Carlini, MD FACS       maxcarlini@tiscali.it    Principal Investigator: Massimo Carlini, MD          Sub-Investigator: Domenico Spoletini, MD          Sub-Investigator: Daniela Apa, MD          Azienda Ospedaliera Universitaria Integrata di Verona Verona, Italy, 37126 Less <<
NCT00729677 - Completed - United States, New York ... More >> Beth Israel Medical Center - Philipps Ambulatory Care Center New York, New York, United States, 10003 Less <<
NCT02142322 Advanced Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00729677 - Completed - -
NCT00415298 Head and Neck Cancer Not Applicable Unknown - United States, California ... More >> Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Less <<
NCT00079274 Adenocarcinoma of the Colon ... More >> Stage III Colon Cancer Less << Phase 3 Completed - -
NCT01575730 Peritoneal Carcinomatosis Phase 2 Unknown July 2015 Belgium ... More >> Ghent University Hospital Recruiting Ghent, Belgium Contact: Wim P Ceelen, MD, PhD       wim.ceelen@ugent.be    Principal Investigator: Wim P Ceelen, MD, PhD Less <<
NCT02119026 Metastatic Colorectal Cancer Phase 2 Unknown December 2014 Austria ... More >> Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Werner Scheithauer, Prof. Dr.    +43-1-40 400 ext 4424    werner.scheithauer@meduniwien.ac.at    Contact: Gabriela 4424 Kornek, Prof. Dr.    +43-1-40 400    gabriela.kornek@meduniwien.ac.at    Principal Investigator: Werner Scheithauer, Prof. Dr. Less <<
NCT01227239 Rectal Carcinoma Phase 1 Phase 2 Unknown August 2016 Japan ... More >> Nagoya University Graduate School of Medicine Nagoya, Japan, 466-8550 Osaka Medical College Osaka, Japan, 569-8686 Jichi Medical University Hospital Tochigi, Japan, 329-0498 Tokyo University Tokyo, Japan, 113-0033 Cancer Institute Hospital Tokyo, Japan, 135-8550 Teikyo University Tokyo, Japan, 173-8606 Less <<
NCT03164655 Colorectal Cancer Metastatic Phase 2 Recruiting November 2021 France ... More >> Ico Paul Papin Active, not recruiting Angers, France Centre Eugene Marquis Active, not recruiting Rennes, France Chp Saint Gregoire Active, not recruiting Saint-Grégoire, France Gustave Roussy Recruiting Villejuif, France, 94 Contact: Valérie Boige, PU PH    33 (0)1 42 11 43 11    valerie.boige@gustaveroussy.fr Less <<
NCT02889666 Recurrent Non-small Cell Lung ... More >>Cancer Less << Phase 1 Recruiting December 2020 China, Jilin ... More >> China-Japan Union Hospital, Jilin University Recruiting Changchun, Jilin, China, 130033 Contact: Xian-Ling Cong, M.D    86-0431-89876626    qingzhao_jilin@126.com    China Shanghai 10th People's Hospital Recruiting Shanghai, China, 200072 Contact: Da Fu, Ph.D    86-15921527578    fu800da900@126.com    Shanghai Pulmonary Hospital, Tongji University School of Medicine Recruiting Shanghai, China, 200433 Contact: Chun-Yan Wu, M.D    86-65115006-3030    51917533@qq.com Less <<
NCT00079274 - Completed - -
NCT00193219 Colon Cancer Phase 2 Completed - United States, Indiana ... More >> Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Mississippi Jackson Oncology Associates Jackson, Mississippi, United States, 39202 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT01579357 Metastatic Colorectal Cancer Phase 2 Completed - Austria ... More >> PMU Salzburg Salzburg, Austria, 5020 AKH Wien Vienna, Austria, 1090 Kaiser Franz Josef Spital Vienna, Austria, 1100 Less <<
NCT01446458 Cancer of Pancreas ... More >> Cancer of the Pancreas Neoplasms, Pancreatic Pancreas Cancer Pancreas Neoplasms Less << Phase 1 Completed - United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00551759 Esophageal Cancer Phase 2 Terminated(The study used a tw... More >>o-stage design. After stage one, the study was terminated due to excess toxicity.) Less << - -
NCT00551759 - Terminated(The study used a tw... More >>o-stage design. After stage one, the study was terminated due to excess toxicity.) Less << - -
NCT00070213 Colorectal Cancer Phase 3 Unknown - United Kingdom ... More >> Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB Clinical Trials and Research Unit of the University of Leeds Leeds, England, United Kingdom, LS2 9JT Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT02551991 Pancreatic Cancer Phase 1 Phase 2 Active, not recruiting February 28, 2020 -
NCT01293942 Metastatic Colorectal Cancer Phase 2 Withdrawn - Canada, Ontario ... More >> The Ottawa Hospital Cancer Center Ottawa, Ontario, Canada, K1H 8L6 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 University Health Network Toronto, Ontario, Canada, M5T 2S8 Canada, Quebec McGill University Health Centre Montreal, Quebec, Canada, H3A 1A1 Less <<
NCT01552980 Gastric Adenocarcinoma Phase 2 Unknown February 2014 China, Guangdong ... More >> Sixth Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yue Cai, Master    86-20-38250745    chilly8518@163.com Less <<
NCT00193219 - Completed - -
NCT00819754 Metastatic Colorectal Cancer Phase 1 Phase 2 Terminated - Canada, Ontario ... More >> The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT01926236 Biliary Tract Cancer ... More >> Gallbladder Cancer Cholangiocarcinoma Ampullary Cancer Less << Phase 3 Active, not recruiting February 2019 United Kingdom ... More >> Queen Elizabeth Hospital Birmingham, United Kingdom Bristol Haematology & Oncology Centre Bristol, United Kingdom North Cumbria University Hospitals Carlisle, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN Castle Hill Hospital Hull, United Kingdom St James' Hospital Leeds, United Kingdom Clatterbridge Cancer Centre Liverpool, United Kingdom Guy's and St Thomas' Hospital London, United Kingdom Hammersmith Hospital London, United Kingdom Royal Free Hospital London, United Kingdom University College London London, United Kingdom Maidstone Hospital Maidstone, United Kingdom The Christie NHS Foundation Trust Manchester, United Kingdom Nottingham City Hospital Nottingham, United Kingdom Churchill Hospital Oxford, United Kingdom Weston Park Hospital Sheffield, United Kingdom Southampton General Hospital Southampton, United Kingdom Less <<
NCT02692248 Diffuse Large B-Cell Lymphoma Phase 2 Recruiting September 2020 Spain ... More >> Hospital Universitario Central de Asturias Recruiting Oviedo, Asturias, Spain, 33011 Contact: Ángel Ramírez Páyer, MD       apayer.angel@gmail.com    Principal Investigator: Ángel Ramírez Páyer, MD          Hospital Especialidades Recruiting Jerez de la Frontera, Cádiz, Spain, 11407 Contact: Mª José Ramírez, MD       mariajoserasa@yahoo.es    Principal Investigator: Mª José Ramírez, MD          Hospital Universitario Donostia Recruiting Donostia San Sebastian, Guipúzcoa, Spain, 20080 Contact: Izaskun Ceberio, MD       IZASKUN.CEBERIOECHECHIPIA@osakidetza.eus    Principal Investigator: Izaskun Ceberio, MD          Hospital Universitario Son Espases Recruiting Palma, Islas Baleares, Spain, 07120 Contact: Antonio Gutiérrez, MD       antoniom.gutierrez@ssib.es    Principal Investigator: Antonio Gutiérrez, MD          Hospital de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: Mª Cruz Viguria, MD       mc.viguria.alegria@cfnavarra.es    Principal Investigator: Mª Cruz Viguria, MD          Complexo Hospitalario Universitario de Vigo Recruiting Vigo, Pontevedra, Spain Contact: Ana Margarita Martínez Castro, MD       ana.margarita.martinez.castro@sergas.es    Principal Investigator: Ana Margarita Martínez Castro, MD          Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact: Pau Abrisqueta, MD       pabrisqueta@vhebron.net    Principal Investigator: Pau Abrisqueta, MD          Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Eva Giné, MD       EGINE@clinic.ub.es    Principal Investigator: Eva Giné, MD          Complejo Hospitalario de Jaén Recruiting Jaén, Spain, 23007 Contact: Soledad Duran Nieto, MD       soledaduran@hotmail.com    Principal Investigator: Soledad Durán Nieto, MD          Hospital Universitario Infanta Leonor Recruiting Madrid, Spain, 28031 Contact: José Antonio Hernández Rivas, MD       jahr_jahr2006@yahoo.es    Principal Investigator: Jose Antonio Hernández Rivas, MD          MD Anderson Cancer Center Recruiting Madrid, Spain, 28033 Contact: Adolfo de la Fuente, MD       afuente@mdanderson.es    Principal Investigator: Adolfo de la Fuente, MD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Carlos Grande, MD       cgrandegar@yahoo.es    Principal Investigator: Carlos Grande, MD          Hospital General Universitario Morales Meseguer Recruiting Murcia, Spain, 30008 Contact: Jose Javier Sánchez Blanco, MD       josej.sanchez3@carm.es    Principal Investigator: Jose Javier Sánchez Blanco, MD          Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain, 41013 Contact: Fátima de la Cruz, MD       fatimadelacruzv@gmail.com    Principal Investigator: Fátima de la Cruz, MD          Hospital Clínic Universitari de València Recruiting Valencia, Spain, 46010 Contact: Mª José Terol, MD       terol39@mail.ono.es    Principal Investigator: Mª Jose Terol, MD          Hospital Universitario y Politécnico La Fe Recruiting Valencia, Spain, 46026 Contact: Rafael Andreu, MD       randreu69@gmail.com    Principal Investigator: Rafael Andreu, MD          Hospital Clínico Universitario de Valladolid Recruiting Valladolid, Spain, 47005 Contact: Mª Jesús Peñarrubia, MD       mpenarrubiap@gmail.com    Principal Investigator: Mª Jesús Peñarrubia, MD Less <<
NCT02574663 Pancreatic Cancer ... More >> Colorectal Cancer Rectal Cancer Gastric Cancer Esophageal Cancer Gastrointestinal Stromal Tumor (GIST) Less << Phase 1 Active, not recruiting February 2019 United States, Tennessee ... More >> TG Therapeutics Trial Site Nashville, Tennessee, United States, 37203 Less <<
NCT00026234 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Liver Metastases Recurrent Colon Cancer Recurrent Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT02311439 Cancer of Pancreas Phase 2 Phase 3 Unknown April 2017 Egypt ... More >> Assiut University Hospitals Recruiting Asyut, Egypt, 71516 Contact: Samir Eid, Professor       samir_eid@hotmail.com Less <<
NCT00070122 Adenocarcinoma of the Colon ... More >> Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Stage III Colon Cancer Stage III Rectal Cancer Stage IV Colon Cancer Stage IV Rectal Cancer Less << Phase 3 Terminated(Administratively co... More >>mplete.) Less << - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT01150045 Colorectal Cancer Phase 3 Active, not recruiting - -
NCT00988897 Colorectal Neoplasms Phase 2 Withdrawn May 2012 Canada ... More >> Sanofi-Aventis Administrative Office Laval, Canada Less <<
NCT02872116 Gastric Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 3 Recruiting October 6, 2022 -
NCT00069108 Colorectal Cancer Phase 3 Completed - -
NCT00069108 - Completed - -
NCT00346099 Rectal Cancer ... More >> Neoplasm Metastasis Less << Phase 2 Withdrawn(Protocol closed base... More >>d on new (and as yet unpublished) information from a phase II clinical trial.) Less << May 2007 -
NCT01279681 Cognitive/Functional Effects ... More >> Colorectal Cancer Neurotoxicity Less << Phase 3 Terminated(Slow accrual) - -
NCT00098787 - Completed - -
NCT01279681 - Terminated(Slow accrual) - -
NCT00145314 Metastatic Colorectal Cancer Phase 3 Completed - Norway ... More >> The Nordic Colorectal Cancer Biomodulation Group Oslo, Norway, NO-0407 Less <<
NCT00003799 Adenocarcinoma of the Rectum ... More >> Mucinous Adenocarcinoma of the Rectum Signet Ring Adenocarcinoma of the Rectum Stage IIA Rectal Cancer Stage IIB Rectal Cancer Stage IIC Rectal Cancer Stage IIIA Rectal Cancer Stage IIIB Rectal Cancer Stage IIIC Rectal Cancer Less << Phase 1 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT01921790 Extranodal NK/T-cell Lymphoma,... More >> Nasal Type Less << Phase 2 Recruiting August 2020 China, Guangdong ... More >> Department of Medical Oncology, Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhiming Li, MD    +86-13719189172    lizhm@sysucc.org.cn    Contact: Yu Wang, MD    +86-20-87343765    wangyu@sysucc.org.cn Less <<
NCT02723253 Rectal Neoplasms Phase 2 Completed - -
NCT00098787 Colorectal Cancer Phase 2 Completed - -
NCT02533323 Lymphoma, Extranodal NK-T-Cell Phase 2 Terminated - China, Guangdong ... More >> Sun Yat-sen University Cancer Center GuangZhou, Guangdong, China, 510060 Less <<
NCT02273713 Esophageal Cancer ... More >> Toxicity Less << Phase 1 Phase 2 Completed - Netherlands ... More >> Academic Medical Center, Medical Oncology Amsterdam, Netherlands, 1100 DD Less <<
NCT02135887 - Recruiting March 31, 2019 Taiwan ... More >> Microbio Co., Ltd. Recruiting Taipei, Taiwan Contact: Kristin Fan    886-4-2325-1900 ext 108    kristin.fan@microbio.com.tw Less <<
NCT00807911 Rectal Cancer Phase 2 Active, not recruiting December 2018 Korea, Republic of ... More >> National Cancer Center Goyang, Korea, Republic of Seoul National Unversity Bundang Hospital Seongnam, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Yeonsei University Hosptial Seoul, Korea, Republic of Less <<
NCT01798251 Gastric Cancer Phase 2 Unknown December 2015 China, Heilongjiang ... More >> The tumor hospital of Harbin medical university Recruiting Harbin, Heilongjiang, China, 150000 Contact: Yuxian BAI, PhD    86 451 86298265    bai_yuxian@126.com    Contact: Hong SUI, PhD    86 13936592698    doctorsui2003@126.com    Principal Investigator: Yuxian BAI, PhD          Sub-Investigator: Hong SUI, PhD Less <<
NCT02344810 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Diffuse Adenocarcinoma of the Stomach Gastrointestinal Cancer Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Stage IIIA Esophageal Cancer Stage IIIA Gastric Cancer Stage IIIB Esophageal Cancer Stage IIIB Gastric Cancer Stage IIIC Esophageal Cancer Stage IIIC Gastric Cancer Stage IV Esophageal Cancer Stage IV Gastric Cancer Less << Phase 1 Phase 2 Withdrawn(The study did not op... More >>en to accrual. No start date and no completion dates.) Less << March 6, 2020 United States, Pennsylvania ... More >> ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00588900 - Terminated - -
NCT00728000 Pancreatic Adenocarcinoma Phase 2 Withdrawn(study withdrawn due ... More >>to lack of enrollment) Less << August 2010 United States, Ohio ... More >> University of Cincinnati Cincinnati, Ohio, United States, 45267 Less <<
NCT02345746 Metastatic Colorectal Cancer Phase 2 Withdrawn(patient population) December 2013 -
NCT00588900 Colorectal Cancer Phase 2 Terminated - United States, Illinois ... More >> Evanston Hospital Evanston, Illinois, United States, 60201-1781 United States, Indiana Elkhart Clinic, LLC Elkhart, Indiana, United States, 46514-2098 Elkhart General Hospital Elkhart, Indiana, United States, 46515 Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States, 46845 Howard Community Hospital Kokomo, Indiana, United States, 46904 Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte, Indiana, United States, 46350 CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States, 46601 Memorial Hospital of South Bend South Bend, Indiana, United States, 46601 Michiana Hematology-Oncology, PC - South Bend South Bend, Indiana, United States, 46601 Saint Joseph Regional Medical Center South Bend, Indiana, United States, 46617 South Bend Clinic South Bend, Indiana, United States, 46617 United States, Iowa Hematology Oncology Associates of the Quad Cities Bettendorf, Iowa, United States, 52722 Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Michigan Lakeside Cancer Specialists, PLLC Saint Joseph, Michigan, United States, 49085 Lakeland Regional Cancer Care Center - St. Joseph St. Joseph, Michigan, United States, 49085 United States, Missouri Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia, Missouri, United States, 65203 United States, Nebraska Cancer Resource Center - Lincoln Lincoln, Nebraska, United States, 68510 CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 Immanuel Medical Center Omaha, Nebraska, United States, 68122 Alegant Health Cancer Center at Bergan Mercy Medical Center Omaha, Nebraska, United States, 68124 Creighton University Medical Center Omaha, Nebraska, United States, 68131-2197 United States, New Hampshire New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care Concord, New Hampshire, United States, 03301 New Hampshire Oncology - Hematology, PA - Hooksett Hooksett, New Hampshire, United States, 03106 Lakes Region General Hospital Laconia, New Hampshire, United States, 03246 United States, New York CCOP - Hematology-Oncology Associates of Central New York East Syracuse, New York, United States, 13057 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wayne Memorial Hospital, Incorporated Goldsboro, North Carolina, United States, 27534 Kinston Medical Specialists Kinston, North Carolina, United States, 28501 Rex Cancer Center at Rex Hospital Raleigh, North Carolina, United States, 27607 Iredell Memorial Hospital Statesville, North Carolina, United States, 28677 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT02008422 Gastric Cancer Phase 3 Unknown August 2016 China, Xinjiang ... More >> Cancer Hospital of Xinjiang Medical University Urumqi, Xinjiang, China, 830011 Less <<
NCT02041481 Recurrent Colon Cancer ... More >> Recurrent Rectal Cancer Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00297141 Rectal Cancer Phase 2 Completed - Austria ... More >> Hospital BHB St. Veit/Glan, Surgery St. Veit a. d. Glan, Carinthia, Austria, 9330 Hospital Wiener Neustadt Wiener Neustadt, Lower Austria, Austria, 2700 Medical University of Graz, Oncology Graz, Styria, Austria, 8036 State Hospital Leoben, Surgery Leoben, Styria, Austria, 8700 Medical University of Innsbruck, Surgery Innsbruck, Tyrol, Austria, 6020 Klinikum Wels-Grieskirchen GmbH Wels, Upper Austria, Austria, 4600 Paracelsus Medical University Salzburg - Oncology Salzburg, Austria, 5020 Medical University of Vienna, Radiotherapy Vienna, Austria, 1090 Less <<
NCT02250209 Gastric Cancer Phase 2 Unknown December 2017 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Guanghai Dai       daigh60@sohu.com    Contact: Yan Shi    13810561979    shibaiwan12@sina.com    Principal Investigator: Guanghai Dai Less <<
NCT01562977 Aggressive Lymphoma ... More >> Diffuse Large B-cell Lymphoma Mantle Cell Lymphoma Less << Phase 2 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Hospital Duran i Reynals Sabadell, Barcelona, Spain Hospital SAS de Jerez Jerez de la Frontera, Cádiz, Spain Hospital Dr. Jose Molina Orosa Arrecife, Lanzarote, Spain Fundación Hospital de Alcorcón Alcorcón, Madrid, Spain Hospital Puerta de Hierro de Majadahonda Majadahonda, Madrid, Spain Hospital Virgen de Arrixaca El Palmar, Murcia, Spain Complejo Hospitalario de A Coruña A Coruña, Spain Hospital Santa Creu i Sant Pau Barcelona, Spain Hospital Vall d´Hebrón Barcelona, Spain Hospital 12 Octubre Madrid, Spain Hospital Gregorio Marañón Madrid, Spain Hospital La Paz Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Morales Meseguer Murcia, Spain Hospital Son Espasses Palma de Mallorca, Spain Hospital Son Llàtzer Palma de Mallorca, Spain Clinica Universitaria de Navarra Pamplona, Spain Corporació Sanitari Parc Taulí Sabadell, Spain Hospital Clínico de Salamanca Salamanca, Spain Hospital Universitario de Canarias Santa Cruz de Tenerife, Spain Hospital Marqués de Valdecilla Santander, Spain Complejo Hospitalario Universitario de Santiago Santiago de Compostela, Spain Hospital Dr. Peset Valencia, Spain Hospital La Fe Valencia, Spain Hospital Virgen de la Concha Zamora, Spain Hospital Clínico Lozano Blesa Zaragoza, Spain Hospital Miguel Servet Zaragoza, Spain Less <<
NCT01739894 Gastric Cancer Phase 2 Unknown August 2018 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Wei Peng Yong, MBBS    (65) 6779 5555    Wei_Peng_Yong@nuhs.edu.sg    Contact: Maricel Cordero    (65) 6772 2612    tiemsim_maricel_cordero@nuhs.edu.sg    Principal Investigator: Wei Peng Yong, MBBS Less <<
NCT01882933 Gastric Adenocarcinoma Phase 3 Recruiting May 2025 France ... More >> Département de Chirurgie Digestive, CHU d'Amiens Recruiting Amiens, France, 80054 Contact: Jean-Luc REGIMBEAU, MD          Principal Investigator: Jean-Luc REGIMBEAU, MD          Service de Chirurgie Digestive Oncologique, CLCC Paul Papin Recruiting Angers, France, 49033 Principal Investigator: Romuald WERNERT, MD          Département de Chirurgie Digestive - CHU d'Angers Recruiting Angers, France, 49100 Principal Investigator: Gérard LORIMIER, MD          Service de Chirurgie Digestive, Hôpital Jean Minjoz, CHU Besançon Recruiting Besançon, France, 25030 Principal Investigator: Bruno HEYD, MD          Service de Chirurgie Viscérale, CLCC François Baclesse Recruiting Caen, France, 14076 Principal Investigator: Jean-Marc GUILLOIT, MD          Service de Chirurgie Viscérale, CHU Estaing Recruiting Clermont-Ferrand, France, 63003 Principal Investigator: Denis PEZET, MD          Service de Chirurgie Générale et Digestive, Hôpital Louis Mourier Recruiting Colombes, France, 92701 Principal Investigator: Simon MSIKA, MD          Service de Chirurgie Digestive, Hôpital du Bocage Recruiting Dijon, France, 21079 Principal Investigator: Patrick RAT, MD          Service de Chirurgie Digestive et de l'Urgence, Hôpital Michallon Recruiting Grenoble, France, 38043 Principal Investigator: Catherine ARVIEUX, MD          Service de Chirurgie Digestive et Générale, Hôpital Huriez Recruiting Lille, France, 59067 Contact: Guillaume PIESSEN, MD          Principal Investigator: Guillaume PIESSEN, MD          Service de Chirurgie Digestive, CLCC Léon Bérard Recruiting Lyon, France, 69373 Principal Investigator: Pierre MEEUS, MD          Service d'Oncologie Digestive, Hôpital de la Timone Recruiting Marseille, France, 13005 Contact: Jean-François SEITZ, MD          Principal Investigator: Jean-François SEITZ, MD          Service de Chirurgie Digestive, CRLC Val d'Aurelle Recruiting Montpellier, France, 34298 Principal Investigator: François QUENET, MD          Service de Chirurgie Digestive, CLCC René Gauducheau Recruiting Nantes, France, 44805 Principal Investigator: Emilie THIBAUDEAU, MD          Service de Chirurgie Digestive, Hôpital Archet II Recruiting Nice, France, 06200 Principal Investigator: Jean-Marc BEREDER, MD          Service de Chirurgie Digestive, Institut Curie Recruiting Paris, France, 75005 Contact: Pascale MARIANI, MD          Principal Investigator: Pascale MARIANI, MD          Service de Chirurgie Digestive, Hépato-Biliaire et Endocrinienne, Hôpital Cochin Recruiting Paris, France, 75014 Contact: Bertrand DOUSSET, MD          Principal Investigator: Bertrand DOUSSET, MD          Service de Chirurgie Digestive, Hôpital Lariboisière Recruiting Paris, France, 75475 Principal Investigator: Marc POCARD, MD          Service de Chirurgie Générale Digestive et Endocrinienne, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon Recruiting Pierre Bénite, France, 69495 Contact: Olivier GLEHEN, MD    4 78 86 13 77 ext +33    olivier.glehen@chu-lyon.fr    Contact: Isabelle BONNEFOY    4 78 86 59 84 ext +33    isabelle.bonnefoy01@chu-lyon.fr    Principal Investigator: Olivier GLEHEN, MD          Service de Chirurgie Viscérale, CHU de Poitiers Recruiting Poitiers, France, 86021 Contact: Michel CARRETIER, MD          Principal Investigator: Michel CARRETIER, MD          Service de Chirurgie Générale et Viscérale, CHU de Reims - Hôpital Robert Debré Recruiting Reims, France, 51092 Contact: Sophie LARDIERE-DEGUELTE, MD          Principal Investigator: Sophie LARDIERE-DEGUELTE, MD          Service de Chirurgie Digestive et de Physiologie Digestive, Hôpital Ch. Nicolle Recruiting Rouen, France, 76031 Principal Investigator: Jean-Jacques TUECH, MD          Sub-Investigator: Pierre MICHEL, MD          Service de Chirurgie Digestive, Hôpital Nord Recruiting Saint-Etienne, France, 42055 Principal Investigator: Jack PORCHERON, MD          Service de Chirurgie Viscérale et Digestive, Hôpital de Hautepierre Recruiting Strasbourg, France, 67200 Principal Investigator: Cécile BRIGAND, MD          Service de Chirurgie Générale et Digestive, Hôpital Purpan Recruiting Toulouse, France, 31059 Principal Investigator: Nicolas CARRERE, MD          Service de Chirurgie Digestive Oncologique, CLCC Alexis Vautrin Recruiting Vandoeuvre lès Nancy, France, 54511 Principal Investigator: Frédéric MARCHAL, MD          Département de Chirurgie Digestive et Hépatobiliaire, Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Diane GOERE, MD          Principal Investigator: Diane GOERE, MD          Spain Hospital Universitario Principe de Asturias Recruiting Alcalá de Henares, Spain, 28805 Contact: Alberto Jose GUITERREZ CALVO, MD          Principal Investigator: Alberto Jose GUITERREZ CALVO, MD          Hospital Sant Joan Despí Moises Broggi Recruiting Barcelona, Spain, 08970 Contact: Pedro BARRIOS SANCHEZ, MD          Principal Investigator: Pedro BARRIOS SANCHEZ, MD          Md Anderson Cancer Center Recruiting Madrid, Spain, 28033 Contact: Santiago GONZALEZ MORENO, MD          Principal Investigator: Santiago GONZALEZ MORENO, MD          Fundación Jiménez Díaz Hospital Recruiting Madrid, Spain, 28040 Contact: Delia CORTES GUIRAL, MD          Principal Investigator: Delia CORTES GUIRAL, MD          Hospital Universitario de La Paz Recruiting Madrid, Spain, 28046 Contact: Maria Isabel PRIETO NIETO, MD          Principal Investigator: Maria Isabel PRIETO NIETO, MD          Hospital Universitario de Fuenlabrada Recruiting Madrid, Spain, 28942 Contact: Israel MANZANEDO ROMERO, MD          Principal Investigator: Israel MANZANEDO ROMERO, MD Less <<
NCT00755118 Colorectal Cancer Phase 2 Terminated(Due to poor Accrual... More >>) Less << - Greece ... More >> University Hospital of Crete, Dep of Medical Oncology Heraklion, Crete, Greece University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Less <<
NCT00166465 Locally Advanced Unresectable ... More >>or Stage IV Colorectal Cancer Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01811277 Biliary Tract Cancer ... More >> Periampullary Adenocarcinoma Pancreatic Cancer Less << Phase 2 Unknown July 2014 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Lin Shen, Prof.    +86 10 88196175    lin100@medmail.com.cn    Contact: Jie Li, Prof.    +86 10 88196561    xiaotong10241@sina.com Less <<
NCT00561470 Colorectal Neoplasms ... More >> Neoplasm Metastasis Less << Phase 3 Completed - -
NCT00278889 - Completed - -
NCT00062426 Colorectal Cancer Phase 3 Completed - -
NCT00613080 Colorectal Cancer Phase 2 Completed - -
NCT00561470 - Completed - -
NCT00278889 Colorectal Cancer Phase 2 Completed - -
NCT00034619 Colorectal Cancer Phase 2 Completed - United States, Alabama ... More >> "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Huntsville, Alabama, United States United States, Massachusetts "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Pittsfield, Massachusetts, United States United States, Michigan "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Kalamazoo, Michigan, United States United States, New York "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Latham, New York, United States United States, North Carolina "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Asheville, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Goldsboro, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Hendersonville, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Winston-Salem, North Carolina, United States United States, Ohio "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Columbus, Ohio, United States United States, Oregon "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Bend, Oregon, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Portland, Oregon, United States United States, Pennsylvania "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Philadelphia, Pennsylvania, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Pittsburgh, Pennsylvania, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Reading, Pennsylvania, United States United States, South Carolina "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Charleston, South Carolina, United States United States, Utah "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Ivins, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Ogden, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Provo, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" St. George, Utah, United States United States, Washington "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Bellevue, Washington, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Seattle, Washington, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Spokane, Washington, United States Less <<
NCT00714077 - Unknown June 2018 China, Beijing ... More >> Jing Jin Recruiting Beijing, Beijing, China, 100021 Contact: Jing Jin, M.D.    8610-87788280    jingjin1025@163.com    Contact: Yexiong Li, M.D.    8610-87788860    yexiong12@163.com    Principal Investigator: Jing Jin, M.D.;Ph.D          Jing Jin Recruiting Beijing, Beijing, China, 100021 Contact: Jing Jin, M.D.    8610-87788280    jingjin25@yahoo.com.cn    Contact: Yexiong Li, M.D.    8610-87788860    yexiong3@yahoo.com.cn    Principal Investigator: Jing Jin, M.D.;Ph.D Less <<
NCT01871571 Mucinous Adenocarcinoma of the... More >> Rectum Signet Ring Adenocarcinoma of the Rectum Stage IIA Rectal Cancer Stage IIB Rectal Cancer Stage IIC Rectal Cancer Stage IIIA Rectal Cancer Stage IIIB Rectal Cancer Stage IIIC Rectal Cancer Less << Phase 2 Active, not recruiting August 2, 2020 United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00613080 - Completed - -
NCT00083616 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - -
NCT00083616 - Completed - -
NCT01289821 Colorectal Neoplasms Phase 2 Completed - United States, Illinois ... More >> Chicago, Illinois, United States, 60611-2906 Australia, New South Wales Concord, New South Wales, Australia, 2139 Australia, South Australia Woodville South, South Australia, Australia, 5011 Belgium Bruxelles - Brussel, Belgium, 1070 Edegem, Belgium, 2650 Leuven, Belgium, 3000 Germany Stuttgart, Baden-Württemberg, Germany, 70199 Oldenburg, Niedersachsen, Germany, 26133 Herne, Nordrhein-Westfalen, Germany, 44625 Dresden, Sachsen, Germany, 01307 Italy Napoli, Campania, Italy, 80131 Genova, Liguria, Italy, 16132 Ancona, Marche, Italy, 60126 Spain Santander, Cantabria, Spain, 39008 Barcelona, Spain, 08035 Madrid, Spain, 28034 United Kingdom Glasgow, United Kingdom, G12 0YN Manchester, United Kingdom, M20 4BX Less <<
NCT00436241 Gastric Cancer Phase 2 Completed - Taiwan ... More >> Chai Yi, Taiwan, 613 Chai Yi, Taiwan, 622 Kaohsiung, Taiwan, 807 Keelung, Taiwan, 204 Taichung, Taiwan, 404 Taichung, Taiwan, 407 Tainan, Taiwan, 704 Tainan, Taiwan, 710 Taipei, Taiwan, 00112 Taipei, Taiwan, 106 Taipei, Taiwan, 110 Taoyuan, Taiwan, 333 Yilan, Taiwan, 265 Less <<
NCT02970916 Metastatic Colorectal Cancer Phase 2 Active, not recruiting May 2019 Spain ... More >> Spanish Cooperative Group for the Treatment of Digestive Tumors Madrona, Spain, 28007 Less <<
NCT03291899 Biliary Tract Cancer Phase 2 Recruiting August 2020 Saudi Arabia ... More >> king Faisal Specialist Hospital and Research Center Recruiting Riyadh, Saudi Arabia, 11211 Contact: Shouki Bazarbashi, MBBS    966505443546    bazarbashi@gmail.com Less <<
NCT02635971 Carcinoma, Pancreatic Phase 2 Not yet recruiting - China, Shanghai ... More >> Fudan University Shanghai Cancer Center Active, not recruiting Shanghai, Shanghai, China, 200032 Less <<
NCT01952951 Rectal Neoplasms ... More >> Adenocarcinoma Less << Phase 2 Active, not recruiting December 2019 Korea, Republic of ... More >> National Cancer Center Goyang, Gyeonggi-do, Korea, Republic of, 410-769 Seoul National University Bundang Hospital Seongnam, Gyeonggi-do, Korea, Republic of, 13620 Hallym University Sacred Heart Hospital Anyang, Korea, Republic of Gangneung Asan Hospital Gangneung, Korea, Republic of Severance Hospital Seoul, Korea, Republic of, 03722 Asan Medical Center Seoul, Korea, Republic of, 05505 Chung-Ang University Hospital Seoul, Korea, Republic of, 06973 Less <<
NCT00051688 Colorectal Neoplasms Phase 2 Terminated - United States, Arizona ... More >> ACRC/Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, California USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Comprehensive Cancer Centers of the Desert Palm Springs, California, United States, 92262 Cancer Institute Medical Group Santa Monica, California, United States, 90404 United States, District of Columbia Georgetown University Medical Center, Lombardi Cancer Center Washington, District of Columbia, United States, 20007 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612-9497 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, Missouri Kansas City Oncology and Hematology Group Kansas City, Missouri, United States, 64111 Less <<
NCT01289821 - Completed - -
NCT06196554 Gastric Cancer|Organoid|Neoadj... More >>uvant Therapy Less << RECRUITING 2024-06-28 Department of Pancreatic and G... More >>astric Surgical Oncology, National Cancer Center/ National Clinical Research for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China Less <<
NCT05611034 Lung Metastases|Colorectal Can... More >>cer Metastatic|Colorectal Cancer Less << PHASE1 RECRUITING 2032-01-01 University Health Network, Tor... More >>onto General Hospital, Toronto, Ontario, M5G 2C4, Canada Less <<
NCT05056389 Peritoneal Metastases|Colo-rec... More >>tal Cancer Less << PHASE1 UNKNOWN 2023-06-30 The Norwegian, Radium Hospital... More >>, Oslo University Hospital, Oslo, 0379, Norway Less <<
NCT00846482 Colon Cancer|Rectal Cancer COMPLETED 2025-12-18 Montefiore Medical Center - We... More >>iler Campus, Bronx, New York, 10461, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, 10467, United States Less <<
NCT04169347 Colorectal Cancer Metastatic PHASE2 UNKNOWN 2025-01-25 University of Arizona Cancer C... More >>enter, Tucson, Arizona, 85724, United States|Yale Cancer Center, New Haven, Connecticut, 06520, United States|Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, 33140, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, 52242, United States|Kansas University Cancer Center, Westwood, Kansas, 66205, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, 10016, United States|Swedish Cancer Institute, Seattle, Washington, 98104, United States Less <<
NCT00336583 Non-Hodgkin's Lymphoma PHASE2 COMPLETED 2025-01-08 Asan Medical Center, Seoul, 13... More >>8-736, Korea, Republic of Less <<
NCT00259363 Rectal Neoplasms PHASE1|PHASE2 TERMINATED - Sanofi-Aventis, Barcelona, Spa... More >>in Less <<
NCT00047177 Brain and Central Nervous Syst... More >>em Tumors Less << PHASE2 COMPLETED 2025-07-07 UCSF Comprehensive Cancer Cent... More >>er, San Francisco, California, 94115, United States|Children's National Medical Center, Washington, District of Columbia, 20010-2970, United States|Children's Memorial Hospital - Chicago, Chicago, Illinois, 60614, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Duke Comprehensive Cancer Center, Durham, North Carolina, 27710, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104-4318, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105-2794, United States|Texas Children's Cancer Center, Houston, Texas, 77030-2399, United States|Children's Hospital and Regional Medical Center - Seattle, Seattle, Washington, 98105, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.52mL

0.50mL

0.25mL

12.59mL

2.52mL

1.26mL

25.17mL

5.03mL

2.52mL

References

[1]Arango D, Wilson AJ, Shi Q, Corner GA, Arañes MJ, Nicholas C, Lesser M, Mariadason JM, Augenlicht LH. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br J Cancer. 2004 Nov 29;91(11):1931-46. doi: 10.1038/sj.bjc.6602215. PMID: 15545975; PMCID: PMC2409767.

[2]Balin-Gauthier D, Delord JP, Rochaix P, Mallard V, Thomas F, Hennebelle I, Bugat R, Canal P, Allal C. In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR. Cancer Chemother Pharmacol. 2006 Jun;57(6):709-18. doi: 10.1007/s00280-005-0123-3. Epub 2005 Dec 1. PMID: 16320055.

[3]Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K, Fojo T. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. Biochem Pharmacol. 1996 Dec 24;52(12):1855-65. doi: 10.1016/s0006-2952(97)81490-6. PMID: 8951344.

[4]Lu M, Zessin AS, Glover W, Hsu DS. Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis. PLoS One. 2017 Jan 6;12(1):e0169439. doi: 10.1371/journal.pone.0169439. PMID: 28060954; PMCID: PMC5218497.

[5]Bu Y, Jia QA, Ren ZG, Zhang JB, Jiang XM, Liang L, Xue TC, Zhang QB, Wang YH, Zhang L, Xie XY, Tang ZY. Maintenance of stemness in oxaliplatin-resistant hepatocellular carcinoma is associated with increased autocrine of IGF1. PLoS One. 2014 Mar 14;9(3):e89686. doi: 10.1371/journal.pone.0089686. PMID: 24632571; PMCID: PMC3954560.

[6]Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Sun J, Tan CJ, Dai Z. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opin Investig Drugs. 2009 Nov;18(11):1595-604. doi: 10.1517/13543780903292626. PMID: 19780708.

[7]Misset JL, Bleiberg H, Sutherland W, Bekradda M, Cvitkovic E. Oxaliplatin clinical activity: a review. Crit Rev Oncol Hematol. 2000 Aug;35(2):75-93. doi: 10.1016/s1040-8428(00)00070-6. PMID: 10936465.

 

Historical Records

Categories

Inhibitors/Agonists
Apoptosis
Apoptosis Inducer
Inhibitors/Agonists
Cell Cycle
DNA/RNA Synthesis
Inhibitors/Agonists
DNA Damage
DNA Alkylator/Crosslinker
Inhibitors/Agonists
DNA Damage
DNA/RNA Synthesis
Inhibitors/Agonists
Other Inhibitors/Agonists
Anti-tumor

Tags: Oxaliplatin | DNA/RNA Synthesis | apoptosis | DNA cross-links | L-OHP | platinum-based chemotherapy | DNA adducts | 61825-94-3